Citrus Sinensis ID: 047619
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 430 | 2.2.26 [Sep-21-2011] | |||||||
| O81832 | 783 | G-type lectin S-receptor- | yes | no | 0.993 | 0.545 | 0.518 | 1e-131 | |
| O81833 | 815 | G-type lectin S-receptor- | no | no | 0.990 | 0.522 | 0.490 | 1e-119 | |
| Q09092 | 857 | Putative serine/threonine | N/A | no | 0.995 | 0.499 | 0.416 | 1e-111 | |
| Q9ZT07 | 833 | G-type lectin S-receptor- | no | no | 0.997 | 0.515 | 0.433 | 1e-110 | |
| Q9SXB8 | 842 | G-type lectin S-receptor- | no | no | 0.981 | 0.501 | 0.420 | 1e-105 | |
| Q9LPZ3 | 845 | G-type lectin S-receptor- | no | no | 0.997 | 0.507 | 0.419 | 1e-103 | |
| Q9SXB4 | 820 | G-type lectin S-receptor- | no | no | 0.948 | 0.497 | 0.424 | 1e-100 | |
| Q9SXB5 | 820 | G-type lectin S-receptor- | no | no | 0.979 | 0.513 | 0.421 | 1e-99 | |
| Q9LPZ9 | 830 | G-type lectin S-receptor- | no | no | 0.983 | 0.509 | 0.417 | 2e-97 | |
| Q9SYA0 | 804 | G-type lectin S-receptor- | no | no | 0.965 | 0.516 | 0.418 | 1e-96 |
| >sp|O81832|Y4729_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290 OS=Arabidopsis thaliana GN=At4g27290 PE=3 SV=4 | Back alignment and function desciption |
|---|
Score = 467 bits (1201), Expect = e-131, Method: Compositional matrix adjust.
Identities = 237/457 (51%), Positives = 310/457 (67%), Gaps = 30/457 (6%)
Query: 1 MKLGWDLKTGLERRITSWKSPDDPSPGNFTWAVERQDNPELIMWKGSRKFHRGGPWNGL- 59
MK G + TGL R +TSW++ DDPS GN+T ++ P+ + K S R GPWNGL
Sbjct: 162 MKYGLNFVTGLNRFLTSWRAIDDPSTGNYTNKMDPNGVPQFFLKKNSVVVFRTGPWNGLR 221
Query: 60 -----------------VFNEDELYYTFDMTDKDVFSRIVMNQTLYVRHQFTWDKATQSW 102
VF E+E+YYT+ + + V +R+ +N + ++TW QSW
Sbjct: 222 FTGMPNLKPNPIYRYEYVFTEEEVYYTYKLENPSVLTRMQLNPNGAL-QRYTWVDNLQSW 280
Query: 103 ELYANVPRDLCDTYALCGDYGICIISDTPFCQCLKGFKPKS-RGYV--DWSQGCVRDKSL 159
Y + D CD Y LCG YG C I+++P C+CLKGF K+ + +V DWS+GCVR L
Sbjct: 281 NFYLSAMMDSCDQYTLCGSYGSCNINESPACRCLKGFVAKTPQAWVAGDWSEGCVRRVKL 340
Query: 160 NYST-QDGFIKFTELKLPDATSSWVSKSMNLYECQDKCLDNSSCMAYTNSDIRGEGSGCA 218
+ +DGF+K ++LKLPD +SW K+M+L EC+ CL N +C AY+ DIR G GC
Sbjct: 341 DCGKGEDGFLKISKLKLPDTRTSWYDKNMDLNECKKVCLRNCTCSAYSPFDIRDGGKGCI 400
Query: 219 MWFGDLIDMRSFPDGGQDFYIRMSASELEKTENNRETDQV-----QNMDLELPLFELATI 273
+WFGDLID+R + + GQD Y+R+++SE+E + RE+ +V + DLELP +L T+
Sbjct: 401 LWFGDLIDIREYNENGQDLYVRLASSEIETLQ--RESSRVSSRKQEEEDLELPFLDLDTV 458
Query: 274 ANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH 333
+ AT FS NKLG+GGFGPVYKGTL GQE+AVKRLS+ S QG++E KNE+ L +KLQH
Sbjct: 459 SEATSGFSAGNKLGQGGFGPVYKGTLACGQEVAVKRLSRTSRQGVEEFKNEIKLIAKLQH 518
Query: 334 RNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 393
RNLVK+LG C+ EE++LIYE+ PNKSLDSFIFD+ER + LDW KR II G ARG++YL
Sbjct: 519 RNLVKILGYCVDEEERMLIYEYQPNKSLDSFIFDKERRRELDWPKRVEIIKGIARGMLYL 578
Query: 394 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
H+DSRLRIIHRDLKASNVLLD DMN KISDFGLAR
Sbjct: 579 HEDSRLRIIHRDLKASNVLLDSDMNAKISDFGLARTL 615
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O81833|SD11_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD1-1 OS=Arabidopsis thaliana GN=SD11 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 427 bits (1099), Expect = e-119, Method: Compositional matrix adjust.
Identities = 242/493 (49%), Positives = 307/493 (62%), Gaps = 67/493 (13%)
Query: 1 MKLGWDLKTGLERRITSWKSPDDPSPGNFTWAVERQDNPELIMWKG--SRKFHRGGPWNG 58
MKLG + KT +E ++SWK+ DPSPG+FT +++ + P+LI+ K S +R G WNG
Sbjct: 162 MKLGKNFKTQMEWSLSSWKTLKDPSPGDFTLSLDTRGLPQLILRKNGDSSYSYRLGSWNG 221
Query: 59 LVFN-------EDELY-YTFDMTDKDV----------FSRIVMNQTLYVRHQFTWDKATQ 100
L F E+ L+ Y F + ++V SR+V+N T + H+F K Q
Sbjct: 222 LSFTGAPAMGRENSLFDYKFTSSAQEVNYSWTPRHRIVSRLVLNNTGKL-HRFIQSKQNQ 280
Query: 101 SWELYANVPRDLCDTYALCGDYGICIIS--DTPFCQCLKGFKPKSRGYVDWSQG---CVR 155
W L P D CD Y++CG Y +C I+ +TP C CL+GFKPKS + S+G CV
Sbjct: 281 -WILANTAPEDECDYYSICGAYAVCGINSKNTPSCSCLQGFKPKSGRKWNISRGAYGCVH 339
Query: 156 DKSLNYSTQDGFIKFTELKLPDATSSW--VSKSMNLYECQDKCLDNSSCMAYTNSDIRGE 213
+ N +D F+KF LKLPD + SW M L +C+ KC N SC AY N+DIR
Sbjct: 340 EIPTNCEKKDAFVKFPGLKLPDTSWSWYDAKNEMTLEDCKIKCSSNCSCTAYANTDIREG 399
Query: 214 GSGCAMWFGDLIDMRSFPDGGQDFYIRMSASELE-------------------------- 247
G GC +WFGDL+DMR + GQD YIRM +++E
Sbjct: 400 GKGCLLWFGDLVDMREYSSFGQDVYIRMGFAKIEFKGREVVGMVVGSVVAIAVVLVVVFA 459
Query: 248 ----------KTENNRETDQVQNMDLELPLFELATIANATDNFSINNKLGEGGFGPVYKG 297
+ EN R+ ++ DL+LP+F+ TI+ ATD+FS N LG GGFGPVYKG
Sbjct: 460 CFRKKIMKRYRGENFRKG--IEEEDLDLPIFDRKTISIATDDFSYVNFLGRGGFGPVYKG 517
Query: 298 TLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVP 357
L DGQEIAVKRLS S QG++E KNEV L +KLQHRNLV+LLGCCIQGEE +LIYE++P
Sbjct: 518 KLEDGQEIAVKRLSANSGQGVEEFKNEVKLIAKLQHRNLVRLLGCCIQGEECMLIYEYMP 577
Query: 358 NKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDM 417
NKSLD FIFD+ R LDW KR +II G ARG++YLHQDSRLRIIHRDLKA NVLLD DM
Sbjct: 578 NKSLDFFIFDERRSTELDWKKRMNIINGVARGILYLHQDSRLRIIHRDLKAGNVLLDNDM 637
Query: 418 NPKISDFGLARAF 430
NPKISDFGLA++F
Sbjct: 638 NPKISDFGLAKSF 650
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q09092|SRK6_BRAOE Putative serine/threonine-protein kinase receptor OS=Brassica oleracea var. acephala GN=SRK6 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 401 bits (1030), Expect = e-111, Method: Compositional matrix adjust.
Identities = 213/512 (41%), Positives = 301/512 (58%), Gaps = 84/512 (16%)
Query: 1 MKLGWDLKTGLERRITSWKSPDDPSPGNFTWAVERQDNPELIMWKGSRKFHRGGPWNGLV 60
MKLG++LKTGL R +TSW+S DDPS GNF++ +E Q PE + + + HR GPWNG+
Sbjct: 169 MKLGYNLKTGLNRFLTSWRSSDDPSSGNFSYKLETQSLPEFYLSRENFPMHRSGPWNGIR 228
Query: 61 F------------------NEDELYYTFDMTDKDVFSRIVMNQTLYVRHQFTWDKATQSW 102
F N +E+ YTF MT+ +SR+ + Y + TW + + W
Sbjct: 229 FSGIPEDQKLSYMVYNFIENNEEVAYTFRMTNNSFYSRLTLISEGYF-QRLTWYPSIRIW 287
Query: 103 ELYANVPRD-LCDTYALCGDYGICIISDTPFCQCLKGFKPKSRGYVD---WSQGCVRDKS 158
+ + P D CDTY +CG Y C ++ +P C C++GF P++ D W+ GC+R
Sbjct: 288 NRFWSSPVDPQCDTYIMCGPYAYCDVNTSPVCNCIQGFNPRNIQQWDQRVWAGGCIRRTQ 347
Query: 159 LNYSTQDGFIKFTELKLPDATSSWVSKSMNLYECQDKCLDNSSCMAYTNSDIRGEGSGCA 218
L+ S DGF + ++KLP+ T + V +S+ + EC+ +C+ + +C A+ N+DIR GSGC
Sbjct: 348 LSCSG-DGFTRMKKMKLPETTMATVDRSIGVKECKKRCISDCNCTAFANADIRNGGSGCV 406
Query: 219 MWFGDLIDMRSFPDG---GQDFYIRM---------------------------------- 241
+W L D+R++ GQD Y+R+
Sbjct: 407 IWTERLEDIRNYATDAIDGQDLYVRLAAADIAKKRNASGKIISLTVGVSVLLLLIMFCLW 466
Query: 242 ---------SASELEKTENNRE--------------TDQVQNMDLELPLFELATIANATD 278
SA + T+ N+ + + + +LELPL E+ T+ AT+
Sbjct: 467 KRKQKRAKASAISIANTQRNQNLPMNEMVLSSKREFSGEYKFEELELPLIEMETVVKATE 526
Query: 279 NFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK 338
NFS NKLG+GGFG VYKG L+DG+EIAVKRLSK S QG E NEV L ++LQH NLV+
Sbjct: 527 NFSSCNKLGQGGFGIVYKGRLLDGKEIAVKRLSKTSVQGTDEFMNEVTLIARLQHINLVQ 586
Query: 339 LLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSR 398
+LGCCI+G+EK+LIYE++ N SLDS++F + R L+W++RF I G ARG++YLHQDSR
Sbjct: 587 VLGCCIEGDEKMLIYEYLENLSLDSYLFGKTRRSKLNWNERFDITNGVARGLLYLHQDSR 646
Query: 399 LRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
RIIHRDLK SN+LLD++M PKISDFG+AR F
Sbjct: 647 FRIIHRDLKVSNILLDKNMIPKISDFGMARIF 678
|
Involved in sporophytic self-incompatibility system (the inability of flowering plants to achieve self-fertilization), probably acting in combination with S-locus-specific glycoproteins. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain. Brassica oleracea var. acephala (taxid: 3713) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 397 bits (1021), Expect = e-110, Method: Compositional matrix adjust.
Identities = 222/512 (43%), Positives = 299/512 (58%), Gaps = 83/512 (16%)
Query: 1 MKLGWDLKTGLERRITSWKSPDDPSPGNFTWAVERQDNPELIMWKGSRKFHRGGPWNG-- 58
M+LG+ K GL+R +TSWKS DP G+ +ER+ P+LI++KG + R G W G
Sbjct: 155 MRLGFTRKDGLDRSLTSWKSHGDPGSGDLILRMERRGFPQLILYKGVTPWWRMGSWTGHR 214
Query: 59 ----------------LVFNEDELYYTFDMTDKDVFSRIVMNQTLYVRHQFTWDKATQSW 102
V NEDE+ +T+ +TD V +R ++N+T + H+FTW + W
Sbjct: 215 WSGVPEMPIGYIFNNSFVNNEDEVSFTYGVTDASVITRTMVNETGTM-HRFTWIARDKRW 273
Query: 103 ELYANVPRDLCDTYALCGDYGIC--IISDTPFCQCLKGFKPK-SRGYV--DWSQGCVRDK 157
+ +VP++ CD YA CG G C S T C CL GF+PK R + D S GC + K
Sbjct: 274 NDFWSVPKEQCDNYAHCGPNGYCDSPSSKTFECTCLPGFEPKFPRHWFLRDSSGGCTKKK 333
Query: 158 SLNY-STQDGFIKFTELKLPDATSSWVSKSMNLYECQDKCLDNSSCMAYTNS--DIRGEG 214
+ S +DGF+K +K+PD + + V ++ L EC+ +CL N SC+AY ++ + +
Sbjct: 334 RASICSEKDGFVKLKRMKIPDTSDASVDMNITLKECKQRCLKNCSCVAYASAYHESKRGA 393
Query: 215 SGCAMWFGDLIDMRSFPDGGQDFYIRMSASEL---------------------------- 246
GC W G ++D R++ + GQDFYIR+ EL
Sbjct: 394 IGCLKWHGGMLDARTYLNSGQDFYIRVDKEELARWNRNGLSGKRRVLLILISLIAAVMLL 453
Query: 247 ---------EKTENNRETDQVQNM-------------------DLELPLFELATIANATD 278
E+ ++NR N + ELPLF+L TI AT+
Sbjct: 454 TVILFCVVRERRKSNRHRSSSANFAPVPFDFDESFRFEQDKARNRELPLFDLNTIVAATN 513
Query: 279 NFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK 338
NFS NKLG GGFGPVYKG L + EIAVKRLS+ S QG++E KNEV L SKLQHRNLV+
Sbjct: 514 NFSSQNKLGAGGFGPVYKGVLQNRMEIAVKRLSRNSGQGMEEFKNEVKLISKLQHRNLVR 573
Query: 339 LLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSR 398
+LGCC++ EEK+L+YE++PNKSLD FIF +E+ LDW KR I+ G ARG++YLHQDSR
Sbjct: 574 ILGCCVELEEKMLVYEYLPNKSLDYFIFHEEQRAELDWPKRMEIVRGIARGILYLHQDSR 633
Query: 399 LRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
LRIIHRDLKASN+LLD +M PKISDFG+AR F
Sbjct: 634 LRIIHRDLKASNILLDSEMIPKISDFGMARIF 665
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB8|Y1133_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330 OS=Arabidopsis thaliana GN=At1g11330 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 382 bits (980), Expect = e-105, Method: Compositional matrix adjust.
Identities = 216/514 (42%), Positives = 287/514 (55%), Gaps = 92/514 (17%)
Query: 1 MKLGWDLKTGLERRITSWKSPDDPSPGNFTWAVERQDNPELIMWKGSRKFHRGGPWNGLV 60
M LG D +TG ++TSW S DDPS GN+T + PEL++WK + R GPWNG V
Sbjct: 169 MTLGTDGRTGGNLKLTSWTSHDDPSTGNYTAGIAPFTFPELLIWKNNVPTWRSGPWNGQV 228
Query: 61 F----NEDELYY----TFDMTDKDVFSRIVMNQTLY---------VRHQFTWDKATQSWE 103
F N D L + + ++ S N + + +Q W + ++W
Sbjct: 229 FIGLPNMDSLLFLDGFNLNSDNQGTISMSYANDSFMYHFNLDPEGIIYQKDWSTSMRTWR 288
Query: 104 LYANVPRDLCDTYALCGDYGICIISDTPFCQCLKGFKPKSR---GYVDWSQGCVRDKSLN 160
+ P CD Y CG +G C + P C+C+KGF PK+ +WS GC+R L
Sbjct: 289 IGVKFPYTDCDAYGRCGRFGSCHAGENPPCKCVKGFVPKNNTEWNGGNWSNGCMRKAPLQ 348
Query: 161 YSTQ------------DGFIKFTELKLP-DATSSWVSKSMNLYECQDKCLDNSSCMAYTN 207
Q DGF+K ++K+P A S S+ + C CLDN SC AY
Sbjct: 349 CERQRNVSNGGGGGKADGFLKLQKMKVPISAERSEASEQV----CPKVCLDNCSCTAYAY 404
Query: 208 SDIRGEGSGCAMWFGDLIDMRSFPDGGQDFYIRMSASEL--------------------- 246
G GC +W GDL+DM+SF G D +IR++ SEL
Sbjct: 405 D----RGIGCMLWSGDLVDMQSFLGSGIDLFIRVAHSELKTHSNLAVMIAAPVIGVMLIA 460
Query: 247 ------------------------------EKTENNRETDQVQNMDLELPLFELATIANA 276
E ++ E+ Q ELPLFE +A +
Sbjct: 461 AVCVLLACRKYKKRPAPAKDRSAELMFKRMEALTSDNESASNQIKLKELPLFEFQVLATS 520
Query: 277 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 336
TD+FS+ NKLG+GGFGPVYKG L +GQEIAVKRLS+ S QGL+EL NEV++ SKLQHRNL
Sbjct: 521 TDSFSLRNKLGQGGFGPVYKGKLPEGQEIAVKRLSRKSGQGLEELMNEVVVISKLQHRNL 580
Query: 337 VKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 396
VKLLGCCI+GEE++L+YE++P KSLD+++FD + KILDW RF+I+ G RG++YLH+D
Sbjct: 581 VKLLGCCIEGEERMLVYEYMPKKSLDAYLFDPMKQKILDWKTRFNIMEGICRGLLYLHRD 640
Query: 397 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
SRL+IIHRDLKASN+LLD+++NPKISDFGLAR F
Sbjct: 641 SRLKIIHRDLKASNILLDENLNPKISDFGLARIF 674
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LPZ3|Y1141_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11410 OS=Arabidopsis thaliana GN=At1g11410 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 375 bits (964), Expect = e-103, Method: Compositional matrix adjust.
Identities = 217/517 (41%), Positives = 304/517 (58%), Gaps = 88/517 (17%)
Query: 1 MKLGWDLKTGLERRITSWKSPDDPSPGNFTWAVERQDNPELIMWKGSRKFHRGGPWNG-- 58
MK G+ ++G++R +TSW+SP DP GN T+ +ER+ P+++M+KG + R G W G
Sbjct: 158 MKFGFTRQSGVDRIMTSWRSPGDPGSGNITYRIERRGFPQMMMYKGLTLWWRTGSWTGQR 217
Query: 59 ----------------LVFNEDELYYTFDMTDKDVFSRIVMNQTLYVRHQFTWDKATQSW 102
V N DE+ T+ + D V +R+V+N+T ++ +F W+ + W
Sbjct: 218 WSGVPEMTNKFIFNISFVNNPDEVSITYGVLDASVTTRMVLNETGTLQ-RFRWNGRDKKW 276
Query: 103 ELYANVPRDLCDTYALCGDYGICIISDTPF--CQCLKGFKPKS-RGYV--DWSQGCVRDK 157
+ + P D CD Y CG G C + T C CL G++PK+ R + D S GC R K
Sbjct: 277 IGFWSAPEDKCDIYNHCGFNGYCDSTSTEKFECSCLPGYEPKTPRDWFLRDASDGCTRIK 336
Query: 158 SLNY-STQDGFIKFTELKLPDATSSWVSKSMNLYECQDKCLDNSSCMAYTNS--DIRGEG 214
+ + + ++GF K +K+P+ ++ V ++ L EC+ +CL N SC+AY ++ + +
Sbjct: 337 ADSICNGKEGFAKLKRVKIPNTSAVNVDMNITLKECEQRCLKNCSCVAYASAYHESQDGA 396
Query: 215 SGCAMWFGDLIDMRSFPDGGQDFYIRMSASEL---------------------------- 246
GC W G+++D R++ GQDFY+R+ SEL
Sbjct: 397 KGCLTWHGNMLDTRTYLSSGQDFYLRVDKSELARWNGNGASGKKRLVLILISLIAVVMLL 456
Query: 247 ------------EKTENNR---------------------ETDQVQNMDLELPLFELATI 273
++T++NR E + ++ ELPLFEL+TI
Sbjct: 457 LISFHCYLRKRRQRTQSNRLRKAPSSFAPSSFDLEDSFILEELEDKSRSRELPLFELSTI 516
Query: 274 ANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH 333
A AT+NF+ NKLG GGFGPVYKG L +G EIAVKRLSK S QG++E KNEV L SKLQH
Sbjct: 517 ATATNNFAFQNKLGAGGFGPVYKGVLQNGMEIAVKRLSKSSGQGMEEFKNEVKLISKLQH 576
Query: 334 RNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 393
RNLV++LGCC++ EEK+L+YE++PNKSLD FIF +E+ LDW KR II G RG++YL
Sbjct: 577 RNLVRILGCCVEFEEKMLVYEYLPNKSLDYFIFHEEQRAELDWPKRMGIIRGIGRGILYL 636
Query: 394 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
HQDSRLRIIHRDLKASNVLLD +M PKI+DFGLAR F
Sbjct: 637 HQDSRLRIIHRDLKASNVLLDNEMIPKIADFGLARIF 673
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB4|Y1130_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11300 OS=Arabidopsis thaliana GN=At1g11300 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 366 bits (939), Expect = e-100, Method: Compositional matrix adjust.
Identities = 209/492 (42%), Positives = 276/492 (56%), Gaps = 84/492 (17%)
Query: 15 ITSWKSPDDPSPGNFTWAVERQDNPELIMWKGSRKFH---RGGPWNGLVFN------EDE 65
ITSWKSP DPSPG++T A+ PEL + + R GPWNG +FN
Sbjct: 176 ITSWKSPSDPSPGSYTAALVLAAYPELFIMNNNNNNSTVWRSGPWNGQMFNGLPDVYAGV 235
Query: 66 LYYTF---DMTDKDVFSRIVMNQTL---YVRHQFT-----WDKATQSWELYANVPRDLCD 114
Y F D T+ V + TL Y+ ++ + W + ++W + VP CD
Sbjct: 236 FLYRFIVNDDTNGSVTMSYANDSTLRYFYMDYRGSVIRRDWSETRRNWTVGLQVPATECD 295
Query: 115 TYALCGDYGICIISDTPFCQCLKGFKPKSR---GYVDWSQGCVRDKSL------NYSTQD 165
Y CG++ C P C C++GF+P++ +WS GC R L N + D
Sbjct: 296 NYRRCGEFATCNPRKNPLCSCIRGFRPRNLIEWNNGNWSGGCTRRVPLQCERQNNNGSAD 355
Query: 166 GFIKFTELKLPD-ATSSWVSKSMNLYECQDKCLDNSSCMAYTNSDIRGEGSGCAMWFGDL 224
GF++ +KLPD A S S+ EC CL SC+A + G G GC +W G L
Sbjct: 356 GFLRLRRMKLPDFARRSEASEP----ECLRTCLQTCSCIAAAH----GLGYGCMIWNGSL 407
Query: 225 IDMRSFPDGGQDFYIRMSASELEKTEN--------------------------------- 251
+D + G D YIR++ SE++ +
Sbjct: 408 VDSQELSASGLDLYIRLAHSEIKTKDKRPILIGTILAGGIFVVAACVLLARRIVMKKRAK 467
Query: 252 --NRETDQV-----------QNMDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGT 298
R+ +Q+ + ELPLFE +A AT+NFS+ NKLG+GGFGPVYKG
Sbjct: 468 KKGRDAEQIFERVEALAGGNKGKLKELPLFEFQVLAAATNNFSLRNKLGQGGFGPVYKGK 527
Query: 299 LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPN 358
L +GQEIAVKRLS+ S QGL+EL NEV++ SKLQHRNLVKLLGCCI GEE++L+YEF+P
Sbjct: 528 LQEGQEIAVKRLSRASGQGLEELVNEVVVISKLQHRNLVKLLGCCIAGEERMLVYEFMPK 587
Query: 359 KSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMN 418
KSLD ++FD R K+LDW RF+II G RG++YLH+DSRLRIIHRDLKASN+LLD+++
Sbjct: 588 KSLDYYLFDSRRAKLLDWKTRFNIINGICRGLLYLHRDSRLRIIHRDLKASNILLDENLI 647
Query: 419 PKISDFGLARAF 430
PKISDFGLAR F
Sbjct: 648 PKISDFGLARIF 659
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB5|Y1135_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11305 OS=Arabidopsis thaliana GN=At1g11305 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 363 bits (933), Expect = 1e-99, Method: Compositional matrix adjust.
Identities = 214/508 (42%), Positives = 283/508 (55%), Gaps = 87/508 (17%)
Query: 1 MKLGWDLKTGLER-RITSWKSPDDPSPGNFTWAVERQDNPELIMWKGS---RKFHRGGPW 56
M +G + +TG ITSW +P DPSPG++T A+ PEL ++ + R GPW
Sbjct: 161 MLVGTNARTGGGNITITSWTNPSDPSPGSYTAALVLAPYPELFIFNNNDNNATVWRSGPW 220
Query: 57 NGLVFNE-DELY-----YTFDMTDKDVFSRIVMNQT--LYVRHQFT----------WDKA 98
NGL+FN ++Y Y F + D D M+ +RH + W +A
Sbjct: 221 NGLMFNGLPDVYPGLFLYRFKVND-DTNGSATMSYANDSTLRHLYLDYRGFAIRRDWSEA 279
Query: 99 TQSWELYANVPRDLCDTYALCGDYGICIISDTPFCQCLKGFKPKSR---GYVDWSQGCVR 155
++W L + VP CD Y+ CG Y C P C C+KGF+P++ +WS GC+R
Sbjct: 280 RRNWTLGSQVPATECDIYSRCGQYTTCNPRKNPHCSCIKGFRPRNLIEWNNGNWSGGCIR 339
Query: 156 DKSL------NYSTQDGFIKFTELKLPD-ATSSWVSKSMNLYECQDKCLDNSSCMAYTNS 208
L N + D F+K +K+PD A S S+ EC CL + SC+A+ +
Sbjct: 340 KLPLQCERQNNKGSADRFLKLQRMKMPDFARRSEASEP----ECFMTCLQSCSCIAFAH- 394
Query: 209 DIRGEGSGCAMWFGDLIDMRSFPDGGQDFYIRMSASE----------------------- 245
G G GC +W L+D + G D IR++ SE
Sbjct: 395 ---GLGYGCMIWNRSLVDSQVLSASGMDLSIRLAHSEFKTQDRRPILIGTSLAGGIFVVA 451
Query: 246 ----------LEKTENNRETDQVQNMDL-------------ELPLFELATIANATDNFSI 282
++K + TD Q ELPLFE +A ATDNFS+
Sbjct: 452 TCVLLARRIVMKKRAKKKGTDAEQIFKRVEALAGGSREKLKELPLFEFQVLATATDNFSL 511
Query: 283 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGC 342
+NKLG+GGFGPVYKG L++GQEIAVKRLS+ S QGL+EL EV++ SKLQHRNLVKL GC
Sbjct: 512 SNKLGQGGFGPVYKGMLLEGQEIAVKRLSQASGQGLEELVTEVVVISKLQHRNLVKLFGC 571
Query: 343 CIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRII 402
CI GEE++L+YEF+P KSLD +IFD K+LDW+ RF II G RG++YLH+DSRLRII
Sbjct: 572 CIAGEERMLVYEFMPKKSLDFYIFDPREAKLLDWNTRFEIINGICRGLLYLHRDSRLRII 631
Query: 403 HRDLKASNVLLDQDMNPKISDFGLARAF 430
HRDLKASN+LLD+++ PKISDFGLAR F
Sbjct: 632 HRDLKASNILLDENLIPKISDFGLARIF 659
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LPZ9|SD113_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD1-13 OS=Arabidopsis thaliana GN=SD113 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 356 bits (914), Expect = 2e-97, Method: Compositional matrix adjust.
Identities = 214/512 (41%), Positives = 285/512 (55%), Gaps = 89/512 (17%)
Query: 1 MKLGWDLKTGLERRITSWKSPDDPSPGNFTWAVERQDNPELIMWKGSRKFHRGGPWNGLV 60
M L D KTG ++ SWKSP DPSPG ++ + PEL++WK R GPWNG
Sbjct: 158 MSLATDTKTGRSLKLRSWKSPFDPSPGRYSAGLIPLPFPELVVWKDDLLMWRSGPWNGQY 217
Query: 61 F----NEDELYYTFDMT-DKDVFSRIVM----NQTLY--------VRHQFTWDKATQSWE 103
F N D F++T D + M N LY Q W+ A Q W+
Sbjct: 218 FIGLPNMDYRINLFELTLSSDNRGSVSMSYAGNTLLYHFLLDSEGSVFQRDWNVAIQEWK 277
Query: 104 LYANVPRDLCDTYALCGDYGICIIS--DTPFCQCLKGFKPKSRGY---VDWSQGCVRDKS 158
+ VP CDTYA CG + C + TP C C++GFKP+S +W+QGCVR
Sbjct: 278 TWLKVPSTKCDTYATCGQFASCRFNPGSTPPCMCIRGFKPQSYAEWNNGNWTQGCVRKAP 337
Query: 159 LNYSTQD---------GFIKFTELKLPDATSSWVSKSMNLYECQDKCLDNSSCMAYTNSD 209
L ++D GF++ ++K+P N +C + CL N SC AY+
Sbjct: 338 LQCESRDNNDGSRKSDGFVRVQKMKVPHNPQR---SGANEQDCPESCLKNCSCTAYSFD- 393
Query: 210 IRGEGSGCAMWFGDLIDMRSFPDGGQDFYIRMSASELEKTEN------------------ 251
G GC +W G+L+DM+ F G FYIR++ SE +K N
Sbjct: 394 ---RGIGCLLWSGNLMDMQEFSGTGVVFYIRLADSEFKKRTNRSIVITVTLLVGAFLFAG 450
Query: 252 ---------------NRET-------DQVQNMDL-----------ELPLFELATIANATD 278
NR T + + + D+ ELPLFE +A AT+
Sbjct: 451 TVVLALWKIAKHREKNRNTRLLNERMEALSSNDVGAILVNQYKLKELPLFEFQVLAVATN 510
Query: 279 NFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK 338
NFSI NKLG+GGFG VYKG L +G +IAVKRLS+ S QG++E NEV++ SKLQHRNLV+
Sbjct: 511 NFSITNKLGQGGFGAVYKGRLQEGLDIAVKRLSRTSGQGVEEFVNEVVVISKLQHRNLVR 570
Query: 339 LLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSR 398
LLG CI+GEE++L+YEF+P LD+++FD + ++LDW RF+II G RG+MYLH+DSR
Sbjct: 571 LLGFCIEGEERMLVYEFMPENCLDAYLFDPVKQRLLDWKTRFNIIDGICRGLMYLHRDSR 630
Query: 399 LRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
L+IIHRDLKASN+LLD+++NPKISDFGLAR F
Sbjct: 631 LKIIHRDLKASNILLDENLNPKISDFGLARIF 662
|
Receptor-like serine/threonine-protein kinase that represses the disease resistance signaling pathway triggered in response to bacterial pathogen such as Pseudomonas syringae pv. tomato. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SYA0|Y1150_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g61500 OS=Arabidopsis thaliana GN=At1g61500 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 353 bits (906), Expect = 1e-96, Method: Compositional matrix adjust.
Identities = 208/497 (41%), Positives = 278/497 (55%), Gaps = 82/497 (16%)
Query: 3 LGWDLKTGLERRITSWKSPDDPSPGNFTWAVERQDNPELIMWKGSRKFHRGGPWNGLVFN 62
L ++L T +R +TSWKS DPSPG+F + Q + + +GS + R GPW F
Sbjct: 158 LTYNLATAEKRVLTSWKSYTDPSPGDFLGQITPQVPSQGFVMRGSTPYWRSGPWAKTRFT 217
Query: 63 ----EDELYYTFDMTDKDV--------------FSRIVMNQTLYVRHQFTWDKATQSWEL 104
DE Y +DV SRI + ++ + WEL
Sbjct: 218 GIPFMDESYTGPFTLHQDVNGSGYLTYFQRDYKLSRITLTSEGSIK---MFRDNGMGWEL 274
Query: 105 YANVPRDLCDTYALCGDYGICIISDTPFCQCLKGFKPKS-----RGYVDWSQGCVRDKSL 159
Y P+ LCD Y CG +G+C++S +P C+C +GF PKS RG +W+ GCVR L
Sbjct: 275 YYEAPKKLCDFYGACGPFGLCVMSPSPMCKCFRGFVPKSVEEWKRG--NWTGGCVRHTEL 332
Query: 160 ----NYSTQDG--FIKFTELKLPDATSSWVSKSMNLYECQDKCLDNSSCMAYTNSDIRGE 213
N + +D F + +K PD + S+N EC +C+ N SC+A+ +
Sbjct: 333 DCLGNSTGEDADDFHQIANIKPPDFYE--FASSVNAEECHQRCVHNCSCLAFAYI----K 386
Query: 214 GSGCAMWFGDLIDMRSFPDGGQDFYIRMSASELEKTENNRETDQVQNM------------ 261
G GC +W DL+D F G+ IR++ SEL+ N R+ V ++
Sbjct: 387 GIGCLVWNQDLMDAVQFSATGELLSIRLARSELDG--NKRKKTIVASIVSLTLFMILGFT 444
Query: 262 ----------------------DLE------LPLFELATIANATDNFSINNKLGEGGFGP 293
DL+ L F++ TI NAT+NFS++NKLG+GGFG
Sbjct: 445 AFGVWRCRVEHIAHISKDAWKNDLKPQDVPGLDFFDMHTIQNATNNFSLSNKLGQGGFGS 504
Query: 294 VYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 353
VYKG L DG+EIAVKRLS S QG +E NE++L SKLQHRNLV++LGCCI+ EEKLLIY
Sbjct: 505 VYKGKLQDGKEIAVKRLSSSSGQGKEEFMNEIVLISKLQHRNLVRVLGCCIEEEEKLLIY 564
Query: 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLL 413
EF+ NKSLD+F+FD + +DW KRF II G ARG++YLH DSRLR+IHRDLK SN+LL
Sbjct: 565 EFMVNKSLDTFLFDSRKRLEIDWPKRFDIIQGIARGLLYLHHDSRLRVIHRDLKVSNILL 624
Query: 414 DQDMNPKISDFGLARAF 430
D+ MNPKISDFGLAR +
Sbjct: 625 DEKMNPKISDFGLARMY 641
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 430 | ||||||
| 224113157 | 786 | predicted protein [Populus trichocarpa] | 0.995 | 0.544 | 0.638 | 1e-171 | |
| 224113153 | 785 | predicted protein [Populus trichocarpa] | 1.0 | 0.547 | 0.638 | 1e-171 | |
| 224124250 | 820 | predicted protein [Populus trichocarpa] | 0.997 | 0.523 | 0.590 | 1e-167 | |
| 224113149 | 820 | predicted protein [Populus trichocarpa] | 0.997 | 0.523 | 0.579 | 1e-166 | |
| 356546914 | 788 | PREDICTED: G-type lectin S-receptor-like | 1.0 | 0.545 | 0.589 | 1e-161 | |
| 224115136 | 843 | predicted protein [Populus trichocarpa] | 1.0 | 0.510 | 0.556 | 1e-154 | |
| 356530645 | 783 | PREDICTED: G-type lectin S-receptor-like | 0.993 | 0.545 | 0.579 | 1e-153 | |
| 449458261 | 814 | PREDICTED: receptor-like serine/threonin | 1.0 | 0.528 | 0.540 | 1e-151 | |
| 449476944 | 1267 | PREDICTED: receptor-like serine/threonin | 1.0 | 0.339 | 0.540 | 1e-150 | |
| 356545293 | 777 | PREDICTED: receptor-like serine/threonin | 0.995 | 0.550 | 0.575 | 1e-150 |
| >gi|224113157|ref|XP_002332644.1| predicted protein [Populus trichocarpa] gi|222832839|gb|EEE71316.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 607 bits (1565), Expect = e-171, Method: Compositional matrix adjust.
Identities = 290/454 (63%), Positives = 353/454 (77%), Gaps = 26/454 (5%)
Query: 1 MKLGWDLKTGLERRITSWKSPDDPSPGNFTWAVERQDNPELIMWKGSRKFHRGGPWNGLV 60
MKLGWDL+TGLERR++SW+S DDPSPG+ TW ++ Q+NPE I+W+GS+++ R GPW G+
Sbjct: 168 MKLGWDLRTGLERRLSSWRSSDDPSPGDLTWGIKLQNNPETIIWRGSQQYFRSGPWTGIA 227
Query: 61 F------------------NEDELYYTFDMTDKDVFSRIVMNQTLYVRHQFTWDKATQSW 102
F +EDE+Y ++++ + FSRIV+NQT R +TW++ATQ+W
Sbjct: 228 FTGAPELVQNPVFKLNFVSSEDEVYLSYNLKNISAFSRIVVNQTTNYREAYTWNEATQTW 287
Query: 103 ELYANVPRDLCDTYALCGDYGICIISDTPFCQCLKGFKPKSR---GYVDWSQGCVRDKSL 159
LYA+VPRD CD YA CG G CII+D P C+CLK FKPKS +DWS GCVR+K L
Sbjct: 288 VLYASVPRDSCDNYASCGANGNCIINDLPICRCLKKFKPKSPEKWNLMDWSDGCVRNKPL 347
Query: 160 NYSTQDGFIKFTELKLPDATSSWVSKSMNLYECQDKCLDNSSCMAYTNSDIRGEGSGCAM 219
N DGF+K+ LK PDAT SW++KSMNL EC+ KCL N SCMAY+NSD+RG GSGC +
Sbjct: 348 NCQKGDGFVKYLGLKWPDATHSWLNKSMNLNECRAKCLQNCSCMAYSNSDVRGGGSGCII 407
Query: 220 WFGDLIDMRSFPDGGQDFYIRMSASELEKTENNRETDQV---QNMDLELPLFELATIANA 276
W+GDLID+R FP GGQ+ YIRM+ SE E +++ DQ+ +N DLELP FE A I NA
Sbjct: 408 WYGDLIDIRQFPAGGQELYIRMNPSE--SAEMDQQNDQITDGENEDLELPQFEFAKIVNA 465
Query: 277 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 336
T+NFSI NKLG+GGFGPVYKGTL DGQEIAVKRLS S QG KE KNEVIL +KLQHRNL
Sbjct: 466 TNNFSIKNKLGQGGFGPVYKGTLEDGQEIAVKRLSMSSRQGSKEFKNEVILINKLQHRNL 525
Query: 337 VKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 396
VKLLGC IQ EE+LL+YE++PNKSLDSF+FDQ + K+LDWSKRF+IICG ARG++YLHQD
Sbjct: 526 VKLLGCSIQREERLLVYEYMPNKSLDSFLFDQTKSKLLDWSKRFNIICGIARGLLYLHQD 585
Query: 397 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
SRLRIIHRDLK+SNVLLD+DMNPKISDFGLAR F
Sbjct: 586 SRLRIIHRDLKSSNVLLDKDMNPKISDFGLARTF 619
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224113153|ref|XP_002332643.1| predicted protein [Populus trichocarpa] gi|222832838|gb|EEE71315.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 607 bits (1564), Expect = e-171, Method: Compositional matrix adjust.
Identities = 288/451 (63%), Positives = 349/451 (77%), Gaps = 21/451 (4%)
Query: 1 MKLGWDLKTGLERRITSWKSPDDPSPGNFTWAVERQDNPELIMWKGSRKFHRGGPWNGLV 60
MKLGWDL+TGLERR++SW+S DDPSPG+ TW ++ Q+NPE I+W+GS+++ R GPW G+
Sbjct: 168 MKLGWDLRTGLERRLSSWRSSDDPSPGDLTWGIKLQNNPETIIWRGSQQYFRSGPWTGIA 227
Query: 61 F------------------NEDELYYTFDMTDKDVFSRIVMNQTLYVRHQFTWDKATQSW 102
F +EDE+Y ++++ + FSRIV+NQT R +TW++ATQ+W
Sbjct: 228 FTGAPELVQNPVFKLNFVSSEDEVYLSYNLKNISAFSRIVVNQTTNYREAYTWNEATQTW 287
Query: 103 ELYANVPRDLCDTYALCGDYGICIISDTPFCQCLKGFKPKSR---GYVDWSQGCVRDKSL 159
LYA+VPRD CD YA CG G CII+D P C+CLK FKPKS +DWS GCVR+K L
Sbjct: 288 VLYASVPRDSCDNYASCGANGNCIINDLPICRCLKKFKPKSPEKWNLMDWSDGCVRNKPL 347
Query: 160 NYSTQDGFIKFTELKLPDATSSWVSKSMNLYECQDKCLDNSSCMAYTNSDIRGEGSGCAM 219
N DGF+K+ LK PDAT SW++KSMNL EC+ KCL N SCMAY+NSD+RG GSGC +
Sbjct: 348 NCQKGDGFVKYLGLKWPDATHSWLNKSMNLNECRAKCLQNCSCMAYSNSDVRGGGSGCII 407
Query: 220 WFGDLIDMRSFPDGGQDFYIRMSASELEKTENNRETDQVQNMDLELPLFELATIANATDN 279
W+G LID+R FP GGQ+ YIRM+ SE E + N + +N DLELP FE A I NAT+N
Sbjct: 408 WYGGLIDIRQFPAGGQELYIRMNPSESEMDQQNDQITDGENEDLELPQFEFAKIVNATNN 467
Query: 280 FSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 339
FSI NKLG+GGFGPVYKGTL DGQEIAVKRLS S QG KE KNEVIL +KLQHRNLVKL
Sbjct: 468 FSIENKLGQGGFGPVYKGTLEDGQEIAVKRLSMSSGQGSKEFKNEVILINKLQHRNLVKL 527
Query: 340 LGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRL 399
LGC IQ EE+LL+YE++PNKSLDSF+FDQ + K+LDWSKRF+IICG ARG++YLHQDSRL
Sbjct: 528 LGCSIQREERLLVYEYMPNKSLDSFLFDQTKSKLLDWSKRFNIICGIARGLLYLHQDSRL 587
Query: 400 RIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
RIIHRDLK+SNVLLD+DMNPKISDFGLAR F
Sbjct: 588 RIIHRDLKSSNVLLDKDMNPKISDFGLARTF 618
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224124250|ref|XP_002319283.1| predicted protein [Populus trichocarpa] gi|222857659|gb|EEE95206.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 595 bits (1533), Expect = e-167, Method: Compositional matrix adjust.
Identities = 290/491 (59%), Positives = 353/491 (71%), Gaps = 62/491 (12%)
Query: 1 MKLGWDLKTGLERRITSWKSPDDPSPGNFTWAVERQDNPELIMWKGSRKFHRGGPWNGLV 60
MKLGWDL+ GL+RR+++WKSPDDPS G+FTW + Q NPEL+MWKGS+K++R GPWNG+
Sbjct: 163 MKLGWDLRIGLDRRLSAWKSPDDPSSGDFTWGTQLQSNPELVMWKGSKKYYRSGPWNGIG 222
Query: 61 F------------------NEDELYYTFDMTDKDVFSRIVMNQTLYVRHQFTWDKATQSW 102
F + +E+YYT+++ +K + +RIVMNQT Y R ++TW++ Q+W
Sbjct: 223 FSGGLALRINPVFYFDFVDDGEEVYYTYNLKNKSLITRIVMNQTTYFRQRYTWNEINQTW 282
Query: 103 ELYANVPRDLCDTYALCGDYGICIISDTPFCQCLKGFKPKSR---GYVDWSQGCVRDKSL 159
LYA VPRD CDTY LCG YG CI+S +P CQCL+ F P+S +DWS+GCVR+K L
Sbjct: 283 VLYATVPRDYCDTYNLCGAYGNCIMSQSPVCQCLEKFTPRSPESWNSMDWSKGCVRNKPL 342
Query: 160 NYSTQDGFIKFTELKLPDATSSWVSKSMNLYECQDKCLDNSSCMAYTNSDIRGEGSGCAM 219
+ DGF+K+ LKLPDAT+SWV+K+MNL EC+ KCL N SCMAYT ++I+ E SGCA+
Sbjct: 343 DCQKGDGFVKYVGLKLPDATNSWVNKTMNLKECRSKCLQNCSCMAYTATNIK-ERSGCAV 401
Query: 220 WFGDLIDMRSFPDGGQDFYIRMSASELEKTE----------------------------- 250
WFGDLID+R F GQ+ YIR++ASE
Sbjct: 402 WFGDLIDIRQFSAAGQEIYIRLNASESRAKAASKIKMTVGSALSIFVACGILLVAYYIFK 461
Query: 251 --------NNRETDQVQN---MDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTL 299
N E DQ+ + DLELPLF+ TIA AT+ FS NNKLGEGGFGPVYKGTL
Sbjct: 462 RKAKHIGGNREENDQIDSGPKEDLELPLFQFTTIAKATNGFSFNNKLGEGGFGPVYKGTL 521
Query: 300 VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNK 359
DGQEIA K LS+ S QGL E KNEVIL +KLQHRNLVKLLGCCIQGEEK+L+YE++PNK
Sbjct: 522 EDGQEIAAKTLSRSSGQGLNEFKNEVILITKLQHRNLVKLLGCCIQGEEKILVYEYMPNK 581
Query: 360 SLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNP 419
SLDSFIFDQ R K+LDWSKRF IICG ARG++YLHQDSRLRI+HRDLKASNVLLD+DMNP
Sbjct: 582 SLDSFIFDQTRGKLLDWSKRFSIICGIARGLLYLHQDSRLRIVHRDLKASNVLLDKDMNP 641
Query: 420 KISDFGLARAF 430
KISDFGLAR F
Sbjct: 642 KISDFGLARMF 652
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224113149|ref|XP_002332642.1| predicted protein [Populus trichocarpa] gi|222832837|gb|EEE71314.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 590 bits (1520), Expect = e-166, Method: Compositional matrix adjust.
Identities = 288/497 (57%), Positives = 354/497 (71%), Gaps = 68/497 (13%)
Query: 1 MKLGWDLKTGLERRITSWKSPDDPSPGNFTWAVERQDNPELIMWKGSRKFHRGGPWNGLV 60
MKLGWDL+ GL+RR+++WKSPDDPS G+FTW + Q NPEL+MWKGS++++R GPWNG+
Sbjct: 157 MKLGWDLRIGLDRRLSAWKSPDDPSSGDFTWGTQLQSNPELVMWKGSKEYYRSGPWNGIG 216
Query: 61 F------------------NEDELYYTFDMTDKDVFSRIVMNQTLYVRHQFTWDKATQSW 102
F + +E+YYT+++ +K + +RIVMNQ+ Y R ++TW++ Q+W
Sbjct: 217 FSGGPELRINPVFYFDFVDDGEEVYYTYNLKNKSLITRIVMNQSTYFRQRYTWNEINQTW 276
Query: 103 ELYANVPRDLCDTYALCGDYGICIISDTPFCQCLKGFKPKSR---GYVDWSQGCVRDKSL 159
LYANVPRD CDTY+LCG YG CIIS +P C+CL+ F PKS +DWSQGCVR+K L
Sbjct: 277 VLYANVPRDYCDTYSLCGAYGNCIISQSPVCECLEKFTPKSPESWNSMDWSQGCVRNKPL 336
Query: 160 NYSTQDGFIKFTELKLPDATSSWVSKSMNLYECQDKCLDNSSCMAYTNSDIRGEGSGCAM 219
+ DGF+K+ LKLPDAT+SWV+K+MNL EC+ CL+N SCMAYT ++I+ E SGCA+
Sbjct: 337 DCQKGDGFVKYVGLKLPDATNSWVNKTMNLKECRSICLENCSCMAYTATNIK-ERSGCAI 395
Query: 220 WFGDLIDMRSFPDGGQDFYIRMSASE---------------------------------- 245
WFGDLID+ P GQ+ YIRM+ASE
Sbjct: 396 WFGDLIDITQLPAAGQEIYIRMNASESSECLSLVLMAVGIALSIFVACGILLVAYYIFKR 455
Query: 246 ---------LEKTENNRETDQVQN---MDLELPLFELATIANATDNFSINNKLGEGGFGP 293
L N E DQ+ + DLELPLF+ TIA AT+ FS NNKLGEGGFGP
Sbjct: 456 KAKLIGKVTLTAFSNREENDQIDSGPKEDLELPLFQFTTIAKATNGFSFNNKLGEGGFGP 515
Query: 294 VYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 353
VYKGTL DGQEIA K S+ S QG+ E KNEVIL +KLQHRNLVKLLGCCIQGEEK+L+Y
Sbjct: 516 VYKGTLEDGQEIAAKTHSRSSGQGINEFKNEVILITKLQHRNLVKLLGCCIQGEEKILVY 575
Query: 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLL 413
E++PNKSLDSFIFDQ R ++LDWSKRF IICG ARG++YLHQDSRLRI+HRDLKASNVLL
Sbjct: 576 EYMPNKSLDSFIFDQTRGELLDWSKRFSIICGIARGLLYLHQDSRLRIVHRDLKASNVLL 635
Query: 414 DQDMNPKISDFGLARAF 430
D+DMNPKISDFGLAR F
Sbjct: 636 DKDMNPKISDFGLARMF 652
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356546914|ref|XP_003541865.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 573 bits (1476), Expect = e-161, Method: Compositional matrix adjust.
Identities = 269/456 (58%), Positives = 346/456 (75%), Gaps = 26/456 (5%)
Query: 1 MKLGWDLKTGLERRITSWKSPDDPSPGNFTWAVERQDNPELIMWKGSRKFHRGGPWNGL- 59
MK GWDL+TGL R++ +WKSPDDPSP +F++ + + PE M KG +KF+R GPWNGL
Sbjct: 167 MKFGWDLRTGLNRKLIAWKSPDDPSPSDFSFGMVLNNYPEAYMMKGDQKFYRSGPWNGLH 226
Query: 60 -----------------VFNEDELYYTFDMTDKDVFSRIVMNQTLYVRHQFTWDKATQSW 102
V N+DELYYT+ + + + SR+V+N T YVR ++ W ++ Q W
Sbjct: 227 SSGSPQVKANPIYDFKFVSNKDELYYTYSLKNSSMISRLVLNATSYVRKRYVWIESKQRW 286
Query: 103 ELYANVPRDLCDTYALCGDYGICIISDTPFCQCLKGFKPK---SRGYVDWSQGCVRDKSL 159
E+Y +VP DLCD+Y+LCG C+ISD+P CQCL+GFKPK + +DWS GC+R+K L
Sbjct: 287 EVYTSVPLDLCDSYSLCGANANCVISDSPVCQCLQGFKPKLPEAWSSMDWSHGCIRNKEL 346
Query: 160 N--YSTQDGFIKFTELKLPDATSSWVSKSMNLYECQDKCLDNSSCMAYTNSDIRGEGSGC 217
+ +DGF K T LK PD T SW+ +++ L EC+ KCLDN SCMAY NSDI G+GSGC
Sbjct: 347 SCENKNKDGFNKLTLLKTPDTTHSWLDQTIGLEECKAKCLDNCSCMAYANSDISGQGSGC 406
Query: 218 AMWFGDLIDMRSFPDGGQDFYIRMSASELEKTENNRETDQVQNM---DLELPLFELATIA 274
AMWFGDLID+R F GGQD Y+R+ ASELE+++ + +++Q M D++LP+F+L+TIA
Sbjct: 407 AMWFGDLIDIRQFAAGGQDVYVRIDASELERSDFSIKSNQNSGMQVDDMDLPVFDLSTIA 466
Query: 275 NATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHR 334
AT NF++ NK+GEGGFGPVY+G+L DGQEIAVKRLS S QGL E KNEV L +KLQHR
Sbjct: 467 KATSNFTVKNKIGEGGFGPVYRGSLTDGQEIAVKRLSASSGQGLTEFKNEVKLIAKLQHR 526
Query: 335 NLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLH 394
NLVKLLGCC++GEEK+L+YE++ N SLDSFIFD++R LDWSKRF+IICG A+G++YLH
Sbjct: 527 NLVKLLGCCLEGEEKMLVYEYMLNGSLDSFIFDEQRSGSLDWSKRFNIICGIAKGLLYLH 586
Query: 395 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
QDSRLRIIHRDLKASNVLLD ++NPKISDFG+AR F
Sbjct: 587 QDSRLRIIHRDLKASNVLLDSELNPKISDFGMARIF 622
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224115136|ref|XP_002316951.1| predicted protein [Populus trichocarpa] gi|222860016|gb|EEE97563.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 551 bits (1421), Expect = e-154, Method: Compositional matrix adjust.
Identities = 278/500 (55%), Positives = 339/500 (67%), Gaps = 70/500 (14%)
Query: 1 MKLGWDLKTGLERRITSWKSPDDPSPGNFTWAVERQDNPELIMWKGSRKFHRGGPWNGLV 60
MK+GWDL+ G + R++SWKS DDPSPG+FT +ER+ NPE++ WKGS+K +R GPWNG+
Sbjct: 158 MKIGWDLRAGFDWRLSSWKSSDDPSPGDFTMGIERESNPEVVAWKGSKKHYRSGPWNGVG 217
Query: 61 F------------------NEDELYYTFDM-TDKDVFSRIVMNQTLYVRHQFTWDKATQS 101
F N E+YY F++ ++ V +R+V+N T R +TW++ TQ+
Sbjct: 218 FSGSTEVKPNPVFYFTFVSNNIEVYYIFNLKSESTVITRLVLNHTTSDRQCYTWNEETQT 277
Query: 102 WELYANVPRDLCDTYALCGDYGICIISDTPFCQCLKGFKPKSR---GYVDWSQGCVRDKS 158
W L +VPRD CD Y LCG CI + P CQCL+ FKPKS +DWSQGCVR+K
Sbjct: 278 WVLQVSVPRDHCDNYGLCGANANCIFNAIPVCQCLEKFKPKSPEEWNKMDWSQGCVRNKE 337
Query: 159 LNYSTQDGFIKFTELKLPDATSSWVSKSMNLYECQDKCLDNSSCMAYTNSDIRGEGSGCA 218
L+ DGFIKF LKLPDAT SWV+K MNL EC+ KCL N SCMAY+N DIRG GSGCA
Sbjct: 338 LDCQKGDGFIKFDGLKLPDATHSWVNKDMNLKECKAKCLGNCSCMAYSNLDIRGGGSGCA 397
Query: 219 MWFGDLIDMRSFPDGGQDFYIRMSASEL-------------------------------- 246
WFGDL+D+R P GGQ+ YIRM ASE+
Sbjct: 398 NWFGDLMDIRLVPGGGQELYIRMHASEIGDREAKANMKIAAIATAVVGLILGTLTISYHV 457
Query: 247 -------------EKTENNRETDQ---VQNMDLELPLFELATIANATDNFSINNKLGEGG 290
E+TEN+ + D Q D+ELPLF + IA+AT+NFS+NNKLGEGG
Sbjct: 458 SKEKAKSAENTSSERTENDWKNDTNNGGQKEDMELPLFAFSAIADATNNFSVNNKLGEGG 517
Query: 291 FGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 350
FGPVY+G L DG EIAVKRLS+ S QG E KNEVIL +KLQHRNLVKLLGCC Q EEK+
Sbjct: 518 FGPVYRGKLEDGLEIAVKRLSRCSGQGFSEFKNEVILINKLQHRNLVKLLGCCSQREEKM 577
Query: 351 LIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASN 410
LIYE++PN+SLD FIFD+ + ++LDWS+RF+II G ARG++YLHQDSRLRIIHRDLKASN
Sbjct: 578 LIYEYMPNRSLDFFIFDETKGRLLDWSRRFNIISGIARGLLYLHQDSRLRIIHRDLKASN 637
Query: 411 VLLDQDMNPKISDFGLARAF 430
VLLD MNPKISDFGLAR F
Sbjct: 638 VLLDDHMNPKISDFGLARMF 657
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356530645|ref|XP_003533891.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 546 bits (1407), Expect = e-153, Method: Compositional matrix adjust.
Identities = 263/454 (57%), Positives = 336/454 (74%), Gaps = 27/454 (5%)
Query: 1 MKLGWDLKTGLERRITSWKSPDDPSPGNFTWAVERQDNPELIMWKGSRKFHRGGPWNGLV 60
MK GWDL+TGL RR+TSWKS DDPS G+FTW VE NP+++MWKG+ ++ R GP+ G +
Sbjct: 163 MKFGWDLRTGLNRRLTSWKSWDDPSSGDFTWGVEIGSNPDIVMWKGNVEYFRTGPYTGNM 222
Query: 61 F------------------NEDELYYTFDMTDKDVFSRIVMNQTLYVRHQFTWDKATQSW 102
F N+DE+YY + + + V + IVMNQTLY+RH+ TW +SW
Sbjct: 223 FSGVYGPRNNPLYDYKFVNNKDEVYYQYTLKNSSVITMIVMNQTLYLRHRLTWIPEAKSW 282
Query: 103 ELYANVPRDLCDTYALCGDYGICIISDTPFCQCLKGFKPKSR---GYVDWSQGCVRDK-- 157
+Y ++PRD CD Y CG G CII+ +P CQCL GF+PKS +DW QGCVR +
Sbjct: 283 TVYQSLPRDSCDVYNTCGPNGNCIIAGSPICQCLDGFEPKSPQQWNVMDWRQGCVRSEEW 342
Query: 158 SLNYSTQDGFIKFTELKLPDATSSWVSKSMNLYECQDKCLDNSSCMAYTNSDIRGEGSGC 217
S +DGF +F +KLP+ T SWV++SM L EC+ KCL+N SC AY+N D RG G+GC
Sbjct: 343 SCGVKNKDGFRRFASMKLPNTTFSWVNESMTLEECRAKCLENCSCKAYSNLDTRGGGNGC 402
Query: 218 AMWFGDLIDMRSFPDGGQDFYIRMSASELEKTE---NNRETDQVQNMDLELPLFELATIA 274
++W GDL+D+R + GQD Y+RM+ S++ KT+ + + D+ + DLELP F+LATI
Sbjct: 403 SIWVGDLVDLRVI-ESGQDLYVRMATSDMGKTKTRMSREDKDEGRQEDLELPFFDLATIV 461
Query: 275 NATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHR 334
NAT+NFSI NKLGEGGFGPVYKGTLV+GQEIA+KRLS+ S QGLKE +NEVIL +KLQHR
Sbjct: 462 NATNNFSIENKLGEGGFGPVYKGTLVNGQEIAIKRLSRSSGQGLKEFRNEVILCAKLQHR 521
Query: 335 NLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLH 394
NLVK+LG CIQGEEK+L+YE++PNKSLD F+FD E+ K L+W RF+I+ ARG++YLH
Sbjct: 522 NLVKVLGYCIQGEEKMLLYEYMPNKSLDLFLFDSEQSKFLNWPVRFNILNAIARGLLYLH 581
Query: 395 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
QDSRLRIIHRDLKASN+LLD +MNPKISDFGLAR
Sbjct: 582 QDSRLRIIHRDLKASNILLDNNMNPKISDFGLAR 615
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449458261|ref|XP_004146866.1| PREDICTED: receptor-like serine/threonine-protein kinase SD1-8-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 541 bits (1394), Expect = e-151, Method: Compositional matrix adjust.
Identities = 264/488 (54%), Positives = 330/488 (67%), Gaps = 58/488 (11%)
Query: 1 MKLGWDLKTGLERRITSWKSPDDPSPGNFTWAVERQDNPELIMWKGSRKFHRGGPWNGLV 60
MKLGWD K G++RR+++WK+ DDPSPG+ T + PE +MW GS ++ R GPWNGL
Sbjct: 160 MKLGWDFKNGIQRRLSAWKTSDDPSPGSLTMEMMNTSYPEPVMWNGSSEYMRSGPWNGLQ 219
Query: 61 F-----------------NEDELYYTFDMTDKDVFSRIVMNQTLYVRHQFTWDKATQSWE 103
F N+ EL Y++++ + + R+V+NQT+ R W + ++W+
Sbjct: 220 FSAKPTSALPILVYSYVNNKSELSYSYELINSSLIGRMVLNQTILRREALLWSEPEKNWK 279
Query: 104 LYANVPRDLCDTYALCGDYGICIISDTPFCQCLKGFKPKSR---GYVDWSQGCVRDKSLN 160
YA +PRD CDTY++CG +G C I P CQCL GF P + +D+++GCVR+K LN
Sbjct: 280 PYAAMPRDYCDTYSVCGAFGSCDIEQVPACQCLFGFHPNVQEKWNLMDYTEGCVRNKPLN 339
Query: 161 YSTQDGFIKFTELKLPDATSSWVSKSMNLYECQDKCLDNSSCMAYTNSDIRGEGSGCAMW 220
S + GF K LKLPD SWV++SM+L EC++KCL N SC+A+ N+DIRG GSGCA+W
Sbjct: 340 CSDKTGFAKLPGLKLPDTKQSWVNESMSLNECREKCLRNCSCVAFANTDIRGSGSGCAIW 399
Query: 221 FGDLIDMRSFPDGGQDFYIRMSASELEKTENNRETDQV---------------------- 258
FG+L+D++ GGQD Y+RM ASELE + + V
Sbjct: 400 FGELVDIKVVRRGGQDLYVRMLASELETKKTSSVAVGVIVGAAALLILGLLLIGFYVIRS 459
Query: 259 ----------------QNMDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDG 302
Q DLELPLF LATI+NATDNFS NKLGEGGFG V++G L DG
Sbjct: 460 KRRKLEATGAGKDLEGQEDDLELPLFNLATISNATDNFSNFNKLGEGGFGAVFRGRLTDG 519
Query: 303 QEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLD 362
+EIAVKRLS S QG E KNEVIL +KLQHRNLVKLLGCCIQGEEK+LIYE++PNKSLD
Sbjct: 520 KEIAVKRLSSYSRQGTDEFKNEVILIAKLQHRNLVKLLGCCIQGEEKMLIYEYMPNKSLD 579
Query: 363 SFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 422
SFIFD R K+LDWSKRF+IICG ARG++YLHQDSRLRIIHRDLKASNVLLD D+NPKIS
Sbjct: 580 SFIFDSARKKLLDWSKRFNIICGVARGILYLHQDSRLRIIHRDLKASNVLLDIDLNPKIS 639
Query: 423 DFGLARAF 430
DFG+AR F
Sbjct: 640 DFGMARTF 647
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449476944|ref|XP_004154883.1| PREDICTED: receptor-like serine/threonine-protein kinase SD1-8-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 538 bits (1387), Expect = e-150, Method: Compositional matrix adjust.
Identities = 264/488 (54%), Positives = 330/488 (67%), Gaps = 58/488 (11%)
Query: 1 MKLGWDLKTGLERRITSWKSPDDPSPGNFTWAVERQDNPELIMWKGSRKFHRGGPWNGL- 59
MKLGWD K G++RR+++WK+ DDPSPG+ T + PE +MW GS ++ R GPWNGL
Sbjct: 160 MKLGWDFKNGIQRRLSAWKTSDDPSPGSLTMEMMNTSYPEPVMWNGSSEYMRSGPWNGLQ 219
Query: 60 ----------------VFNEDELYYTFDMTDKDVFSRIVMNQTLYVRHQFTWDKATQSWE 103
V N+ EL Y++++ + + R+V+NQT+ R W + ++W+
Sbjct: 220 YSAKPTSALPILVYSYVNNKSELSYSYELINSSLIGRMVLNQTILRREALLWSEPEKNWK 279
Query: 104 LYANVPRDLCDTYALCGDYGICIISDTPFCQCLKGFKPKSR---GYVDWSQGCVRDKSLN 160
YA +PRD CDTY++CG +G C I P CQCL GF P + +D+++GCVR+K LN
Sbjct: 280 PYAAMPRDYCDTYSVCGAFGSCDIEQVPACQCLFGFHPNVQEKWNLMDYTEGCVRNKPLN 339
Query: 161 YSTQDGFIKFTELKLPDATSSWVSKSMNLYECQDKCLDNSSCMAYTNSDIRGEGSGCAMW 220
S + GF K LKLPD SWV++SM+L EC++KCL N SC+A+ N+DIRG GSGCA+W
Sbjct: 340 CSDKTGFAKLPGLKLPDTKQSWVNESMSLNECREKCLRNCSCVAFANTDIRGSGSGCAIW 399
Query: 221 FGDLIDMRSFPDGGQDFYIRMSASELEKTENNRETDQV---------------------- 258
FG+L+D++ GGQD Y+RM ASELE + + V
Sbjct: 400 FGELVDIKVVRRGGQDLYVRMLASELETKKTSSVAVGVIVGAAALLILGLLLIGFYVIRS 459
Query: 259 ----------------QNMDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDG 302
Q DLELPLF LATI+NATDNFS NKLGEGGFG V++G L DG
Sbjct: 460 KRRKLEATGAGKDLEGQEDDLELPLFNLATISNATDNFSNFNKLGEGGFGAVFRGRLTDG 519
Query: 303 QEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLD 362
+EIAVKRLS S QG E KNEVIL +KLQHRNLVKLLGCCIQGEEK+LIYE++PNKSLD
Sbjct: 520 KEIAVKRLSSYSRQGTDEFKNEVILIAKLQHRNLVKLLGCCIQGEEKMLIYEYMPNKSLD 579
Query: 363 SFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 422
SFIFD R K+LDWSKRF+IICG ARG++YLHQDSRLRIIHRDLKASNVLLD D+NPKIS
Sbjct: 580 SFIFDSARKKLLDWSKRFNIICGVARGILYLHQDSRLRIIHRDLKASNVLLDIDLNPKIS 639
Query: 423 DFGLARAF 430
DFG+AR F
Sbjct: 640 DFGMARTF 647
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356545293|ref|XP_003541078.1| PREDICTED: receptor-like serine/threonine-protein kinase SD1-7-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 537 bits (1383), Expect = e-150, Method: Compositional matrix adjust.
Identities = 260/452 (57%), Positives = 331/452 (73%), Gaps = 24/452 (5%)
Query: 1 MKLGWDLKTGLERRITSWKSPDDPSPGNFTWAVERQDNPELIMWKGSRKFHRGGPWNGLV 60
MKLGWDLK GL R +T+WK+ DDPSPG+FT ++ +NPE++MWKG+ +++ GPW+G V
Sbjct: 160 MKLGWDLKKGLNRVLTAWKNWDDPSPGDFTLSILHTNNPEVVMWKGTTQYYGSGPWDGTV 219
Query: 61 F------------------NEDELYYTFDMTDKDVFSRIVMNQTLYVRHQFTWDKATQSW 102
F N+DE Y T+ + DK + SR+V+NQT YVR + W+ +Q W
Sbjct: 220 FSGSPSVSSDSNVNYAIVSNKDEFYITYSLIDKSLISRVVINQTKYVRQRLLWNIDSQMW 279
Query: 103 ELYANVPRDLCDTYALCGDYGICIISDTPFCQCLKGFKPKS-RGY--VDWSQGCVRDK-- 157
+ + +P D CD Y CG +GIC+I P C+CL GFKPKS R + + W+QGCV ++
Sbjct: 280 RVSSELPTDFCDQYNTCGAFGICVIGQVPACKCLDGFKPKSPRNWTQMSWNQGCVHNQTW 339
Query: 158 SLNYSTQDGFIKFTELKLPDATSSWVSKSMNLYECQDKCLDNSSCMAYTNSDIRGEGSGC 217
S +DGF KF +K PD SWV+ SM L EC++KC +N SC AY NSDI+G GSGC
Sbjct: 340 SCRKKGRDGFNKFNSVKAPDTRRSWVNASMTLDECKNKCWENCSCTAYANSDIKGGGSGC 399
Query: 218 AMWFGDLIDMRSFPDGGQDFYIRMSASELEK-TENNRETDQVQNMDLELPLFELATIANA 276
A+WF DL+++R P+ GQD YIR++ SE E T + ++ Q D ELPLF+LA+IA+A
Sbjct: 400 AIWFSDLLNIRLMPNAGQDLYIRLAVSETEIITGIEGKNNKSQQEDFELPLFDLASIAHA 459
Query: 277 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 336
T+NFS +NKLGEGGFGPVYKG L DGQE+AVKRLS+ S QGLKE KNEV+L ++LQHRNL
Sbjct: 460 TNNFSHDNKLGEGGFGPVYKGILPDGQEVAVKRLSRTSRQGLKEFKNEVMLCAELQHRNL 519
Query: 337 VKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 396
VK+LGCCIQ +EKLLIYE++ NKSLD F+FD + K+LDW KRF II G ARG++YLHQD
Sbjct: 520 VKVLGCCIQDDEKLLIYEYMANKSLDVFLFDSSQGKLLDWPKRFCIINGIARGLLYLHQD 579
Query: 397 SRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
SRLRIIHRDLKASNVLLD +MNPKISDFGLAR
Sbjct: 580 SRLRIIHRDLKASNVLLDNEMNPKISDFGLAR 611
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 430 | ||||||
| TAIR|locus:2141181 | 850 | RK3 "receptor kinase 3" [Arabi | 0.393 | 0.198 | 0.662 | 6.2e-121 | |
| TAIR|locus:2131694 | 815 | AT4G27300 [Arabidopsis thalian | 0.416 | 0.219 | 0.701 | 9.3e-117 | |
| TAIR|locus:2018506 | 847 | RK2 "receptor kinase 2" [Arabi | 0.434 | 0.220 | 0.631 | 2.3e-112 | |
| TAIR|locus:2131684 | 783 | AT4G27290 [Arabidopsis thalian | 0.855 | 0.469 | 0.558 | 2.9e-112 | |
| TAIR|locus:2200151 | 830 | SD1-13 "S-domain-1 13" [Arabid | 0.388 | 0.201 | 0.658 | 3.4e-101 | |
| TAIR|locus:2018546 | 843 | RK1 "receptor kinase 1" [Arabi | 0.390 | 0.199 | 0.690 | 4.7e-100 | |
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.388 | 0.196 | 0.682 | 1.1e-96 | |
| TAIR|locus:2197729 | 805 | SD1-29 "S-domain-1 29" [Arabid | 0.434 | 0.232 | 0.633 | 4.3e-95 | |
| UNIPROTKB|O49974 | 848 | KIK1 "Serine/threonine-protein | 0.444 | 0.225 | 0.614 | 1.8e-94 | |
| TAIR|locus:2200908 | 842 | AT1G61610 [Arabidopsis thalian | 0.402 | 0.205 | 0.634 | 4.8e-94 |
| TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 570 (205.7 bits), Expect = 6.2e-121, Sum P(3) = 6.2e-121
Identities = 112/169 (66%), Positives = 132/169 (78%)
Query: 262 DLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKEL 321
DLELPL E +A AT+NFS NKLG+GGFG VYKG L+DGQE+AVKRLSK S QG E
Sbjct: 508 DLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEMAVKRLSKTSVQGTDEF 567
Query: 322 KNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFH 381
KNEV L ++LQH NLV+LL CC+ EK+LIYE++ N SLDS +FD+ R L+W RF
Sbjct: 568 KNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKSRNSKLNWQMRFD 627
Query: 382 IICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
II G ARG++YLHQDSR RIIHRDLKASN+LLD+ M PKISDFG+AR F
Sbjct: 628 IINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARIF 676
|
|
| TAIR|locus:2131694 AT4G27300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 644 (231.8 bits), Expect = 9.3e-117, Sum P(3) = 9.3e-117
Identities = 127/181 (70%), Positives = 148/181 (81%)
Query: 250 ENNRETDQVQNMDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKR 309
EN R+ ++ DL+LP+F+ TI+ ATD+FS N LG GGFGPVYKG L DGQEIAVKR
Sbjct: 472 ENFRKG--IEEEDLDLPIFDRKTISIATDDFSYVNFLGRGGFGPVYKGKLEDGQEIAVKR 529
Query: 310 LSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQE 369
LS S QG++E KNEV L +KLQHRNLV+LLGCCIQGEE +LIYE++PNKSLD FIFD+
Sbjct: 530 LSANSGQGVEEFKNEVKLIAKLQHRNLVRLLGCCIQGEECMLIYEYMPNKSLDFFIFDER 589
Query: 370 RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429
R LDW KR +II G ARG++YLHQDSRLRIIHRDLKA NVLLD DMNPKISDFGLA++
Sbjct: 590 RSTELDWKKRMNIINGVARGILYLHQDSRLRIIHRDLKAGNVLLDNDMNPKISDFGLAKS 649
Query: 430 F 430
F
Sbjct: 650 F 650
|
|
| TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 591 (213.1 bits), Expect = 2.3e-112, Sum P(3) = 2.3e-112
Identities = 118/187 (63%), Positives = 143/187 (76%)
Query: 244 SELEKTENNRETDQVQNMDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQ 303
+EL K + + + + LELPL E +A AT+NFS +NKLG+GGFG VYKG L+DG+
Sbjct: 487 NELVKASRSYTSKENKTDYLELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGK 546
Query: 304 EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDS 363
EIAVKRLSK+S QG E NEV L +KLQH NLV+LLGCC+ EK+LIYE++ N SLDS
Sbjct: 547 EIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDS 606
Query: 364 FIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD 423
+FDQ R L+W KRF II G ARG++YLHQDSR RIIHRDLKASNVLLD++M PKISD
Sbjct: 607 HLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISD 666
Query: 424 FGLARAF 430
FG+AR F
Sbjct: 667 FGMARIF 673
|
|
| TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1108 (395.1 bits), Expect = 2.9e-112, P = 2.9e-112
Identities = 210/376 (55%), Positives = 276/376 (73%)
Query: 60 VFNEDELYYTFDMTDKDVFSRIVMNQTLYVRHQFTWDKATQSWELYANVPRDLCDTYALC 119
VF E+E+YYT+ + + V +R+ +N ++ ++TW QSW Y + D CD Y LC
Sbjct: 239 VFTEEEVYYTYKLENPSVLTRMQLNPNGALQ-RYTWVDNLQSWNFYLSAMMDSCDQYTLC 297
Query: 120 GDYGICIISDTPFCQCLKGFKPKS-RGYV--DWSQGCVRDKSLNYST-QDGFIKFTELKL 175
G YG C I+++P C+CLKGF K+ + +V DWS+GCVR L+ +DGF+K ++LKL
Sbjct: 298 GSYGSCNINESPACRCLKGFVAKTPQAWVAGDWSEGCVRRVKLDCGKGEDGFLKISKLKL 357
Query: 176 PDATSSWVSKSMNLYECQDKCLDNSSCMAYTNSDIRGEGSGCAMWFGDLIDMRSFPDGGQ 235
PD +SW K+M+L EC+ CL N +C AY+ DIR G GC +WFGDLID+R + + GQ
Sbjct: 358 PDTRTSWYDKNMDLNECKKVCLRNCTCSAYSPFDIRDGGKGCILWFGDLIDIREYNENGQ 417
Query: 236 DFYIRMSASELE--KTENNRETDQVQNM-DLELPLFELATIANATDNFSINNKLGEGGFG 292
D Y+R+++SE+E + E++R + + Q DLELP +L T++ AT FS NKLG+GGFG
Sbjct: 418 DLYVRLASSEIETLQRESSRVSSRKQEEEDLELPFLDLDTVSEATSGFSAGNKLGQGGFG 477
Query: 293 PVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 352
PVYKGTL GQE+AVKRLS+ S QG++E KNE+ L +KLQHRNLVK+LG C+ EE++LI
Sbjct: 478 PVYKGTLACGQEVAVKRLSRTSRQGVEEFKNEIKLIAKLQHRNLVKILGYCVDEEERMLI 537
Query: 353 YEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVL 412
YE+ PNKSLDSFIFD+ER + LDW KR II G ARG++YLH+DSRLRIIHRDLKASNVL
Sbjct: 538 YEYQPNKSLDSFIFDKERRRELDWPKRVEIIKGIARGMLYLHEDSRLRIIHRDLKASNVL 597
Query: 413 LDQDMNPKISDFGLAR 428
LD DMN KISDFGLAR
Sbjct: 598 LDSDMNAKISDFGLAR 613
|
|
| TAIR|locus:2200151 SD1-13 "S-domain-1 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 596 (214.9 bits), Expect = 3.4e-101, Sum P(3) = 3.4e-101
Identities = 110/167 (65%), Positives = 140/167 (83%)
Query: 264 ELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKN 323
ELPLFE +A AT+NFSI NKLG+GGFG VYKG L +G +IAVKRLS+ S QG++E N
Sbjct: 496 ELPLFEFQVLAVATNNFSITNKLGQGGFGAVYKGRLQEGLDIAVKRLSRTSGQGVEEFVN 555
Query: 324 EVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHII 383
EV++ SKLQHRNLV+LLG CI+GEE++L+YEF+P LD+++FD + ++LDW RF+II
Sbjct: 556 EVVVISKLQHRNLVRLLGFCIEGEERMLVYEFMPENCLDAYLFDPVKQRLLDWKTRFNII 615
Query: 384 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
G RG+MYLH+DSRL+IIHRDLKASN+LLD+++NPKISDFGLAR F
Sbjct: 616 DGICRGLMYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLARIF 662
|
|
| TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 592 (213.5 bits), Expect = 4.7e-100, Sum P(2) = 4.7e-100
Identities = 116/168 (69%), Positives = 136/168 (80%)
Query: 263 LELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELK 322
LELPL EL +A AT+NFS +NKLG+GGFG VYKG L+DG+EIAVKRLSK+S QG E
Sbjct: 502 LELPLLELEALATATNNFSNDNKLGQGGFGIVYKGRLLDGKEIAVKRLSKMSSQGTDEFM 561
Query: 323 NEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHI 382
NEV L +KLQH NLV+LLGCC+ EK+LIYE++ N SLDS +FDQ R L+W KRF I
Sbjct: 562 NEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDI 621
Query: 383 ICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
I G ARG++YLHQDSR RIIHRDLKASNVLLD++M PKISDFG+AR F
Sbjct: 622 INGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIF 669
|
|
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 606 (218.4 bits), Expect = 1.1e-96, Sum P(3) = 1.1e-96
Identities = 114/167 (68%), Positives = 138/167 (82%)
Query: 264 ELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKN 323
ELP+F L IA AT++F N+LG GGFGPVYKG L DG+EIAVKRLS S QG+ E KN
Sbjct: 513 ELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGREIAVKRLSGKSGQGVDEFKN 572
Query: 324 EVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHII 383
E+IL +KLQHRNLV+LLGCC +GEEK+L+YE++PNKSLD F+FD+ + ++DW RF II
Sbjct: 573 EIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWKLRFSII 632
Query: 384 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
G ARG++YLH+DSRLRIIHRDLK SNVLLD +MNPKISDFG+AR F
Sbjct: 633 EGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIF 679
|
|
| TAIR|locus:2197729 SD1-29 "S-domain-1 29" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 590 (212.7 bits), Expect = 4.3e-95, Sum P(3) = 4.3e-95
Identities = 121/191 (63%), Positives = 142/191 (74%)
Query: 240 RMSASELEKTENNRETDQVQNMDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTL 299
R A + + +N E V ++ FE+ TI AT+NFS +NKLG+GGFGPVYKG L
Sbjct: 452 RYRAKQNDAWKNGFERQDVSGVNF----FEMHTIRTATNNFSPSNKLGQGGFGPVYKGKL 507
Query: 300 VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNK 359
VDG+EI VKRL+ S QG +E NE+ L SKLQHRNLV+LLG CI GEEKLLIYEF+ NK
Sbjct: 508 VDGKEIGVKRLASSSGQGTEEFMNEITLISKLQHRNLVRLLGYCIDGEEKLLIYEFMVNK 567
Query: 360 SLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNP 419
SLD FIFD LDW KRF+II G ARG++YLH+DSRLR+IHRDLK SN+LLD MNP
Sbjct: 568 SLDIFIFDPCLKFELDWPKRFNIIQGIARGLLYLHRDSRLRVIHRDLKVSNILLDDRMNP 627
Query: 420 KISDFGLARAF 430
KISDFGLAR F
Sbjct: 628 KISDFGLARMF 638
|
|
| UNIPROTKB|O49974 KIK1 "Serine/threonine-protein kinase" [Zea mays (taxid:4577)] | Back alignment and assigned GO terms |
|---|
Score = 620 (223.3 bits), Expect = 1.8e-94, Sum P(3) = 1.8e-94
Identities = 118/192 (61%), Positives = 154/192 (80%)
Query: 240 RMSASELEKTENNRETDQVQN-MDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGT 298
+ +++ L+ +++ R D V++ EL ++ L I AT NFS +NKLGEGGFGPVY GT
Sbjct: 489 QQNSAMLDISQSIRFDDDVEDGKSHELKVYSLDRIRTATSNFSDSNKLGEGGFGPVYMGT 548
Query: 299 LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPN 358
L G+E+AVKRL + S QGL+E KNEVIL +KLQHRNLV+LLGCCI EEK+L+YE++PN
Sbjct: 549 LPGGEEVAVKRLCRNSGQGLEEFKNEVILIAKLQHRNLVRLLGCCIPREEKILVYEYMPN 608
Query: 359 KSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMN 418
KSLD+F+F+ E+ ++LDW KRF II G ARG++YLH+DSRLR++HRDLKASN+LLD DM
Sbjct: 609 KSLDAFLFNPEKQRLLDWKKRFDIIEGIARGLLYLHRDSRLRVVHRDLKASNILLDADMK 668
Query: 419 PKISDFGLARAF 430
PKISDFG+AR F
Sbjct: 669 PKISDFGMARMF 680
|
|
| TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 598 (215.6 bits), Expect = 4.8e-94, Sum P(3) = 4.8e-94
Identities = 111/175 (63%), Positives = 143/175 (81%)
Query: 256 DQVQNMDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISE 315
DQV DL P+F ++A+AT +F+ NKLG+GGFG VYKG +G+EIAVKRLS S+
Sbjct: 503 DQVDTPDL--PIFSFDSVASATGDFAEENKLGQGGFGTVYKGNFSEGREIAVKRLSGKSK 560
Query: 316 QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILD 375
QGL+E KNE++L +KLQHRNLV+LLGCCI+ EK+L+YE++PNKSLD F+FD+ + LD
Sbjct: 561 QGLEEFKNEILLIAKLQHRNLVRLLGCCIEDNEKMLLYEYMPNKSLDRFLFDESKQGSLD 620
Query: 376 WSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
W KR+ +I G ARG++YLH+DSRL+IIHRDLKASN+LLD +MNPKISDFG+AR F
Sbjct: 621 WRKRWEVIGGIARGLLYLHRDSRLKIIHRDLKASNILLDTEMNPKISDFGMARIF 675
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 430 | |||
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-41 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 6e-41 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-38 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-36 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 6e-35 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-34 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-33 | |
| pfam00954 | 110 | pfam00954, S_locus_glycop, S-locus glycoprotein fa | 2e-32 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-32 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-27 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-26 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-24 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-24 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-23 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-22 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-22 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-22 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-22 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-22 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 8e-22 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-21 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 8e-21 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-20 | |
| pfam08276 | 66 | pfam08276, PAN_2, PAN-like domain | 2e-20 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-20 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-20 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 5e-20 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-20 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 7e-20 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-19 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-19 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-19 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 9e-19 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-18 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-18 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-18 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-18 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-18 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-18 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-18 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 6e-18 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-17 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-17 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-17 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-17 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 7e-17 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 8e-17 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-16 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-16 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-16 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-16 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-16 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-16 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-16 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-16 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 6e-16 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 6e-16 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 8e-16 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 8e-16 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 8e-16 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 8e-16 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 9e-16 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-15 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-15 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-15 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-15 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-15 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-15 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-15 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-15 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-15 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 8e-15 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 8e-15 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 9e-15 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-14 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-14 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-14 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-14 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-14 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-14 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-14 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-14 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 6e-14 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 7e-14 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 8e-14 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 8e-14 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 9e-14 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 9e-14 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-13 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-13 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-13 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-13 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-13 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-13 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-13 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-13 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-13 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-13 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-13 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-13 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 6e-13 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 6e-13 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 7e-13 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 8e-13 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-12 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-12 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-12 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-12 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-12 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-12 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-12 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-12 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-12 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-12 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-12 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-12 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-12 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-12 | |
| smart00473 | 78 | smart00473, PAN_AP, divergent subfamily of APPLE d | 4e-12 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-12 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 6e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 7e-12 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 7e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 9e-12 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-11 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-11 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-11 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-11 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-11 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-11 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-11 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-11 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-11 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-11 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-11 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-11 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-11 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-11 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-11 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-11 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-11 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-11 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-11 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-11 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-11 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-11 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 5e-11 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 5e-11 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 5e-11 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 6e-11 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 6e-11 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 6e-11 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 7e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 7e-11 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 7e-11 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 8e-11 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 8e-11 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 9e-11 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-10 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-10 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-10 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-10 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-10 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-10 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-10 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-10 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-10 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-10 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-10 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 5e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-10 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 7e-10 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 7e-10 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-10 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 8e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 8e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 8e-10 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 8e-10 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-09 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-09 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-09 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-09 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-09 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-09 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-09 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-09 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-09 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-09 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 5e-09 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 7e-09 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 8e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-08 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-08 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-08 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-08 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-08 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-08 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-08 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-08 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 6e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 7e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-07 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-07 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-07 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-07 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-07 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-07 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-07 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 6e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 6e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 8e-07 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-06 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-06 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-06 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-06 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-06 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-06 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 6e-06 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-05 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-05 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-05 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-05 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-05 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-05 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-05 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-05 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-05 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 4e-05 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-05 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-05 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-05 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 7e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-04 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-04 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-04 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-04 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-04 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 4e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 4e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 5e-04 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 5e-04 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 5e-04 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 6e-04 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 6e-04 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 6e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 6e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 7e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 0.001 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.002 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 0.002 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.002 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 0.002 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 0.002 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 0.002 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 0.003 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 0.003 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 0.003 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 0.003 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 0.003 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 0.003 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.003 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.004 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 0.004 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 0.004 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 3e-41
Identities = 62/155 (40%), Positives = 84/155 (54%), Gaps = 10/155 (6%)
Query: 281 SINNKLGEGGFGPVYKGTLVDG-----QEIAVKRLSKI-SEQGLKELKNEVILFSKLQHR 334
++ KLGEG FG VYKGTL E+AVK L + SEQ ++E E + KL H
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 335 NLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLH 394
N+VKLLG C + E +++ E++P L ++ R K L S ARG+ YL
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKN-RPKELSLSDLLSFALQIARGMEYLE 120
Query: 395 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429
IHRDL A N L+ +++ KISDFGL+R
Sbjct: 121 ---SKNFIHRDLAARNCLVGENLVVKISDFGLSRD 152
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 145 bits (369), Expect = 6e-41
Identities = 59/155 (38%), Positives = 82/155 (52%), Gaps = 11/155 (7%)
Query: 281 SINNKLGEGGFGPVYKGTLVD-----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHR 334
++ KLGEG FG VYKG L E+AVK L + SEQ ++E E + KL H
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 335 NLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLH 394
N+VKLLG C + E ++ E++ L S++ ++ L S ARG+ YL
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLE 119
Query: 395 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429
IHRDL A N L+ +++ KISDFGL+R
Sbjct: 120 ---SKNFIHRDLAARNCLVGENLVVKISDFGLSRD 151
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (351), Expect = 3e-38
Identities = 56/156 (35%), Positives = 77/156 (49%), Gaps = 14/156 (8%)
Query: 284 NKLGEGGFGPVYKGTLVDGQ----EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVK 338
KLGEG FG VYKG L E+AVK L + SE+ K+ E + KL H N+V+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 339 LLGCCIQGEEKLLIYEFVPNKSLDSFI------FDQERCKILDWSKRFHIICGTARGVMY 392
LLG C + E L+ E++ L ++ F L A+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 393 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
L + +HRDL A N L+ +D+ KISDFGL+R
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSR 153
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 2e-36
Identities = 57/156 (36%), Positives = 80/156 (51%), Gaps = 11/156 (7%)
Query: 280 FSINNKLGEGGFGPVYKGTLVD-----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQH 333
+ KLGEG FG VYKGTL ++AVK L + SE+ +E E + KL H
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60
Query: 334 RNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 393
N+V+LLG C QGE ++ E++P L F+ L + A+G+ YL
Sbjct: 61 PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEK--LTLKDLLQMALQIAKGMEYL 118
Query: 394 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429
+HRDL A N L+ +++ KISDFGL+R
Sbjct: 119 E---SKNFVHRDLAARNCLVTENLVVKISDFGLSRD 151
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 6e-35
Identities = 53/148 (35%), Positives = 73/148 (49%), Gaps = 8/148 (5%)
Query: 286 LGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHRNLVKLLGCC 343
LGEGGFG VY G+++A+K + K L E L E+ + KL H N+VKL G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 344 IQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIH 403
L+ E+ SL + +E L + I+ G+ YLH IIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLL--KENEGKLSEDEILRILLQILEGLEYLHS---NGIIH 115
Query: 404 RDLKASNVLLDQD-MNPKISDFGLARAF 430
RDLK N+LLD D K++DFGL++
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLL 143
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 3e-34
Identities = 49/154 (31%), Positives = 74/154 (48%), Gaps = 9/154 (5%)
Query: 280 FSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNL 336
+ + KLG G FG VYK G+ +AVK L K + + + E+ + +L H N+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 337 VKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 396
V+L+ + L+ E+ L ++ L + I RG+ YLH
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRG---GPLSEDEAKKIALQILRGLEYLH-- 115
Query: 397 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
IIHRDLK N+LLD++ KI+DFGLA+
Sbjct: 116 -SNGIIHRDLKPENILLDENGVVKIADFGLAKKL 148
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 2e-33
Identities = 49/153 (32%), Positives = 80/153 (52%), Gaps = 8/153 (5%)
Query: 280 FSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHRNLV 337
+ I KLGEG FG VY G+ +A+K + K + +E + E+ + KL+H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 338 KLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 397
+L ++ L+ E+ L + ++R ++ + RF + + YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLL--KKRGRLSEDEARF-YLRQILSALEYLHS-- 115
Query: 398 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
I+HRDLK N+LLD+D + K++DFGLAR
Sbjct: 116 -KGIVHRDLKPENILLDEDGHVKLADFGLARQL 147
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-32
Identities = 40/111 (36%), Positives = 61/111 (54%), Gaps = 19/111 (17%)
Query: 51 HRGGPWNGLVF------------------NEDELYYTFDMTDKDVFSRIVMNQTLYVRHQ 92
R GPWNG+ F N +E+YYT+ MT+ ++SR+ ++ + +
Sbjct: 1 WRSGPWNGIRFSGIPEMQKLSYYVYNFTENNEEVYYTYRMTNNSIYSRLTLSSEGSL-ER 59
Query: 93 FTWDKATQSWELYANVPRDLCDTYALCGDYGICIISDTPFCQCLKGFKPKS 143
FTW +Q W L+ + P+D CD Y CG YG C ++ +P C C+KGF PK+
Sbjct: 60 FTWIPNSQDWNLFWSAPKDQCDVYGRCGPYGYCDVNTSPKCNCIKGFVPKN 110
|
In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 4e-32
Identities = 54/159 (33%), Positives = 84/159 (52%), Gaps = 19/159 (11%)
Query: 279 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRN 335
++ LG G FG VY D G+ +AVK LS SE+ L+ L+ E+ + S LQH N
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 336 LVKLLGCCIQGEEK-LLIY-EFVPNKSLDSFIFDQERCKILDWS--KRF--HIICGTARG 389
+V+ G E+ L I+ E+V SL S + ++ L +++ I+ G
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLL---KKFGKLPEPVIRKYTRQILEG---- 113
Query: 390 VMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
+ YLH I+HRD+K +N+L+D D K++DFG A+
Sbjct: 114 LAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAK 149
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-27
Identities = 55/162 (33%), Positives = 85/162 (52%), Gaps = 29/162 (17%)
Query: 279 NFSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLS--KISEQGLKELKNEVILFSKLQHRN 335
N+ + + +G G FG VYKG L G +A+K++S KI E+ LK + E+ L L+H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 336 LVKLLGCCIQGEEKLLIY-EFVPNKSLDSFIFDQERCKILDWSKRFH------IICGTA- 387
+VK +G I+ + L I E+ N SL I K+F +
Sbjct: 61 IVKYIG-SIETSDSLYIILEYAENGSLRQII------------KKFGPFPESLVAVYVYQ 107
Query: 388 --RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
+G+ YLH+ +IHRD+KA+N+L +D K++DFG+A
Sbjct: 108 VLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVA 146
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 5e-26
Identities = 51/149 (34%), Positives = 84/149 (56%), Gaps = 6/149 (4%)
Query: 280 FSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK 338
F I K+G+GGFG VYK G+E+A+K + S++ +++ NE+ + K +H N+VK
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 339 LLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSR 398
G ++ +E ++ EF SL + + + L S+ ++ +G+ YLH
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLL--KSTNQTLTESQIAYVCKELLKGLEYLHS--- 116
Query: 399 LRIIHRDLKASNVLLDQDMNPKISDFGLA 427
IIHRD+KA+N+LL D K+ DFGL+
Sbjct: 117 NGIIHRDIKAANILLTSDGEVKLIDFGLS 145
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 4e-24
Identities = 49/149 (32%), Positives = 80/149 (53%), Gaps = 4/149 (2%)
Query: 280 FSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 339
F++ KLG G FG V++G + +A+K L ++ + EV +L+H++L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 340 LGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRL 399
C GE +I E + SL +F+ E ++L + + C A G+ YL +
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEG-QVLPVASLIDMACQVAEGMAYLEEQ--- 123
Query: 400 RIIHRDLKASNVLLDQDMNPKISDFGLAR 428
IHRDL A N+L+ +D+ K++DFGLAR
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLAR 152
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 4e-24
Identities = 47/174 (27%), Positives = 90/174 (51%), Gaps = 21/174 (12%)
Query: 262 DLELPLFELATIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKE 320
+L+ L ++ + + + + K+GEG G VYK T G+E+A+K++ ++ +Q +
Sbjct: 3 ELKAALKDIVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKEL 61
Query: 321 LKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRF 380
+ NE+++ +H N+V + G+E ++ E++ SL I+ +
Sbjct: 62 IINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSL---------TDIITQNFVR 112
Query: 381 ----HI--ICG-TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
I +C +G+ YLH +IHRD+K+ N+LL +D + K++DFG A
Sbjct: 113 MNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFA 163
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 4e-23
Identities = 51/154 (33%), Positives = 75/154 (48%), Gaps = 13/154 (8%)
Query: 284 NKLGEGGFGPVYKGT---LVDGQ--EIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLV 337
+LGEG FG V L D ++AVK L+ EQ + + E+ + L H N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 338 KLLGCC--IQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ 395
K G C G LI E++P+ SL ++ Q ++ + +G+ YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLGS 127
Query: 396 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429
R IHRDL A N+L++ + KISDFGLA+
Sbjct: 128 ---QRYIHRDLAARNILVESEDLVKISDFGLAKV 158
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 2e-22
Identities = 57/163 (34%), Positives = 81/163 (49%), Gaps = 23/163 (14%)
Query: 286 LGEGGFGPVYKGTLV------DGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVK 338
LGEG FG VYKG L +A+K L + +E ++ E + E L S LQH N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 339 LLGCCIQGEEKLLIYEFVPNKSLDSFIF-------------DQERCKILDWSKRFHIICG 385
LLG C + + +++E++ + L F+ D+ LD S HI
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 386 TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
A G+ YL S +HRDL A N L+ + + KISDFGL+R
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 2e-22
Identities = 45/149 (30%), Positives = 78/149 (52%), Gaps = 8/149 (5%)
Query: 280 FSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK 338
F I KLGEG +G VYK GQ +A+K + E+ L+E+ E+ + + +VK
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYIVK 62
Query: 339 LLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSR 398
G + + ++ E+ S+ + + K L + I+ T +G+ YLH
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIM--KITNKTLTEEEIAAILYQTLKGLEYLHS--- 117
Query: 399 LRIIHRDLKASNVLLDQDMNPKISDFGLA 427
+ IHRD+KA N+LL+++ K++DFG++
Sbjct: 118 NKKIHRDIKAGNILLNEEGQAKLADFGVS 146
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (238), Expect = 3e-22
Identities = 58/160 (36%), Positives = 89/160 (55%), Gaps = 21/160 (13%)
Query: 280 FSINNKLGEGGFGPVYKGT-LVDGQEIAVK--RLSKISEQGLKE--LKNEVILFSKLQHR 334
+ KLGEG +G VYK G+ +A+K RL E+G+ L+ E+ L +L+H
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALR-EISLLKELKHP 58
Query: 335 NLVKLLGCCIQGEEKL-LIYEFVPNKSLDSFIFDQERCKI-LDWSKR--FHIICGTARGV 390
N+VKLL I E KL L++E+ + L ++ D+ + + K + ++ G A
Sbjct: 59 NIVKLL-DVIHTERKLYLVFEYC-DMDLKKYL-DKRPGPLSPNLIKSIMYQLLRGLA--- 112
Query: 391 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
Y H RI+HRDLK N+L+++D K++DFGLARAF
Sbjct: 113 -YCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAF 148
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 94.5 bits (236), Expect = 4e-22
Identities = 48/160 (30%), Positives = 80/160 (50%), Gaps = 19/160 (11%)
Query: 279 NFSINNKLGEGGFGPVYKGT-LVDGQEIAVKR--LSKISEQGLKELKNEVILFSKLQHRN 335
+ I ++G+G FG VY DG+ +K LS +SE+ ++ NEV + KL H N
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 336 LVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERC-------KILDWSKRFHIICGTAR 388
++K + + ++ E+ L I Q++ +ILDW F +C
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDW---FVQLC---L 114
Query: 389 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
+ YLH SR +I+HRD+K N+ L + K+ DFG+++
Sbjct: 115 ALKYLH--SR-KILHRDIKPQNIFLTSNGLVKLGDFGISK 151
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 4e-22
Identities = 55/169 (32%), Positives = 79/169 (46%), Gaps = 33/169 (19%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK---ISEQGLKELKNEVILFSKL-Q 332
D+F +GEG F V +E A+K L K I E+ +K +K E + ++L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 333 HRNLVKLLGCCIQGEEKL-LIYEFVPNKSLDSFI-----FDQERCK-----ILDWSKRFH 381
H ++KL Q EE L + E+ PN L +I D++ + IL
Sbjct: 61 HPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILL------ 113
Query: 382 IICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
+ YLH IIHRDLK N+LLD+DM+ KI+DFG A+
Sbjct: 114 -------ALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVL 152
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 8e-22
Identities = 52/151 (34%), Positives = 76/151 (50%), Gaps = 12/151 (7%)
Query: 284 NKLGEGGFGPVYKGTLV--DGQEI--AVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVK 338
+LG G FG V KG + G+E+ AVK L + K E E + ++L H +V+
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 339 LLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSR 398
L+G C +GE +L+ E P L ++ + + D + H + A G+ YL
Sbjct: 61 LIGVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV---AMGMAYLESK-- 114
Query: 399 LRIIHRDLKASNVLLDQDMNPKISDFGLARA 429
+HRDL A NVLL KISDFG++RA
Sbjct: 115 -HFVHRDLAARNVLLVNRHQAKISDFGMSRA 144
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 93.7 bits (231), Expect = 6e-21
Identities = 51/157 (32%), Positives = 76/157 (48%), Gaps = 10/157 (6%)
Query: 279 NFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH-R 334
++ I KLGEG FG VY D + +A+K L+K + ++ E+ + + L H
Sbjct: 1 SYRILRKLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 335 NLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLH 394
N+VKL L+ E+V SL+ + R L S+ I+ + YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 395 QDSRLRIIHRDLKASNVLLDQDMN-PKISDFGLARAF 430
IIHRD+K N+LLD+D K+ DFGLA+
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLL 152
|
Length = 384 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 8e-21
Identities = 46/161 (28%), Positives = 75/161 (46%), Gaps = 21/161 (13%)
Query: 286 LGEGGFGPVYKGT---LVDGQE---IAVKRLSKISEQGLKE-LKNEVILFSKLQHRNLVK 338
LGEG FG V+ G L + +AVK L + + ++ + E L + QH N+VK
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 339 LLGCCIQGEEKLLIYEFVPNKSLDSF---------IFDQER--CKILDWSKRFHIICGTA 387
G C +G+ ++++E++ + L+ F L S+ I A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 388 RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
G++YL + +HRDL N L+ D+ KI DFG++R
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 1e-20
Identities = 54/146 (36%), Positives = 80/146 (54%), Gaps = 8/146 (5%)
Query: 285 KLGEGGFGPVYKGTLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRNLVKLLGC 342
K+G+G FG VYKG L E+AVK R + + K L+ IL + H N+VKL+G
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEIL-KQYDHPNIVKLIGV 60
Query: 343 CIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRII 402
C+Q + ++ E VP SL +F+ +++ L K + A G+ YL + I
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFL--RKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CI 115
Query: 403 HRDLKASNVLLDQDMNPKISDFGLAR 428
HRDL A N L+ ++ KISDFG++R
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|219774 pfam08276, PAN_2, PAN-like domain | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 2e-20
Identities = 33/65 (50%), Positives = 46/65 (70%), Gaps = 1/65 (1%)
Query: 163 TQDGFIKFTELKLPDATSSWVSKSMNLYECQDKCLDNSSCMAYTNSDIRGEGSGCAMWFG 222
DGF++ +KLPD T++ V +S+ L EC+ +CL N SC AY +DIRG GSGC +W G
Sbjct: 3 GGDGFLRLPNMKLPDTTAAIVDRSIGLKECEQRCLSNCSCTAYAYADIRG-GSGCLIWTG 61
Query: 223 DLIDM 227
+L+DM
Sbjct: 62 ELVDM 66
|
Length = 66 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.1 bits (222), Expect = 3e-20
Identities = 52/153 (33%), Positives = 77/153 (50%), Gaps = 18/153 (11%)
Query: 286 LGEGGFGPVYKGTLV----DGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVK 338
LG+G FG V LV G+ A+K L K I + ++ E + S++ H +VK
Sbjct: 1 LGKGSFGKVL---LVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK 57
Query: 339 LLGCCIQGEEKL-LIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 397
L Q EEKL L+ E+ P L S + +E + ++ + + YLH
Sbjct: 58 LH-YAFQTEEKLYLVLEYAPGGELFSHL-SKEGRFSEERARFY--AAEIVLALEYLH--- 110
Query: 398 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
L II+RDLK N+LLD D + K++DFGLA+
Sbjct: 111 SLGIIYRDLKPENILLDADGHIKLTDFGLAKEL 143
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 4e-20
Identities = 50/145 (34%), Positives = 76/145 (52%), Gaps = 8/145 (5%)
Query: 286 LGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ 345
+G+G FG V G GQ++AVK L K + E + + L+H NLV+LLG +Q
Sbjct: 14 IGKGEFGDVMLGDY-RGQKVAVKCL-KDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 346 GEEKLLIYEFVPNKSLDSFIFDQERCKI-LDWSKRFHIICGTARGVMYLHQDSRLRIIHR 404
G ++ E++ SL ++ + R I L F + G+ YL + +HR
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFAL--DVCEGMEYLEEK---NFVHR 126
Query: 405 DLKASNVLLDQDMNPKISDFGLARA 429
DL A NVL+ +D+ K+SDFGLA+
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAKE 151
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 5e-20
Identities = 29/79 (36%), Positives = 46/79 (58%), Gaps = 5/79 (6%)
Query: 162 STQDGFIKFTELKLPDATSSWVSKSMNLYECQDKCLDNSSCMAYTNSDIRGEGSGCAMWF 221
+ DGF+K ++KLPD ++ +++L EC++ CL N SC AY ++ GC +W
Sbjct: 9 GSTDGFLKLPDVKLPD--NASAITAISLEECREACLSNCSCTAYAYNNG---SGGCLLWN 63
Query: 222 GDLIDMRSFPDGGQDFYIR 240
G L ++RS GG Y+R
Sbjct: 64 GLLNNLRSLSSGGGTLYLR 82
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 5e-20
Identities = 50/154 (32%), Positives = 83/154 (53%), Gaps = 22/154 (14%)
Query: 286 LGEGGFGPVYKGT-LVDGQ----EIAVKRL-SKISEQGLKELKNEVILFSKLQHRNLVKL 339
LG G FG VYKG + +G+ +A+K L + S + KE+ +E + + + H ++V+L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 340 LGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKI-----LDWSKRFHIICGTARGVMYLH 394
LG C+ + LI + +P L ++ + I L+W + A+G+ YL
Sbjct: 75 LGICL-SSQVQLITQLMPLGCLLDYV-RNHKDNIGSQYLLNWCVQI------AKGMSYLE 126
Query: 395 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
+ R++HRDL A NVL+ + KI+DFGLA+
Sbjct: 127 EK---RLVHRDLAARNVLVKTPQHVKITDFGLAK 157
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 7e-20
Identities = 50/149 (33%), Positives = 73/149 (48%), Gaps = 5/149 (3%)
Query: 280 FSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 339
+ KLG G FG V+ GT ++AVK L K + E + KL+H LV+L
Sbjct: 8 LKLERKLGAGQFGEVWMGTWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQL 66
Query: 340 LGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRL 399
C + E ++ E++ SL F+ E K L + + A G+ YL
Sbjct: 67 YAVCSEEEPIYIVTEYMSKGSLLDFLKSGEG-KKLRLPQLVDMAAQIAEGMAYLE---SR 122
Query: 400 RIIHRDLKASNVLLDQDMNPKISDFGLAR 428
IHRDL A N+L+ +++ KI+DFGLAR
Sbjct: 123 NYIHRDLAARNILVGENLVCKIADFGLAR 151
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 4e-19
Identities = 57/152 (37%), Positives = 83/152 (54%), Gaps = 13/152 (8%)
Query: 285 KLGEGGFGPVYKG-TLVDGQEIAVKRLSKISE-QGLKELK-NEVILFSKLQHRNLVKLLG 341
K+GEG +G VYKG GQ +A+K++ SE +G+ E+ L +LQH N+V L
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 342 CCIQGEEKLLIYEFVP---NKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSR 398
+Q LI+EF+ K LDS Q L S + I+ +G+++ H
Sbjct: 67 VLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQIL----QGILFCH---S 119
Query: 399 LRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
R++HRDLK N+L+D K++DFGLARAF
Sbjct: 120 RRVLHRDLKPQNLLIDNKGVIKLADFGLARAF 151
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 4e-19
Identities = 60/162 (37%), Positives = 77/162 (47%), Gaps = 24/162 (14%)
Query: 286 LGEGGFGPVYKGTLVD-------GQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRN 335
LG G FG VY+GT D +AVK L K E+ KE E L S H N
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEK--KEFLKEAHLMSNFNHPN 60
Query: 336 LVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCK----ILDWSKRFHIICGTARGVM 391
+VKLLG C+ E + +I E + L S++ D + +L + I A+G +
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 392 YLHQDSRLRIIHRDLKASNVLL-----DQDMNPKISDFGLAR 428
YL Q + IHRDL A N L+ D D KI DFGLAR
Sbjct: 121 YLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 6e-19
Identities = 41/159 (25%), Positives = 72/159 (45%), Gaps = 19/159 (11%)
Query: 278 DNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRL-SKISEQGLKELKNEV-ILFSKLQHR 334
+ LG+G G VYK G+ A+K++ E+ K+L E+ L S +
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSC-ESP 59
Query: 335 NLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTA-----RG 389
+VK G + E ++ E++ SL + ++ + + +G
Sbjct: 60 YVVKCYGAFYKEGEISIVLEYMDGGSLADLL---KKVGK--IPEP---VLAYIARQILKG 111
Query: 390 VMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
+ YLH IIHRD+K SN+L++ KI+DFG+++
Sbjct: 112 LDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISK 148
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 9e-19
Identities = 47/156 (30%), Positives = 81/156 (51%), Gaps = 10/156 (6%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLV--DGQEI--AVKRL-SKISEQGLKELKNEVILFSKLQ 332
+I +G G FG V +G L +EI A+K L + S++ + E + +
Sbjct: 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFD 63
Query: 333 HRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMY 392
H N+++L G + ++I E++ N SLD F+ +E + ++ G A G+ Y
Sbjct: 64 HPNIIRLEGVVTKSRPVMIITEYMENGSLDKFL--RENDGKFTVGQLVGMLRGIASGMKY 121
Query: 393 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
L S + +HRDL A N+L++ ++ K+SDFGL+R
Sbjct: 122 L---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSR 154
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.9 bits (211), Expect = 1e-18
Identities = 44/166 (26%), Positives = 81/166 (48%), Gaps = 31/166 (18%)
Query: 280 FSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISE------QGLKELKNEVILFSKLQ 332
+ ++GEG +G VYK G+ +A+K++ +E ++E+K L KL+
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIK----LLQKLR 56
Query: 333 HRNLVKLLGCCIQGEEK--LLIYEFVPNKSLDSFI------FDQERCKILDWSKRFHIIC 384
H N+V+L + +++E++ + L + F + + K +
Sbjct: 57 HPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIK--------CYMK 107
Query: 385 GTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
G+ YLH + I+HRD+K SN+L++ D K++DFGLAR +
Sbjct: 108 QLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPY 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 2e-18
Identities = 55/160 (34%), Positives = 83/160 (51%), Gaps = 34/160 (21%)
Query: 286 LGEGGFGPVYKG-TLVDGQEIAVKRLS-----KISEQGLKELKNEVILFSKLQHRNLVKL 339
LG G FG VY+G L DG AVK +S + ++ +K+L+ E+ L SKLQH N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 340 LGCCIQGEEKLLIY-EFVPNKSLDSFI-----FDQERCK-----ILDWSKRFHIICGTAR 388
LG + E+ L I+ E VP SL + F + + IL
Sbjct: 68 LG-TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL------------- 113
Query: 389 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
G+ YLH +HRD+K +N+L+D + K++DFG+A+
Sbjct: 114 GLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAK 150
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 2e-18
Identities = 56/167 (33%), Positives = 91/167 (54%), Gaps = 34/167 (20%)
Query: 284 NKLGEGGFGPVYKGT-LVDGQEIAVKRLS-KISEQG--LKELKNEVILFSKLQ---HRNL 336
++GEG +G VYK L G+ +A+K++ +SE+G L L+ E+ L +L+ H N+
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLR-EIALLKQLESFEHPNI 63
Query: 337 VKLLGCC--IQGEEKL---LIYEFVPNKSLDSFIFDQERC--------KILDWSKRFHII 383
V+LL C + + +L L++E V ++ L +++ +C I D ++
Sbjct: 64 VRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYL---SKCPKPGLPPETIKDLMRQL--- 116
Query: 384 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
RGV +LH RI+HRDLK N+L+ D KI+DFGLAR +
Sbjct: 117 ---LRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIY 157
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 2e-18
Identities = 51/155 (32%), Positives = 78/155 (50%), Gaps = 20/155 (12%)
Query: 285 KLGEGGFGPVYKG-TLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRNLVKLLG 341
K+GEG +G VYK + G+ +A+K RL E E+ L +L H N+V+LL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 342 CCIQGEEKLLIYEFVP---NKSLDS---FIFDQERCKILDWSKRFHIICGTARGVMYLHQ 395
+ L++EF+ K +DS D K + + +G+ Y H
Sbjct: 66 VVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIK-----SYLYQLL---QGIAYCHS 117
Query: 396 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
R++HRDLK N+L+D++ K++DFGLARAF
Sbjct: 118 H---RVLHRDLKPQNLLIDREGALKLADFGLARAF 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 3e-18
Identities = 48/153 (31%), Positives = 82/153 (53%), Gaps = 17/153 (11%)
Query: 285 KLGEGGFGPVYKG-TLVDGQEIAVKRLSK------ISEQGLKELKNEVILFSKLQHRNLV 337
K+GEG +G VYK + G+ +A+K++ I + L+E+K L +L H N++
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIK----LLKELNHPNII 61
Query: 338 KLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 397
KLL + L++EF+ + L I ++R + L S + +G+ + H
Sbjct: 62 KLLDVFRHKGDLYLVFEFM-DTDLYKLI--KDRQRGLPESLIKSYLYQLLQGLAFCHSH- 117
Query: 398 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
I+HRDLK N+L++ + K++DFGLAR+F
Sbjct: 118 --GILHRDLKPENLLINTEGVLKLADFGLARSF 148
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 3e-18
Identities = 60/167 (35%), Positives = 74/167 (44%), Gaps = 45/167 (26%)
Query: 286 LGEGGFG--------PVYKGTLVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHRNL 336
LGEG FG P GT G+ +AVK L + Q K E+ + L H N+
Sbjct: 12 LGEGHFGKVSLYCYDPANDGT---GEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68
Query: 337 VKLLGCCIQGEEK--LLIYEFVPNKSLDSF------------IFDQERCKILDWSKRFHI 382
VK GCC + K LI E+VP SL + +F Q+ C+
Sbjct: 69 VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICE---------- 118
Query: 383 ICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429
G+ YLH IHRDL A NVLLD D KI DFGLA+A
Sbjct: 119 ------GMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKA 156
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 5e-18
Identities = 49/162 (30%), Positives = 80/162 (49%), Gaps = 21/162 (12%)
Query: 285 KLGEGGFGPVYKG---TLVDGQE---IAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK 338
+LGEG FG V+ L+ Q+ +AVK L + SE ++ + E L + LQH+++V+
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 339 LLGCCIQGEEKLLIYEFVPNKSLDSF---------IFDQER---CKILDWSKRFHIICGT 386
G C +G L+++E++ + L+ F I L + I
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 387 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
A G++YL + L +HRDL N L+ Q + KI DFG++R
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 6e-18
Identities = 47/167 (28%), Positives = 78/167 (46%), Gaps = 24/167 (14%)
Query: 280 FSINNKLGEGGFGPVYKGTLV--DG--QEIAVK--RLSKISEQGLKELKNEVILFSKLQH 333
+ LGEG FG V +G L DG ++AVK +L + ++E +E H
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 334 RNLVKLLGCCIQGEEK------LLIYEFVPNKSLDSFIFDQERCKILDWSKRFHI----- 382
N++KL+G C + ++I F+ + L SF+ ++ ++ +
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLL---YSRLGGLPEKLPLQTLLK 117
Query: 383 -ICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
+ A G+ YL S IHRDL A N +L +DM ++DFGL++
Sbjct: 118 FMVDIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 2e-17
Identities = 52/160 (32%), Positives = 78/160 (48%), Gaps = 30/160 (18%)
Query: 284 NKLGEGGFGPVYKGTLVDGQEIAVKRLS------KISEQGLKELKNEVILFSKLQHRNLV 337
LG+G +G VY G GQ IAVK++ +E+ ++L+ EV L L+H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 338 KLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFH-----IICGTAR---- 388
+ LG C+ + EFVP S+ S + RF + C +
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSIL------------NRFGPLPEPVFCKYTKQILD 113
Query: 389 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
GV YLH + ++HRD+K +NV+L + K+ DFG AR
Sbjct: 114 GVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCAR 150
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 4e-17
Identities = 57/159 (35%), Positives = 86/159 (54%), Gaps = 16/159 (10%)
Query: 279 NFSINNKLGEGGFGPVYKG-TLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRN 335
NF K+GEG +G VYK + G+ +A+K RL +E E+ L +L H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 336 LVKLLGCCIQGEEKL-LIYEFVPNKSLDSFIFDQERCKI---LDWSKRFHIICGTARGVM 391
+VKLL I E KL L++EF+ ++ L F+ I L S F ++ +G+
Sbjct: 61 IVKLLDV-IHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLL----QGLA 114
Query: 392 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
+ H R++HRDLK N+L++ + K++DFGLARAF
Sbjct: 115 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 150
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 5e-17
Identities = 52/160 (32%), Positives = 82/160 (51%), Gaps = 19/160 (11%)
Query: 279 NFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLS------KISEQGLKELKNEVILFSKL 331
+ I ++GEG G V+K G+ +A+K+++ I Q L+E+K
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIK----ALQAC 56
Query: 332 QHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRF-HIICGTARGV 390
QH +VKLL G +L+ E++P+ L + D+ER K + ++ +GV
Sbjct: 57 QHPYVVKLLDVFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRMLL---KGV 112
Query: 391 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
Y+H I+HRDLK +N+L+ D KI+DFGLAR F
Sbjct: 113 AYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLF 149
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 5e-17
Identities = 51/156 (32%), Positives = 78/156 (50%), Gaps = 18/156 (11%)
Query: 284 NKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKN-----EVILFSKLQHRNLV 337
KLGEG + VYK G+ +A+K++ + K+ N E+ L +L+H N++
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 338 KLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIIC---GTARGVMYLH 394
LL L++EF+ L+ I D K + + I T RG+ YLH
Sbjct: 66 GLLDVFGHKSNINLVFEFMET-DLEKVIKD----KSIVLTPA-DIKSYMLMTLRGLEYLH 119
Query: 395 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
I+HRDLK +N+L+ D K++DFGLAR+F
Sbjct: 120 ---SNWILHRDLKPNNLLIASDGVLKLADFGLARSF 152
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 7e-17
Identities = 52/173 (30%), Positives = 79/173 (45%), Gaps = 26/173 (15%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRL-SKISEQGLKELKNEVILFSK 330
D ++ LGEG FG V K V +AVK L +E+ L +L +E+ +
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM 71
Query: 331 L-QHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICG---- 385
+ +H+N++ LLG C Q ++ E+ + +L F+ + R S
Sbjct: 72 IGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRAR-RPPGEYASPDDPRPPEETLT 130
Query: 386 ----------TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
ARG+ +L + IHRDL A NVL+ +D KI+DFGLAR
Sbjct: 131 QKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLAR 180
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 8e-17
Identities = 50/154 (32%), Positives = 65/154 (42%), Gaps = 18/154 (11%)
Query: 285 KLGEGGFGPVYKGTLVDGQ----EIAVKRLSKISEQG-LKELKNEVILFSKLQHRNLVKL 339
KLG+G FG V +G +AVK L + + E + L H NL++L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 340 LGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICG----TARGVMYLHQ 395
G + + + E P SL D+ R L +C A G+ YL
Sbjct: 62 YGVVLTHPLMM-VTELAPLGSL----LDRLRKDALG-HFLISTLCDYAVQIANGMRYLES 115
Query: 396 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429
R IHRDL A N+LL D KI DFGL RA
Sbjct: 116 K---RFIHRDLAARNILLASDDKVKIGDFGLMRA 146
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 2e-16
Identities = 53/154 (34%), Positives = 81/154 (52%), Gaps = 20/154 (12%)
Query: 286 LGEGGFGPVYK---GTLVD--GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLL 340
LG+G FG V L D G+ +AVK+L + + L++ + E+ + LQH N+VK
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 341 GCCIQ-GEEKL-LIYEFVPNKSL-DSFIFDQERC---KILDWSKRFHIICGTARGVMYLH 394
G C G L L+ E++P SL D +ER K+L ++ + IC +G+ YL
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQ---IC---KGMEYL- 124
Query: 395 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
R +HRDL N+L++ + KI DFGL +
Sbjct: 125 --GSKRYVHRDLATRNILVESENRVKIGDFGLTK 156
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 2e-16
Identities = 49/166 (29%), Positives = 83/166 (50%), Gaps = 19/166 (11%)
Query: 279 NFSINNKLGEGGFGPVYKG---TLVDGQE---IAVKRLSKISEQGLKELKNEVILFSKLQ 332
N + +LGEG FG V+ L Q+ +AVK L S+ K+ E L + LQ
Sbjct: 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 65
Query: 333 HRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKI----------LDWSKRFHI 382
H ++VK G C++G+ ++++E++ + L+ F+ + L S+ HI
Sbjct: 66 HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125
Query: 383 ICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
A G++YL + +HRDL N L+ +++ KI DFG++R
Sbjct: 126 AQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR 168
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 2e-16
Identities = 51/144 (35%), Positives = 76/144 (52%), Gaps = 6/144 (4%)
Query: 286 LGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLLGCCI 344
LG+G FG V+KGTL D +AVK + Q LK + +E + + H N+VKL+G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 345 QGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHR 404
Q + ++ E VP SF+ +++ L + A G+ YL + IHR
Sbjct: 63 QRQPIYIVMELVPGGDFLSFL--RKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117
Query: 405 DLKASNVLLDQDMNPKISDFGLAR 428
DL A N L+ ++ KISDFG++R
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 2e-16
Identities = 45/156 (28%), Positives = 79/156 (50%), Gaps = 13/156 (8%)
Query: 279 NFSINNKLGEGGFGPVYKGTL-VDGQEIAVKR--LSKISEQGLKELKNEVILFSKLQHRN 335
+F I NK+G+G FG V+K D + A+K+ LSK++ + +E +E + +KL
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 336 LVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILD---WSKRFHIICGTARGVMY 392
+++ + + ++ E+ N L + Q + + W RF I G+ +
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVW--RFFI--QILLGLAH 116
Query: 393 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
LH +I+HRD+K+ N+ LD N KI D G+A+
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAK 149
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 2e-16
Identities = 51/149 (34%), Positives = 84/149 (56%), Gaps = 11/149 (7%)
Query: 286 LGEGGFGPVYKGTLVD--GQEI--AVKRLSKISE-QGLKELKNEVILFSKLQHRNLVKLL 340
+G+G FG VY GTL+D GQ+I AVK L++I++ + +++ E I+ H N++ LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 341 GCCIQGE-EKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRL 399
G C+ E L++ ++ + L +FI + + F + A+G+ YL
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGL--QVAKGMEYLASK--- 117
Query: 400 RIIHRDLKASNVLLDQDMNPKISDFGLAR 428
+ +HRDL A N +LD+ K++DFGLAR
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLAR 146
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 3e-16
Identities = 51/160 (31%), Positives = 82/160 (51%), Gaps = 29/160 (18%)
Query: 286 LGEGGFGPVYKGTLVD-GQEIAVKRL---SKISEQG-------LKELKNEVILFSKLQHR 334
+G+G +G VY V G+ +AVK++ + I+ + +K L++E+ L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 335 NLVKLLGCCIQGEEKLLIY-EFVPNKSLDSFI-----FDQERCKILDWSKRFHIICGTAR 388
N+V+ LG EE L I+ E+VP S+ S + F+++ +
Sbjct: 69 NIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVR--------FFTEQVLE 119
Query: 389 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
G+ YLH I+HRDLKA N+L+D D KISDFG+++
Sbjct: 120 GLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISK 156
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 4e-16
Identities = 48/152 (31%), Positives = 78/152 (51%), Gaps = 19/152 (12%)
Query: 286 LGEGGFGPVYKGTLVDGQ-EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCI 344
LG+G +G VY + Q IA+K + + + ++ L E+ L S L+HRN+V+ LG
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 345 QGEEKLLIYEFVPNKSLDSFI-------FDQERCKILDWSKRFHIICGTARGVMYLHQDS 397
+ + E VP SL + + D E+ I+ ++K+ G+ YLH
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQ-TIIFYTKQI------LEGLKYLHD-- 126
Query: 398 RLRIIHRDLKASNVLLDQDMNP-KISDFGLAR 428
+I+HRD+K NVL++ KISDFG ++
Sbjct: 127 -NQIVHRDIKGDNVLVNTYSGVVKISDFGTSK 157
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 5e-16
Identities = 48/177 (27%), Positives = 80/177 (45%), Gaps = 39/177 (22%)
Query: 276 ATDNFSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQ------GLKELKNEVILF 328
++ I KLGEG FG VYK + G+ +A+K++ +E+ L+E+K +
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIK----IL 61
Query: 329 SKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIF-------DQERCKILDWSKRFH 381
KL+H N+V L+ + E D + +L+ +
Sbjct: 62 KKLKHPNVVPLID---------MAVERPDKSKRKRGSVYMVTPYMDHDLSGLLE-NPSVK 111
Query: 382 IICGTARGVM--------YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
+ + M YLH++ I+HRD+KA+N+L+D KI+DFGLAR +
Sbjct: 112 LTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPY 165
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 6e-16
Identities = 52/155 (33%), Positives = 80/155 (51%), Gaps = 8/155 (5%)
Query: 275 NATDNFSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH 333
N D + I +LG+G FG VYK G A K + SE+ L++ E+ + S+ +H
Sbjct: 2 NPNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKH 61
Query: 334 RNLVKLLGCCIQGEEKLLIY-EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMY 392
N+V L E KL I EF +LDS + + ER L + ++ + +
Sbjct: 62 PNIVGLYEAYFY-ENKLWILIEFCDGGALDSIMLELER--GLTEPQIRYVCRQMLEALNF 118
Query: 393 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
LH ++IHRDLKA N+LL D + K++DFG++
Sbjct: 119 LHSH---KVIHRDLKAGNILLTLDGDVKLADFGVS 150
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 6e-16
Identities = 52/167 (31%), Positives = 78/167 (46%), Gaps = 17/167 (10%)
Query: 276 ATDNFSINNKLGEGGFGPVYKGTLV----DGQE--IAVKRLSKI-SEQGLKELKNEVILF 328
D+ ++ LG G FG VY+G D E +AVK L + SEQ + E ++
Sbjct: 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIM 63
Query: 329 SKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFD----QERCKILDWSKRFHIIC 384
SK H+N+V+L+G + + ++ E + L SF+ + ER L
Sbjct: 64 SKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123
Query: 385 GTARGVMYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKISDFGLAR 428
A+G YL ++ IHRD+ A N LL KI+DFG+AR
Sbjct: 124 DVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 8e-16
Identities = 52/151 (34%), Positives = 76/151 (50%), Gaps = 5/151 (3%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 337
++ + KLG G FG V+ G + ++AVK L K ++ E L LQH LV
Sbjct: 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLV 64
Query: 338 KLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 397
+L + E +I E++ SL F+ E K+L K A G+ Y+
Sbjct: 65 RLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIE--- 120
Query: 398 RLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
R IHRDL+A+NVL+ + + KI+DFGLAR
Sbjct: 121 RKNYIHRDLRAANVLVSESLMCKIADFGLAR 151
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 8e-16
Identities = 53/164 (32%), Positives = 81/164 (49%), Gaps = 23/164 (14%)
Query: 285 KLGEGGFGPVYKGTLV------DGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHRNLV 337
+LGE FG VYKG L Q +A+K L +E L+E K+E ++ S+LQH N+V
Sbjct: 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71
Query: 338 KLLGCCIQGEEKLLIYEFVPNKSLDSFIF-------------DQERCKILDWSKRFHIIC 384
LLG + + +I+ + + L F+ D+ L+ + HI+
Sbjct: 72 CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131
Query: 385 GTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
A G+ +L S ++H+DL NVL+ +N KISD GL R
Sbjct: 132 QIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 8e-16
Identities = 52/155 (33%), Positives = 85/155 (54%), Gaps = 8/155 (5%)
Query: 279 NFSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLKELK-NEVILFSKLQHRNL 336
NF KLGEG + VYKG G+ +A+K + +E+G E+ L +L+H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 337 VKLLGCCIQGEEKL-LIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ 395
V+L I E KL L++E++ +K L ++ LD + +G+ + H+
Sbjct: 61 VRLHDV-IHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118
Query: 396 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
+ R++HRDLK N+L+++ K++DFGLARAF
Sbjct: 119 N---RVLHRDLKPQNLLINKRGELKLADFGLARAF 150
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 8e-16
Identities = 48/149 (32%), Positives = 77/149 (51%), Gaps = 13/149 (8%)
Query: 284 NKLGEGGFGPVYKG-TLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRNLVKLL 340
NK+G G FG VY L G+ +AVK R+ + +KE+ +E+ + L+H NLVK
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 341 GCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWS--KRFHIICGTARGVMYLHQDSR 398
G + E+ + E+ +L+ + E +ILD + + + G+ YLH
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELL---EHGRILDEHVIRVYTL--QLLEGLAYLHSH-- 118
Query: 399 LRIIHRDLKASNVLLDQDMNPKISDFGLA 427
I+HRD+K +N+ LD + K+ DFG A
Sbjct: 119 -GIVHRDIKPANIFLDHNGVIKLGDFGCA 146
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 9e-16
Identities = 48/158 (30%), Positives = 78/158 (49%), Gaps = 26/158 (16%)
Query: 286 LGEGGFGPVYKG-TLVDGQEIAVKR--LSKISEQG-------LKELKNEVILFSKLQHRN 335
+G G FG VY G G+ +AVK+ L +S L L E+ L +LQH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 336 LVKLLGCCIQGEEKLLIYEFVPNKSLDSFI-----FDQERCKILDWSKRFHIICGTARGV 390
+V+ LG + + + E+VP S+ + + F++ + + + +G+
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR--------NFVRQILKGL 119
Query: 391 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
YLH IIHRD+K +N+L+D KISDFG+++
Sbjct: 120 NYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 1e-15
Identities = 49/152 (32%), Positives = 82/152 (53%), Gaps = 18/152 (11%)
Query: 286 LGEGGFGPVYKGTLVD-GQEIAVKR-----LSKISEQGLKELKNEVILFSKLQHRNLVKL 339
LG+G FG VY VD G+E+AVK+ S +++ + L+ E+ L LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 340 LGCCIQGEEKLLIY-EFVPNKSLDSFIFDQERCKILDWSKRF--HIICGTARGVMYLHQD 396
G C++ +E L I+ E++P S+ + ++++ I+ GV YLH +
Sbjct: 70 YG-CLRDDETLSIFMEYMPGGSVKDQL-KAYGALTETVTRKYTRQIL----EGVEYLHSN 123
Query: 397 SRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
I+HRD+K +N+L D N K+ DFG ++
Sbjct: 124 ---MIVHRDIKGANILRDSAGNVKLGDFGASK 152
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 1e-15
Identities = 51/151 (33%), Positives = 76/151 (50%), Gaps = 6/151 (3%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 337
+ + KLG G FG V+ G ++A+K L K + E L +LQH LV
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSL-KQGSMSPEAFLAEANLMKQLQHPRLV 64
Query: 338 KLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 397
+L Q E +I E++ N SL F+ E K L +K + A G+ ++
Sbjct: 65 RLYAVVTQ-EPIYIITEYMENGSLVDFLKTPEGIK-LTINKLIDMAAQIAEGMAFIE--- 119
Query: 398 RLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
R IHRDL+A+N+L+ + + KI+DFGLAR
Sbjct: 120 RKNYIHRDLRAANILVSETLCCKIADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 1e-15
Identities = 47/156 (30%), Positives = 75/156 (48%), Gaps = 16/156 (10%)
Query: 286 LGEGGFGPVY----KGTLVDGQE--IAVKRLSKISEQG-LKELKNEVILFSKLQHRNLVK 338
LG G FG V+ KG +G E + VK L K ++ E + E+ +F KL H+N+V+
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 339 LLGCCIQGEEKLLIYEFVPNKSLDSFI------FDQERCKILDWSKRFHIICGTARGVMY 392
LLG C + E +I E+ L F+ ++ + L ++ + A G+ +
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 393 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
L S R +HRDL A N L+ K+S L++
Sbjct: 133 L---SNARFVHRDLAARNCLVSSQREVKVSLLSLSK 165
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 1e-15
Identities = 47/170 (27%), Positives = 78/170 (45%), Gaps = 31/170 (18%)
Query: 286 LGEGGFGPVYKGT---LVDGQE---IAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVK 338
+G+G FG V++ L+ + +AVK L + S + + E L ++ H N+VK
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 339 LLGCCIQGEEKLLIYEFVPNKSLDSFI--------------------FDQERCKILDWSK 378
LLG C G+ L++E++ L+ F+ L ++
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLP-LSCTE 131
Query: 379 RFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
+ I A G+ YL S + +HRDL N L+ ++M KI+DFGL+R
Sbjct: 132 QLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR 178
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-15
Identities = 44/155 (28%), Positives = 78/155 (50%), Gaps = 14/155 (9%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRN 335
++ ++G G FG V+ G ++ +++A+K R +SE+ E E + KL H
Sbjct: 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIE---EAQVMMKLSHPK 60
Query: 336 LVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKR--FHIICGTARGVMYL 393
LV+L G C + L++EF+ + L ++ R + +S+ + G+ YL
Sbjct: 61 LVQLYGVCTERSPICLVFEFMEHGCLSDYL----RAQRGKFSQETLLGMCLDVCEGMAYL 116
Query: 394 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
+ +IHRDL A N L+ ++ K+SDFG+ R
Sbjct: 117 ESSN---VIHRDLAARNCLVGENQVVKVSDFGMTR 148
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 3e-15
Identities = 54/178 (30%), Positives = 79/178 (44%), Gaps = 31/178 (17%)
Query: 279 NFSINNKLGEGGFGPVYKGT------LVDGQEIAVKRLSKISEQG-LKELKNEVILFSKL 331
N + LGEG FG V K T +AVK L + + L++L +E L ++
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 332 QHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFI---------------------FDQER 370
H +++KL G C Q LLI E+ SL SF+ D
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 371 CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
+ L +RG+ YL + ++++HRDL A NVL+ + KISDFGL+R
Sbjct: 121 ERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSR 175
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 3e-15
Identities = 44/149 (29%), Positives = 79/149 (53%), Gaps = 6/149 (4%)
Query: 281 SINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 339
++ +KLG G +G VY+G +AVK L K ++E E + +++H NLV+L
Sbjct: 9 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQL 67
Query: 340 LGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRL 399
LG C + +I EF+ +L ++ + R + ++ ++ + + YL + +
Sbjct: 68 LGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLEKKN-- 124
Query: 400 RIIHRDLKASNVLLDQDMNPKISDFGLAR 428
IHRDL A N L+ ++ K++DFGL+R
Sbjct: 125 -FIHRDLAARNCLVGENHLVKVADFGLSR 152
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 4e-15
Identities = 46/146 (31%), Positives = 70/146 (47%), Gaps = 5/146 (3%)
Query: 285 KLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCI 344
KLG G FG V++G + +AVK L K K+ E + KL+H L++L C
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 345 QGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHR 404
E ++ E + SL ++ + L + + A G+ YL + IHR
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGGAG-RALKLPQLIDMAAQVASGMAYLEAQN---YIHR 127
Query: 405 DLKASNVLLDQDMNPKISDFGLARAF 430
DL A NVL+ ++ K++DFGLAR
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVI 153
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 6e-15
Identities = 49/151 (32%), Positives = 80/151 (52%), Gaps = 10/151 (6%)
Query: 280 FSINNKLGEGGFGPVYKGTLVDGQEIAVKRLS-KISEQGLKELKNEVILFSKLQHRNLVK 338
++ +GEG FG V +G GQ++AVK + ++ Q E E + +KL H+NLV+
Sbjct: 8 LTLGEIIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQAFLE---ETAVMTKLHHKNLVR 63
Query: 339 LLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSR 398
LLG I ++ E + +L +F+ + R ++ + A G+ YL
Sbjct: 64 LLGV-ILHNGLYIVMELMSKGNLVNFLRTRGRA-LVSVIQLLQFSLDVAEGMEYLESK-- 119
Query: 399 LRIIHRDLKASNVLLDQDMNPKISDFGLARA 429
+++HRDL A N+L+ +D K+SDFGLAR
Sbjct: 120 -KLVHRDLAARNILVSEDGVAKVSDFGLARV 149
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 8e-15
Identities = 56/169 (33%), Positives = 84/169 (49%), Gaps = 35/169 (20%)
Query: 279 NFSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQG---LKELKNEVILFSKLQHR 334
F N++GEG +G VY+ G+ +A+K++ +E+ + L+ E+ L L+H
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLNLRHP 66
Query: 335 NLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIF------DQERCKILDWSKR-FH------ 381
N+V+L E V K LDS IF +Q+ +LD F
Sbjct: 67 NIVELK-------------EVVVGKHLDS-IFLVMEYCEQDLASLLDNMPTPFSESQVKC 112
Query: 382 IICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
++ RG+ YLH++ IIHRDLK SN+LL KI+DFGLAR +
Sbjct: 113 LMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 8e-15
Identities = 48/168 (28%), Positives = 83/168 (49%), Gaps = 23/168 (13%)
Query: 275 NATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKL-Q 332
+ T F + +GEG +G VYK GQ +A+K + I ++ +E+K E + K
Sbjct: 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKYSN 61
Query: 333 HRNLVKLLGCCIQ-----GEEKL-LIYEFVPNKSLDSFIFDQERCKILDWSKRF------ 380
H N+ G I+ +++L L+ E S + D + + KR
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGS----VTDLVK-GLRKKGKRLKEEWIA 116
Query: 381 HIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
+I+ T RG+ YLH++ ++IHRD+K N+LL ++ K+ DFG++
Sbjct: 117 YILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSA 161
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 9e-15
Identities = 49/155 (31%), Positives = 82/155 (52%), Gaps = 8/155 (5%)
Query: 275 NATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQH 333
+ + + I +LG+G FG VYK + G A K + SE+ L++ E+ + + H
Sbjct: 9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNH 68
Query: 334 RNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTA-RGVMY 392
+VKLLG + ++ EF P ++D+ + + +R + +IC + Y
Sbjct: 69 PYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLT---EPQIQVICRQMLEALQY 125
Query: 393 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
LH ++IIHRDLKA NVLL D + K++DFG++
Sbjct: 126 LHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVS 157
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 1e-14
Identities = 50/153 (32%), Positives = 84/153 (54%), Gaps = 20/153 (13%)
Query: 286 LGEGGFGPVYKGTLVDGQE-----IAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKL 339
LG G FG VYKG V E +A+K L++ + + E +E ++ + + H +LV+L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 340 LGCCIQGEEKLLIYEFVPNKSLDSFIFDQE----RCKILDWSKRFHIICGTARGVMYLHQ 395
LG C+ +L + + +P+ L ++ + + +L+W + A+G+MYL +
Sbjct: 75 LGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMYLEE 127
Query: 396 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
R++HRDL A NVL+ + KI+DFGLAR
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLAR 157
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-14
Identities = 55/164 (33%), Positives = 84/164 (51%), Gaps = 23/164 (14%)
Query: 278 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHR 334
D + K+GEG +G VYK V + IA+K RL + E E+ L ++QH
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 335 NLVKLLGCCIQGEEKL-LIYEFVP---NKSLDS---FIFDQERCKILDWSKRFHIICGTA 387
N+V+L + E++L L++E++ K +DS F + K +
Sbjct: 62 NIVRLQDV-VHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQ--------IL 112
Query: 388 RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLARAF 430
RG+ Y H R++HRDLK N+L+D+ N K++DFGLARAF
Sbjct: 113 RGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAF 153
|
Length = 294 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 1e-14
Identities = 49/167 (29%), Positives = 81/167 (48%), Gaps = 24/167 (14%)
Query: 277 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRL-------SKISEQGLKELKNEVILF 328
NF I K+G+G F VYK L+DG+ +A+K++ +K + LKE+ L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEID----LL 56
Query: 329 SKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFI-FDQERCKILD----WSKRFHII 383
+L H N++K L I+ E ++ E L I +++ +++ W K F +
Sbjct: 57 KQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIW-KYFVQL 115
Query: 384 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
C + ++H RI+HRD+K +NV + K+ D GL R F
Sbjct: 116 C---SALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFF 156
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-14
Identities = 52/164 (31%), Positives = 77/164 (46%), Gaps = 23/164 (14%)
Query: 285 KLGEGGFGPVYKGTLV-----DGQEIAVKRLSKISE-QGLKELKNEVILFSKLQHRNLVK 338
+LGE FG +YKG L Q +A+K L I+ Q E + E L ++L H N+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 339 LLGCCIQGEEKLLIYEFVPNKSLDSFIF--------------DQERCKILDWSKRFHIIC 384
LLG Q + +++E++ L F+ D LD HI
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 385 GTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
A G+ YL S +H+DL A N+L+ + ++ KISD GL+R
Sbjct: 132 QIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 3e-14
Identities = 55/159 (34%), Positives = 75/159 (47%), Gaps = 12/159 (7%)
Query: 278 DNFSINNKLGEGGFGPVYKGT---LVDGQ---EIAVKRLSKISEQGLKE-LKNEVILFSK 330
+N S LG G FG V + T L ++AVK L + +E L +E+ + S
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 331 L-QHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARG 389
L H N+V LLG C G L+I E+ L +F+ ++R L A+G
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFL-RRKRESFLTLEDLLSFSYQVAKG 153
Query: 390 VMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
+ +L + IHRDL A NVLL KI DFGLAR
Sbjct: 154 MAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR 189
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 4e-14
Identities = 49/158 (31%), Positives = 83/158 (52%), Gaps = 22/158 (13%)
Query: 282 INNKLGEGGFGPVYKGTL-VDGQE---IAVKRL-SKISEQGLKELKNEVILFSKLQHRNL 336
I +G G FG V +G L + G+ +A+K L S +E+ ++ +E + + H N+
Sbjct: 8 IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNI 67
Query: 337 VKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIIC------GTARGV 390
+ L G + ++I EF+ N +LDSF+ + +F +I G A G+
Sbjct: 68 IHLEGVVTKSRPVMIITEFMENGALDSFLRQND--------GQFTVIQLVGMLRGIAAGM 119
Query: 391 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
YL S + +HRDL A N+L++ ++ K+SDFGL+R
Sbjct: 120 KYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSR 154
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 5e-14
Identities = 44/150 (29%), Positives = 87/150 (58%), Gaps = 14/150 (9%)
Query: 286 LGEGGFGPVYKGTL-VDGQE---IAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLL 340
+G G FG V++G L + G++ +A+K L +E+ ++ +E + + H N+++L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 341 GCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWS--KRFHIICGTARGVMYLHQDSR 398
G + + ++I E++ N +LD ++ D + ++S + ++ G A G+ YL S
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDG----EFSSYQLVGMLRGIAAGMKYL---SD 125
Query: 399 LRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
+ +HRDL A N+L++ ++ K+SDFGL+R
Sbjct: 126 MNYVHRDLAARNILVNSNLECKVSDFGLSR 155
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 5e-14
Identities = 47/155 (30%), Positives = 81/155 (52%), Gaps = 8/155 (5%)
Query: 275 NATDNFSINNKLGEGGFGPVYKGTLVDGQEIAV-KRLSKISEQGLKELKNEVILFSKLQH 333
N + + I +LG+G FG VYK + +A K + SE+ L++ E+ + + H
Sbjct: 2 NPEEFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDH 61
Query: 334 RNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICG-TARGVMY 392
N+VKLL ++ EF ++D+ + + ER + ++C T + Y
Sbjct: 62 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLT---EPQIRVVCKQTLEALNY 118
Query: 393 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
LH++ +IIHRDLKA N+L D + K++DFG++
Sbjct: 119 LHEN---KIIHRDLKAGNILFTLDGDIKLADFGVS 150
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 6e-14
Identities = 47/145 (32%), Positives = 71/145 (48%), Gaps = 10/145 (6%)
Query: 286 LGEGGFGPVYKGTLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCC 343
LG G FG V+ G ++A+K + + +SE E E + KL H NLV+L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIE---EAKVMMKLSHPNLVQLYGVC 68
Query: 344 IQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIH 403
+ ++ E++ N L +++ +ER L + + YL + IH
Sbjct: 69 TKQRPIFIVTEYMANGCLLNYL--RERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIH 123
Query: 404 RDLKASNVLLDQDMNPKISDFGLAR 428
RDL A N L+ +D K+SDFGLAR
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLAR 148
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 7e-14
Identities = 47/162 (29%), Positives = 91/162 (56%), Gaps = 10/162 (6%)
Query: 267 LFELATIANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKEL-KNE 324
L + +I + ++ K+G+G G V+ V GQE+A+K+++ + +Q KEL NE
Sbjct: 8 LRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQIN-LQKQPKKELIINE 66
Query: 325 VILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIIC 384
+++ +L++ N+V L + G+E ++ E++ SL + E C +D ++ +
Sbjct: 67 ILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVV--TETC--MDEAQIAAVCR 122
Query: 385 GTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 426
+ + +LH + ++IHRD+K+ NVLL D + K++DFG
Sbjct: 123 ECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGF 161
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 8e-14
Identities = 46/153 (30%), Positives = 77/153 (50%), Gaps = 7/153 (4%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDGQE-IAVKR--LSKISEQGLKELKNEVILFSKLQHR 334
D++ + +G G VY + E +A+KR L K + EL+ EV S+ H
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTS-VDELRKEVQAMSQCNHP 59
Query: 335 NLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLH 394
N+VK + G+E L+ ++ SL + LD + ++ +G+ YLH
Sbjct: 60 NVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH 119
Query: 395 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
+ + IHRD+KA N+LL +D + KI+DFG++
Sbjct: 120 SNGQ---IHRDIKAGNILLGEDGSVKIADFGVS 149
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.1 bits (175), Expect = 8e-14
Identities = 41/150 (27%), Positives = 80/150 (53%), Gaps = 9/150 (6%)
Query: 280 FSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLS-KISEQGLKELKNEVILFSKLQHRNLV 337
F++ +G+G FG VYK Q +A+K + + +E +++++ E+ S+ + +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 338 KLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 397
K G ++G + +I E+ S D + LD + I+ G+ YLH++
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGS----CLDLLKPGKLDETYIAFILREVLLGLEYLHEE- 117
Query: 398 RLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
IHRD+KA+N+LL ++ + K++DFG++
Sbjct: 118 --GKIHRDIKAANILLSEEGDVKLADFGVS 145
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 9e-14
Identities = 48/166 (28%), Positives = 88/166 (53%), Gaps = 18/166 (10%)
Query: 267 LFELATIANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELK-NE 324
L + ++ + ++ K+G+G G VY V GQE+A+K+++ + +Q KEL NE
Sbjct: 8 LRTIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMN-LQQQPKKELIINE 66
Query: 325 VILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIIC 384
+++ + +H N+V L + G+E ++ E++ SL + E C +D I
Sbjct: 67 ILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETC--MDEG----QIA 118
Query: 385 GTARGVM----YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 426
R + +LH + ++IHRD+K+ N+LL D + K++DFG
Sbjct: 119 AVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGF 161
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 9e-14
Identities = 47/166 (28%), Positives = 79/166 (47%), Gaps = 22/166 (13%)
Query: 282 INNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN 335
+ +LGEG FG V+ D +AVK L + K+ + E L + LQH +
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 336 LVKLLGCCIQGEEKLLIYEFVPNKSLDSF----------IFDQERCKI---LDWSKRFHI 382
+VK G C G+ ++++E++ + L+ F + D + + L S+ HI
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128
Query: 383 ICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
A G++YL + +HRDL N L+ ++ KI DFG++R
Sbjct: 129 ASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 171
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 1e-13
Identities = 51/167 (30%), Positives = 78/167 (46%), Gaps = 33/167 (19%)
Query: 280 FSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELK-NEVI-------LFSKL 331
+ + +LG+G FG VY + D + +A +RL + E + EL NE + L SKL
Sbjct: 2 YILQQRLGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKL 59
Query: 332 QHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCK----------ILDWSKRFH 381
H +VK ++ + +I E+ + LD E K + +W
Sbjct: 60 DHPAIVKFHASFLERDAFCIITEYCEGRDLD---CKLEELKHTGKTLSENQVCEW----- 111
Query: 382 IICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
GV Y+HQ RI+HRDLKA N+ L ++ KI DFG++R
Sbjct: 112 -FIQLLLGVHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSR 153
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 1e-13
Identities = 39/152 (25%), Positives = 76/152 (50%), Gaps = 8/152 (5%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNL 336
+++ + ++G G +G VYK + E+ ++ K+ + ++ E+ + + +H N+
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62
Query: 337 VKLLGCCIQGEEKLLI-YEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ 395
V G +KL I E+ SL Q L + ++ T +G+ YLH+
Sbjct: 63 VAYFGS-YLRRDKLWIVMEYCGGGSLQDIY--QVTRGPLSELQIAYVCRETLKGLAYLHE 119
Query: 396 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
IHRD+K +N+LL +D + K++DFG++
Sbjct: 120 ---TGKIHRDIKGANILLTEDGDVKLADFGVS 148
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 1e-13
Identities = 46/149 (30%), Positives = 76/149 (51%), Gaps = 13/149 (8%)
Query: 285 KLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKN----EVILFSKLQHRNLVKL 339
+GEG +G V K + GQ +A+K+ + + K +K E+ + +L+H NLV L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD--KMVKKIAMREIRMLKQLRHENLVNL 65
Query: 340 LGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRL 399
+ + + L++EFV + LD ++ LD S+ + RG+ + H +
Sbjct: 66 IEVFRRKKRLYLVFEFVDHTVLDDL---EKYPNGLDESRVRKYLFQILRGIEFCHSHN-- 120
Query: 400 RIIHRDLKASNVLLDQDMNPKISDFGLAR 428
IIHRD+K N+L+ Q K+ DFG AR
Sbjct: 121 -IIHRDIKPENILVSQSGVVKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 46/169 (27%), Positives = 80/169 (47%), Gaps = 28/169 (16%)
Query: 285 KLGEGGFGPVY-------------KGTLVDGQE--IAVKRL-SKISEQGLKELKNEVILF 328
KLGEG FG V+ DGQ +AVK L + +++ + E+ +
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 329 SKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQE-RCKI--------LDWSKR 379
S+L++ N+++LLG C+ + +I E++ N L+ F+ +E + +
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 380 FHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
++ A G+ YL + L +HRDL N L+ KI+DFG++R
Sbjct: 132 LYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSR 177
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 71.1 bits (175), Expect = 2e-13
Identities = 56/164 (34%), Positives = 85/164 (51%), Gaps = 28/164 (17%)
Query: 280 FSINNKLGEGGFGPVYKGTLVD---GQEIAVKRLSKI-----SEQGLKELKNEVILFSKL 331
+ I KLG+G +G V+K +D + +A+K KI + + E++ +L
Sbjct: 9 YEILQKLGKGAYGIVWKA--IDRRTKEVVALK---KIFDAFRNATDAQRTFREIMFLQEL 63
Query: 332 -QHRNLVKLLGCCIQGEEKLLIY---EFVPNKSLDSFIFDQERCKIL-DWSKRFHIICGT 386
H N+VKLL I+ E IY E++ L + I R IL D KR+ I+
Sbjct: 64 GDHPNIVKLLNV-IKAENDKDIYLVFEYM-ETDLHAVI----RANILEDVHKRY-IMYQL 116
Query: 387 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
+ + Y+H S +IHRDLK SN+LL+ D K++DFGLAR+
Sbjct: 117 LKALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSL 157
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 2e-13
Identities = 43/159 (27%), Positives = 76/159 (47%), Gaps = 20/159 (12%)
Query: 284 NKLGEGGFGPVYKGTLV----DGQEIAVKRLS--KISEQGLKELKNEVILFSKLQHRNLV 337
+G+G FG V K V DG+ + K + ++E+ ++L +EV + +L+H N+V
Sbjct: 6 ETIGKGSFGTVRK---VRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIV 62
Query: 338 KLLGCCIQGEEKLL--IYEFVPNKSLDSFIFDQERCK----ILDWSKRFHIICGTARGVM 391
+ I + L + E+ L I ++CK ++ + I+ +
Sbjct: 63 RYYDRIIDRSNQTLYIVMEYCEGGDLAQLI---QKCKKERKYIEEEFIWRILTQLLLALY 119
Query: 392 YLH--QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
H D ++HRDLK +N+ LD + N K+ DFGLA+
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK 158
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 2e-13
Identities = 50/155 (32%), Positives = 85/155 (54%), Gaps = 21/155 (13%)
Query: 285 KLGEGGFGPVYKGTLVDGQEI-AVKRLSKISE-QGLKELK-NEVILFSKLQHRNLVKLLG 341
K+GEG +G V+K + EI A+KR+ + +G+ E+ L +L+H+N+V+L
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 342 CCIQGEEKL-LIYEFVPN---KSLDSF--IFDQERCKILDWSKRFHIICGTARGVMYLHQ 395
+ ++KL L++E+ K DS D E K S F ++ +G+ + H
Sbjct: 67 V-LHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVK----SFMFQLL----KGLAFCHS 117
Query: 396 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
++HRDLK N+L++++ K++DFGLARAF
Sbjct: 118 H---NVLHRDLKPQNLLINKNGELKLADFGLARAF 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 47/182 (25%), Positives = 80/182 (43%), Gaps = 52/182 (28%)
Query: 280 FSINNKLGEGGFGPVYKG---TLVDGQEIAVKRL--SKISEQGLKELK-NEVILFSKLQH 333
+ I +G G +G VYK DG+E A+K+ K G+ + E+ L +L+H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 334 RNLVKLLGCCIQGEEKL--LIYEF-------------------VPNKSLDSFIFDQERCK 372
N+V L+ ++ +K L++++ +P + S ++ +
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLW-----Q 116
Query: 373 ILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNP----KISDFGLAR 428
IL+ GV YLH + ++HRDLK +N+L+ + KI D GLAR
Sbjct: 117 ILN-------------GVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLAR 160
Query: 429 AF 430
F
Sbjct: 161 LF 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 3e-13
Identities = 47/171 (27%), Positives = 85/171 (49%), Gaps = 21/171 (12%)
Query: 273 IANATDNFSINNKLGEGGFGPVYKGTLVDG-----QEIAVKRLSK-ISEQGLKELKNEVI 326
IA + D ++++ L EG FG ++ G L+D +E+ VK + SE + L E
Sbjct: 1 IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESC 60
Query: 327 LFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKS-LDSFIFDQERCKILDWSKR------ 379
L L H+N++ +L CI+ E + N L F+ ++C++ + +
Sbjct: 61 LLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFL---QQCRLGEANNPQALSTQ 117
Query: 380 --FHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
H+ A G+ YLH + +IH+D+ A N ++D+++ KI+D L+R
Sbjct: 118 QLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSR 165
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 3e-13
Identities = 45/167 (26%), Positives = 83/167 (49%), Gaps = 21/167 (12%)
Query: 278 DNFSINNKLGEGGFGPVYKG---TLVDGQ---EIAVKRLSK---ISEQGLKELKNEVILF 328
+ ++ +LG+G FG VY+G +V G+ +A+K +++ + E+ E NE +
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRER--IEFLNEASVM 63
Query: 329 SKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIF----DQERCKILD--WSKRFHI 382
+ ++V+LLG G+ L++ E + L S++ + E L ++F
Sbjct: 64 KEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQ 123
Query: 383 ICG-TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
+ A G+ YL + +HRDL A N ++ +D+ KI DFG+ R
Sbjct: 124 MAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.1 bits (170), Expect = 4e-13
Identities = 46/151 (30%), Positives = 74/151 (49%), Gaps = 16/151 (10%)
Query: 285 KLGEGGFGPVYKGTLVDGQEI-AVKR----LSKISE-QGLKELKNEVILFSKLQ-HRNLV 337
+LG+G FG VY + E+ A+K+ E L+E+K+ KL H N+V
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKS----LRKLNEHPNIV 61
Query: 338 KLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 397
KL + +E ++E++ +L + D++ K S II +G+ ++H
Sbjct: 62 KLKEVFRENDELYFVFEYM-EGNLYQLMKDRKG-KPFSESVIRSIIYQILQGLAHIH--- 116
Query: 398 RLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
+ HRDLK N+L+ KI+DFGLAR
Sbjct: 117 KHGFFHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (170), Expect = 5e-13
Identities = 43/169 (25%), Positives = 77/169 (45%), Gaps = 37/169 (21%)
Query: 280 FSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKN---EVILFSKLQHRN 335
+ + +G G +G V G+++A+K++S + L + K E+ L L+H N
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNV-FDDLIDAKRILREIKLLRHLRHEN 60
Query: 336 LVKLLGCCIQGEEKLLIYEFVPNKSLDSF--------IFDQERCKILDWSKRF------- 380
++ LL + + S + F + + + K++ S +
Sbjct: 61 IIGLL-------------DILRPPSPEDFNDVYIVTELMETDLHKVIK-SPQPLTDDHIQ 106
Query: 381 HIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429
+ + RG+ YLH +IHRDLK SN+L++ + + KI DFGLAR
Sbjct: 107 YFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARG 152
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 6e-13
Identities = 48/153 (31%), Positives = 76/153 (49%), Gaps = 6/153 (3%)
Query: 276 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN 335
++ + KLG G FG V+ GT ++AVK L K + E + KL+H
Sbjct: 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTL-KPGTMSPESFLEEAQIMKKLRHDK 62
Query: 336 LVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ 395
LV+L + E ++ E++ SL F+ D E + L + A G+ Y+
Sbjct: 63 LVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKDGEG-RALKLPNLVDMAAQVAAGMAYIE- 119
Query: 396 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
R+ IHRDL+++N+L+ + KI+DFGLAR
Sbjct: 120 --RMNYIHRDLRSANILVGDGLVCKIADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 6e-13
Identities = 46/162 (28%), Positives = 81/162 (50%), Gaps = 17/162 (10%)
Query: 281 SINNKLGEGGFGPVYKGTLVDGQEI---AVK--RLSKISEQGLKELKNEVILFSKLQHRN 335
++ LGEG FG V +G L I AVK +++ + +++ +E + + H N
Sbjct: 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPN 61
Query: 336 LVKLLGCCIQGEEK------LLIYEFVPNKSLDSFIFDQ---ERCKILDWSKRFHIICGT 386
+++L+G C+Q E ++I F+ + L SF+ + + L +
Sbjct: 62 VMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDI 121
Query: 387 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
A G+ YL S IHRDL A N +L+++MN ++DFGL++
Sbjct: 122 ASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 7e-13
Identities = 50/156 (32%), Positives = 78/156 (50%), Gaps = 16/156 (10%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 337
++ + KLG G FG V+ T ++AVK + K ++ E + LQH LV
Sbjct: 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLV 64
Query: 338 KLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQE-----RCKILDWSKRFHIICGTARGVMY 392
KL + E +I EF+ SL F+ E K++D+S + A G+ +
Sbjct: 65 KL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI------AEGMAF 117
Query: 393 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
+ Q + IHRDL+A+N+L+ + KI+DFGLAR
Sbjct: 118 IEQRN---YIHRDLRAANILVSASLVCKIADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 8e-13
Identities = 46/144 (31%), Positives = 75/144 (52%), Gaps = 6/144 (4%)
Query: 285 KLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCI 344
KLG+G FG V+ GT +A+K L K + E + KL+H LV+L +
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 70
Query: 345 QGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHR 404
E ++ E++ SL F+ E K L + + A G+ Y+ R+ +HR
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 126
Query: 405 DLKASNVLLDQDMNPKISDFGLAR 428
DL+A+N+L+ +++ K++DFGLAR
Sbjct: 127 DLRAANILVGENLVCKVADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 51/153 (33%), Positives = 80/153 (52%), Gaps = 20/153 (13%)
Query: 285 KLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLLGC 342
KLGEG + VYKG + + GQ +A+K + E+G E L L+H N+V L
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIV-TLHD 70
Query: 343 CIQGEEKL-LIYEFVPNKSLDSFIFDQERC-KILDWSK----RFHIICGTARGVMYLHQD 396
I ++ L L++E++ + L ++ + C L F ++ RG+ Y HQ
Sbjct: 71 IIHTKKTLTLVFEYL-DTDLKQYM---DDCGGGLSMHNVRLFLFQLL----RGLAYCHQR 122
Query: 397 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429
R++HRDLK N+L+ + K++DFGLARA
Sbjct: 123 ---RVLHRDLKPQNLLISERGELKLADFGLARA 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 58/174 (33%), Positives = 85/174 (48%), Gaps = 26/174 (14%)
Query: 278 DNFSINNKLGEGGFGPVYK----GTLVDGQE----IAVKRLS-KISEQGLKELKNEVILF 328
D + LGEG FG V + G + +AVK L +++ L +L +E+ L
Sbjct: 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELM 71
Query: 329 SKL-QHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFI-----------FDQERCKILDW 376
+ +H+N++ LLG C Q +I E+ +L F+ FD +
Sbjct: 72 KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131
Query: 377 SKRFHIICG--TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
S + + C ARG+ YL +SR R IHRDL A NVL+ +D KI+DFGLAR
Sbjct: 132 SFKDLVSCAYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKIADFGLAR 182
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 1e-12
Identities = 47/152 (30%), Positives = 70/152 (46%), Gaps = 13/152 (8%)
Query: 284 NKLGEGGFGPVYKG---TLVDGQEIAVKRL---SKISEQGLKELKNEVILFSKLQHRNLV 337
+++G G FG V G + + VK L + EQ L EV + +L H N++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLL--FLQEVQPYRELNHPNVL 58
Query: 338 KLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRF--HIICGTARGVMYLHQ 395
+ LG CI+ LL+ EF P L +++ K + C A G+++LHQ
Sbjct: 59 QCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ 118
Query: 396 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
IH DL N L D++ KI D+GLA
Sbjct: 119 ---ADFIHSDLALRNCQLTADLSVKIGDYGLA 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 52/165 (31%), Positives = 81/165 (49%), Gaps = 27/165 (16%)
Query: 286 LGEGGFGPVYKGTL-VDG--QEIAVKRLSK-ISEQGLKELKNEVILFSKL-QHRNLVKLL 340
+GEG FG V K + DG + A+KR+ + S+ ++ E+ + KL H N++ LL
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 341 GCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTA------------- 387
G C L E+ P+ +L F+ + ++L+ F I TA
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFL---RKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 388 ---RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429
RG+ YL Q + IHRDL A N+L+ ++ KI+DFGL+R
Sbjct: 132 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRG 173
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 48/158 (30%), Positives = 75/158 (47%), Gaps = 16/158 (10%)
Query: 280 FSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSKISEQGLKE---LKNEVILFSKLQHRN 335
F I ++G+GG+G V+ D EI A+KR+ K L E + E + + +
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 336 LVKLLGCCIQGEEKL-LIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLH 394
LVKLL Q +E L L E+VP + + + + RF++ M+
Sbjct: 63 LVKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLS--EDHARFYMA------EMFEA 113
Query: 395 QDS--RLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
D+ L IHRDLK N L+D + K++DFGL++
Sbjct: 114 VDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGI 151
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 47/153 (30%), Positives = 85/153 (55%), Gaps = 20/153 (13%)
Query: 286 LGEGGFGPVYKGTLV-DGQEI----AVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKL 339
LG G FG VYKG + +G+++ A+K L + S + KE+ +E + + + + ++ +L
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 340 LGCCIQGEEKLLIYEFVPNKSLDSFIFD-QERC---KILDWSKRFHIICGTARGVMYLHQ 395
LG C+ +L I + +P L ++ + ++ +L+W + A+G+ YL +
Sbjct: 75 LGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYLEE 127
Query: 396 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
R++HRDL A NVL+ + KI+DFGLA+
Sbjct: 128 R---RLVHRDLAARNVLVKTPQHVKITDFGLAK 157
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 2e-12
Identities = 46/161 (28%), Positives = 83/161 (51%), Gaps = 22/161 (13%)
Query: 279 NFSINNKLGEGGFGPVYKGTL-VDGQE---IAVKRL-SKISEQGLKELKNEVILFSKLQH 333
I +G G FG V G L + G+ +A+K L + +E+ ++ +E + + H
Sbjct: 5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDH 64
Query: 334 RNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIIC------GTA 387
N++ L G + + +++ E++ N SLD+F+ + +F +I G A
Sbjct: 65 PNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHD--------GQFTVIQLVGMLRGIA 116
Query: 388 RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
G+ YL S + +HRDL A N+L++ ++ K+SDFGL+R
Sbjct: 117 SGMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSR 154
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 43/157 (27%), Positives = 72/157 (45%), Gaps = 13/157 (8%)
Query: 278 DNFSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLKELKN----EVILFSKLQ 332
+ + + +GEG +G V K G+ +A+K+ K SE +++K EV + +L+
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKF-KESEDD-EDVKKTALREVKVLRQLR 58
Query: 333 HRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMY 392
H N+V L + L++E+V L+ + L I + + Y
Sbjct: 59 HENIVNLKEAFRRKGRLYLVFEYVERTLLELL---EASPGGLPPDAVRSYIWQLLQAIAY 115
Query: 393 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429
H IIHRD+K N+L+ + K+ DFG ARA
Sbjct: 116 CH---SHNIIHRDIKPENILVSESGVLKLCDFGFARA 149
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 2e-12
Identities = 45/159 (28%), Positives = 81/159 (50%), Gaps = 15/159 (9%)
Query: 279 NFSINNKLGEGGFGPVYK-GTLVDGQEIAVKR--LSKISEQGLKELKNEVILFSKLQHRN 335
+F + KLG+G +G VYK L D Q A+K L +S++ ++ NE+ + + + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 336 LVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKIL-----DWSKRFHIICGTARGV 390
++ + G + ++ E+ P L I +++ + L W I RG+
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWR----IFIQLLRGL 116
Query: 391 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429
LH+ +I+HRDLK++N+LL + KI D G+++
Sbjct: 117 QALHE---QKILHRDLKSANILLVANDLVKIGDLGISKV 152
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 2e-12
Identities = 44/162 (27%), Positives = 75/162 (46%), Gaps = 22/162 (13%)
Query: 279 NFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQHR 334
+F + +G+G FG V D +++ A+K ++K + + ++ + NE + +L H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 335 NLVKLLGCCIQGEEKL-LIYEFVPNKSLDSFI-----FDQERCKILDWSKRFHIICGTAR 388
LV L Q EE + L+ + + L + F +E+ K IC
Sbjct: 61 FLVNLWYS-FQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKF--------WICEIVL 111
Query: 389 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
+ YLH IIHRD+K N+LLD+ + I+DF +A
Sbjct: 112 ALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKV 150
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 46/150 (30%), Positives = 77/150 (51%), Gaps = 13/150 (8%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 336
DNF K+GEG G V T G+++AVK++ +Q + L NEV++ QH N+
Sbjct: 22 DNF---VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI 78
Query: 337 VKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIIC-GTARGVMYLHQ 395
V++ + G+E ++ EF+ +L I R ++ +C + + +LH
Sbjct: 79 VEMYSSYLVGDELWVVMEFLEGGALTD-IVTHTRMN----EEQIATVCLAVLKALSFLHA 133
Query: 396 DSRLRIIHRDLKASNVLLDQDMNPKISDFG 425
+IHRD+K+ ++LL D K+SDFG
Sbjct: 134 Q---GVIHRDIKSDSILLTSDGRVKLSDFG 160
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 3e-12
Identities = 50/152 (32%), Positives = 81/152 (53%), Gaps = 18/152 (11%)
Query: 285 KLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLLGC 342
KLGEG + VYKG + ++GQ +A+K +S +E+G+ E L L+H N+V LL
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIV-LLHD 70
Query: 343 CIQGEEKL-LIYEFVPNKSLDSFIFDQ----ERCKILDWSKRFHIICGTARGVMYLHQDS 397
I +E L ++E++ + L ++ + + F ++ RG+ Y+H
Sbjct: 71 IIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLF--MFQLL----RGLAYIH--- 120
Query: 398 RLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429
I+HRDLK N+L+ K++DFGLARA
Sbjct: 121 GQHILHRDLKPQNLLISYLGELKLADFGLARA 152
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 3e-12
Identities = 55/166 (33%), Positives = 86/166 (51%), Gaps = 12/166 (7%)
Query: 270 LATIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEV-IL 327
L ++ + TD + I +G+G +G VYK T DG AVK L IS+ +E++ E IL
Sbjct: 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEYNIL 72
Query: 328 FSKLQHRNLVKLLGCCIQ-----GEEKLLIYEFVPNKSLDSFIFDQERC-KILDWSKRFH 381
S H N+VK G + G + L+ E S+ + C + LD + +
Sbjct: 73 QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISY 132
Query: 382 IICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
I+ G G+ +LH + RIIHRD+K +N+LL + K+ DFG++
Sbjct: 133 ILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVS 175
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 3e-12
Identities = 44/157 (28%), Positives = 79/157 (50%), Gaps = 28/157 (17%)
Query: 286 LGEGGFGPVYK------GTLVDGQEIAVKRLSKISEQG--LKELKNEVILFSKLQHRNLV 337
LG G F Y+ GTL+ +++ R + SEQ ++ L+ E+ L ++L H +++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTS-SEQEEVVEALRKEIRLMARLNHPHII 66
Query: 338 KLLGCCIQGEEKLLIYEFVPNKSLDSFIFD----QERCKILDWSKRFHIICGTARGVMYL 393
++LG + L E++ S+ + +E I + RG+ YL
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVII----NYTEQLL---RGLSYL 119
Query: 394 HQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLA 427
H++ +IIHRD+K +N+L+D Q + +I+DFG A
Sbjct: 120 HEN---QIIHRDVKGANLLIDSTGQRL--RIADFGAA 151
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 4e-12
Identities = 44/162 (27%), Positives = 89/162 (54%), Gaps = 10/162 (6%)
Query: 267 LFELATIANATDNFSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLKELK-NE 324
L + ++ + ++ K+G+G G VY + GQE+A+K+++ + +Q KEL NE
Sbjct: 8 LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMN-LQQQPKKELIINE 66
Query: 325 VILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIIC 384
+++ + ++ N+V L + G+E ++ E++ SL + E C +D + +
Sbjct: 67 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETC--MDEGQIAAVCR 122
Query: 385 GTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 426
+ + +LH + ++IHRD+K+ N+LL D + K++DFG
Sbjct: 123 ECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGF 161
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|214680 smart00473, PAN_AP, divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 4e-12
Identities = 29/81 (35%), Positives = 40/81 (49%), Gaps = 6/81 (7%)
Query: 162 STQDGFIKFTELKLPDATSSWVSKSMNLYECQDKCLD-NSSCMAYTNSDIRGEGSGCAMW 220
+ D F++ KLP S V +L EC KCL+ N SC ++T ++ GC +W
Sbjct: 1 KSDDCFVRLPNTKLPG-FSRIVISVASLEECASKCLNSNCSCRSFTYNN---GTKGCLLW 56
Query: 221 -FGDLIDMRSFPDGGQDFYIR 240
L D R FP GG D Y +
Sbjct: 57 SESSLGDARLFPSGGVDLYEK 77
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. Length = 78 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 6e-12
Identities = 48/151 (31%), Positives = 79/151 (52%), Gaps = 6/151 (3%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 337
++ ++ KLG+G FG V+ GT ++A+K L K + E + KL+H LV
Sbjct: 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTL-KPGTMMPEAFLQEAQIMKKLRHDKLV 64
Query: 338 KLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 397
L + E ++ EF+ SL F+ + + K L + + A G+ Y+
Sbjct: 65 PLYAV-VSEEPIYIVTEFMGKGSLLDFLKEGDG-KYLKLPQLVDMAAQIADGMAYIE--- 119
Query: 398 RLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
R+ IHRDL+A+N+L+ ++ KI+DFGLAR
Sbjct: 120 RMNYIHRDLRAANILVGDNLVCKIADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 6e-12
Identities = 43/162 (26%), Positives = 89/162 (54%), Gaps = 10/162 (6%)
Query: 267 LFELATIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELK-NE 324
L + ++ + ++ K+G+G G VY + GQE+A+++++ + +Q KEL NE
Sbjct: 9 LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN-LQQQPKKELIINE 67
Query: 325 VILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIIC 384
+++ + ++ N+V L + G+E ++ E++ SL + E C +D + +
Sbjct: 68 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETC--MDEGQIAAVCR 123
Query: 385 GTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 426
+ + +LH + ++IHRD+K+ N+LL D + K++DFG
Sbjct: 124 ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGF 162
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 7e-12
Identities = 48/161 (29%), Positives = 78/161 (48%), Gaps = 16/161 (9%)
Query: 279 NFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLS---KISEQGLKELKNEVILFSKLQHR 334
NF I K+G G F VY+ T L+D + +A+K++ + + ++ E+ L +L H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 335 NLVKLLGCCIQGEEKLLIYEFVPNKSLDSFI--FDQERCKILD---WSKRFHIICGTARG 389
N++K L I+ E ++ E L I F +++ I + W K F +C
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVW-KYFVQLCSAVE- 120
Query: 390 VMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
H SR R++HRD+K +NV + K+ D GL R F
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFF 156
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 7e-12
Identities = 46/149 (30%), Positives = 74/149 (49%), Gaps = 9/149 (6%)
Query: 285 KLGEGGFGPVYKGTLVDG---QEIAVKRL-SKISEQGLKELKNEVILFSKLQHRNLVKLL 340
++G G FG V G + G ++ VK L S Q + E + LQH NL++ L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 341 GCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKIL--DWSKRFHIICGTARGVMYLHQDSR 398
G C + LL+ EF P L ++ + +++ D + + C A G+++LH+++
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120
Query: 399 LRIIHRDLKASNVLLDQDMNPKISDFGLA 427
IH DL N LL D+ KI D+GL+
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 9e-12
Identities = 56/155 (36%), Positives = 83/155 (53%), Gaps = 19/155 (12%)
Query: 286 LGEGGFGPVY------KGTLVDGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVK 338
LGEG FG V +G G+++AVK L S + +LK E+ + L H N+VK
Sbjct: 12 LGEGHFGKVELCRYDPEGDNT-GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 339 LLGCCIQGEEK--LLIYEFVPNKSLDSFIFDQERCKI-LDWSKRFHI-ICGTARGVMYLH 394
G C + LI EF+P+ SL ++ + + KI L ++ + IC +G+ YL
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYL-PRNKNKINLKQQLKYAVQIC---KGMDYL- 125
Query: 395 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429
SR + +HRDL A NVL++ + KI DFGL +A
Sbjct: 126 -GSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKA 158
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 41/150 (27%), Positives = 76/150 (50%), Gaps = 18/150 (12%)
Query: 286 LGEGGFGPVYKGTLV-DGQEIAVKRLS-KISEQGLKELKNEVILFSKLQH---RNLVKLL 340
+G G +G VY+G V G+ +A+K ++ + + +++ EV L S+L+ N+ K
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 341 GCCIQGEEKLLIYEFVPNKSLDSFIFDQ---ERCKILDWSKRFHIICGTARGVMYLHQDS 397
G ++G +I E+ S+ + + E+ + II + Y+H+
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISV-------IIREVLVALKYIHKVG 121
Query: 398 RLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
+IHRD+KA+N+L+ N K+ DFG+A
Sbjct: 122 ---VIHRDIKAANILVTNTGNVKLCDFGVA 148
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 53/176 (30%), Positives = 85/176 (48%), Gaps = 26/176 (14%)
Query: 276 ATDNFSINNKLGEGGFGPVYKGTLV--DGQE------IAVKRL-SKISEQGLKELKNEVI 326
D + LGEG FG V + D ++ +AVK L S +E+ L +L +E+
Sbjct: 16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEME 75
Query: 327 LFSKL-QHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFI-----------FDQERCKIL 374
+ + +H+N++ LLG C Q +I E+ +L ++ ++ +
Sbjct: 76 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEE 135
Query: 375 DWSKRFHIICG--TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
S + + C ARG+ YL + + IHRDL A NVL+ +D KI+DFGLAR
Sbjct: 136 QLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 188
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-11
Identities = 53/163 (32%), Positives = 85/163 (52%), Gaps = 24/163 (14%)
Query: 279 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRL-----SKISEQGLKELKNEVILFSKLQ 332
N+ + LG G FG VY D G+E+AVK++ S+ + + + L+ E+ L L+
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 333 HRNLVKLLGCCIQGEEKLL--IYEFVPNKSLDSFIFDQERCK---ILDWSKRF--HIICG 385
H +V+ GC EEK L E++P S I DQ + + ++R+ I+
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGS----IKDQLKAYGALTENVTRRYTRQIL-- 116
Query: 386 TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
+GV YLH + I+HRD+K +N+L D N K+ DFG ++
Sbjct: 117 --QGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 44/174 (25%), Positives = 81/174 (46%), Gaps = 41/174 (23%)
Query: 275 NATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQ-----GLKELKNEVILF 328
+ + + +GEG +G V T G ++A+K++S Q L+E+K +
Sbjct: 2 DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIK----IL 57
Query: 329 SKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSF--------IFDQERCKILDWSKRF 380
+ +H N++ I + + S +SF + + + K++ ++
Sbjct: 58 RRFKHENIIG-------------ILDIIRPPSFESFNDVYIVQELMETDLYKLIK-TQHL 103
Query: 381 ---HI---ICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
HI + RG+ Y+H + ++HRDLK SN+LL+ + + KI DFGLAR
Sbjct: 104 SNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLAR 154
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-11
Identities = 48/153 (31%), Positives = 82/153 (53%), Gaps = 20/153 (13%)
Query: 286 LGEGGFGPVYKGTLV-DGQEI----AVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKL 339
LG G FG VYKG + DG+ + A+K L + S + KE+ +E + + + + +L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 340 LGCCIQGEEKLLIYEFVPNKSLDSFIFDQE----RCKILDWSKRFHIICGTARGVMYLHQ 395
LG C+ +L + + +P L ++ + + +L+W + A+G+ YL +
Sbjct: 75 LGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYLEE 127
Query: 396 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
+R++HRDL A NVL+ + KI+DFGLAR
Sbjct: 128 ---VRLVHRDLAARNVLVKSPNHVKITDFGLAR 157
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 1e-11
Identities = 46/146 (31%), Positives = 74/146 (50%), Gaps = 10/146 (6%)
Query: 285 KLGEGGFGPVYKGTLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGC 342
+LG G FG V+ G ++A+K +++ +SE+ E E + KL H LV+L G
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIE---EAKVMMKLSHPKLVQLYGV 67
Query: 343 CIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRII 402
C Q + ++ EF+ N L +++ ++R L + G+ YL ++S I
Sbjct: 68 CTQQKPLYIVTEFMENGCLLNYL--RQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FI 122
Query: 403 HRDLKASNVLLDQDMNPKISDFGLAR 428
HRDL A N L+ K+SDFG+ R
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTR 148
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 47/147 (31%), Positives = 76/147 (51%), Gaps = 10/147 (6%)
Query: 285 KLGEGGFGPVYKGTLVDGQEI-AVKRLS---KISEQGLKELKNEVILFSKLQHRNLVKLL 340
++G G FG VY V E+ A+K++S K S + +++ EV +L+H N ++
Sbjct: 22 EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYK 81
Query: 341 GCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLR 400
GC ++ L+ E+ + D I + + K L + I G +G+ YLH R
Sbjct: 82 GCYLREHTAWLVMEYCLGSASD--ILEVHK-KPLQEVEIAAICHGALQGLAYLHSHER-- 136
Query: 401 IIHRDLKASNVLLDQDMNPKISDFGLA 427
IHRD+KA N+LL + K++DFG A
Sbjct: 137 -IHRDIKAGNILLTEPGTVKLADFGSA 162
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 2e-11
Identities = 43/144 (29%), Positives = 73/144 (50%), Gaps = 8/144 (5%)
Query: 286 LGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ 345
+G+G FG V G G ++AVK + ++ + E + ++L+H NLV+LLG ++
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 346 GEEKLLIY-EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHR 404
+ L I E++ SL ++ + R +L + YL ++ +HR
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEANN---FVHR 126
Query: 405 DLKASNVLLDQDMNPKISDFGLAR 428
DL A NVL+ +D K+SDFGL +
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 63.8 bits (156), Expect = 2e-11
Identities = 45/154 (29%), Positives = 74/154 (48%), Gaps = 28/154 (18%)
Query: 289 GGFGPVY----KGTLVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLG 341
G +G V+ K T G A+K + K I + + ++ E + S+ Q +VKL
Sbjct: 4 GAYGRVFLAKKKST---GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59
Query: 342 CCIQGEEKL-LIYEFVPNKSLDSFI-----FDQERCKILDWSKRFHIICGTARGVMYLHQ 395
QG++ L L+ E++P L S + D++ +I I + YLH
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARI--------YIAEIVLALEYLHS 111
Query: 396 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429
IIHRDLK N+L+D + + K++DFGL++
Sbjct: 112 ---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKV 142
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 44/146 (30%), Positives = 69/146 (47%), Gaps = 7/146 (4%)
Query: 285 KLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLLGC 342
++G G FG V+ G L D +AVK + LK + E + + H N+V+L+G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 343 CIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRII 402
C Q + ++ E V +F+ + L + ++ A G+ YL I
Sbjct: 62 CTQKQPIYIVMELVQGGDFLTFL--RTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 403 HRDLKASNVLLDQDMNPKISDFGLAR 428
HRDL A N L+ + KISDFG++R
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR 142
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 2e-11
Identities = 48/153 (31%), Positives = 77/153 (50%), Gaps = 22/153 (14%)
Query: 286 LGEGGFGPVYKGTLV-DGQEI----AVKRL-SKISEQGLKELKNEVILFSKLQHRNLVKL 339
LG G FG V+KG + +G I A+K + + Q +E+ + ++ L H +V+L
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 340 LGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKI-----LDWSKRFHIICGTARGVMYLH 394
LG C G L+ + P SL + Q R + L+W + A+G+ YL
Sbjct: 75 LGIC-PGASLQLVTQLSPLGSLLDHV-RQHRDSLDPQRLLNWCVQI------AKGMYYLE 126
Query: 395 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
+ R++HR+L A N+LL D +I+DFG+A
Sbjct: 127 EH---RMVHRNLAARNILLKSDSIVQIADFGVA 156
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 43/152 (28%), Positives = 79/152 (51%), Gaps = 10/152 (6%)
Query: 280 FSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLS---KISEQGLKELKNEVILFSKLQHRN 335
F+ ++G G FG VY V E+ A+K++S K S + +++ EV +++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 336 LVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ 395
++ GC ++ L+ E+ + D ++ + ++ + H G +G+ YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITH---GALQGLAYLHS 143
Query: 396 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
+ +IHRD+KA N+LL + K++DFG A
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSA 172
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 51/174 (29%), Positives = 83/174 (47%), Gaps = 26/174 (14%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLV--------DGQEIAVKRLS-KISEQGLKELKNEVILF 328
D ++ LGEG FG V + + +AVK L +E+ L +L +E+ +
Sbjct: 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 74
Query: 329 SKL-QHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFI-----------FDQERCKILDW 376
+ +H+N++ LLG C Q +I E+ +L ++ +D R
Sbjct: 75 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQM 134
Query: 377 SKRFHIICG--TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
+ + + C ARG+ YL + + IHRDL A NVL+ ++ KI+DFGLAR
Sbjct: 135 TFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 185
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 45/167 (26%), Positives = 81/167 (48%), Gaps = 13/167 (7%)
Query: 269 ELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILF 328
+L+ + + F + +G G +G VYKG V ++A ++ ++E +E+K E+ +
Sbjct: 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINML 66
Query: 329 SKL-QHRNLVKLLGCCI------QGEEKLLIYEFVPNKSLDSFIFDQE-RCKILDWSKRF 380
K HRN+ G I ++ L+ EF S+ + + + DW
Sbjct: 67 KKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIA-- 124
Query: 381 HIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
+I RG+ +LH ++IHRD+K NVLL ++ K+ DFG++
Sbjct: 125 YICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVS 168
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 46/152 (30%), Positives = 78/152 (51%), Gaps = 10/152 (6%)
Query: 280 FSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLS---KISEQGLKELKNEVILFSKLQHRN 335
FS ++G G FG VY V E+ A+K++S K S + +++ EV KL+H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 336 LVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ 395
++ GC ++ L+ E+ + D ++ + ++ + H G +G+ YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTH---GALQGLAYLHS 133
Query: 396 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
+ +IHRD+KA N+LL + K+ DFG A
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSA 162
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 44/144 (30%), Positives = 72/144 (50%), Gaps = 10/144 (6%)
Query: 285 KLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC 343
K+GEG G V T G+++AVK++ +Q + L NEV++ H N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 344 IQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIIC-GTARGVMYLHQDSRLRII 402
+ G+E ++ EF+ +L I R ++ +C R + YLH +I
Sbjct: 89 LVGDELWVVMEFLEGGALTD-IVTHTRMN----EEQIATVCLSVLRALSYLHNQG---VI 140
Query: 403 HRDLKASNVLLDQDMNPKISDFGL 426
HRD+K+ ++LL D K+SDFG
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGF 164
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 54/155 (34%), Positives = 82/155 (52%), Gaps = 10/155 (6%)
Query: 278 DNFSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRN 335
D++ KLGEG + VYKG + V+G+ +A+K + E+G E L L+H N
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 336 LVKLLGCCIQGEEKL-LIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLH 394
+V LL I +E L L++E+V + L ++ + K F + RG+ Y+H
Sbjct: 65 IV-LLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLF--LFQLLRGLSYIH 120
Query: 395 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429
Q I+HRDLK N+L+ K++DFGLARA
Sbjct: 121 QRY---ILHRDLKPQNLLISDTGELKLADFGLARA 152
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 43/148 (29%), Positives = 78/148 (52%), Gaps = 10/148 (6%)
Query: 284 NKLGEGGFGPVYKGTLVDGQEI-AVKRLS---KISEQGLKELKNEVILFSKLQHRNLVKL 339
+++G G FG VY T E+ AVK++S K + + +++ EV +L+H N ++
Sbjct: 27 HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86
Query: 340 LGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRL 399
GC ++ L+ E+ + D ++ + ++ + H G +G+ YLH +
Sbjct: 87 KGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITH---GALQGLAYLHSHN-- 141
Query: 400 RIIHRDLKASNVLLDQDMNPKISDFGLA 427
+IHRD+KA N+LL + K++DFG A
Sbjct: 142 -MIHRDIKAGNILLTEPGQVKLADFGSA 168
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 3e-11
Identities = 46/146 (31%), Positives = 71/146 (48%), Gaps = 10/146 (6%)
Query: 285 KLGEGGFGPVYKGTLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGC 342
+LG G FG V G ++A+K + + +SE E E + KL H LV+L G
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMKLSHEKLVQLYGV 67
Query: 343 CIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRII 402
C + ++ E++ N L +++ +E K S+ + G+ YL + I
Sbjct: 68 CTKQRPIYIVTEYMSNGCLLNYL--REHGKRFQPSQLLEMCKDVCEGMAYLESK---QFI 122
Query: 403 HRDLKASNVLLDQDMNPKISDFGLAR 428
HRDL A N L+D K+SDFGL+R
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSR 148
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 3e-11
Identities = 45/144 (31%), Positives = 69/144 (47%), Gaps = 29/144 (20%)
Query: 299 LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFV 356
V GQ +A+K+LS+ + K E++L + H+N++ LL F
Sbjct: 38 TVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNV------------FT 85
Query: 357 PNKSLDSF--------IFDQERCKI----LDWSKRFHIICGTARGVMYLHQDSRLRIIHR 404
P KSL+ F + D C++ LD + +++ G+ +LH IIHR
Sbjct: 86 PQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAG---IIHR 142
Query: 405 DLKASNVLLDQDMNPKISDFGLAR 428
DLK SN+++ D KI DFGLAR
Sbjct: 143 DLKPSNIVVKSDCTLKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 3e-11
Identities = 49/178 (27%), Positives = 82/178 (46%), Gaps = 37/178 (20%)
Query: 285 KLGEGGFGPVYKGTLVDGQE-----------------IAVKRL-SKISEQGLKELKNEVI 326
KLGEG FG V+ +V+ Q+ +AVK L ++ + EV
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 327 LFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFI---------------FDQERC 371
+ S+L+ N+++LLG C+ + +I E++ N L+ F+ C
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 372 -KILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
+ +S H+ A G+ YL S L +HRDL N L+ +++ KI+DFG++R
Sbjct: 132 LPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSR 186
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 4e-11
Identities = 46/158 (29%), Positives = 68/158 (43%), Gaps = 28/158 (17%)
Query: 284 NKLGEGGFGPVYKGTLV-DGQEIAVKRL-----SKISEQGLKELKNEVILFSKLQHRNLV 337
+LG G G V K G+ +AVK + I +Q L+EL IL K +V
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELD---ILH-KCNSPYIV 62
Query: 338 KLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILD-WSKRF------HIICGTARGV 390
G + + E++ SLD KIL R I +G+
Sbjct: 63 GFYGAFYNNGDISICMEYMDGGSLD---------KILKEVQGRIPERILGKIAVAVLKGL 113
Query: 391 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
YLH + +IIHRD+K SN+L++ K+ DFG++
Sbjct: 114 TYLH--EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSG 149
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 50/172 (29%), Positives = 84/172 (48%), Gaps = 26/172 (15%)
Query: 280 FSINNKLGEGGFGPVYKGTLVDGQE--------IAVKRLSK-ISEQGLKELKNEVILFSK 330
++ LGEG FG V + + +AVK L +++ L +L +E+ +
Sbjct: 14 LTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKM 73
Query: 331 L-QHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFI---------FDQERCKILDWSKRF 380
+ +H+N++ LLG C Q ++ E+ +L ++ + + CK+ + F
Sbjct: 74 IGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTF 133
Query: 381 H--IICG--TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
+ C ARG+ YL + + IHRDL A NVL+ +D KI+DFGLAR
Sbjct: 134 KDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLAR 182
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 4e-11
Identities = 40/154 (25%), Positives = 79/154 (51%), Gaps = 7/154 (4%)
Query: 275 NATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISE-QGLKELKNEVILFSKLQH 333
N ++F + ++G G +G VYK V+ E+A ++ K+ + ++ E+I+ +H
Sbjct: 6 NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKH 65
Query: 334 RNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 393
N+V G ++ ++ + EF SL L S+ ++ T +G+ YL
Sbjct: 66 SNIVAYFGSYLRRDKLWICMEFCGGGSLQDIY---HVTGPLSESQIAYVSRETLQGLYYL 122
Query: 394 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
H + +HRD+K +N+LL + + K++DFG++
Sbjct: 123 HSKGK---MHRDIKGANILLTDNGHVKLADFGVS 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 4e-11
Identities = 46/151 (30%), Positives = 76/151 (50%), Gaps = 13/151 (8%)
Query: 278 DNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 336
DNF K+GEG G V T+ G+ +AVK++ +Q + L NEV++ QH N+
Sbjct: 23 DNFI---KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79
Query: 337 VKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIIC-GTARGVMYLHQ 395
V++ + G+E ++ EF+ +L I R ++ +C + + LH
Sbjct: 80 VEMYNSYLVGDELWVVMEFLEGGALTD-IVTHTRMN----EEQIAAVCLAVLKALSVLHA 134
Query: 396 DSRLRIIHRDLKASNVLLDQDMNPKISDFGL 426
+IHRD+K+ ++LL D K+SDFG
Sbjct: 135 QG---VIHRDIKSDSILLTHDGRVKLSDFGF 162
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 4e-11
Identities = 51/170 (30%), Positives = 84/170 (49%), Gaps = 41/170 (24%)
Query: 284 NKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQ------GLKELKNEVILFSKLQHRNL 336
K+G+G FG V+K Q +A+K++ +E+ L+E+K IL L+H N+
Sbjct: 18 AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIK---IL-QLLKHENV 73
Query: 337 VKLLGCC---IQGEEK-----LLIYEF--------VPNKSLDSFIFDQERCKILDWSKRF 380
V L+ C + L++EF + NK++ F K
Sbjct: 74 VNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVK---FTLSEIK-------- 122
Query: 381 HIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
++ G+ Y+H R +I+HRD+KA+N+L+ +D K++DFGLARAF
Sbjct: 123 KVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAF 169
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 5e-11
Identities = 51/149 (34%), Positives = 81/149 (54%), Gaps = 10/149 (6%)
Query: 284 NKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLLG 341
+KLGEG + VYKG + + +A+K + E+G EV L L+H N+V L
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 342 CCIQGEEKL-LIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLR 400
I E+ L L++E++ +K L ++ D + K F + RG+ Y H R +
Sbjct: 72 I-IHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLF--LFQLLRGLNYCH---RRK 124
Query: 401 IIHRDLKASNVLLDQDMNPKISDFGLARA 429
++HRDLK N+L+++ K++DFGLARA
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARA 153
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 5e-11
Identities = 41/164 (25%), Positives = 83/164 (50%), Gaps = 16/164 (9%)
Query: 279 NFSINNKLGEGGFGPVYK-------GTLVDGQEIAVKRLS-----KISEQGLKELKNEV- 325
+++ LG G FG VYK L+ +EI V + + ++ + ++ +EV
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 326 ILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSL-DSFIFDQERCKILDWSKRFHIIC 384
I+ +L+H N+V+ ++ + ++ + + L + F +E+ + + ++I
Sbjct: 61 IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120
Query: 385 GTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
+ YLH++ R I+HRDL +N++L +D I+DFGLA+
Sbjct: 121 QMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK 162
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 5e-11
Identities = 50/163 (30%), Positives = 81/163 (49%), Gaps = 24/163 (14%)
Query: 279 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRL-----SKISEQGLKELKNEVILFSKLQ 332
N+ + LG+G FG VY D G+E+AVK++ S + + + L+ E+ L L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 333 HRNLVKLLGCCIQGEEKLL--IYEFVPNKSLDSFIFDQERCK---ILDWSKRF--HIICG 385
H +V+ GC E+ L E +P S I DQ + + ++++ I+
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGS----IKDQLKSYGALTENVTRKYTRQIL-- 116
Query: 386 TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
GV YLH + I+HRD+K +N+L D N K+ DFG ++
Sbjct: 117 --EGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 6e-11
Identities = 45/144 (31%), Positives = 75/144 (52%), Gaps = 10/144 (6%)
Query: 285 KLGEGGFGPV-YKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC 343
K+GEG G V G+++AVK + +Q + L NEV++ QH+N+V++
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 344 IQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTA-RGVMYLHQDSRLRII 402
+ GEE ++ EF+ +L I Q R ++ +C + + + YLH +I
Sbjct: 88 LVGEELWVLMEFLQGGALTD-IVSQTRLN----EEQIATVCESVLQALCYLHSQG---VI 139
Query: 403 HRDLKASNVLLDQDMNPKISDFGL 426
HRD+K+ ++LL D K+SDFG
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGF 163
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 6e-11
Identities = 48/161 (29%), Positives = 77/161 (47%), Gaps = 22/161 (13%)
Query: 279 NFSINNKLGEGGFGPVY--KGTLVDGQEIAVKR--LSKISEQGLKELKNEVILFSKLQHR 334
+ I K+GEG FG +Y K D + +K L+K+ + + K EVIL +K++H
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHP 59
Query: 335 NLVKLLGCCIQGEEKLLI-YEFVPNKSLDSFIFDQ-----ERCKILDWSKRFHIICGTAR 388
N+V Q +L I E+ L I Q +IL W +
Sbjct: 60 NIVTFFA-SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW------FVQISL 112
Query: 389 GVMYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLAR 428
G+ ++H +I+HRD+K+ N+ L ++ M K+ DFG+AR
Sbjct: 113 GLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIAR 150
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 6e-11
Identities = 47/167 (28%), Positives = 83/167 (49%), Gaps = 17/167 (10%)
Query: 276 ATDNFSINNKLGEGGFGPVY----KGTLVDGQE--IAVKRLSKISEQGLK-ELKNEVILF 328
A + +++ +LG+G FG VY KG + D E +A+K +++ + + E NE +
Sbjct: 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 63
Query: 329 SKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIF----DQERCKIL---DWSKRFH 381
+ ++V+LLG QG+ L+I E + L S++ + E + K
Sbjct: 64 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQ 123
Query: 382 IICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
+ A G+ YL+ + + +HRDL A N ++ +D KI DFG+ R
Sbjct: 124 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 7e-11
Identities = 39/149 (26%), Positives = 73/149 (48%), Gaps = 13/149 (8%)
Query: 286 LGEGGFGP--VYK----GTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 339
LG+G FG +Y+ +LV +E+ + RLS E+ ++ NE+++ S LQH N++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS---EKERRDALNEIVILSLLQHPNIIAY 64
Query: 340 LGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRL 399
+ L+ E+ +L I Q+ ++ + + V Y+H+
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTLYDKIVRQKG-QLFEEEMVLWYLFQIVSAVSYIHKAG-- 121
Query: 400 RIIHRDLKASNVLLDQDMNPKISDFGLAR 428
I+HRD+K N+ L + K+ DFG+++
Sbjct: 122 -ILHRDIKTLNIFLTKAGLIKLGDFGISK 149
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 7e-11
Identities = 47/148 (31%), Positives = 77/148 (52%), Gaps = 8/148 (5%)
Query: 284 NKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLLG 341
KLGEG + V+KG + + +A+K + E+G EV L L+H N+V L
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 342 CCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRI 401
+ L++E++ +K L ++ D + K F + RG+ Y H R ++
Sbjct: 72 IVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIF--LYQILRGLAYCH---RRKV 125
Query: 402 IHRDLKASNVLLDQDMNPKISDFGLARA 429
+HRDLK N+L+++ K++DFGLARA
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARA 153
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 62.2 bits (152), Expect = 7e-11
Identities = 59/167 (35%), Positives = 78/167 (46%), Gaps = 34/167 (20%)
Query: 278 DNFSINNKLGEGGFGPV----YKGTLVDGQEIAVKRLSK--ISEQGLKE-LKNEVILFSK 330
D+F LG G FG V +KG+ G+ A+K LSK I + E + NE +
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGS---GKYYALKILSKAKIVKLKQVEHVLNEKRILQS 57
Query: 331 LQHRNLVKLLGCCIQGEEKL-LIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTAR- 388
++H LV L G Q + L L+ E+VP L S L S RF AR
Sbjct: 58 IRHPFLVNLYGS-FQDDSNLYLVMEYVPGGELFSH---------LRKSGRFPE--PVARF 105
Query: 389 -------GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
+ YLH L I++RDLK N+LLD D KI+DFG A+
Sbjct: 106 YAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAK 149
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 8e-11
Identities = 48/161 (29%), Positives = 76/161 (47%), Gaps = 16/161 (9%)
Query: 279 NFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLS---KISEQGLKELKNEVILFSKLQHR 334
NF I K+G G F VY+ T L+DG +A+K++ + + + E+ L +L H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 335 NLVKLLGCCIQGEEKLLIYEFVPNKSLDSFI--FDQERCKILD---WSKRFHIICGTARG 389
N++K I+ E ++ E L I F +++ I + W K F +C
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVW-KYFVQLCSALE- 120
Query: 390 VMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
H SR R++HRD+K +NV + K+ D GL R F
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFF 156
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 8e-11
Identities = 42/151 (27%), Positives = 75/151 (49%), Gaps = 16/151 (10%)
Query: 286 LGEGGFGPVY------KGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 339
+G G FG V+ LV ++I V++++K + NE + L H N+++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQ---NECQVLKLLSHPNIIEY 64
Query: 340 LGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCK-ILDWSKRFHIICGTARGVMYLHQDSR 398
++ + +++ E+ P +L +I Q+RC +LD H + ++H
Sbjct: 65 YENFLEDKALMIVMEYAPGGTLAEYI--QKRCNSLLDEDTILHFFVQILLALHHVHTKL- 121
Query: 399 LRIIHRDLKASNVLLDQ-DMNPKISDFGLAR 428
I+HRDLK N+LLD+ M KI DFG+++
Sbjct: 122 --ILHRDLKTQNILLDKHKMVVKIGDFGISK 150
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 9e-11
Identities = 48/170 (28%), Positives = 73/170 (42%), Gaps = 29/170 (17%)
Query: 285 KLGEGGFGPVYKGTLVDGQEI-----------------AVKRLSK-ISEQGLKELKNEVI 326
KLGEG FG V+ Q+ AVK L S+ ++ EV
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71
Query: 327 LFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFI--------FDQERCKILDWSK 378
+ S+L N+ +LLG C +I E++ N L+ F+ K L +S
Sbjct: 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131
Query: 379 RFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
++ A G+ YL L +HRDL N L+ ++ KI+DFG++R
Sbjct: 132 LLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 50/152 (32%), Positives = 78/152 (51%), Gaps = 16/152 (10%)
Query: 286 LGEGGFGPVYKGTLVD-GQEIAVKRL-----SKISEQGLKELKNEVILFSKLQHRNLVKL 339
LG+G FG VY VD G+E+A K++ S + + + L+ E+ L LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 340 LGCCI-QGEEKLLIY-EFVPNKSLDSFIFDQERC-KILDWSKRFHIICGTARGVMYLHQD 396
GC + E+ L I+ E++P S+ DQ + L S G+ YLH +
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVK----DQLKAYGALTESVTRKYTRQILEGMSYLHSN 125
Query: 397 SRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
I+HRD+K +N+L D N K+ DFG ++
Sbjct: 126 ---MIVHRDIKGANILRDSAGNVKLGDFGASK 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 1e-10
Identities = 46/164 (28%), Positives = 76/164 (46%), Gaps = 18/164 (10%)
Query: 280 FSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQH 333
F++ LG+G FG V + L Q++AVK L S ++E E + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 334 RNLVKLLGCCIQGEEK------LLIYEFVPNKSLDSFIFDQ---ERCKILDWSKRFHIIC 384
N++KL+G ++ K ++I F+ + L +F+ E L +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 385 GTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
A G+ YL S IHRDL A N +L+++M ++DFGL++
Sbjct: 121 DIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 51/173 (29%), Positives = 83/173 (47%), Gaps = 27/173 (15%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLV-DGQEI--AVKRLSKI-SEQGLKELKNEVILFSKL-Q 332
++ + +GEG FG V + + DG ++ A+K L + SE ++ E+ + KL
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH 61
Query: 333 HRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTAR---- 388
H N++ LLG C + E+ P +L F+ + ++L+ F GTA
Sbjct: 62 HPNIINLLGACENRGYLYIAIEYAPYGNLLDFL---RKSRVLETDPAFAKEHGTASTLTS 118
Query: 389 ------------GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429
G+ YL S + IHRDL A NVL+ +++ KI+DFGL+R
Sbjct: 119 QQLLQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRG 168
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 1e-10
Identities = 47/195 (24%), Positives = 90/195 (46%), Gaps = 12/195 (6%)
Query: 235 QDFYIRMSASELEKTENNRETDQVQNMDLEL-PLFELATIANATDNFSINNKLGEGGFGP 293
+D Y +S +LE ++++ ++ + D L P + A A+ +++ L G G
Sbjct: 22 EDLYSDISDGDLEYSDDDSASESDDDDDDGLIPTKQKAREVVASLGYTVIKTLTPGSEGR 81
Query: 294 VYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 353
V+ T GQ V + KI ++G + E +L + H +++++ + G ++
Sbjct: 82 VFVAT-KPGQPDPV--VLKIGQKGTTLI--EAMLLQNVNHPSVIRMKDTLVSGAITCMV- 135
Query: 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLL 413
+P+ S D + + +R + L + I G+ YLH RIIHRD+K N+ +
Sbjct: 136 --LPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFI 190
Query: 414 DQDMNPKISDFGLAR 428
+ I D G A+
Sbjct: 191 NDVDQVCIGDLGAAQ 205
|
Length = 357 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 41/157 (26%), Positives = 71/157 (45%), Gaps = 11/157 (7%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDGQ----EIAVKRLSKISEQGLKEL-KNEVILFSKLQ 332
++ ++ +GEG FG VY+G + + +AVK + ++E E + +
Sbjct: 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD 65
Query: 333 HRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMY 392
H ++VKL+G + ++ E P L S++ Q LD + + + Y
Sbjct: 66 HPHIVKLIGVITE-NPVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAY 122
Query: 393 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429
L R +HRD+ A NVL+ K+ DFGL+R
Sbjct: 123 LES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRY 156
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 41/150 (27%), Positives = 81/150 (54%), Gaps = 9/150 (6%)
Query: 280 FSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLV 337
F+ ++G+G FG VYKG +E+ ++ + +E +++++ E+ + S+ +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 338 KLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 397
+ G ++G + +I E++ S D + L+ + I+ +G+ YLH +
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGS----ALDLLKPGPLEETYIATILREILKGLDYLHSE- 120
Query: 398 RLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
R IHRD+KA+NVLL + + K++DFG+A
Sbjct: 121 --RKIHRDIKAANVLLSEQGDVKLADFGVA 148
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (148), Expect = 2e-10
Identities = 44/155 (28%), Positives = 75/155 (48%), Gaps = 11/155 (7%)
Query: 280 FSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVK 338
F + +G G +G VYKG V ++A ++ ++ +E+K E+ + K HRN+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 339 LLGCCIQ------GEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMY 392
G I+ ++ L+ EF S+ I + L +I RG+ +
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI-KNTKGNTLKEEWIAYICREILRGLSH 126
Query: 393 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
LHQ ++IHRD+K NVLL ++ K+ DFG++
Sbjct: 127 LHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVS 158
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 47/160 (29%), Positives = 72/160 (45%), Gaps = 33/160 (20%)
Query: 286 LGEGGFGPVYKGTLVD-GQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGC 342
+G G +G V G+++A+K+LS+ S K E+ L + H N++ LL
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDV 82
Query: 343 CIQGEEKLLIYEFVPNKSLDSF--------IFDQERCKILDWSKRF---HI---ICGTAR 388
F P SL+ F + + I+ ++ HI + R
Sbjct: 83 ------------FTPASSLEDFQDVYLVTHLMGADLNNIVK-CQKLSDDHIQFLVYQILR 129
Query: 389 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
G+ Y+H IIHRDLK SN+ +++D KI DFGLAR
Sbjct: 130 GLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 45/143 (31%), Positives = 69/143 (48%), Gaps = 29/143 (20%)
Query: 300 VDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVP 357
V G +AVK+LS+ ++ K E++L + H+N++ LL F P
Sbjct: 44 VLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV------------FTP 91
Query: 358 NKSLDSF--------IFDQERCKI----LDWSKRFHIICGTARGVMYLHQDSRLRIIHRD 405
KSL+ F + D C++ LD + +++ G+ +LH IIHRD
Sbjct: 92 QKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRD 148
Query: 406 LKASNVLLDQDMNPKISDFGLAR 428
LK SN+++ D KI DFGLAR
Sbjct: 149 LKPSNIVVKSDCTLKILDFGLAR 171
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 2e-10
Identities = 48/168 (28%), Positives = 78/168 (46%), Gaps = 22/168 (13%)
Query: 270 LATIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK------ISEQGLKELK 322
T+ T+ + +G G FG V + GQ +A+K++ K ++++ +ELK
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK 61
Query: 323 NEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRF-- 380
L L+H N++ L I E IY D R K+F
Sbjct: 62 ----LLKHLRHENIISLSDIFISPLED--IYFVTELLGTDLHRLLTSR----PLEKQFIQ 111
Query: 381 HIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
+ + RG+ Y+H ++HRDLK SN+L++++ + KI DFGLAR
Sbjct: 112 YFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLAR 156
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 60.7 bits (148), Expect = 3e-10
Identities = 52/169 (30%), Positives = 86/169 (50%), Gaps = 33/169 (19%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSKISEQG----LKELKNEVILFSKLQ 332
D + N++ EG +G VY+ EI A+K+L K+ ++ + L+ E+ + KLQ
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKL-KMEKEKEGFPITSLR-EINILLKLQ 62
Query: 333 HRNLVKL----LGCCIQGEEKLLIYEFVPN--KSL-----DSFIFDQERCKILDWSKRFH 381
H N+V + +G + ++ ++ E+V + KSL F+ + +C +L
Sbjct: 63 HPNIVTVKEVVVGSNL--DKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQ------ 114
Query: 382 IICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
GV +LH + I+HRDLK SN+LL+ KI DFGLAR +
Sbjct: 115 ----LLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREY 156
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 3e-10
Identities = 42/150 (28%), Positives = 82/150 (54%), Gaps = 9/150 (6%)
Query: 280 FSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLS-KISEQGLKELKNEVILFSKLQHRNLV 337
F+ ++G+G FG V+KG Q++ A+K + + +E +++++ E+ + S+ +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 338 KLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 397
K G ++G + +I E++ S D R D + ++ +G+ YLH +
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGS----ALDLLRAGPFDEFQIATMLKEILKGLDYLHSEK 121
Query: 398 RLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
+ IHRD+KA+NVLL + + K++DFG+A
Sbjct: 122 K---IHRDIKAANVLLSEQGDVKLADFGVA 148
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 3e-10
Identities = 51/162 (31%), Positives = 78/162 (48%), Gaps = 21/162 (12%)
Query: 286 LGEGGFGPVYKGTLV-DGQEI--AVKRLSK-ISEQGLKELKNEVILFSKL-QHRNLVKLL 340
+GEG FG V K + DG + A+KR+ + S+ ++ E+ + KL H N++ LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 341 GCCIQGEEKLLIYEFVPNKSLDSFI-----------FDQERCKILDWSKR--FHIICGTA 387
G C L E+ P+ +L F+ F S + H A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 388 RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429
RG+ YL S+ + IHRDL A N+L+ ++ KI+DFGL+R
Sbjct: 123 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRG 161
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 4e-10
Identities = 51/156 (32%), Positives = 74/156 (47%), Gaps = 30/156 (19%)
Query: 286 LGEGGFGPV----YKGTLVDGQEIAVKRLSK---ISEQGLKELKNEVILF---SKLQHRN 335
LG G FG V YK T G+ A+K L K I+ ++ L E +F + +H
Sbjct: 7 LGRGHFGKVLLAEYKKT---GELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63
Query: 336 LVKLLGCCIQGEEKL-LIYEFVPNKSLDSFI----FDQERCKILDWSKRFHIICGTARGV 390
LV L C Q E+ + + E+ L I F + R F+ C G+
Sbjct: 64 LVNLF-ACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAV-------FYAAC-VVLGL 114
Query: 391 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 426
YLH++ +I++RDLK N+LLD + KI+DFGL
Sbjct: 115 QYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGL 147
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 5e-10
Identities = 46/177 (25%), Positives = 79/177 (44%), Gaps = 29/177 (16%)
Query: 278 DNFSINNKLGEGGFGPVY------------KGTLVDGQE-----IAVKRL-SKISEQGLK 319
+ KLGEG FG V+ K +D +AVK L ++
Sbjct: 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARN 64
Query: 320 ELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFI--------FDQERC 371
+ E+ + S+L+ N+++LL CI + +I E++ N L+ F+ ++
Sbjct: 65 DFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADV 124
Query: 372 KILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
+ +S + A G+ YL S L +HRDL N L+ ++ KI+DFG++R
Sbjct: 125 VTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 6e-10
Identities = 47/151 (31%), Positives = 76/151 (50%), Gaps = 12/151 (7%)
Query: 285 KLGEGGFGPVYKG---TLVDGQEIAVKRLSKIS-EQGLK-ELKNEVILFSKLQHRNLVKL 339
+LG G FG V KG + +AVK L + + LK EL E + +L + +V++
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 340 LGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRL 399
+G C + E +L+ E L+ F+ + + ++ H + + G+ YL + +
Sbjct: 62 IGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQV---SMGMKYLEETN-- 115
Query: 400 RIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
+HRDL A NVLL KISDFGL++A
Sbjct: 116 -FVHRDLAARNVLLVTQHYAKISDFGLSKAL 145
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 7e-10
Identities = 51/163 (31%), Positives = 81/163 (49%), Gaps = 39/163 (23%)
Query: 285 KLGEGGFGPVYKGTLV----DGQEIAVKRL--SKISEQGLKELKNEVILFSKLQHRNLVK 338
K+GEG FG K LV DG++ +K + SK+S + +E + EV + S ++H N+V+
Sbjct: 7 KIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ 63
Query: 339 L------LGC-------CIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICG 385
G C G+ +Y+ + + F DQ ILDW F IC
Sbjct: 64 YQESFEENGNLYIVMDYCEGGD----LYKKINAQRGVLFPEDQ----ILDW---FVQIC- 111
Query: 386 TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
+ ++H +I+HRD+K+ N+ L +D K+ DFG+AR
Sbjct: 112 --LALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIAR 149
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 7e-10
Identities = 46/150 (30%), Positives = 77/150 (51%), Gaps = 18/150 (12%)
Query: 284 NKLGEGGFGPVYK----GTLVDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVK 338
N++G G G VYK T G+ A+K + E ++ ++ E+ + + H N+VK
Sbjct: 80 NRIGSGAGGTVYKVIHRPT---GRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVK 136
Query: 339 LLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSR 398
E ++ EF+ SL+ E+ + D +++ I+ G A YLH R
Sbjct: 137 CHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQ-FLADVARQ--ILSGIA----YLH---R 186
Query: 399 LRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
I+HRD+K SN+L++ N KI+DFG++R
Sbjct: 187 RHIVHRDIKPSNLLINSAKNVKIADFGVSR 216
|
Length = 353 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 7e-10
Identities = 48/182 (26%), Positives = 84/182 (46%), Gaps = 18/182 (9%)
Query: 248 KTENNRETDQVQNMD--LELPLFELA-----TIANATDNFSINNKLGEGGFGPVYKG-TL 299
+ NN E +V+N D EL F+ TI + + N + G G YKG ++
Sbjct: 653 RGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSI 712
Query: 300 VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNK 359
+G + VK ++ ++ +E+ KLQH N+VKL+G C + LI+E++ K
Sbjct: 713 KNGMQFVVKEINDVNSIPS----SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGK 768
Query: 360 SLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNP 419
+L E + L W +R I G A+ + +LH ++ +L +++D P
Sbjct: 769 NL------SEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEP 822
Query: 420 KI 421
+
Sbjct: 823 HL 824
|
Length = 968 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 8e-10
Identities = 41/150 (27%), Positives = 79/150 (52%), Gaps = 9/150 (6%)
Query: 280 FSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLV 337
F+ K+G+G FG V+KG Q++ ++ + +E +++++ E+ + S+ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 338 KLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 397
K G ++ + +I E++ S D LD ++ I+ +G+ YLH +
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLHSEK 121
Query: 398 RLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
+ IHRD+KA+NVLL + K++DFG+A
Sbjct: 122 K---IHRDIKAANVLLSEHGEVKLADFGVA 148
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 8e-10
Identities = 50/154 (32%), Positives = 81/154 (52%), Gaps = 20/154 (12%)
Query: 284 NKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLLG 341
+KLGEG + V+KG + + +A+K + E+G EV L L+H N+V L
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70
Query: 342 CCIQGEEKL-LIYEFVPN---KSLDSF--IFDQERCKILDWSKRFHIICGTARGVMYLHQ 395
I E L L++E++ + + LD+ + KI F ++ RG+ Y H
Sbjct: 71 I-IHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIF----MFQLL----RGLSYCH- 120
Query: 396 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429
+ +I+HRDLK N+L+++ K++DFGLARA
Sbjct: 121 --KRKILHRDLKPQNLLINEKGELKLADFGLARA 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 8e-10
Identities = 39/158 (24%), Positives = 76/158 (48%), Gaps = 15/158 (9%)
Query: 275 NATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQG--LKELKNEVILFSKLQ 332
N ++ + ++G G +G VYK + E+A ++ K+ E G ++ E+ + + +
Sbjct: 6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKL-EPGDDFSLIQQEIFMVKECK 64
Query: 333 HRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIF---DQERCKILDWSKRFHIICGTARG 389
H N+V G + E+ + E+ SL +I ++ T +G
Sbjct: 65 HCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIA------YVCRETLQG 118
Query: 390 VMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
+ YLH ++ HRD+K +N+LL + + K++DFG+A
Sbjct: 119 LAYLHSKGKM---HRDIKGANILLTDNGDVKLADFGVA 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 8e-10
Identities = 47/157 (29%), Positives = 75/157 (47%), Gaps = 24/157 (15%)
Query: 285 KLGEGGFGPVYKGT--LVDGQ-EIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLL 340
+LG G FG V KG + Q ++A+K L +E+ ++ E+ E + +L + +V+++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 341 GCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS--- 397
G C + E +L+ E L+ F+ K+ I + V +HQ S
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFLS----------GKKDEIT--VSNVVELMHQVSMGM 108
Query: 398 ----RLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
+HRDL A NVLL KISDFGL++A
Sbjct: 109 KYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKAL 145
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 45/151 (29%), Positives = 66/151 (43%), Gaps = 21/151 (13%)
Query: 289 GGFGPVYKG-TLVDGQEIAVKRLSKISEQGLKELKN----EVILFSKLQHRNLVKLLGCC 343
G FG VY G A+K L K ++ N I+ + + + KL
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66
Query: 344 IQGEEKLLIYEFVPNKSLDSFIFDQERCKIL-----DWSKRFHIICGTARGVMYLHQDSR 398
+ L+ E++ S I K L DW+K++ I GV LHQ
Sbjct: 67 QSKDYLYLVMEYLNGGDCASLI------KTLGGLPEDWAKQY--IAEVVLGVEDLHQRG- 117
Query: 399 LRIIHRDLKASNVLLDQDMNPKISDFGLARA 429
IIHRD+K N+L+DQ + K++DFGL+R
Sbjct: 118 --IIHRDIKPENLLIDQTGHLKLTDFGLSRN 146
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 42/140 (30%), Positives = 68/140 (48%), Gaps = 29/140 (20%)
Query: 303 QEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKS 360
+ +A+K+LS+ ++ K E++L + H+N++ LL F P KS
Sbjct: 50 RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV------------FTPQKS 97
Query: 361 LDSF--------IFDQERCKI----LDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKA 408
L+ F + D C++ LD + +++ G+ +LH IIHRDLK
Sbjct: 98 LEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKP 154
Query: 409 SNVLLDQDMNPKISDFGLAR 428
SN+++ D KI DFGLAR
Sbjct: 155 SNIVVKSDCTLKILDFGLAR 174
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (142), Expect = 1e-09
Identities = 44/148 (29%), Positives = 74/148 (50%), Gaps = 12/148 (8%)
Query: 286 LGEGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQHRNLVKLLG 341
LG GGFG V + + A+K + K I E G +E + +E + + H +VKL
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY- 59
Query: 342 CCIQGEEKL-LIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLR 400
+ ++ + ++ E+ L + + ++R +++ RF+I C YLH
Sbjct: 60 RTFKDKKYIYMLMEYCLGGELWTIL--RDRGLFDEYTARFYIACVV-LAFEYLH---NRG 113
Query: 401 IIHRDLKASNVLLDQDMNPKISDFGLAR 428
II+RDLK N+LLD + K+ DFG A+
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAK 141
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 48/153 (31%), Positives = 76/153 (49%), Gaps = 21/153 (13%)
Query: 286 LGEGGFGPV----YKGTLVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKL-QHRNLV 337
LG+G FG V KGT + AVK L K + + ++ E + + +H L
Sbjct: 3 LGKGSFGKVLLAELKGT---DELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLT 59
Query: 338 KLLGCCIQGEEKL-LIYEFVPNKSLDSFIFDQERCKILDWSK-RFHIICGTARGVMYLHQ 395
+L C Q +++L + E+V L +F +R D + RF+ G+ +LH+
Sbjct: 60 QLH-SCFQTKDRLFFVMEYVNGGDL---MFHIQRSGRFDEPRARFYAAE-IVLGLQFLHE 114
Query: 396 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
II+RDLK NVLLD + + KI+DFG+ +
Sbjct: 115 RG---IIYRDLKLDNVLLDSEGHIKIADFGMCK 144
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 42/140 (30%), Positives = 68/140 (48%), Gaps = 29/140 (20%)
Query: 303 QEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKS 360
+ +A+K+LS+ ++ K E++L + H+N++ LL F P KS
Sbjct: 43 RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV------------FTPQKS 90
Query: 361 LDSF--------IFDQERCKI----LDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKA 408
L+ F + D C++ LD + +++ G+ +LH IIHRDLK
Sbjct: 91 LEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKP 147
Query: 409 SNVLLDQDMNPKISDFGLAR 428
SN+++ D KI DFGLAR
Sbjct: 148 SNIVVKSDCTLKILDFGLAR 167
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 48/166 (28%), Positives = 79/166 (47%), Gaps = 18/166 (10%)
Query: 278 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKR-LSKISEQGLKELK-NEVILFSKLQHR 334
D + K+GEG +G VYK G+ +A+K+ ++ E+G+ E+ L L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 335 N-LVKLLGCCIQGEEKL------LIYEFVPNKSLDSFIFDQER--CKILDWSKRFHIICG 385
+V+LL EEK L++E++ + L F+ R + L +
Sbjct: 61 IYIVRLL-DVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118
Query: 386 TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLARAF 430
+GV + H + ++HRDLK N+L+D+ KI+D GL RAF
Sbjct: 119 LLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF 161
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 2e-09
Identities = 41/158 (25%), Positives = 69/158 (43%), Gaps = 18/158 (11%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRL------SKISEQGLKELKNEVILFSKL 331
+ ++LGEG G V K L + I + + +Q L+EL+ +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELE----INKSC 56
Query: 332 QHRNLVKLLGCCIQGEEKLL--IYEFVPNKSLDSFIFDQERCKILDWSKRF--HIICGTA 387
+ +VK G + + E+ SLDS I+ + + + ++ I
Sbjct: 57 KSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGEKVLGKIAESVL 115
Query: 388 RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 425
+G+ YLH +IIHRD+K SN+LL + K+ DFG
Sbjct: 116 KGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFG 150
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 2e-09
Identities = 40/147 (27%), Positives = 74/147 (50%), Gaps = 9/147 (6%)
Query: 285 KLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGL--KELKNEVILFSKLQHRNLVKLLG 341
K+GEG +G V+K + GQ +A+K+ + + + K E+ + +L+H NLV L+
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 342 CCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRI 401
+ + L++E+ + L+ ++ + + II T + V + H+
Sbjct: 68 VFRRKRKLHLVFEYCDHTVLNEL---EKNPRGVPEHLIKKIIWQTLQAVNFCHK---HNC 121
Query: 402 IHRDLKASNVLLDQDMNPKISDFGLAR 428
IHRD+K N+L+ + K+ DFG AR
Sbjct: 122 IHRDVKPENILITKQGQIKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 48/166 (28%), Positives = 79/166 (47%), Gaps = 33/166 (19%)
Query: 285 KLGEGGFGPVYKGTLVD--GQEIAVKRLS-KISEQG--LKELKNEVIL--FSKLQHRNLV 337
++GEG +G V+K + G+ +A+KR+ + E+G L ++ +L +H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 338 KLLGCCIQG----EEKL-LIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMY 392
+L C E KL L++E V DQ+ LD + T + +M+
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHV----------DQDLTTYLDKVPEPGVPTETIKDMMF 117
Query: 393 --------LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
LH R++HRDLK N+L+ K++DFGLAR +
Sbjct: 118 QLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY 160
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 3e-09
Identities = 49/150 (32%), Positives = 72/150 (48%), Gaps = 16/150 (10%)
Query: 286 LGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLG 341
LG+GGFG V + G+ A K+L K +G + NE + K+ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 342 CCIQGEEKL-LIYEFVPNKSLDSFIFDQERCKILDWSKRFH---IICGTARGVMYLHQDS 397
+ ++ L L+ + L I++ + F+ IICG + +LHQ
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICG----LEHLHQ-- 113
Query: 398 RLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
RI++RDLK NVLLD N +ISD GLA
Sbjct: 114 -RRIVYRDLKPENVLLDDHGNVRISDLGLA 142
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 49/165 (29%), Positives = 83/165 (50%), Gaps = 32/165 (19%)
Query: 285 KLGEGGFGPVYKGTLVD-GQEIAVKRLS-KISEQGLK-ELKNEVILFSKLQ---HRNLVK 338
++G G +G VYK G +A+K + + +E GL EV L +L+ H N+V+
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 339 LLGCCIQG----EEKL-LIYEFVPNKSLDSFIFDQERC--------KILDWSKRFHIICG 385
L+ C E K+ L++E V ++ L +++ ++ I D ++F
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHV-DQDLRTYL---DKVPPPGLPAETIKDLMRQF----- 117
Query: 386 TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
RG+ +LH + I+HRDLK N+L+ K++DFGLAR +
Sbjct: 118 -LRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 5e-09
Identities = 46/149 (30%), Positives = 73/149 (48%), Gaps = 13/149 (8%)
Query: 286 LGEGGFGPVYKGTL-VDGQEIAVKRLSK---ISEQGLK-ELKNEVILFSKLQHRNLVKLL 340
LG+G FG V L G+ AVK L K + + ++ + + IL H L +L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 341 GCCIQGEEKLL-IYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRL 399
CC Q ++L + EFV L +F ++ + D ++ +M+LH
Sbjct: 63 -CCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAAEITSALMFLHDKG-- 116
Query: 400 RIIHRDLKASNVLLDQDMNPKISDFGLAR 428
II+RDLK NVLLD + + K++DFG+ +
Sbjct: 117 -IIYRDLKLDNVLLDHEGHCKLADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 7e-09
Identities = 39/160 (24%), Positives = 79/160 (49%), Gaps = 20/160 (12%)
Query: 278 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLS---KISEQGLKELKNEVILFSKLQH 333
D+ +G G FG V+ + A+K ++ I + + + NE + ++ H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 334 RNLVKLLGCCIQGEEKLL--IYEFVPNKSLDSFIFDQERCKILDWSKRFH---IICGTAR 388
+++L + +++ L + E+VP L S++ + + + + F+ I+C
Sbjct: 61 PFIIRLF--WTEHDQRFLYMLMEYVPGGELFSYL--RNSGRFSNSTGLFYASEIVCA--- 113
Query: 389 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
+ YLH I++RDLK N+LLD++ + K++DFG A+
Sbjct: 114 -LEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK 149
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 8e-09
Identities = 47/155 (30%), Positives = 76/155 (49%), Gaps = 26/155 (16%)
Query: 286 LGEGGFGPVYKGTLV----DGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRNLVKL 339
+GEG FG + LV Q+ A+K RL K S +++ + E +L +K++H N+V
Sbjct: 8 VGEGSFG---RALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAF 63
Query: 340 LGCCIQGEEKL-LIYEFVPNKSLDSFIFDQE-----RCKILDWSKRFHIICGTARGVMYL 393
+ + L ++ E+ L I Q IL W F +C GV ++
Sbjct: 64 KES-FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQW---FVQMC---LGVQHI 116
Query: 394 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
H+ R++HRD+K+ N+ L Q+ K+ DFG AR
Sbjct: 117 HEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSAR 148
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 49/173 (28%), Positives = 77/173 (44%), Gaps = 31/173 (17%)
Query: 272 TIANATDNFSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL--KELKNEVILF 328
TI + + + +G G +G V G +AVK+LS+ + + K E+ L
Sbjct: 11 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 70
Query: 329 SKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSF-------------IFDQERCKILD 375
++H N++ LL F P +SL+ F + + +C+ L
Sbjct: 71 KHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 118
Query: 376 WSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
+I RG+ Y+H IIHRDLK SN+ +++D KI DFGLAR
Sbjct: 119 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 168
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 41/174 (23%), Positives = 76/174 (43%), Gaps = 42/174 (24%)
Query: 282 INNKLGEGGFGPVYKG-TLVDGQEIAVKRL-------------SKISEQG-----LKELK 322
LGEG +G V K + G+ +A+K++ + G L+ELK
Sbjct: 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72
Query: 323 NEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRF-- 380
+ ++++H N++ L+ ++G+ L+ + I + K++D R
Sbjct: 73 ----IMNEIKHENIMGLVDVYVEGDFINLVMD----------IMASDLKKVVDRKIRLTE 118
Query: 381 -HIIC---GTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
+ C G+ LH+ +HRDL +N+ ++ KI+DFGLAR +
Sbjct: 119 SQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRY 169
|
Length = 335 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 1e-08
Identities = 53/154 (34%), Positives = 74/154 (48%), Gaps = 22/154 (14%)
Query: 286 LGEGGFGPVY------KGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 339
LG+GGFG V G L +++ KRL K +G + E + +K+ R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKK--RKGYEGAMVEKRILAKVHSRFIVSL 58
Query: 340 LGCCIQGEEKL-LIYEFVPNKSLDSFIF--DQERCKILDWSKRFH---IICGTARGVMYL 393
Q + L L+ + L I+ D+E + F+ II G + +L
Sbjct: 59 -AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISG----LEHL 113
Query: 394 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
HQ RII+RDLK NVLLD D N +ISD GLA
Sbjct: 114 HQR---RIIYRDLKPENVLLDNDGNVRISDLGLA 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 1e-08
Identities = 50/161 (31%), Positives = 79/161 (49%), Gaps = 24/161 (14%)
Query: 279 NFSINNKLGEGGFGPV----YKGTLVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKL 331
+F + LG G FG V +KGT G+ A+K L K + + ++ + E + +L
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQHVAQEKSILMEL 75
Query: 332 QHRNLVKLLGCCIQGEEKL-LIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGV 390
H +V ++ C Q E ++ + EFV L + + R D +K +H A V
Sbjct: 76 SHPFIVNMM-CSFQDENRVYFLLEFVVGGELFTHLRKAGRFPN-DVAKFYH-----AELV 128
Query: 391 M---YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
+ YLH II+RDLK N+LLD + K++DFG A+
Sbjct: 129 LAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK 166
|
Length = 329 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 2e-08
Identities = 46/155 (29%), Positives = 77/155 (49%), Gaps = 12/155 (7%)
Query: 278 DNFSIN--NKLGEGGFGPVYKG--TLVDGQE--IAVKRL-SKISEQGLKELKNEVILFSK 330
DN SI LG G FG + +G L +E +A+ L + S++ + E + +
Sbjct: 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQ 62
Query: 331 LQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGV 390
H N+V+L G +G +++ E++ N +LDSF+ E L + ++ G A G+
Sbjct: 63 FDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGM 120
Query: 391 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 425
YL S + +H+ L A VL++ D+ KIS F
Sbjct: 121 KYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFR 152
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 51/171 (29%), Positives = 85/171 (49%), Gaps = 29/171 (16%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQ------GLKELKNEVILFSK 330
D F I ++GEG +G VYK D G+ +A+K++ +E+ ++E+K + +
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIK----ILRQ 62
Query: 331 LQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIF---DQERCKILDWSKRFHI----I 383
L HRN+V L ++ L +F +K +F D + +L+ S H I
Sbjct: 63 LNHRNIVNLKEIVTDKQDAL---DFKKDKGAFYLVFEYMDHDLMGLLE-SGLVHFSEDHI 118
Query: 384 CGTAR----GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
+ G+ Y H+ + L HRD+K SN+LL+ K++DFGLAR +
Sbjct: 119 KSFMKQLLEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLY 166
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 2e-08
Identities = 46/158 (29%), Positives = 69/158 (43%), Gaps = 30/158 (18%)
Query: 286 LGEGGFGPVYKGT-LVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGC 342
+G G +G V G+++A+K+LS+ SE K E+ L +QH N++ LL
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 343 CIQGEEKLLIYEFVPNKSLDSF----------IFDQERCKILDWS--KRFHIICGTARGV 390
F S D F D ++ S K +++ G+
Sbjct: 83 ------------FTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGL 130
Query: 391 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
Y+H IIHRDLK N+ +++D KI DFGLAR
Sbjct: 131 KYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 165
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 3e-08
Identities = 47/160 (29%), Positives = 75/160 (46%), Gaps = 26/160 (16%)
Query: 286 LGEGGFGPVYKGTLVD---GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGC 342
LG G G V+ VD + +AVK++ Q +K E+ + +L H N+VK+
Sbjct: 13 LGCGSNGLVFSA--VDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEV 70
Query: 343 CIQGEEKLLIYEFVPNKS-LDSFIFDQER-----CKIL-------DWSKRFHIICGTARG 389
L E V + + L+S QE +L + ++ F + RG
Sbjct: 71 LGPSGSDL--TEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLF--MYQLLRG 126
Query: 390 VMYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLAR 428
+ Y+H + ++HRDLK +NV ++ D+ KI DFGLAR
Sbjct: 127 LKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLAR 163
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 41/176 (23%), Positives = 73/176 (41%), Gaps = 48/176 (27%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVD---GQEIAVKRLSKISE------QGLKELKNEVILF 328
+ +G G +G V +D G+++A+K++ + + L+ELK +
Sbjct: 5 SRYKPIENIGSGAYGVVCSA--IDTRSGKKVAIKKIPHAFDVPTLAKRTLRELK----IL 58
Query: 329 SKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTA- 387
+H N++ + ++ +V + D L S HII
Sbjct: 59 RHFKHDNIIAIRDI-LRPPGADFKDVYV--------VMD------LMESDLHHIIHSDQP 103
Query: 388 --------------RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429
RG+ Y+H + +IHRDLK SN+L+++D +I DFG+AR
Sbjct: 104 LTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG 156
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 4e-08
Identities = 43/171 (25%), Positives = 80/171 (46%), Gaps = 25/171 (14%)
Query: 276 ATDNFSINNKLGEGGFGPVYKGT---LVDGQ---EIAVKRLSK-ISEQGLKELKNEVILF 328
+ + ++ +LG+G FG VY+G ++ G+ +AVK +++ S + E NE +
Sbjct: 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVM 63
Query: 329 SKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILD-----------WS 377
++V+LLG +G+ L++ E + + L S++ R +
Sbjct: 64 KGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYL----RSLRPEAENNPGRPPPTLQ 119
Query: 378 KRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
+ + A G+ YL+ + +HRDL A N ++ D KI DFG+ R
Sbjct: 120 EMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 4e-08
Identities = 52/172 (30%), Positives = 79/172 (45%), Gaps = 40/172 (23%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSKISEQGLKELKNEVILFSKLQH 333
D+F + +G G FG V+ LV GQ A+K L K +K +N++
Sbjct: 1 DDFEVIKVIGRGAFGEVW---LVRDKDTGQVYAMKVLRK--SDMIK--RNQIAHV--RAE 51
Query: 334 RN---------LVKLLGCCIQGEEKL-LIYEFVPNKSL-----DSFIFDQERCKILDWSK 378
R+ +VKL Q EE L L+ E++P L +F +E +
Sbjct: 52 RDILADADSPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEE-------TA 103
Query: 379 RFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
RF+I A V+ L +L IHRD+K N+L+D D + K++DFGL +
Sbjct: 104 RFYI----AELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKM 151
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 5e-08
Identities = 45/151 (29%), Positives = 77/151 (50%), Gaps = 16/151 (10%)
Query: 286 LGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKN-----EVILFSKLQHRNLVKL 339
+G G FG V K G +AVKR+ ++ KE K +V++ S +VK
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSS-DCPYIVKF 68
Query: 340 LGCCIQGEEKLLIYEFVPNKSLDSF---IFDQERCKILDWSKRFHIICGTARGVMYLHQD 396
G + + + E + + SLD F +++ + ++ I T + + YL ++
Sbjct: 69 YGALFREGDCWICMELM-DISLDKFYKYVYEVLK-SVIPEEILGKIAVATVKALNYLKEE 126
Query: 397 SRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
L+IIHRD+K SN+LLD++ N K+ DFG++
Sbjct: 127 --LKIIHRDVKPSNILLDRNGNIKLCDFGIS 155
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 6e-08
Identities = 40/153 (26%), Positives = 72/153 (47%), Gaps = 20/153 (13%)
Query: 285 KLGEGGFGPVYKGTLVDGQEIA---VKRLSKISEQGLKELKNEVIL----FSKLQHRNLV 337
++G G FG V + +A VK L + KE +NE + + LQH N++
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELK--ANASSKE-QNEFLQQGDPYRILQHPNIL 58
Query: 338 KLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQE----RCKILDWSKRFHIICGTARGVMYL 393
+ LG C++ LL++E+ L S++ ++ ++L + + C A GV ++
Sbjct: 59 QCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQR---MACEIAAGVTHM 115
Query: 394 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 426
H + +H DL N L D+ K+ D+G+
Sbjct: 116 H---KHNFLHSDLALRNCFLTSDLTVKVGDYGI 145
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 7e-08
Identities = 45/159 (28%), Positives = 73/159 (45%), Gaps = 31/159 (19%)
Query: 286 LGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGL--KELKNEVILFSKLQHRNLVKLLGC 342
+G G +G V Q++AVK+LS+ + + + E+ L ++H N++ LL
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 343 CIQGEEKLLIYEFVPNKSLDSF-------------IFDQERCKILDWSKRFHIICGTARG 389
F P S+++F + + +C+ L +I RG
Sbjct: 83 ------------FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRG 130
Query: 390 VMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
+ Y+H IIHRDLK SNV +++D +I DFGLAR
Sbjct: 131 LKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 44/168 (26%), Positives = 76/168 (45%), Gaps = 29/168 (17%)
Query: 279 NFSINNKLGEGGFGPV----YKGTLVDGQEIAVKRLSKI------SEQGLKELKNEVILF 328
+ + +LG+G +G V T + + +A+K+++ + +++ L+ELK +L
Sbjct: 1 RYELIKELGQGAYGIVCSARNAET-SEEETVAIKKITNVFSKKILAKRALRELK---LLR 56
Query: 329 SKLQHRNLVKLLGCCI---QGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHI--- 382
H+N+ L I +L +YE + L I + H
Sbjct: 57 HFRGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLT------DAHFQSF 110
Query: 383 ICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
I G+ Y+H + ++HRDLK N+L++ D KI DFGLAR F
Sbjct: 111 IYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGF 155
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 46/150 (30%), Positives = 77/150 (51%), Gaps = 15/150 (10%)
Query: 286 LGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLK-ELKNEVILFSKLQHRNLVKLL 340
LG+G FG V L E+ A+K L K + + + + + IL +H L L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 341 GCCIQGEEKLL-IYEFVPNKSLDSFIFDQERCKILDWSK-RFHIICGTARGVMYLHQDSR 398
CC Q +++L + E+V L +F +R + D + RF+ T +M+LH+
Sbjct: 63 -CCFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPRSRFYAAEVTL-ALMFLHRHG- 116
Query: 399 LRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
+I+RDLK N+LLD + + K++DFG+ +
Sbjct: 117 --VIYRDLKLDNILLDAEGHCKLADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 43/161 (26%), Positives = 76/161 (47%), Gaps = 15/161 (9%)
Query: 279 NFSINNKLGEGGFGPVY----KGTLVDGQEIAVKRLSKIS----EQGLKELKNEVILFSK 330
NF + LG G +G V+ G G+ A+K L K + + + + E +
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 331 LQHRNLVKLLGCCIQGEEKL-LIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARG 389
++ + L Q + KL LI ++V L + ++ +E + R +I A
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFT--ESEVRVYI----AEI 114
Query: 390 VMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
V+ L +L II+RD+K N+LLD + + ++DFGL++ F
Sbjct: 115 VLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 52/149 (34%), Positives = 72/149 (48%), Gaps = 13/149 (8%)
Query: 286 LGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEV----ILFSKLQHRNLVKLL 340
+G+G FG V DG AVK L K + KE + + +L L+H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL- 61
Query: 341 GCCIQGEEKL-LIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRL 399
Q EKL + ++V L F +ERC L+ RF+ A + YLH L
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGEL-FFHLQRERC-FLEPRARFYA-AEVASAIGYLHS---L 115
Query: 400 RIIHRDLKASNVLLDQDMNPKISDFGLAR 428
II+RDLK N+LLD + ++DFGL +
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 2e-07
Identities = 40/158 (25%), Positives = 73/158 (46%), Gaps = 21/158 (13%)
Query: 286 LGEGGFGPVYKGT---LVDGQ-----EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 337
LG+G F ++KG + D E+ +K L K + + S+L H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 338 KLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 397
G C+ G+E +++ E+V SLD+++ + + W + + A + +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLEDKG 120
Query: 398 RLRIIHRDLKASNVLL-----DQDMNP---KISDFGLA 427
+ H ++ A NVLL + NP K+SD G++
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 45/162 (27%), Positives = 70/162 (43%), Gaps = 37/162 (22%)
Query: 286 LGEGGFGPV-YKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGC 342
+G G +G V G ++A+K+L + SE K E+ L ++H N++ LL
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 343 CIQGEEKLLIYEFVPNKSLDSF----------------IFDQERCKILDWSKRFHIICGT 386
F P+ SLD F + E+ L + ++
Sbjct: 83 ------------FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEK---LSEDRIQFLVYQM 127
Query: 387 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
+G+ Y+H IIHRDLK N+ +++D KI DFGLAR
Sbjct: 128 LKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 39/160 (24%), Positives = 75/160 (46%), Gaps = 33/160 (20%)
Query: 286 LGEGGFGPVYKGTLVD-GQEIAVKRLSKISE------QGLKELKNEVILFSKLQHRNLVK 338
+G G +G V + +++A+K+++ + + L+E+K L L H N++
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIK----LLRHLDHENVIA 68
Query: 339 LLGCCI-----QGEEKLLIYEFVPNKSLDSFI-----FDQERCKILDWSKRFHIICGTAR 388
+ + ++YE + + L I + C+ + ++ R
Sbjct: 69 IKDIMPPPHREAFNDVYIVYELM-DTDLHQIIRSSQTLSDDHCQYF----LYQLL----R 119
Query: 389 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
G+ Y+H + ++HRDLK SN+LL+ + + KI DFGLAR
Sbjct: 120 GLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 4e-07
Identities = 47/159 (29%), Positives = 75/159 (47%), Gaps = 17/159 (10%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRL-SKISEQGLKELKNEV-ILFSKLQHR 334
D+ + +LG G +G V K V G +AVKR+ + ++ Q K L ++ I +
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCP 60
Query: 335 NLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRF------HIICGTAR 388
V G + E + I V + SLD F K+ D I +
Sbjct: 61 YTVTFYGALFR-EGDVWICMEVMDTSLDKFYK-----KVYDKGLTIPEDILGKIAVSIVK 114
Query: 389 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
+ YLH S+L +IHRD+K SNVL++++ K+ DFG++
Sbjct: 115 ALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGIS 151
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 5e-07
Identities = 49/149 (32%), Positives = 72/149 (48%), Gaps = 13/149 (8%)
Query: 286 LGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEV----ILFSKLQHRNLVKLL 340
+G+G FG V DG+ AVK L K + KE K+ + +L ++H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 341 GCCIQGEEKL-LIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRL 399
Q +KL + ++V L F +ER + RF+ A + YLH L
Sbjct: 62 HYSFQTADKLYFVLDYVNGGEL-FFHLQRERS-FPEPRARFYA-AEIASALGYLHS---L 115
Query: 400 RIIHRDLKASNVLLDQDMNPKISDFGLAR 428
II+RDLK N+LLD + ++DFGL +
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 5e-07
Identities = 46/159 (28%), Positives = 72/159 (45%), Gaps = 17/159 (10%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDGQ--EIAVKRLSK---ISEQGLKELKNEVILFSKLQ 332
++F+ LG G FG V T + +A+KR K I ++ + + +E + + +
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89
Query: 333 HRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICG---TARG 389
H V L G L+ EFV +F L +KRF G A+
Sbjct: 90 HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTF---------LRRNKRFPNDVGCFYAAQI 140
Query: 390 VMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
V+ L I++RDLK N+LLD+D K++DFG A+
Sbjct: 141 VLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAK 179
|
Length = 340 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 6e-07
Identities = 53/158 (33%), Positives = 78/158 (49%), Gaps = 30/158 (18%)
Query: 286 LGEGGFGPVY---KGTLVD-GQEIAVKRLSKISEQGLK-----ELKNEVILFSKLQHRNL 336
LG+G FG V+ K T D GQ A+K L K + LK K E + +++ H +
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKAT---LKVRDRVRTKMERDILAEVNHPFI 60
Query: 337 VKLLGCCIQGEEKL-LIYEFVPNKSL-----DSFIFDQERCKILDWSKRFHIICGTARGV 390
VKL Q E KL LI +F+ L +F +E K + A +
Sbjct: 61 VKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFY--------LAELALAL 111
Query: 391 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
+LH L II+RDLK N+LLD++ + K++DFGL++
Sbjct: 112 DHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK 146
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 6e-07
Identities = 49/161 (30%), Positives = 74/161 (45%), Gaps = 34/161 (21%)
Query: 286 LGEGGFGPVYKGTLV----DGQEIAVKRLSKISEQGLKE----LKNEVILFSKLQHRNLV 337
+G G FG V LV G A+K+L K SE KE ++ E + ++ + +V
Sbjct: 9 IGRGAFGEV---RLVQKKDTGHIYAMKKLRK-SEMLEKEQVAHVRAERDILAEADNPWVV 64
Query: 338 KLLGCCIQGEEKL-LIYEFVPNKSL-------DSFIFDQERCKILDWSKRFHIICGTARG 389
KL Q E L LI E++P + D+F ++ RF+I A
Sbjct: 65 KLY-YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEE---------TRFYI----AET 110
Query: 390 VMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
++ + +L IHRD+K N+LLD + K+SDFGL
Sbjct: 111 ILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGL 151
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 8e-07
Identities = 38/163 (23%), Positives = 63/163 (38%), Gaps = 39/163 (23%)
Query: 286 LGEGGFGPVYK----GTLVDGQEIAVKR--LSKISEQGLKELKNEVILFSKLQHRNLVKL 339
+ + K TLV AVK+ L S++ LK L+ E+I +LQH N++
Sbjct: 10 FEDLMIVHLAKHKPTNTLV-----AVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPY 64
Query: 340 LGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFH--------IICGTARGVM 391
+ I E ++ + S C+ L + H I + V+
Sbjct: 65 VTSFIVDSELYVVSPLMAYGS----------CEDL---LKTHFPEGLPELAIAFILKDVL 111
Query: 392 ----YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
Y+H IHR +KAS++LL D +S + +
Sbjct: 112 NALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSM 151
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 1e-06
Identities = 51/166 (30%), Positives = 73/166 (43%), Gaps = 47/166 (28%)
Query: 286 LGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILF-----SKLQHRNLVKL- 339
LG+G FG V L E +K LK +V+L + R ++ L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFF----------AIKALKKDVVLEDDDVECTMVERRVLALA 52
Query: 340 --------LGCCIQGEEKLL-IYEFVPNKSL-----DSFIFDQERCKILDWSKRFH---I 382
L C Q +E L + E++ L S FD+ R RF+ I
Sbjct: 53 WEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARA-------RFYAAEI 105
Query: 383 ICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
ICG + +LH+ II+RDLK NVLLD+D + KI+DFG+ +
Sbjct: 106 ICG----LQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 20/41 (48%), Positives = 27/41 (65%), Gaps = 3/41 (7%)
Query: 388 RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
RG+ YLH I+HRD+K N+L++ + KI DFGLAR
Sbjct: 114 RGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLAR 151
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 42/161 (26%), Positives = 74/161 (45%), Gaps = 25/161 (15%)
Query: 286 LGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNE----------VILFSKLQHR 334
LG+G F +YKG L V V ++S LK L ++ L S+L H+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVV-LKVLGSDHRDSLAFFETASLMSQLSHK 61
Query: 335 NLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLH 394
+LVKL G C++ +E +++ E+V LD F+ ++ L W + + A + YL
Sbjct: 62 HLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLE 118
Query: 395 QDSRLRIIHRDLKASNVLLDQDMNP-------KISDFGLAR 428
+++H ++ N+L+ + K+SD G+
Sbjct: 119 DK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI 156
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 3e-06
Identities = 45/151 (29%), Positives = 75/151 (49%), Gaps = 16/151 (10%)
Query: 286 LGEGGFGPVYKGTLV----DGQEIAVKRLS--KISEQGLKELKNEVILFSKLQHRNLVKL 339
+G+G +G V +LV DG++ +K+L+ S + K + E L S+L+H N+V
Sbjct: 8 VGKGSYGEV---SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 340 LGCCIQGEEKLL--IYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 397
+GE+ LL + F L + +++ K+L ++ A + YLH+
Sbjct: 65 RESW-EGEDGLLYIVMGFCEGGDLYHKL-KEQKGKLLPENQVVEWFVQIAMALQYLHEK- 121
Query: 398 RLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
I+HRDLK NV L + K+ D G+AR
Sbjct: 122 --HILHRDLKTQNVFLTRTNIIKVGDLGIAR 150
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 48.0 bits (115), Expect = 3e-06
Identities = 38/160 (23%), Positives = 72/160 (45%), Gaps = 30/160 (18%)
Query: 284 NKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLKELKN--EVILFSKLQ-HRNLVKL 339
K+GEG F V K + G+ A+K + K + L+++ N E+ +L H N+++L
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHF-KSLEQVNNLREIQALRRLSPHPNILRL 63
Query: 340 LGCCIQGEEKLL----------IYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARG 389
+ + L +YE + + ++R K S + ++
Sbjct: 64 IEVLFDRKTGRLALVFELMDMNLYELIKGRK---RPLPEKRVK----SYMYQLLKS---- 112
Query: 390 VMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429
+ ++H++ I HRD+K N+L+ D K++DFG R
Sbjct: 113 LDHMHRNG---IFHRDIKPENILIKDD-ILKLADFGSCRG 148
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 4e-06
Identities = 60/221 (27%), Positives = 85/221 (38%), Gaps = 76/221 (34%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDGQE------IAVKRL---SKISEQG--LKELKNEVI 326
D + LG G FG V + + ++ +AVK L + SE + ELK I
Sbjct: 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELK---I 63
Query: 327 LFSKLQHRNLVKLLGCCIQGEEKLLI------------------YEFVPNKS-------- 360
L H N+V LLG C + L++ F P ++
Sbjct: 64 LIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREM 123
Query: 361 ---------LDS-----------FIFD------QERCKILDWSKRF----HIICGT---A 387
LDS FI D +E + + K +I + A
Sbjct: 124 KQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVA 183
Query: 388 RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
RG+ +L SR + IHRDL A N+LL ++ KI DFGLAR
Sbjct: 184 RGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLAR 221
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 4e-06
Identities = 42/161 (26%), Positives = 79/161 (49%), Gaps = 12/161 (7%)
Query: 275 NATDNFSINNKLGEGGFGPVYK-GTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ- 332
+ +D + I +G+G +G V+K +G + AVK L I + +E++ E + L
Sbjct: 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEAEYNILKALSD 73
Query: 333 HRNLVKLLGC-----CIQGEEKLLIYEFVPNKSLDSFIFDQ-ERCKILDWSKRFHIICGT 386
H N+VK G G++ L+ E S+ + +R + ++ +I+
Sbjct: 74 HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEA 133
Query: 387 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
G+ +LH + + IHRD+K +N+LL + K+ DFG++
Sbjct: 134 LMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVS 171
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 5e-06
Identities = 41/148 (27%), Positives = 69/148 (46%), Gaps = 12/148 (8%)
Query: 286 LGEGGFGPV------YKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 339
LG+GGFG V G + +++ KRL K S + + L+ E++ K+ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEIL--EKVNSPFIVNL 58
Query: 340 LGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRL 399
L+ + L I++ + L+ + H G+++LH +
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVGE-RGLEMERVIHYSAQITCGILHLHS---M 114
Query: 400 RIIHRDLKASNVLLDQDMNPKISDFGLA 427
I++RD+K NVLLD N ++SD GLA
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLA 142
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 6e-06
Identities = 49/156 (31%), Positives = 75/156 (48%), Gaps = 27/156 (17%)
Query: 286 LGEGGFGPVY----KGTLVDGQEIAVKRLSK----ISEQGLKELKNEVILFSKLQHRNLV 337
LG+G FG V+ KGT Q A+K L K + + + + +L +H L
Sbjct: 3 LGKGSFGKVFLAELKGT---NQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 59
Query: 338 KLLGCCIQGEEKLL-IYEFVPNKSLDSFIFDQERCKILDWSK-RFH---IICGTARGVMY 392
L C Q +E L + E++ L +F + C D + F+ IICG + +
Sbjct: 60 HLY-CTFQTKENLFFVMEYLNGGDL---MFHIQSCHKFDLPRATFYAAEIICG----LQF 111
Query: 393 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
LH I++RDLK N+LLD D + KI+DFG+ +
Sbjct: 112 LHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 6e-06
Identities = 43/161 (26%), Positives = 75/161 (46%), Gaps = 15/161 (9%)
Query: 279 NFSINNKLGEGGFGPVYKGTLVDGQE----IAVKRLSKIS----EQGLKELKNEVILFSK 330
NF + LG G +G V+ V G + A+K L K + + + + E +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 331 LQHRNLVKLLGCCIQGEEKL-LIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARG 389
++ + L Q + KL LI +++ L + + +ER K + I G
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK----EQEVQIYSGEI-- 114
Query: 390 VMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
V+ L +L II+RD+K N+LLD + + ++DFGL++ F
Sbjct: 115 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 1e-05
Identities = 45/149 (30%), Positives = 66/149 (44%), Gaps = 14/149 (9%)
Query: 286 LGEGGFGPVYKGTL-VDGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLG 341
LG+GGFG V + G+ A K+L K +G NE + K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67
Query: 342 CCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFH---IICGTARGVMYLHQDSR 398
+ L+ + L I+ + F+ I CG + LHQ+
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCG----LEDLHQE-- 121
Query: 399 LRIIHRDLKASNVLLDQDMNPKISDFGLA 427
RI++RDLK N+LLD + +ISD GLA
Sbjct: 122 -RIVYRDLKPENILLDDHGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 38/123 (30%), Positives = 62/123 (50%), Gaps = 13/123 (10%)
Query: 297 GTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFV 356
GTLV + + L +E+ LK L+NEV+L +H N++ G +I F+
Sbjct: 25 GTLV---TVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFM 81
Query: 357 PNKSLDSFI---FDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLL 413
S +S + F + + L + I+ G RG+ YLHQ+ IHR++KAS++L+
Sbjct: 82 AYGSANSLLKTYFPEGMSEALIGN----ILFGALRGLNYLHQNG---YIHRNIKASHILI 134
Query: 414 DQD 416
D
Sbjct: 135 SGD 137
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 48/149 (32%), Positives = 70/149 (46%), Gaps = 13/149 (8%)
Query: 286 LGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEV----ILFSKLQHRNLVKLL 340
+G+G FG V +DG+ AVK L K KE K+ + +L ++H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 341 GCCIQGEEKL-LIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRL 399
Q EKL + +FV L F Q + RF+ A + YLH +
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGEL--FFHLQRERSFPEPRARFYA-AEIASALGYLHS---I 115
Query: 400 RIIHRDLKASNVLLDQDMNPKISDFGLAR 428
I++RDLK N+LLD + ++DFGL +
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 45/165 (27%), Positives = 73/165 (44%), Gaps = 25/165 (15%)
Query: 280 FSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLSK-ISEQGL--KELKNEVILFSKLQHRN 335
+ I +G+GG G VY V + +A+K++ + +SE L K E + + L H
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPG 63
Query: 336 LVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKR-------------FHI 382
+V + C G+ ++ +L S + + + L SK FH
Sbjct: 64 IVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESL--SKELAEKTSVGAFLSIFHK 121
Query: 383 ICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
IC T + Y+H S+ ++HRDLK N+LL I D+G A
Sbjct: 122 ICAT---IEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAA 160
|
Length = 932 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 41/155 (26%), Positives = 73/155 (47%), Gaps = 22/155 (14%)
Query: 286 LGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLG 341
+G G FG V VD + A+K L K + +K E + ++ + +VKL
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLY- 67
Query: 342 CCIQGEEKL-LIYEFVPNKSLDSF-----IFDQERCKILDWSKRFHIICGTARGVMYLHQ 395
Q ++ L + +++P + S IF+++ RF+I + +H
Sbjct: 68 YSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLA-------RFYI-AELTCAIESVH- 118
Query: 396 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
++ IHRD+K N+L+D+D + K++DFGL F
Sbjct: 119 --KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 40/158 (25%), Positives = 77/158 (48%), Gaps = 17/158 (10%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRL------SKISEQGLKELKNEVILFSK 330
+ F + +GEG +G V K + +EI A+K+ ++ E L+ELK +
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELK----MLRT 56
Query: 331 LQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGV 390
L+ N+V+L + + L++E+V L+ + ++ + R +I + +
Sbjct: 57 LKQENIVELKEAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVRSYIY-QLIKAI 113
Query: 391 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
+ H++ I+HRD+K N+L+ + K+ DFG AR
Sbjct: 114 HWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 2e-05
Identities = 43/151 (28%), Positives = 69/151 (45%), Gaps = 18/151 (11%)
Query: 286 LGEGGFGPVYKGTL-VDGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLG 341
LG+GGFG V + G+ A KRL K +G NE + K+ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67
Query: 342 CCIQGEEKLLIYEFVPNKSLDSFIFDQ-----ERCKILDWSKRFHIICGTARGVMYLHQD 396
+ L+ + L I++ E + L ++ I+CG + LH++
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAE--ILCG----LEDLHRE 121
Query: 397 SRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
+ ++RDLK N+LLD + +ISD GLA
Sbjct: 122 N---TVYRDLKPENILLDDYGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 3e-05
Identities = 47/167 (28%), Positives = 74/167 (44%), Gaps = 30/167 (17%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSK---ISEQGLKELKNEVILFSK 330
++F +G+G FG V LV G+ A+K L K + L +K E + ++
Sbjct: 1 EDFHTVKVIGKGAFGEV---RLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAE 57
Query: 331 LQHRNLVKLLGCCIQGEEKLLIYEFVPNKSL-------DSFIFDQERCKILDWSKRFHII 383
+V L + LI EF+P L D+F D RF++
Sbjct: 58 SDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSED---------VTRFYM- 107
Query: 384 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
A V+ + +L IHRD+K N+L+D+ + K+SDFGL+ F
Sbjct: 108 ---AECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 3e-05
Identities = 39/150 (26%), Positives = 67/150 (44%), Gaps = 19/150 (12%)
Query: 286 LGEGGFGPVYK------GTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 339
LG G G V K GT++ + + + S + +Q L+EL+ + + + +V
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQ----IMHECRSPYIVSF 68
Query: 340 LGCCIQGEEKLLIYEFVPNKSLDSFI--FDQERCKILDWSKRFHIICGTARGVMYLHQDS 397
G + + EF+ SLD +IL I G+ YL+ +
Sbjct: 69 YGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGLTYLY--N 121
Query: 398 RLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
RI+HRD+K SN+L++ K+ DFG++
Sbjct: 122 VHRIMHRDIKPSNILVNSRGQIKLCDFGVS 151
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 4e-05
Identities = 43/153 (28%), Positives = 74/153 (48%), Gaps = 18/153 (11%)
Query: 286 LGEGGFGPVYKGTLVDGQE----IAVKRLSKI----SEQGLKELKNEVILFSKLQHRNLV 337
LG+GG+G V++ V G + A+K L K +++ K E + ++H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 338 KLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQ-ERCKI-LDWSKRFHIICGTARGVMYLHQ 395
L+ G + LI E++ L F ER I ++ + F++ + + L
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGEL----FMHLEREGIFMEDTACFYL----SEISLALEH 115
Query: 396 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
+ II+RDLK N+LLD + K++DFGL +
Sbjct: 116 LHQQGIIYRDLKPENILLDAQGHVKLTDFGLCK 148
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 4e-05
Identities = 47/151 (31%), Positives = 73/151 (48%), Gaps = 17/151 (11%)
Query: 286 LGEGGFGPVYKGTLV-DGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLG 341
LG+G FG V L G+ AVK L K + + ++ E + + + L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 342 CCIQGEEKLL-IYEFVPNKSLDSFIFDQERCKILDWSKRFH---IICGTARGVMYLHQDS 397
C Q +E L + EF+ L I D+ R + + F+ I+CG + +LH
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDL--YRATFYAAEIVCG----LQFLHSKG 116
Query: 398 RLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
II+RDLK NV+LD+D + KI+DFG+ +
Sbjct: 117 ---IIYRDLKLDNVMLDRDGHIKIADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 4e-05
Identities = 51/162 (31%), Positives = 70/162 (43%), Gaps = 40/162 (24%)
Query: 286 LGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELK------NEVILFSKLQHRNLVK 338
LG+GGFG V + G+ A K+L K + +K+ K NE + K+ R +V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEK---KRIKKRKGEAMALNEKQILEKVNSRFVVS 64
Query: 339 LL-------GCCI------QGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICG 385
L C+ G+ K IY FD+ER I CG
Sbjct: 65 LAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPG------FDEERAVFY----AAEITCG 114
Query: 386 TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
+ LH R RI++RDLK N+LLD + +ISD GLA
Sbjct: 115 ----LEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 4e-05
Identities = 47/213 (22%), Positives = 90/213 (42%), Gaps = 33/213 (15%)
Query: 229 SFPDGGQDFYIRMSASELEKTENNRETDQVQNMDLELPLFELATIANATDNFSINNKLGE 288
F + E E++ NN + + + + ++ + N +G
Sbjct: 27 KFEMNDK------KLDEEERSHNNNAGEDEDEEKM----IDNDINRSPNKSYKLGNIIGN 76
Query: 289 GGFGPVYKGTLVDGQE-IAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGC----C 343
G FG VY+ +D E +A+K++ + + +EL ++ L H N++ L C
Sbjct: 77 GSFGVVYEAICIDTSEKVAIKKVLQDPQYKNREL----LIMKNLNHINIIFLKDYYYTEC 132
Query: 344 IQGEEKLL----IYEFVP---NKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 396
+ EK + + EF+P +K + + + + + +C R + Y+H
Sbjct: 133 FKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLC---RALAYIHSK 189
Query: 397 SRLRIIHRDLKASNVLLDQDMNP-KISDFGLAR 428
I HRDLK N+L+D + + K+ DFG A+
Sbjct: 190 F---ICHRDLKPQNLLIDPNTHTLKLCDFGSAK 219
|
Length = 440 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 4e-05
Identities = 19/42 (45%), Positives = 28/42 (66%), Gaps = 3/42 (7%)
Query: 387 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
A G+ +LH II+RDLK NV+LD + + KI+DFG+ +
Sbjct: 111 AIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCK 149
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 4e-05
Identities = 19/42 (45%), Positives = 25/42 (59%), Gaps = 3/42 (7%)
Query: 388 RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429
R + Y+H + + HRDLK N+L + D KI DFGLAR
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARV 152
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 4e-05
Identities = 39/161 (24%), Positives = 77/161 (47%), Gaps = 15/161 (9%)
Query: 279 NFSINNKLGEGGFGPVYKGTLVDGQE----IAVKRLSKIS----EQGLKELKNEVILFSK 330
NF + LG G +G V+ V G + A+K L K + + ++ + E +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 331 LQHRNLVKLLGCCIQGEEKL-LIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARG 389
++ + L Q E KL LI ++V + + ++ ++ + RF+ +
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFS--EDEVRFY----SGEI 114
Query: 390 VMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
++ L +L I++RD+K N+LLD + + ++DFGL++ F
Sbjct: 115 ILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 5e-05
Identities = 34/96 (35%), Positives = 48/96 (50%), Gaps = 8/96 (8%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVD-GQE-----IAVKRLSKISEQGLKE-LKNEVILFSK 330
DN LG G FG V + T G+E +AVK L + +E L +E+ + S
Sbjct: 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSH 97
Query: 331 L-QHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFI 365
L QH+N+V LLG C G L+I E+ L +F+
Sbjct: 98 LGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFL 133
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 5e-05
Identities = 59/227 (25%), Positives = 85/227 (37%), Gaps = 82/227 (36%)
Query: 278 DNFSINNKLGEGGFGPVYKGT------LVDGQEIAVKRLSKISEQG-----LKELKNEVI 326
D + LG G FG V + + +AVK L + + + ELK I
Sbjct: 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK---I 63
Query: 327 LFSKLQHRNLVKLLGCCIQGEEKLLIY------------------EFVPNKS-------- 360
L H N+V LLG C + L++ EFVP K+
Sbjct: 64 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQG 123
Query: 361 --------------LDS-----------FIFDQERCKIL-------DWSKRF----HIIC 384
LDS F+ ++ + D K+ +IC
Sbjct: 124 KSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLIC 183
Query: 385 GT---ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
+ A+G+ +L SR + IHRDL A N+LL ++ KI DFGLAR
Sbjct: 184 YSFQVAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLAR 227
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 5e-05
Identities = 43/165 (26%), Positives = 65/165 (39%), Gaps = 48/165 (29%)
Query: 286 LGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKN-----EVILFSKLQHR--NLV 337
+G G G VYK G +AVK++ + + +E K +V+L S H +V
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKS---HDCPYIV 77
Query: 338 KLLGCCIQGE-------------EKLL--IYEFVPNKSLDSFIFDQERCKILDWSKRFHI 382
K G I +KLL I +P L +
Sbjct: 78 KCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILG------------------KM 119
Query: 383 ICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
+ + YL + +IHRD+K SN+LLD N K+ DFG++
Sbjct: 120 TVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGIS 162
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 7e-05
Identities = 38/156 (24%), Positives = 69/156 (44%), Gaps = 12/156 (7%)
Query: 278 DNFSINNKLGEGGFGPVYK------GTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL 331
D + ++LG+G +G VYK G + +EI RL + E ++ E+ + K
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEI---RLE-LDESKFNQIIMELDILHKA 56
Query: 332 QHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 391
+V G + E++ SLD + + I +G+
Sbjct: 57 VSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLK 116
Query: 392 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
+L ++ IIHRD+K +NVL++ + K+ DFG++
Sbjct: 117 FLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVS 150
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 49/170 (28%), Positives = 76/170 (44%), Gaps = 40/170 (23%)
Query: 278 DNFSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLSK---ISEQGLKELKNE--------- 324
+ F I + G FG VY G + + AVK + K I++ + +++ E
Sbjct: 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS 63
Query: 325 ---VILFSKLQHRNLVKL-LGCCIQGEEK--LLIYEFVPNKSLDSFIFDQERCKILDWSK 378
V L+ LQ N V L + I G+ K L IY + FD+E
Sbjct: 64 PFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGY----------FDEE-------MA 106
Query: 379 RFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
+I A + YLH+ IIHRDLK N+L+ + + K++DFGL++
Sbjct: 107 VKYI-SEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 39/149 (26%), Positives = 69/149 (46%), Gaps = 10/149 (6%)
Query: 286 LGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLG 341
LG G FG V VD + A+K L K ++ + +K E + ++ + +VKL
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 342 CCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRI 401
+ + +++P + S + E + RF+I A + + ++
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRME--VFPEVLARFYI----AELTLAIESVHKMGF 122
Query: 402 IHRDLKASNVLLDQDMNPKISDFGLARAF 430
IHRD+K N+L+D D + K++DFGL F
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGF 151
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 46/149 (30%), Positives = 73/149 (48%), Gaps = 13/149 (8%)
Query: 286 LGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEV----ILFSKLQHRNLVKLL 340
+G+G FG V + + AVK L K + KE K+ + +L ++H LV L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL- 61
Query: 341 GCCIQGEEKL-LIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRL 399
Q +KL + +++ L + +ERC L+ RF+ A + YLH L
Sbjct: 62 HFSFQTADKLYFVLDYINGGEL-FYHLQRERC-FLEPRARFYA-AEIASALGYLHS---L 115
Query: 400 RIIHRDLKASNVLLDQDMNPKISDFGLAR 428
I++RDLK N+LLD + ++DFGL +
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 40/158 (25%), Positives = 73/158 (46%), Gaps = 15/158 (9%)
Query: 285 KLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLLGCC 343
K+G G +G VYK DG++ L +I G+ E+ L +L+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67
Query: 344 IQGEEK--LLIYEFVPNKSLDSFIFDQ-----ERCKILDWSKRFHIICGTARGVMYLHQD 396
+ ++ L++++ + F + ++ L S ++ G+ YLH +
Sbjct: 68 LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127
Query: 397 SRLRIIHRDLKASNVLL----DQDMNPKISDFGLARAF 430
++HRDLK +N+L+ + KI+D G AR F
Sbjct: 128 ---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 17/37 (45%), Positives = 26/37 (70%), Gaps = 3/37 (8%)
Query: 392 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
YLH +++RDLK N++LD+D + KI+DFGL +
Sbjct: 110 YLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK 143
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 47/159 (29%), Positives = 68/159 (42%), Gaps = 34/159 (21%)
Query: 286 LGEGGFGPVYKGTL-VDGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLL- 340
LG+GGFG V + G+ A K+L K +G NE + K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67
Query: 341 ------GCCI------QGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTAR 388
C+ G+ K IY ++ + FD++R + CG
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIY------NMGNPGFDEQRAIFY----AAELCCG--- 114
Query: 389 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
L R RI++RDLK N+LLD + +ISD GLA
Sbjct: 115 ----LEDLQRERIVYRDLKPENILLDDRGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 40/150 (26%), Positives = 71/150 (47%), Gaps = 15/150 (10%)
Query: 286 LGEGGFGPVYKGTLVDGQEIAVKRLSKIS----EQGLKELKNEVILFSKLQHRNLVKLLG 341
+G G + V L +I ++ K ++ + ++ E +F + + L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 342 CCIQGEEKL-LIYEFVPNKSLDSFIFDQERCKILDWSKRFHI--ICGTARGVMYLHQDSR 398
C Q +L L+ E+V L F ++R K+ + RF+ IC + +LH+
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDL-MFHMQRQR-KLPEEHARFYAAEIC---IALNFLHERG- 116
Query: 399 LRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
II+RDLK NVLLD D + K++D+G+ +
Sbjct: 117 --IIYRDLKLDNVLLDADGHIKLTDYGMCK 144
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 42/153 (27%), Positives = 72/153 (47%), Gaps = 10/153 (6%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH 333
D+F +G G FG V D G A+K L K + ++ + ++ E + +
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 334 RNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 393
+VK+ LI EF+P + + + ++ + + + +F+I T + +
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKD--TLSEEATQFYI-AETVLAIDAI 117
Query: 394 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 426
HQ L IHRD+K N+LLD + K+SDFGL
Sbjct: 118 HQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 4e-04
Identities = 31/132 (23%), Positives = 57/132 (43%), Gaps = 13/132 (9%)
Query: 302 GQEIAVKRLSKISEQGLKE---LKNEVILFSKLQHRNLVKLLGCCIQGEEKLL-IYEFVP 357
G E+A+K L + + + + E L ++L H N+V LL L ++E+VP
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 358 NKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLL---D 414
++L + L + ++ + H I+HRDLK N+++
Sbjct: 63 GRTLREVLAAD---GALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTG 116
Query: 415 QDMNPKISDFGL 426
+ K+ DFG+
Sbjct: 117 VRPHAKVLDFGI 128
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 4e-04
Identities = 15/26 (57%), Positives = 19/26 (73%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDGQ 303
D+F + KLGEG FG VYK +LV+ Q
Sbjct: 132 DDFVLGKKLGEGAFGVVYKASLVNKQ 157
|
Length = 566 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 4e-04
Identities = 30/148 (20%), Positives = 53/148 (35%), Gaps = 17/148 (11%)
Query: 285 KLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV--KLLGC 342
L G VY ++ +K S + + + EV + L + L K+L
Sbjct: 5 LLKGGLTNRVYLLGT-KDEDYVLKINP--SREKGADREREVAILQLLARKGLPVPKVLAS 61
Query: 343 CIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMY-LHQDSRLRI 401
L+ E++ ++LD +++ I ++ LHQ L +
Sbjct: 62 GESDGWSYLLMEWIEGETLDEVSEEEKE-----------DIAEQLAELLAKLHQLPLLVL 110
Query: 402 IHRDLKASNVLLDQDMNPKISDFGLARA 429
H DL N+L+D I D+ A
Sbjct: 111 CHGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 5e-04
Identities = 40/153 (26%), Positives = 71/153 (46%), Gaps = 10/153 (6%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH 333
++F +G G FG V D G A+K L K + ++ + ++ E + +
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 334 RNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 393
+VK+ LI EF+P + + + ++ + + +F+I A V+ +
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKD--TLTEEETQFYI----AETVLAI 114
Query: 394 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 426
+L IHRD+K N+LLD + K+SDFGL
Sbjct: 115 DSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 5e-04
Identities = 30/90 (33%), Positives = 48/90 (53%), Gaps = 7/90 (7%)
Query: 340 LGCCIQGEEKL-LIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSR 398
L C Q E +L + EFV L F ++R K+ + RF+ +A + L+
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDL-MFHMQRQR-KLPEEHARFY----SAEISLALNFLHE 114
Query: 399 LRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
II+RDLK NVLLD + + K++D+G+ +
Sbjct: 115 RGIIYRDLKLDNVLLDAEGHIKLTDYGMCK 144
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 5e-04
Identities = 40/155 (25%), Positives = 77/155 (49%), Gaps = 17/155 (10%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSKI-----SEQGLKELKNEVILFSKL 331
+++ + +G G FG V Q++ A+K LSK S+ + +++ F+
Sbjct: 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-- 100
Query: 332 QHRNLVKLLGCCIQGEEKL-LIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGV 390
+ V L C Q ++ L ++ E++P L + + + + + W+K + TA V
Sbjct: 101 -NSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE--KWAKFY-----TAEVV 152
Query: 391 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 425
+ L + +IHRD+K N+LLD+ + K++DFG
Sbjct: 153 LALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFG 187
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 5e-04
Identities = 23/42 (54%), Positives = 29/42 (69%), Gaps = 3/42 (7%)
Query: 387 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
ARG+ +L SR + IHRDL A N+LL ++ KI DFGLAR
Sbjct: 184 ARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLAR 222
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 6e-04
Identities = 39/149 (26%), Positives = 67/149 (44%), Gaps = 20/149 (13%)
Query: 286 LGEGGFGPVYKGTLVDGQEI-AVKRLS-KISEQGLKELKNEVILFSKLQHRNLVKLLGCC 343
LG G G VYK + + I AVK + I+ + K++ +E+ + K ++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 344 IQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTA----RGVMYLHQDSRL 399
+ EF+ SLD + H++ A +G+ YL L
Sbjct: 69 FVENRISICTEFMDGGSLDVY-----------RKIPEHVLGRIAVAVVKGLTYLWS---L 114
Query: 400 RIIHRDLKASNVLLDQDMNPKISDFGLAR 428
+I+HRD+K SN+L++ K+ DFG++
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVST 143
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 6e-04
Identities = 52/162 (32%), Positives = 70/162 (43%), Gaps = 33/162 (20%)
Query: 286 LGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLG 341
+G GGFG VY D G+ A+K L K +QG NE I+ S LV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS------LVSTGD 55
Query: 342 C----CIQGEEKLLIYEF-VPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL--- 393
C C+ Y F P+K SFI D L + H + A Y
Sbjct: 56 CPFIVCMS-------YAFHTPDKL--SFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEI 106
Query: 394 -----HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
H +R +++RDLK +N+LLD+ + +ISD GLA F
Sbjct: 107 ILGLEHMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDF 147
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 6e-04
Identities = 44/154 (28%), Positives = 69/154 (44%), Gaps = 22/154 (14%)
Query: 285 KLGEGGFGPVY----KGTLVDGQEIAVKRLSKISEQGLKELKN---EVILFSKLQHRNLV 337
LG+G G V+ KGT G+ A+K L K ++K E + + L H L
Sbjct: 8 LLGKGDVGRVFLVRLKGT---GKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLP 64
Query: 338 KLLGCCIQGEEKL-LIYEFVPNKSLDSFIFDQERCKILDWSKRFH---IICGTARGVMYL 393
L Q E L L+ ++ P L + Q + + RF+ ++ + YL
Sbjct: 65 TLY-ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLA----LEYL 119
Query: 394 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
H L I++RDLK N+LL + + +SDF L+
Sbjct: 120 HL---LGIVYRDLKPENILLHESGHIMLSDFDLS 150
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 6e-04
Identities = 34/120 (28%), Positives = 55/120 (45%), Gaps = 20/120 (16%)
Query: 320 ELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI---YEFVPNKSLDSFIFDQERCKILDW 376
+L+NE++ +L H N++K+ +I Y+F L SF++D+ DW
Sbjct: 209 QLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF----DLYSFMYDEA----FDW 260
Query: 377 SKR------FHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
R I+ V Y+H ++IHRD+K N+ L+ D + DFG A F
Sbjct: 261 KDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPF 317
|
Length = 501 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 7e-04
Identities = 39/158 (24%), Positives = 72/158 (45%), Gaps = 15/158 (9%)
Query: 285 KLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLLGCC 343
K+G G +G VYK DG++ L +I G+ E+ L +L+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67
Query: 344 IQGEEK--LLIYEFVPNKSLDSFIFDQ-----ERCKILDWSKRFHIICGTARGVMYLHQD 396
+ ++ L++++ + F + ++ L ++ G+ YLH +
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 127
Query: 397 SRLRIIHRDLKASNVLL----DQDMNPKISDFGLARAF 430
++HRDLK +N+L+ + KI+D G AR F
Sbjct: 128 ---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.001
Identities = 38/161 (23%), Positives = 70/161 (43%), Gaps = 25/161 (15%)
Query: 286 LGEGGFGPVYKGTLVD---------GQEIAVKRLSKISEQGLKELK----NEVILFSKLQ 332
LG G +Y G L E +K + K+ + +++ + ++
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 333 HRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMY 392
H+++V L G C++ E +++ EFV LD F+ + W +F + A + Y
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQLASALSY 120
Query: 393 LHQDSRLRIIHRDLKASNVLL-----DQDMNP--KISDFGL 426
L +D L +H ++ N+LL D + P K+SD G+
Sbjct: 121 L-EDKDL--VHGNVCTKNILLAREGIDGECGPFIKLSDPGI 158
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.002
Identities = 17/27 (62%), Positives = 18/27 (66%)
Query: 402 IHRDLKASNVLLDQDMNPKISDFGLAR 428
IHRDL A N+LL KI DFGLAR
Sbjct: 236 IHRDLAARNILLTHGRITKICDFGLAR 262
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.002
Identities = 16/40 (40%), Positives = 28/40 (70%), Gaps = 2/40 (5%)
Query: 388 RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
RG+ YL + + +I+HRD+K SN+L++ K+ DFG++
Sbjct: 110 RGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS 147
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 39/150 (26%), Positives = 69/150 (46%), Gaps = 12/150 (8%)
Query: 286 LGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLG 341
LG G FG V VD + + A+K L K + + +K E + ++ + +V+L
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68
Query: 342 CCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWS-KRFHIICGTARGVMYLHQDSRLR 400
+ + +++P + S + R I RF+I A + ++
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLI---RMGIFPEDLARFYI----AELTCAVESVHKMG 121
Query: 401 IIHRDLKASNVLLDQDMNPKISDFGLARAF 430
IHRD+K N+L+D+D + K++DFGL F
Sbjct: 122 FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 44/157 (28%), Positives = 72/157 (45%), Gaps = 13/157 (8%)
Query: 277 TDNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQ 332
NF + LG+G FG V E+ A+K L K I + ++ E + +
Sbjct: 1 DFNFLM--VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQD 58
Query: 333 HRNLVKLLGCCIQGEEKL-LIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 391
+ L C Q ++L + E+V L I Q+ K + F+ + G+
Sbjct: 59 KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHI--QQVGKFKEPQAVFYA-AEISVGLF 115
Query: 392 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
+LH+ II+RDLK NV+LD + + KI+DFG+ +
Sbjct: 116 FLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 149
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.002
Identities = 42/151 (27%), Positives = 73/151 (48%), Gaps = 13/151 (8%)
Query: 286 LGEGGFGPVYKGTLVDGQEI-AVKRLSKISEQGLKEL-----KNEVILFSKLQHRNLVKL 339
+G+G FG VY+ D + I A+K LSK KE+ + +++ + L +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 340 LGCCIQGEEKL-LIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSR 398
L Q + L L+ +++ L F Q+ + + +F+I A V+ L +
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGEL--FWHLQKEGRFSEDRAKFYI----AELVLALEHLHK 114
Query: 399 LRIIHRDLKASNVLLDQDMNPKISDFGLARA 429
I++RDLK N+LLD + + DFGL++A
Sbjct: 115 YDIVYRDLKPENILLDATGHIALCDFGLSKA 145
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 17/37 (45%), Positives = 27/37 (72%), Gaps = 2/37 (5%)
Query: 392 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
YLH + +++RDLK N++LD+D + KI+DFGL +
Sbjct: 110 YLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK 144
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.003
Identities = 17/47 (36%), Positives = 30/47 (63%), Gaps = 4/47 (8%)
Query: 379 RFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 425
RF++ A V+ + +L +HRD+K NVLLD++ + +++DFG
Sbjct: 105 RFYL----AEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFG 147
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.003
Identities = 39/158 (24%), Positives = 72/158 (45%), Gaps = 17/158 (10%)
Query: 278 DNFSINNKLGEGGFGPVY----KGTLVDGQEIAVKRLSK---ISEQGLKELKNEVILFSK 330
+F + + +G G FG V K T G A+K + K ++++ + + E + S
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKAT---GDIYAMKVMKKSVLLAQETVSFFEEERDILSI 57
Query: 331 LQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWS-KRFHIICGTARG 389
+ +L + L+ E+ P L S + E D +F++ A
Sbjct: 58 SNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYE--DQFDEDMAQFYL----AEL 111
Query: 390 VMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
V+ +H ++ +HRD+K NVL+D+ + K++DFG A
Sbjct: 112 VLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSA 149
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.003
Identities = 32/115 (27%), Positives = 60/115 (52%), Gaps = 7/115 (6%)
Query: 315 EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL-IYEFVPNKSLDSFIFDQERCKI 373
++ + ++ E +F + + + L C Q E +L + E+V L F ++R K+
Sbjct: 36 DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL-MFHMQRQR-KL 93
Query: 374 LDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
+ RF+ + + YLH+ II+RDLK NVLLD + + K++D+G+ +
Sbjct: 94 PEEHARFYS-AEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK 144
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.003
Identities = 28/106 (26%), Positives = 48/106 (45%), Gaps = 11/106 (10%)
Query: 324 EVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIF--DQERCKILDWSKRFH 381
E + + H ++++L G + LI +P D + + + I D
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAICDI---LA 186
Query: 382 IICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
I R + YLH++ RIIHRD+KA N+ ++ + + DFG A
Sbjct: 187 IERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA 229
|
Length = 391 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.003
Identities = 18/37 (48%), Positives = 27/37 (72%), Gaps = 3/37 (8%)
Query: 392 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
YLH +I++RDLK N++LD+D + KI+DFGL +
Sbjct: 110 YLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCK 143
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.003
Identities = 50/162 (30%), Positives = 68/162 (41%), Gaps = 33/162 (20%)
Query: 286 LGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLG 341
+G GGFG VY D G+ A+K L K +QG NE I+ S LV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS------LVSTGD 55
Query: 342 C----CIQGEEKLLIYEF-VPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL--- 393
C C + Y F P+K FI D L + H + Y
Sbjct: 56 CPFIVC-------MTYAFHTPDKL--CFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEI 106
Query: 394 -----HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
H +R +++RDLK +N+LLD+ + +ISD GLA F
Sbjct: 107 ILGLEHMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDF 147
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.003
Identities = 22/42 (52%), Positives = 26/42 (61%), Gaps = 3/42 (7%)
Query: 387 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
ARG+ +L + +HRDL A NVLL Q KI DFGLAR
Sbjct: 247 ARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLAR 285
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.004
Identities = 17/27 (62%), Positives = 18/27 (66%)
Query: 402 IHRDLKASNVLLDQDMNPKISDFGLAR 428
IHRD+ A NVLL KI DFGLAR
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLAR 260
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.004
Identities = 19/42 (45%), Positives = 28/42 (66%), Gaps = 3/42 (7%)
Query: 387 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
A G+ +LH II+RDLK NV+LD + + KI+DFG+ +
Sbjct: 111 AIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 149
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.004
Identities = 16/37 (43%), Positives = 26/37 (70%), Gaps = 3/37 (8%)
Query: 392 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
YLH +++RD+K N++LD+D + KI+DFGL +
Sbjct: 110 YLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK 143
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 430 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 99.98 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 99.97 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 99.97 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 99.97 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 99.97 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 99.97 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 99.97 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.97 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 99.97 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 99.96 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 99.96 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 99.96 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.96 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 99.96 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.95 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 99.95 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.95 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.95 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.95 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.95 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.95 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.95 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 99.95 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.95 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.94 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.94 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.94 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.94 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.94 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.94 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.94 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.94 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.94 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.94 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.94 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 99.94 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.94 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.94 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.94 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.94 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.93 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.93 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.93 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.93 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.93 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.93 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.93 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.93 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.93 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.93 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.93 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.93 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.93 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.93 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.93 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.93 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.93 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.93 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.93 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.93 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.93 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.93 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.93 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.93 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.93 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.93 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.93 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.93 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.93 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.93 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.93 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.93 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.93 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.93 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.93 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.93 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.93 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.93 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.93 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.93 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.93 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.93 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.93 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.92 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.92 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.92 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.92 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.92 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.92 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.92 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.92 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.92 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.92 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.92 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.92 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.92 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.92 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.92 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.92 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.92 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.92 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.92 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.92 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.92 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.92 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.92 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.92 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.92 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.92 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.92 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.92 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.92 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.92 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.92 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.92 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.92 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.92 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.92 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.92 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.92 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.92 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.92 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.92 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.92 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.92 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.92 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.92 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.92 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.92 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.92 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.91 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.91 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.91 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.91 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.91 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.91 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.91 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.91 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.91 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.91 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.91 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.91 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.91 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.91 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.91 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.91 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.91 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.91 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.91 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.91 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.91 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.91 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.91 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.91 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.91 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.91 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.91 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.91 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.91 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.91 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.91 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.91 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.91 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.91 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.91 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.91 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.91 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.91 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.91 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.91 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.91 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.91 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.91 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.91 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.91 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.91 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.91 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.91 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.91 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.91 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.91 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.91 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.91 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.91 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.91 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.91 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.91 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.9 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.9 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.9 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.9 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.9 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.9 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.9 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.9 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.9 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.9 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.9 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.9 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.9 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.9 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.9 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.9 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.9 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.9 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.9 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.9 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.9 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.9 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.9 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.9 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.9 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.9 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.9 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.9 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.9 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.9 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.9 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.9 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.9 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.9 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.9 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.9 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.9 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.9 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.9 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.9 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.9 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.9 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.9 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.9 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.9 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.9 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.89 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.89 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.89 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.89 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.89 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.89 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.89 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.89 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.89 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.89 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.89 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.89 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.89 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.89 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.89 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.89 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.89 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.89 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.89 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.89 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.89 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.89 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.89 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.89 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.89 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.89 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.89 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.89 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.89 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.89 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.88 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.88 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.88 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.88 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.88 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.88 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.88 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.88 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.88 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.88 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.88 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.88 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.88 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.88 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.88 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.88 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.88 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.88 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.88 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.88 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.88 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.88 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.88 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.88 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.87 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.87 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.87 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.87 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.87 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.87 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.87 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.87 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.87 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.87 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.87 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.87 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.87 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.87 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.87 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.87 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.87 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.87 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.86 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.86 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.86 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.86 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.86 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.86 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.86 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.86 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.86 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.86 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.86 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.86 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.86 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.85 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.84 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.84 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.84 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.84 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.83 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.83 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.83 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.83 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.83 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.83 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.82 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.82 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.82 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.81 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.81 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.81 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.81 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.8 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.79 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.79 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.79 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.79 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.79 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.79 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.79 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.78 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.78 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.75 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.74 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.74 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.73 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.73 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.71 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.68 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.66 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.63 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.61 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.54 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.5 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.49 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.42 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.4 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.4 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 99.39 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.38 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 99.35 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.33 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.33 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.31 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.23 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.15 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.15 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.14 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.12 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.05 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.0 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 98.97 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 98.91 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.87 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.86 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.86 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.83 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.76 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.76 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.75 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.74 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.66 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.61 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.57 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.55 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 98.51 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.49 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.45 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.44 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.42 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 98.41 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.33 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 98.32 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.26 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.25 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.19 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.16 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.11 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.08 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.02 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.96 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.96 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.88 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.74 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.67 | |
| PLN02236 | 344 | choline kinase | 97.64 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.61 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.58 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.48 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 97.45 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.38 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.33 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.13 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.09 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 97.03 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.9 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.82 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.76 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.71 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.61 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 96.59 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.53 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.53 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.47 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 96.45 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.44 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 96.21 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.2 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=286.81 Aligned_cols=165 Identities=52% Similarity=0.881 Sum_probs=151.5
Q ss_pred CCCcccHHhHHhhcCCcccceeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEE
Q 047619 264 ELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC 343 (430)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 343 (430)
....|++.++..++++|...+.||+|+||.||+|.+.++..||||++.....+...+|.+|+.++.+++|||||+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 56678999999999999999999999999999999999999999988764332156699999999999999999999999
Q ss_pred EeCC-EEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeec
Q 047619 344 IQGE-EKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 422 (430)
Q Consensus 344 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~ 422 (430)
.+.+ +.+||+|||++|+|.++|+..... +++|..|++|+.++|+||+|||+...++||||||||+|||||+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 9999 599999999999999999776543 78999999999999999999999887889999999999999999999999
Q ss_pred CCCcccc
Q 047619 423 DFGLARA 429 (430)
Q Consensus 423 DFGlar~ 429 (430)
|||+|+.
T Consensus 220 DFGLa~~ 226 (361)
T KOG1187|consen 220 DFGLAKL 226 (361)
T ss_pred CccCccc
Confidence 9999975
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=266.87 Aligned_cols=149 Identities=32% Similarity=0.561 Sum_probs=135.3
Q ss_pred hcCCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc--ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 352 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 352 (430)
...+|.+.++||+|+||+||+|+++ ++..||||.+.+. .....+.+..|+.+|+.++|||||++++++..++..+||
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 3468889999999999999999965 4889999999764 667788899999999999999999999999999999999
Q ss_pred EEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCC------CCeeecCCCc
Q 047619 353 YEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQD------MNPKISDFGL 426 (430)
Q Consensus 353 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~------~~~kl~DFGl 426 (430)
||||.||+|..+|.... .+++..+..++.|++.||++||+++ ||||||||+||||+.. -.+||+|||+
T Consensus 88 MEyC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 99999999999996543 5999999999999999999999999 9999999999999764 4589999999
Q ss_pred cccC
Q 047619 427 ARAF 430 (430)
Q Consensus 427 ar~~ 430 (430)
||.+
T Consensus 162 AR~L 165 (429)
T KOG0595|consen 162 ARFL 165 (429)
T ss_pred hhhC
Confidence 9964
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-32 Score=253.64 Aligned_cols=148 Identities=30% Similarity=0.471 Sum_probs=130.0
Q ss_pred hcCCcccceeecccCCcceEEEEE-cCCcEEEEEEecccCh-------HhHHHHHHHHHHHhcCCCCcccceEEEEEeCC
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISE-------QGLKELKNEVILFSKLQHRNLVKLLGCCIQGE 347 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 347 (430)
..+.|.+.+.||+|+||.|-+|.. .+++.||||++++... .....+++|+++|++|+|||||++++++..++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 556788899999999999999984 5699999999976211 12334679999999999999999999999999
Q ss_pred EEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCC---CCeeecCC
Q 047619 348 EKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQD---MNPKISDF 424 (430)
Q Consensus 348 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~---~~~kl~DF 424 (430)
..||||||++||+|.+.+..+ +.+.+.....+++|++.||.|||++| |+||||||+|||+..+ ..+||+||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~n---k~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVAN---KYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ceEEEEEEecCccHHHHHHhc---cccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence 999999999999999999654 34777888899999999999999999 9999999999999765 67999999
Q ss_pred Ccccc
Q 047619 425 GLARA 429 (430)
Q Consensus 425 Glar~ 429 (430)
|+||.
T Consensus 324 GlAK~ 328 (475)
T KOG0615|consen 324 GLAKV 328 (475)
T ss_pred chhhc
Confidence 99985
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=246.24 Aligned_cols=148 Identities=29% Similarity=0.455 Sum_probs=135.1
Q ss_pred hcCCcccceeecccCCcceEEEEEcC-CcEEEEEEeccc---ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 351 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 351 (430)
..++|++++.||+|+||+||+++.++ ++.+|+|++++. .....+...+|..||.+++||.||+++..|++.+.+||
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 34789999999999999999999655 889999999862 33457788999999999999999999999999999999
Q ss_pred EEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 352 IYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 352 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|+||+.||.|...|.++ ..+++..+..++.+|+.||.|||+.+ ||||||||+|||||.+|+++|+|||+||.
T Consensus 103 Vld~~~GGeLf~hL~~e---g~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~ 174 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQRE---GRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKE 174 (357)
T ss_pred EEeccCCccHHHHHHhc---CCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchh
Confidence 99999999999999544 34899999999999999999999999 99999999999999999999999999984
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=243.72 Aligned_cols=147 Identities=28% Similarity=0.372 Sum_probs=132.0
Q ss_pred CCcccceeecccCCcceEEEEEc-CCcEEEEEEecc-cChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCC-EEEEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-EKLLIYE 354 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e 354 (430)
++.+..+.||+|..|+||+++++ +++.+|+|.+.. ..+...+++.+|+++++..+||+||++||+|..+. ...|+||
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 45566789999999999999975 588999999953 45667889999999999999999999999999999 5999999
Q ss_pred ccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCcEEeCCCCCCcEEEcCCCCeeecCCCccccC
Q 047619 355 FVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ-DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430 (430)
Q Consensus 355 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~-~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~~ 430 (430)
||.+|+|++++... +.+++...-.|+.+|++||.|||+ .+ ||||||||+||||+..|+|||+|||.++.+
T Consensus 159 YMDgGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~l 229 (364)
T KOG0581|consen 159 YMDGGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGIL 229 (364)
T ss_pred hcCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHh
Confidence 99999999999544 458999999999999999999996 55 999999999999999999999999999853
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=253.07 Aligned_cols=146 Identities=31% Similarity=0.470 Sum_probs=135.6
Q ss_pred CCcccceeecccCCcceEEEEE-cCCcEEEEEEecc---cChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 353 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 353 (430)
..|...+.||+|||+.||+++. ..|+.||+|++.+ ......+.+.+||+|.+.|+|||||+++++|++.++.|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5699999999999999999997 6699999999976 24556778999999999999999999999999999999999
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|+|+.++|..++. +.+++++.++..+++||+.||.|||+++ |||||||..||+|+++.+|||+|||||..
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~ 167 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQ 167 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeee
Confidence 9999999999985 4467999999999999999999999998 99999999999999999999999999975
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=236.71 Aligned_cols=147 Identities=26% Similarity=0.421 Sum_probs=129.1
Q ss_pred CCcccceeecccCCcceEEEEEcC-CcEEEEEEeccc--ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 354 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 354 (430)
+.|+.+.++|+|+||+||+++.++ |+.||||++... ++...+-..+|+++|++|+|+|+|.|+++|.....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 468888999999999999999765 999999999642 34445667899999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCccccC
Q 047619 355 FVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430 (430)
Q Consensus 355 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~~ 430 (430)
|++..-|.++ .... ..++...+..+++|++.|+.|+|+++ ||||||||+||||+.+|.+||+|||+||.+
T Consensus 82 ~~dhTvL~eL-e~~p--~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L 151 (396)
T KOG0593|consen 82 YCDHTVLHEL-ERYP--NGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTL 151 (396)
T ss_pred ecchHHHHHH-Hhcc--CCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhh
Confidence 9987655554 3333 34889999999999999999999998 999999999999999999999999999964
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=249.39 Aligned_cols=148 Identities=37% Similarity=0.648 Sum_probs=130.5
Q ss_pred CcccceeecccCCcceEEEEEcCCcEEEEEEecccC--hHhHHHHHHHHHHHhcCCCCcccceEEEEEeCC-EEEEEEEc
Q 047619 279 NFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-EKLLIYEF 355 (430)
Q Consensus 279 ~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~ 355 (430)
...+.+.||+|+||+||+|.+.....||||++.... ....+.|.+|+.+|.+++|||||+++|++.++. ...|||||
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy 121 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY 121 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence 444556799999999999998655559999997532 223679999999999999999999999999988 79999999
Q ss_pred cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCC-CeeecCCCcccc
Q 047619 356 VPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLARA 429 (430)
Q Consensus 356 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DFGlar~ 429 (430)
+++|+|..++... ....+++..++.++.+|++|++|||+++. ||||||||+||||+.++ ++||+|||+||.
T Consensus 122 ~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~ 193 (362)
T KOG0192|consen 122 MPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSRE 193 (362)
T ss_pred CCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCcccee
Confidence 9999999999764 34569999999999999999999999863 99999999999999998 999999999974
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=246.98 Aligned_cols=149 Identities=28% Similarity=0.447 Sum_probs=130.7
Q ss_pred hcCCcccceeecccCCcceEEEEE-cCCcEEEEEEeccc--ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeC--CEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKL 350 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 350 (430)
..+.|+.+++||+|.||.||+|+. .+++.||+|++... .+....-..+||.||++|+||||++|.+...+. ..+|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 446788889999999999999995 56999999998643 344566678999999999999999999998887 6899
Q ss_pred EEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCccccC
Q 047619 351 LIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430 (430)
Q Consensus 351 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~~ 430 (430)
||+|||+ .+|.-++... ...+++.++..++.|++.||+|+|+++ |+|||||.+|||||.+|.+||+|||||+++
T Consensus 195 lVFeYMd-hDL~GLl~~p--~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 195 LVFEYMD-HDLSGLLSSP--GVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred EEEeccc-chhhhhhcCC--CcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeec
Confidence 9999996 5787777443 345899999999999999999999999 999999999999999999999999999964
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=248.95 Aligned_cols=150 Identities=33% Similarity=0.475 Sum_probs=135.3
Q ss_pred hhcCCcccceeecccCCcceEEEEEc-CCcEEEEEEecc---cChHhHHHHHHHHHHHhcC-CCCcccceEEEEEeCCEE
Q 047619 275 NATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK---ISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEK 349 (430)
Q Consensus 275 ~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 349 (430)
....+|.+.+.||+|+|++|++|+.. .++++|||++.+ ..+...+.+.+|-.+|.+| .||.|++|+..|.+...+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 34578999999999999999999954 489999999975 2344456678899999999 899999999999999999
Q ss_pred EEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 350 LLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 350 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|+|+||+++|+|.++|.+. +.+++.....++.+|+.||+|||+.| ||||||||+|||||+++++||+|||.|+.
T Consensus 150 YFvLe~A~nGdll~~i~K~---Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKY---GSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred EEEEEecCCCcHHHHHHHh---CcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeecccccc
Confidence 9999999999999999554 45999999999999999999999998 99999999999999999999999999997
Q ss_pred C
Q 047619 430 F 430 (430)
Q Consensus 430 ~ 430 (430)
|
T Consensus 224 l 224 (604)
T KOG0592|consen 224 L 224 (604)
T ss_pred C
Confidence 5
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-30 Score=245.36 Aligned_cols=150 Identities=27% Similarity=0.392 Sum_probs=136.1
Q ss_pred HhhcCCcccceeecccCCcceEEEEEcC-CcEEEEEEeccc---ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEE
Q 047619 274 ANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 349 (430)
Q Consensus 274 ~~~~~~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 349 (430)
....++|+++..||+|+||.||+|+.++ |..+|+|++++. .....+.++.|-.+|....+|.||+|+..|.+.+.+
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 3466899999999999999999999655 999999999873 334566788999999999999999999999999999
Q ss_pred EEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 350 LLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 350 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||||||++||++..+|.. ...+++..+..++.+++.||+.||+.| +|||||||+|+|||..|++||+||||++-
T Consensus 217 YLiMEylPGGD~mTLL~~---~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~g 290 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMR---KDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTG 290 (550)
T ss_pred EEEEEecCCccHHHHHHh---cCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccch
Confidence 999999999999999954 356999999999999999999999998 99999999999999999999999999863
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=227.02 Aligned_cols=147 Identities=34% Similarity=0.545 Sum_probs=131.0
Q ss_pred CCcccceeecccCCcceEEEEE-cCCcEEEEEEecccC--hHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 354 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 354 (430)
++|...++||+|.||.||+|+. .+++.||||+++... ........+||+.|+.++|+||+.++++|...+.+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4677889999999999999995 559999999997432 2224567899999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCccccC
Q 047619 355 FVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430 (430)
Q Consensus 355 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~~ 430 (430)
||+ .+|+..|++. ...+...++..++.++++||+|+|++. |+||||||.|+||+++|.+||+|||+||.|
T Consensus 82 fm~-tdLe~vIkd~--~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f 151 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDK--NIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFF 151 (318)
T ss_pred ecc-ccHHHHhccc--ccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhcc
Confidence 995 7999999654 356899999999999999999999988 999999999999999999999999999975
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-30 Score=227.86 Aligned_cols=147 Identities=31% Similarity=0.408 Sum_probs=133.3
Q ss_pred cCCcccceeecccCCcceEEEEEcC-CcEEEEEEeccc---ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEE
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 352 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 352 (430)
.++|+.++.||.|+||.|.+++.+. +.-+|+|++++. .....+...+|..+|+.+.||+++++++.+.+...+|||
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 4678899999999999999999654 889999999863 234456677899999999999999999999999999999
Q ss_pred EEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 353 YEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 353 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|||++||.|..++++. ..+++..+..++.||+.||+|||+.+ |++|||||+|||||++|.+||+|||+||.
T Consensus 123 meyv~GGElFS~Lrk~---~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~ 193 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKS---GRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKR 193 (355)
T ss_pred EeccCCccHHHHHHhc---CCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEE
Confidence 9999999999999554 45899999999999999999999998 99999999999999999999999999986
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-31 Score=235.20 Aligned_cols=153 Identities=26% Similarity=0.487 Sum_probs=133.0
Q ss_pred CCcccceeecccCCcceEEEE-EcCCcEEEEEEec--ccChHhHHHHHHHHHHHhcCCCCcccceEE-EEEeCCE-EEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLS--KISEQGLKELKNEVILFSKLQHRNLVKLLG-CCIQGEE-KLLI 352 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~-~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~-~~lv 352 (430)
.+|++.++||+|+||.||++. ..++..+|.|.+. ..+.+..+.+..|+.+|++|+|||||++++ .+.++.. ++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 468899999999999999998 5679999999986 345677788999999999999999999998 4555555 8999
Q ss_pred EEccCCCChhHHhhcC-CCCCCCCHHHHHHHHHHHHHHHHHhhhcC-CCcEEeCCCCCCcEEEcCCCCeeecCCCccccC
Q 047619 353 YEFVPNKSLDSFIFDQ-ERCKILDWSKRFHIICGTARGVMYLHQDS-RLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430 (430)
Q Consensus 353 ~e~~~~gsL~~~l~~~-~~~~~~~~~~~~~i~~~i~~aL~yLH~~~-~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~~ 430 (430)
|||+.+|+|...|..- +..+.++++.+++++.|++.||..+|.+= +.-|+||||||.||+|+.+|.|||.|||++|.|
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 9999999999999753 23467999999999999999999999831 113999999999999999999999999999964
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-31 Score=247.72 Aligned_cols=149 Identities=30% Similarity=0.458 Sum_probs=131.8
Q ss_pred hcCCcccceeecccCCcceEEEEE-cCCcEEEEEEecccChH-hHHHHHHHHHHHhcCC-CCcccceEEEEEeCC-EEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQ-GLKELKNEVILFSKLQ-HRNLVKLLGCCIQGE-EKLL 351 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~l 351 (430)
..++|+++++||.|.||.||+|+. ..+..||||++++.... ..-.=.+|+..|++|+ |||||+|.+++.+.+ .+++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 457899999999999999999985 45889999999763222 2223468999999999 999999999999988 9999
Q ss_pred EEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCccccC
Q 047619 352 IYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430 (430)
Q Consensus 352 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~~ 430 (430)
|||||+ .+|.+++.++ ...+++..+..|+.||++||+|+|.+| +.|||+||+|||+.....+||+|||+||.+
T Consensus 88 VfE~Md-~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 88 VFEFMD-CNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eHHhhh-hhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccc
Confidence 999995 7999999765 567999999999999999999999999 999999999999998889999999999963
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=234.86 Aligned_cols=147 Identities=29% Similarity=0.528 Sum_probs=135.3
Q ss_pred cCCcccceeecccCCcceEEEEE-cCCcEEEEEEecc---cChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEE
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 352 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 352 (430)
..+|++.+.||.|.||.|-+|.. ..|+.||||.+.+ .+.+++-.+++||+||..|+||||+.++++|+..+.+.||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 35788999999999999999984 6799999999875 3567778899999999999999999999999999999999
Q ss_pred EEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 353 YEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 353 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|||..+|.|.++|.+. ..+++.++.++++||..|+.|.|.++ ++|||||.+|||||.++++||+|||++-+
T Consensus 132 MEYaS~GeLYDYiSer---~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNl 202 (668)
T KOG0611|consen 132 MEYASGGELYDYISER---GSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNL 202 (668)
T ss_pred EEecCCccHHHHHHHh---ccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhh
Confidence 9999999999999654 45999999999999999999999988 99999999999999999999999999854
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=239.63 Aligned_cols=148 Identities=33% Similarity=0.585 Sum_probs=134.0
Q ss_pred cCCcccceeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEcc
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFV 356 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 356 (430)
.+.+++.+.||+|-||.|+.|.+.....||+|.++.. ....+.|.+|+.+|++|+|++||+++++|..++.++||||||
T Consensus 205 r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m 283 (468)
T KOG0197|consen 205 REELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYM 283 (468)
T ss_pred HHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEec
Confidence 3456677899999999999999987889999999753 344577889999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 357 PNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 357 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+.|+|.++|... .+..+...+.+.++.||++|++||++++ +|||||.+.||||+++..+||+||||||.
T Consensus 284 ~~GsLl~yLr~~-~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~ 352 (468)
T KOG0197|consen 284 PKGSLLDYLRTR-EGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARL 352 (468)
T ss_pred ccCcHHHHhhhc-CCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccc
Confidence 999999999763 3456889999999999999999999998 99999999999999999999999999995
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.1e-29 Score=238.46 Aligned_cols=146 Identities=32% Similarity=0.530 Sum_probs=133.5
Q ss_pred CCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc--ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 354 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 354 (430)
++|.+.+.||+|+||.||+|+.+ +.+.||+|.+.+. .....+.+++|++|++.|+|||||.+++.|+...++++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57889999999999999999854 4789999999763 45667889999999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCccccC
Q 047619 355 FVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430 (430)
Q Consensus 355 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~~ 430 (430)
|+.| +|..+|... ..++++.+..++.+++.||.|||+.+ |+|||+||.|||++..+.+|++|||+||.+
T Consensus 82 ~a~g-~L~~il~~d---~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m 150 (808)
T KOG0597|consen 82 YAVG-DLFTILEQD---GKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAM 150 (808)
T ss_pred hhhh-hHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhc
Confidence 9976 999999554 34999999999999999999999988 999999999999999999999999999863
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-28 Score=227.10 Aligned_cols=148 Identities=32% Similarity=0.493 Sum_probs=130.8
Q ss_pred cCCcccceeecccCCcceEEEEEcC-CcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCC--EEEEEE
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE--EKLLIY 353 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~ 353 (430)
..+|...+.||+|+||.||++...+ +...|||.+........+.+.+|+.+|.+++|||||+++|.....+ .++|+|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 3467788999999999999999755 8999999987643333778999999999999999999999755444 689999
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcC-CCCeeecCCCcccc
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLARA 429 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DFGlar~ 429 (430)
||+++|+|.+++..... .+++..+..+++||++||+|||+++ ||||||||+||||+. ++.+||+|||+|+.
T Consensus 96 Ey~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~ 167 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKK 167 (313)
T ss_pred eccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccc
Confidence 99999999999976543 5999999999999999999999998 999999999999999 79999999999985
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-28 Score=224.90 Aligned_cols=149 Identities=30% Similarity=0.466 Sum_probs=128.4
Q ss_pred cCCcccceeecccCCcceEEEEE-cCCcEEEEEEecccCh--HhHHHHHHHHHHHhcCCCCc-ccceEEEEEeCC-----
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISE--QGLKELKNEVILFSKLQHRN-LVKLLGCCIQGE----- 347 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~----- 347 (430)
...|..+++||+|+||+||+|+. .+|+.||+|++.-... ..-....+|+.+++.|+|+| |+++++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 34577788999999999999995 5689999999864322 23345688999999999999 999999999888
Q ss_pred -EEEEEEEccCCCChhHHhhcCCCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCC
Q 047619 348 -EKLLIYEFVPNKSLDSFIFDQERC-KILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 425 (430)
Q Consensus 348 -~~~lv~e~~~~gsL~~~l~~~~~~-~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFG 425 (430)
.+++|+||+ .-+|..++...... ..++...+..+++||+.||+|||+++ |+||||||+||||++.|.+||+|||
T Consensus 90 ~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence 789999999 47999999665421 34777889999999999999999998 9999999999999999999999999
Q ss_pred cccc
Q 047619 426 LARA 429 (430)
Q Consensus 426 lar~ 429 (430)
+||.
T Consensus 166 lAra 169 (323)
T KOG0594|consen 166 LARA 169 (323)
T ss_pred hHHH
Confidence 9985
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.5e-28 Score=233.83 Aligned_cols=149 Identities=27% Similarity=0.469 Sum_probs=133.1
Q ss_pred hhcCCcccceeecccCCcceEEEEE-cCCcEEEEEEeccc----Ch-HhHHHHHHHHHHHhcCC-CCcccceEEEEEeCC
Q 047619 275 NATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI----SE-QGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGE 347 (430)
Q Consensus 275 ~~~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 347 (430)
...++|.+.+.||+|+||.|+.|.. .++..||+|++.+. .. ...+.+.+|+.+++.++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3457899999999999999999975 45899999977652 12 34567778999999999 999999999999999
Q ss_pred EEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCC-CCeeecCCCc
Q 047619 348 EKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGL 426 (430)
Q Consensus 348 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DFGl 426 (430)
..++||||+.+|+|.+++... ..+.+..+..++.|++.|++|+|+.+ |+||||||+|||++.+ +++||+|||+
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~---g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNK---GRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred eEEEEEEecCCccHHHHHHHc---CCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence 999999999999999999662 45888999999999999999999998 9999999999999999 9999999999
Q ss_pred ccc
Q 047619 427 ARA 429 (430)
Q Consensus 427 ar~ 429 (430)
|+.
T Consensus 168 s~~ 170 (370)
T KOG0583|consen 168 SAI 170 (370)
T ss_pred ccc
Confidence 975
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=222.87 Aligned_cols=149 Identities=29% Similarity=0.430 Sum_probs=127.4
Q ss_pred hcCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccCh--HhHHHHHHHHHHHhcCCCCcccceEEEEEeC--CEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISE--QGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKL 350 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 350 (430)
..++|+.+++|++|+||.||+|+++ +++.||+|+++.... ..--.-.+||.+|.+++|||||.+.++.... +..|
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence 3457889999999999999999964 588999999974321 1122356899999999999999999987754 5689
Q ss_pred EEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCccccC
Q 047619 351 LIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430 (430)
Q Consensus 351 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~~ 430 (430)
|||||++ .+|..++.... .++...++..++.|+++||+|||.+. |+||||||+|+|+...|.+||+|||+||.+
T Consensus 154 ~VMe~~E-hDLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 154 IVMEYVE-HDLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred eeHHHHH-hhHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhh
Confidence 9999996 58999886544 46888999999999999999999987 999999999999999999999999999964
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-28 Score=229.07 Aligned_cols=147 Identities=29% Similarity=0.455 Sum_probs=126.3
Q ss_pred hcCCcccceeecccCCcceEEEEE-cCCcEEEEEEecccC--------------hHhHHHHHHHHHHHhcCCCCcccceE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKIS--------------EQGLKELKNEVILFSKLQHRNLVKLL 340 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~--------------~~~~~~~~~E~~~l~~l~h~niv~l~ 340 (430)
..++|++.+.||+|.||.|-+|.. .+++.||||++.+.. ....+.+++||.||++++|||||+|+
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 457899999999999999999985 458999999997521 11245789999999999999999999
Q ss_pred EEEEeC--CEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCC
Q 047619 341 GCCIQG--EEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMN 418 (430)
Q Consensus 341 ~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~ 418 (430)
++..++ +.+|||+||+..|.+...= .....+.+.++..++++++.||+|||.++ ||||||||+|+||+++|+
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCc
Confidence 998765 5689999999988875432 22222899999999999999999999999 999999999999999999
Q ss_pred eeecCCCccc
Q 047619 419 PKISDFGLAR 428 (430)
Q Consensus 419 ~kl~DFGlar 428 (430)
|||+|||.+-
T Consensus 249 VKIsDFGVs~ 258 (576)
T KOG0585|consen 249 VKISDFGVSN 258 (576)
T ss_pred EEeeccceee
Confidence 9999999875
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-28 Score=211.94 Aligned_cols=148 Identities=32% Similarity=0.459 Sum_probs=132.9
Q ss_pred hcCCcccceeecccCCcceEEEEE-cCCcEEEEEEeccc---ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 351 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 351 (430)
..++|.+.+.||+|.||.||.|+. +++..||+|++.+. ..+...++++|++|-..|+||||++++++|.+....||
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 457899999999999999999995 45789999999763 23446789999999999999999999999999999999
Q ss_pred EEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcc
Q 047619 352 IYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427 (430)
Q Consensus 352 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla 427 (430)
++||.+.|+|...|.... ...+++.....++.|++.||.|+|..+ ||||||||+|+|++.++.+||+|||-+
T Consensus 100 ilEya~~gel~k~L~~~~-~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGws 171 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGR-MKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWS 171 (281)
T ss_pred EEEecCCchHHHHHHhcc-cccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCce
Confidence 999999999999996543 355889999999999999999999887 999999999999999999999999965
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-27 Score=230.94 Aligned_cols=146 Identities=27% Similarity=0.392 Sum_probs=131.1
Q ss_pred CCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc---ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 353 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 353 (430)
++|++.+.||+|+||.||+|... +++.+|+|++.+. .......+.+|+.++.+++||||+++++.+.+....+|||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47889999999999999999864 4889999999752 2234567888999999999999999999999999999999
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||||+.++.+||+|||+|+.
T Consensus 81 E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~ 150 (363)
T cd05628 81 EFLPGGDMMTLLMKK---DTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTG 150 (363)
T ss_pred cCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccc
Confidence 999999999998543 35899999999999999999999988 99999999999999999999999999874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-27 Score=221.00 Aligned_cols=149 Identities=26% Similarity=0.408 Sum_probs=134.9
Q ss_pred hcCCcccceeecccCCcceEEEE-EcCCcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 353 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 353 (430)
..+.|++.+.||.|..++||+|+ .+.+..||||++.-. .....+.+++|+..|+.++||||++++..|..+..+|+||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 45789999999999999999998 456899999999742 2334789999999999999999999999999999999999
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCccc
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar 428 (430)
.||.+|++.++++..-. ..+++..+..|++++++||.|||.+| .||||||+.||||+.+|.|||+|||.+-
T Consensus 104 pfMa~GS~ldIik~~~~-~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa 174 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYP-DGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSA 174 (516)
T ss_pred hhhcCCcHHHHHHHHcc-ccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeee
Confidence 99999999999976543 34899999999999999999999999 9999999999999999999999999864
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-27 Score=231.66 Aligned_cols=145 Identities=26% Similarity=0.370 Sum_probs=130.4
Q ss_pred CCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc---ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 353 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 353 (430)
++|++.+.||+|+||.||++... +++.||||++.+. .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46889999999999999999864 5889999998642 2334567889999999999999999999999999999999
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCccc
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar 428 (430)
||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+
T Consensus 81 E~~~gg~L~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~ 149 (377)
T cd05629 81 EFLPGGDLMTMLIKY---DTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLST 149 (377)
T ss_pred eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccc
Confidence 999999999998543 35888999999999999999999998 9999999999999999999999999996
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=192.07 Aligned_cols=92 Identities=42% Similarity=1.045 Sum_probs=86.2
Q ss_pred EecCCCCCc------------------cccCCeeEEEEEecCCCcEEEEEEeeccceEEEEEEeCCCCcEEEEEEecCCC
Q 047619 51 HRGGPWNGL------------------VFNEDELYYTFDMTDKDVFSRIVMNQTLYVRHQFTWDKATQSWELYANVPRDL 112 (430)
Q Consensus 51 ~~sg~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~~l~~dG~~~~~~~~~~~~~~W~~~~~~p~~~ 112 (430)
||+|||+|. +.++++.+|+|.+.+.++++|++||++| ++++|.|++.++.|.+.|.+|.|+
T Consensus 1 wrsG~WnG~~f~g~p~~~~~~~~~~~fv~~~~e~~~t~~~~~~s~~~r~~ld~~G-~l~~~~w~~~~~~W~~~~~~p~d~ 79 (110)
T PF00954_consen 1 WRSGPWNGQRFSGIPEMSSNSLYNYSFVSNNEEVYYTYSLSNSSVLSRLVLDSDG-QLQRYIWNESTQSWSVFWSAPKDQ 79 (110)
T ss_pred CCccccCCeEECCcccccccceeEEEEEECCCeEEEEEecCCCceEEEEEEeeee-EEEEEEEecCCCcEEEEEEecccC
Confidence 899999987 4467889999999999999999999999 999999999999999999999999
Q ss_pred cccCCcccCceeeecCCCCccccCCCcccCC
Q 047619 113 CDTYALCGDYGICIISDTPFCQCLKGFKPKS 143 (430)
Q Consensus 113 C~~~~~CG~~~~C~~~~~~~C~C~~gf~~~~ 143 (430)
||+|+.||+||+|+.+..+.|.|||||+|++
T Consensus 80 Cd~y~~CG~~g~C~~~~~~~C~Cl~GF~P~n 110 (110)
T PF00954_consen 80 CDVYGFCGPNGICNSNNSPKCSCLPGFEPKN 110 (110)
T ss_pred CCCccccCCccEeCCCCCCceECCCCcCCCc
Confidence 9999999999999988889999999999974
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.5e-27 Score=230.65 Aligned_cols=145 Identities=24% Similarity=0.367 Sum_probs=130.1
Q ss_pred CcccceeecccCCcceEEEEEc-CCcEEEEEEeccc---ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEE
Q 047619 279 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 354 (430)
Q Consensus 279 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 354 (430)
.|++++.||+|+||.||+|... +++.+|+|++.+. .......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5888999999999999999864 4789999999652 23445678999999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 355 FVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 355 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|+.
T Consensus 82 ~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~ 150 (381)
T cd05626 82 YIPGGDMMSLLIRM---EVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTG 150 (381)
T ss_pred cCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcc
Confidence 99999999998543 34888899999999999999999988 99999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.4e-27 Score=229.87 Aligned_cols=146 Identities=26% Similarity=0.392 Sum_probs=131.4
Q ss_pred CCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc---ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 353 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 353 (430)
++|++.+.||+|+||.||+|... +++.||||++.+. .......+.+|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47899999999999999999965 5889999999752 2334566889999999999999999999999999999999
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 81 E~~~~g~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~ 150 (364)
T cd05599 81 EYLPGGDMMTLLMKK---DTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTG 150 (364)
T ss_pred CCCCCcHHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeeccccee
Confidence 999999999998543 34899999999999999999999998 99999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.3e-27 Score=229.20 Aligned_cols=145 Identities=24% Similarity=0.369 Sum_probs=129.7
Q ss_pred CCcccceeecccCCcceEEEEEc-CCcEEEEEEecccC---hHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 353 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 353 (430)
++|++.+.||+|+||.||+|... +++.||+|++.+.. ......+.+|+.++..++||||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36899999999999999999864 48899999986421 233566889999999999999999999999999999999
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCccc
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar 428 (430)
||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+
T Consensus 81 E~~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~ 149 (376)
T cd05598 81 DYIPGGDMMSLLIRL---GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCT 149 (376)
T ss_pred eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCc
Confidence 999999999999543 35788888999999999999999988 9999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-27 Score=230.50 Aligned_cols=152 Identities=34% Similarity=0.576 Sum_probs=134.4
Q ss_pred HHhhcCCcccceeecccCCcceEEEEEcC--C--cE-EEEEEecc---cChHhHHHHHHHHHHHhcCCCCcccceEEEEE
Q 047619 273 IANATDNFSINNKLGEGGFGPVYKGTLVD--G--QE-IAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCI 344 (430)
Q Consensus 273 ~~~~~~~~~~~~~ig~G~fg~Vy~~~~~~--~--~~-vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 344 (430)
.+...++..+.++||+|+||.||+|.+.. + .. ||||.... .......++.+|+++|++++|||||+++|+..
T Consensus 152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~ 231 (474)
T KOG0194|consen 152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV 231 (474)
T ss_pred cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 34455666677999999999999998643 2 23 89998874 45677889999999999999999999999999
Q ss_pred eCCEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCC
Q 047619 345 QGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDF 424 (430)
Q Consensus 345 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DF 424 (430)
....++||||+++||+|.++|..... .++..+++.++.+.+.||+|||+++ +|||||-.+|+|++.++.+||+||
T Consensus 232 ~~~Pl~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDF 306 (474)
T KOG0194|consen 232 LEEPLMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDF 306 (474)
T ss_pred CCCccEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCcc
Confidence 99999999999999999999966543 5899999999999999999999998 999999999999999999999999
Q ss_pred Ccccc
Q 047619 425 GLARA 429 (430)
Q Consensus 425 Glar~ 429 (430)
|+|+.
T Consensus 307 GLs~~ 311 (474)
T KOG0194|consen 307 GLSRA 311 (474)
T ss_pred ccccC
Confidence 99973
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-27 Score=218.69 Aligned_cols=149 Identities=29% Similarity=0.345 Sum_probs=134.6
Q ss_pred cCCcccceeecccCCcceEEEEEcC-CcEEEEEEeccc---ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEE
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 352 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 352 (430)
.++|++++.||.|.-|+||++.+.+ +..+|+|++.+. ......+.+.|-+||+.++||.++.||..++.++..+++
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 3568888999999999999999765 589999999863 344566788899999999999999999999999999999
Q ss_pred EEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 353 YEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 353 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||||+||+|..+.+++. .+.+++..+..++.+|+.||+|||..| ||.|||||+||||.++|++.|+||.|+..
T Consensus 156 meyCpGGdL~~LrqkQp-~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~ 228 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQP-GKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLR 228 (459)
T ss_pred EecCCCccHHHHHhhCC-CCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeecccccc
Confidence 99999999999887655 466999999999999999999999998 99999999999999999999999999864
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=224.62 Aligned_cols=147 Identities=26% Similarity=0.380 Sum_probs=131.7
Q ss_pred cCCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc---ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEE
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 352 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 352 (430)
.++|++.+.||+|+||.||+|... +++.||+|++.+. .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 367999999999999999999975 4889999998642 223456788999999999999999999999999999999
Q ss_pred EEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 353 YEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 353 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||||+.++.+||+|||+|+.
T Consensus 97 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 167 (329)
T PTZ00263 97 LEFVVGGELFTHLRKA---GRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKK 167 (329)
T ss_pred EcCCCCChHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceE
Confidence 9999999999998643 34788889999999999999999998 99999999999999999999999999874
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.6e-27 Score=228.62 Aligned_cols=150 Identities=20% Similarity=0.270 Sum_probs=132.6
Q ss_pred HHhhcCCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc---ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCE
Q 047619 273 IANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 348 (430)
Q Consensus 273 ~~~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 348 (430)
+....++|++.+.||+|+||.||++... +++.+|+|.+.+. .......+.+|+.+++.++||||+++++++.+++.
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 3445578999999999999999999975 4789999998642 22345568899999999999999999999999999
Q ss_pred EEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCccc
Q 047619 349 KLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428 (430)
Q Consensus 349 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar 428 (430)
.++||||+++++|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+|+
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~ 190 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCM 190 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccce
Confidence 99999999999999998532 3788899999999999999999988 9999999999999999999999999987
Q ss_pred c
Q 047619 429 A 429 (430)
Q Consensus 429 ~ 429 (430)
.
T Consensus 191 ~ 191 (370)
T cd05621 191 K 191 (370)
T ss_pred e
Confidence 4
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=228.83 Aligned_cols=144 Identities=25% Similarity=0.369 Sum_probs=129.4
Q ss_pred CcccceeecccCCcceEEEEEc-CCcEEEEEEeccc---ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEE
Q 047619 279 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 354 (430)
Q Consensus 279 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 354 (430)
.|+++++||+|+||.||+|... +++.+|+|++.+. .......+.+|+.++++++||||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888999999999999999864 4789999998652 23345678899999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCccc
Q 047619 355 FVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428 (430)
Q Consensus 355 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar 428 (430)
|+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+
T Consensus 82 ~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~ 149 (382)
T cd05625 82 YIPGGDMMSLLIRM---GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCT 149 (382)
T ss_pred CCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCc
Confidence 99999999998543 35788899999999999999999998 9999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.1e-27 Score=226.67 Aligned_cols=151 Identities=32% Similarity=0.496 Sum_probs=128.4
Q ss_pred hcCCcccceeecccCCcceEEEEE------cCCcEEEEEEeccc-ChHhHHHHHHHHHHHhcC-CCCcccceEEEEEeCC
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTL------VDGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGE 347 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 347 (430)
..++|++.++||+|+||.||+|.. .++..||||++... .......+.+|+.++..+ +||||+++++++...+
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 346899999999999999999974 22568999998753 234456789999999999 8999999999887654
Q ss_pred -EEEEEEEccCCCChhHHhhcCCC--------------------------------------------------------
Q 047619 348 -EKLLIYEFVPNKSLDSFIFDQER-------------------------------------------------------- 370 (430)
Q Consensus 348 -~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 370 (430)
..++||||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 57899999999999999864311
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 371 ---CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 371 ---~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
..++++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~ 223 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARD 223 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccc
Confidence 134778888999999999999999988 99999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=224.90 Aligned_cols=148 Identities=27% Similarity=0.373 Sum_probs=131.3
Q ss_pred hcCCcccceeecccCCcceEEEEEcC--CcEEEEEEeccc---ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLVD--GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 350 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~~--~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 350 (430)
..++|++.+.||+|+||.||+|.... +..||+|++.+. .....+.+.+|+.++..++||||+++++++.+.+..+
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 34579999999999999999998543 368999998642 2334567889999999999999999999999999999
Q ss_pred EEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 351 LIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 351 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 108 lv~Ey~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~ 180 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRRN---KRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKV 180 (340)
T ss_pred EEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCee
Confidence 999999999999999543 35889999999999999999999998 99999999999999999999999999974
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7e-28 Score=221.51 Aligned_cols=144 Identities=31% Similarity=0.482 Sum_probs=118.7
Q ss_pred CcccceeecccCCcceEEEEEcC-CcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCE-----EEEE
Q 047619 279 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE-----KLLI 352 (430)
Q Consensus 279 ~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----~~lv 352 (430)
.|...+.+|.|+||.||+|.... ++.||||++-... +.-.+|+++|+++.|||||+|..+|..... ..+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~----r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK----RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC----CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 46667899999999999999654 7899999985422 223469999999999999999998875432 2489
Q ss_pred EEccCCCChhHHhhcC-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCC-CCeeecCCCccccC
Q 047619 353 YEFVPNKSLDSFIFDQ-ERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLARAF 430 (430)
Q Consensus 353 ~e~~~~gsL~~~l~~~-~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DFGlar~~ 430 (430)
||||| .+|...+... .....++...+.-+..||++||.|||+.+ |+||||||+|||+|.+ |.+||+|||.||.+
T Consensus 101 leymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 99997 5888888642 11234777788889999999999999987 9999999999999977 89999999999964
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=220.22 Aligned_cols=149 Identities=30% Similarity=0.551 Sum_probs=129.4
Q ss_pred CCcccceeecccCCcceEEEEEcC-----------------CcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccce
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLVD-----------------GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKL 339 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~~-----------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l 339 (430)
++|.+.++||+|+||.||+|...+ +..||+|.+... .......+.+|+.++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 578899999999999999997532 336999998753 34456679999999999999999999
Q ss_pred EEEEEeCCEEEEEEEccCCCChhHHhhcCCC----------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEe
Q 047619 340 LGCCIQGEEKLLIYEFVPNKSLDSFIFDQER----------------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIH 403 (430)
Q Consensus 340 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~----------------~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH 403 (430)
++++.+.+..++||||+++++|.+++..... ...+++..+..++.||+.||.|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 9999999999999999999999999854211 124677889999999999999999988 999
Q ss_pred CCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 404 RDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 404 ~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|||||+|||++.++.+||+|||+|+.
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~ 187 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRN 187 (304)
T ss_pred cCcchhheEEcCCccEEECCCcccee
Confidence 99999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.1e-27 Score=221.51 Aligned_cols=146 Identities=24% Similarity=0.351 Sum_probs=130.6
Q ss_pred CCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc---ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 353 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 353 (430)
++|++.+.||+|+||.||+|... +++.+|+|++... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46889999999999999999965 5889999998642 2234567889999999999999999999999999999999
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||+++++|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+.
T Consensus 81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~ 150 (291)
T cd05612 81 EYVPGGELFSYLRNS---GRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKK 150 (291)
T ss_pred eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchh
Confidence 999999999998543 35888999999999999999999998 99999999999999999999999999874
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=223.79 Aligned_cols=146 Identities=29% Similarity=0.459 Sum_probs=131.2
Q ss_pred CCcccceeecccCCcceEEEEEcC-CcEEEEEEeccc---ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 353 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 353 (430)
++|++.+.||+|+||.||+|.... ++.||+|++.+. .......+.+|+.++..++||||+++++++...+..+|||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 468999999999999999999754 889999998753 2234567889999999999999999999999999999999
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 81 e~~~g~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~ 150 (333)
T cd05600 81 EYVPGGDFRTLLNNL---GVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKG 150 (333)
T ss_pred eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCcc
Confidence 999999999999543 35888999999999999999999998 99999999999999999999999999974
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.9e-27 Score=236.97 Aligned_cols=151 Identities=33% Similarity=0.482 Sum_probs=133.3
Q ss_pred hcCCcccceeecccCCcceEEEEEcCC-cEEEEEEecccChHhHHHHHHHHHHHhcCC-CCcccceEEE-EEeC------
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLVDG-QEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGC-CIQG------ 346 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~-~~~~------ 346 (430)
...+.++.+.|.+|||+.||.|....+ ..+|+|++...++..++.+.+||++|++|+ |+|||.+++. ....
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 345678889999999999999998765 999999998778899999999999999997 9999999993 2211
Q ss_pred CEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCc
Q 047619 347 EEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 426 (430)
Q Consensus 347 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGl 426 (430)
-+.+|+||||++|.|-+++..+... .|.+.++++|++++++|+.+||... ++|||||||-|||||+.++..||||||.
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~-~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQT-RLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhc-cCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcccc
Confidence 2468999999999999999755443 3999999999999999999999985 7899999999999999999999999999
Q ss_pred cc
Q 047619 427 AR 428 (430)
Q Consensus 427 ar 428 (430)
|.
T Consensus 193 at 194 (738)
T KOG1989|consen 193 AT 194 (738)
T ss_pred cc
Confidence 85
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.1e-26 Score=223.26 Aligned_cols=146 Identities=27% Similarity=0.400 Sum_probs=130.8
Q ss_pred CCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc---ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 353 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 353 (430)
++|++.+.||+|+||.||++... +++.||+|++.+. .......+.+|+.++..++||+|+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46889999999999999999865 4889999998642 2334567888999999999999999999999999999999
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||||+.++.+||+|||+|+.
T Consensus 81 E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~ 150 (360)
T cd05627 81 EFLPGGDMMTLLMKK---DTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTG 150 (360)
T ss_pred eCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcc
Confidence 999999999998543 34889999999999999999999988 99999999999999999999999999874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-26 Score=219.65 Aligned_cols=140 Identities=24% Similarity=0.323 Sum_probs=125.1
Q ss_pred eeecccCCcceEEEEEc-CCcEEEEEEeccc---ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEccCCC
Q 047619 284 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNK 359 (430)
Q Consensus 284 ~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 359 (430)
+.||+|+||.||++... +++.+|+|++.+. .......+.+|+.++++++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999864 5889999998752 2334566788999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 360 SLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 360 sL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|+.
T Consensus 81 ~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~ 144 (323)
T cd05571 81 ELFFHLSRE---RVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKE 144 (323)
T ss_pred cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcc
Confidence 999988543 35889999999999999999999998 99999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-26 Score=225.37 Aligned_cols=147 Identities=22% Similarity=0.279 Sum_probs=130.6
Q ss_pred hcCCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc---ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 351 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 351 (430)
..++|++.+.||+|+||.||++... +++.+|+|++.+. .....+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 4568999999999999999999865 4889999998642 22344567889999999999999999999999999999
Q ss_pred EEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 352 IYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 352 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||||+++++|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+|+.
T Consensus 121 v~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~ 191 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (370)
T ss_pred EEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceee
Confidence 99999999999998532 3788888899999999999999988 99999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.1e-26 Score=220.02 Aligned_cols=147 Identities=23% Similarity=0.295 Sum_probs=130.7
Q ss_pred CCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc---ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 353 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 353 (430)
++|++.+.||+|+||.||++... +++.||+|++.+. .....+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47899999999999999999965 4889999998642 2334566889999999999999999999999999999999
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||+++++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 151 (331)
T cd05597 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLR 151 (331)
T ss_pred ecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceee
Confidence 999999999998542 234889999999999999999999998 99999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.7e-27 Score=225.68 Aligned_cols=149 Identities=28% Similarity=0.491 Sum_probs=135.4
Q ss_pred hhcCCcccceeecccCCcceEEEEE-cCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEE
Q 047619 275 NATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 353 (430)
Q Consensus 275 ~~~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 353 (430)
.....|...++||+|+.|.||.|.. ..++.||||++........+-+.+|+.+|+..+|+|||.+++.+...+.+|+||
T Consensus 270 dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM 349 (550)
T KOG0578|consen 270 DPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM 349 (550)
T ss_pred ChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence 3455788889999999999999984 458899999998766667778899999999999999999999999999999999
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCccccC
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~~ 430 (430)
|||+||+|.+.+.. ..+++.++..|.+++++||+|||.++ |+|||||.+|||++.+|.+||+|||++..+
T Consensus 350 Eym~ggsLTDvVt~----~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi 419 (550)
T KOG0578|consen 350 EYMEGGSLTDVVTK----TRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQI 419 (550)
T ss_pred eecCCCchhhhhhc----ccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeecc
Confidence 99999999999843 34899999999999999999999999 999999999999999999999999998653
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.3e-26 Score=223.79 Aligned_cols=153 Identities=20% Similarity=0.257 Sum_probs=133.7
Q ss_pred HHhHHhhcCCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc---ChHhHHHHHHHHHHHhcCCCCcccceEEEEEe
Q 047619 270 LATIANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ 345 (430)
Q Consensus 270 ~~~~~~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 345 (430)
+..+....++|++.+.||+|+||.||++... +++.+|+|.+.+. .......+.+|+.+++.++||||+++++.+.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 3344455689999999999999999999965 4789999998642 23344567889999999999999999999999
Q ss_pred CCEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCC
Q 047619 346 GEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 425 (430)
Q Consensus 346 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFG 425 (430)
+...++||||+++++|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG 187 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG 187 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCC
Confidence 99999999999999999998532 3788888999999999999999998 9999999999999999999999999
Q ss_pred cccc
Q 047619 426 LARA 429 (430)
Q Consensus 426 lar~ 429 (430)
+|+.
T Consensus 188 ~a~~ 191 (371)
T cd05622 188 TCMK 191 (371)
T ss_pred ceeE
Confidence 9874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.6e-26 Score=219.14 Aligned_cols=147 Identities=24% Similarity=0.324 Sum_probs=131.7
Q ss_pred CCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc---ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 353 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 353 (430)
++|++.+.||+|+||.||++... +++.+|+|++.+. .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46899999999999999999864 5889999999752 2335567889999999999999999999999999999999
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 81 e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~ 151 (330)
T cd05601 81 EYQPGGDLLSLLNRYE--DQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAAR 151 (330)
T ss_pred CCCCCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeE
Confidence 9999999999996542 35899999999999999999999988 99999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.1e-26 Score=214.33 Aligned_cols=147 Identities=28% Similarity=0.379 Sum_probs=129.0
Q ss_pred CcccceeecccCCcceEEEEE-cCCcEEEEEEecccC---hHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEE
Q 047619 279 NFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 354 (430)
Q Consensus 279 ~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 354 (430)
.|++.+.||+|+||.||++.. .+++.||+|.+.+.. ......+.+|+.++.+++|++|+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 377889999999999999986 468999999986422 2334567889999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 355 FVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 355 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|+++++|..++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+|+.
T Consensus 81 ~~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~ 151 (285)
T cd05631 81 IMNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQ 151 (285)
T ss_pred ecCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEE
Confidence 999999998875432 235889999999999999999999988 99999999999999999999999999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.3e-26 Score=218.95 Aligned_cols=147 Identities=22% Similarity=0.273 Sum_probs=130.3
Q ss_pred CCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc---ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 353 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 353 (430)
++|++.+.||+|+||.||++... +++.+|+|.+.+. .......+.+|+.++..++|++|+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999865 4788999998642 2233456788999999999999999999999999999999
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 81 Ey~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~ 151 (331)
T cd05624 81 DYYVGGDLLTLLSKFE--DRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLK 151 (331)
T ss_pred eCCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceee
Confidence 9999999999996532 35788999999999999999999988 99999999999999999999999999864
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=226.90 Aligned_cols=149 Identities=30% Similarity=0.486 Sum_probs=132.9
Q ss_pred HhhcCCcccceeecccCCcceEEEEEcC-CcEEEEEEecc---cChHhHHHHHHHHHHHhcCC-CCcccceEEEEEeCCE
Q 047619 274 ANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK---ISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEE 348 (430)
Q Consensus 274 ~~~~~~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 348 (430)
....++|.+.++||+|+||+|+++..+. ++.+|||.+++ ....+.+....|.+|+.... ||.|+.++..|.+.++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 4456789999999999999999999654 78999999987 34567788899999988885 9999999999999999
Q ss_pred EEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCccc
Q 047619 349 KLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428 (430)
Q Consensus 349 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar 428 (430)
+|+||||+.||++..++ ....+++..+..++..|+.||.|||+++ ||+||||.+|||||.+|.+||+||||+|
T Consensus 444 l~fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred EEEEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccc
Confidence 99999999999954443 2345999999999999999999999999 9999999999999999999999999998
Q ss_pred c
Q 047619 429 A 429 (430)
Q Consensus 429 ~ 429 (430)
.
T Consensus 517 e 517 (694)
T KOG0694|consen 517 E 517 (694)
T ss_pred c
Confidence 4
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.4e-26 Score=222.07 Aligned_cols=146 Identities=26% Similarity=0.418 Sum_probs=131.9
Q ss_pred CCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc---ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 353 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 353 (430)
++|.+.+.||+|+||.||+|... +++.||+|++.+. .......+.+|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46899999999999999999965 5899999998752 2234567889999999999999999999999999999999
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||||+.++.+||+|||+|+.
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~ 150 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKK 150 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCcc
Confidence 999999999999654 45889999999999999999999988 99999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.9e-26 Score=214.75 Aligned_cols=146 Identities=29% Similarity=0.473 Sum_probs=128.0
Q ss_pred CCcccceeecccCCcceEEEEEc-CCcEEEEEEecccC-hHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEc
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 355 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 355 (430)
++|++.++||+|+||.||+|... +++.||+|++.... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 57999999999999999999864 58899999986422 23345678999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 356 VPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 356 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+++ +|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.
T Consensus 85 ~~~-~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~ 152 (288)
T cd07871 85 LDS-DLKQYLDNCG--NLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARA 152 (288)
T ss_pred CCc-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceee
Confidence 975 8988885432 34788999999999999999999988 99999999999999999999999999863
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.2e-26 Score=217.93 Aligned_cols=140 Identities=26% Similarity=0.344 Sum_probs=125.2
Q ss_pred eeecccCCcceEEEEEc-CCcEEEEEEeccc---ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEccCCC
Q 047619 284 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNK 359 (430)
Q Consensus 284 ~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 359 (430)
+.||+|+||.||++... +++.||+|++.+. .......+.+|+.+++.++||||+++++.+...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999864 5889999999752 2344567889999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 360 SLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 360 sL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|+.
T Consensus 81 ~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~ 144 (328)
T cd05593 81 ELFFHLSRE---RVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKE 144 (328)
T ss_pred CHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCcc
Confidence 999888543 35889999999999999999999988 99999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.5e-26 Score=218.09 Aligned_cols=140 Identities=24% Similarity=0.329 Sum_probs=124.8
Q ss_pred eeecccCCcceEEEEEc-CCcEEEEEEeccc---ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEccCCC
Q 047619 284 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNK 359 (430)
Q Consensus 284 ~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 359 (430)
+.||+|+||.||++... +++.||+|++.+. .......+.+|+.+++.++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999864 5899999998752 2334566788999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 360 SLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 360 sL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 81 ~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~ 144 (323)
T cd05595 81 ELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKE 144 (323)
T ss_pred cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhcc
Confidence 999888543 35889999999999999999999988 99999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=214.33 Aligned_cols=147 Identities=33% Similarity=0.466 Sum_probs=128.1
Q ss_pred cCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccC-hHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEE
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 354 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 354 (430)
.++|++.++||+|+||.||+|... +++.+|+|++.... ......+.+|+.+++.++||||+++++++.+....++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999975 58899999986432 2233467789999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 355 FVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 355 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|++ ++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 84 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 152 (303)
T cd07869 84 YVH-TDLCQYMDKH--PGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARA 152 (303)
T ss_pred CCC-cCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCccee
Confidence 996 6777777543 234788899999999999999999998 99999999999999999999999999863
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=215.68 Aligned_cols=138 Identities=24% Similarity=0.307 Sum_probs=124.0
Q ss_pred ecccCCcceEEEEEc-CCcEEEEEEeccc---ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEccCCCCh
Q 047619 286 LGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSL 361 (430)
Q Consensus 286 ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 361 (430)
||+|+||.||+|... +++.||+|++.+. .......+.+|+.++.+++||||+++++++...+..++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999975 4789999998642 334556788999999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 362 DSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 362 ~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 81 ~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~ 142 (312)
T cd05585 81 FHHLQRE---GRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKL 142 (312)
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECccccc
Confidence 9998543 34889999999999999999999988 99999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=216.75 Aligned_cols=145 Identities=24% Similarity=0.354 Sum_probs=128.0
Q ss_pred CcccceeecccCCcceEEEEEc----CCcEEEEEEeccc----ChHhHHHHHHHHHHHhcC-CCCcccceEEEEEeCCEE
Q 047619 279 NFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSKI----SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEK 349 (430)
Q Consensus 279 ~~~~~~~ig~G~fg~Vy~~~~~----~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 349 (430)
+|++.+.||+|+||.||++... +++.+|+|++.+. .....+.+.+|+.++..+ +||+|+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4788999999999999999753 4789999998642 223345678899999999 589999999999999999
Q ss_pred EEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 350 LLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 350 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 81 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR---DNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 9999999999999998543 34889999999999999999999988 99999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-26 Score=221.62 Aligned_cols=150 Identities=26% Similarity=0.453 Sum_probs=135.1
Q ss_pred cCCcccceeecccCCcceEEEEEc-CCcEEEEEEecc--cChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCE-EEEE
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE-KLLI 352 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv 352 (430)
.++|..+++||+|+||.++.++.+ +.+.+++|++.- ......+...+|+.++++++|||||.+.+.|+.++. .+||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 367889999999999999999854 478999999863 344555678899999999999999999999999998 8999
Q ss_pred EEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCccccC
Q 047619 353 YEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430 (430)
Q Consensus 353 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~~ 430 (430)
|+|++||+|.+.|.... +..++++.+..++.|++.|+.|||++. |+|||||+.||++.+++.|||.|||+||.+
T Consensus 83 m~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l 156 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKIL 156 (426)
T ss_pred EeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhc
Confidence 99999999999997765 467999999999999999999999887 999999999999999999999999999974
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-25 Score=214.91 Aligned_cols=140 Identities=24% Similarity=0.329 Sum_probs=123.9
Q ss_pred eeecccCCcceEEEEEc-CCcEEEEEEeccc---ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEccCCC
Q 047619 284 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNK 359 (430)
Q Consensus 284 ~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 359 (430)
+.||+|+||.||++... +++.||+|++.+. .......+.+|++++..++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999864 5889999998752 2334566788999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 360 SLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ-DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 360 sL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~-~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+|..++... ..+++..+..++.||+.||.|||+ .+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 81 ~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~ 145 (325)
T cd05594 81 ELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKE 145 (325)
T ss_pred cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCee
Confidence 999888543 358999999999999999999997 56 99999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-26 Score=224.75 Aligned_cols=146 Identities=29% Similarity=0.446 Sum_probs=132.6
Q ss_pred CCcccceeecccCCcceEEEEE-cCCcEEEEEEeccc---ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 353 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 353 (430)
.-|++.+.||.|+.|.|-+|++ .+|+.+|||++.+. .......+.+|+.||+.|.||||+++++++++..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 4688899999999999999985 56999999999763 3344567889999999999999999999999999999999
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||+++|-|.+++... +++++.++.+++.||+.|+.|.|..+ |+||||||+|+|||..+++||+|||+|-+
T Consensus 92 Eyv~gGELFdylv~k---G~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsL 161 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRK---GPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASL 161 (786)
T ss_pred EecCCchhHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeec
Confidence 999999999999654 45899999999999999999999988 99999999999999999999999999964
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-25 Score=214.76 Aligned_cols=148 Identities=24% Similarity=0.327 Sum_probs=131.8
Q ss_pred cCCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEE
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 354 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 354 (430)
.++|++.+.||+|+||.||++... ++..+|+|.+... .....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 468999999999999999999965 4788999988653 34456779999999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 355 FVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 355 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|+++++|.+++... ..+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||+|+.
T Consensus 84 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 153 (331)
T cd06649 84 HMDGGSLDQVLKEA---KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 153 (331)
T ss_pred cCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccc
Confidence 99999999998543 34889999999999999999999853 399999999999999999999999999874
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=226.11 Aligned_cols=149 Identities=18% Similarity=0.234 Sum_probs=131.3
Q ss_pred CCcccceeecccCCcceEEEEEc-C-CcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEc
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV-D-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 355 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 355 (430)
..|.+.+.||+|+||.||+|... + +..||+|.+..........+.+|+.+++.++||||+++++++...+..+|||||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 34899999999999999999853 3 577888887655555566788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcC-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 356 VPNKSLDSFIFDQ-ERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 356 ~~~gsL~~~l~~~-~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+++++|.+++... ....++++..+..++.|++.||.|||+.+ |+||||||+||||+.++.+||+|||+|+.
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~ 218 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQ 218 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCcee
Confidence 9999999988542 22346889999999999999999999988 99999999999999999999999999975
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=216.33 Aligned_cols=147 Identities=20% Similarity=0.282 Sum_probs=129.8
Q ss_pred CCcccceeecccCCcceEEEEEcC-CcEEEEEEeccc---ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 353 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 353 (430)
++|++.++||+|+||.||++.... ++.+|+|.+.+. .......+.+|+.++..++|++|+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 478899999999999999998754 778999998642 2233455788999999999999999999999999999999
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||+++|+|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 81 ey~~~g~L~~~l~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~ 151 (332)
T cd05623 81 DYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLK 151 (332)
T ss_pred eccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchhee
Confidence 9999999999996532 35888999999999999999999988 99999999999999999999999999864
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-26 Score=223.51 Aligned_cols=150 Identities=33% Similarity=0.596 Sum_probs=134.1
Q ss_pred HhHHhhcCCcccceeecccCCcceEEEEEcCCcEEEEEEecc--cChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCE
Q 047619 271 ATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 348 (430)
Q Consensus 271 ~~~~~~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 348 (430)
.+..+..+...+.+.||+|+||+||+|.+ ...||||++.. ..++..+.|++|+.++++-+|.||+-+.|++..+..
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~w--hGdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRW--HGDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccc--ccceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 34455556778889999999999999997 35799999874 456678999999999999999999999999998877
Q ss_pred EEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCccc
Q 047619 349 KLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428 (430)
Q Consensus 349 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar 428 (430)
.||+.+++|.+|..+|+..+ ..++..+...|+.||++|+.|||.++ |||||||..||+|.+++.|||+|||||.
T Consensus 463 -AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLat 536 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLAT 536 (678)
T ss_pred -eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEeccccee
Confidence 99999999999999997544 45888999999999999999999998 9999999999999999999999999985
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=221.29 Aligned_cols=150 Identities=34% Similarity=0.489 Sum_probs=129.6
Q ss_pred cCCcccceeecccCCcceEEEEE------cCCcEEEEEEeccc-ChHhHHHHHHHHHHHhcC-CCCcccceEEEEEeCCE
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTL------VDGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEE 348 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 348 (430)
.++|++.+.||+|+||.||+|.. ..+..||||+++.. .....+.+.+|+.++..+ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 35788999999999999999973 23568999998643 234456788999999999 89999999999999999
Q ss_pred EEEEEEccCCCChhHHhhcCCC----------------------------------------------------------
Q 047619 349 KLLIYEFVPNKSLDSFIFDQER---------------------------------------------------------- 370 (430)
Q Consensus 349 ~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 370 (430)
.++||||+++|+|.+++.....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999999864221
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 371 --------------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 371 --------------~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~ 263 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARD 263 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCcccee
Confidence 124788889999999999999999988 99999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.4e-26 Score=215.22 Aligned_cols=143 Identities=31% Similarity=0.486 Sum_probs=123.8
Q ss_pred ceeecccCCcceEEEEE-cCCcEEEEEEeccc--ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEccCCC
Q 047619 283 NNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNK 359 (430)
Q Consensus 283 ~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 359 (430)
.+.||.|.||+||-|+. ++|+.||||++.+. ......++++|+.||++++||.||.+.-.|++.+..++|||-+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 37899999999999986 45999999999863 345568899999999999999999999999999999999999965
Q ss_pred ChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCC---CCeeecCCCccccC
Q 047619 360 SLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQD---MNPKISDFGLARAF 430 (430)
Q Consensus 360 sL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~---~~~kl~DFGlar~~ 430 (430)
++.+.|...+. ..+++.....++.||+.||.|||.++ |+|+||||+|||+.+. ..+||+|||+||++
T Consensus 648 DMLEMILSsEk-gRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiI 717 (888)
T KOG4236|consen 648 DMLEMILSSEK-GRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARII 717 (888)
T ss_pred hHHHHHHHhhc-ccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeec
Confidence 55555544443 45899988999999999999999998 9999999999999654 47999999999975
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.2e-26 Score=209.47 Aligned_cols=147 Identities=30% Similarity=0.495 Sum_probs=129.0
Q ss_pred hcCCcccceeecccCCcceEEEEE-cCCcEEEEEEecc--cChHhHHHHHHHHHHHhcCCCCcccceEEEEEe-----CC
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ-----GE 347 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~ 347 (430)
....|...+.||+|+||.|..+.. .+++.||||++.. ......++..+|+.+|+.++|+||+.+.+.+.. -+
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 335666678999999999999986 4589999999974 345567888999999999999999999999876 35
Q ss_pred EEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcc
Q 047619 348 EKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427 (430)
Q Consensus 348 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla 427 (430)
..|+|+|+| +-+|...|+.+ ..++...+..+++|+++||+|+|+.+ |+||||||.|+|++.+..+||+|||+|
T Consensus 100 DvYiV~elM-etDL~~iik~~---~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQ---QDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcC---ccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccce
Confidence 679999999 68999999554 34889999999999999999999998 999999999999999999999999999
Q ss_pred cc
Q 047619 428 RA 429 (430)
Q Consensus 428 r~ 429 (430)
|.
T Consensus 173 R~ 174 (359)
T KOG0660|consen 173 RY 174 (359)
T ss_pred ee
Confidence 85
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.5e-26 Score=220.28 Aligned_cols=150 Identities=31% Similarity=0.529 Sum_probs=133.9
Q ss_pred hcCCcccceeecccCCcceEEEEEcCCcEEEEEEecccChH-hHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 354 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 354 (430)
..+...+.++||+|-||.|.++....+..||||+++..... ....|..|+++|.+|+|||||+|+|+|..++.+++|+|
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence 33567788999999999999999877899999999875443 45899999999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 355 FVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 355 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||++|+|.+++..+.... +......+|+.||+.|++||.+.+ +|||||.+.|+|++.++++||+|||+||-
T Consensus 616 YmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~ 686 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRN 686 (807)
T ss_pred HHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccc
Confidence 999999999997664322 455667789999999999999887 99999999999999999999999999984
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-25 Score=214.23 Aligned_cols=144 Identities=26% Similarity=0.363 Sum_probs=126.6
Q ss_pred CcccceeecccCCcceEEEEEcC-CcEEEEEEeccc---ChHhHHHHHHHHHHHhcCCCC-cccceEEEEEeCCEEEEEE
Q 047619 279 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHR-NLVKLLGCCIQGEEKLLIY 353 (430)
Q Consensus 279 ~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~ 353 (430)
+|++.+.||+|+||.||+|.... ++.||+|++.+. .....+.+..|++++..+.|+ +|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 47889999999999999998654 779999998752 234456788899999999765 5888999999999999999
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCccc
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar 428 (430)
||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+
T Consensus 81 E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~ 149 (324)
T cd05587 81 EYVNGGDLMYHIQQV---GKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCK 149 (324)
T ss_pred cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcce
Confidence 999999999988543 34788999999999999999999988 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-25 Score=215.04 Aligned_cols=140 Identities=29% Similarity=0.439 Sum_probs=123.6
Q ss_pred eeecccCCcceEEEEEc----CCcEEEEEEeccc----ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEc
Q 047619 284 NKLGEGGFGPVYKGTLV----DGQEIAVKRLSKI----SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 355 (430)
Q Consensus 284 ~~ig~G~fg~Vy~~~~~----~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 355 (430)
+.||+|+||.||++... .++.||+|.+.+. .......+.+|+.+++.++||||+++++.+..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 68999999999999852 4789999998752 223345678899999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 356 VPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 356 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+++++|.+++... ..+.+..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 82 ~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 149 (323)
T cd05584 82 LSGGELFMHLERE---GIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKE 149 (323)
T ss_pred CCCchHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCee
Confidence 9999999998543 34788888899999999999999988 99999999999999999999999999863
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.6e-25 Score=207.29 Aligned_cols=147 Identities=28% Similarity=0.482 Sum_probs=130.2
Q ss_pred cCCcccceeecccCCcceEEEEEc----CCcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEE
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 351 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 351 (430)
.++|++.+.||+|+||.||+|.+. .+..||+|.+... .......+.+|+.++.+++||||+++++++...+..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 356889999999999999999753 3568999998753 33445678899999999999999999999999999999
Q ss_pred EEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCccc
Q 047619 352 IYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428 (430)
Q Consensus 352 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar 428 (430)
||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||.+.
T Consensus 84 v~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~ 155 (266)
T cd05064 84 VTEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQ 155 (266)
T ss_pred EEEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccc
Confidence 999999999999986532 35889999999999999999999988 9999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.6e-25 Score=206.52 Aligned_cols=148 Identities=30% Similarity=0.491 Sum_probs=133.3
Q ss_pred cCCcccceeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEcc
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFV 356 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 356 (430)
.++|++.+.||+|++|.||+|...+++.||+|.+... ....+++.+|+.++++++||||+++++++...+..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPG-TMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCC-cccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 4678999999999999999999877889999998753 234567889999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 357 PNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 357 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++.
T Consensus 84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~ 152 (261)
T cd05068 84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARV 152 (261)
T ss_pred cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEE
Confidence 9999999996543 345899999999999999999999988 99999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-26 Score=191.89 Aligned_cols=146 Identities=29% Similarity=0.495 Sum_probs=126.8
Q ss_pred CcccceeecccCCcceEEEEEcC-CcEEEEEEecc--cChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEc
Q 047619 279 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 355 (430)
Q Consensus 279 ~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 355 (430)
+|.-.++||+|.||+||+|+..+ ++.||+|++.- ..+..-....+|+.+++.++|.|||++++....+..+-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 56667899999999999999654 78899998863 2222345678899999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCccccC
Q 047619 356 VPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430 (430)
Q Consensus 356 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~~ 430 (430)
+ ..+|..+...- ...++.+....++.|+++||.|.|+++ +.||||||+|+||+.+|++||+|||+||.|
T Consensus 83 c-dqdlkkyfdsl--ng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglaraf 151 (292)
T KOG0662|consen 83 C-DQDLKKYFDSL--NGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAF 151 (292)
T ss_pred h-hHHHHHHHHhc--CCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhc
Confidence 9 46888887543 345888999999999999999999988 999999999999999999999999999965
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.3e-25 Score=206.19 Aligned_cols=146 Identities=29% Similarity=0.472 Sum_probs=130.8
Q ss_pred CCcccceeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEccC
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVP 357 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 357 (430)
++|++.+.||+|+||.||++...++..+|+|.+... ....+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 468888999999999999999887889999988642 2334678899999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 358 NKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 358 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~ 149 (256)
T cd05114 83 NGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRY 149 (256)
T ss_pred CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccc
Confidence 999999986432 34789999999999999999999988 99999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.2e-25 Score=213.81 Aligned_cols=148 Identities=23% Similarity=0.331 Sum_probs=131.2
Q ss_pred cCCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEE
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 354 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 354 (430)
.++|++.++||+|+||.||++... ++..+|+|.+... .......+.+|++++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 468999999999999999999875 4788999988643 34455778999999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 355 FVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 355 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|+++++|.+++... ..+++..+..++.+++.||.|||+.+ +|+||||||+|||++.++.+||+|||+|+.
T Consensus 84 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~ 153 (333)
T cd06650 84 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 153 (333)
T ss_pred cCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchh
Confidence 99999999998543 34788999999999999999999752 399999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-25 Score=213.47 Aligned_cols=140 Identities=29% Similarity=0.354 Sum_probs=124.3
Q ss_pred eeecccCCcceEEEEE----cCCcEEEEEEecccC--hHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEccC
Q 047619 284 NKLGEGGFGPVYKGTL----VDGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVP 357 (430)
Q Consensus 284 ~~ig~G~fg~Vy~~~~----~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 357 (430)
+.||+|+||.||++.. .+++.+|+|++.+.. ......+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 6799999999999875 247899999987522 2334567789999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 358 NKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 358 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 82 ~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 147 (318)
T cd05582 82 GGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKE 147 (318)
T ss_pred CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcc
Confidence 99999998543 35899999999999999999999988 99999999999999999999999999874
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.4e-25 Score=213.61 Aligned_cols=143 Identities=29% Similarity=0.462 Sum_probs=124.2
Q ss_pred cccceeecccCCcceEEEEEc-CCcEEEEEEeccc---ChHhHHHHHHHHHHH---hcCCCCcccceEEEEEeCCEEEEE
Q 047619 280 FSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILF---SKLQHRNLVKLLGCCIQGEEKLLI 352 (430)
Q Consensus 280 ~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv 352 (430)
|++.+.||+|+||.||+|... +++.||||++.+. .....+.+.+|+.++ ..++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 667899999999999999864 5889999999742 223345666676655 567899999999999999999999
Q ss_pred EEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 353 YEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 353 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|||+++++|..++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+|+.
T Consensus 81 ~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~ 150 (324)
T cd05589 81 MEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKE 150 (324)
T ss_pred EcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCcc
Confidence 999999999988743 34899999999999999999999988 99999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-25 Score=210.49 Aligned_cols=146 Identities=24% Similarity=0.392 Sum_probs=128.4
Q ss_pred CCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc--ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 354 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 354 (430)
++|++.+.||+|+||.||+++.. +++.+|+|++... .....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46899999999999999999975 4789999998642 23345678899999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 355 FVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 355 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|++++.+..+... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 149 (287)
T cd07848 81 YVEKNMLELLEEM---PNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARN 149 (287)
T ss_pred cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccc
Confidence 9998877665432 235889999999999999999999988 99999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-25 Score=216.62 Aligned_cols=149 Identities=29% Similarity=0.452 Sum_probs=133.2
Q ss_pred HhhcCCcccceeecccCCcceEEEEEcC-CcEEEEEEecccCh---HhHHHHHHHHHHHhcCC-CCcccceEEEEEeCCE
Q 047619 274 ANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISE---QGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEE 348 (430)
Q Consensus 274 ~~~~~~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 348 (430)
......|++.+.||+|.||.||+++.+. |+.+|+|.+.+... .....+.+|+.+|+++. |||||.+++++++...
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~ 110 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS 110 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence 3455689999999999999999999765 99999999976433 34568999999999999 9999999999999999
Q ss_pred EEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCC----CCeeecCC
Q 047619 349 KLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQD----MNPKISDF 424 (430)
Q Consensus 349 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~----~~~kl~DF 424 (430)
.++|||++.||.|.+.|... . +++..+..++.|++.|+.|||+.+ |+||||||+|+|+... +.+|++||
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~---~-~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DF 183 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKK---H-YSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDF 183 (382)
T ss_pred EEEEEEecCCchHHHHHHHc---c-CCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeC
Confidence 99999999999999999665 2 899999999999999999999988 9999999999999543 47999999
Q ss_pred Ccccc
Q 047619 425 GLARA 429 (430)
Q Consensus 425 Glar~ 429 (430)
|+|+.
T Consensus 184 Gla~~ 188 (382)
T KOG0032|consen 184 GLAKF 188 (382)
T ss_pred CCceE
Confidence 99975
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.7e-26 Score=224.70 Aligned_cols=149 Identities=30% Similarity=0.465 Sum_probs=129.1
Q ss_pred CcccceeecccCCcceEEEEE-cCCcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCC------EEE
Q 047619 279 NFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE------EKL 350 (430)
Q Consensus 279 ~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~ 350 (430)
.|...+.||+|+||.||+++. ..|+.||||.+.+. .....+..-+|+++|++++|||||++++.-++.. ...
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 455668999999999999994 56999999998763 3345667788999999999999999999866544 458
Q ss_pred EEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEc--CCC--CeeecCCCc
Q 047619 351 LIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLD--QDM--NPKISDFGL 426 (430)
Q Consensus 351 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~--~~~--~~kl~DFGl 426 (430)
+|||||.+|||...+.+......+++.+.+.++..+..||.|||+++ |+||||||.||++- .+| .-||+|||.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 99999999999999988888788999999999999999999999998 99999999999983 334 379999999
Q ss_pred cccC
Q 047619 427 ARAF 430 (430)
Q Consensus 427 ar~~ 430 (430)
||.+
T Consensus 171 Arel 174 (732)
T KOG4250|consen 171 AREL 174 (732)
T ss_pred cccC
Confidence 9964
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=219.38 Aligned_cols=151 Identities=35% Similarity=0.534 Sum_probs=129.9
Q ss_pred hcCCcccceeecccCCcceEEEEEc------CCcEEEEEEeccc-ChHhHHHHHHHHHHHhcC-CCCcccceEEEEEeCC
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGE 347 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 347 (430)
..++|++.+.||+|+||.||+|... ++..||+|++... .......+.+|+.+++.+ +|+||+++++++....
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 3457999999999999999998742 2357999999753 334456788999999999 8999999999999999
Q ss_pred EEEEEEEccCCCChhHHhhcCC----------------------------------------------------------
Q 047619 348 EKLLIYEFVPNKSLDSFIFDQE---------------------------------------------------------- 369 (430)
Q Consensus 348 ~~~lv~e~~~~gsL~~~l~~~~---------------------------------------------------------- 369 (430)
..++||||+++|+|.+++....
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 9999999999999999885421
Q ss_pred ---------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 370 ---------RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 370 ---------~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
...++++..+..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+|+.
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~ 261 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARD 261 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeee
Confidence 0124778889999999999999999988 99999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.5e-25 Score=213.21 Aligned_cols=140 Identities=26% Similarity=0.379 Sum_probs=124.3
Q ss_pred eeecccCCcceEEEEEc-CCcEEEEEEeccc---ChHhHHHHHHHHHHHhcC-CCCcccceEEEEEeCCEEEEEEEccCC
Q 047619 284 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFVPN 358 (430)
Q Consensus 284 ~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 358 (430)
+.||+|+||.||++... +++.||+|++++. .....+.+.+|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999864 4889999999752 233456688999999988 699999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 359 KSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 359 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++|..++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 81 g~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~ 145 (329)
T cd05588 81 GDLMFHMQRQ---RKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKE 145 (329)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccc
Confidence 9999888543 35899999999999999999999998 99999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-25 Score=217.70 Aligned_cols=142 Identities=29% Similarity=0.426 Sum_probs=125.1
Q ss_pred CCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEc
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 355 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 355 (430)
++|+..++||+|+||.||+|... +++.||||++... .......+.+|+++++.++|+||+++++++...+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 45677789999999999999864 5899999998643 334457789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 356 VPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 356 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+++++|.... ..++..+..++.||+.||+|||+.+ |+||||||+||||++++.+||+|||+|+.
T Consensus 154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~ 217 (353)
T PLN00034 154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRI 217 (353)
T ss_pred CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccccccee
Confidence 9999986532 2566778889999999999999988 99999999999999999999999999874
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.93 E-value=4e-25 Score=206.16 Aligned_cols=148 Identities=32% Similarity=0.512 Sum_probs=133.2
Q ss_pred cCCcccceeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEcc
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFV 356 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 356 (430)
.++|++.++||+|+||.||+|...++..||+|.+... ....+.+.+|+.++++++|+||+++++.+...+..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 4679999999999999999999878889999998653 334578899999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 357 PNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 357 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++++|.+++.... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+|+.
T Consensus 84 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~ 152 (261)
T cd05072 84 AKGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARV 152 (261)
T ss_pred CCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCcccee
Confidence 9999999986543 345788899999999999999999988 99999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.3e-25 Score=212.74 Aligned_cols=140 Identities=26% Similarity=0.380 Sum_probs=123.7
Q ss_pred eeecccCCcceEEEEEc-CCcEEEEEEeccc---ChHhHHHHHHHHHHHhcC-CCCcccceEEEEEeCCEEEEEEEccCC
Q 047619 284 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFVPN 358 (430)
Q Consensus 284 ~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 358 (430)
+.||+|+||.||+|... +++.+|+|++.+. .......+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999964 4789999998752 334456678899888776 799999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 359 KSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 359 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++|..++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~ 145 (329)
T cd05618 81 GDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE 145 (329)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCcccc
Confidence 9999888543 35899999999999999999999998 99999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.4e-25 Score=208.33 Aligned_cols=147 Identities=29% Similarity=0.383 Sum_probs=129.2
Q ss_pred CcccceeecccCCcceEEEEEc-CCcEEEEEEecccC---hHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEE
Q 047619 279 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 354 (430)
Q Consensus 279 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 354 (430)
.|++.+.||+|+||.||++... +++.||+|++.... ......+.+|+.+++.++||||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4788899999999999999864 58899999986422 2234557789999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 355 FVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 355 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|+++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||+++.
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~ 151 (285)
T cd05605 81 LMNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVE 151 (285)
T ss_pred ccCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCcee
Confidence 999999998885432 245899999999999999999999988 99999999999999999999999999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.1e-25 Score=211.77 Aligned_cols=145 Identities=26% Similarity=0.357 Sum_probs=126.2
Q ss_pred CcccceeecccCCcceEEEEEcC-CcEEEEEEeccc---ChHhHHHHHHHHHHHhcC-CCCcccceEEEEEeCCEEEEEE
Q 047619 279 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIY 353 (430)
Q Consensus 279 ~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 353 (430)
+|.+.+.||+|+||.||+|.... ++.+|+|++.+. .....+.+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 47888999999999999998654 789999998752 223345567788888777 5899999999999999999999
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||+++++|..++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+|+.
T Consensus 81 E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~ 150 (323)
T cd05616 81 EYVNGGDLMYQIQQV---GRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE 150 (323)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCcee
Confidence 999999999988543 34889999999999999999999988 99999999999999999999999999873
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-25 Score=206.91 Aligned_cols=149 Identities=33% Similarity=0.595 Sum_probs=136.1
Q ss_pred cCCcccceeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEcc
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFV 356 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 356 (430)
..+|++.++||.|+||.||+|...++..+|+|.+..........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 45788999999999999999998889999999998765556778999999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 357 PNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 357 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||+++.
T Consensus 85 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~ 153 (261)
T cd05148 85 EKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARL 153 (261)
T ss_pred ccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhh
Confidence 9999999996543 345899999999999999999999988 99999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.7e-25 Score=217.67 Aligned_cols=141 Identities=21% Similarity=0.330 Sum_probs=125.2
Q ss_pred hcCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 354 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 354 (430)
...+|++.+.||+|+||.||++... .++.||+|.... ..+.+|+.++++++||||+++++++......++|||
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e 163 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP 163 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence 3467999999999999999999864 488999997532 346789999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 355 FVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 355 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++. ++|..++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 164 ~~~-~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~ 231 (391)
T PHA03212 164 RYK-TDLYCYLAAK---RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACF 231 (391)
T ss_pred cCC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccc
Confidence 995 6888887543 34789999999999999999999988 99999999999999999999999999963
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.8e-25 Score=204.69 Aligned_cols=146 Identities=29% Similarity=0.490 Sum_probs=130.9
Q ss_pred CCcccceeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEccC
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVP 357 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 357 (430)
++|++.+.||+|+||.||++...++..+|+|.+... ....+.+.+|+.++++++||||+++++++......+++|||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 468889999999999999998877778999988743 2335678999999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 358 NKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 358 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+++|.+++.... ..+++..++.++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||+++.
T Consensus 83 ~~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~ 149 (256)
T cd05113 83 NGCLLNYLREHG--KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRY 149 (256)
T ss_pred CCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCcccee
Confidence 999999986533 25899999999999999999999988 99999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.6e-25 Score=206.95 Aligned_cols=147 Identities=30% Similarity=0.561 Sum_probs=130.2
Q ss_pred CCcccceeecccCCcceEEEEEc-----CCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeC--CEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV-----DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKL 350 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 350 (430)
.+|++.+.||+|+||.||++... ++..||+|++........+.+.+|++++++++||||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 57888999999999999999742 4789999999876666678899999999999999999999987543 4678
Q ss_pred EEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 351 LIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 351 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++.
T Consensus 84 lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR--ERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred EEEEecCCCCHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCccccc
Confidence 9999999999999985432 34889999999999999999999988 99999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.93 E-value=5e-25 Score=213.53 Aligned_cols=144 Identities=25% Similarity=0.490 Sum_probs=124.9
Q ss_pred CcccceeecccCCcceEEEEEc-CCcEEEEEEeccc--ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCC-----EEE
Q 047619 279 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-----EKL 350 (430)
Q Consensus 279 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 350 (430)
+|++.+.||+|+||.||+|... +++.||||++... .......+.+|+.++++++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5888999999999999999864 5899999998642 2234557889999999999999999999886543 479
Q ss_pred EEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 351 LIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 351 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+||||++ ++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 81 lv~e~~~-~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELME-SDLHQVIKAN---DDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecCC-CCHHHHHHhc---ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccc
Confidence 9999995 6898888543 34889999999999999999999998 99999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.3e-26 Score=228.68 Aligned_cols=151 Identities=34% Similarity=0.597 Sum_probs=133.6
Q ss_pred hcCCcccceeecccCCcceEEEEEc------CCcEEEEEEecccC-hHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 348 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 348 (430)
...+....+.||+|.||+||+|+.. +...||||.++... .+...+|++|++++..|+|||||+|+|+|.+++.
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P 563 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP 563 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence 4456667799999999999999842 35689999998654 4478999999999999999999999999999999
Q ss_pred EEEEEEccCCCChhHHhhcCCC-----------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCC
Q 047619 349 KLLIYEFVPNKSLDSFIFDQER-----------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDM 417 (430)
Q Consensus 349 ~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~ 417 (430)
+++|+|||..|+|.++|..... ..+++..+.+.|+.|||.|++||-++. +|||||-..|.||.++.
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENL 640 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccce
Confidence 9999999999999999964211 234888999999999999999999887 99999999999999999
Q ss_pred CeeecCCCcccc
Q 047619 418 NPKISDFGLARA 429 (430)
Q Consensus 418 ~~kl~DFGlar~ 429 (430)
.|||+||||+|-
T Consensus 641 ~VKIsDfGLsRd 652 (774)
T KOG1026|consen 641 VVKISDFGLSRD 652 (774)
T ss_pred EEEecccccchh
Confidence 999999999985
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.2e-25 Score=217.68 Aligned_cols=151 Identities=32% Similarity=0.488 Sum_probs=129.8
Q ss_pred hcCCcccceeecccCCcceEEEEEcC------CcEEEEEEeccc-ChHhHHHHHHHHHHHhcCC-CCcccceEEEEEeCC
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGE 347 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 347 (430)
..++|.+.+.||+|+||.||+|.... ...||||++... .....+.+.+|+.++.++. ||||+++++++.+..
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 45689999999999999999998532 347999999753 3344567899999999996 999999999999999
Q ss_pred EEEEEEEccCCCChhHHhhcCCC---------------------------------------------------------
Q 047619 348 EKLLIYEFVPNKSLDSFIFDQER--------------------------------------------------------- 370 (430)
Q Consensus 348 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 370 (430)
..+|||||+++|+|.++|.....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 99999999999999998854210
Q ss_pred ------------------------------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEc
Q 047619 371 ------------------------------------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLD 414 (430)
Q Consensus 371 ------------------------------------~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~ 414 (430)
...+++..+..++.|++.||.|||+.+ |+||||||+|||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEe
Confidence 124778888999999999999999988 99999999999999
Q ss_pred CCCCeeecCCCcccc
Q 047619 415 QDMNPKISDFGLARA 429 (430)
Q Consensus 415 ~~~~~kl~DFGlar~ 429 (430)
+++.+||+|||+|+.
T Consensus 272 ~~~~~kL~DfGla~~ 286 (400)
T cd05105 272 QGKIVKICDFGLARD 286 (400)
T ss_pred CCCEEEEEeCCccee
Confidence 999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.5e-25 Score=210.91 Aligned_cols=140 Identities=29% Similarity=0.396 Sum_probs=120.7
Q ss_pred eeecccCCcceEEEEEc-CCcEEEEEEeccc---ChHhHHHHHHHHHHHhc-CCCCcccceEEEEEeCCEEEEEEEccCC
Q 047619 284 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSK-LQHRNLVKLLGCCIQGEEKLLIYEFVPN 358 (430)
Q Consensus 284 ~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 358 (430)
+.||+|+||.||+|... +++.||+|.+.+. .....+.+..|..++.. .+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999865 4788999998752 22334555667777765 4899999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 359 KSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 359 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++|..++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 81 g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~ 145 (316)
T cd05592 81 GDLMFHIQSS---GRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKE 145 (316)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeE
Confidence 9999988543 34889999999999999999999988 99999999999999999999999999873
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.8e-25 Score=211.23 Aligned_cols=146 Identities=31% Similarity=0.562 Sum_probs=127.3
Q ss_pred CCcccceeecccCCcceEEEEEcC-Cc----EEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLVD-GQ----EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 351 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~~-~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 351 (430)
.+|++.+.||+|+||.||+|.+.. +. .||+|.+... .....+++.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 569999999999999999998533 33 4899998643 345567889999999999999999999998764 5779
Q ss_pred EEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 352 IYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 352 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++||+++|+|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+|+.
T Consensus 86 v~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred eeecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccc
Confidence 999999999999986543 34788899999999999999999988 99999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.2e-25 Score=215.95 Aligned_cols=150 Identities=31% Similarity=0.498 Sum_probs=133.8
Q ss_pred hhcCCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc--ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEE
Q 047619 275 NATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 351 (430)
Q Consensus 275 ~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 351 (430)
.....|.+..+||.|.|+.|.+|+.. .+..||||.+.+. ....+..+.+|+++|..|+|||||+++.+.+....+|+
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 34567999999999999999999864 4899999999873 34445668999999999999999999999999999999
Q ss_pred EEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCccccC
Q 047619 352 IYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430 (430)
Q Consensus 352 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~~ 430 (430)
||||+.+|.+.+++....+ +.+..+..++.|+..|++|+|+++ |+|||||++||||+.+.++||+|||++..|
T Consensus 133 V~eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~ 205 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFF 205 (596)
T ss_pred EEEeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceee
Confidence 9999999999999976654 455788889999999999999998 999999999999999999999999998643
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.6e-25 Score=211.86 Aligned_cols=140 Identities=26% Similarity=0.406 Sum_probs=122.8
Q ss_pred eeecccCCcceEEEEEcC-CcEEEEEEeccc---ChHhHHHHHHHHHHHhcC-CCCcccceEEEEEeCCEEEEEEEccCC
Q 047619 284 NKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFVPN 358 (430)
Q Consensus 284 ~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 358 (430)
+.||+|+||.||+|.... ++.||+|++.+. .....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 369999999999998654 789999998752 233455677888888866 799999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 359 KSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 359 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++|...+... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~ 145 (321)
T cd05591 81 GDLMFQIQRS---RKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKE 145 (321)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeeccccee
Confidence 9999888543 34888999999999999999999998 99999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.6e-25 Score=207.19 Aligned_cols=141 Identities=32% Similarity=0.418 Sum_probs=123.5
Q ss_pred ecccCCcceEEEEEc-CCcEEEEEEecccC---hHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEccCCCCh
Q 047619 286 LGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSL 361 (430)
Q Consensus 286 ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 361 (430)
||+|+||.||++... +++.+|+|++.+.. ....+.+..|+.+++.++||||+++.+++......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999864 58899999986422 22345678899999999999999999999999999999999999999
Q ss_pred hHHhhcC-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 362 DSFIFDQ-ERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 362 ~~~l~~~-~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
..++... .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 146 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVE 146 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCcccee
Confidence 9887532 22345899999999999999999999988 99999999999999999999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.2e-26 Score=197.51 Aligned_cols=154 Identities=27% Similarity=0.362 Sum_probs=137.4
Q ss_pred hhcCCcccceeecccCCcceEEEE-EcCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCC-----E
Q 047619 275 NATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-----E 348 (430)
Q Consensus 275 ~~~~~~~~~~~ig~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~ 348 (430)
...++|.+.+.||+|||+.||+++ ..+++.+|+|++.-...++.+...+|++..++++||||++++++...+. .
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 455789999999999999999998 5568999999998777788899999999999999999999998876544 4
Q ss_pred EEEEEEccCCCChhHHhhcCCC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcc
Q 047619 349 KLLIYEFVPNKSLDSFIFDQER-CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427 (430)
Q Consensus 349 ~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla 427 (430)
.||+++|...|+|.+.|..... +..+++.+++.|+.+|++||++||+.. ++++||||||.|||+.+++.++|.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCc
Confidence 8999999999999999876443 447999999999999999999999986 57999999999999999999999999998
Q ss_pred cc
Q 047619 428 RA 429 (430)
Q Consensus 428 r~ 429 (430)
..
T Consensus 177 ~~ 178 (302)
T KOG2345|consen 177 TQ 178 (302)
T ss_pred cc
Confidence 64
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=206.10 Aligned_cols=149 Identities=33% Similarity=0.553 Sum_probs=130.1
Q ss_pred CCcccceeecccCCcceEEEEE-----cCCcEEEEEEecc-cChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTL-----VDGQEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 351 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~-----~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 351 (430)
++|++.+.||+|+||.||+|.. ..+..+|+|.+.. ........+.+|+.+++.++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 5688889999999999999984 2357899999874 334455788999999999999999999999999999999
Q ss_pred EEEccCCCChhHHhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCC
Q 047619 352 IYEFVPNKSLDSFIFDQER--------------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDM 417 (430)
Q Consensus 352 v~e~~~~gsL~~~l~~~~~--------------~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~ 417 (430)
||||+++++|.+++..... ...+++..+..++.|++.||.|||+++ |+||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 9999999999999853211 234788889999999999999999988 99999999999999999
Q ss_pred CeeecCCCcccc
Q 047619 418 NPKISDFGLARA 429 (430)
Q Consensus 418 ~~kl~DFGlar~ 429 (430)
.+||+|||+++.
T Consensus 162 ~~kl~dfg~~~~ 173 (283)
T cd05090 162 HVKISDLGLSRE 173 (283)
T ss_pred cEEecccccccc
Confidence 999999999974
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-26 Score=207.85 Aligned_cols=144 Identities=31% Similarity=0.519 Sum_probs=132.0
Q ss_pred CcccceeecccCCcceEEEEEc-CCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEccC
Q 047619 279 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVP 357 (430)
Q Consensus 279 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 357 (430)
-|.++++||+|+||.||+|.++ .|+.+|||++. ...+++++..|+.||+++..|++|++||.+.....++||||||.
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VP--V~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVP--VDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecC--ccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 4778899999999999999865 49999999986 35678899999999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 358 NKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 358 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
.|++.+++.. +.+++.+.++..+++..++||+|||... -||||||..||||+.+|.+||+|||.|-.
T Consensus 112 AGSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQ 178 (502)
T KOG0574|consen 112 AGSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQ 178 (502)
T ss_pred CCcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccch
Confidence 9999999954 3567999999999999999999999876 89999999999999999999999999854
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.4e-25 Score=229.34 Aligned_cols=149 Identities=22% Similarity=0.336 Sum_probs=130.5
Q ss_pred CCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc---ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 353 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 353 (430)
++|++.++||+|+||.||+|... .++.||+|++... .....+++.+|+.++++++||||+++++++.+++..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57999999999999999999865 4889999998642 2334567899999999999999999999999999999999
Q ss_pred EccCCCChhHHhhcCC--------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCC
Q 047619 354 EFVPNKSLDSFIFDQE--------RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 425 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~--------~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFG 425 (430)
||+++++|.+++.... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999885421 1123566778899999999999999988 9999999999999999999999999
Q ss_pred cccc
Q 047619 426 LARA 429 (430)
Q Consensus 426 lar~ 429 (430)
+|+.
T Consensus 159 LAk~ 162 (932)
T PRK13184 159 AAIF 162 (932)
T ss_pred ccee
Confidence 9974
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=204.12 Aligned_cols=147 Identities=25% Similarity=0.443 Sum_probs=132.1
Q ss_pred cCCcccceeecccCCcceEEEEE-cCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEc
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 355 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 355 (430)
.++|++.+.||+|+||.||+|.. .+++.+|+|++..........+.+|+.++.+++||||+++++.+...+..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 35799999999999999999996 45889999998754444556788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 356 VPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 356 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 88 ~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~ 155 (267)
T cd06646 88 CGGGSLQDIYHVT---GPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAK 155 (267)
T ss_pred CCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCcccee
Confidence 9999999988543 35889999999999999999999988 99999999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.3e-25 Score=210.85 Aligned_cols=145 Identities=26% Similarity=0.365 Sum_probs=126.3
Q ss_pred CcccceeecccCCcceEEEEEc-CCcEEEEEEeccc---ChHhHHHHHHHHHHHhcCC-CCcccceEEEEEeCCEEEEEE
Q 047619 279 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIY 353 (430)
Q Consensus 279 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 353 (430)
+|++.+.||+|+||.||+|... +++.||+|++.+. .....+.+..|+.++..+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3677899999999999999864 5889999998752 2234556778899988886 577888999999999999999
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+|+.
T Consensus 81 Ey~~~g~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~ 150 (323)
T cd05615 81 EYVNGGDLMYHIQQV---GKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE 150 (323)
T ss_pred cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccc
Confidence 999999999998543 34889999999999999999999988 99999999999999999999999999873
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.5e-25 Score=210.95 Aligned_cols=140 Identities=29% Similarity=0.385 Sum_probs=120.7
Q ss_pred eeecccCCcceEEEEEc-CCcEEEEEEeccc---ChHhHHHHHHHHH-HHhcCCCCcccceEEEEEeCCEEEEEEEccCC
Q 047619 284 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVI-LFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPN 358 (430)
Q Consensus 284 ~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 358 (430)
+.||+|+||.||+|... +++.+|+|++.+. .......+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999864 5889999998642 2233345555654 56789999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 359 KSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 359 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~ 145 (325)
T cd05604 81 GELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKE 145 (325)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCccc
Confidence 9999888543 35889999999999999999999988 99999999999999999999999999873
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=210.21 Aligned_cols=140 Identities=28% Similarity=0.385 Sum_probs=120.3
Q ss_pred eeecccCCcceEEEEEc-CCcEEEEEEecccC---hHhHHHHHHHHH-HHhcCCCCcccceEEEEEeCCEEEEEEEccCC
Q 047619 284 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVI-LFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPN 358 (430)
Q Consensus 284 ~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 358 (430)
+.||+|+||.||+|... +++.||+|++.+.. ......+.+|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999974 58999999986421 222344455544 56789999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 359 KSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 359 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 81 g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~ 145 (323)
T cd05575 81 GELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKE 145 (323)
T ss_pred CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcc
Confidence 9999988543 35889999999999999999999998 99999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.6e-25 Score=210.81 Aligned_cols=140 Identities=31% Similarity=0.450 Sum_probs=122.9
Q ss_pred eeecccCCcceEEEEEc-CCcEEEEEEeccc---ChHhHHHHHHHHHHHhcC-CCCcccceEEEEEeCCEEEEEEEccCC
Q 047619 284 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFVPN 358 (430)
Q Consensus 284 ~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 358 (430)
+.||+|+||.||+|... +++.||+|++.+. .....+.+..|+.++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999865 4789999998742 223456677888888876 699999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 359 KSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 359 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++|..++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 g~L~~~i~~~---~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~ 145 (320)
T cd05590 81 GDLMFHIQKS---RRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKE 145 (320)
T ss_pred chHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCee
Confidence 9999988543 34889999999999999999999988 99999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=209.71 Aligned_cols=140 Identities=29% Similarity=0.382 Sum_probs=120.0
Q ss_pred eeecccCCcceEEEEEc-CCcEEEEEEecccC---hHhHHHHHHHHH-HHhcCCCCcccceEEEEEeCCEEEEEEEccCC
Q 047619 284 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVI-LFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPN 358 (430)
Q Consensus 284 ~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 358 (430)
+.||+|+||.||+|... +++.+|+|++.+.. ......+..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 47899999986421 223344555554 67889999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 359 KSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 359 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++|...+... ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+|+.
T Consensus 81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 145 (321)
T cd05603 81 GELFFHLQRE---RCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKE 145 (321)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCcc
Confidence 9999888543 34788888999999999999999988 99999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=208.60 Aligned_cols=146 Identities=29% Similarity=0.489 Sum_probs=127.3
Q ss_pred CCcccceeecccCCcceEEEEEc-CCcEEEEEEecccC-hHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEc
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 355 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 355 (430)
++|.+.++||+|+||.||+|... +++.+|+|.+.... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 57999999999999999999865 47889999986432 22334677899999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 356 VPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 356 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+++ +|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 86 ~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 153 (309)
T cd07872 86 LDK-DLKQYMDDCG--NIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARA 153 (309)
T ss_pred CCC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcccccee
Confidence 975 7888775432 34788899999999999999999988 99999999999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.9e-25 Score=203.36 Aligned_cols=146 Identities=29% Similarity=0.477 Sum_probs=130.2
Q ss_pred CCcccceeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEccC
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVP 357 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 357 (430)
.+|++.+.||+|+||.||++....+..+|+|.+.+. ......+.+|+.++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccC-CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 357888999999999999999877778999998642 2234568889999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 358 NKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 358 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++.
T Consensus 83 ~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~ 149 (256)
T cd05059 83 NGCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARY 149 (256)
T ss_pred CCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCccccee
Confidence 999999986533 35889999999999999999999998 99999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-24 Score=202.55 Aligned_cols=147 Identities=29% Similarity=0.535 Sum_probs=130.8
Q ss_pred CCcccceeecccCCcceEEEEEcC----CcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 352 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 352 (430)
++|++.+.||+|+||.||+|.... ...||+|.+... .......+.+|+.++.+++||||+++++++...+..+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 578899999999999999998642 457999988653 344456788999999999999999999999999999999
Q ss_pred EEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 353 YEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 353 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||||+|||+++++.+||+|||+++.
T Consensus 84 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~ 155 (266)
T cd05033 84 TEYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRR 155 (266)
T ss_pred EEcCCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhc
Confidence 99999999999986533 35889999999999999999999988 99999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=210.41 Aligned_cols=140 Identities=26% Similarity=0.380 Sum_probs=124.0
Q ss_pred eeecccCCcceEEEEEc-CCcEEEEEEeccc---ChHhHHHHHHHHHHHhcC-CCCcccceEEEEEeCCEEEEEEEccCC
Q 047619 284 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFVPN 358 (430)
Q Consensus 284 ~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 358 (430)
+.||+|+||.||+|... +++.+|+|++.+. .....+.+.+|+.++.++ +||+|+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999864 4789999999753 233456688999999888 699999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 359 KSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 359 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++|..++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~ 145 (327)
T cd05617 81 GDLMFHMQRQ---RKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKE 145 (327)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEecccccee
Confidence 9999888543 35899999999999999999999998 99999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=209.12 Aligned_cols=140 Identities=25% Similarity=0.364 Sum_probs=118.8
Q ss_pred eeecccCCcceEEEEEc-CCcEEEEEEecccC---hHhHHHHHHHH-HHHhcCCCCcccceEEEEEeCCEEEEEEEccCC
Q 047619 284 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEV-ILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPN 358 (430)
Q Consensus 284 ~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 358 (430)
+.||+|+||.||+|... +++.+|+|++.+.. ......+..|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999865 47789999986421 12233444444 456789999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 359 KSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 359 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++|.+++... ..+.+..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 81 ~~L~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~ 145 (325)
T cd05602 81 GELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKE 145 (325)
T ss_pred CcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcc
Confidence 9999998543 34778888889999999999999998 99999999999999999999999999873
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=227.58 Aligned_cols=147 Identities=26% Similarity=0.405 Sum_probs=132.2
Q ss_pred cCCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc---ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEE
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 352 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 352 (430)
.++|.+.++||+|+||.||+|... +++.||||++... .......+.+|+.++..++||||+++++.+......+||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 368999999999999999999975 5889999998642 234457788999999999999999999999999999999
Q ss_pred EEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 353 YEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 353 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|||+++++|.+++... ..+++..++.++.||+.||.|||..+ |+||||||+||||+.++.+||+|||+|+.
T Consensus 83 mEy~~g~~L~~li~~~---~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~~ 153 (669)
T cd05610 83 MEYLIGGDVKSLLHIY---GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153 (669)
T ss_pred EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCcc
Confidence 9999999999998543 34788899999999999999999987 99999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=209.10 Aligned_cols=139 Identities=30% Similarity=0.417 Sum_probs=121.5
Q ss_pred eeecccCCcceEEEEEc-CCcEEEEEEecccC---hHhHHHHHHHHHHHhcC-CCCcccceEEEEEeCCEEEEEEEccCC
Q 047619 284 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFVPN 358 (430)
Q Consensus 284 ~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 358 (430)
+.||+|+||.||+|... +++.||+|.+.+.. ......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999975 48899999987521 23445667788888754 899999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCccc
Q 047619 359 KSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428 (430)
Q Consensus 359 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar 428 (430)
++|..++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+
T Consensus 81 g~L~~~i~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~ 144 (316)
T cd05620 81 GDLMFHIQDK---GRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCK 144 (316)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCe
Confidence 9999988543 34788999999999999999999988 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=208.48 Aligned_cols=140 Identities=29% Similarity=0.407 Sum_probs=121.8
Q ss_pred eeecccCCcceEEEEEcC-CcEEEEEEeccc---ChHhHHHHHHHHHHHhc-CCCCcccceEEEEEeCCEEEEEEEccCC
Q 047619 284 NKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSK-LQHRNLVKLLGCCIQGEEKLLIYEFVPN 358 (430)
Q Consensus 284 ~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 358 (430)
+.||+|+||.||+|.... ++.||||.+.+. .......+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 469999999999999754 789999998752 12334556678888876 4899999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 359 KSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 359 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++|..++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+|+.
T Consensus 81 g~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~ 145 (316)
T cd05619 81 GDLMFHIQSC---HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKE 145 (316)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceE
Confidence 9999998543 34788999999999999999999988 99999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-24 Score=203.57 Aligned_cols=151 Identities=29% Similarity=0.524 Sum_probs=130.0
Q ss_pred hcCCcccceeecccCCcceEEEEEc------CCcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 348 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 348 (430)
..++|++.+.||+|+||.||+|... .+..+|+|++... ......++.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567999999999999999998753 2467999998642 23445678899999999999999999999999999
Q ss_pred EEEEEEccCCCChhHHhhcCCC-------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeee
Q 047619 349 KLLIYEFVPNKSLDSFIFDQER-------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKI 421 (430)
Q Consensus 349 ~~lv~e~~~~gsL~~~l~~~~~-------~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl 421 (430)
.++||||+++++|.+++..... ...+++..+..++.|++.||.|||+.+ ++|+||||+|||+++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 9999999999999999864321 123577888999999999999999988 999999999999999999999
Q ss_pred cCCCcccc
Q 047619 422 SDFGLARA 429 (430)
Q Consensus 422 ~DFGlar~ 429 (430)
+|||+|+.
T Consensus 161 ~dfg~~~~ 168 (277)
T cd05062 161 GDFGMTRD 168 (277)
T ss_pred CCCCCccc
Confidence 99999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-24 Score=204.69 Aligned_cols=149 Identities=33% Similarity=0.624 Sum_probs=132.2
Q ss_pred CCcccceeecccCCcceEEEEEc------CCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 351 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 351 (430)
++|.+.+.||+|+||.||++... ++..+|+|.+..........+.+|+.++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 57889999999999999999742 245689999876666667789999999999999999999999999999999
Q ss_pred EEEccCCCChhHHhhcCC----------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeee
Q 047619 352 IYEFVPNKSLDSFIFDQE----------RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKI 421 (430)
Q Consensus 352 v~e~~~~gsL~~~l~~~~----------~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl 421 (430)
||||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 999999999999986432 1234899999999999999999999988 999999999999999999999
Q ss_pred cCCCcccc
Q 047619 422 SDFGLARA 429 (430)
Q Consensus 422 ~DFGlar~ 429 (430)
+|||+|+.
T Consensus 162 ~dfg~~~~ 169 (288)
T cd05093 162 GDFGMSRD 169 (288)
T ss_pred ccCCcccc
Confidence 99999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-24 Score=201.85 Aligned_cols=147 Identities=29% Similarity=0.521 Sum_probs=129.9
Q ss_pred CCcccceeecccCCcceEEEEEcC----CcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 352 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 352 (430)
.+|++.+.||+|+||.||+|.... ...+|+|.+... .....+.+.+|+.++.+++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 578889999999999999998632 347999988642 344567889999999999999999999999999999999
Q ss_pred EEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 353 YEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 353 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|||+++++|.+++.... ..+++.++..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||+++.
T Consensus 84 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd05066 84 TEYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRV 155 (267)
T ss_pred EEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccc
Confidence 99999999999996543 35789999999999999999999988 99999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-24 Score=200.20 Aligned_cols=141 Identities=30% Similarity=0.527 Sum_probs=125.9
Q ss_pred eeecccCCcceEEEEEc-CCcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEccCCCCh
Q 047619 284 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSL 361 (430)
Q Consensus 284 ~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 361 (430)
+.||+|+||.||+|... +++.+|+|.+... .......+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999864 5889999987643 344567799999999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 362 DSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 362 ~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 143 (252)
T cd05084 81 LTFLRTE--GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSRE 143 (252)
T ss_pred HHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcc
Confidence 9998543 235789999999999999999999988 99999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.1e-24 Score=205.43 Aligned_cols=146 Identities=25% Similarity=0.313 Sum_probs=129.8
Q ss_pred CCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEc
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 355 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 355 (430)
++|++.+.||+|+||.||++... ++..+|+|.+... ......++.+|++++.+++||||+++++++..++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46889999999999999999864 4788899988643 344556788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 356 VPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD-SRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 356 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+++++|.+++... ..+++..+..++.|++.||.|||+. + |+|+||||+|||+++++.+||+|||+++.
T Consensus 81 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 149 (308)
T cd06615 81 MDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQ 149 (308)
T ss_pred cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccc
Confidence 9999999999543 4588999999999999999999974 5 99999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-24 Score=201.41 Aligned_cols=147 Identities=29% Similarity=0.516 Sum_probs=131.3
Q ss_pred CCcccceeecccCCcceEEEEEcC-CcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEcc
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFV 356 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 356 (430)
.+|.+.+.||+|+||.||+|...+ ++.+|+|.+.. .......+.+|+.+++.++||||+++++++...+..+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecC-CchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 458888999999999999998654 78999999875 3344677899999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 357 PNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 357 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++++|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.
T Consensus 85 ~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~ 153 (263)
T cd05052 85 TYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRL 153 (263)
T ss_pred CCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccc
Confidence 9999999986533 245889999999999999999999988 99999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=221.01 Aligned_cols=154 Identities=22% Similarity=0.295 Sum_probs=132.4
Q ss_pred HHhhcCCcccceeecccCCcceEEEEE-cCCcEEEEEEecc--cChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCC--
Q 047619 273 IANATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-- 347 (430)
Q Consensus 273 ~~~~~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-- 347 (430)
.....++|++.+.||+|+||.||+|.. .+++.||||++.. ........+.+|+.++..++|+||++++..+...+
T Consensus 27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 344557999999999999999999985 4589999999864 24555677889999999999999999988776433
Q ss_pred ------EEEEEEEccCCCChhHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCee
Q 047619 348 ------EKLLIYEFVPNKSLDSFIFDQE-RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPK 420 (430)
Q Consensus 348 ------~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~k 420 (430)
..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+.+ |+||||||+||||+.++.+|
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vk 183 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVK 183 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEE
Confidence 3679999999999999986432 2346889999999999999999999988 99999999999999999999
Q ss_pred ecCCCcccc
Q 047619 421 ISDFGLARA 429 (430)
Q Consensus 421 l~DFGlar~ 429 (430)
|+|||+|+.
T Consensus 184 L~DFGls~~ 192 (496)
T PTZ00283 184 LGDFGFSKM 192 (496)
T ss_pred EEecccCee
Confidence 999999874
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=213.54 Aligned_cols=144 Identities=28% Similarity=0.466 Sum_probs=126.3
Q ss_pred CcccceeecccCCcceEEEEEc-CCcEEEEEEeccc--ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCC-----EEE
Q 047619 279 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-----EKL 350 (430)
Q Consensus 279 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 350 (430)
+|++.+.||+|+||.||++... +++.||+|++... .....+.+.+|+.+++.++||||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4778899999999999999864 5899999998642 2334567889999999999999999999998876 789
Q ss_pred EEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 351 LIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 351 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+||||++ ++|.+.+... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 81 lv~e~~~-~~l~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP---QPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeeccc-cCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceee
Confidence 9999996 5788777433 35899999999999999999999998 99999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-24 Score=204.88 Aligned_cols=151 Identities=27% Similarity=0.507 Sum_probs=129.2
Q ss_pred hcCCcccceeecccCCcceEEEEEcC------CcEEEEEEecccC-hHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 348 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 348 (430)
..++|++.+.||+|+||.||+|...+ +..||+|.+.... ......+.+|+.+++.++||||+++++++...+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 45689999999999999999997532 4589999886432 3344567889999999999999999999999999
Q ss_pred EEEEEEccCCCChhHHhhcCCC-------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeee
Q 047619 349 KLLIYEFVPNKSLDSFIFDQER-------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKI 421 (430)
Q Consensus 349 ~~lv~e~~~~gsL~~~l~~~~~-------~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl 421 (430)
.++||||+++++|.+++..... ....++..+..++.|++.||.|||+++ |+||||||+|||+++++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999964221 233566788899999999999999988 999999999999999999999
Q ss_pred cCCCcccc
Q 047619 422 SDFGLARA 429 (430)
Q Consensus 422 ~DFGlar~ 429 (430)
+|||+|+.
T Consensus 161 ~Dfg~~~~ 168 (288)
T cd05061 161 GDFGMTRD 168 (288)
T ss_pred CcCCcccc
Confidence 99999874
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-24 Score=200.97 Aligned_cols=149 Identities=33% Similarity=0.536 Sum_probs=133.8
Q ss_pred hcCCcccceeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEc
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 355 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 355 (430)
..++|.+.+.||+|+||.||+|...+++.+|||.+... ....+.+.+|+.++++++||||+++++++......++||||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCC-ccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 45689999999999999999999877889999998753 23456789999999999999999999999998999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 356 VPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 356 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+++++|.+++.... ...+++..+..++.+++.||.|||+++ |+|+||||+||++++++.+||+|||+++.
T Consensus 83 ~~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~ 152 (261)
T cd05034 83 MSKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARL 152 (261)
T ss_pred cCCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECcccccee
Confidence 99999999996543 235899999999999999999999988 99999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=8e-25 Score=215.15 Aligned_cols=145 Identities=24% Similarity=0.396 Sum_probs=128.6
Q ss_pred CcccceeecccCCcceEEEEE-cCCcEEEEEEecccChHhHHHHHHHHHHHhcCC-C-----CcccceEEEEEeCCEEEE
Q 047619 279 NFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-H-----RNLVKLLGCCIQGEEKLL 351 (430)
Q Consensus 279 ~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~~l 351 (430)
+|.+.+.||+|+||.|.+|.+ .+++.||||+++. ......+...|+.+|..|+ | -|+|+++++|...++.+|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN-~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN-KKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeecc-ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 899999999999999999985 4589999999976 4566777888999999997 4 379999999999999999
Q ss_pred EEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCC--CCeeecCCCcccc
Q 047619 352 IYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQD--MNPKISDFGLARA 429 (430)
Q Consensus 352 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~--~~~kl~DFGlar~ 429 (430)
|+|.+ ..+|.++|+.+.- ..++...+..++.||+.||.+||+.+ |||+||||+||||... ..+||+|||.|..
T Consensus 266 VfELL-~~NLYellK~n~f-~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNNKF-RGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eehhh-hhhHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence 99999 5799999977654 45999999999999999999999988 9999999999999654 3699999999863
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-24 Score=202.18 Aligned_cols=142 Identities=30% Similarity=0.510 Sum_probs=121.8
Q ss_pred eecccCCcceEEEEEcC---CcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEccCCCC
Q 047619 285 KLGEGGFGPVYKGTLVD---GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKS 360 (430)
Q Consensus 285 ~ig~G~fg~Vy~~~~~~---~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 360 (430)
.||+|+||.||+|.... ...+|+|.+... .......+.+|+.+++.++||||+++++.+......++||||+++++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 69999999999997533 357888877543 33445678899999999999999999999999999999999999999
Q ss_pred hhHHhhcCCC--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 361 LDSFIFDQER--CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 361 L~~~l~~~~~--~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|.+++..... ....++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 149 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALE 149 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccc
Confidence 9999965432 223467788899999999999999988 99999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-24 Score=205.67 Aligned_cols=149 Identities=28% Similarity=0.500 Sum_probs=129.1
Q ss_pred CCcccceeecccCCcceEEEEEcC---------------CcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLVD---------------GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLG 341 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~~---------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~ 341 (430)
++|++.+.||+|+||.||++.... ...||+|.+... .......+.+|++++++++||||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 578999999999999999987532 235899998753 3445667999999999999999999999
Q ss_pred EEEeCCEEEEEEEccCCCChhHHhhcCCC---------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEE
Q 047619 342 CCIQGEEKLLIYEFVPNKSLDSFIFDQER---------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVL 412 (430)
Q Consensus 342 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NIL 412 (430)
++...+..++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++|+||||+|||
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 99999999999999999999999854321 123688899999999999999999988 999999999999
Q ss_pred EcCCCCeeecCCCcccc
Q 047619 413 LDQDMNPKISDFGLARA 429 (430)
Q Consensus 413 l~~~~~~kl~DFGlar~ 429 (430)
+++++.+||+|||+++.
T Consensus 162 l~~~~~~kl~dfg~~~~ 178 (295)
T cd05097 162 VGNHYTIKIADFGMSRN 178 (295)
T ss_pred EcCCCcEEecccccccc
Confidence 99999999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-24 Score=203.73 Aligned_cols=149 Identities=32% Similarity=0.621 Sum_probs=131.4
Q ss_pred CCcccceeecccCCcceEEEEEcC------CcEEEEEEecccChH-hHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 350 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 350 (430)
++|.+.+.||+|+||.||+|...+ +..+|+|.+...... ..+.+.+|++++++++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 568889999999999999998633 478999998754333 5678999999999999999999999999999999
Q ss_pred EEEEccCCCChhHHhhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCe
Q 047619 351 LIYEFVPNKSLDSFIFDQE-----------RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNP 419 (430)
Q Consensus 351 lv~e~~~~gsL~~~l~~~~-----------~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~ 419 (430)
+||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 9999999999999996432 1234788899999999999999999988 9999999999999999999
Q ss_pred eecCCCcccc
Q 047619 420 KISDFGLARA 429 (430)
Q Consensus 420 kl~DFGlar~ 429 (430)
||+|||+|+.
T Consensus 162 kl~d~g~~~~ 171 (280)
T cd05049 162 KIGDFGMSRD 171 (280)
T ss_pred EECCccccee
Confidence 9999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-25 Score=197.78 Aligned_cols=151 Identities=27% Similarity=0.416 Sum_probs=131.1
Q ss_pred HhhcCCcccceeecccCCcceEEEEE-cCCcEEEEEEeccc--------ChHhHHHHHHHHHHHhcC-CCCcccceEEEE
Q 047619 274 ANATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI--------SEQGLKELKNEVILFSKL-QHRNLVKLLGCC 343 (430)
Q Consensus 274 ~~~~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~--------~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 343 (430)
.....+|...+.||.|..+.|.++.. ..++++|+|++... ...-.+.-.+|+.||+++ -||+|+++.+++
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 44556788889999999999988875 45889999998531 122345567899999998 599999999999
Q ss_pred EeCCEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecC
Q 047619 344 IQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD 423 (430)
Q Consensus 344 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~D 423 (430)
+++...++|+|.|+.|.|.++|.+. ..+++++..+|++|++.|++|||..+ |+||||||+|||+|++.++||+|
T Consensus 93 es~sF~FlVFdl~prGELFDyLts~---VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isD 166 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYLTSK---VTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISD 166 (411)
T ss_pred cCcchhhhhhhhcccchHHHHhhhh---eeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEec
Confidence 9999999999999999999999543 46899999999999999999999988 99999999999999999999999
Q ss_pred CCccccC
Q 047619 424 FGLARAF 430 (430)
Q Consensus 424 FGlar~~ 430 (430)
||+|..+
T Consensus 167 FGFa~~l 173 (411)
T KOG0599|consen 167 FGFACQL 173 (411)
T ss_pred cceeecc
Confidence 9999754
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=204.89 Aligned_cols=149 Identities=24% Similarity=0.408 Sum_probs=132.0
Q ss_pred CCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEc
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 355 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 355 (430)
++|++.+.||+|+||.||++... .++.+|+|.+... .......+.+|+.++.+++||||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 46888999999999999999975 5899999988642 344567889999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 356 VPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD-SRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 356 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+++++|..++........+++..+..++.+++.||.|||+. + |+|+||||+||+++.++.+||+|||+|+.
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 152 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGN 152 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCccc
Confidence 99999999986543334689999999999999999999974 5 99999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-24 Score=201.12 Aligned_cols=147 Identities=29% Similarity=0.497 Sum_probs=128.6
Q ss_pred cCCcccceeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEcc
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFV 356 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 356 (430)
.++|++.++||+|+||.||+|...+...||+|++... ....+.+.+|+.+++.++||||+++++.+. ....++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~-~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccC-ccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 3569999999999999999999877778999998752 223467899999999999999999999874 45679999999
Q ss_pred CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 357 PNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 357 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||+|+.
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~ 151 (262)
T cd05071 83 SKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARL 151 (262)
T ss_pred CCCcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceee
Confidence 9999999996532 245789999999999999999999988 99999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.6e-24 Score=202.26 Aligned_cols=147 Identities=32% Similarity=0.519 Sum_probs=129.6
Q ss_pred CcccceeecccCCcceEEEEEc-CCcEEEEEEeccc--ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEc
Q 047619 279 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 355 (430)
Q Consensus 279 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 355 (430)
+|++.+.||+|++|.||+|... +++.||+|++... .......+.+|+.++..++||||+++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4788899999999999999864 5889999998642 223346788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 356 VPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 356 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++ ++|.+++........+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||+++.
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 150 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARA 150 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceee
Confidence 97 688888865444456899999999999999999999988 99999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-24 Score=202.52 Aligned_cols=146 Identities=27% Similarity=0.494 Sum_probs=131.8
Q ss_pred CCcccceeecccCCcceEEEEEc-CCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEcc
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFV 356 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 356 (430)
++|++.+.||+|+||.||+|... +++.+|+|.+..........+.+|+.+++.++||||+++++.+...+..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 57888999999999999999864 58899999987654455667889999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 357 PNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 357 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++++|.+++... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||+|+.
T Consensus 89 ~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd06645 89 GGGSLQDIYHVT---GPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQ 155 (267)
T ss_pred CCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeE
Confidence 999999998543 35889999999999999999999988 99999999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-24 Score=206.93 Aligned_cols=139 Identities=29% Similarity=0.419 Sum_probs=123.2
Q ss_pred eeecccCCcceEEEEEcC-CcEEEEEEeccc---ChHhHHHHHHHHHHHhcC-CCCcccceEEEEEeCCEEEEEEEccCC
Q 047619 284 NKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFVPN 358 (430)
Q Consensus 284 ~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 358 (430)
+.||+|+||.||+|.... ++.+|+|++.+. .......+.+|+.++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999998654 789999998752 233456677899999887 699999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCccc
Q 047619 359 KSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428 (430)
Q Consensus 359 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar 428 (430)
++|..++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 144 (318)
T cd05570 81 GDLMFHIQRS---GRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCK 144 (318)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCe
Confidence 9999988543 35899999999999999999999988 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-24 Score=203.71 Aligned_cols=148 Identities=31% Similarity=0.476 Sum_probs=134.3
Q ss_pred cCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEc
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 355 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 355 (430)
.++|++.+.||+|+||.||++... ++..+|+|.+........+.+.+|+.++++++||||+++++.+..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 467999999999999999999864 5889999998766666677899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 356 VPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 356 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++..
T Consensus 84 ~~~~~L~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~ 152 (280)
T cd06611 84 CDGGALDSIMLELE--RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAK 152 (280)
T ss_pred cCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchh
Confidence 99999999985432 35899999999999999999999998 99999999999999999999999998753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.3e-24 Score=202.69 Aligned_cols=147 Identities=32% Similarity=0.543 Sum_probs=128.9
Q ss_pred CCcccceeecccCCcceEEEEE-----cCCcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeC--CEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTL-----VDGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEK 349 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 349 (430)
..|++.+.||+|+||.||++.. .++..||+|.+... .......+.+|+.++++++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3478889999999999999974 24778999998753 344567899999999999999999999998875 568
Q ss_pred EEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 350 LLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 350 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNK--NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 99999999999999985432 35899999999999999999999998 99999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-24 Score=200.69 Aligned_cols=143 Identities=32% Similarity=0.559 Sum_probs=127.4
Q ss_pred cccceeecccCCcceEEEEEcC-CcEEEEEEecccChHhH--HHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEcc
Q 047619 280 FSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGL--KELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFV 356 (430)
Q Consensus 280 ~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 356 (430)
|++.+.||+|+||.||++.... ++.+|+|++........ ....+|+.++++++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 6788999999999999999765 66899999986443332 23456999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCccc
Q 047619 357 PNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428 (430)
Q Consensus 357 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar 428 (430)
++++|.+++. ....+++..+..++.|++.||.+||+.+ |+|+||||+||++++++.++|+|||++.
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~ 146 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSV 146 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTE
T ss_pred cccccccccc---cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccc
Confidence 9999999996 2345899999999999999999999998 9999999999999999999999999986
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.8e-24 Score=202.93 Aligned_cols=146 Identities=32% Similarity=0.426 Sum_probs=131.2
Q ss_pred CCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc---ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 353 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 353 (430)
++|++.+.||+|+||.||++... +++.+|+|.+.+. .....+.+.+|++++++++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46889999999999999999865 4889999998642 2334567889999999999999999999999999999999
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+|+||+|+|||++.++.+||+|||+++.
T Consensus 81 e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~ 150 (290)
T cd05580 81 EYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKR 150 (290)
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccc
Confidence 999999999998554 45889999999999999999999988 99999999999999999999999999875
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.5e-24 Score=202.60 Aligned_cols=148 Identities=32% Similarity=0.510 Sum_probs=134.1
Q ss_pred cCCcccceeecccCCcceEEEEEcC-CcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEc
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 355 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 355 (430)
.+.|++.++||.|+||.||+|.... ++.+++|.+........+.+.+|+.+++.++||||+++++.+..+...++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 4679999999999999999998754 889999999876666778899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 356 VPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 356 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+++++|..++.... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 91 ~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 159 (292)
T cd06644 91 CPGGAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAK 159 (292)
T ss_pred CCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCcccee
Confidence 99999998875432 34889999999999999999999988 99999999999999999999999998763
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.8e-24 Score=203.60 Aligned_cols=149 Identities=29% Similarity=0.518 Sum_probs=129.4
Q ss_pred CCcccceeecccCCcceEEEEEc-----------------CCcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccce
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV-----------------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKL 339 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~-----------------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l 339 (430)
++|++.++||+|+||.||++... +...+|+|.+... .......+.+|+.+++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 57999999999999999998532 1346899998753 34456789999999999999999999
Q ss_pred EEEEEeCCEEEEEEEccCCCChhHHhhcCCC--------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcE
Q 047619 340 LGCCIQGEEKLLIYEFVPNKSLDSFIFDQER--------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNV 411 (430)
Q Consensus 340 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NI 411 (430)
++++...+..+++|||+++++|.+++..... ...+++..+..++.|++.||+|||+.+ |+|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 9999999999999999999999999865321 124677889999999999999999998 99999999999
Q ss_pred EEcCCCCeeecCCCcccc
Q 047619 412 LLDQDMNPKISDFGLARA 429 (430)
Q Consensus 412 Ll~~~~~~kl~DFGlar~ 429 (430)
|+++++.++|+|||+|+.
T Consensus 162 li~~~~~~~l~dfg~~~~ 179 (296)
T cd05095 162 LVGKNYTIKIADFGMSRN 179 (296)
T ss_pred EEcCCCCEEeccCccccc
Confidence 999999999999999874
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.8e-24 Score=198.94 Aligned_cols=147 Identities=32% Similarity=0.598 Sum_probs=132.5
Q ss_pred cCCcccceeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEcc
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFV 356 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 356 (430)
.++|++.+.||.|+||.||+|... ++.||+|.+..... ..+++.+|+.++++++|+||+++++++......++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 357888999999999999999864 78999999976433 5678999999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 357 PNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 357 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++++|.+++..... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||+|+.
T Consensus 83 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~ 151 (256)
T cd05039 83 AKGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKE 151 (256)
T ss_pred CCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccc
Confidence 99999999865432 35899999999999999999999988 99999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.6e-24 Score=199.60 Aligned_cols=149 Identities=26% Similarity=0.460 Sum_probs=131.4
Q ss_pred CCcccceeecccCCcceEEEEEc-CCcEEEEEEecc---cChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 353 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 353 (430)
++|++.+.||+|+||.||+|... +++.||||.+.. ........+.+|+.+++.++||||+++++++...+..+++|
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57899999999999999999864 589999998753 23444567889999999999999999999999999999999
Q ss_pred EccCCCChhHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 354 EFVPNKSLDSFIFDQE-RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~-~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||+++++|.+++.... ....+++..+..++.|++.||.|||+++ |+|+||||+|||++.++.++|+|||+++.
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~ 155 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRF 155 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECcccccee
Confidence 9999999999885422 2345788999999999999999999988 99999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.7e-24 Score=203.39 Aligned_cols=139 Identities=19% Similarity=0.331 Sum_probs=122.7
Q ss_pred eeecccCCcceEEEEEcCCcEEEEEEecccChH---hHHHHHHHHHHHhcCCCCcccceEEEEEe----CCEEEEEEEcc
Q 047619 284 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQ---GLKELKNEVILFSKLQHRNLVKLLGCCIQ----GEEKLLIYEFV 356 (430)
Q Consensus 284 ~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~ 356 (430)
..|++|+++.||+|.. +++.||||++...... ..+.+.+|+.+|.+++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5799999999999987 6899999999753222 25778899999999999999999999877 34678999999
Q ss_pred CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 357 PNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD-SRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 357 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++|+|.+++... ..+++.....++.+++.||.|||+. + ++||||||+|||+++++.+||+|||+|+.
T Consensus 105 ~~g~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~ 172 (283)
T PHA02988 105 TRGYLREVLDKE---KDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKI 172 (283)
T ss_pred CCCcHHHHHhhC---CCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhh
Confidence 999999999653 3588899999999999999999984 5 88999999999999999999999999874
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.8e-24 Score=200.42 Aligned_cols=148 Identities=32% Similarity=0.510 Sum_probs=130.8
Q ss_pred hcCCcccceeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEc
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 355 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 355 (430)
..++|++.++||+|+||.||+|...+++.+|+|.+.... .....+.+|+.++++++||||+++++++ ..+..+++|||
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~ 81 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEY 81 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEc
Confidence 346799999999999999999998888999999987532 3456788999999999999999999986 45678999999
Q ss_pred cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 356 VPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 356 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+++++|.+++.... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||+++.
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 151 (260)
T cd05067 82 MENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARL 151 (260)
T ss_pred CCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceee
Confidence 99999999986543 345889999999999999999999988 99999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.2e-24 Score=204.87 Aligned_cols=148 Identities=33% Similarity=0.614 Sum_probs=128.6
Q ss_pred CCcccceeecccCCcceEEEEEcC-Cc--EEEEEEeccc-ChHhHHHHHHHHHHHhcC-CCCcccceEEEEEeCCEEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLVD-GQ--EIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLI 352 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 352 (430)
++|++.+.||+|+||.||+|.... +. .+|+|.+... .......+.+|+.++.++ +||||+++++++...+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 578899999999999999998643 43 4678877642 344567888999999999 899999999999999999999
Q ss_pred EEccCCCChhHHhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCe
Q 047619 353 YEFVPNKSLDSFIFDQER-------------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNP 419 (430)
Q Consensus 353 ~e~~~~gsL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~ 419 (430)
|||+++++|.+++..... ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 999999999999864321 235789999999999999999999988 9999999999999999999
Q ss_pred eecCCCccc
Q 047619 420 KISDFGLAR 428 (430)
Q Consensus 420 kl~DFGlar 428 (430)
||+|||+++
T Consensus 164 kl~dfg~~~ 172 (303)
T cd05088 164 KIADFGLSR 172 (303)
T ss_pred EeCccccCc
Confidence 999999985
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.7e-24 Score=201.91 Aligned_cols=146 Identities=27% Similarity=0.369 Sum_probs=128.2
Q ss_pred cccceeecccCCcceEEEEEc-CCcEEEEEEecccC---hHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEc
Q 047619 280 FSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 355 (430)
Q Consensus 280 ~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 355 (430)
|+..+.||+|+||.||++... +++.+|+|.+.... ......+.+|+.++++++|+||+++++.+..++..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 667789999999999999864 58899999986422 22345678899999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 356 VPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 356 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+++++|..++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++.
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~ 151 (285)
T cd05632 82 MNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVK 151 (285)
T ss_pred ccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCccee
Confidence 99999998885432 235899999999999999999999988 99999999999999999999999999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.2e-24 Score=201.69 Aligned_cols=149 Identities=36% Similarity=0.623 Sum_probs=130.0
Q ss_pred CCcccceeecccCCcceEEEEEcC------CcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 350 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 350 (430)
++|++.+.||+|+||.||+|.... ...+|+|.+... .......+.+|+.++.+++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 468889999999999999998543 257999998643 3445667899999999999999999999999999999
Q ss_pred EEEEccCCCChhHHhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCC
Q 047619 351 LIYEFVPNKSLDSFIFDQER-------------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDM 417 (430)
Q Consensus 351 lv~e~~~~gsL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~ 417 (430)
++|||+++++|.+++..... ...+++..+..++.|++.||.|||+.+ |+|+||||+|||+++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999865321 135788899999999999999999988 99999999999999999
Q ss_pred CeeecCCCcccc
Q 047619 418 NPKISDFGLARA 429 (430)
Q Consensus 418 ~~kl~DFGlar~ 429 (430)
.+||+|||+|+.
T Consensus 162 ~~~L~dfg~~~~ 173 (283)
T cd05048 162 TVKISDFGLSRD 173 (283)
T ss_pred cEEECCCcceee
Confidence 999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.4e-24 Score=200.20 Aligned_cols=147 Identities=30% Similarity=0.550 Sum_probs=126.7
Q ss_pred cccceeecccCCcceEEEEEcC----CcEEEEEEeccc--ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCE-----
Q 047619 280 FSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE----- 348 (430)
Q Consensus 280 ~~~~~~ig~G~fg~Vy~~~~~~----~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 348 (430)
|++.+.||+|+||.||+|.... +..+|+|++... .......+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5677899999999999998642 367999998742 34456789999999999999999999999876654
Q ss_pred -EEEEEEccCCCChhHHhhcCC---CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCC
Q 047619 349 -KLLIYEFVPNKSLDSFIFDQE---RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDF 424 (430)
Q Consensus 349 -~~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DF 424 (430)
.+++|||+++++|..++.... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 789999999999999985432 2235889999999999999999999988 999999999999999999999999
Q ss_pred Ccccc
Q 047619 425 GLARA 429 (430)
Q Consensus 425 Glar~ 429 (430)
|+|+.
T Consensus 158 g~~~~ 162 (273)
T cd05035 158 GLSKK 162 (273)
T ss_pred cceee
Confidence 99874
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.9e-24 Score=202.71 Aligned_cols=147 Identities=28% Similarity=0.492 Sum_probs=121.0
Q ss_pred CCcccceeecccCCcceEEEEEc--CCcEEEEEEecccC--hHhHHHHHHHHHHHhcC---CCCcccceEEEEEe-----
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV--DGQEIAVKRLSKIS--EQGLKELKNEVILFSKL---QHRNLVKLLGCCIQ----- 345 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~----- 345 (430)
++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36889999999999999999863 36789999886422 22234556677776665 69999999999863
Q ss_pred CCEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCC
Q 047619 346 GEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 425 (430)
Q Consensus 346 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFG 425 (430)
....++||||++ ++|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 356899999996 689888864332 34889999999999999999999998 9999999999999999999999999
Q ss_pred cccc
Q 047619 426 LARA 429 (430)
Q Consensus 426 lar~ 429 (430)
+|+.
T Consensus 156 ~~~~ 159 (290)
T cd07862 156 LARI 159 (290)
T ss_pred ceEe
Confidence 9874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.92 E-value=5e-24 Score=199.76 Aligned_cols=147 Identities=31% Similarity=0.537 Sum_probs=130.2
Q ss_pred CCcccceeecccCCcceEEEEEcC-C---cEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLVD-G---QEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 352 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 352 (430)
..|++.+.||+|+||.||+|.... + ..||+|.+... ......++..|+.+++.++||||+++++++..+...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 457888999999999999998643 3 36999998753 455567899999999999999999999999999999999
Q ss_pred EEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 353 YEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 353 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.
T Consensus 84 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~ 155 (269)
T cd05065 84 TEFMENGALDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRF 155 (269)
T ss_pred EecCCCCcHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccc
Confidence 99999999999986432 35789999999999999999999988 99999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.8e-24 Score=200.55 Aligned_cols=145 Identities=39% Similarity=0.662 Sum_probs=125.8
Q ss_pred ccceeecccCCcceEEEEEc-----CCcEEEEEEecc-cChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEE
Q 047619 281 SINNKLGEGGFGPVYKGTLV-----DGQEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 354 (430)
Q Consensus 281 ~~~~~ig~G~fg~Vy~~~~~-----~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 354 (430)
.+.+.||.|.||.||+|.+. .+..|+||.++. ......+.+.+|++++++++||||+++++++...+..++|||
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 35689999999999999976 256899999964 344557899999999999999999999999998888999999
Q ss_pred ccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 355 FVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 355 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|+++++|.++|.... ...+++..+..|+.|++.||.|||+.+ |+|+||+|+|||+++++.+||+|||+++.
T Consensus 82 ~~~~g~L~~~L~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~ 152 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKN-KEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRP 152 (259)
T ss_dssp --TTEBHHHHHHHTC-TTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEE
T ss_pred ccccccccccccccc-ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccc
Confidence 999999999997652 245899999999999999999999988 99999999999999999999999999874
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.5e-24 Score=201.16 Aligned_cols=140 Identities=29% Similarity=0.403 Sum_probs=121.8
Q ss_pred ecccCCcceEEEEEc-CCcEEEEEEecccC---hHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEccCCCCh
Q 047619 286 LGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSL 361 (430)
Q Consensus 286 ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 361 (430)
||+|+||.||++... +++.+|+|++.... ......+..|++++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999864 48999999986421 12234556799999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 362 DSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 362 ~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
..++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||+|+.
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~ 144 (277)
T cd05607 81 KYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVE 144 (277)
T ss_pred HHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeee
Confidence 98885433 234888999999999999999999988 99999999999999999999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.9e-24 Score=202.93 Aligned_cols=148 Identities=31% Similarity=0.587 Sum_probs=128.5
Q ss_pred CCcccceeecccCCcceEEEEEcC-C--cEEEEEEecc-cChHhHHHHHHHHHHHhcC-CCCcccceEEEEEeCCEEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLVD-G--QEIAVKRLSK-ISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLI 352 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~~-~--~~vavK~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 352 (430)
++|++.+.||+|+||.||+|...+ + ..+++|.++. ......+.+.+|+.++.++ +||||+++++++......+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578999999999999999998654 3 3478888864 2344566789999999999 799999999999999999999
Q ss_pred EEccCCCChhHHhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCe
Q 047619 353 YEFVPNKSLDSFIFDQE-------------RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNP 419 (430)
Q Consensus 353 ~e~~~~gsL~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~ 419 (430)
|||+++++|.+++.... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999986432 1134788999999999999999999988 9999999999999999999
Q ss_pred eecCCCccc
Q 047619 420 KISDFGLAR 428 (430)
Q Consensus 420 kl~DFGlar 428 (430)
||+|||+++
T Consensus 159 kl~dfg~~~ 167 (297)
T cd05089 159 KIADFGLSR 167 (297)
T ss_pred EECCcCCCc
Confidence 999999985
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.4e-24 Score=204.07 Aligned_cols=149 Identities=25% Similarity=0.485 Sum_probs=133.7
Q ss_pred HhhcCCcccceeecccCCcceEEEEE-cCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEE
Q 047619 274 ANATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 352 (430)
Q Consensus 274 ~~~~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 352 (430)
.....+|++.+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++|
T Consensus 15 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 94 (297)
T cd06656 15 GDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 94 (297)
T ss_pred CChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence 34557899999999999999999986 46899999998764445567788999999999999999999999999999999
Q ss_pred EEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 353 YEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 353 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||+++.
T Consensus 95 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~ 164 (297)
T cd06656 95 MEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQ 164 (297)
T ss_pred ecccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceE
Confidence 999999999999843 24788999999999999999999988 99999999999999999999999998863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.8e-24 Score=203.12 Aligned_cols=152 Identities=34% Similarity=0.548 Sum_probs=132.1
Q ss_pred hhcCCcccceeecccCCcceEEEEEcC------CcEEEEEEeccc-ChHhHHHHHHHHHHHhcC-CCCcccceEEEEEeC
Q 047619 275 NATDNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG 346 (430)
Q Consensus 275 ~~~~~~~~~~~ig~G~fg~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 346 (430)
...++|++.+.||+|+||.||++.... ...+|+|.+... .......+.+|+.++.++ +|+||+++++++...
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 345679999999999999999998642 367999988752 334556788999999999 799999999999999
Q ss_pred CEEEEEEEccCCCChhHHhhcC-------------CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEE
Q 047619 347 EEKLLIYEFVPNKSLDSFIFDQ-------------ERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLL 413 (430)
Q Consensus 347 ~~~~lv~e~~~~gsL~~~l~~~-------------~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl 413 (430)
+..+++|||+++++|..++... .....+++..++.++.|++.||.|||+.+ |+||||||+|||+
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEE
Confidence 9999999999999999998542 12345889999999999999999999988 9999999999999
Q ss_pred cCCCCeeecCCCcccc
Q 047619 414 DQDMNPKISDFGLARA 429 (430)
Q Consensus 414 ~~~~~~kl~DFGlar~ 429 (430)
+.++.+||+|||+++.
T Consensus 166 ~~~~~~kL~Dfg~~~~ 181 (293)
T cd05053 166 TEDHVMKIADFGLARD 181 (293)
T ss_pred cCCCeEEeCccccccc
Confidence 9999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.2e-24 Score=200.57 Aligned_cols=146 Identities=32% Similarity=0.502 Sum_probs=131.3
Q ss_pred CcccceeecccCCcceEEEEEcC-CcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEccC
Q 047619 279 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVP 357 (430)
Q Consensus 279 ~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 357 (430)
.|++.+.||+|+||.||++.... +..+++|.+........+.+.+|+.+++.++||||+++++++...+..++||||++
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 36788999999999999999754 77889999876566667889999999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 358 NKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 358 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+++|..++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 86 ~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~ 152 (282)
T cd06643 86 GGAVDAVMLELE--RPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAK 152 (282)
T ss_pred CCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccc
Confidence 999998875422 35899999999999999999999988 99999999999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.7e-24 Score=206.94 Aligned_cols=138 Identities=24% Similarity=0.314 Sum_probs=118.7
Q ss_pred ecccCCcceEEEEEc-CCcEEEEEEeccc---ChHhHHHHHHHHHHHhcC---CCCcccceEEEEEeCCEEEEEEEccCC
Q 047619 286 LGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKL---QHRNLVKLLGCCIQGEEKLLIYEFVPN 358 (430)
Q Consensus 286 ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~ 358 (430)
||+|+||.||+|... +++.||+|++.+. .......+..|..++..+ .||||+++++.+.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999864 4889999998642 122334455666776655 699999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 359 KSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 359 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++|..++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.
T Consensus 81 g~L~~~l~~~---~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~ 145 (330)
T cd05586 81 GELFWHLQKE---GRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKA 145 (330)
T ss_pred ChHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcC
Confidence 9999988543 34889999999999999999999998 99999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.7e-24 Score=201.32 Aligned_cols=147 Identities=29% Similarity=0.383 Sum_probs=128.4
Q ss_pred CcccceeecccCCcceEEEEEc-CCcEEEEEEeccc---ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEE
Q 047619 279 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 354 (430)
Q Consensus 279 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 354 (430)
.|++.+.||+|+||.||++... +++.+|+|.+... .......+.+|+.++++++|++|+.+++.+.+.+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3677789999999999999864 5889999998642 12334567789999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 355 FVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 355 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|+++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||+++.
T Consensus 81 ~~~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~ 151 (285)
T cd05630 81 LMNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVH 151 (285)
T ss_pred ecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceee
Confidence 999999999885433 235889999999999999999999988 99999999999999999999999999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.8e-24 Score=201.82 Aligned_cols=149 Identities=31% Similarity=0.577 Sum_probs=131.5
Q ss_pred CCcccceeecccCCcceEEEEEc------CCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 351 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 351 (430)
.+|.+.+.||+|+||.||+|... +...+++|.+........+.+.+|+.++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 46888899999999999999742 345689999876566666789999999999999999999999999999999
Q ss_pred EEEccCCCChhHHhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCC
Q 047619 352 IYEFVPNKSLDSFIFDQE-------------RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMN 418 (430)
Q Consensus 352 v~e~~~~gsL~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~ 418 (430)
||||+++++|.+++.... ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999996432 1234789999999999999999999998 999999999999999999
Q ss_pred eeecCCCcccc
Q 047619 419 PKISDFGLARA 429 (430)
Q Consensus 419 ~kl~DFGlar~ 429 (430)
+||+|||+|+.
T Consensus 162 ~~l~dfg~a~~ 172 (291)
T cd05094 162 VKIGDFGMSRD 172 (291)
T ss_pred EEECCCCcccc
Confidence 99999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.2e-24 Score=199.79 Aligned_cols=146 Identities=30% Similarity=0.590 Sum_probs=123.4
Q ss_pred ccceeecccCCcceEEEEEcCC-c--EEEEEEeccc--ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeC------CEE
Q 047619 281 SINNKLGEGGFGPVYKGTLVDG-Q--EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG------EEK 349 (430)
Q Consensus 281 ~~~~~ig~G~fg~Vy~~~~~~~-~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~ 349 (430)
.+.+.||+|+||.||+|..... . .+|+|.++.. .....+.+.+|+.+++.++||||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 4668999999999999987543 2 6899988642 345567889999999999999999999987543 246
Q ss_pred EEEEEccCCCChhHHhhcC---CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCc
Q 047619 350 LLIYEFVPNKSLDSFIFDQ---ERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 426 (430)
Q Consensus 350 ~lv~e~~~~gsL~~~l~~~---~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGl 426 (430)
+++|||+++++|.+++... .....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence 8999999999999887432 12345789999999999999999999988 99999999999999999999999999
Q ss_pred ccc
Q 047619 427 ARA 429 (430)
Q Consensus 427 ar~ 429 (430)
|+.
T Consensus 159 ~~~ 161 (272)
T cd05075 159 SKK 161 (272)
T ss_pred ccc
Confidence 875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-24 Score=213.65 Aligned_cols=151 Identities=32% Similarity=0.507 Sum_probs=129.0
Q ss_pred hcCCcccceeecccCCcceEEEEEc------CCcEEEEEEeccc-ChHhHHHHHHHHHHHhcCC-CCcccceEEEEEeCC
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGE 347 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 347 (430)
..++|.+.++||+|+||.||+|++. .+..||+|++... .....+.+.+|+.++.++. ||||+++++++....
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 3456888899999999999999853 2468999999753 2333457889999999997 999999999999999
Q ss_pred EEEEEEEccCCCChhHHhhcCCC---------------------------------------------------------
Q 047619 348 EKLLIYEFVPNKSLDSFIFDQER--------------------------------------------------------- 370 (430)
Q Consensus 348 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 370 (430)
..++||||+++|+|.+++.....
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 99999999999999999864311
Q ss_pred --------------------------------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEE
Q 047619 371 --------------------------------------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVL 412 (430)
Q Consensus 371 --------------------------------------~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NIL 412 (430)
...+++..+..++.|++.||+|||+.+ |+||||||+|||
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiL 271 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVL 271 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEE
Confidence 123567778899999999999999987 999999999999
Q ss_pred EcCCCCeeecCCCcccc
Q 047619 413 LDQDMNPKISDFGLARA 429 (430)
Q Consensus 413 l~~~~~~kl~DFGlar~ 429 (430)
+++++.+||+|||+++.
T Consensus 272 l~~~~~~kL~DfGla~~ 288 (401)
T cd05107 272 ICEGKLVKICDFGLARD 288 (401)
T ss_pred EeCCCEEEEEecCccee
Confidence 99999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.9e-24 Score=204.27 Aligned_cols=152 Identities=32% Similarity=0.542 Sum_probs=131.1
Q ss_pred hhcCCcccceeecccCCcceEEEEEc--------CCcEEEEEEeccc-ChHhHHHHHHHHHHHhcC-CCCcccceEEEEE
Q 047619 275 NATDNFSINNKLGEGGFGPVYKGTLV--------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCI 344 (430)
Q Consensus 275 ~~~~~~~~~~~ig~G~fg~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 344 (430)
...++|.+.+.||+|+||.||+|... ++..+|+|.+... .......+.+|+.++..+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 34567889999999999999999742 2347999988643 344567889999999999 8999999999999
Q ss_pred eCCEEEEEEEccCCCChhHHhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcE
Q 047619 345 QGEEKLLIYEFVPNKSLDSFIFDQER-------------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNV 411 (430)
Q Consensus 345 ~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NI 411 (430)
.....+++|||+++++|.+++..... ...+++..+..++.||+.||.|||+.+ |+||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceE
Confidence 99999999999999999999965321 134788889999999999999999988 99999999999
Q ss_pred EEcCCCCeeecCCCcccc
Q 047619 412 LLDQDMNPKISDFGLARA 429 (430)
Q Consensus 412 Ll~~~~~~kl~DFGlar~ 429 (430)
|+++++.+||+|||+|+.
T Consensus 169 li~~~~~~kl~D~g~~~~ 186 (304)
T cd05101 169 LVTENNVMKIADFGLARD 186 (304)
T ss_pred EEcCCCcEEECCCcccee
Confidence 999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.5e-24 Score=201.81 Aligned_cols=148 Identities=36% Similarity=0.561 Sum_probs=128.1
Q ss_pred CcccceeecccCCcceEEEEEcC------CcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEE
Q 047619 279 NFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 351 (430)
Q Consensus 279 ~~~~~~~ig~G~fg~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 351 (430)
+|++.+.||+|+||.||+|.... ...+++|.+... .......+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 47788999999999999998532 356888888653 33456788999999999999999999999999999999
Q ss_pred EEEccCCCChhHHhhcCC---------------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCc
Q 047619 352 IYEFVPNKSLDSFIFDQE---------------------RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASN 410 (430)
Q Consensus 352 v~e~~~~gsL~~~l~~~~---------------------~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~N 410 (430)
+|||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ |+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999985421 1235788999999999999999999988 9999999999
Q ss_pred EEEcCCCCeeecCCCcccc
Q 047619 411 VLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 411 ILl~~~~~~kl~DFGlar~ 429 (430)
||+++++.+||+|||+|+.
T Consensus 158 ill~~~~~~kl~dfg~~~~ 176 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRD 176 (290)
T ss_pred EEEcCCCcEEecccccccc
Confidence 9999999999999999874
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.5e-24 Score=204.98 Aligned_cols=150 Identities=33% Similarity=0.548 Sum_probs=130.6
Q ss_pred cCCcccceeecccCCcceEEEEEcC--------CcEEEEEEeccc-ChHhHHHHHHHHHHHhcC-CCCcccceEEEEEeC
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLVD--------GQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG 346 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~~--------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 346 (430)
.++|.+.+.||+|+||.||++.... ...+|+|.+... .......+.+|+.++.++ +||||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 4679999999999999999997522 346999998753 344566788999999999 799999999999999
Q ss_pred CEEEEEEEccCCCChhHHhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEE
Q 047619 347 EEKLLIYEFVPNKSLDSFIFDQER-------------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLL 413 (430)
Q Consensus 347 ~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl 413 (430)
+..++||||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ ++||||||+|||+
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 999999999999999999965321 134788999999999999999999988 9999999999999
Q ss_pred cCCCCeeecCCCcccc
Q 047619 414 DQDMNPKISDFGLARA 429 (430)
Q Consensus 414 ~~~~~~kl~DFGlar~ 429 (430)
++++.+||+|||+|+.
T Consensus 174 ~~~~~~kL~dfg~a~~ 189 (307)
T cd05098 174 TEDNVMKIADFGLARD 189 (307)
T ss_pred cCCCcEEECCCccccc
Confidence 9999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.7e-24 Score=199.72 Aligned_cols=142 Identities=25% Similarity=0.364 Sum_probs=126.6
Q ss_pred CCcccceeecccCCcceEEEEE-cCCcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEc
Q 047619 278 DNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 355 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 355 (430)
++|++.+.||+|+||.||+|.. .+++.+|+|.+... .......+.+|+.++.+++||||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3678889999999999999985 45889999998643 344556789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 356 VPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 356 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+++++|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||+|+.
T Consensus 81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~ 144 (279)
T cd06619 81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQ 144 (279)
T ss_pred CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCccee
Confidence 9999997542 3678888899999999999999988 99999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.9e-24 Score=199.44 Aligned_cols=147 Identities=31% Similarity=0.520 Sum_probs=129.4
Q ss_pred cCCcccceeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEcc
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFV 356 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 356 (430)
.++|++.++||+|+||.||+|...++..+|+|.+.... ...+.+.+|+.++++++|+||+++++++. ....+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCC-CCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 35789999999999999999998888889999987532 23467899999999999999999999875 45689999999
Q ss_pred CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 357 PNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 357 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++++|.+++.... ...+++..+..++.+++.||.|||+.+ |+||||||+||++++++.++|+|||+++.
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~ 151 (260)
T cd05070 83 SKGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARL 151 (260)
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeee
Confidence 9999999986533 234789999999999999999999988 99999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.6e-24 Score=197.00 Aligned_cols=148 Identities=24% Similarity=0.488 Sum_probs=133.7
Q ss_pred cCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEc
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 355 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 355 (430)
.++|++.+.||+|+||.||+|... +++.+++|.+........+.+.+|+.++++++||||+++++++......+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 367999999999999999999864 4788999998765555678899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 356 VPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 356 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||+++.
T Consensus 82 ~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~ 150 (262)
T cd06613 82 CGGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQ 150 (262)
T ss_pred CCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchh
Confidence 99999999885432 35889999999999999999999988 99999999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.3e-24 Score=208.43 Aligned_cols=150 Identities=31% Similarity=0.507 Sum_probs=126.9
Q ss_pred cCCcccceeecccCCcceEEEEE------cCCcEEEEEEeccc-ChHhHHHHHHHHHHHhcC-CCCcccceEEEEEeC-C
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTL------VDGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG-E 347 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~ 347 (430)
.++|++.+.||+|+||.||+|.. .+++.||||++... .......+.+|+.++.++ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 35799999999999999999973 24678999999752 234456788999999999 689999999988654 4
Q ss_pred EEEEEEEccCCCChhHHhhcCCC---------------------------------------------------------
Q 047619 348 EKLLIYEFVPNKSLDSFIFDQER--------------------------------------------------------- 370 (430)
Q Consensus 348 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 370 (430)
..+++|||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 57899999999999999864210
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 371 -------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 371 -------~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+|+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~ 228 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARD 228 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccc
Confidence 123677888899999999999999988 99999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.91 E-value=7e-24 Score=199.93 Aligned_cols=151 Identities=30% Similarity=0.552 Sum_probs=132.1
Q ss_pred hcCCcccceeecccCCcceEEEEEcC-----CcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEe-CCE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLVD-----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ-GEE 348 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~ 348 (430)
..++|++.+.||+|+||.||+|.... +..|++|++... .....+.+.+|+.++++++||||+++++++.. +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 45689999999999999999999765 678999988653 34556778999999999999999999998776 467
Q ss_pred EEEEEEccCCCChhHHhhcCCCC-----CCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecC
Q 047619 349 KLLIYEFVPNKSLDSFIFDQERC-----KILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD 423 (430)
Q Consensus 349 ~~lv~e~~~~gsL~~~l~~~~~~-----~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~D 423 (430)
.++++||+++++|.+++...... ..+++..+..++.|++.||+|||+.+ |+|+||||+|||+++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999998654322 45889999999999999999999988 99999999999999999999999
Q ss_pred CCcccc
Q 047619 424 FGLARA 429 (430)
Q Consensus 424 FGlar~ 429 (430)
||+|+.
T Consensus 161 ~g~~~~ 166 (280)
T cd05043 161 NALSRD 166 (280)
T ss_pred CCCccc
Confidence 999974
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.7e-24 Score=213.63 Aligned_cols=142 Identities=25% Similarity=0.332 Sum_probs=125.2
Q ss_pred hcCCcccceeecccCCcceEEEEEcC-CcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 354 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 354 (430)
....|.+.+.||+|+||.||++.... ++.||||.... ..+.+|++++++++|+|||++++++...+..++|||
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 34579999999999999999999754 78899996432 345689999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 355 FVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 355 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++. ++|..++.... ..+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+|+.
T Consensus 241 ~~~-~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~ 309 (461)
T PHA03211 241 KYR-SDLYTYLGARL--RPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACF 309 (461)
T ss_pred ccC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCcee
Confidence 995 68888875432 35899999999999999999999988 99999999999999999999999999874
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.5e-24 Score=207.66 Aligned_cols=150 Identities=31% Similarity=0.504 Sum_probs=127.4
Q ss_pred cCCcccceeecccCCcceEEEEEc------CCcEEEEEEeccc-ChHhHHHHHHHHHHHhcC-CCCcccceEEEEEeC-C
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG-E 347 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~ 347 (430)
.++|++.+.||+|+||.||+|... .++.||+|++... .....+.+.+|+.++.++ +|+||+++++++... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 457999999999999999999642 2478999998643 233456778899999999 899999999988754 5
Q ss_pred EEEEEEEccCCCChhHHhhcCCC---------------------------------------------------------
Q 047619 348 EKLLIYEFVPNKSLDSFIFDQER--------------------------------------------------------- 370 (430)
Q Consensus 348 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 370 (430)
..+++|||+++++|.+++.....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 67899999999999999854221
Q ss_pred -CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 371 -CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 371 -~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+|+.
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~ 222 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARD 222 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchh
Confidence 125788999999999999999999988 99999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.7e-24 Score=197.23 Aligned_cols=149 Identities=26% Similarity=0.474 Sum_probs=132.6
Q ss_pred CCcccceeecccCCcceEEEEEc-CCcEEEEEEecc---cChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 353 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 353 (430)
++|++.+.||+|+||.||+|... +++.+|+|.++. ......+.+.+|++++++++|+||+++++.+...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57999999999999999999975 689999998863 23344678899999999999999999999999999999999
Q ss_pred EccCCCChhHHhhcC-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 354 EFVPNKSLDSFIFDQ-ERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 354 e~~~~gsL~~~l~~~-~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||+++++|..++... .....+++..+..++.+++.||.|||+.+ |+|+||||+||+++.++.++|+|||+++.
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~ 155 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRF 155 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeee
Confidence 999999999998643 22345889999999999999999999988 99999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.8e-24 Score=197.94 Aligned_cols=146 Identities=32% Similarity=0.506 Sum_probs=129.8
Q ss_pred CCcccceeecccCCcceEEEEEc-CCcEEEEEEecccC-----hHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-----EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 351 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 351 (430)
++|.+.+.||+|++|.||++... +++.+|+|.+.... ....+.+.+|+.++++++||||+++++++...+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 56889999999999999999864 58899999886421 2234578899999999999999999999999999999
Q ss_pred EEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 352 IYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 352 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.++|+|||+++.
T Consensus 82 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~ 153 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY---GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 153 (263)
T ss_pred EEEECCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccccee
Confidence 99999999999998543 34788999999999999999999988 99999999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.4e-24 Score=200.37 Aligned_cols=149 Identities=31% Similarity=0.563 Sum_probs=131.8
Q ss_pred CCcccceeecccCCcceEEEEEc------CCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 351 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 351 (430)
.+|.+.++||+|+||.||++... ++..+|+|.+..........+.+|++++..++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 46778899999999999999642 356899999887666777889999999999999999999999999999999
Q ss_pred EEEccCCCChhHHhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCe
Q 047619 352 IYEFVPNKSLDSFIFDQER------------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNP 419 (430)
Q Consensus 352 v~e~~~~gsL~~~l~~~~~------------~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~ 419 (430)
+|||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999865321 134788999999999999999999988 9999999999999999999
Q ss_pred eecCCCcccc
Q 047619 420 KISDFGLARA 429 (430)
Q Consensus 420 kl~DFGlar~ 429 (430)
||+|||+++.
T Consensus 162 kL~dfg~~~~ 171 (280)
T cd05092 162 KIGDFGMSRD 171 (280)
T ss_pred EECCCCceeE
Confidence 9999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.2e-24 Score=201.44 Aligned_cols=150 Identities=31% Similarity=0.491 Sum_probs=131.3
Q ss_pred cCCcccceeecccCCcceEEEEEcC-----------------CcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccc
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLVD-----------------GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVK 338 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~~-----------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~ 338 (430)
.++|++.+.||+|+||.||+|...+ +..||+|.+... .....+.+.+|+.++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3578999999999999999987543 245899998753 3455678899999999999999999
Q ss_pred eEEEEEeCCEEEEEEEccCCCChhHHhhcCC--------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCc
Q 047619 339 LLGCCIQGEEKLLIYEFVPNKSLDSFIFDQE--------RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASN 410 (430)
Q Consensus 339 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~N 410 (430)
+++++..++..+++|||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ |+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999986543 1125899999999999999999999988 9999999999
Q ss_pred EEEcCCCCeeecCCCcccc
Q 047619 411 VLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 411 ILl~~~~~~kl~DFGlar~ 429 (430)
|+++.++.++|+|||+++.
T Consensus 161 ili~~~~~~~l~dfg~~~~ 179 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRN 179 (296)
T ss_pred eeecCCCceEEccccceee
Confidence 9999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.9e-24 Score=199.54 Aligned_cols=147 Identities=31% Similarity=0.546 Sum_probs=127.2
Q ss_pred cCCcccceeecccCCcceEEEEEc-CCc----EEEEEEecc-cChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEE
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLV-DGQ----EIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 350 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~----~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 350 (430)
.++|++.+.||+|+||.||+|... +++ .||+|.+.. ........+.+|+.++..++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 357889999999999999999853 344 489998864 344456788999999999999999999999875 4578
Q ss_pred EEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 351 LIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 351 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++|||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+|+.
T Consensus 85 l~~~~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENK--DRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEEcCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceee
Confidence 9999999999999986432 35889999999999999999999988 99999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.8e-24 Score=200.02 Aligned_cols=150 Identities=27% Similarity=0.507 Sum_probs=130.8
Q ss_pred cCCcccceeecccCCcceEEEEEcC------CcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEE
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 349 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 349 (430)
.++|++.+.||+|+||.||+|.... +..+|+|.+... .......+.+|+.++..++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 4678999999999999999998642 368999998643 334456788999999999999999999999999999
Q ss_pred EEEEEccCCCChhHHhhcCCC-------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeec
Q 047619 350 LLIYEFVPNKSLDSFIFDQER-------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 422 (430)
Q Consensus 350 ~lv~e~~~~gsL~~~l~~~~~-------~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~ 422 (430)
++||||+++++|.+++..... ...+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 999999999999999864321 224688899999999999999999988 9999999999999999999999
Q ss_pred CCCcccc
Q 047619 423 DFGLARA 429 (430)
Q Consensus 423 DFGlar~ 429 (430)
|||+|+.
T Consensus 162 dfg~~~~ 168 (277)
T cd05032 162 DFGMTRD 168 (277)
T ss_pred Ccccchh
Confidence 9999864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.9e-24 Score=214.40 Aligned_cols=146 Identities=24% Similarity=0.442 Sum_probs=120.4
Q ss_pred hcCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeC--------
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-------- 346 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------- 346 (430)
...+|++.+.||+|+||.||+|... .++.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 3467999999999999999999864 47899999886422 2345799999999999999999887532
Q ss_pred CEEEEEEEccCCCChhHHhhcC-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCC-CeeecCC
Q 047619 347 EEKLLIYEFVPNKSLDSFIFDQ-ERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDF 424 (430)
Q Consensus 347 ~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DF 424 (430)
..+++||||+++ +|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+||||+.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 246799999975 676666432 22346899999999999999999999998 99999999999998665 6999999
Q ss_pred Ccccc
Q 047619 425 GLARA 429 (430)
Q Consensus 425 Glar~ 429 (430)
|+|+.
T Consensus 216 Gla~~ 220 (440)
T PTZ00036 216 GSAKN 220 (440)
T ss_pred ccchh
Confidence 99974
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.3e-24 Score=202.17 Aligned_cols=149 Identities=24% Similarity=0.486 Sum_probs=133.3
Q ss_pred HhhcCCcccceeecccCCcceEEEEE-cCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEE
Q 047619 274 ANATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 352 (430)
Q Consensus 274 ~~~~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 352 (430)
.....+|++.+.||+|+||.||+|.. .+++.+|+|.+........+.+.+|+.+++.+.||||+++++.+..+...++|
T Consensus 16 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv 95 (296)
T cd06654 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (296)
T ss_pred CCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence 34556899999999999999999985 45889999998765445567788999999999999999999999999999999
Q ss_pred EEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 353 YEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 353 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|||+++++|.+++.. ..+++.++..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 96 ~e~~~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~ 165 (296)
T cd06654 96 MEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQ 165 (296)
T ss_pred ecccCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchh
Confidence 999999999999843 24788999999999999999999988 99999999999999999999999998763
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-23 Score=195.85 Aligned_cols=147 Identities=27% Similarity=0.432 Sum_probs=131.7
Q ss_pred CcccceeecccCCcceEEEEEc-CCcEEEEEEecc--cChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEc
Q 047619 279 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 355 (430)
Q Consensus 279 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 355 (430)
+|++.+.||+|++|.||+|... +++.+++|.+.. ........+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4778899999999999999864 588999998863 2445677889999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 356 VPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 356 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+++++|.+++.... ...+++..+..++.+++.||.|||+.+ |+|+||||+||+++.++.+||+|||+++.
T Consensus 81 ~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~ 150 (256)
T cd08529 81 AENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKL 150 (256)
T ss_pred CCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEccccccee
Confidence 99999999986542 345889999999999999999999988 99999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-24 Score=225.40 Aligned_cols=150 Identities=37% Similarity=0.654 Sum_probs=134.0
Q ss_pred cCCcccceeecccCCcceEEEEEcC--Cc----EEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEE
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLVD--GQ----EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 349 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~~--~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 349 (430)
....++.+.||+|.||.||.|...+ +. .||||.+.+. +.+...+|.+|..+|++++|||||+++|++.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 3556777899999999999999654 33 5999999874 567788999999999999999999999999999999
Q ss_pred EEEEEccCCCChhHHhhcCC----CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCC
Q 047619 350 LLIYEFVPNKSLDSFIFDQE----RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 425 (430)
Q Consensus 350 ~lv~e~~~~gsL~~~l~~~~----~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFG 425 (430)
+|++|||++|+|..+|++.. +...+.....+.++.+||+|++||++++ .|||||..+|+||+....|||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence 99999999999999997641 1345888999999999999999999998 9999999999999999999999999
Q ss_pred cccc
Q 047619 426 LARA 429 (430)
Q Consensus 426 lar~ 429 (430)
|||-
T Consensus 848 lArD 851 (1025)
T KOG1095|consen 848 LARD 851 (1025)
T ss_pred hhHh
Confidence 9993
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.3e-24 Score=197.78 Aligned_cols=151 Identities=29% Similarity=0.399 Sum_probs=130.5
Q ss_pred hcCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 354 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 354 (430)
.++.+.....||+|+||.||+|... ++..||+|.+........+.+.+|+.+++.++|+||+++++++..++..++|+|
T Consensus 6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 85 (268)
T cd06624 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFME 85 (268)
T ss_pred ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEe
Confidence 4455656679999999999999864 477899999877666677789999999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcC-CCCeeecCCCcccc
Q 047619 355 FVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLARA 429 (430)
Q Consensus 355 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DFGlar~ 429 (430)
|+++++|.+++.........++..+..++.|++.||.|||+.+ |+||||||+||+++. ++.+||+|||+++.
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 86 QVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred cCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 9999999999965422111278888899999999999999988 999999999999976 67899999998864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.3e-24 Score=202.12 Aligned_cols=146 Identities=30% Similarity=0.486 Sum_probs=127.9
Q ss_pred CCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEc
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 355 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 355 (430)
++|.+.++||+|+||.||+|... +++.||+|.+... .......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 57999999999999999999864 4789999998642 223345677899999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 356 VPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 356 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++ ++|.+++... ...+++..+..++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||+++.
T Consensus 86 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 153 (301)
T cd07873 86 LD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARA 153 (301)
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhc
Confidence 97 5888888543 235788999999999999999999988 99999999999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=195.16 Aligned_cols=141 Identities=34% Similarity=0.549 Sum_probs=126.1
Q ss_pred eeecccCCcceEEEEEcCCcEEEEEEecccC-hHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEccCCCChh
Q 047619 284 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLD 362 (430)
Q Consensus 284 ~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 362 (430)
+.||+|+||.||+|...+++.+|+|.+.... ......+.+|+.++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 3699999999999998888999999987543 334457889999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 363 SFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 363 ~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+++.... ..+++..+..++.+++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~ 142 (250)
T cd05085 81 SFLRKKK--DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQ 142 (250)
T ss_pred HHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCcccee
Confidence 9985432 34789999999999999999999988 99999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.1e-24 Score=201.17 Aligned_cols=149 Identities=33% Similarity=0.533 Sum_probs=128.8
Q ss_pred CCcccceeecccCCcceEEEEEcC------CcEEEEEEecccC-hHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 350 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 350 (430)
.+|.+.+.||+|+||.||+|...+ ++.||+|++.... ....+.+.+|+.++..++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 357788999999999999998532 4789999997533 334567889999999999999999999999999999
Q ss_pred EEEEccCCCChhHHhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCC
Q 047619 351 LIYEFVPNKSLDSFIFDQE-------------RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDM 417 (430)
Q Consensus 351 lv~e~~~~gsL~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~ 417 (430)
+++||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ |+||||||+|||+++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence 9999999999999985321 1234788889999999999999999988 99999999999999999
Q ss_pred CeeecCCCcccc
Q 047619 418 NPKISDFGLARA 429 (430)
Q Consensus 418 ~~kl~DFGlar~ 429 (430)
.+||+|||+++.
T Consensus 162 ~~kl~Dfg~~~~ 173 (283)
T cd05091 162 NVKISDLGLFRE 173 (283)
T ss_pred ceEecccccccc
Confidence 999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.4e-24 Score=199.60 Aligned_cols=148 Identities=28% Similarity=0.448 Sum_probs=130.4
Q ss_pred CCcccceeecccCCcceEEEEEc------CCcEEEEEEecccChH-hHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 350 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 350 (430)
++|++.+.||+|+||.||+|+.. +.+.+++|.+...... ..+.+.+|++++++++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57888999999999999999853 2467999988653333 5678999999999999999999999999989999
Q ss_pred EEEEccCCCChhHHhhcCCCC------CCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCC
Q 047619 351 LIYEFVPNKSLDSFIFDQERC------KILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDF 424 (430)
Q Consensus 351 lv~e~~~~gsL~~~l~~~~~~------~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DF 424 (430)
+||||+++++|.+++...... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999654321 15899999999999999999999988 999999999999999999999999
Q ss_pred Cccc
Q 047619 425 GLAR 428 (430)
Q Consensus 425 Glar 428 (430)
|+++
T Consensus 162 ~~~~ 165 (275)
T cd05046 162 SLSK 165 (275)
T ss_pred cccc
Confidence 9986
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-23 Score=194.48 Aligned_cols=147 Identities=25% Similarity=0.409 Sum_probs=130.8
Q ss_pred CcccceeecccCCcceEEEEEc-CCcEEEEEEecc-cChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEcc
Q 047619 279 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFV 356 (430)
Q Consensus 279 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 356 (430)
+|++.+.||+|+||.||++... +++.+|+|.+.. ......+.+.+|+.+++.++||||+++++.+.+.+..+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4788899999999999999864 588999998853 23445677889999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 357 PNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 357 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.++|+|||+++.
T Consensus 81 ~~~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~ 149 (255)
T cd08219 81 DGGDLMQKIKLQR-GKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARL 149 (255)
T ss_pred CCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCccee
Confidence 9999999885432 345789999999999999999999988 99999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.7e-24 Score=205.16 Aligned_cols=140 Identities=22% Similarity=0.247 Sum_probs=113.9
Q ss_pred HhhcCCcccceeecccCCcceEEEEEc--CCcEEEEEEeccc-----ChHhHHHHHHHHHHHhcCCCCcccc-eEEEEEe
Q 047619 274 ANATDNFSINNKLGEGGFGPVYKGTLV--DGQEIAVKRLSKI-----SEQGLKELKNEVILFSKLQHRNLVK-LLGCCIQ 345 (430)
Q Consensus 274 ~~~~~~~~~~~~ig~G~fg~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~ 345 (430)
....++|.+.+.||+|+||+||+|... +++.+|||++... .....+.+.+|+++|++++|+|++. +++
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---- 89 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---- 89 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----
Confidence 445678999999999999999999864 4677899987532 2234567999999999999999985 443
Q ss_pred CCEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCC-CCCcEEEcCCCCeeecCC
Q 047619 346 GEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDL-KASNVLLDQDMNPKISDF 424 (430)
Q Consensus 346 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dl-kp~NILl~~~~~~kl~DF 424 (430)
.+..+|||||++|++|.... . .. ...++.++++||.|||+.+ |+|||| ||+|||++.++.+||+||
T Consensus 90 ~~~~~LVmE~~~G~~L~~~~---~----~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDF 156 (365)
T PRK09188 90 TGKDGLVRGWTEGVPLHLAR---P----HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDF 156 (365)
T ss_pred cCCcEEEEEccCCCCHHHhC---c----cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEEC
Confidence 24679999999999996321 1 11 1357889999999999988 999999 999999999999999999
Q ss_pred CccccC
Q 047619 425 GLARAF 430 (430)
Q Consensus 425 Glar~~ 430 (430)
|+|+.+
T Consensus 157 GlA~~~ 162 (365)
T PRK09188 157 QLASVF 162 (365)
T ss_pred ccceec
Confidence 999853
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.3e-24 Score=196.95 Aligned_cols=146 Identities=32% Similarity=0.509 Sum_probs=127.9
Q ss_pred CCcccceeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEccC
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVP 357 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 357 (430)
++|.+.+.||+|++|.||+|....+..+|+|.+... ....+.+.+|+.++++++|||++++++++. .+..+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPG-TMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccC-CccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 568899999999999999999877778999988642 234467889999999999999999998875 556899999999
Q ss_pred CCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 358 NKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 358 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+++|.+++.... ...+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.++|+|||+|+.
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~ 151 (260)
T cd05069 84 KGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARL 151 (260)
T ss_pred CCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceE
Confidence 999999996533 245789999999999999999999988 99999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=6e-24 Score=207.91 Aligned_cols=145 Identities=30% Similarity=0.452 Sum_probs=124.3
Q ss_pred hcCCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc--ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCC-----
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE----- 347 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 347 (430)
..++|++.+.||+|+||.||++... .+..||+|++... .......+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 4578999999999999999999864 4889999998642 3344567889999999999999999999987543
Q ss_pred -EEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCc
Q 047619 348 -EKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 426 (430)
Q Consensus 348 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGl 426 (430)
..++||||+++ +|...+. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 47999999975 5655552 23788889999999999999999998 99999999999999999999999999
Q ss_pred ccc
Q 047619 427 ARA 429 (430)
Q Consensus 427 ar~ 429 (430)
|+.
T Consensus 170 a~~ 172 (359)
T cd07876 170 ART 172 (359)
T ss_pred ccc
Confidence 874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=5e-24 Score=207.16 Aligned_cols=147 Identities=29% Similarity=0.452 Sum_probs=126.3
Q ss_pred hhcCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccC--hHhHHHHHHHHHHHhcCCCCcccceEEEEEeC-----
Q 047619 275 NATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG----- 346 (430)
Q Consensus 275 ~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 346 (430)
...++|++.+.||+|+||.||+|... +++.||||++.... ......+.+|+.++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 34578999999999999999999864 57899999987532 23445677899999999999999999987643
Q ss_pred -CEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCC
Q 047619 347 -EEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 425 (430)
Q Consensus 347 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFG 425 (430)
...++++|++ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC----QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCc
Confidence 3468999988 7899888742 34899999999999999999999998 9999999999999999999999999
Q ss_pred cccc
Q 047619 426 LARA 429 (430)
Q Consensus 426 lar~ 429 (430)
+|+.
T Consensus 164 ~~~~ 167 (343)
T cd07878 164 LARQ 167 (343)
T ss_pred ccee
Confidence 9874
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.9e-24 Score=197.79 Aligned_cols=143 Identities=31% Similarity=0.502 Sum_probs=122.7
Q ss_pred eeecccCCcceEEEEEcC---CcEEEEEEecccC-hHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEccCCC
Q 047619 284 NKLGEGGFGPVYKGTLVD---GQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNK 359 (430)
Q Consensus 284 ~~ig~G~fg~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 359 (430)
+.||+|+||.||+|...+ +..+|+|.+.... ......+.+|+.++++++||||+++++++.+....++||||++++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999998543 4579999886532 344567889999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCC--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 360 SLDSFIFDQER--CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 360 sL~~~l~~~~~--~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+|.+++..... ....++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+|+.
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~ 149 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHN 149 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCcccccc
Confidence 99999864322 234567778889999999999999988 99999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=7e-24 Score=197.26 Aligned_cols=139 Identities=26% Similarity=0.465 Sum_probs=120.5
Q ss_pred eeecccCCcceEEEEEcCCc-----------EEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEE
Q 047619 284 NKLGEGGFGPVYKGTLVDGQ-----------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 352 (430)
Q Consensus 284 ~~ig~G~fg~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 352 (430)
+.||+|+||.||+|...+.. .+++|.+...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999975432 5778876543322 6788899999999999999999999988 778999
Q ss_pred EEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCC-------CeeecCCC
Q 047619 353 YEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDM-------NPKISDFG 425 (430)
Q Consensus 353 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~-------~~kl~DFG 425 (430)
|||+++++|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 99999999999996543 25889999999999999999999988 99999999999999887 79999999
Q ss_pred cccc
Q 047619 426 LARA 429 (430)
Q Consensus 426 lar~ 429 (430)
+|+.
T Consensus 154 ~a~~ 157 (259)
T cd05037 154 IPIT 157 (259)
T ss_pred cccc
Confidence 9874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-23 Score=196.75 Aligned_cols=148 Identities=32% Similarity=0.495 Sum_probs=131.2
Q ss_pred hcCCcccceeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEc
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 355 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 355 (430)
..++|++.++||+|+||.||++...++..+|+|.+... ....+.+.+|+.++++++|+||+++++.+.. ...+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 34689999999999999999999777788999988653 3345678899999999999999999999887 778999999
Q ss_pred cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 356 VPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 356 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~ 151 (260)
T cd05073 82 MAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARV 151 (260)
T ss_pred CCCCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceee
Confidence 99999999996543 345788899999999999999999988 99999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.2e-24 Score=199.84 Aligned_cols=145 Identities=38% Similarity=0.575 Sum_probs=125.8
Q ss_pred CCc-ccceeecccCCcceEEEEE-----cCCcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeC--CE
Q 047619 278 DNF-SINNKLGEGGFGPVYKGTL-----VDGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EE 348 (430)
Q Consensus 278 ~~~-~~~~~ig~G~fg~Vy~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~ 348 (430)
++| ++.+.||+|+||.||++.. .++..+|+|.+... .......+.+|+.++++++||||+++++++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 344 8889999999999988652 34778999998753 234567788999999999999999999988764 45
Q ss_pred EEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCccc
Q 047619 349 KLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428 (430)
Q Consensus 349 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar 428 (430)
.+++|||+++++|.+++... .+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++
T Consensus 83 ~~lv~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~ 155 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAK 155 (283)
T ss_pred EEEEecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeeccccc
Confidence 78999999999999998542 3899999999999999999999998 9999999999999999999999999987
Q ss_pred c
Q 047619 429 A 429 (430)
Q Consensus 429 ~ 429 (430)
.
T Consensus 156 ~ 156 (283)
T cd05080 156 A 156 (283)
T ss_pred c
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.3e-24 Score=199.88 Aligned_cols=139 Identities=24% Similarity=0.366 Sum_probs=119.2
Q ss_pred eecccCCcceEEEEEcC-------------------------CcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccce
Q 047619 285 KLGEGGFGPVYKGTLVD-------------------------GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 339 (430)
Q Consensus 285 ~ig~G~fg~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 339 (430)
.||+|+||.||+|.... ...||+|.+..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997421 13588998875444455678889999999999999999
Q ss_pred EEEEEeCCEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCC--
Q 047619 340 LGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDM-- 417 (430)
Q Consensus 340 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~-- 417 (430)
++++......++||||+++++|..++.... ..+++..+..++.|+++||+|||+.+ |+||||||+|||+++.+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK--GRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 999999999999999999999999985432 35789999999999999999999988 99999999999997643
Q ss_pred -----CeeecCCCccc
Q 047619 418 -----NPKISDFGLAR 428 (430)
Q Consensus 418 -----~~kl~DFGlar 428 (430)
.+||+|||+++
T Consensus 157 ~~~~~~~kl~d~g~~~ 172 (274)
T cd05076 157 EGTSPFIKLSDPGVSF 172 (274)
T ss_pred cCccceeeecCCcccc
Confidence 37999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-23 Score=201.56 Aligned_cols=145 Identities=21% Similarity=0.353 Sum_probs=129.8
Q ss_pred CCcccceeecccCCcceEEEEEcC-CcEEEEEEecccC---hHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 353 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 353 (430)
++|++.+.||+|+||.||++.... ++.||+|.+.... ......+.+|+.+++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 468899999999999999998654 7899999987532 234567889999999999999999999999999999999
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCccc
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar 428 (430)
||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~ 149 (305)
T cd05609 81 EYVEGGDCATLLKNI---GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSK 149 (305)
T ss_pred ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCcc
Confidence 999999999999543 35889999999999999999999988 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.3e-24 Score=202.69 Aligned_cols=150 Identities=34% Similarity=0.553 Sum_probs=130.0
Q ss_pred cCCcccceeecccCCcceEEEEEc--------CCcEEEEEEeccc-ChHhHHHHHHHHHHHhcC-CCCcccceEEEEEeC
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLV--------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG 346 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 346 (430)
.++|.+.++||+|+||.||+|... ....+|+|.+... .......+.+|+.++.++ +||||+++++++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 357889999999999999999742 2457899988743 344567788999999999 699999999999999
Q ss_pred CEEEEEEEccCCCChhHHhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEE
Q 047619 347 EEKLLIYEFVPNKSLDSFIFDQER-------------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLL 413 (430)
Q Consensus 347 ~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl 413 (430)
...+++|||+++++|.+++..... ...+++..+..++.|++.||.|||+.+ |+||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence 999999999999999999965321 235788999999999999999999988 9999999999999
Q ss_pred cCCCCeeecCCCcccc
Q 047619 414 DQDMNPKISDFGLARA 429 (430)
Q Consensus 414 ~~~~~~kl~DFGlar~ 429 (430)
+.++.+||+|||+|+.
T Consensus 168 ~~~~~~kL~Dfg~~~~ 183 (314)
T cd05099 168 TEDNVMKIADFGLARG 183 (314)
T ss_pred cCCCcEEEcccccccc
Confidence 9999999999999974
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=197.19 Aligned_cols=148 Identities=28% Similarity=0.553 Sum_probs=130.4
Q ss_pred cCCcccceeecccCCcceEEEEEcC-C---cEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEE
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLVD-G---QEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 351 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 351 (430)
.++|+..+.||+|+||.||+|.... + ..+|+|.+... .....+.+.+|++++.+++||||+++++++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 3568888999999999999998643 3 37999998653 34456778999999999999999999999999999999
Q ss_pred EEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 352 IYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 352 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||+++.
T Consensus 84 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 156 (268)
T cd05063 84 ITEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRV 156 (268)
T ss_pred EEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCcccee
Confidence 999999999999985432 35889999999999999999999988 99999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=197.02 Aligned_cols=145 Identities=34% Similarity=0.537 Sum_probs=129.3
Q ss_pred CcccceeecccCCcceEEEEEcCCcEEEEEEeccc------ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEE
Q 047619 279 NFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI------SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 352 (430)
Q Consensus 279 ~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 352 (430)
+|++.+.||+|+||.||+|...+++.+|+|.+... .......+.+|+++++.++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 47788999999999999999878899999988632 123346688999999999999999999999999999999
Q ss_pred EEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 353 YEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 353 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|||+++++|.+++.+. ..+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||+++.
T Consensus 81 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 151 (265)
T cd06631 81 MEFVPGGSISSILNRF---GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARR 151 (265)
T ss_pred EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHh
Confidence 9999999999999543 34788999999999999999999988 99999999999999999999999998863
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.2e-24 Score=198.75 Aligned_cols=149 Identities=25% Similarity=0.456 Sum_probs=131.6
Q ss_pred CCcccceeecccCCcceEEEEE-cCCcEEEEEEeccc---ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 353 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 353 (430)
++|++.+.||+|+||.||++.. .+++.+|||.+... .......+.+|+.+++.++||||+++++++...+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688889999999999999995 56899999987642 2344567889999999999999999999999999999999
Q ss_pred EccCCCChhHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 354 EFVPNKSLDSFIFDQE-RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~-~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||+++.
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRF 155 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhc
Confidence 9999999999886422 2345899999999999999999999988 99999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.8e-26 Score=198.82 Aligned_cols=148 Identities=30% Similarity=0.490 Sum_probs=129.8
Q ss_pred hcCCcccceeecccCCcceEEEEE-cCCcEEEEEEec--ccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLS--KISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 352 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 352 (430)
..+.|++.+.||+|.|+.|++... +.|+.+|+|++. +....+.+.+.+|++|.+.|+||||++|++.+.+....|||
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 457899999999999999999874 568999999875 34556788999999999999999999999999999999999
Q ss_pred EEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCC---CCeeecCCCcccc
Q 047619 353 YEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQD---MNPKISDFGLARA 429 (430)
Q Consensus 353 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~---~~~kl~DFGlar~ 429 (430)
+|+|.|++|..-|... ...++..+-..++||+.||.|.|.++ |||||+||+|+|+.+. --+||+|||+|..
T Consensus 89 Fe~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred EecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEE
Confidence 9999999998766433 34788888999999999999999998 9999999999999543 3599999999974
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=198.01 Aligned_cols=146 Identities=31% Similarity=0.560 Sum_probs=128.3
Q ss_pred CCcccceeecccCCcceEEEEEcC-C----cEEEEEEecccC-hHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLVD-G----QEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 351 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~~-~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 351 (430)
.+|++.+.||+|+||.||+|...+ + ..+|+|.+.... ......+.+|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 578889999999999999998643 3 268999886543 4456788999999999999999999999887 78899
Q ss_pred EEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 352 IYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 352 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 86 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHK--DNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred EEecCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccc
Confidence 999999999999986543 34899999999999999999999988 99999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=198.93 Aligned_cols=146 Identities=27% Similarity=0.434 Sum_probs=129.2
Q ss_pred CCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc--ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 354 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 354 (430)
++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.++++++||||+++++++..+...++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46889999999999999999975 4889999988642 22234567899999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 355 FVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 355 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|+++++|..++... ..+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||+++.
T Consensus 81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 149 (286)
T cd07847 81 YCDHTVLNELEKNP---RGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARI 149 (286)
T ss_pred ccCccHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECcccccee
Confidence 99999988877432 34899999999999999999999988 99999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.5e-24 Score=207.46 Aligned_cols=142 Identities=21% Similarity=0.339 Sum_probs=124.2
Q ss_pred hcCCcccceeecccCCcceEEEEEcC-CcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 354 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 354 (430)
...+|.+.+.||+|+||.||+|.... ++.||+|+..+. ....|+.++++++||||+++++++......++|||
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 34579999999999999999999754 678999975432 23468999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 355 FVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 355 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++. ++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 138 ~~~-~~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 206 (357)
T PHA03209 138 HYS-SDLYTYLTKR--SRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQF 206 (357)
T ss_pred ccC-CcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccc
Confidence 995 6888887543 345899999999999999999999988 99999999999999999999999999873
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.8e-24 Score=199.04 Aligned_cols=146 Identities=30% Similarity=0.536 Sum_probs=124.5
Q ss_pred CCcccceeecccCCcceEEEEEc-CCc----EEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV-DGQ----EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 351 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 351 (430)
++|++.+.||+|+||.||+|... +++ .+++|.+... ......++..|+.++.++.||||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 46888899999999999999864 344 4778877542 2334567888999999999999999999875 456789
Q ss_pred EEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 352 IYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 352 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||+++.
T Consensus 86 i~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~ 158 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHR--DSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADL 158 (279)
T ss_pred EEEeCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCcccee
Confidence 999999999999996432 35899999999999999999999988 99999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-23 Score=195.37 Aligned_cols=139 Identities=31% Similarity=0.525 Sum_probs=120.9
Q ss_pred eecccCCcceEEEEEc---CCcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEccCCCC
Q 047619 285 KLGEGGFGPVYKGTLV---DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKS 360 (430)
Q Consensus 285 ~ig~G~fg~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 360 (430)
.||+|+||.||+|.+. .+..||+|++... .....+.+.+|+.++++++||||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999753 3557999988653 3344567899999999999999999999875 457899999999999
Q ss_pred hhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 361 LDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 361 L~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|.+++... ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~ 144 (257)
T cd05115 81 LNKFLSGK--KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKA 144 (257)
T ss_pred HHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCcccc
Confidence 99998543 245899999999999999999999988 99999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-24 Score=204.18 Aligned_cols=146 Identities=35% Similarity=0.593 Sum_probs=127.2
Q ss_pred cCCcccceeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhc--CCCCcccceEEEEEeCC----EEE
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSK--LQHRNLVKLLGCCIQGE----EKL 350 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~~ 350 (430)
....++.+.||+|.||.||+|.+ +++.||||++. .+..+.+++|-.|... ++|+||++++++-.... .++
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp---~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFP---EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred CCchhhHHHhhcCccceeehhhc-cCceeEEEecC---HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 34566778999999999999998 45999999995 4666778888777665 58999999999877665 789
Q ss_pred EEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhc------CCCcEEeCCCCCCcEEEcCCCCeeecCC
Q 047619 351 LIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD------SRLRIIHRDLKASNVLLDQDMNPKISDF 424 (430)
Q Consensus 351 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~------~~~~iiH~Dlkp~NILl~~~~~~kl~DF 424 (430)
||+||.+.|+|.++|..+ .++|....+|+.-+++||+|||+. .+++|+|||||..||||..|++..|+||
T Consensus 285 LVt~fh~kGsL~dyL~~n----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLKAN----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred EEeeeccCCcHHHHHHhc----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 999999999999999543 489999999999999999999975 3457999999999999999999999999
Q ss_pred CccccC
Q 047619 425 GLARAF 430 (430)
Q Consensus 425 Glar~~ 430 (430)
|+|.++
T Consensus 361 GLAl~~ 366 (534)
T KOG3653|consen 361 GLALRL 366 (534)
T ss_pred ceeEEe
Confidence 999764
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-23 Score=194.61 Aligned_cols=147 Identities=24% Similarity=0.400 Sum_probs=131.4
Q ss_pred CcccceeecccCCcceEEEEE-cCCcEEEEEEecc--cChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEc
Q 047619 279 NFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 355 (430)
Q Consensus 279 ~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 355 (430)
+|++.+.||+|+||.||.++. .+++.+++|.+.. ........+.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 588899999999999999985 4488999998764 2455567788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 356 VPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 356 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||+++.
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~ 150 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKI 150 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEE
Confidence 99999999996543 345889999999999999999999988 99999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=197.81 Aligned_cols=150 Identities=32% Similarity=0.550 Sum_probs=129.6
Q ss_pred cCCcccceeecccCCcceEEEEEcC------CcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEE
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 349 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 349 (430)
.++|++.+.||+|+||.||+|.... +..||+|.+... .......+.+|+.+++.++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4679999999999999999998653 567899988643 344456789999999999999999999999999999
Q ss_pred EEEEEccCCCChhHHhhcCCC----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCC---Ceeec
Q 047619 350 LLIYEFVPNKSLDSFIFDQER----CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDM---NPKIS 422 (430)
Q Consensus 350 ~lv~e~~~~gsL~~~l~~~~~----~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~---~~kl~ 422 (430)
++||||+++++|.+++..... ...+++..+..++.||+.||+|||+.+ ++||||||+|||++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence 999999999999999865321 135889999999999999999999988 99999999999998764 59999
Q ss_pred CCCcccc
Q 047619 423 DFGLARA 429 (430)
Q Consensus 423 DFGlar~ 429 (430)
|||+|+.
T Consensus 162 dfg~~~~ 168 (277)
T cd05036 162 DFGMARD 168 (277)
T ss_pred cCccccc
Confidence 9999974
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.4e-24 Score=199.95 Aligned_cols=156 Identities=27% Similarity=0.446 Sum_probs=132.2
Q ss_pred HHhHHhhcCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccChHhHHHHHHHHHHHhcC-CCCcccceEEEEE---
Q 047619 270 LATIANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCI--- 344 (430)
Q Consensus 270 ~~~~~~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~--- 344 (430)
+..+....++|++.+.||+|+||.||++... .++.+|+|.+... ......+.+|+.++.++ +||||+++++++.
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 3455667789999999999999999999864 4789999988642 22345678899999999 6999999999874
Q ss_pred --eCCEEEEEEEccCCCChhHHhhcC-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeee
Q 047619 345 --QGEEKLLIYEFVPNKSLDSFIFDQ-ERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKI 421 (430)
Q Consensus 345 --~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl 421 (430)
.++..++||||+++++|.+++... .....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl 165 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKL 165 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEE
Confidence 345689999999999999987532 22345788999999999999999999988 999999999999999999999
Q ss_pred cCCCcccc
Q 047619 422 SDFGLARA 429 (430)
Q Consensus 422 ~DFGlar~ 429 (430)
+|||+++.
T Consensus 166 ~dfg~~~~ 173 (286)
T cd06638 166 VDFGVSAQ 173 (286)
T ss_pred ccCCceee
Confidence 99999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.7e-24 Score=198.63 Aligned_cols=149 Identities=32% Similarity=0.502 Sum_probs=129.5
Q ss_pred hcCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccChHhHHHHHHHHHHHhcC-CCCcccceEEEEEeC------C
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG------E 347 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~------~ 347 (430)
+.+.|++.+.||+|+||.||+|... +++.+|+|.+... ......+.+|+.++.++ +||||+++++++... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC-CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 4567889999999999999999864 4788999998653 34456788999999998 699999999998763 4
Q ss_pred EEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcc
Q 047619 348 EKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427 (430)
Q Consensus 348 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla 427 (430)
..+++|||+++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||+|
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCc
Confidence 6799999999999999986532 345889999999999999999999988 999999999999999999999999998
Q ss_pred cc
Q 047619 428 RA 429 (430)
Q Consensus 428 r~ 429 (430)
+.
T Consensus 159 ~~ 160 (272)
T cd06637 159 AQ 160 (272)
T ss_pred ee
Confidence 74
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-23 Score=195.30 Aligned_cols=146 Identities=29% Similarity=0.476 Sum_probs=127.2
Q ss_pred CCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc-----ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeC--CEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-----SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEK 349 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 349 (430)
.+|++.+.||+|+||.||++... ++..||+|.+... .....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47889999999999999999864 4889999987521 123456788999999999999999999998764 467
Q ss_pred EEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 350 LLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 350 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+++|||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY---GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 8999999999999998543 34788889999999999999999988 99999999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=196.87 Aligned_cols=145 Identities=32% Similarity=0.557 Sum_probs=128.1
Q ss_pred CcccceeecccCCcceEEEEEc-CCcEEEEEEecccCh---------HhHHHHHHHHHHHhcCCCCcccceEEEEEeCCE
Q 047619 279 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISE---------QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 348 (430)
Q Consensus 279 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 348 (430)
+|.+...||+|++|.||+|... +++.+|+|.+..... ...+.+.+|+.++++++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4777899999999999999864 478999998864211 223578899999999999999999999999999
Q ss_pred EEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCccc
Q 047619 349 KLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428 (430)
Q Consensus 349 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar 428 (430)
.+++|||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY---GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 99999999999999999543 35788999999999999999999988 9999999999999999999999999987
Q ss_pred c
Q 047619 429 A 429 (430)
Q Consensus 429 ~ 429 (430)
.
T Consensus 155 ~ 155 (267)
T cd06628 155 K 155 (267)
T ss_pred c
Confidence 4
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.8e-25 Score=227.30 Aligned_cols=154 Identities=21% Similarity=0.266 Sum_probs=138.0
Q ss_pred cHHhHHhhcCCcccceeecccCCcceEEEEEcC-CcEEEEEEecc---cChHhHHHHHHHHHHHhcCCCCcccceEEEEE
Q 047619 269 ELATIANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCI 344 (430)
Q Consensus 269 ~~~~~~~~~~~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 344 (430)
...++....++|.+++.||+|+||.|..++.+. ++.+|+|++++ ........|+.|-.+|..-+.+-|++++.+|.
T Consensus 66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ 145 (1317)
T KOG0612|consen 66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ 145 (1317)
T ss_pred HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence 344555667899999999999999999999654 88999999987 44556678999999999999999999999999
Q ss_pred eCCEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCC
Q 047619 345 QGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDF 424 (430)
Q Consensus 345 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DF 424 (430)
++.++|+|||||+||+|-.++.... .+++..+..++..|+.||.-||+.| +|||||||+|||||..|++||+||
T Consensus 146 D~~~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADF 219 (1317)
T KOG0612|consen 146 DERYLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADF 219 (1317)
T ss_pred CccceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccc
Confidence 9999999999999999999996543 5899999999999999999999988 999999999999999999999999
Q ss_pred Cccc
Q 047619 425 GLAR 428 (430)
Q Consensus 425 Glar 428 (430)
|.+-
T Consensus 220 GsCl 223 (1317)
T KOG0612|consen 220 GSCL 223 (1317)
T ss_pred hhHH
Confidence 9864
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=200.92 Aligned_cols=149 Identities=35% Similarity=0.520 Sum_probs=130.5
Q ss_pred cCCcccceeecccCCcceEEEEEc------CCcEEEEEEeccc-ChHhHHHHHHHHHHHhcC-CCCcccceEEEEEeCCE
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEE 348 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 348 (430)
.++|.+.+.||+|+||.||++... .+..+|+|.+... .....+.+.+|+.+++++ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 357899999999999999999742 2457999988753 334456789999999999 79999999999999999
Q ss_pred EEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCccc
Q 047619 349 KLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428 (430)
Q Consensus 349 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar 428 (430)
.+++|||+++++|.+++.... ...+++.++..++.+++.||+|||+++ |+|+||||+|||++.++.+||+|||+|+
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence 999999999999999986433 234899999999999999999999988 9999999999999999999999999987
Q ss_pred c
Q 047619 429 A 429 (430)
Q Consensus 429 ~ 429 (430)
.
T Consensus 190 ~ 190 (302)
T cd05055 190 D 190 (302)
T ss_pred c
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-23 Score=194.64 Aligned_cols=145 Identities=33% Similarity=0.536 Sum_probs=129.7
Q ss_pred CcccceeecccCCcceEEEEEc-CCcEEEEEEecccC-----hHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEE
Q 047619 279 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-----EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 352 (430)
Q Consensus 279 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 352 (430)
+|+..+.||+|++|.||+|... +++.|++|.+.... .+..+.+.+|+.+++.++|+||+++++++......+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677789999999999999975 68999999886422 34567889999999999999999999999999999999
Q ss_pred EEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 353 YEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 353 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+|||+++.
T Consensus 81 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~ 151 (258)
T cd06632 81 LELVPGGSLAKLLKKY---GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQ 151 (258)
T ss_pred EEecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCcccee
Confidence 9999999999998543 34789999999999999999999988 99999999999999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=203.73 Aligned_cols=149 Identities=32% Similarity=0.542 Sum_probs=129.1
Q ss_pred CCcccceeecccCCcceEEEEEcC--------CcEEEEEEeccc-ChHhHHHHHHHHHHHhcC-CCCcccceEEEEEeCC
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLVD--------GQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGE 347 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~~--------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 347 (430)
.+|++.+.||+|+||.||+|.... ...+|+|.+... .....+.+.+|+.++.++ +||||+++++++...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 468999999999999999997421 236899988642 344567889999999999 7999999999999999
Q ss_pred EEEEEEEccCCCChhHHhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEc
Q 047619 348 EKLLIYEFVPNKSLDSFIFDQE-------------RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLD 414 (430)
Q Consensus 348 ~~~lv~e~~~~gsL~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~ 414 (430)
..+++|||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 9999999999999999986532 1234788889999999999999999988 99999999999999
Q ss_pred CCCCeeecCCCcccc
Q 047619 415 QDMNPKISDFGLARA 429 (430)
Q Consensus 415 ~~~~~kl~DFGlar~ 429 (430)
.++.+||+|||+|+.
T Consensus 169 ~~~~~kL~Dfg~~~~ 183 (334)
T cd05100 169 EDNVMKIADFGLARD 183 (334)
T ss_pred CCCcEEECCccccee
Confidence 999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=199.99 Aligned_cols=145 Identities=32% Similarity=0.492 Sum_probs=128.4
Q ss_pred CcccceeecccCCcceEEEEEc-CCcEEEEEEecccC-----hHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEE
Q 047619 279 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-----EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 352 (430)
Q Consensus 279 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 352 (430)
+|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4778899999999999999864 58899999987532 22345577899999999999999999999999999999
Q ss_pred EEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 353 YEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 353 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|||+ +++|.+++.... ..+++..+..++.||++||.|||+.+ |+|+||||+|||++.++.+||+|||+++.
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~ 151 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARS 151 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeee
Confidence 9999 899999995533 35899999999999999999999998 99999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=199.35 Aligned_cols=146 Identities=32% Similarity=0.488 Sum_probs=128.1
Q ss_pred CCcccceeecccCCcceEEEEEc-CCcEEEEEEecccC-hHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEc
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 355 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 355 (430)
++|++.+.||+|++|.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 67999999999999999999865 57899999986432 22234567899999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 356 VPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 356 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+++ +|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 85 ~~~-~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 152 (291)
T cd07844 85 LDT-DLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARA 152 (291)
T ss_pred CCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccc
Confidence 985 8998885443 35789999999999999999999988 99999999999999999999999999863
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.9e-25 Score=196.63 Aligned_cols=139 Identities=29% Similarity=0.411 Sum_probs=126.4
Q ss_pred eeecccCCcceEEEE-EcCCcEEEEEEecccChHhHHHHHHHHHHHhcCC-CCcccceEEEEEeCCEEEEEEEccCCCCh
Q 047619 284 NKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYEFVPNKSL 361 (430)
Q Consensus 284 ~~ig~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL 361 (430)
+.||+|+|+.|--+. ..++.++|||++.+.......++.+|++++...+ |+||++|+++|+++...|||||-|.||+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 689999999999887 5679999999999877778889999999999996 99999999999999999999999999999
Q ss_pred hHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCC---CeeecCCCccc
Q 047619 362 DSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDM---NPKISDFGLAR 428 (430)
Q Consensus 362 ~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~---~~kl~DFGlar 428 (430)
...|..+ +-+++.++.++..+|+.||.|||.+| |.||||||+|||-.... -+||+||.++.
T Consensus 164 LshI~~~---~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgS 227 (463)
T KOG0607|consen 164 LSHIQKR---KHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGS 227 (463)
T ss_pred HHHHHHh---hhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeecccccc
Confidence 9999654 34899999999999999999999999 99999999999996554 38999998864
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-24 Score=215.27 Aligned_cols=148 Identities=30% Similarity=0.540 Sum_probs=133.7
Q ss_pred CCcccceeecccCCcceEEEEEcC----CcEEEEEEecc-cChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 352 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~~----~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 352 (430)
....+.+.||.|.||.|++|+++- ...||||.++. ..+.....|..|+.||.+++||||++|.|+.......+||
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 455677999999999999999643 45799999985 3456678899999999999999999999999999999999
Q ss_pred EEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCccccC
Q 047619 353 YEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430 (430)
Q Consensus 353 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~~ 430 (430)
+|||++|+|+.+|..+.. .+.+.+...++++|+.|++||-+.+ +|||||...||||+.+-..|++||||+|.+
T Consensus 709 TEyMENGsLDsFLR~~DG--qftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvl 781 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQNDG--QFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 781 (996)
T ss_pred hhhhhCCcHHHHHhhcCC--ceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeec
Confidence 999999999999977653 4888999999999999999999888 999999999999999999999999999864
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=199.10 Aligned_cols=150 Identities=31% Similarity=0.544 Sum_probs=131.0
Q ss_pred cCCcccceeecccCCcceEEEEEc------CCcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEE
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 349 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 349 (430)
.++|++.+.||+|+||.||+|... ++..+|+|.+... ......++.+|+.++.+++||||+++++++..+...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467899999999999999999853 3678999998653 344567799999999999999999999999999999
Q ss_pred EEEEEccCCCChhHHhhcCC-------------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCc
Q 047619 350 LLIYEFVPNKSLDSFIFDQE-------------------RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASN 410 (430)
Q Consensus 350 ~lv~e~~~~gsL~~~l~~~~-------------------~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~N 410 (430)
+++|||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999999986421 1124678889999999999999999988 9999999999
Q ss_pred EEEcCCCCeeecCCCcccc
Q 047619 411 VLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 411 ILl~~~~~~kl~DFGlar~ 429 (430)
||+++++.+||+|||+++.
T Consensus 161 il~~~~~~~~l~dfg~~~~ 179 (288)
T cd05050 161 CLVGENMVVKIADFGLSRN 179 (288)
T ss_pred eEecCCCceEECcccccee
Confidence 9999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-23 Score=194.59 Aligned_cols=145 Identities=28% Similarity=0.497 Sum_probs=127.1
Q ss_pred CCcccceeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEE-eCCEEEEEEEcc
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCI-QGEEKLLIYEFV 356 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~ 356 (430)
++|++.+.||+|+||.||++.. .+..+|+|.+... ...+.+.+|+.++++++|+||+++++++. ..+..+++|||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 5788999999999999999976 4788999998642 23467889999999999999999999765 456789999999
Q ss_pred CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 357 PNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 357 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++++|.+++.... ...+++..+..++.|++.||+|||+++ |+||||||+||++++++.+||+|||+++.
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~ 151 (256)
T cd05082 83 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKE 151 (256)
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCcccee
Confidence 9999999986543 235889999999999999999999988 99999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=195.39 Aligned_cols=141 Identities=33% Similarity=0.490 Sum_probs=125.5
Q ss_pred eeecccCCcceEEEEEcC--C--cEEEEEEecccCh-HhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEccCC
Q 047619 284 NKLGEGGFGPVYKGTLVD--G--QEIAVKRLSKISE-QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPN 358 (430)
Q Consensus 284 ~~ig~G~fg~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 358 (430)
+.||+|++|.||+|.+.. + ..+|+|.+..... ...+.+.+|+.++++++||||+++++.+.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998643 2 3689999986544 567789999999999999999999999988 889999999999
Q ss_pred CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 359 KSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 359 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++|.+++..... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~ 146 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRA 146 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccc
Confidence 999999966442 45899999999999999999999988 99999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=199.83 Aligned_cols=148 Identities=26% Similarity=0.515 Sum_probs=132.8
Q ss_pred hhcCCcccceeecccCCcceEEEEE-cCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEE
Q 047619 275 NATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 353 (430)
Q Consensus 275 ~~~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 353 (430)
....+|++.+.||.|++|.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++|+
T Consensus 16 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 95 (296)
T cd06655 16 DPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM 95 (296)
T ss_pred CCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence 3445799999999999999999985 458899999987544445677889999999999999999999999999999999
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||+++++|..++.. ..+++.++..++.+++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.
T Consensus 96 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~ 164 (296)
T cd06655 96 EYLAGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQ 164 (296)
T ss_pred EecCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchh
Confidence 99999999998843 24789999999999999999999998 99999999999999999999999998763
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=196.06 Aligned_cols=141 Identities=23% Similarity=0.414 Sum_probs=121.3
Q ss_pred eeecccCCcceEEEEEcC-------------CcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEE
Q 047619 284 NKLGEGGFGPVYKGTLVD-------------GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 350 (430)
Q Consensus 284 ~~ig~G~fg~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 350 (430)
+.||+|+||.||+|.... ...+++|.+..........+.+|+.++..++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999997432 2258888876654555667888999999999999999999999999999
Q ss_pred EEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCC-------eeecC
Q 047619 351 LIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMN-------PKISD 423 (430)
Q Consensus 351 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~-------~kl~D 423 (430)
+||||+++++|..++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +|++|
T Consensus 81 lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS--DVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 9999999999998885432 35899999999999999999999988 999999999999987664 89999
Q ss_pred CCcccc
Q 047619 424 FGLARA 429 (430)
Q Consensus 424 FGlar~ 429 (430)
||+++.
T Consensus 156 ~g~~~~ 161 (262)
T cd05077 156 PGIPIT 161 (262)
T ss_pred CCCCcc
Confidence 999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=196.91 Aligned_cols=141 Identities=26% Similarity=0.466 Sum_probs=120.6
Q ss_pred eecccCCcceEEEEEcCC---cEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEccCCCC
Q 047619 285 KLGEGGFGPVYKGTLVDG---QEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKS 360 (430)
Q Consensus 285 ~ig~G~fg~Vy~~~~~~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 360 (430)
.||+|+||.||++...++ ..+++|.+... .....+.+.+|+.++..++||||+++++.+......++||||+++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 699999999999975443 34667766543 23456789999999999999999999999999999999999999999
Q ss_pred hhHHhhcCCC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCccc
Q 047619 361 LDSFIFDQER-CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428 (430)
Q Consensus 361 L~~~l~~~~~-~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar 428 (430)
|.+++..... ....++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~ 147 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGP 147 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEeccccccc
Confidence 9999865322 234677778899999999999999988 9999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.1e-24 Score=206.32 Aligned_cols=145 Identities=29% Similarity=0.437 Sum_probs=124.4
Q ss_pred hcCCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc--ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeC------
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG------ 346 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 346 (430)
..++|++.+.||+|+||.||++... .++.+|+|++... .......+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999864 4889999998752 334456788899999999999999999988654
Q ss_pred CEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCc
Q 047619 347 EEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 426 (430)
Q Consensus 347 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGl 426 (430)
...++||||+++ +|.+.+. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence 346999999975 6666663 23788889999999999999999988 99999999999999999999999999
Q ss_pred ccc
Q 047619 427 ARA 429 (430)
Q Consensus 427 ar~ 429 (430)
|+.
T Consensus 166 ~~~ 168 (355)
T cd07874 166 ART 168 (355)
T ss_pred ccc
Confidence 974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=208.46 Aligned_cols=142 Identities=23% Similarity=0.330 Sum_probs=124.5
Q ss_pred hcCCcccceeecccCCcceEEEEEc---CCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV---DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 352 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 352 (430)
...+|.+.+.||+|+||.||++... .+..||+|.+... ....+|+.++++++||||+++++++......+++
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 3457999999999999999999753 3578999988642 2346799999999999999999999999999999
Q ss_pred EEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 353 YEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 353 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||++. ++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 165 ~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~ 234 (392)
T PHA03207 165 MPKYK-CDLFTYVDR---SGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACK 234 (392)
T ss_pred ehhcC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccc
Confidence 99995 688888832 345899999999999999999999988 99999999999999999999999999864
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-23 Score=196.92 Aligned_cols=147 Identities=33% Similarity=0.560 Sum_probs=129.7
Q ss_pred CCcccceeecccCCcceEEEEEc-----CCcEEEEEEecccCh-HhHHHHHHHHHHHhcCCCCcccceEEEEEe--CCEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV-----DGQEIAVKRLSKISE-QGLKELKNEVILFSKLQHRNLVKLLGCCIQ--GEEK 349 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 349 (430)
+.|++.+.||+|+||.||+|... .+..+|+|.+..... ...+.+.+|+.+++.++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 46788899999999999999853 367899999975433 256789999999999999999999999887 5578
Q ss_pred EEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 350 LLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 350 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+++|||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||+++.
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc--cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 99999999999999996543 24899999999999999999999988 99999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-23 Score=194.09 Aligned_cols=143 Identities=37% Similarity=0.607 Sum_probs=127.7
Q ss_pred eeecccCCcceEEEEEcC----CcEEEEEEecccChH-hHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEccCC
Q 047619 284 NKLGEGGFGPVYKGTLVD----GQEIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPN 358 (430)
Q Consensus 284 ~~ig~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 358 (430)
+.||+|+||.||+|.... +..+|+|.+...... ..+.+.+|+.++..++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999998654 788999998764332 367899999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCC------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 359 KSLDSFIFDQER------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 359 gsL~~~l~~~~~------~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++|.+++..... ...+++..+..++.|++.||+|||+++ |+|+||||+||++++++.+||+|||.++.
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~ 154 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRD 154 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEcccccccc
Confidence 999999965421 256899999999999999999999988 99999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-23 Score=193.68 Aligned_cols=146 Identities=27% Similarity=0.525 Sum_probs=130.1
Q ss_pred CCcccceeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEccC
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVP 357 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 357 (430)
.+|++.+.||+|+||.||++...++..+|+|.+... ......+.+|++++++++||||+++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 468888999999999999998877889999988642 2234578899999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 358 NKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 358 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+++|.+++.... ..+++..+..++.+++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.
T Consensus 83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~ 149 (256)
T cd05112 83 HGCLSDYLRAQR--GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRF 149 (256)
T ss_pred CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceee
Confidence 999999985432 34788999999999999999999988 99999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=196.40 Aligned_cols=147 Identities=26% Similarity=0.467 Sum_probs=127.9
Q ss_pred cCCcccceeecccCCcceEEEEEcC----CcEEEEEEecccC-hHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEE
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 351 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 351 (430)
.++|++.+.||+|+||.||+|...+ ...+|+|...... ....+.+.+|+.++++++||||+++++++.+ +..++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 3568888999999999999998643 2468999886543 4566789999999999999999999998875 56789
Q ss_pred EEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 352 IYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 352 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||||+++++|.+++.... ..+++..+..++.+++.||+|||+.+ ++|+||||+|||++.++.+||+|||+++.
T Consensus 84 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~ 156 (270)
T cd05056 84 VMELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRY 156 (270)
T ss_pred EEEcCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeee
Confidence 999999999999996532 34899999999999999999999988 99999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-23 Score=199.44 Aligned_cols=148 Identities=26% Similarity=0.339 Sum_probs=131.8
Q ss_pred CCcccceeecccCCcceEEEEEcC-CcEEEEEEecccC---hHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 353 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 353 (430)
++|++.+.||+|++|.||+|...+ ++.+|+|.+.+.. ....+.+.+|++++..++||||+++++.+......++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 368899999999999999999754 8999999987532 235567889999999999999999999999999999999
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||+++++|.+++.... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 81 e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 152 (316)
T cd05574 81 DYCPGGELFRLLQRQP-GKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQ 152 (316)
T ss_pred EecCCCCHHHHHHhCC-CCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhc
Confidence 9999999999986432 345899999999999999999999988 99999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=220.76 Aligned_cols=156 Identities=24% Similarity=0.371 Sum_probs=129.8
Q ss_pred HhhcCCcccceeecccCCcceEEEEEcC-CcEEEEEEecc--cChHhHHHHHHHHHHHhcCCCCcccceEEEEEeC--CE
Q 047619 274 ANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EE 348 (430)
Q Consensus 274 ~~~~~~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~ 348 (430)
....++|.+.+.||+|+||.||+|.... +..+|+|.+.. ........+..|+.++..|+|||||++++++... ..
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 3455789999999999999999999654 67889998864 2344567889999999999999999999988653 56
Q ss_pred EEEEEEccCCCChhHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCC----CcEEeCCCCCCcEEEcC--------
Q 047619 349 KLLIYEFVPNKSLDSFIFDQE-RCKILDWSKRFHIICGTARGVMYLHQDSR----LRIIHRDLKASNVLLDQ-------- 415 (430)
Q Consensus 349 ~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~~i~~~i~~aL~yLH~~~~----~~iiH~Dlkp~NILl~~-------- 415 (430)
++|||||+++++|.++|.... ....+++..++.|+.||+.||.|||+.+. .+||||||||+||||+.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 899999999999999986421 23458999999999999999999998531 24999999999999964
Q ss_pred ---------CCCeeecCCCcccc
Q 047619 416 ---------DMNPKISDFGLARA 429 (430)
Q Consensus 416 ---------~~~~kl~DFGlar~ 429 (430)
.+.+||+|||+|+.
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~ 191 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKN 191 (1021)
T ss_pred cccccccCCCCceEEccCCcccc
Confidence 23489999999874
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-23 Score=197.44 Aligned_cols=158 Identities=32% Similarity=0.478 Sum_probs=134.5
Q ss_pred ccHHhHHhhcCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccChHhHHHHHHHHHHHhcC-CCCcccceEEEEEe
Q 047619 268 FELATIANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQ 345 (430)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 345 (430)
+...++..+.++|++.+.||+|+||.||++... +++.+|+|.+.... .....+.+|+.++.++ +||||+++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 444566667889999999999999999999864 58899999986532 2345678899999998 79999999999876
Q ss_pred CC-----EEEEEEEccCCCChhHHhhcC-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCe
Q 047619 346 GE-----EKLLIYEFVPNKSLDSFIFDQ-ERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNP 419 (430)
Q Consensus 346 ~~-----~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~ 419 (430)
.+ ..++||||+++++|.+++... .....+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence 43 579999999999999988532 22345889999999999999999999988 9999999999999999999
Q ss_pred eecCCCcccc
Q 047619 420 KISDFGLARA 429 (430)
Q Consensus 420 kl~DFGlar~ 429 (430)
||+|||+++.
T Consensus 168 kl~dfg~~~~ 177 (291)
T cd06639 168 KLVDFGVSAQ 177 (291)
T ss_pred EEeecccchh
Confidence 9999999874
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-23 Score=193.39 Aligned_cols=138 Identities=33% Similarity=0.513 Sum_probs=121.0
Q ss_pred eecccCCcceEEEEE---cCCcEEEEEEeccc--ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEccCCC
Q 047619 285 KLGEGGFGPVYKGTL---VDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNK 359 (430)
Q Consensus 285 ~ig~G~fg~Vy~~~~---~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 359 (430)
+||+|+||.||+|.+ .+++.+|+|++... .....+++.+|+.+++.++||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 689999999999964 34788999998642 2345678899999999999999999999875 55678999999999
Q ss_pred ChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 360 SLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 360 sL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+|+.
T Consensus 81 ~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~ 144 (257)
T cd05116 81 PLNKFLQKN---KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKA 144 (257)
T ss_pred cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccc
Confidence 999998543 34889999999999999999999988 99999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-23 Score=204.69 Aligned_cols=145 Identities=28% Similarity=0.426 Sum_probs=124.2
Q ss_pred hcCCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc--ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeC------
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG------ 346 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 346 (430)
..++|++.+.||+|+||.||++... .++.||||++... .......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3478999999999999999999864 4889999998752 234456788999999999999999999987643
Q ss_pred CEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCc
Q 047619 347 EEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 426 (430)
Q Consensus 347 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGl 426 (430)
...++||||+++ +|...+.. .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence 357999999965 67776632 3788889999999999999999988 99999999999999999999999999
Q ss_pred ccc
Q 047619 427 ARA 429 (430)
Q Consensus 427 ar~ 429 (430)
|+.
T Consensus 173 a~~ 175 (364)
T cd07875 173 ART 175 (364)
T ss_pred ccc
Confidence 974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.1e-24 Score=207.63 Aligned_cols=150 Identities=23% Similarity=0.364 Sum_probs=132.1
Q ss_pred HhhcCCcccceeecccCCcceEEEEEcC-CcEEEEEEeccc---ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEE
Q 047619 274 ANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 349 (430)
Q Consensus 274 ~~~~~~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 349 (430)
.....-|..++.||-|+||+|-++...| ...+|+|.+.+. .......++.|-.||.....+-||+|+..|.+.+.+
T Consensus 625 KMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnL 704 (1034)
T KOG0608|consen 625 KMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNL 704 (1034)
T ss_pred hccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCce
Confidence 3344568888999999999999998655 668999998763 344556688899999999999999999999999999
Q ss_pred EEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 350 LLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 350 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|+||+|++||++-.+|-+ ...+++..+..++.++..|+++.|..| +|||||||+|||||.+|++||+||||+.-
T Consensus 705 YFVMdYIPGGDmMSLLIr---mgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTG 778 (1034)
T KOG0608|consen 705 YFVMDYIPGGDMMSLLIR---MGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTG 778 (1034)
T ss_pred EEEEeccCCccHHHHHHH---hccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeecccccc
Confidence 999999999999998844 356889999999999999999999888 99999999999999999999999999863
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-23 Score=196.48 Aligned_cols=147 Identities=30% Similarity=0.508 Sum_probs=129.6
Q ss_pred CcccceeecccCCcceEEEEEc-CCcEEEEEEecccC-hHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEcc
Q 047619 279 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFV 356 (430)
Q Consensus 279 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 356 (430)
+|++.++||+|++|.||+|... +++.||+|++.... ......+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4788999999999999999975 48899999987532 233566778999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 357 PNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 357 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++ +|.+++........+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.++|+|||+++.
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~ 149 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARA 149 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhh
Confidence 85 88888865444456899999999999999999999988 99999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.7e-23 Score=196.33 Aligned_cols=145 Identities=31% Similarity=0.479 Sum_probs=130.3
Q ss_pred CcccceeecccCCcceEEEEEc-CCcEEEEEEecccC--hHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEc
Q 047619 279 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 355 (430)
Q Consensus 279 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 355 (430)
+|++.+.||+|+||.||+|... +++.+|+|++.... ......+.+|+.++++++||||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4788999999999999999964 58899999987532 33456789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 356 VPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 356 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+ +++|.+++.... ..+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||+++.
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~ 148 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARL 148 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeeccc
Confidence 9 999999986433 45899999999999999999999988 99999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.5e-25 Score=196.42 Aligned_cols=149 Identities=30% Similarity=0.458 Sum_probs=124.3
Q ss_pred CCcccceeecccCCcceEEEEEcC-----CcEEEEEEecccCh--HhHHHHHHHHHHHhcCCCCcccceEEEEEe-CCEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLVD-----GQEIAVKRLSKISE--QGLKELKNEVILFSKLQHRNLVKLLGCCIQ-GEEK 349 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 349 (430)
..|++...||+|.||.||+|.-.+ .+.+|+|+++.... .......+|+.+++.|+||||+.|..++.. +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 468889999999999999996332 34789999975311 123446789999999999999999999888 7789
Q ss_pred EEEEEccCCCChhHHhhcC--CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCC----CCeeecC
Q 047619 350 LLIYEFVPNKSLDSFIFDQ--ERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQD----MNPKISD 423 (430)
Q Consensus 350 ~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~----~~~kl~D 423 (430)
++++||.+ -+|..+|+.. ...+.++...+..|+.||+.|+.|||++= |+||||||+||||..+ |.|||+|
T Consensus 104 ~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence 99999996 4777777532 33456889999999999999999999986 9999999999999877 8999999
Q ss_pred CCccccC
Q 047619 424 FGLARAF 430 (430)
Q Consensus 424 FGlar~~ 430 (430)
||+||+|
T Consensus 180 lGlaR~~ 186 (438)
T KOG0666|consen 180 LGLARLF 186 (438)
T ss_pred ccHHHHh
Confidence 9999975
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.6e-25 Score=211.28 Aligned_cols=146 Identities=30% Similarity=0.475 Sum_probs=127.6
Q ss_pred CCcccceeecccCCcceEEEEE-cCCcEEEEEEeccc---ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 353 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 353 (430)
..|.-++.||.|+||.||-|+. .+...||||+++-. +...-..+..|+..|.+++|||+|.+.|+|......||||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 3466778999999999999985 45788999998732 3334567889999999999999999999999999999999
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||| -|+-.+++.-. .+++.+.++..|..+.+.||.|||+.+ .||||||..||||.+.|.|||+|||.|.+
T Consensus 106 EYC-lGSAsDlleVh--kKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi 175 (948)
T KOG0577|consen 106 EYC-LGSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASI 175 (948)
T ss_pred HHH-hccHHHHHHHH--hccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhh
Confidence 999 56777877443 357899999999999999999999988 99999999999999999999999999864
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.9e-23 Score=196.96 Aligned_cols=147 Identities=31% Similarity=0.450 Sum_probs=126.7
Q ss_pred cCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccC-hHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEE
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 354 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 354 (430)
.++|.+.+.||+|+||.||+|... +++.+|+|.+.... ......+.+|+.+++.++|+||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 468999999999999999999864 58899999986432 2233467789999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 355 FVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 355 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|++ ++|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||+|+.
T Consensus 84 ~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~ 152 (291)
T cd07870 84 YMH-TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARA 152 (291)
T ss_pred ccc-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccc
Confidence 996 67777664332 34778888899999999999999988 99999999999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-23 Score=195.41 Aligned_cols=145 Identities=27% Similarity=0.493 Sum_probs=128.1
Q ss_pred CcccceeecccCCcceEEEEE-cCCcEEEEEEecccC------hHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEE
Q 047619 279 NFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKIS------EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 351 (430)
Q Consensus 279 ~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 351 (430)
+|+..+.||+|++|.||++.. .+++.+|+|.+.... ....+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999985 458899999986422 2245788999999999999999999999999999999
Q ss_pred EEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCC-CeeecCCCcccc
Q 047619 352 IYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLARA 429 (430)
Q Consensus 352 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DFGlar~ 429 (430)
||||+++++|.+++... .++++..+..++.|++.||.|||+.+ ++|+||||+||+++.++ .+||+|||+++.
T Consensus 81 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY---GAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 99999999999998543 35889999999999999999999998 99999999999998776 599999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.5e-23 Score=192.20 Aligned_cols=146 Identities=39% Similarity=0.658 Sum_probs=129.0
Q ss_pred cccceeecccCCcceEEEEEcC-----CcEEEEEEecccChH-hHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEE
Q 047619 280 FSINNKLGEGGFGPVYKGTLVD-----GQEIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 353 (430)
Q Consensus 280 ~~~~~~ig~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 353 (430)
+++.+.||.|+||.||++...+ +..+|+|.+...... ..+.+.+|+.++..++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567899999999999998654 378999999754332 5778999999999999999999999999999999999
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||+++++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 81 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~ 152 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRD 152 (258)
T ss_pred eccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCcee
Confidence 99999999999865332 12899999999999999999999988 99999999999999999999999999874
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=195.08 Aligned_cols=145 Identities=26% Similarity=0.406 Sum_probs=131.0
Q ss_pred CcccceeecccCCcceEEEEEc-CCcEEEEEEeccc---ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEE
Q 047619 279 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 354 (430)
Q Consensus 279 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 354 (430)
+|++.+.||.|+||.||+|... +++.+|+|.+.+. .....+.+.+|+.++++++||||+++++.+..+...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4888999999999999999975 4889999998752 23456789999999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 355 FVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 355 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|+++++|.+++... ..+++..+..++.|+++||.|||+.+ |+|+||||+||++++++.++|+|||++..
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~ 149 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATK 149 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccc
Confidence 99999999998543 35889999999999999999999988 99999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=3e-23 Score=192.28 Aligned_cols=141 Identities=35% Similarity=0.595 Sum_probs=126.6
Q ss_pred eeecccCCcceEEEEEcCCcEEEEEEecccCh-HhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEccCCCChh
Q 047619 284 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISE-QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLD 362 (430)
Q Consensus 284 ~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 362 (430)
++||+|+||.||++...+++.||+|++..... .....+.+|+.++++++||||+++++++......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 47999999999999976799999999875332 35678999999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 363 SFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 363 ~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+++.... ..+++..+..++.+++.||.|||+++ ++||||||+|||++.++.+||+|||+++.
T Consensus 81 ~~l~~~~--~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~ 142 (251)
T cd05041 81 TFLRKKK--NRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRE 142 (251)
T ss_pred HHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeecccccc
Confidence 9985432 35788999999999999999999988 99999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.9e-23 Score=195.91 Aligned_cols=148 Identities=28% Similarity=0.427 Sum_probs=125.0
Q ss_pred CCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc-ChHhHHHHHHHHHH-HhcCCCCcccceEEEEEeCCEEEEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVIL-FSKLQHRNLVKLLGCCIQGEEKLLIYE 354 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e 354 (430)
++|++.+.||+|+||.||++... +++.||+|++... .......+..|+.+ ++.++||||+++++++..++..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46889999999999999999865 5899999998753 22334455566665 666789999999999999999999999
Q ss_pred ccCCCChhHHhhcC-CCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 355 FVPNKSLDSFIFDQ-ERCKILDWSKRFHIICGTARGVMYLHQD-SRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 355 ~~~~gsL~~~l~~~-~~~~~~~~~~~~~i~~~i~~aL~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|++ ++|.+++... .....+++..+..++.|++.||+|||++ + |+||||||+|||++.++.+||+|||+|+.
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~ 153 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGY 153 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecccccc
Confidence 996 6888777542 2235689999999999999999999986 6 99999999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.3e-23 Score=193.62 Aligned_cols=142 Identities=35% Similarity=0.627 Sum_probs=123.0
Q ss_pred eeecccCCcceEEEEEcC-Cc--EEEEEEeccc-ChHhHHHHHHHHHHHhcC-CCCcccceEEEEEeCCEEEEEEEccCC
Q 047619 284 NKLGEGGFGPVYKGTLVD-GQ--EIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFVPN 358 (430)
Q Consensus 284 ~~ig~G~fg~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 358 (430)
+.||+|+||.||+|...+ +. .+++|.+... .....+.+.+|+.++.++ +||||+++++++...+..+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999998754 33 5688888643 344566788999999999 799999999999999999999999999
Q ss_pred CChhHHhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCC
Q 047619 359 KSLDSFIFDQE-------------RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 425 (430)
Q Consensus 359 gsL~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFG 425 (430)
++|.+++.... ....+++..+..++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999986432 1234788999999999999999999988 9999999999999999999999999
Q ss_pred ccc
Q 047619 426 LAR 428 (430)
Q Consensus 426 lar 428 (430)
+++
T Consensus 158 l~~ 160 (270)
T cd05047 158 LSR 160 (270)
T ss_pred Ccc
Confidence 985
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-23 Score=193.34 Aligned_cols=144 Identities=31% Similarity=0.570 Sum_probs=126.3
Q ss_pred CCcccceeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEccC
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVP 357 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 357 (430)
++|++.+.||+|+||.||++.. .++.+|+|.+.... ....+.+|+.++.+++||||+++++++... ..+++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4688999999999999999874 67889999986422 346788999999999999999999998654 5799999999
Q ss_pred CCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 358 NKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 358 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+++|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+|+.
T Consensus 82 ~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~ 149 (254)
T cd05083 82 KGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARV 149 (254)
T ss_pred CCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCcccee
Confidence 999999996543 235789999999999999999999988 99999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.5e-23 Score=193.02 Aligned_cols=146 Identities=30% Similarity=0.481 Sum_probs=127.3
Q ss_pred CCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc-----ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeC--CEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-----SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEK 349 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 349 (430)
.+|++.+.||+|+||.||+|... .+..+|+|++... .......+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46889999999999999999864 4889999988532 123456788999999999999999999988763 567
Q ss_pred EEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 350 LLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 350 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+++|||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||+|+.
T Consensus 82 ~l~~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY---GALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 8999999999999998543 34788999999999999999999988 99999999999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.6e-23 Score=196.78 Aligned_cols=146 Identities=29% Similarity=0.486 Sum_probs=120.6
Q ss_pred CcccceeecccCCcceEEEEEc-CCcEEEEEEecccC--hHhHHHHHHHHHHHhcC---CCCcccceEEEEEeC-----C
Q 047619 279 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKL---QHRNLVKLLGCCIQG-----E 347 (430)
Q Consensus 279 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~-----~ 347 (430)
+|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.+++.+ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4788899999999999999865 48899999886421 12233455677776655 799999999988653 4
Q ss_pred EEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcc
Q 047619 348 EKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427 (430)
Q Consensus 348 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla 427 (430)
..+++|||++ ++|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPP-PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 5789999997 488888854332 34899999999999999999999998 999999999999999999999999998
Q ss_pred cc
Q 047619 428 RA 429 (430)
Q Consensus 428 r~ 429 (430)
+.
T Consensus 156 ~~ 157 (288)
T cd07863 156 RI 157 (288)
T ss_pred cc
Confidence 74
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.3e-24 Score=202.54 Aligned_cols=149 Identities=27% Similarity=0.386 Sum_probs=131.6
Q ss_pred cCCcccceeecccCCcceEEEEE-cCCcEEEEEEeccc--ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEE
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 353 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 353 (430)
..-|.+.+.||+|.|++|-+|++ -.|..||||++.+. .......+.+|++.|+.++|||||+||++..+...+|||+
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 35678889999999999999984 46999999999864 3444567889999999999999999999999999999999
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEE-cCCCCeeecCCCccccC
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLL-DQDMNPKISDFGLARAF 430 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl-~~~~~~kl~DFGlar~~ 430 (430)
|+=.+|+|.++|-.... .+.+..+.+++.||+.|+.|.|+.+ +|||||||+|+++ .+-|-|||+|||++-.|
T Consensus 97 ELGD~GDl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf 169 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKF 169 (864)
T ss_pred EecCCchHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccC
Confidence 99999999999966553 4899999999999999999999988 9999999999987 45689999999998643
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-23 Score=200.14 Aligned_cols=140 Identities=26% Similarity=0.437 Sum_probs=116.4
Q ss_pred eeecccCCcceEEEEEc---CCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEe--CCEEEEEEEccCC
Q 047619 284 NKLGEGGFGPVYKGTLV---DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ--GEEKLLIYEFVPN 358 (430)
Q Consensus 284 ~~ig~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~ 358 (430)
.+||+|+||.||+|... +++.+|+|.+.... ....+.+|+.++++++||||+++++++.. +...+++|||++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE- 83 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-
Confidence 68999999999999864 36789999986432 23456789999999999999999999864 456789999986
Q ss_pred CChhHHhhcCC------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEE----cCCCCeeecCCCccc
Q 047619 359 KSLDSFIFDQE------RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLL----DQDMNPKISDFGLAR 428 (430)
Q Consensus 359 gsL~~~l~~~~------~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl----~~~~~~kl~DFGlar 428 (430)
++|.+++.... ....+++..+..++.||+.||.|||+++ |+||||||+|||+ +..+.+||+|||+|+
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 84 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 57877764321 1235888999999999999999999998 9999999999999 456789999999997
Q ss_pred c
Q 047619 429 A 429 (430)
Q Consensus 429 ~ 429 (430)
.
T Consensus 161 ~ 161 (317)
T cd07868 161 L 161 (317)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.90 E-value=4e-23 Score=199.48 Aligned_cols=142 Identities=20% Similarity=0.273 Sum_probs=124.4
Q ss_pred cceeeccc--CCcceEEEEE-cCCcEEEEEEeccc--ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEcc
Q 047619 282 INNKLGEG--GFGPVYKGTL-VDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFV 356 (430)
Q Consensus 282 ~~~~ig~G--~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 356 (430)
+.++||+| +|++||++.. .+++.||+|++... .....+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 6789999986 45899999998642 2344567888999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcc
Q 047619 357 PNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427 (430)
Q Consensus 357 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla 427 (430)
++++|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++++||+.+
T Consensus 82 ~~~~l~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~ 148 (327)
T cd08227 82 AYGSAKDLICTHFM-DGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSN 148 (327)
T ss_pred CCCcHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchh
Confidence 99999999864322 34889999999999999999999988 999999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.7e-23 Score=192.08 Aligned_cols=146 Identities=30% Similarity=0.525 Sum_probs=132.1
Q ss_pred cCCcccceeecccCCcceEEEEEcC-CcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEc
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 355 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 355 (430)
.++|++.+.||+|+||.||+|...+ ++.+++|.+.... ..+++.+|++++++++||||+++++.+......++++||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH--HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 3679999999999999999999765 7899999987532 267899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 356 VPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 356 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++..
T Consensus 80 ~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~ 148 (256)
T cd06612 80 CGAGSVSDIMKIT--NKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQ 148 (256)
T ss_pred CCCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchh
Confidence 9999999998543 245899999999999999999999988 99999999999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.5e-23 Score=192.36 Aligned_cols=145 Identities=31% Similarity=0.524 Sum_probs=130.7
Q ss_pred CcccceeecccCCcceEEEEEc-CCcEEEEEEecccCh--HhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEc
Q 047619 279 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISE--QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 355 (430)
Q Consensus 279 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 355 (430)
+|++.+.||+|+||.||++... +++.+|+|.+..... ...+.+.+|+.+++.++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5788899999999999999864 588999999875333 4678899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 356 VPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 356 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+++++|.+++... ..+++..+..++.+++.||.|||+.+ |+|+||+|+||++++++.+||+|||+++.
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~ 148 (264)
T cd06626 81 CSGGTLEELLEHG---RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVK 148 (264)
T ss_pred CCCCcHHHHHhhc---CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccc
Confidence 9999999998543 34788899999999999999999988 99999999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.4e-23 Score=191.59 Aligned_cols=149 Identities=29% Similarity=0.477 Sum_probs=132.6
Q ss_pred CCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEc
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 355 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 355 (430)
++|++.+.||.|+||.||+|... ++..+|+|++... .......+.+|+.+++.++|+||+++++.+...+..++|||+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47899999999999999999864 5789999998642 233567899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 356 VPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 356 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+++++|.+++........+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.++|+|||++..
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~ 151 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSAS 151 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHH
Confidence 999999999965433345899999999999999999999988 99999999999999999999999999864
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.7e-23 Score=196.11 Aligned_cols=145 Identities=24% Similarity=0.325 Sum_probs=127.6
Q ss_pred CcccceeecccCCcceEEEEE----cCCcEEEEEEecccC----hHhHHHHHHHHHHHhcC-CCCcccceEEEEEeCCEE
Q 047619 279 NFSINNKLGEGGFGPVYKGTL----VDGQEIAVKRLSKIS----EQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEK 349 (430)
Q Consensus 279 ~~~~~~~ig~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 349 (430)
+|++.+.||+|+||.||+|.. .++..||+|.+.... ....+.+.+|+.++.++ +|+||+++++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478889999999999999985 357899999986422 22346778899999999 589999999999999999
Q ss_pred EEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 350 LLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 350 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQR---ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 9999999999999998543 34788899999999999999999988 99999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-23 Score=198.72 Aligned_cols=144 Identities=28% Similarity=0.475 Sum_probs=128.3
Q ss_pred CcccceeecccCCcceEEEEEc-CCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEccC
Q 047619 279 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVP 357 (430)
Q Consensus 279 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 357 (430)
.|.....||+|+||.||++... ++..+|||++........+.+.+|+.+++.++||||+++++.+..++..++||||++
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 3444578999999999999864 588999999876555667778999999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 358 NKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 358 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++.
T Consensus 103 ~~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~ 167 (292)
T cd06658 103 GGALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQ 167 (292)
T ss_pred CCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhh
Confidence 9999998843 23788999999999999999999988 99999999999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.6e-25 Score=204.65 Aligned_cols=145 Identities=28% Similarity=0.471 Sum_probs=130.1
Q ss_pred CCcccceeecccCCcceEEEEE-cCCcEEEEEEecc-cChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEc
Q 047619 278 DNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 355 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 355 (430)
..|+..+.||+|+||.||+|.. ..++.||+|++.- ......+.+++|+.++..++++||.++|+.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 4577779999999999999996 4488999999974 3445578899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCccc
Q 047619 356 VPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428 (430)
Q Consensus 356 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar 428 (430)
+.||++.+.+.. ...+++..+..|+++++.||.|||.++ .+|||||+.|||+..+|.+||+|||+|-
T Consensus 93 ~~gGsv~~lL~~---~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ 159 (467)
T KOG0201|consen 93 CGGGSVLDLLKS---GNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAG 159 (467)
T ss_pred hcCcchhhhhcc---CCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceee
Confidence 999999999843 344688888899999999999999998 9999999999999999999999999974
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.3e-23 Score=193.90 Aligned_cols=145 Identities=28% Similarity=0.481 Sum_probs=130.8
Q ss_pred CCcccceeecccCCcceEEEEEc-CCcEEEEEEecccC-hHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEc
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 355 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 355 (430)
++|++.+.||.|++|.||+|... +++.+|+|.+.... ......+.+|+.+++.++|+||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 46888899999999999999965 48899999986432 44556788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 356 VPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 356 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+++++|.+++... .+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++.
T Consensus 81 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~ 147 (274)
T cd06609 81 CGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQ 147 (274)
T ss_pred eCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccccccee
Confidence 9999999998543 5899999999999999999999988 99999999999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-23 Score=198.20 Aligned_cols=146 Identities=31% Similarity=0.470 Sum_probs=129.1
Q ss_pred CCcccceeecccCCcceEEEEEc-CCcEEEEEEecccC--hHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 354 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 354 (430)
++|++.++||+|+||.||+|... .++.+|+|++.+.. ....+.+.+|+++++.++||||+++++++..+...++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46889999999999999999975 48899999886422 2235678899999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 355 FVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 355 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|+++++|..++... ..+++..+..++.|++.||.|||+.+ |+|+||+|+||++++++.++|+|||+++.
T Consensus 81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~ 149 (286)
T cd07846 81 FVDHTVLDDLEKYP---NGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFART 149 (286)
T ss_pred cCCccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeee
Confidence 99999998876432 34899999999999999999999988 99999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.3e-23 Score=191.33 Aligned_cols=146 Identities=29% Similarity=0.497 Sum_probs=127.7
Q ss_pred CCcccceeecccCCcceEEEEEc-CCcEEEEEEecc-----cChHhHHHHHHHHHHHhcCCCCcccceEEEEEeC--CEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK-----ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEK 349 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~-----~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 349 (430)
.+|.+.+.||+|+||.||+|... +++.+|+|.+.. ...+....+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47889999999999999999864 488999998742 1234556889999999999999999999998764 457
Q ss_pred EEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 350 LLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 350 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++++||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY---GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 8999999999999998543 34788899999999999999999998 99999999999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.9e-24 Score=206.44 Aligned_cols=133 Identities=33% Similarity=0.522 Sum_probs=119.2
Q ss_pred ceeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEccCCCChh
Q 047619 283 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLD 362 (430)
Q Consensus 283 ~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 362 (430)
++-||.|+-|.||+|++ .++.||||++.... ..+|+-|++|+|||||.+.|+|....-++||||||..|.|.
T Consensus 129 LeWlGSGaQGAVF~Grl-~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~ 200 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRL-HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY 200 (904)
T ss_pred hhhhccCcccceeeeec-cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence 45799999999999997 47899999986432 24778899999999999999999999999999999999999
Q ss_pred HHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 363 SFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 363 ~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
..|+.. ..+.......+..+||.|+.|||.+. |||||||..||||..+..|||+|||.+|.
T Consensus 201 ~VLka~---~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e 261 (904)
T KOG4721|consen 201 EVLKAG---RPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKE 261 (904)
T ss_pred HHHhcc---CccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHh
Confidence 999543 45777888899999999999999987 99999999999999999999999999875
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.4e-23 Score=197.86 Aligned_cols=147 Identities=29% Similarity=0.449 Sum_probs=125.7
Q ss_pred CcccceeecccCCcceEEEEEc---CCcEEEEEEecccC---hHhHHHHHHHHHHHhcCCCCcccceEEEEEeC--CEEE
Q 047619 279 NFSINNKLGEGGFGPVYKGTLV---DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKL 350 (430)
Q Consensus 279 ~~~~~~~ig~G~fg~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 350 (430)
+|++.++||+|+||.||+|... .++.+|+|.+.... ......+.+|+.++.+++||||+++++++... ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4788899999999999999964 47899999987632 33346678899999999999999999999988 8899
Q ss_pred EEEEccCCCChhHHhhcCCC--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcC----CCCeeecCC
Q 047619 351 LIYEFVPNKSLDSFIFDQER--CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ----DMNPKISDF 424 (430)
Q Consensus 351 lv~e~~~~gsL~~~l~~~~~--~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~----~~~~kl~DF 424 (430)
+||||+++ +|.+++..... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 66666643221 235889999999999999999999988 999999999999999 899999999
Q ss_pred Ccccc
Q 047619 425 GLARA 429 (430)
Q Consensus 425 Glar~ 429 (430)
|+|+.
T Consensus 157 g~~~~ 161 (316)
T cd07842 157 GLARL 161 (316)
T ss_pred ccccc
Confidence 99874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.6e-23 Score=193.43 Aligned_cols=145 Identities=32% Similarity=0.482 Sum_probs=127.5
Q ss_pred CcccceeecccCCcceEEEEEc-CCcEEEEEEecccC----------hHhHHHHHHHHHHHhcCCCCcccceEEEEEeCC
Q 047619 279 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS----------EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE 347 (430)
Q Consensus 279 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 347 (430)
+|.+.+.||+|+||.||+|... +++.+|+|.+.... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4778899999999999999854 58899999875311 112356788999999999999999999999999
Q ss_pred EEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcc
Q 047619 348 EKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427 (430)
Q Consensus 348 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla 427 (430)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 999999999999999998544 35888999999999999999999988 999999999999999999999999998
Q ss_pred cc
Q 047619 428 RA 429 (430)
Q Consensus 428 r~ 429 (430)
+.
T Consensus 156 ~~ 157 (272)
T cd06629 156 KK 157 (272)
T ss_pred cc
Confidence 64
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-23 Score=195.57 Aligned_cols=145 Identities=28% Similarity=0.491 Sum_probs=128.8
Q ss_pred CCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEc
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 355 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 355 (430)
+.|+..+.||+|+||.||+|... ++..||+|.+... .....+.+.+|+.++++++||||+++++.+......++||||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 34777789999999999999864 4788999988643 234566789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 356 VPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 356 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++.
T Consensus 84 ~~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~ 150 (277)
T cd06642 84 LGGGSALDLLKP----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQ 150 (277)
T ss_pred cCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEcccccccc
Confidence 999999998843 34788999999999999999999988 99999999999999999999999999874
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.4e-23 Score=195.74 Aligned_cols=146 Identities=23% Similarity=0.330 Sum_probs=130.0
Q ss_pred CCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEc
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 355 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 355 (430)
++|++.+.||+|+||.||++... +++.+|+|++... .....+.+.+|+++++.++||||+++++++...+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 57888999999999999999864 5889999987643 344567889999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 356 VPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD-SRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 356 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+++++|..++... ..+++..+..++.+++.||.|||+. + |+||||||+||++++++.++|+|||+++.
T Consensus 85 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~ 153 (284)
T cd06620 85 MDCGSLDRIYKKG---GPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGE 153 (284)
T ss_pred CCCCCHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccc
Confidence 9999999988542 3589999999999999999999974 5 99999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-23 Score=194.18 Aligned_cols=141 Identities=26% Similarity=0.474 Sum_probs=121.8
Q ss_pred eeecccCCcceEEEEEcC--------CcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEc
Q 047619 284 NKLGEGGFGPVYKGTLVD--------GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 355 (430)
Q Consensus 284 ~~ig~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 355 (430)
+.||+|+||.||+|.... ...+|+|.+........+.+.+|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998532 234888887654455567788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCC--------eeecCCCcc
Q 047619 356 VPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMN--------PKISDFGLA 427 (430)
Q Consensus 356 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~--------~kl~DFGla 427 (430)
+++++|..++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. ++++|||++
T Consensus 81 ~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 99999999996543 35789999999999999999999988 999999999999987765 699999988
Q ss_pred cc
Q 047619 428 RA 429 (430)
Q Consensus 428 r~ 429 (430)
..
T Consensus 156 ~~ 157 (258)
T cd05078 156 IT 157 (258)
T ss_pred cc
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.8e-23 Score=190.66 Aligned_cols=146 Identities=27% Similarity=0.378 Sum_probs=132.5
Q ss_pred CCcccceeecccCCcceEEEEEcC-CcEEEEEEecccCh-HhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEc
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISE-QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 355 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 355 (430)
++|++.+.||+|++|.||+|.... ++.+++|++..... .....+.+|+.++.+++|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 368888999999999999999764 89999999875433 4567899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 356 VPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ-DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 356 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~-~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+++++|.+++... ..+++..+..++.|++.||.|||+ .+ ++|+||+|+||+++.++.++|+|||+++.
T Consensus 81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~ 149 (264)
T cd06623 81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKV 149 (264)
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCcccee
Confidence 9999999999643 458999999999999999999999 88 99999999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.7e-23 Score=189.75 Aligned_cols=147 Identities=27% Similarity=0.397 Sum_probs=128.0
Q ss_pred CcccceeecccCCcceEEEEEc-CCcEEEEEEeccc--ChHhHHHHHHHHHHHhcCCCCcccceEEEEEe-CCEEEEEEE
Q 047619 279 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ-GEEKLLIYE 354 (430)
Q Consensus 279 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e 354 (430)
+|++.+.||+|++|.||++... +++.+|+|++... .....+.+.+|+.++++++|+|++++++.+.. ....+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4888999999999999999864 4788999998642 33456678899999999999999999998764 446789999
Q ss_pred ccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 355 FVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 355 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|+++++|.+++.... ...+++.++..++.+++.||++||+.+ |+|+||||+||+++.++.++|+|||+++.
T Consensus 81 ~~~~~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~ 151 (257)
T cd08223 81 FCEGGDLYHKLKEQK-GKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARV 151 (257)
T ss_pred ccCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEE
Confidence 999999999986532 345899999999999999999999998 99999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.8e-23 Score=189.38 Aligned_cols=147 Identities=24% Similarity=0.411 Sum_probs=130.4
Q ss_pred CcccceeecccCCcceEEEEEc-CCcEEEEEEecc--cChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEc
Q 047619 279 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 355 (430)
Q Consensus 279 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 355 (430)
+|++.+.||+|+||.||++... +++.+|+|.+.. ......+++.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 5888999999999999999864 588999999863 2344556889999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 356 VPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 356 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||+|+|||++.++.++|+|||+++.
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~ 150 (256)
T cd08218 81 CEGGDLYKKINAQR-GVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARV 150 (256)
T ss_pred CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceee
Confidence 99999999885432 234788999999999999999999988 99999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-23 Score=212.68 Aligned_cols=150 Identities=24% Similarity=0.373 Sum_probs=118.5
Q ss_pred hhcCCcccceeecccCCcceEEEEEcC--CcEEEEE------------------EecccChHhHHHHHHHHHHHhcCCCC
Q 047619 275 NATDNFSINNKLGEGGFGPVYKGTLVD--GQEIAVK------------------RLSKISEQGLKELKNEVILFSKLQHR 334 (430)
Q Consensus 275 ~~~~~~~~~~~ig~G~fg~Vy~~~~~~--~~~vavK------------------~~~~~~~~~~~~~~~E~~~l~~l~h~ 334 (430)
...++|++.++||+|+||.||++.... +...++| .+. ........+.+|+.++.+++||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCC
Confidence 345789999999999999999987432 2112222 111 1233456788999999999999
Q ss_pred cccceEEEEEeCCEEEEEEEccCCCChhHHhhcCCC--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEE
Q 047619 335 NLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQER--CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVL 412 (430)
Q Consensus 335 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NIL 412 (430)
||+++++++...+..++|+|++. ++|..++..... ........+..++.||+.||+|||+++ |+||||||+|||
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NIL 299 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIF 299 (501)
T ss_pred CcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEE
Confidence 99999999999999999999985 567666643211 112345667789999999999999988 999999999999
Q ss_pred EcCCCCeeecCCCcccc
Q 047619 413 LDQDMNPKISDFGLARA 429 (430)
Q Consensus 413 l~~~~~~kl~DFGlar~ 429 (430)
|+.++.+||+|||+|+.
T Consensus 300 l~~~~~vkL~DFGla~~ 316 (501)
T PHA03210 300 LNCDGKIVLGDFGTAMP 316 (501)
T ss_pred ECCCCCEEEEeCCCcee
Confidence 99999999999999974
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.2e-23 Score=196.47 Aligned_cols=146 Identities=32% Similarity=0.608 Sum_probs=124.8
Q ss_pred CCcccceeecccCCcceEEEEEc-CCc----EEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV-DGQ----EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 351 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 351 (430)
++|+..+.||+|+||.||+|... ++. .+|+|.+... ......++.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 46788899999999999999853 343 5788888653 233345788999999999999999999998754 4679
Q ss_pred EEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 352 IYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 352 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++||+++|+|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 86 v~e~~~~g~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHK--DNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred eehhcCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccc
Confidence 999999999999986432 34788999999999999999999988 99999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.90 E-value=8e-23 Score=190.67 Aligned_cols=141 Identities=33% Similarity=0.580 Sum_probs=120.3
Q ss_pred eeecccCCcceEEEEEcC----CcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEe-CCEEEEEEEccC
Q 047619 284 NKLGEGGFGPVYKGTLVD----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ-GEEKLLIYEFVP 357 (430)
Q Consensus 284 ~~ig~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~~ 357 (430)
+.||+|+||.||+|...+ ...+|+|++... .....+.+.+|+.+++.++||||+++++++.. +...+++|||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 368999999999998532 357999998642 34556788899999999999999999998764 456789999999
Q ss_pred CCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 358 NKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 358 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+++|.+++.... ...++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+|+.
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~ 147 (262)
T cd05058 81 HGDLRNFIRSET--HNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARD 147 (262)
T ss_pred CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCcccccc
Confidence 999999986432 23677788899999999999999988 99999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.4e-23 Score=192.37 Aligned_cols=145 Identities=28% Similarity=0.482 Sum_probs=129.8
Q ss_pred CCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEc
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 355 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 355 (430)
..|+..+.||.|+||.||+|... .+..+|+|.+... .......+.+|+.+++.+.||||+++++.+.++...++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 45778899999999999999864 4889999988643 345567889999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 356 VPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 356 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+++++|.+++.. ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||+++.
T Consensus 84 ~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~ 150 (277)
T cd06640 84 LGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQ 150 (277)
T ss_pred CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEccccccee
Confidence 999999999853 24788899999999999999999988 99999999999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.5e-23 Score=192.28 Aligned_cols=151 Identities=30% Similarity=0.510 Sum_probs=131.3
Q ss_pred hhcCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccChHhHHHHHHHHHHHhcC-CCCcccceEEEEEeCC-----
Q 047619 275 NATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGE----- 347 (430)
Q Consensus 275 ~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~----- 347 (430)
...++|++.+.||+|++|.||+|... +++.+++|.+.... ...+.+.+|+.+++++ .|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 35689999999999999999999975 47889999987533 3456789999999999 6999999999997654
Q ss_pred -EEEEEEEccCCCChhHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCC
Q 047619 348 -EKLLIYEFVPNKSLDSFIFDQE-RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 425 (430)
Q Consensus 348 -~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFG 425 (430)
..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ |+|+||+|+||++++++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence 4899999999999999886432 2346889999999999999999999988 9999999999999999999999999
Q ss_pred cccc
Q 047619 426 LARA 429 (430)
Q Consensus 426 lar~ 429 (430)
+++.
T Consensus 159 ~~~~ 162 (275)
T cd06608 159 VSAQ 162 (275)
T ss_pred ccee
Confidence 8863
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-23 Score=196.61 Aligned_cols=145 Identities=27% Similarity=0.466 Sum_probs=126.4
Q ss_pred CcccceeecccCCcceEEEEEc-CCcEEEEEEeccc--ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEc
Q 047619 279 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 355 (430)
Q Consensus 279 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 355 (430)
+|++.+.||+|+||.||+|... +++.+|+|++... .......+.+|+.++++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4788899999999999999965 5889999998642 222345677899999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 356 VPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 356 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++ ++|.+++... ...+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 81 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~ 148 (284)
T cd07839 81 CD-QDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARA 148 (284)
T ss_pred CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhc
Confidence 97 5787777543 235899999999999999999999988 99999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-22 Score=191.36 Aligned_cols=144 Identities=28% Similarity=0.475 Sum_probs=128.5
Q ss_pred CcccceeecccCCcceEEEEEc-CCcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEcc
Q 047619 279 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFV 356 (430)
Q Consensus 279 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 356 (430)
-|++.+.||+|+||.||+|... ++..+|+|.+... .......+.+|+.++.+++||||+++++++..++..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 4777899999999999999864 5789999987642 2344567889999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 357 PNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 357 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++++|.+++.. ..+++..+..++.+++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 85 ~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~ 150 (277)
T cd06641 85 GGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQ 150 (277)
T ss_pred CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeeccccee
Confidence 99999999843 24789999999999999999999988 99999999999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=7e-23 Score=194.53 Aligned_cols=148 Identities=30% Similarity=0.429 Sum_probs=125.9
Q ss_pred CCcccceeecccCCcceEEEEEc-CCcEEEEEEecccC--hHhHHHHHHHHHHHhcCC-CCcccceEEEEEeCCE-----
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEE----- 348 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~----- 348 (430)
++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.+++++. ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46889999999999999999964 58899999876422 223456888999999995 6999999999987766
Q ss_pred EEEEEEccCCCChhHHhhcCCC--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcC-CCCeeecCCC
Q 047619 349 KLLIYEFVPNKSLDSFIFDQER--CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFG 425 (430)
Q Consensus 349 ~~lv~e~~~~gsL~~~l~~~~~--~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DFG 425 (430)
.++||||+++ +|.+++..... ...+++..+..++.||+.||.|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999985 78888754322 245899999999999999999999988 999999999999998 8899999999
Q ss_pred cccc
Q 047619 426 LARA 429 (430)
Q Consensus 426 lar~ 429 (430)
+++.
T Consensus 157 ~~~~ 160 (295)
T cd07837 157 LGRA 160 (295)
T ss_pred ccee
Confidence 9874
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=7e-23 Score=194.66 Aligned_cols=146 Identities=27% Similarity=0.510 Sum_probs=131.0
Q ss_pred hcCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 354 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 354 (430)
..++|.+.+.||+|+||.||++... +++.+|+|.+........+.+.+|+.++++++||||+++++.+...+..++|+|
T Consensus 17 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e 96 (293)
T cd06647 17 PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVME 96 (293)
T ss_pred chhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEe
Confidence 3468999999999999999999854 578999999865444456778899999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCccc
Q 047619 355 FVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428 (430)
Q Consensus 355 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar 428 (430)
|+++++|.+++... .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.
T Consensus 97 ~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~ 163 (293)
T cd06647 97 YLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCA 163 (293)
T ss_pred cCCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCccee
Confidence 99999999998532 3788899999999999999999998 9999999999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-22 Score=190.66 Aligned_cols=147 Identities=29% Similarity=0.524 Sum_probs=124.3
Q ss_pred cccceeecccCCcceEEEEEc----CCcEEEEEEeccc--ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCC------
Q 047619 280 FSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE------ 347 (430)
Q Consensus 280 ~~~~~~ig~G~fg~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 347 (430)
|.+.+.||+|+||.||+|... .++.+|||.+... .....+++.+|+.++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999999853 3678999988642 3445677899999999999999999999887543
Q ss_pred EEEEEEEccCCCChhHHhhcCC---CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCC
Q 047619 348 EKLLIYEFVPNKSLDSFIFDQE---RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDF 424 (430)
Q Consensus 348 ~~~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DF 424 (430)
..++++||+++++|..++.... ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2478999999999998875321 1224788899999999999999999988 999999999999999999999999
Q ss_pred Ccccc
Q 047619 425 GLARA 429 (430)
Q Consensus 425 Glar~ 429 (430)
|+|+.
T Consensus 158 g~~~~ 162 (273)
T cd05074 158 GLSKK 162 (273)
T ss_pred ccccc
Confidence 99874
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-23 Score=185.14 Aligned_cols=137 Identities=19% Similarity=0.187 Sum_probs=107.0
Q ss_pred ceeecccCCcceEEEEEcCCcEEEEEEecccCh--Hh------------------------HHHHHHHHHHHhcCCCCcc
Q 047619 283 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISE--QG------------------------LKELKNEVILFSKLQHRNL 336 (430)
Q Consensus 283 ~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~------------------------~~~~~~E~~~l~~l~h~ni 336 (430)
.+.||+|+||.||+|...+|+.||||++..... .. .....+|+.++.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 468999999999999987899999999864211 01 1123459999999988876
Q ss_pred cceEEEEEeCCEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHh-hhcCCCcEEeCCCCCCcEEEcC
Q 047619 337 VKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL-HQDSRLRIIHRDLKASNVLLDQ 415 (430)
Q Consensus 337 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yL-H~~~~~~iiH~Dlkp~NILl~~ 415 (430)
........ ...+|||||++++++...+... ..++...+..++.|++.+|.++ |+.+ |+||||||+|||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~---~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD---APLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence 54433322 2338999999988776543222 3578899999999999999999 6777 99999999999998
Q ss_pred CCCeeecCCCccc
Q 047619 416 DMNPKISDFGLAR 428 (430)
Q Consensus 416 ~~~~kl~DFGlar 428 (430)
++.++|+|||+|.
T Consensus 153 ~~~v~LiDFG~a~ 165 (190)
T cd05147 153 DGKLYIIDVSQSV 165 (190)
T ss_pred CCcEEEEEccccc
Confidence 4789999999996
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.8e-23 Score=196.85 Aligned_cols=143 Identities=29% Similarity=0.463 Sum_probs=127.1
Q ss_pred cccceeecccCCcceEEEEEc-CCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEccCC
Q 047619 280 FSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPN 358 (430)
Q Consensus 280 ~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 358 (430)
|.....||+|+||.||++... +++.||+|.+........+.+.+|+.++..++||||+++++.+..++..+++|||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 444568999999999999864 5889999998654444566788999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 359 KSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 359 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++|..++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 103 ~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~ 166 (297)
T cd06659 103 GALTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQ 166 (297)
T ss_pred CCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhh
Confidence 999998743 34789999999999999999999988 99999999999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=5e-23 Score=195.50 Aligned_cols=146 Identities=32% Similarity=0.446 Sum_probs=127.3
Q ss_pred CCcccceeecccCCcceEEEEEc-CCcEEEEEEecccC--hHhHHHHHHHHHHHhcCCCCcccceEEEEEeC--CEEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKLLI 352 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 352 (430)
++|++.+.||+|+||.||+|... +++.+|+|.+.... ......+.+|+.++.+++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 57889999999999999999975 47899999986422 22334567899999999999999999999887 889999
Q ss_pred EEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 353 YEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 353 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|||++ ++|.+++.... ..+++..+..++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||+++.
T Consensus 85 ~e~~~-~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~ 155 (293)
T cd07843 85 MEYVE-HDLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLARE 155 (293)
T ss_pred ehhcC-cCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceee
Confidence 99997 48988885433 35899999999999999999999988 99999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=189.35 Aligned_cols=139 Identities=37% Similarity=0.582 Sum_probs=121.6
Q ss_pred eeecccCCcceEEEEEcC----CcEEEEEEecccCh-HhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEccCC
Q 047619 284 NKLGEGGFGPVYKGTLVD----GQEIAVKRLSKISE-QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPN 358 (430)
Q Consensus 284 ~~ig~G~fg~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 358 (430)
++||+|+||.||+|.... +..+|+|.+..... ...+++.+|+.+++.+.||||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999997532 26899999875332 35677899999999999999999999875 5568999999999
Q ss_pred CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 359 KSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 359 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++|.+++.... .+++..+..++.|++.||+|||..+ ++|+||||+|||++.++.+||+|||+|+.
T Consensus 80 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~ 144 (257)
T cd05060 80 GPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRA 144 (257)
T ss_pred CcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccce
Confidence 99999996543 5889999999999999999999988 99999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=6e-23 Score=191.75 Aligned_cols=147 Identities=27% Similarity=0.383 Sum_probs=131.4
Q ss_pred CCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEc
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 355 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 355 (430)
++|++.+.||+|++|.||++... +++.+|+|.+... ......++.+|+.++++++||||+++++.+......++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 36788899999999999999875 5889999998753 345567789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 356 VPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ-DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 356 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~-~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+++++|.+++.... ..+++..+..++.|++.||+|||+ .+ ++|+||||+||++++++.++|+|||+++.
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~ 150 (265)
T cd06605 81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQ 150 (265)
T ss_pred cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchh
Confidence 99999999986542 468899999999999999999999 77 99999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.89 E-value=9e-23 Score=195.91 Aligned_cols=140 Identities=28% Similarity=0.444 Sum_probs=116.0
Q ss_pred eeecccCCcceEEEEEcC---CcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEe--CCEEEEEEEccCC
Q 047619 284 NKLGEGGFGPVYKGTLVD---GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ--GEEKLLIYEFVPN 358 (430)
Q Consensus 284 ~~ig~G~fg~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~ 358 (430)
.+||+|+||.||+|...+ +..+|+|.+.... ....+.+|+.++++++||||+++++++.. ....++||||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 689999999999998643 5789999987532 23457789999999999999999999854 4577999999864
Q ss_pred CChhHHhhcC------CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEE----cCCCCeeecCCCccc
Q 047619 359 KSLDSFIFDQ------ERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLL----DQDMNPKISDFGLAR 428 (430)
Q Consensus 359 gsL~~~l~~~------~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl----~~~~~~kl~DFGlar 428 (430)
+|.+++... .....+++..+..++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||+|+
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 777766421 12235788899999999999999999988 9999999999999 556789999999997
Q ss_pred c
Q 047619 429 A 429 (430)
Q Consensus 429 ~ 429 (430)
.
T Consensus 161 ~ 161 (317)
T cd07867 161 L 161 (317)
T ss_pred c
Confidence 5
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=191.41 Aligned_cols=144 Identities=27% Similarity=0.475 Sum_probs=128.7
Q ss_pred CcccceeecccCCcceEEEEE-cCCcEEEEEEeccc-ChHhHHHHHHHHHHHhcCC---CCcccceEEEEEeCCEEEEEE
Q 047619 279 NFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQ---HRNLVKLLGCCIQGEEKLLIY 353 (430)
Q Consensus 279 ~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~ 353 (430)
.|++.+.||+|+||.||+|.. .+++.+|+|.+... ......++.+|+.++++++ |||++++++++......++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477889999999999999996 45889999998643 3445677889999999996 999999999999999999999
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||+++++|.+++... .+++..+..++.|++.||.|||+.+ |+|+||+|+||++++++.++|+|||+++.
T Consensus 82 e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 150 (277)
T cd06917 82 EYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAAL 150 (277)
T ss_pred ecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceee
Confidence 999999999998432 5889999999999999999999988 99999999999999999999999998864
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.9e-23 Score=193.74 Aligned_cols=146 Identities=28% Similarity=0.430 Sum_probs=128.7
Q ss_pred CCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc--ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 354 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 354 (430)
++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|++++++++|+||+++++++...+..+++||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36889999999999999999875 4789999988642 23345778999999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 355 FVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 355 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|++++.+..++... ..+++..+..++.|++.||.|||+.+ |+|+||+|+||++++++.+||+|||+++.
T Consensus 81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~ 149 (288)
T cd07833 81 YVERTLLELLEASP---GGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARA 149 (288)
T ss_pred cCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccc
Confidence 99987777665332 34889999999999999999999988 99999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=187.85 Aligned_cols=147 Identities=24% Similarity=0.419 Sum_probs=129.1
Q ss_pred CcccceeecccCCcceEEEEEc-CCcEEEEEEeccc--ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEc
Q 047619 279 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 355 (430)
Q Consensus 279 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 355 (430)
+|++.+.||+|+||.||++... +++.+|+|.+... .......+.+|+.++++++||||+++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5888999999999999999864 5889999998642 334567889999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCC-CeeecCCCcccc
Q 047619 356 VPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLARA 429 (430)
Q Consensus 356 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DFGlar~ 429 (430)
+++++|.+++.... ...+++..+..++.+++.||+|||+++ |+|+||||+||++++++ .+||+|||+++.
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~ 151 (256)
T cd08220 81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKI 151 (256)
T ss_pred CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCcee
Confidence 99999999996533 345889999999999999999999988 99999999999998654 589999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-22 Score=186.64 Aligned_cols=145 Identities=33% Similarity=0.543 Sum_probs=131.1
Q ss_pred CcccceeecccCCcceEEEEEc-CCcEEEEEEecccCh--HhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEc
Q 047619 279 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISE--QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 355 (430)
Q Consensus 279 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 355 (430)
+|++.+.||+|++|.||++... +++.+++|.+..... ...+.+.+|++++.+++|||++++++++.+.+..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4788899999999999999865 478999999876432 4667899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 356 VPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 356 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||+|+.
T Consensus 81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~ 148 (254)
T cd06627 81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATK 148 (254)
T ss_pred CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEecccccee
Confidence 9999999998543 45899999999999999999999988 99999999999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1e-22 Score=192.15 Aligned_cols=154 Identities=30% Similarity=0.497 Sum_probs=131.2
Q ss_pred HhHHhhcCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccChHhHHHHHHHHHHHhcC-CCCcccceEEEEEe---
Q 047619 271 ATIANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQ--- 345 (430)
Q Consensus 271 ~~~~~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~--- 345 (430)
.++....+.|++.+.||.|+||.||+|... +++.+|+|.+... ......+..|+.++.++ +|+||+++++++..
T Consensus 9 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 87 (282)
T cd06636 9 SALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSP 87 (282)
T ss_pred hhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccc
Confidence 344445678999999999999999999964 4789999988653 34456788899999998 69999999999863
Q ss_pred ---CCEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeec
Q 047619 346 ---GEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 422 (430)
Q Consensus 346 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~ 422 (430)
....+++|||+++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.++|+
T Consensus 88 ~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~ 163 (282)
T cd06636 88 PGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLV 163 (282)
T ss_pred cCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEe
Confidence 457899999999999999986533 245788889999999999999999988 9999999999999999999999
Q ss_pred CCCcccc
Q 047619 423 DFGLARA 429 (430)
Q Consensus 423 DFGlar~ 429 (430)
|||+++.
T Consensus 164 dfg~~~~ 170 (282)
T cd06636 164 DFGVSAQ 170 (282)
T ss_pred eCcchhh
Confidence 9999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=191.65 Aligned_cols=140 Identities=31% Similarity=0.415 Sum_probs=123.1
Q ss_pred ecccCCcceEEEEEc-CCcEEEEEEecccC---hHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEccCCCCh
Q 047619 286 LGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSL 361 (430)
Q Consensus 286 ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 361 (430)
||+|+||.||++... +++.+|+|.+.... ......+.+|+.+++.++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999854 58899999986421 22345667899999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 362 DSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 362 ~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
.+++..... ..+++..+..++.|++.||.|||+.+ |+|+||+|+||++++++.+||+|||+++.
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~ 144 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVE 144 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhh
Confidence 999865432 35899999999999999999999988 99999999999999999999999998863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.3e-23 Score=193.32 Aligned_cols=146 Identities=31% Similarity=0.499 Sum_probs=127.8
Q ss_pred CcccceeecccCCcceEEEEEc-CCcEEEEEEecccC--hHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEc
Q 047619 279 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 355 (430)
Q Consensus 279 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 355 (430)
+|++.+.||.|++|.||+|... +++.+|||++.... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999864 58899999886422 22345788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 356 VPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 356 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++ ++|..++.... ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||+++.
T Consensus 81 ~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~ 149 (284)
T cd07860 81 LH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARA 149 (284)
T ss_pred cc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhh
Confidence 96 68888885543 245899999999999999999999988 99999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=192.38 Aligned_cols=149 Identities=28% Similarity=0.501 Sum_probs=134.2
Q ss_pred HhhcCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEE
Q 047619 274 ANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 352 (430)
Q Consensus 274 ~~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 352 (430)
....+.|++.+.||+|++|.||+|... +++.+++|.+..... ..+.+.+|+++++.++|+||+++++.+...+..+++
T Consensus 15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred CCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 446678999999999999999999975 588999999875433 567788999999999999999999999999999999
Q ss_pred EEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCccc
Q 047619 353 YEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428 (430)
Q Consensus 353 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar 428 (430)
+||+++++|.+++.... ..+++..+..++.+++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.
T Consensus 94 ~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~ 164 (286)
T cd06614 94 MEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAA 164 (286)
T ss_pred EeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhh
Confidence 99999999999996543 36899999999999999999999988 9999999999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-22 Score=190.95 Aligned_cols=149 Identities=28% Similarity=0.362 Sum_probs=128.7
Q ss_pred CCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeC--CEEEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKLLIY 353 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 353 (430)
++|...+.||.|++|.||++... +++.+|+|.+... .......+.+|++++++++||||+++++++... ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46888899999999999999974 4789999998753 334567789999999999999999999988654 4689999
Q ss_pred EccCCCChhHHhhcC-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 354 EFVPNKSLDSFIFDQ-ERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 354 e~~~~gsL~~~l~~~-~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||+++++|.+++... .....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||+++.
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~ 154 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGE 154 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccc
Confidence 999999999887532 22345788999999999999999999988 99999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-23 Score=217.63 Aligned_cols=150 Identities=30% Similarity=0.492 Sum_probs=124.9
Q ss_pred hhcCCcccceeecccCCcceEEEEE-cCCcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEe-------
Q 047619 275 NATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ------- 345 (430)
Q Consensus 275 ~~~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------- 345 (430)
.-..+|+.++.||+||||.||+++. -||+.+|||+|.-. +......+.+|+.++++|+|||||+++..+.+
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 3446788889999999999999994 57999999999742 34456678899999999999999998763310
Q ss_pred --------------------------------------------------------------------------------
Q 047619 346 -------------------------------------------------------------------------------- 345 (430)
Q Consensus 346 -------------------------------------------------------------------------------- 345 (430)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ------------------------C--------CEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 047619 346 ------------------------G--------EEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 393 (430)
Q Consensus 346 ------------------------~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yL 393 (430)
. ..+||-||||+.-+|.+++.++.... .....++++++|+.||.|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHH
Confidence 0 13489999999988888886554321 4677889999999999999
Q ss_pred hhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 394 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 394 H~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|++| ||||||||.||+|+++..|||.|||+|+.
T Consensus 714 H~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~ 746 (1351)
T KOG1035|consen 714 HDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATD 746 (1351)
T ss_pred HhCc---eeeccCCcceeEEcCCCCeeecccccchh
Confidence 9999 99999999999999999999999999974
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-22 Score=196.26 Aligned_cols=149 Identities=29% Similarity=0.472 Sum_probs=128.3
Q ss_pred HHhhcCCcccceeecccCCcceEEEEE-cCCcEEEEEEeccc--ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCC--
Q 047619 273 IANATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-- 347 (430)
Q Consensus 273 ~~~~~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-- 347 (430)
+....++|++.+.||+|+||.||++.. .++..||||++.+. .......+.+|+.++++++||||+++++++....
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 344668899999999999999999985 45889999998642 2334456889999999999999999999987654
Q ss_pred ----EEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecC
Q 047619 348 ----EKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD 423 (430)
Q Consensus 348 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~D 423 (430)
..++||||+ +++|..++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~d 161 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILD 161 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEee
Confidence 358999999 7799888743 34889999999999999999999988 99999999999999999999999
Q ss_pred CCcccc
Q 047619 424 FGLARA 429 (430)
Q Consensus 424 FGlar~ 429 (430)
||+|+.
T Consensus 162 fg~~~~ 167 (343)
T cd07880 162 FGLARQ 167 (343)
T ss_pred cccccc
Confidence 999874
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.2e-22 Score=184.70 Aligned_cols=146 Identities=35% Similarity=0.580 Sum_probs=132.5
Q ss_pred CcccceeecccCCcceEEEEEc-CCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEccC
Q 047619 279 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVP 357 (430)
Q Consensus 279 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 357 (430)
+|++.+.||+|++|.||++... +++.+++|++..........+.+|+.++++++|++|+++++.+......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4778899999999999999975 588999999976554567889999999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 358 NKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 358 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+++|.+++.... ..+++..+..++.|++.||.+||..+ ++|+||+|+||++++++.++|+|||+++.
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~ 147 (253)
T cd05122 81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQ 147 (253)
T ss_pred CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccc
Confidence 999999986542 45899999999999999999999987 99999999999999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=180.09 Aligned_cols=139 Identities=20% Similarity=0.223 Sum_probs=110.1
Q ss_pred ceeecccCCcceEEEEEcCCcEEEEEEecccChH--------------------------hHHHHHHHHHHHhcCCCCcc
Q 047619 283 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQ--------------------------GLKELKNEVILFSKLQHRNL 336 (430)
Q Consensus 283 ~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~h~ni 336 (430)
.+.||+|++|.||+|...+|+.||||++...... ....+.+|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4789999999999999778999999998753110 01234678999999999987
Q ss_pred cceEEEEEeCCEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCcEEeCCCCCCcEEEcC
Q 047619 337 VKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ-DSRLRIIHRDLKASNVLLDQ 415 (430)
Q Consensus 337 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~-~~~~~iiH~Dlkp~NILl~~ 415 (430)
.....+... ..+|||||++++++....... ..++......++.|++.+|.+||+ .+ |+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 655444333 248999999988654432211 346788889999999999999999 87 99999999999998
Q ss_pred CCCeeecCCCccccC
Q 047619 416 DMNPKISDFGLARAF 430 (430)
Q Consensus 416 ~~~~kl~DFGlar~~ 430 (430)
++.++|+|||+|+.+
T Consensus 153 ~~~~~liDFG~a~~~ 167 (190)
T cd05145 153 DGKPYIIDVSQAVEL 167 (190)
T ss_pred CCCEEEEEcccceec
Confidence 789999999999853
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-23 Score=204.90 Aligned_cols=145 Identities=29% Similarity=0.453 Sum_probs=124.0
Q ss_pred ccceeecccCCcceEEEEEcC-CcEEE---EEEec-ccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCE--EEEEE
Q 047619 281 SINNKLGEGGFGPVYKGTLVD-GQEIA---VKRLS-KISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE--KLLIY 353 (430)
Q Consensus 281 ~~~~~ig~G~fg~Vy~~~~~~-~~~va---vK~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lv~ 353 (430)
...+.||+|+|-+||+|.+.. |-+|| ||.-. ...+..+++|..|+++|+.|+|||||+++.++.+... .-+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 455899999999999998643 66666 22111 1255667899999999999999999999999998776 67999
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCC-CCeeecCCCcccc
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLARA 429 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DFGlar~ 429 (430)
|++..|+|..|+.+.. .++.+.+..+++||++||.|||++. ++|||||||-+||+|+.+ |.|||.|+|||.+
T Consensus 123 EL~TSGtLr~Y~kk~~---~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl 195 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHR---RVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATL 195 (632)
T ss_pred ecccCCcHHHHHHHhc---cCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHH
Confidence 9999999999996654 4788999999999999999999986 789999999999999765 8999999999975
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-22 Score=192.79 Aligned_cols=148 Identities=30% Similarity=0.487 Sum_probs=128.4
Q ss_pred hcCCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc---ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 351 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 351 (430)
....|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.+++.++||||+++++++...+..++
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l 92 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL 92 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence 3456889999999999999999864 5889999988632 23445678899999999999999999999999999999
Q ss_pred EEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 352 IYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 352 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||||++ ++|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||+|+||++++++.+||+|||+++.
T Consensus 93 v~e~~~-g~l~~~~~~~~--~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~ 164 (307)
T cd06607 93 VMEYCL-GSASDILEVHK--KPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASL 164 (307)
T ss_pred EHHhhC-CCHHHHHHHcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCccee
Confidence 999997 57766664322 35899999999999999999999988 99999999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.5e-24 Score=208.05 Aligned_cols=148 Identities=28% Similarity=0.486 Sum_probs=133.7
Q ss_pred hcCCcccceeecccCCcceEEEEEcCCc-EEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLVDGQ-EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 354 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~~~~-~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 354 (430)
..+.|.|+..||.|+||.||+|..++.. ..|.|.|.......++.+.-||+||..+.||+||+|++.|...+.++|+.|
T Consensus 30 P~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 30 PRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 3456888899999999999999876643 456788877778889999999999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCccc
Q 047619 355 FVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428 (430)
Q Consensus 355 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar 428 (430)
||.||-.+.++.... ..+.+.++..+.+|++.||.|||++. |||||||..|||+.-+|.++|+|||.+-
T Consensus 110 FC~GGAVDaimlEL~--r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSA 178 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLELG--RVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSA 178 (1187)
T ss_pred ecCCchHhHHHHHhc--cccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccc
Confidence 999999999986554 46999999999999999999999998 9999999999999999999999999874
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.3e-22 Score=187.36 Aligned_cols=148 Identities=26% Similarity=0.475 Sum_probs=127.8
Q ss_pred CcccceeecccCCcceEEEEEc-CCcEEEEEEecc--cChHhHHHHHHHHHHHhcCCCCcccceEEEEEe--CCEEEEEE
Q 047619 279 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ--GEEKLLIY 353 (430)
Q Consensus 279 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~ 353 (430)
+|++.+.||.|+||.||++... +++.+|+|.+.. ......+++.+|+.++++++||||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4788899999999999999854 578999998863 244556778899999999999999999998764 45679999
Q ss_pred EccCCCChhHHhhcC-CCCCCCCHHHHHHHHHHHHHHHHHhh-----hcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcc
Q 047619 354 EFVPNKSLDSFIFDQ-ERCKILDWSKRFHIICGTARGVMYLH-----QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427 (430)
Q Consensus 354 e~~~~gsL~~~l~~~-~~~~~~~~~~~~~i~~~i~~aL~yLH-----~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla 427 (430)
||+++++|.+++... .....+++..+..++.|++.||.||| +.+ |+|+||||+||+++.++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999998653 22346899999999999999999999 665 999999999999999999999999998
Q ss_pred cc
Q 047619 428 RA 429 (430)
Q Consensus 428 r~ 429 (430)
+.
T Consensus 158 ~~ 159 (265)
T cd08217 158 KI 159 (265)
T ss_pred cc
Confidence 74
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.3e-22 Score=189.93 Aligned_cols=147 Identities=29% Similarity=0.461 Sum_probs=125.4
Q ss_pred CCcccceeecccCCcceEEEEEc-CCcEEEEEEecccC--hHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 354 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 354 (430)
++|++.+.||+|++|.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57899999999999999999865 58899999886422 2334678899999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcC-CCCeeecCCCcccc
Q 047619 355 FVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLARA 429 (430)
Q Consensus 355 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DFGlar~ 429 (430)
|++ ++|.+++..... ..+++..+..++.||+.||+|||+.+ |+|+||||+||++++ ++.+||+|||+++.
T Consensus 82 ~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~ 152 (294)
T PLN00009 82 YLD-LDLKKHMDSSPD-FAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARA 152 (294)
T ss_pred ccc-ccHHHHHHhCCC-CCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccc
Confidence 996 578777754332 33678888899999999999999988 999999999999985 45799999999864
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1e-23 Score=190.54 Aligned_cols=148 Identities=25% Similarity=0.341 Sum_probs=131.2
Q ss_pred hcCCcccceeecccCCcceEEEEE-cCCcEEEEEEeccc---ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 351 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 351 (430)
..++|..++.||+|.||.|.+++- ..++.+|+|++++. .......-..|-++|+..+||.+..|...|...+.+++
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 446888999999999999999984 45899999999863 34445556778999999999999999999999999999
Q ss_pred EEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 352 IYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 352 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||||+.||.|.-+|.+ ...+++.....+...|+.||.|||+++ ||.||||.+|+|+|++|++||+|||++|.
T Consensus 246 VMeyanGGeLf~HLsr---er~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE 317 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSR---ERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKE 317 (516)
T ss_pred EEEEccCceEeeehhh---hhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchh
Confidence 9999999999887743 356888888889999999999999988 99999999999999999999999999873
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-23 Score=203.37 Aligned_cols=152 Identities=28% Similarity=0.496 Sum_probs=135.9
Q ss_pred HhhcCCcccceeecccCCcceEEEEEcC-CcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEE
Q 047619 274 ANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 352 (430)
Q Consensus 274 ~~~~~~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 352 (430)
+....+.....+||-|.||.||.|.++. .-.||||.++. +....++|..|+.+|+.++|||+|+|+|+|......|||
T Consensus 263 EmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE-DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIi 341 (1157)
T KOG4278|consen 263 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYII 341 (1157)
T ss_pred hccchheeeeeccCCCcccceeeeeeeccceeeehhhhhh-cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEE
Confidence 3344566677899999999999999865 56899999975 556788999999999999999999999999999999999
Q ss_pred EEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCccccC
Q 047619 353 YEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430 (430)
Q Consensus 353 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~~ 430 (430)
+|||..|+|.++|.+-.+ ..++.-..+.++.||..|++||..++ +|||||...|.|+.++..|||+||||+|++
T Consensus 342 TEfM~yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlM 415 (1157)
T KOG4278|consen 342 TEFMCYGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLM 415 (1157)
T ss_pred EecccCccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhh
Confidence 999999999999977554 34777788899999999999999988 999999999999999999999999999975
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=6e-23 Score=192.74 Aligned_cols=156 Identities=26% Similarity=0.443 Sum_probs=130.0
Q ss_pred CCCCcccHHhHHhhcCCcccceeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhc--CCCCcccceE
Q 047619 263 LELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSK--LQHRNLVKLL 340 (430)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~ 340 (430)
..+|++-..++ ..+.++.+.||+|.||.||+|.+ .|..||||++... +.....+|.+|.+. |+|+||+.++
T Consensus 199 SGlplLVQRTi---arqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFI 271 (513)
T KOG2052|consen 199 SGLPLLVQRTI---ARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFI 271 (513)
T ss_pred CCchhHhHHhh---hheeEEEEEecCccccceeeccc-cCCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhh
Confidence 44555544443 35788999999999999999998 4889999999643 34556677777664 6999999999
Q ss_pred EEEEeCC----EEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhh-----cCCCcEEeCCCCCCcE
Q 047619 341 GCCIQGE----EKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ-----DSRLRIIHRDLKASNV 411 (430)
Q Consensus 341 ~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~-----~~~~~iiH~Dlkp~NI 411 (430)
+.-..++ +++||++|.+.|||.++|.+ ..++....++++..++.||++||. +|++.|.|||||..||
T Consensus 272 aaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNI 347 (513)
T KOG2052|consen 272 AADNKDNGSWTQLWLVTDYHEHGSLYDYLNR----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNI 347 (513)
T ss_pred hccccCCCceEEEEEeeecccCCcHHHHHhh----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccE
Confidence 8866543 57999999999999999954 458999999999999999999995 5788899999999999
Q ss_pred EEcCCCCeeecCCCcccc
Q 047619 412 LLDQDMNPKISDFGLARA 429 (430)
Q Consensus 412 Ll~~~~~~kl~DFGlar~ 429 (430)
|+.+++..-|+|+|||-.
T Consensus 348 LVKkn~~C~IADLGLAv~ 365 (513)
T KOG2052|consen 348 LVKKNGTCCIADLGLAVR 365 (513)
T ss_pred EEccCCcEEEeeceeeEE
Confidence 999999999999999853
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-22 Score=192.86 Aligned_cols=148 Identities=32% Similarity=0.493 Sum_probs=126.5
Q ss_pred hcCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccC--hHhHHHHHHHHHHHhcCCCCcccceEEEEEeC--CEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKL 350 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 350 (430)
..++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.++++++|+||+++++++... +..+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 3468999999999999999999964 48899999986422 22233566899999999999999999998765 5689
Q ss_pred EEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 351 LIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 351 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+||||++ ++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 85 lv~e~~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~ 157 (309)
T cd07845 85 LVMEYCE-QDLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLART 157 (309)
T ss_pred EEEecCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeee
Confidence 9999996 48888875432 45899999999999999999999998 99999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=189.16 Aligned_cols=138 Identities=28% Similarity=0.443 Sum_probs=124.3
Q ss_pred ecccCCcceEEEEEcC-CcEEEEEEecccCh---HhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEccCCCCh
Q 047619 286 LGEGGFGPVYKGTLVD-GQEIAVKRLSKISE---QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSL 361 (430)
Q Consensus 286 ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 361 (430)
||.|+||.||++.... ++.+++|.+..... ...+.+.+|+.++.+++||||+++++.+......+++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999764 89999999865322 4567789999999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 362 DSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 362 ~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
.+++.... .+++..+..++.|++.||.|||+.+ |+|+||+|+||++++++.++|+|||+++.
T Consensus 81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~ 142 (265)
T cd05579 81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKV 142 (265)
T ss_pred HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchh
Confidence 99986532 5899999999999999999999988 99999999999999999999999998863
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.8e-22 Score=195.67 Aligned_cols=145 Identities=30% Similarity=0.448 Sum_probs=125.1
Q ss_pred hcCCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc--ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeC------
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG------ 346 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 346 (430)
..++|++.+.||+|+||.||+|... +++.||+|.+.+. .......+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999864 5889999998642 334456778899999999999999999988644
Q ss_pred CEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCc
Q 047619 347 EEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 426 (430)
Q Consensus 347 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGl 426 (430)
...++||||++ ++|.+.+.. .++...+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 35699999996 578777732 2788899999999999999999988 99999999999999999999999999
Q ss_pred ccc
Q 047619 427 ARA 429 (430)
Q Consensus 427 ar~ 429 (430)
|+.
T Consensus 165 ~~~ 167 (353)
T cd07850 165 ART 167 (353)
T ss_pred cee
Confidence 974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-22 Score=192.19 Aligned_cols=149 Identities=28% Similarity=0.457 Sum_probs=127.5
Q ss_pred hhcCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccC--hHhHHHHHHHHHHHhcCCCCcccceEEEEEeCC----
Q 047619 275 NATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE---- 347 (430)
Q Consensus 275 ~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 347 (430)
...++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34578999999999999999999975 48899999986422 223456778999999999999999999987755
Q ss_pred ------EEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeee
Q 047619 348 ------EKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKI 421 (430)
Q Consensus 348 ------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl 421 (430)
..++|+||+++ +|...+... ...+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence 78999999986 676766443 235899999999999999999999988 999999999999999999999
Q ss_pred cCCCcccc
Q 047619 422 SDFGLARA 429 (430)
Q Consensus 422 ~DFGlar~ 429 (430)
+|||+++.
T Consensus 158 ~dfg~~~~ 165 (302)
T cd07864 158 ADFGLARL 165 (302)
T ss_pred Cccccccc
Confidence 99999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.7e-22 Score=189.29 Aligned_cols=139 Identities=27% Similarity=0.343 Sum_probs=116.1
Q ss_pred eecccCCcceEEEEEc-CCcEEEEEEecccC---hHhHHHHHHHHHH---HhcCCCCcccceEEEEEeCCEEEEEEEccC
Q 047619 285 KLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVIL---FSKLQHRNLVKLLGCCIQGEEKLLIYEFVP 357 (430)
Q Consensus 285 ~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~---l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 357 (430)
.||+|+||.||++... +++.+|+|.+.+.. ......+.+|..+ +...+||||+.+++.+...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999864 48899999886421 1222333444433 344579999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 358 NKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 358 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.++|+|||+|+.
T Consensus 81 ~~~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~ 146 (279)
T cd05633 81 GGDLHYHLSQH---GVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 146 (279)
T ss_pred CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCccee
Confidence 99999988543 34899999999999999999999988 99999999999999999999999999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.9e-22 Score=187.71 Aligned_cols=148 Identities=24% Similarity=0.498 Sum_probs=126.4
Q ss_pred CcccceeecccCCcceEEEEEcC--CcEEEEEEecc----------cChHhHHHHHHHHHHHhc-CCCCcccceEEEEEe
Q 047619 279 NFSINNKLGEGGFGPVYKGTLVD--GQEIAVKRLSK----------ISEQGLKELKNEVILFSK-LQHRNLVKLLGCCIQ 345 (430)
Q Consensus 279 ~~~~~~~ig~G~fg~Vy~~~~~~--~~~vavK~~~~----------~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~ 345 (430)
+|++.+.||+|+||.||+|.... ++.+|+|.+.. ........+.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999999755 67899998753 123345567788888865 799999999999999
Q ss_pred CCEEEEEEEccCCCChhHHhhcC-CCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCcEEeCCCCCCcEEEcCCCCeeecC
Q 047619 346 GEEKLLIYEFVPNKSLDSFIFDQ-ERCKILDWSKRFHIICGTARGVMYLHQ-DSRLRIIHRDLKASNVLLDQDMNPKISD 423 (430)
Q Consensus 346 ~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~~~i~~~i~~aL~yLH~-~~~~~iiH~Dlkp~NILl~~~~~~kl~D 423 (430)
.+..+++|||+++++|.+++... .....+++..++.++.|++.||.|||+ .+ |+|+||||+|||+++++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 99999999999999999887542 223458899999999999999999996 55 99999999999999999999999
Q ss_pred CCcccc
Q 047619 424 FGLARA 429 (430)
Q Consensus 424 FGlar~ 429 (430)
||+++.
T Consensus 158 fg~~~~ 163 (269)
T cd08528 158 FGLAKQ 163 (269)
T ss_pred ccceee
Confidence 999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.5e-22 Score=187.43 Aligned_cols=138 Identities=28% Similarity=0.368 Sum_probs=123.9
Q ss_pred ecccCCcceEEEEEcC-CcEEEEEEecccC---hHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEccCCCCh
Q 047619 286 LGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSL 361 (430)
Q Consensus 286 ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 361 (430)
||.|++|.||++.... ++.+|+|.+.+.. ....+.+.+|+.+++.++||||+++++.+.++...+++|||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 6899999999999754 8899999986522 23457799999999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 362 DSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 362 ~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 81 ~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~ 142 (262)
T cd05572 81 WTILRDR---GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKK 142 (262)
T ss_pred HHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccc
Confidence 9999543 34888999999999999999999988 99999999999999999999999999874
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.6e-22 Score=191.81 Aligned_cols=148 Identities=29% Similarity=0.482 Sum_probs=125.0
Q ss_pred hcCCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc--ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCE----
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE---- 348 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 348 (430)
..++|++.++||+|+||.||+|... +++.||||++... .......+.+|+.++++++||||+++++++...+.
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 3457999999999999999999864 5889999988542 22223456789999999999999999999876543
Q ss_pred ----EEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCC
Q 047619 349 ----KLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDF 424 (430)
Q Consensus 349 ----~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DF 424 (430)
.++||||++ ++|.+++... ...+++..+..++.|++.||+|||+++ |+|+||||+||+++.++.+||+||
T Consensus 90 ~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 90 YKGSFYLVFEFCE-HDLAGLLSNK--NVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred CCceEEEEEcCCC-cCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcC
Confidence 499999996 4787777433 235899999999999999999999988 999999999999999999999999
Q ss_pred Ccccc
Q 047619 425 GLARA 429 (430)
Q Consensus 425 Glar~ 429 (430)
|+++.
T Consensus 164 g~~~~ 168 (310)
T cd07865 164 GLARA 168 (310)
T ss_pred CCccc
Confidence 99864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-22 Score=190.62 Aligned_cols=146 Identities=34% Similarity=0.497 Sum_probs=131.1
Q ss_pred CCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc---ChHhHHHHHHHHHHHhcCC-CCcccceEEEEEeCCEEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLI 352 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 352 (430)
++|.+.+.||+|+||.||++... +++.+|+|++.+. .....+.+.+|+.++.+++ ||||+++++.+...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46889999999999999999865 5899999998642 2344567889999999998 99999999999999999999
Q ss_pred EEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 353 YEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 353 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 81 ~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~ 151 (280)
T cd05581 81 LEYAPNGELLQYIRKY---GSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKV 151 (280)
T ss_pred EcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccc
Confidence 9999999999999543 35899999999999999999999988 99999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.4e-22 Score=184.53 Aligned_cols=145 Identities=32% Similarity=0.484 Sum_probs=131.0
Q ss_pred CcccceeecccCCcceEEEEEc-CCcEEEEEEecccC--hHhHHHHHHHHHHHhcCCCCcccceEEEEEeC--CEEEEEE
Q 047619 279 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKLLIY 353 (430)
Q Consensus 279 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 353 (430)
+|++.+.||+|++|.||+|... +++.+++|++.... ....+.+.+|+.++++++||||+++++.+... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4778899999999999999976 58899999986533 35578899999999999999999999999988 8899999
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||+++++|.+++.... .+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.++.
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~ 150 (260)
T cd06606 81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKR 150 (260)
T ss_pred EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEe
Confidence 9999999999986543 6899999999999999999999988 99999999999999999999999998864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.2e-22 Score=187.90 Aligned_cols=144 Identities=28% Similarity=0.466 Sum_probs=128.3
Q ss_pred CcccceeecccCCcceEEEEE-cCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEccC
Q 047619 279 NFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVP 357 (430)
Q Consensus 279 ~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 357 (430)
.|...+.||+|++|.||++.. .+++.+++|++........+.+.+|+.+++.++||||+++++++...+..++++||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 355557999999999999985 4588999999865455556678899999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 358 NKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 358 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||+++.
T Consensus 100 ~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~ 164 (285)
T cd06648 100 GGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQ 164 (285)
T ss_pred CCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchh
Confidence 9999999854 34788999999999999999999988 99999999999999999999999998763
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.2e-22 Score=190.03 Aligned_cols=140 Identities=29% Similarity=0.474 Sum_probs=125.7
Q ss_pred ceeecccCCcceEEEEE-cCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEccCCCCh
Q 047619 283 NNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSL 361 (430)
Q Consensus 283 ~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 361 (430)
..+||+|+||.||++.. .+++.+|+|++..........+.+|+.+++.++|+||+++++.+...+..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 36899999999999986 45889999998654555667789999999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 362 DSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 362 ~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
.+++.. ..+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.++|+|||+++.
T Consensus 105 ~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~ 165 (292)
T cd06657 105 TDIVTH----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQ 165 (292)
T ss_pred HHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEccccccee
Confidence 998743 23788999999999999999999988 99999999999999999999999998753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.3e-22 Score=203.49 Aligned_cols=148 Identities=24% Similarity=0.330 Sum_probs=119.7
Q ss_pred HHhhcCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccChHhHHHHHHHHHHHhcCCC------CcccceEEEEEe
Q 047619 273 IANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQH------RNLVKLLGCCIQ 345 (430)
Q Consensus 273 ~~~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~~~ 345 (430)
+....++|++.++||+|+||.||+|... .++.||||++... ......+..|+.+++.++| ++|+++++++..
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV-PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc-hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 3445688999999999999999999864 4788999998642 2334455667777777654 458889888876
Q ss_pred C-CEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCcEEeCCCCCCcEEEcCCC------
Q 047619 346 G-EEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD-SRLRIIHRDLKASNVLLDQDM------ 417 (430)
Q Consensus 346 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~-~~~~iiH~Dlkp~NILl~~~~------ 417 (430)
. ...++|||++ +++|.+++... ..+++..+..|+.||+.||+|||++ + ||||||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~ 275 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKH---GPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPV 275 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccc
Confidence 5 4688999988 67888887543 3588999999999999999999974 6 99999999999998765
Q ss_pred ----------CeeecCCCccc
Q 047619 418 ----------NPKISDFGLAR 428 (430)
Q Consensus 418 ----------~~kl~DFGlar 428 (430)
.+||+|||+++
T Consensus 276 ~~~~~~~~~~~vkl~DfG~~~ 296 (467)
T PTZ00284 276 TNRALPPDPCRVRICDLGGCC 296 (467)
T ss_pred cccccCCCCceEEECCCCccc
Confidence 49999999875
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.2e-23 Score=194.78 Aligned_cols=152 Identities=27% Similarity=0.377 Sum_probs=134.5
Q ss_pred HhhcCCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc---ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEE
Q 047619 274 ANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 349 (430)
Q Consensus 274 ~~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 349 (430)
....+.|..-+.||+|+||.|+-++.. +|+.+|+|++.+. ..++.....+|-.||++++.+.||.+-.+|++.+.+
T Consensus 181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~L 260 (591)
T KOG0986|consen 181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDAL 260 (591)
T ss_pred hccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCce
Confidence 344567888899999999999999854 4899999988642 345566778999999999999999999999999999
Q ss_pred EEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 350 LLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 350 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++||..|.||+|.-+|.+... ..+++..+..++.+|+.||++||... ||.|||||+|||||+.|+++|+|+|||-.
T Consensus 261 ClVLtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAve 336 (591)
T KOG0986|consen 261 CLVLTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVE 336 (591)
T ss_pred EEEEEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEe
Confidence 999999999999988866543 56999999999999999999999887 99999999999999999999999999964
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.1e-22 Score=189.00 Aligned_cols=144 Identities=30% Similarity=0.484 Sum_probs=126.9
Q ss_pred cccceeecccCCcceEEEEEcC-CcEEEEEEeccc--ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeC--CEEEEEEE
Q 047619 280 FSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKLLIYE 354 (430)
Q Consensus 280 ~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 354 (430)
|++.+.||+|+||.||+|...+ ++.+|+|++... .......+.+|+.+++.++||||+++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 5678999999999999998754 789999999754 233446688999999999999999999999988 88999999
Q ss_pred ccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 355 FVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 355 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|+++ +|.+++.... ..+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++.
T Consensus 81 ~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~ 149 (287)
T cd07840 81 YMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARP 149 (287)
T ss_pred cccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceee
Confidence 9974 8888885432 45899999999999999999999988 99999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.1e-22 Score=189.52 Aligned_cols=145 Identities=27% Similarity=0.369 Sum_probs=126.8
Q ss_pred CcccceeecccCCcceEEEEEc----CCcEEEEEEecccC----hHhHHHHHHHHHHHhcC-CCCcccceEEEEEeCCEE
Q 047619 279 NFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSKIS----EQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEK 349 (430)
Q Consensus 279 ~~~~~~~ig~G~fg~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 349 (430)
+|++.+.||+|++|.||++... ++..+|||.+.+.. ....+.+.+|+.++.++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4778899999999999999742 46789999986421 23345688999999999 599999999999999999
Q ss_pred EEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 350 LLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 350 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++||||+++++|.+++... ..+++..+..++.|+++||.|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR---EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhhc---CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 9999999999999998543 34788999999999999999999988 99999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.7e-22 Score=189.17 Aligned_cols=143 Identities=41% Similarity=0.617 Sum_probs=123.1
Q ss_pred eeecccCCcceEEEEEcC-------CcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEc
Q 047619 284 NKLGEGGFGPVYKGTLVD-------GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 355 (430)
Q Consensus 284 ~~ig~G~fg~Vy~~~~~~-------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 355 (430)
+.||+|+||.||+|...+ +..+|+|.+... .......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998643 257899987643 234567888999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCC----CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCC-----CeeecCCCc
Q 047619 356 VPNKSLDSFIFDQE----RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDM-----NPKISDFGL 426 (430)
Q Consensus 356 ~~~gsL~~~l~~~~----~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~-----~~kl~DFGl 426 (430)
+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++ .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999996432 2234788999999999999999999988 99999999999999877 899999999
Q ss_pred ccc
Q 047619 427 ARA 429 (430)
Q Consensus 427 ar~ 429 (430)
++.
T Consensus 158 ~~~ 160 (269)
T cd05044 158 ARD 160 (269)
T ss_pred ccc
Confidence 863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.7e-22 Score=194.39 Aligned_cols=146 Identities=27% Similarity=0.467 Sum_probs=125.4
Q ss_pred hcCCcccceeecccCCcceEEEEE-cCCcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeC-----CE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-----EE 348 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 348 (430)
..++|++.+.||+|+||.||+|.. .+++.||+|++... .......+.+|+.++++++||||+++++++... ..
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 347899999999999999999985 45889999998642 233456678899999999999999999987654 35
Q ss_pred EEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCccc
Q 047619 349 KLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428 (430)
Q Consensus 349 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar 428 (430)
.++++||++ ++|..++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+
T Consensus 83 ~~lv~e~~~-~~l~~~~~~----~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 83 VYIVQELME-TDLYKLIKT----QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred EEEEehhcc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECccccee
Confidence 799999996 478777733 34889999999999999999999988 9999999999999999999999999986
Q ss_pred c
Q 047619 429 A 429 (430)
Q Consensus 429 ~ 429 (430)
.
T Consensus 155 ~ 155 (336)
T cd07849 155 I 155 (336)
T ss_pred e
Confidence 4
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.9e-23 Score=198.56 Aligned_cols=146 Identities=27% Similarity=0.387 Sum_probs=126.3
Q ss_pred cCCcccceeecccCCcceEEEEEcC-CcEEEEEEecccC--------hHhHHHHHHHHHHHhcCC---CCcccceEEEEE
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS--------EQGLKELKNEVILFSKLQ---HRNLVKLLGCCI 344 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~ 344 (430)
..+|+.++.+|+|+||.|+.|.++. ...|+||.+.+.. ...+-.+-.||.||..|+ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 3468899999999999999999754 6789999887621 112223557999999997 999999999999
Q ss_pred eCCEEEEEEEcc-CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecC
Q 047619 345 QGEEKLLIYEFV-PNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD 423 (430)
Q Consensus 345 ~~~~~~lv~e~~-~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~D 423 (430)
+++.+||+||-. ++.+|.++|... +.+++.++..|++||+.|+++||+++ |||||||-+|+.++.+|-+||+|
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~k---p~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFK---PRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhcc---CccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEee
Confidence 999999999976 567899999544 45899999999999999999999999 99999999999999999999999
Q ss_pred CCccc
Q 047619 424 FGLAR 428 (430)
Q Consensus 424 FGlar 428 (430)
||.|-
T Consensus 714 fgsaa 718 (772)
T KOG1152|consen 714 FGSAA 718 (772)
T ss_pred ccchh
Confidence 99885
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.9e-22 Score=182.52 Aligned_cols=148 Identities=26% Similarity=0.435 Sum_probs=132.2
Q ss_pred CcccceeecccCCcceEEEEEc-CCcEEEEEEeccc--ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEc
Q 047619 279 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 355 (430)
Q Consensus 279 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 355 (430)
+|.+.+.||.|+||.||++... +++.+|+|++... .......+.+|+++++.++|||++++++.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4788899999999999999965 5889999998753 235667889999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 356 VPNKSLDSFIFDQE-RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 356 ~~~gsL~~~l~~~~-~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+++++|.+++.... ....+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~ 152 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKV 152 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceee
Confidence 99999999986532 1356899999999999999999999988 99999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4e-22 Score=185.23 Aligned_cols=147 Identities=26% Similarity=0.474 Sum_probs=128.7
Q ss_pred CcccceeecccCCcceEEEEEc-CCcEEEEEEeccc--ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEc
Q 047619 279 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 355 (430)
Q Consensus 279 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 355 (430)
+|++.+.||+|+||.||++... ++..+|+|.+... .....+.+.+|+.+++.++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4788899999999999999965 4789999998642 223456788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCC-eeecCCCcccc
Q 047619 356 VPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMN-PKISDFGLARA 429 (430)
Q Consensus 356 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~-~kl~DFGlar~ 429 (430)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+|+||||+||++++++. +||+|||+++.
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~ 151 (257)
T cd08225 81 CDGGDLMKRINRQR-GVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQ 151 (257)
T ss_pred CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchh
Confidence 99999999986543 235789999999999999999999988 999999999999988864 69999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.8e-22 Score=195.52 Aligned_cols=145 Identities=23% Similarity=0.451 Sum_probs=125.9
Q ss_pred CCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc--ChHhHHHHHHHHHHHhcCCCCcccceEEEEEe----CCEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ----GEEKL 350 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~ 350 (430)
++|++.+.||+|+||.||+|... +++.||+|++... .......+.+|+.++++++||||+++++++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 68999999999999999999864 5899999998753 22345677889999999999999999988763 35689
Q ss_pred EEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 351 LIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 351 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+||||++ ++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||++++++.+||+|||+|+.
T Consensus 85 lv~e~~~-~~l~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 85 VVMDLME-SDLHHIIHSD---QPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEehhh-hhHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence 9999996 6898888433 34899999999999999999999988 99999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.4e-22 Score=192.49 Aligned_cols=152 Identities=30% Similarity=0.452 Sum_probs=129.1
Q ss_pred HHhHHhhcCCcccceeecccCCcceEEEEE-cCCcEEEEEEeccc--ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeC
Q 047619 270 LATIANATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG 346 (430)
Q Consensus 270 ~~~~~~~~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 346 (430)
..++....++|++.+.||+|+||.||++.. .+++.||+|++.+. .....+.+.+|+.++.+++||||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 345566779999999999999999999985 45889999998753 223356688899999999999999999988643
Q ss_pred ------CEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCee
Q 047619 347 ------EEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPK 420 (430)
Q Consensus 347 ------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~k 420 (430)
...+++++++ +++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+|
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEE
Confidence 3467888877 7899888743 24889999999999999999999988 99999999999999999999
Q ss_pred ecCCCcccc
Q 047619 421 ISDFGLARA 429 (430)
Q Consensus 421 l~DFGlar~ 429 (430)
|+|||+++.
T Consensus 161 l~dfg~~~~ 169 (345)
T cd07877 161 ILDFGLARH 169 (345)
T ss_pred Eeccccccc
Confidence 999999874
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.9e-22 Score=189.58 Aligned_cols=145 Identities=30% Similarity=0.506 Sum_probs=126.2
Q ss_pred CcccceeecccCCcceEEEEEc-CCcEEEEEEeccc---ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEE
Q 047619 279 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 354 (430)
Q Consensus 279 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 354 (430)
.|...+.||+|+||.||++... ++..+|+|++... .......+.+|+.++++++|||++++++++..++..++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 4777889999999999999864 5889999998642 23345678899999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 355 FVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 355 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|+++ +|.+++... ...+++..+..++.+++.||.|||+.+ |+||||+|+||+++.++.+||+|||+++.
T Consensus 106 ~~~g-~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~ 174 (317)
T cd06635 106 YCLG-SASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASI 174 (317)
T ss_pred CCCC-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccc
Confidence 9974 777776433 245899999999999999999999988 99999999999999999999999998763
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.6e-22 Score=186.49 Aligned_cols=139 Identities=27% Similarity=0.333 Sum_probs=116.3
Q ss_pred eecccCCcceEEEEEc-CCcEEEEEEecccC---hHhHHHHHHHH---HHHhcCCCCcccceEEEEEeCCEEEEEEEccC
Q 047619 285 KLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEV---ILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVP 357 (430)
Q Consensus 285 ~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~---~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 357 (430)
.||+|+||.||+|... +++.||+|.+.+.. ......+..|. .++....||+|+++++.+...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999864 48899999886421 11122233343 34455689999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 358 NKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 358 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+++|..++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 81 g~~L~~~l~~~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~ 146 (278)
T cd05606 81 GGDLHYHLSQH---GVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 146 (278)
T ss_pred CCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccc
Confidence 99999988543 45899999999999999999999988 99999999999999999999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.4e-22 Score=187.89 Aligned_cols=145 Identities=31% Similarity=0.504 Sum_probs=127.1
Q ss_pred cccceeecccCCcceEEEEEc-CCcEEEEEEecccC--hHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEcc
Q 047619 280 FSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFV 356 (430)
Q Consensus 280 ~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 356 (430)
|++.+.||.|++|.||+|... ++..||+|++.... ......+.+|+.+++.++||||+++++++.+.+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567899999999999999864 68999999986432 223456888999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 357 PNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 357 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+ ++|.+++..... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||+++.
T Consensus 81 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~ 148 (283)
T cd07835 81 D-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARA 148 (283)
T ss_pred C-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccc
Confidence 5 689998855432 35899999999999999999999987 99999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.5e-22 Score=184.36 Aligned_cols=140 Identities=29% Similarity=0.387 Sum_probs=118.8
Q ss_pred eeecccCCcceEEEEEc-CCcEEEEEEecccC---hHhHHHHHHHHHH-HhcCCCCcccceEEEEEeCCEEEEEEEccCC
Q 047619 284 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVIL-FSKLQHRNLVKLLGCCIQGEEKLLIYEFVPN 358 (430)
Q Consensus 284 ~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 358 (430)
+.||+|+||.||+|... +++.||+|.+.+.. ......+..|..+ ....+|+||+++++++...+..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999864 48899999986532 1223334455544 4455899999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 359 KSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 359 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++|.+++... ..+++..+..++.|++.||.|||+.+ |+|+||+|+||++++++.+||+|||+++.
T Consensus 82 ~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 146 (260)
T cd05611 82 GDCASLIKTL---GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRN 146 (260)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeeccccee
Confidence 9999998543 35889999999999999999999988 99999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.7e-22 Score=193.52 Aligned_cols=146 Identities=31% Similarity=0.547 Sum_probs=126.1
Q ss_pred hcCCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc--ChHhHHHHHHHHHHHhcC-CCCcccceEEEEEeC--CEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG--EEK 349 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~~ 349 (430)
..++|++.+.||+|+||.||+|... +++.+|+|++.+. .......+.+|+.++.++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4578999999999999999999865 4789999988542 233455677899999999 999999999998654 368
Q ss_pred EEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 350 LLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 350 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++||||++ ++|..++... .+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 85 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 99999997 5898888432 5788899999999999999999988 99999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.5e-22 Score=198.63 Aligned_cols=142 Identities=32% Similarity=0.497 Sum_probs=126.4
Q ss_pred eeecccCCcceEEEEEcC-CcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEccCCCChh
Q 047619 284 NKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLD 362 (430)
Q Consensus 284 ~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 362 (430)
-.||+|.||+||-|++.+ ..++|||.+.....+..+-+..||.+.+.|+|.|||+++|.+.+++..-|.||-+|||+|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 379999999999999765 5689999998766777788899999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCCC--CHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcC-CCCeeecCCCccccC
Q 047619 363 SFIFDQERCKIL--DWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLARAF 430 (430)
Q Consensus 363 ~~l~~~~~~~~~--~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DFGlar~~ 430 (430)
+++...= +++ .+..+-.+.+||++||.|||++. |||||||-+|+||+. .|.+||+|||.+|++
T Consensus 661 sLLrskW--GPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRL 726 (1226)
T KOG4279|consen 661 SLLRSKW--GPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRL 726 (1226)
T ss_pred HHHHhcc--CCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhh
Confidence 9996532 344 77888889999999999999998 999999999999964 688999999999874
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.4e-22 Score=186.08 Aligned_cols=143 Identities=24% Similarity=0.395 Sum_probs=121.5
Q ss_pred cccceeecccCCcceEEEEEc-CCcEEEEEEeccc-ChHhHHHHHHHHHHHhcCC-CCcccceEEEEEeC--CEEEEEEE
Q 047619 280 FSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQG--EEKLLIYE 354 (430)
Q Consensus 280 ~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e 354 (430)
|++.++||+|+||.||+|... +++.+|+|++... .........+|+.++.++. |+||+++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 567899999999999999864 5889999998653 1222234457888899885 99999999999988 88999999
Q ss_pred ccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 355 FVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 355 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|++ ++|.+.+.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++. +.+||+|||+++.
T Consensus 81 ~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~ 148 (282)
T cd07831 81 LMD-MNLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRG 148 (282)
T ss_pred cCC-ccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccc
Confidence 997 57777775432 45899999999999999999999988 999999999999999 9999999999874
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.9e-23 Score=192.89 Aligned_cols=151 Identities=29% Similarity=0.404 Sum_probs=125.9
Q ss_pred hcCCcccceeecccCCcceEEEEEc-CCcEEEEEEec--cc-----ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeC-
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLS--KI-----SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG- 346 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~--~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~- 346 (430)
..++|-++..||+|||+.||+|.+. ..+-||||+-. +. .....+...+|.+|.+.|.||.||++|+++.-+
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 4467888899999999999999854 46677888643 21 122344567899999999999999999998754
Q ss_pred CEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcC---CCCeeecC
Q 047619 347 EEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKISD 423 (430)
Q Consensus 347 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~D 423 (430)
+..+-|+||++|.+|+-+|... +.++++++..|+.||+.||.||.+.. ++|||-||||.||||.. -|.+||+|
T Consensus 541 dsFCTVLEYceGNDLDFYLKQh---klmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQH---KLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred ccceeeeeecCCCchhHHHHhh---hhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeee
Confidence 5678999999999999999543 56899999999999999999999984 78999999999999943 47899999
Q ss_pred CCccccC
Q 047619 424 FGLARAF 430 (430)
Q Consensus 424 FGlar~~ 430 (430)
||++|++
T Consensus 617 FGLSKIM 623 (775)
T KOG1151|consen 617 FGLSKIM 623 (775)
T ss_pred cchhhhc
Confidence 9999975
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.2e-22 Score=184.26 Aligned_cols=148 Identities=28% Similarity=0.504 Sum_probs=130.3
Q ss_pred CcccceeecccCCcceEEEEEc-CCcEEEEEEeccc--ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEc
Q 047619 279 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 355 (430)
Q Consensus 279 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 355 (430)
+|++.+.||+|+||.||++... +++.+|+|.+... .......+.+|+.++++++|+||+++++++......++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4788899999999999999854 5789999998642 334456778899999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 356 VPNKSLDSFIFDQE-RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 356 ~~~gsL~~~l~~~~-~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||+++.
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~ 152 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKV 152 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhh
Confidence 99999999986522 1345889999999999999999999988 99999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.4e-22 Score=192.38 Aligned_cols=146 Identities=26% Similarity=0.478 Sum_probs=126.1
Q ss_pred cCCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc--ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeC-----CE
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-----EE 348 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 348 (430)
.++|.+.+.||+|+||.||+|... +++.||||.+... .......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457999999999999999999864 5889999998642 233455677899999999999999999987654 34
Q ss_pred EEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCccc
Q 047619 349 KLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428 (430)
Q Consensus 349 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar 428 (430)
.++||||+. ++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+|+
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS---QTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 799999996 6888888543 35899999999999999999999988 9999999999999999999999999987
Q ss_pred c
Q 047619 429 A 429 (430)
Q Consensus 429 ~ 429 (430)
.
T Consensus 157 ~ 157 (337)
T cd07858 157 T 157 (337)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.5e-22 Score=198.89 Aligned_cols=151 Identities=24% Similarity=0.384 Sum_probs=118.1
Q ss_pred hcCCcccceeecccCCcceEEEEE-----------------cCCcEEEEEEecccChHhHHH--------------HHHH
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTL-----------------VDGQEIAVKRLSKISEQGLKE--------------LKNE 324 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~E 324 (430)
..++|.+.++||+|+||.||+|.. ..++.||||++........++ ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999963 235679999986533222222 3346
Q ss_pred HHHHhcCCCCcc-----cceEEEEEe--------CCEEEEEEEccCCCChhHHhhcCCC---------------------
Q 047619 325 VILFSKLQHRNL-----VKLLGCCIQ--------GEEKLLIYEFVPNKSLDSFIFDQER--------------------- 370 (430)
Q Consensus 325 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~--------------------- 370 (430)
+.++.+++|.++ +++++++.. .+..+|||||+++++|.+++.....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 677777776554 677777653 3567999999999999999864211
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 371 CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 371 ~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~ 358 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVD 358 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccc
Confidence 112456778899999999999999988 99999999999999999999999999864
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.2e-22 Score=191.29 Aligned_cols=146 Identities=25% Similarity=0.403 Sum_probs=124.9
Q ss_pred cCCcc-cceeecccCCcceEEEEEc-CCcEEEEEEecccChHh--------------HHHHHHHHHHHhcCCCCcccceE
Q 047619 277 TDNFS-INNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQG--------------LKELKNEVILFSKLQHRNLVKLL 340 (430)
Q Consensus 277 ~~~~~-~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~ 340 (430)
.++|. +.+.||+|+||.||+|... .++.||+|++....... ...+.+|+.++..++||||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 35665 4577999999999999864 58899999986422111 12477899999999999999999
Q ss_pred EEEEeCCEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCee
Q 047619 341 GCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPK 420 (430)
Q Consensus 341 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~k 420 (430)
+++...+..++||||++ ++|.+++... ..+++.....++.|++.||+|||+.+ |+|+||||+||+++.++.+|
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDRK---IRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEE
Confidence 99999999999999997 6898888543 34889999999999999999999988 99999999999999999999
Q ss_pred ecCCCcccc
Q 047619 421 ISDFGLARA 429 (430)
Q Consensus 421 l~DFGlar~ 429 (430)
|+|||+++.
T Consensus 160 l~dfg~~~~ 168 (335)
T PTZ00024 160 IADFGLARR 168 (335)
T ss_pred ECCccceee
Confidence 999999864
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.6e-22 Score=189.90 Aligned_cols=148 Identities=29% Similarity=0.464 Sum_probs=127.2
Q ss_pred HhhcCCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc--ChHhHHHHHHHHHHHhcCCCCcccceEEEEEe-CCEE
Q 047619 274 ANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ-GEEK 349 (430)
Q Consensus 274 ~~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 349 (430)
..+.++|++.+.||+|+||.||+|... +++.+|+|++.+. .....+.+.+|+.++..++||||+++++++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 346788999999999999999999854 6889999987542 22345678899999999999999999999876 4578
Q ss_pred EEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 350 LLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 350 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+++|||+ +++|..++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++.
T Consensus 86 ~lv~e~~-~~~L~~~~~~----~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 86 YFVTELL-GTDLHRLLTS----RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEEeehh-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccc
Confidence 9999998 5689888743 24778888899999999999999988 99999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=182.94 Aligned_cols=146 Identities=23% Similarity=0.294 Sum_probs=119.9
Q ss_pred HHhhcCCcccceee--cccCCcceEEEEEc-CCcEEEEEEecccChHhHHHHHHHHHHHhc-CCCCcccceEEEEEeCCE
Q 047619 273 IANATDNFSINNKL--GEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSK-LQHRNLVKLLGCCIQGEE 348 (430)
Q Consensus 273 ~~~~~~~~~~~~~i--g~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~ 348 (430)
.....++|.+.+.+ |+|+||.||++... ++..+|+|.+........ |+..... .+||||+++++.+...+.
T Consensus 9 ~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~ 83 (267)
T PHA03390 9 LVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKG 83 (267)
T ss_pred HHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCe
Confidence 34445677777776 99999999999864 578899998864221111 2222222 269999999999999999
Q ss_pred EEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCC-CeeecCCCcc
Q 047619 349 KLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLA 427 (430)
Q Consensus 349 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DFGla 427 (430)
.++||||+++++|.+++... ..+++..+..++.|+++||.|||+.+ |+||||||+||+++.++ .++|+|||++
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~ 157 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKKE---GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLC 157 (267)
T ss_pred eEEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence 99999999999999999543 26899999999999999999999988 99999999999999988 9999999998
Q ss_pred cc
Q 047619 428 RA 429 (430)
Q Consensus 428 r~ 429 (430)
+.
T Consensus 158 ~~ 159 (267)
T PHA03390 158 KI 159 (267)
T ss_pred ee
Confidence 64
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.6e-22 Score=192.19 Aligned_cols=144 Identities=29% Similarity=0.504 Sum_probs=127.6
Q ss_pred CcccceeecccCCcceEEEEEcC-CcEEEEEEecccC--hHhHHHHHHHHHHHhcCCCCcccceEEEEEeCC-----EEE
Q 047619 279 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-----EKL 350 (430)
Q Consensus 279 ~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 350 (430)
+|++.+.||+|++|.||+|.... ++.+|+|++.... ....+.+.+|+.+++.++||||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 58889999999999999999754 8899999987533 445677899999999999999999999988875 789
Q ss_pred EEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 351 LIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 351 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++|||++ ++|.+++... ..+++..+..++.+++.||+|||+.+ |+|+||||+|||++.++.++|+|||+++.
T Consensus 81 lv~e~~~-~~l~~~l~~~---~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELME-TDLHKVIKSP---QPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchh-hhHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 9999997 5888888543 36899999999999999999999998 99999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.4e-22 Score=195.14 Aligned_cols=147 Identities=26% Similarity=0.537 Sum_probs=127.5
Q ss_pred CCcccceeecccCCcceEEEEEcC---Cc--EEEEEEecc-cChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLVD---GQ--EIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 351 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~~---~~--~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 351 (430)
....+.+.||+|-||.||+|...+ |+ .||||..+. ......+.|.+|..+|++++|||||+|+|+|.+ ...+|
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wi 467 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWI 467 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeE
Confidence 344556889999999999998533 33 588998876 345667889999999999999999999999874 57899
Q ss_pred EEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCccccC
Q 047619 352 IYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430 (430)
Q Consensus 352 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~~ 430 (430)
|||+++-|.|..+|..+. ..++......+..||..||.|||+.. .|||||...|||+.+..-|||+|||++|-+
T Consensus 468 vmEL~~~GELr~yLq~nk--~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ 541 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQNK--DSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYL 541 (974)
T ss_pred EEecccchhHHHHHHhcc--ccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhc
Confidence 999999999999996554 45888888899999999999999987 999999999999999999999999999853
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.5e-22 Score=188.60 Aligned_cols=141 Identities=22% Similarity=0.247 Sum_probs=120.0
Q ss_pred ceeecccCCcceEEEEEcCCcEEEEEEeccc--ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEccCCCC
Q 047619 283 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKS 360 (430)
Q Consensus 283 ~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 360 (430)
.+.+|.|+++.|+++.. +++.+|+|++... .....+.+.+|+.+++.++||||+++++++...+..+++|||+++++
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 34445555555555443 5899999998653 45567789999999999999999999999999999999999999999
Q ss_pred hhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCccc
Q 047619 361 LDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428 (430)
Q Consensus 361 L~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar 428 (430)
|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||.+.
T Consensus 86 l~~~l~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~ 149 (314)
T cd08216 86 CEDLLKTHFP-EGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSV 149 (314)
T ss_pred HHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccce
Confidence 9999865422 34888999999999999999999988 9999999999999999999999999875
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=189.43 Aligned_cols=140 Identities=27% Similarity=0.372 Sum_probs=122.3
Q ss_pred eeeccc--CCcceEEEEEc-CCcEEEEEEecc--cChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEccCC
Q 047619 284 NKLGEG--GFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPN 358 (430)
Q Consensus 284 ~~ig~G--~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 358 (430)
..||+| +|++||++... .++.||+|++.. ......+.+.+|+.+++.++||||+++++++..++..++||||+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456776 89999999864 689999999864 2334467889999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcc
Q 047619 359 KSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427 (430)
Q Consensus 359 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla 427 (430)
++|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++++||+.+
T Consensus 84 ~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~ 148 (328)
T cd08226 84 GSANSLLKTYFP-EGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHL 148 (328)
T ss_pred CCHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHH
Confidence 999999865432 34889999999999999999999988 999999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=197.50 Aligned_cols=156 Identities=30% Similarity=0.519 Sum_probs=137.0
Q ss_pred cHHhHHhhcCCcccceeecccCCcceEEEEE-cCCcEEEEEEecccChHhHHHHHHHHHHHhcC-CCCcccceEEEEEe-
Q 047619 269 ELATIANATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQ- 345 (430)
Q Consensus 269 ~~~~~~~~~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~- 345 (430)
.+..+...++.|.+.+.||.|.+|.||+++. .+++..|+|++.. .....+++..|..+++.+ +|||++.+++++..
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~-~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDP-TEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecC-CccccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 4555666778999999999999999999984 4588899998865 445567788899999888 58999999999874
Q ss_pred ----CCEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeee
Q 047619 346 ----GEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKI 421 (430)
Q Consensus 346 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl 421 (430)
++.+|||||||.+||..+++..-. +..+.|..+..|++.++.||.+||.+. ++|||||-.|||++.++.|||
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKL 164 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKL 164 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEE
Confidence 578999999999999999997655 567999999999999999999999987 999999999999999999999
Q ss_pred cCCCcccc
Q 047619 422 SDFGLARA 429 (430)
Q Consensus 422 ~DFGlar~ 429 (430)
.|||++..
T Consensus 165 vDFGvSaQ 172 (953)
T KOG0587|consen 165 VDFGVSAQ 172 (953)
T ss_pred eeeeeeee
Confidence 99999864
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-21 Score=185.38 Aligned_cols=148 Identities=24% Similarity=0.404 Sum_probs=125.0
Q ss_pred hcCCcccceeecccCCcceEEEEEcC-CcEEEEEEeccc-ChHhHHHHHHHHHHHhcCC-CCcccceEEEEEeCCEEEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLI 352 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 352 (430)
..++|++.+.||+|+||.||+|.... ++.+|||.+.+. .......+..|+.++.++. ||||+++++++.+....+++
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 34678899999999999999999765 889999998753 2334456667777776665 99999999999999999999
Q ss_pred EEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 353 YEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD-SRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 353 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|||++ ++|.+++.... ..+++..+..++.|++.||.|||+. + |+||||+|+||++++++.+||+|||+++.
T Consensus 93 ~e~~~-~~l~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~ 164 (296)
T cd06618 93 MELMS-TCLDKLLKRIQ--GPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGR 164 (296)
T ss_pred eeccC-cCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchh
Confidence 99985 57777764432 3688999999999999999999974 6 99999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.4e-23 Score=215.65 Aligned_cols=152 Identities=30% Similarity=0.450 Sum_probs=133.1
Q ss_pred HHhhcCCcccceeecccCCcceEEEEEc-CCcEEEEEEecc--cChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEE
Q 047619 273 IANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 349 (430)
Q Consensus 273 ~~~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 349 (430)
+...+-+|+-...||.|.||.||.|... +|...|+|-+.. ........+.+|..++..|+|||+|+++|+-.+.+..
T Consensus 1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence 3445567788889999999999999854 588899998753 3355667788999999999999999999999999999
Q ss_pred EEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 350 LLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 350 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+|.||||++|+|.+++.. +...++.....+..|++.||.|||++| ||||||||+||+|+.+|.+|+.|||.|+.
T Consensus 1310 ~IFMEyC~~GsLa~ll~~---gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~k 1383 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEH---GRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVK 1383 (1509)
T ss_pred HHHHHHhccCcHHHHHHh---cchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeE
Confidence 999999999999999843 345777888888999999999999999 99999999999999999999999999975
Q ss_pred C
Q 047619 430 F 430 (430)
Q Consensus 430 ~ 430 (430)
+
T Consensus 1384 i 1384 (1509)
T KOG4645|consen 1384 I 1384 (1509)
T ss_pred e
Confidence 3
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.8e-21 Score=188.34 Aligned_cols=144 Identities=28% Similarity=0.441 Sum_probs=121.5
Q ss_pred CcccceeecccCCcceEEEEEc-C--CcEEEEEEeccc--ChHhHHHHHHHHHHHhcC-CCCcccceEEEEEeC----CE
Q 047619 279 NFSINNKLGEGGFGPVYKGTLV-D--GQEIAVKRLSKI--SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG----EE 348 (430)
Q Consensus 279 ~~~~~~~ig~G~fg~Vy~~~~~-~--~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~ 348 (430)
+|++.+.||+|+||.||++... . +..+|+|++... .....+.+.+|+.+++++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4788899999999999999964 3 678999998642 222356678899999999 599999999875533 45
Q ss_pred EEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCccc
Q 047619 349 KLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428 (430)
Q Consensus 349 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar 428 (430)
.++++||++ ++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG---QPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 789999986 6898888432 45889999999999999999999988 9999999999999999999999999987
Q ss_pred c
Q 047619 429 A 429 (430)
Q Consensus 429 ~ 429 (430)
.
T Consensus 154 ~ 154 (332)
T cd07857 154 G 154 (332)
T ss_pred e
Confidence 4
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.3e-22 Score=185.59 Aligned_cols=145 Identities=31% Similarity=0.463 Sum_probs=125.7
Q ss_pred cccceeecccCCcceEEEEEcC-CcEEEEEEecccC-hHhHHHHHHHHHHHhcCC-CCcccceEEEEEeCCEEEEEEEcc
Q 047619 280 FSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS-EQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYEFV 356 (430)
Q Consensus 280 ~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 356 (430)
|++.+.||+|++|.||+|...+ ++.+|+|++.... ........+|+..+.+++ ||||+++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 5678999999999999999754 7889999986532 122334567999999999 999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 357 PNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 357 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+++|.+++.... ...+++..+..++.|++.||.|||+++ |+|+||+|+||++++++.++|+|||+++.
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~ 148 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLARE 148 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeeccccee
Confidence 789988886543 245899999999999999999999988 99999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1e-22 Score=200.03 Aligned_cols=148 Identities=33% Similarity=0.515 Sum_probs=129.6
Q ss_pred CCcccceeecccCCcceEEEEEcC--Cc--EEEEEEecccChH-hHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLVD--GQ--EIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 352 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~~--~~--~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 352 (430)
++..+.++||+|.||.|++|.+.. |+ .||||.+...... ....|.+|+.+|.+|+|+|+|+|||+..+ ....||
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV 188 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV 188 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence 345566899999999999998743 43 6899999754333 78899999999999999999999999887 778899
Q ss_pred EEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCccccC
Q 047619 353 YEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430 (430)
Q Consensus 353 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~~ 430 (430)
+|+++.|+|.+.|.. .....+.......++.||+.|+.||.+++ +|||||-..||||-..-.|||+||||.|.+
T Consensus 189 ~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaL 262 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRAL 262 (1039)
T ss_pred hhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceecc
Confidence 999999999999977 34456778888899999999999999988 999999999999999889999999999864
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1e-22 Score=182.30 Aligned_cols=145 Identities=28% Similarity=0.360 Sum_probs=120.9
Q ss_pred hcCCcccc-eeecccCCcceEEEEE-cCCcEEEEEEecccChHhHHHHHHHHHHHhcC-CCCcccceEEEEEeC----CE
Q 047619 276 ATDNFSIN-NKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG----EE 348 (430)
Q Consensus 276 ~~~~~~~~-~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~ 348 (430)
.+++|++. ++||-|-.|.|..+.. .+++.+|+|++.. ....++|+++.-.. .|||||.++++++.. ..
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 45667664 6799999999999875 4588999998853 23456788876665 599999999998753 45
Q ss_pred EEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcC---CCCeeecCCC
Q 047619 349 KLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKISDFG 425 (430)
Q Consensus 349 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~DFG 425 (430)
+.+|||.|+||.|...|.++.. ..+.++++..|+.||..|+.|||+.+ |.||||||+|+|... +..+||+|||
T Consensus 134 LLiVmE~meGGeLfsriq~~g~-~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGD-QAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHHccc-ccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence 6899999999999999976543 56999999999999999999999987 999999999999964 4569999999
Q ss_pred cccc
Q 047619 426 LARA 429 (430)
Q Consensus 426 lar~ 429 (430)
+||.
T Consensus 210 FAK~ 213 (400)
T KOG0604|consen 210 FAKE 213 (400)
T ss_pred cccc
Confidence 9985
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.7e-22 Score=170.76 Aligned_cols=149 Identities=27% Similarity=0.401 Sum_probs=125.5
Q ss_pred CCcccceeecccCCcceEEEEE-cCCcEEEEEEecc-cChHhHHHHHHHHHHHhcC-CCCcccceEEEEEeCCEEEEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSK-ISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYE 354 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 354 (430)
+.......||+|++|.|-+.++ .+|...|+|++.. ...+..+++.+|+.+..+. ..|.+|.++|........+|.||
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME 125 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME 125 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence 3444557899999999988875 5699999999974 4566778888999877665 68999999999999999999999
Q ss_pred ccCCCChhHHhhc-CCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 355 FVPNKSLDSFIFD-QERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 355 ~~~~gsL~~~l~~-~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
.| .-||+.+..+ -.++..+++..+-+|+..+..||.|||++ +.+||||+||+||||+.+|++|++|||++-.
T Consensus 126 ~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~ 198 (282)
T KOG0984|consen 126 LM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGY 198 (282)
T ss_pred Hh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEccccccee
Confidence 99 4788877543 23456689999999999999999999995 4699999999999999999999999999753
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=187.47 Aligned_cols=147 Identities=31% Similarity=0.511 Sum_probs=124.0
Q ss_pred cCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccC--hHhHHHHHHHHHHHhcCCCCcccceEEEEEeCC------
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE------ 347 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 347 (430)
.++|++.++||+|+||.||+|... +++.+|+|++.... ......+.+|+++++.++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478999999999999999999864 58899999886422 222345678999999999999999999876543
Q ss_pred --EEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCC
Q 047619 348 --EKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 425 (430)
Q Consensus 348 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFG 425 (430)
..++||||+++ +|...+... ...+++..+..++.|+++||.|||+.+ |+|+||||+|||+++++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENP--SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 46999999964 676666432 245899999999999999999999998 9999999999999999999999999
Q ss_pred cccc
Q 047619 426 LARA 429 (430)
Q Consensus 426 lar~ 429 (430)
+++.
T Consensus 161 ~~~~ 164 (311)
T cd07866 161 LARP 164 (311)
T ss_pred cchh
Confidence 9874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=190.55 Aligned_cols=145 Identities=27% Similarity=0.429 Sum_probs=124.7
Q ss_pred cCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeC---------
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--------- 346 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------- 346 (430)
..+|.+.+.||.|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 468999999999999999999864 4889999998765555667788999999999999999999776554
Q ss_pred -----CEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcC-CCCee
Q 047619 347 -----EEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ-DMNPK 420 (430)
Q Consensus 347 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~k 420 (430)
...++||||++ ++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++. ++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ----GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence 35789999997 588888743 24889999999999999999999988 999999999999974 55789
Q ss_pred ecCCCcccc
Q 047619 421 ISDFGLARA 429 (430)
Q Consensus 421 l~DFGlar~ 429 (430)
|+|||+++.
T Consensus 156 l~dfg~~~~ 164 (342)
T cd07854 156 IGDFGLARI 164 (342)
T ss_pred ECCccccee
Confidence 999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=185.81 Aligned_cols=148 Identities=28% Similarity=0.414 Sum_probs=123.2
Q ss_pred CCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc-ChHhHHHHHHHHHHHhcCC-CCcccceEEEEEeCCEEEEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYE 354 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 354 (430)
++|+..+.||+|+||.||++... +++.+|+|++... .......+.+|+.++.++. ||||+++++++..+...+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 35666789999999999999864 4889999998642 2345667889999999996 9999999999999999999999
Q ss_pred ccCCCChhHHhhc--CCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 355 FVPNKSLDSFIFD--QERCKILDWSKRFHIICGTARGVMYLHQD-SRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 355 ~~~~gsL~~~l~~--~~~~~~~~~~~~~~i~~~i~~aL~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|++ ++|.++... ......+++..+..++.+++.||+|||+. + |+||||||+|||++.++.+||+|||+|+.
T Consensus 84 ~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 157 (288)
T cd06616 84 LMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQ 157 (288)
T ss_pred ccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHH
Confidence 986 455544321 11224589999999999999999999975 5 99999999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.2e-21 Score=183.55 Aligned_cols=143 Identities=31% Similarity=0.512 Sum_probs=124.3
Q ss_pred cccceeecccCCcceEEEEEc-CCcEEEEEEeccc---ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEc
Q 047619 280 FSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 355 (430)
Q Consensus 280 ~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 355 (430)
|...++||+|+||.||+|+.. +++.+++|++... .......+.+|+.+++.++|||++++++++.+.+..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 666788999999999999864 5889999998642 233446788899999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCccc
Q 047619 356 VPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428 (430)
Q Consensus 356 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar 428 (430)
+. ++|.+++... ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++.
T Consensus 103 ~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~ 169 (313)
T cd06633 103 CL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSAS 169 (313)
T ss_pred CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCc
Confidence 96 5777776433 245889999999999999999999988 9999999999999999999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.3e-21 Score=184.51 Aligned_cols=144 Identities=32% Similarity=0.498 Sum_probs=126.4
Q ss_pred cccceeecccCCcceEEEEEc-CCcEEEEEEecccC--hHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEcc
Q 047619 280 FSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFV 356 (430)
Q Consensus 280 ~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 356 (430)
|++.+.||+|++|.||++... +++.+++|++.... ......+.+|+.++++++|+||+++++++..+...++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567789999999999999864 58899999986532 234567889999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 357 PNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 357 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++ +|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||.+..
T Consensus 81 ~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~ 147 (283)
T cd05118 81 DT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARS 147 (283)
T ss_pred CC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEe
Confidence 75 8888775432 45899999999999999999999988 99999999999999999999999998864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.7e-22 Score=190.08 Aligned_cols=149 Identities=27% Similarity=0.387 Sum_probs=128.1
Q ss_pred hhcCCcccceeecccCCcceEEEEEcCCcEEEEEEec--ccChHhHHHHHHHHHHHhcCC-CCcccceEEEEEeCCEEEE
Q 047619 275 NATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLS--KISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLL 351 (430)
Q Consensus 275 ~~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 351 (430)
.....|+++++||.||.+.||++...+.+.+|+|++. ..+.+.+..+.+|+.+|.+|+ |.+||+|++|-..++.+||
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 3446799999999999999999998888899998875 346777889999999999996 8999999999999999999
Q ss_pred EEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCccccC
Q 047619 352 IYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430 (430)
Q Consensus 352 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~~ 430 (430)
||||= ..+|..+|..... ....| .+..+..||+.|+.++|++| |||.||||+|+|+ -.|.+||+|||+|+.+
T Consensus 438 vmE~G-d~DL~kiL~k~~~-~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLl-VkG~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 438 VMECG-DIDLNKILKKKKS-IDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLL-VKGRLKLIDFGIANAI 509 (677)
T ss_pred Eeecc-cccHHHHHHhccC-CCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEE-EeeeEEeeeechhccc
Confidence 99975 6899999965433 22234 66778999999999999998 9999999999999 4678999999999853
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.7e-21 Score=184.19 Aligned_cols=146 Identities=31% Similarity=0.508 Sum_probs=126.1
Q ss_pred CCcccceeecccCCcceEEEEEc-CCcEEEEEEecc---cChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 353 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 353 (430)
..|+..+.||+|+||.||+|... +++.+|+|.+.. ........+.+|+.+++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 44777889999999999999964 478899998863 23344567888999999999999999999999999999999
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||+. ++|.+++.... ..+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++.
T Consensus 95 e~~~-~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 164 (308)
T cd06634 95 EYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASI 164 (308)
T ss_pred EccC-CCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCccccee
Confidence 9996 57777764332 34789999999999999999999988 99999999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.5e-21 Score=181.15 Aligned_cols=145 Identities=32% Similarity=0.524 Sum_probs=122.2
Q ss_pred cccceeecccCCcceEEEEEcC-CcEEEEEEeccc--ChHhHHHHHHHHHHHhcC---CCCcccceEEEEEeCCE-----
Q 047619 280 FSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKL---QHRNLVKLLGCCIQGEE----- 348 (430)
Q Consensus 280 ~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~----- 348 (430)
|++.+.||+|+||.||+|.... ++.+|+|++... .......+.+|+.++.++ +||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5678999999999999999764 899999998642 122234566777776655 69999999999998877
Q ss_pred EEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCccc
Q 047619 349 KLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428 (430)
Q Consensus 349 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar 428 (430)
.+++|||++ ++|.+++..... ..+++..+..++.|++.||.|||+.+ |+|+||+|+||++++++.+||+|||+++
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 899999997 488888855332 35899999999999999999999988 9999999999999999999999999986
Q ss_pred c
Q 047619 429 A 429 (430)
Q Consensus 429 ~ 429 (430)
.
T Consensus 156 ~ 156 (287)
T cd07838 156 I 156 (287)
T ss_pred e
Confidence 4
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.1e-21 Score=183.46 Aligned_cols=147 Identities=20% Similarity=0.281 Sum_probs=110.2
Q ss_pred hcCCcccceeecccCCcceEEEEEcCC----cEEEEEEecccChHh-----------HHHHHHHHHHHhcCCCCcccceE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLVDG----QEIAVKRLSKISEQG-----------LKELKNEVILFSKLQHRNLVKLL 340 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~~~----~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~l~ 340 (430)
..++|++.+.||+|+||.||+|...+. ..+|+|+........ ......+...+..++|++|++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 446899999999999999999986543 455666432211110 01122344456678899999999
Q ss_pred EEEEeCC----EEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCC
Q 047619 341 GCCIQGE----EKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQD 416 (430)
Q Consensus 341 ~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~ 416 (430)
+.+.... ..++++|++. .++.+.+... ...++..+..++.|++.||+|||+.+ |+||||||+|||++.+
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLV-ENTKEIFKRI---KCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGN 162 (294)
T ss_pred EeeeEecCCceEEEEEEehhc-cCHHHHHHhh---ccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCC
Confidence 9766554 3478888774 4666665332 23577888999999999999999988 9999999999999999
Q ss_pred CCeeecCCCcccc
Q 047619 417 MNPKISDFGLARA 429 (430)
Q Consensus 417 ~~~kl~DFGlar~ 429 (430)
+.++|+|||+|+.
T Consensus 163 ~~~~l~DFGla~~ 175 (294)
T PHA02882 163 NRGYIIDYGIASH 175 (294)
T ss_pred CcEEEEEcCCcee
Confidence 9999999999974
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.5e-21 Score=183.85 Aligned_cols=144 Identities=33% Similarity=0.510 Sum_probs=127.4
Q ss_pred cccceeecccCCcceEEEEEcC-CcEEEEEEecccC--hHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEcc
Q 047619 280 FSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFV 356 (430)
Q Consensus 280 ~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 356 (430)
|++.+.||+|++|.||+|.... ++.+|+|.+.... ....+.+.+|+.++++++|+||+++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 5567899999999999999754 8999999987532 334567788999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 357 PNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 357 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+ ++|.+++.... ..+++..+..++.+++.||.|||+.+ |+|+||+|+||++++++.+||+|||+++.
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~ 147 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARA 147 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccc
Confidence 7 58999996542 35899999999999999999999998 99999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.6e-22 Score=174.65 Aligned_cols=142 Identities=27% Similarity=0.470 Sum_probs=123.3
Q ss_pred hcCCcccceeecccCCcceEEEEE-cCCcEEEEEEecccChHhHHHHHHHHHHHhcCC-CCcccceEEEEEeCCE--EEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEE--KLL 351 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~--~~l 351 (430)
..++|++.+++|+|.+++||.|.. .+.+.++||++++ ...+.+.+|+.||..|. ||||++|++...++.. ..|
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech---HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 447899999999999999999984 5678899999864 44577899999999998 9999999999887654 579
Q ss_pred EEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCC-CCeeecCCCcccc
Q 047619 352 IYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLARA 429 (430)
Q Consensus 352 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DFGlar~ 429 (430)
|+||+.+.+...+. ..+....+..++.+++.||.|.|+.| |+|||+||.|++||.. -.++|+|+|+|..
T Consensus 113 iFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEF 182 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
T ss_pred HhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhh
Confidence 99999998887765 33667788889999999999999999 9999999999999865 4699999999964
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.8e-21 Score=171.87 Aligned_cols=134 Identities=19% Similarity=0.273 Sum_probs=105.4
Q ss_pred ceeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcC-----CCCcccceEEEEEeCC---EEE-EEE
Q 047619 283 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL-----QHRNLVKLLGCCIQGE---EKL-LIY 353 (430)
Q Consensus 283 ~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~~~-lv~ 353 (430)
.+.||+|+||.||. +++....+||++........+.+.+|+.+++.+ .||||++++++++++. ..+ +|+
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~ 84 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA 84 (210)
T ss_pred cceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence 47899999999995 444344479988654444567899999999999 5799999999999874 334 789
Q ss_pred Ec--cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHH-HHhhhcCCCcEEeCCCCCCcEEEcCC----CCeeecCCCc
Q 047619 354 EF--VPNKSLDSFIFDQERCKILDWSKRFHIICGTARGV-MYLHQDSRLRIIHRDLKASNVLLDQD----MNPKISDFGL 426 (430)
Q Consensus 354 e~--~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL-~yLH~~~~~~iiH~Dlkp~NILl~~~----~~~kl~DFGl 426 (430)
|| .++++|.+++.+. .+++. ..++.+++.++ +|||+++ |+||||||+|||++.. ..++|+||+-
T Consensus 85 e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 85 DFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred cCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 99 5589999999542 24544 35677888887 9999998 9999999999999743 3799999444
Q ss_pred c
Q 047619 427 A 427 (430)
Q Consensus 427 a 427 (430)
+
T Consensus 156 ~ 156 (210)
T PRK10345 156 E 156 (210)
T ss_pred C
Confidence 4
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.4e-21 Score=187.19 Aligned_cols=145 Identities=30% Similarity=0.481 Sum_probs=123.7
Q ss_pred hcCCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc--ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCC-----
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE----- 347 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 347 (430)
..++|.+.+.||+|+||.||+|... +++.||+|++.+. .......+.+|+.+++.++||||+++++++....
T Consensus 13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 3478999999999999999999864 5899999998652 2233456789999999999999999999987553
Q ss_pred -EEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCc
Q 047619 348 -EKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 426 (430)
Q Consensus 348 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGl 426 (430)
..++|+||+. .+|..++. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 93 ~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 93 QDFYLVMPYMQ-TDLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred ceEEEEecccc-cCHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCC
Confidence 4689999996 47766651 24788999999999999999999988 99999999999999999999999999
Q ss_pred ccc
Q 047619 427 ARA 429 (430)
Q Consensus 427 ar~ 429 (430)
++.
T Consensus 164 ~~~ 166 (342)
T cd07879 164 ARH 166 (342)
T ss_pred CcC
Confidence 874
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.7e-21 Score=189.44 Aligned_cols=146 Identities=29% Similarity=0.484 Sum_probs=127.4
Q ss_pred hcCCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc--ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCE----
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE---- 348 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 348 (430)
..++|++.+.||+|++|.||+|... +++.+|+|++... .......+.+|+.++++++||||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4678999999999999999999975 4789999998642 23345667889999999999999999998876655
Q ss_pred --EEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCc
Q 047619 349 --KLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 426 (430)
Q Consensus 349 --~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGl 426 (430)
.++|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence 89999998 6799998853 34899999999999999999999988 99999999999999999999999999
Q ss_pred ccc
Q 047619 427 ARA 429 (430)
Q Consensus 427 ar~ 429 (430)
++.
T Consensus 165 ~~~ 167 (343)
T cd07851 165 ARH 167 (343)
T ss_pred ccc
Confidence 874
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=6e-23 Score=180.95 Aligned_cols=148 Identities=31% Similarity=0.407 Sum_probs=122.0
Q ss_pred CCcccceeecccCCcceEEEEE-cCCcEEEEEEeccc-ChHhHHHHHHHHHHHhcC-CCCcccceEEEEEeCCEEEEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYE 354 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 354 (430)
++.+-...||.|+||+|++..+ +.|+.+|||++... .....+++..|.+...+- +.||||+++|++..++..||-||
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME 143 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME 143 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence 3455567899999999999985 45999999999753 346678889999876665 67999999999999999999999
Q ss_pred ccCCCChhHHhhc--CCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCccc
Q 047619 355 FVPNKSLDSFIFD--QERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428 (430)
Q Consensus 355 ~~~~gsL~~~l~~--~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar 428 (430)
+| ..||+.+... ......+++...-.|....+.||.||.+.. .||||||||+||||+..|.+||+|||++-
T Consensus 144 LM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcG 216 (361)
T KOG1006|consen 144 LM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICG 216 (361)
T ss_pred HH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchH
Confidence 99 4788766432 111234788877788888999999999854 69999999999999999999999999874
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=4e-21 Score=177.69 Aligned_cols=138 Identities=31% Similarity=0.415 Sum_probs=123.5
Q ss_pred ecccCCcceEEEEEc-CCcEEEEEEecccC---hHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEccCCCCh
Q 047619 286 LGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSL 361 (430)
Q Consensus 286 ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 361 (430)
||+|+||.||++... +++.+|+|.+.+.. ......+..|+.++++++||||+++++.+..+...+++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999865 48899999986532 23456789999999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 362 DSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 362 ~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 81 ~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~ 142 (250)
T cd05123 81 FSHLSKE---GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKE 142 (250)
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCccee
Confidence 9998543 24889999999999999999999988 99999999999999999999999999864
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-23 Score=184.33 Aligned_cols=147 Identities=31% Similarity=0.550 Sum_probs=120.8
Q ss_pred CCcccceeecccCCcceEEEEEcC-CcEEEEEEeccc--ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeC--------
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-------- 346 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------- 346 (430)
+.|.-..+||+|.||.||+|+..+ ++.||+|++.-. ....-....+|+.+|..|+|+|++.+++.|...
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 456667899999999999998644 778898876421 222234457899999999999999998877542
Q ss_pred CEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCc
Q 047619 347 EEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 426 (430)
Q Consensus 347 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGl 426 (430)
...|+|+.+++ .+|.-++... ...++..++.+++.+++.||.|+|... |+|||+||+|+||+.+|.+||+|||+
T Consensus 97 ~t~ylVf~~ce-hDLaGlLsn~--~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 97 ATFYLVFDFCE-HDLAGLLSNR--KVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ceeeeeHHHhh-hhHHHHhcCc--cccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence 24689999996 5788887443 245888999999999999999999887 99999999999999999999999999
Q ss_pred cccC
Q 047619 427 ARAF 430 (430)
Q Consensus 427 ar~~ 430 (430)
||.|
T Consensus 171 ar~f 174 (376)
T KOG0669|consen 171 ARAF 174 (376)
T ss_pred ccce
Confidence 9865
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.1e-21 Score=180.94 Aligned_cols=147 Identities=31% Similarity=0.454 Sum_probs=122.7
Q ss_pred CcccceeecccCCcceEEEEEcC-CcEEEEEEeccc-----ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEE
Q 047619 279 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI-----SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 352 (430)
Q Consensus 279 ~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 352 (430)
+|.+.+.||+|+||.||++.... +..+++|.++.. ......++.+|+.++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 57888999999999999998643 444555555431 223344677899999999999999999999999999999
Q ss_pred EEccCCCChhHHhhcC-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 353 YEFVPNKSLDSFIFDQ-ERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 353 ~e~~~~gsL~~~l~~~-~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|||+++++|.+++... .....+++..+..++.|++.||.|||+.+ ++|+||||+||+++. +.+||+|||+++.
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~ 154 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRL 154 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceee
Confidence 9999999999988642 22346899999999999999999999988 999999999999975 5799999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-21 Score=173.66 Aligned_cols=147 Identities=23% Similarity=0.385 Sum_probs=123.1
Q ss_pred CCcccceeecccCCcceEEEEEcC-CcEEEEEEeccc-ChHhHHHHHHHHHHHhcCC-CCcccceEEEEEeCCEEEEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYE 354 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 354 (430)
++.+.+..||.|+.|.|++++... +..+|||.+.+. +....+++...+.++.+.+ .|.||+.+|+|..+...+|.||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 345566789999999999999654 899999999863 4556677888888877765 7999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 355 FVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 355 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
.|. --++.++.+-. .++++..+-++...+..||.||.+++ +|||||+||+|||+|+.|++||+|||+|-+
T Consensus 172 lMs-~C~ekLlkrik--~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGr 241 (391)
T KOG0983|consen 172 LMS-TCAEKLLKRIK--GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGR 241 (391)
T ss_pred HHH-HHHHHHHHHhc--CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccce
Confidence 984 44555554332 45888888889999999999999865 699999999999999999999999999864
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.84 E-value=1e-20 Score=174.07 Aligned_cols=130 Identities=21% Similarity=0.160 Sum_probs=112.8
Q ss_pred cCCcceEEEEEc-CCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEccCCCChhHHhhc
Q 047619 289 GGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFD 367 (430)
Q Consensus 289 G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 367 (430)
|.+|.||++... +++.+|+|++.+.. .+.+|...+....||||+++++++...+..+++|||+++++|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999964 58899999997532 233455556666799999999999999999999999999999999854
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 368 QERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 368 ~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||+++.
T Consensus 79 ~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~ 134 (237)
T cd05576 79 F---LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSE 134 (237)
T ss_pred h---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhc
Confidence 3 24889999999999999999999988 99999999999999999999999998653
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-21 Score=195.98 Aligned_cols=145 Identities=32% Similarity=0.573 Sum_probs=126.9
Q ss_pred cccceeecccCCcceEEEEE-cCC----cEEEEEEecc-cChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEE
Q 047619 280 FSINNKLGEGGFGPVYKGTL-VDG----QEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 353 (430)
Q Consensus 280 ~~~~~~ig~G~fg~Vy~~~~-~~~----~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 353 (430)
....++||+|+||.||+|.+ +++ -+||+|++.. ...+...++..|+.+|.++.||||++|+++|..+. +.||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 34457999999999999985 444 3689998864 34556788999999999999999999999998776 88999
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCccccC
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~~ 430 (430)
+|++.|.|.++++.+. ..+..+..+.+..||++|+.|||++. ++||||-..||||.+...+||.|||+|+++
T Consensus 777 q~mP~G~LlDyvr~hr--~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll 848 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHR--DNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLL 848 (1177)
T ss_pred HhcccchHHHHHHHhh--ccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhcc
Confidence 9999999999996643 45788889999999999999999887 999999999999999999999999999974
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.3e-20 Score=167.60 Aligned_cols=145 Identities=34% Similarity=0.507 Sum_probs=129.7
Q ss_pred cccceeecccCCcceEEEEEcC-CcEEEEEEecccChH-hHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEccC
Q 047619 280 FSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVP 357 (430)
Q Consensus 280 ~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 357 (430)
|.+.+.||+|++|.||++...+ ++.+|+|.+...... ..+.+.+|++.+.+++|+|++++++++......++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5667899999999999999765 889999999764443 67889999999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 358 NKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 358 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+++|.+++..... .+++..+..++.+++.+|.+||+.+ ++|+||+|.||+++.++.++|+|||+++.
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~ 147 (225)
T smart00221 81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARF 147 (225)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeE
Confidence 9999999865332 1788999999999999999999987 99999999999999999999999998874
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3e-22 Score=177.12 Aligned_cols=143 Identities=29% Similarity=0.486 Sum_probs=120.2
Q ss_pred cccceeecccCCcceEEEEE-cCCcEEEEEEecccC--hHhHHHHHHHHHHHhcCCCCcccceEEEEEeCC-----EEEE
Q 047619 280 FSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-----EKLL 351 (430)
Q Consensus 280 ~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~l 351 (430)
.+-.+.||-|+||.||.+++ ++++.||+|++.... -..-+.+.+|+.+|.-++|.|++..++...-.. ++|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 34457899999999999986 469999999986532 233567889999999999999999888765443 4578
Q ss_pred EEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 352 IYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 352 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++|.| ..+|.++|... ..++...+.-+++||++||+|||+.+ |.||||||.|+|++++..+||+|||+||.
T Consensus 135 ~TELm-QSDLHKIIVSP---Q~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARv 205 (449)
T KOG0664|consen 135 LTELM-QSDLHKIIVSP---QALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLART 205 (449)
T ss_pred HHHHH-HhhhhheeccC---CCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccc
Confidence 88988 47888888554 34788888889999999999999988 99999999999999999999999999984
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.8e-20 Score=192.25 Aligned_cols=147 Identities=24% Similarity=0.342 Sum_probs=104.9
Q ss_pred hcCCcccceeecccCCcceEEEEEcC-----CcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEE------EE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLVD-----GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGC------CI 344 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~~ 344 (430)
..++|.+.+.||+|+||.||+|.+.+ +..||+|++...... +....| .+....+.+++.+... ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 55789999999999999999999644 689999998643221 111111 1122222222222211 24
Q ss_pred eCCEEEEEEEccCCCChhHHhhcCCCC-----------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCC
Q 047619 345 QGEEKLLIYEFVPNKSLDSFIFDQERC-----------------KILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLK 407 (430)
Q Consensus 345 ~~~~~~lv~e~~~~gsL~~~l~~~~~~-----------------~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlk 407 (430)
.....+|||||+++++|.+++...... .......+..++.|++.||+|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 566789999999999999988643210 01123345679999999999999988 9999999
Q ss_pred CCcEEEcC-CCCeeecCCCcccc
Q 047619 408 ASNVLLDQ-DMNPKISDFGLARA 429 (430)
Q Consensus 408 p~NILl~~-~~~~kl~DFGlar~ 429 (430)
|+|||++. ++.+||+|||+|+.
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~ 305 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAAD 305 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccc
Confidence 99999986 57899999999974
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.7e-21 Score=173.43 Aligned_cols=148 Identities=24% Similarity=0.355 Sum_probs=130.4
Q ss_pred hcCCcccceeecccCCcceEEEEEc-CCcEEEEEEecc---cChHhHHHHHHHHHHHhcC-CCCcccceEEEEEeCCEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK---ISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKL 350 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 350 (430)
..++|.++..||+|+|+.|.+++++ +.+.+|+|++++ ...++.+.++.|-.+..+. +||.+|.++.+|.+...++
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 4578999999999999999999864 478899999976 2445667788888888776 6999999999999999999
Q ss_pred EEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 351 LIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 351 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+|.||++||+|--.+.+ ...++++.+..+..+|..||.|||+.| ||.||||.+|+|||..|++||+|+|++|.
T Consensus 328 fvieyv~ggdlmfhmqr---qrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke 400 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKE 400 (593)
T ss_pred EEEEEecCcceeeehhh---hhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhc
Confidence 99999999999666633 345899999999999999999999999 99999999999999999999999999874
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=7.5e-21 Score=168.23 Aligned_cols=145 Identities=23% Similarity=0.409 Sum_probs=121.2
Q ss_pred cCCcccceeecccCCcceEEEEEcC-CcEEEEEEecccChHhHHHHHHHHHHHhcC-CCCcccceEE-EEEeCCEEEEEE
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLG-CCIQGEEKLLIY 353 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~-~~~~~~~~~lv~ 353 (430)
.+.|.+.+.||+|.||.+-++.++. .+.+++|.+.+ .....++|.+|...---| .|.||+.-++ .|++.+.+++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~-p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR-PQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCc-chhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 3679999999999999999998754 77899998875 345678899998765555 5889988775 467778888999
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEc--CCCCeeecCCCcccc
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLD--QDMNPKISDFGLARA 429 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~--~~~~~kl~DFGlar~ 429 (430)
||+|.|+|.+-+.. ..+.+.....++.|++.||.|||+++ +||||||.+||||- +..++||+|||+.+.
T Consensus 102 E~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k 172 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRK 172 (378)
T ss_pred ccCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccc
Confidence 99999999987743 23778888899999999999999998 99999999999993 335799999999864
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.3e-20 Score=203.15 Aligned_cols=141 Identities=26% Similarity=0.502 Sum_probs=120.1
Q ss_pred hcCCcccceeecccCCcceEEEEE-cCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 354 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 354 (430)
....+...+.||+|+||.||+|.. .++..||||++...... ...|++++++++|||||++++++.+.+..++|||
T Consensus 688 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 688 ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred HHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 345677778999999999999986 56899999998653321 2346889999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcc
Q 047619 355 FVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427 (430)
Q Consensus 355 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla 427 (430)
|+++++|.+++. .++|..+..++.|+++||+|||..+..+|+||||||+||+++.++.+++. ||.+
T Consensus 764 y~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~ 829 (968)
T PLN00113 764 YIEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLP 829 (968)
T ss_pred CCCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccc
Confidence 999999999983 27899999999999999999996644569999999999999998887775 5544
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.8e-20 Score=163.24 Aligned_cols=147 Identities=22% Similarity=0.399 Sum_probs=123.8
Q ss_pred hcCCcccceeecccCCcceEEEE-EcCCcEEEEEEecccChHhHHHHHHHHHHHhcCCC-CcccceEEEEEeCCEEEEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH-RNLVKLLGCCIQGEEKLLIY 353 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~ 353 (430)
...+|.++++||.|+||.+|.|. ..+|.+||||.-+... ..-++.-|..+...|++ ..|+.+..+..+.....+||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 44689999999999999999998 4569999999865422 23456778899999986 67888888888889999999
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCC---CCeeecCCCccccC
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQD---MNPKISDFGLARAF 430 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~---~~~kl~DFGlar~~ 430 (430)
+.+ |.+|+++..--. ..++.++.+-++-|++.-|+|+|.++ .|||||||+|+|+.-+ ..+.|+|||+||.+
T Consensus 91 dLL-GPsLEdLfnfC~--R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFCS--RRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred ecc-CccHHHHHHHHh--hhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhh
Confidence 998 899999874333 34888999999999999999999998 9999999999998533 45899999999864
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.2e-21 Score=180.39 Aligned_cols=147 Identities=27% Similarity=0.363 Sum_probs=125.7
Q ss_pred cCCcccceeecccCCcceEEEEEcC-CcEEEEEEeccc---ChHhHHHHHHHHHHHhcC-CCCcccceEEEEEeCCEEEE
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLL 351 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 351 (430)
..+|..+..||+|+||.|.+|..+. .+.+|||++++. ...+.+--..|-++|... +-|.+++++.+|.+-+.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 3578888999999999999997544 678999999862 334445556677777766 46889999999999999999
Q ss_pred EEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 352 IYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 352 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||||+.||+|--.|.+- ..+.+..+..++.+|+-||-+||+++ ||.||||.+|||||.+|++||+|||++|.
T Consensus 428 VMEyvnGGDLMyhiQQ~---GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKE 499 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQV---GKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE 499 (683)
T ss_pred EEEEecCchhhhHHHHh---cccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccc
Confidence 99999999998888443 34778888899999999999999999 99999999999999999999999999874
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.2e-20 Score=165.81 Aligned_cols=138 Identities=14% Similarity=0.160 Sum_probs=113.2
Q ss_pred hcCCcccceeecccCCcceEEEEEcCCcEEEEEEecccC---hHhHHH------HHHHHHHHhcCCCCcccceEEEEEeC
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKIS---EQGLKE------LKNEVILFSKLQHRNLVKLLGCCIQG 346 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~---~~~~~~------~~~E~~~l~~l~h~niv~l~~~~~~~ 346 (430)
..++|.+.+.||.|+||.||++.. ++..+|+|.+.... +..... +.+|+..+.++.||+|+.+..++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 457899999999999999999765 57789999996422 222222 67999999999999999999886644
Q ss_pred --------CEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCC
Q 047619 347 --------EEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMN 418 (430)
Q Consensus 347 --------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~ 418 (430)
...+|+|||++|.+|.++.. +++ ....+++.+|..+|+.+ ++||||||+||++++++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-
Confidence 35789999999999988741 222 24568999999999998 99999999999999988
Q ss_pred eeecCCCcccc
Q 047619 419 PKISDFGLARA 429 (430)
Q Consensus 419 ~kl~DFGlar~ 429 (430)
++|+|||.++.
T Consensus 173 i~liDfg~~~~ 183 (232)
T PRK10359 173 LRIIDLSGKRC 183 (232)
T ss_pred EEEEECCCccc
Confidence 99999998764
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.1e-21 Score=186.58 Aligned_cols=147 Identities=24% Similarity=0.320 Sum_probs=128.9
Q ss_pred CCcccceeecccCCcceEEEEEcCCc-EEEEEEecc---cChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLVDGQ-EIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 353 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~~~~-~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 353 (430)
.+++.+..||-|+||.|=++...... .+|+|++++ ......+.+..|-.||...+.|.||++|..|.+....|++|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 45667788999999999998865433 488888875 34455677889999999999999999999999999999999
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCccccC
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~~ 430 (430)
|-|-||.|...+.+. ..++......++..+++|++|||.++ ||.|||||+|.||+.+|.+||.|||+||.+
T Consensus 500 EaClGGElWTiLrdR---g~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki 570 (732)
T KOG0614|consen 500 EACLGGELWTILRDR---GSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKI 570 (732)
T ss_pred HhhcCchhhhhhhhc---CCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHh
Confidence 999999999999654 34888888889999999999999998 999999999999999999999999999864
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.7e-19 Score=158.46 Aligned_cols=131 Identities=20% Similarity=0.240 Sum_probs=104.6
Q ss_pred ccceeecccCCcceEEEEEcCCcEEEEEEecccCh----HhHHHHHHHHHHHhcCC-CCcccceEEEEEeCCEEEEEEEc
Q 047619 281 SINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISE----QGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYEF 355 (430)
Q Consensus 281 ~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 355 (430)
.+...|++|+||+|+.+.. .+.+++.+.+..... -....+.+|+++|++|+ |+++++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3457899999999997765 677888777754221 11225889999999995 4889999886 457999999
Q ss_pred cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCC-CCCcEEEcCCCCeeecCCCcccc
Q 047619 356 VPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDL-KASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 356 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dl-kp~NILl~~~~~~kl~DFGlar~ 429 (430)
++|.+|...+.. ....++.|++.+|+++|++| |+|||| ||+|||++.++.++|+|||+|+.
T Consensus 80 I~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~ 141 (218)
T PRK12274 80 LAGAAMYQRPPR----------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVR 141 (218)
T ss_pred ecCccHHhhhhh----------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCcee
Confidence 999998654311 11346789999999999998 999999 79999999999999999999974
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.9e-19 Score=158.78 Aligned_cols=139 Identities=37% Similarity=0.614 Sum_probs=123.9
Q ss_pred ecccCCcceEEEEEcC-CcEEEEEEecccChH-hHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEccCCCChhH
Q 047619 286 LGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDS 363 (430)
Q Consensus 286 ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 363 (430)
||+|++|.||++.... ++.+++|++...... ..+.+.+|+.+++.++|++|+++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999754 899999999754322 45788999999999999999999999999999999999999999999
Q ss_pred HhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcC-CCCeeecCCCcccc
Q 047619 364 FIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLARA 429 (430)
Q Consensus 364 ~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DFGlar~ 429 (430)
++.... ..+++..+..++.+++++|.+||+.+ ++|+||+|.||+++. ++.++|+|||.++.
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~ 142 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKL 142 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEE
Confidence 985432 35789999999999999999999998 999999999999998 89999999998864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.3e-19 Score=165.79 Aligned_cols=144 Identities=18% Similarity=0.160 Sum_probs=111.3
Q ss_pred hcCCcccceeecccCCcceEEEE--EcCCcEEEEEEecccCh------------------------HhHHHHHHHHHHHh
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGT--LVDGQEIAVKRLSKISE------------------------QGLKELKNEVILFS 329 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~--~~~~~~vavK~~~~~~~------------------------~~~~~~~~E~~~l~ 329 (430)
....|.+.+.||+|+||.||+|. ..+++.||+|++..... .....+.+|+.++.
T Consensus 26 ~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~ 105 (237)
T smart00090 26 RGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQ 105 (237)
T ss_pred cCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHH
Confidence 33458899999999999999998 56799999999864211 01134678999999
Q ss_pred cCCCCc--ccceEEEEEeCCEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCC
Q 047619 330 KLQHRN--LVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLK 407 (430)
Q Consensus 330 ~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlk 407 (430)
++.+.. ++++++. ...++||||+++.+|....... ..+.......++.|++.+|.+||+.+ +|+|||||
T Consensus 106 ~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dik 176 (237)
T smart00090 106 RLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD---VEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLS 176 (237)
T ss_pred HHHhcCCCCCeeeEe----cCceEEEEEecCCccccccccc---CCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCC
Confidence 997633 4444442 2358999999998887654222 23555667789999999999999875 39999999
Q ss_pred CCcEEEcCCCCeeecCCCcccc
Q 047619 408 ASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 408 p~NILl~~~~~~kl~DFGlar~ 429 (430)
|+||+++ ++.++|+|||.|+.
T Consensus 177 p~NIli~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 177 EYNILVH-DGKVVIIDVSQSVE 197 (237)
T ss_pred hhhEEEE-CCCEEEEEChhhhc
Confidence 9999998 78999999999874
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.5e-21 Score=188.62 Aligned_cols=148 Identities=26% Similarity=0.455 Sum_probs=134.7
Q ss_pred hhcCCcccceeecccCCcceEEEEE-cCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEE
Q 047619 275 NATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 353 (430)
Q Consensus 275 ~~~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 353 (430)
+..++|.++..+|.|.||.||++++ ..++..|+|.++-.......-+++|+-+++..+|||||.+++.+...+..+|.|
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 4557899999999999999999995 458899999998766677888899999999999999999999999999999999
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCccc
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar 428 (430)
||+.+|+|.+..+- -.++++.++....+..++||+|||+.+ -+|||||-.|||+++.|.+||+|||.+-
T Consensus 92 EycgggslQdiy~~---TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsa 160 (829)
T KOG0576|consen 92 EYCGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSA 160 (829)
T ss_pred EecCCCcccceeee---cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchh
Confidence 99999999987643 356899999999999999999999998 8999999999999999999999999874
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.7e-19 Score=162.92 Aligned_cols=134 Identities=21% Similarity=0.292 Sum_probs=113.1
Q ss_pred eeecccCCcceEEEEEcCCcEEEEEEecccC---h-----HhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEc
Q 047619 284 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKIS---E-----QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 355 (430)
Q Consensus 284 ~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~---~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 355 (430)
+.||+|++|.||+|.. .+..+++|+..... . .....+.+|+.++..+.|++|+....++...+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 67789999764311 1 1234578899999999999998888888788889999999
Q ss_pred cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 356 VPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 356 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++|++|.+++... .. .+..++.+++.+|.+||+.+ ++|+|++|.|||++ ++.++|+|||+|+.
T Consensus 81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999998432 12 77889999999999999988 99999999999998 78899999999874
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.5e-19 Score=160.25 Aligned_cols=142 Identities=19% Similarity=0.188 Sum_probs=110.8
Q ss_pred hHHhhcCCcccceeecccCCcceEEEEEcCCcEEEEEEecccCh----------------------HhHHHHHHHHHHHh
Q 047619 272 TIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISE----------------------QGLKELKNEVILFS 329 (430)
Q Consensus 272 ~~~~~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~ 329 (430)
++......|.+.+.||+|+||.||++...+++.+|||++..... .....+.+|+.++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 34444445888899999999999999987899999998653210 01123677899999
Q ss_pred cCCCCc--ccceEEEEEeCCEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCC
Q 047619 330 KLQHRN--LVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLK 407 (430)
Q Consensus 330 ~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlk 407 (430)
.+.|++ ++..++ ....++||||+++++|..+... .....++.+++.++.++|+.+ |+|||||
T Consensus 89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~ 152 (198)
T cd05144 89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG---IIHGDLS 152 (198)
T ss_pred HHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC---CCcCCCC
Confidence 998874 444443 2455899999999999765420 234568889999999999988 9999999
Q ss_pred CCcEEEcCCCCeeecCCCcccc
Q 047619 408 ASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 408 p~NILl~~~~~~kl~DFGlar~ 429 (430)
|+||++++++.++|+|||+|..
T Consensus 153 p~Nill~~~~~~~liDfg~~~~ 174 (198)
T cd05144 153 EFNILVDDDEKIYIIDWPQMVS 174 (198)
T ss_pred cccEEEcCCCcEEEEECCcccc
Confidence 9999999999999999999964
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.8e-19 Score=161.68 Aligned_cols=134 Identities=31% Similarity=0.473 Sum_probs=120.3
Q ss_pred CCcceEEEEEcC-CcEEEEEEecccChHh-HHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEccCCCChhHHhhc
Q 047619 290 GFGPVYKGTLVD-GQEIAVKRLSKISEQG-LKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFD 367 (430)
Q Consensus 290 ~fg~Vy~~~~~~-~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 367 (430)
+||.||+|.... ++.+|+|++....... .+.+.+|++.+++++|+||+++++.+......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999764 8899999987644333 68899999999999999999999999999999999999999999999855
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 368 QERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 368 ~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
.. .+++..+..++.+++.+|.+||+.+ |+|+||+|.||+++.++.++|+|||++..
T Consensus 81 ~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~ 136 (244)
T smart00220 81 RG---RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQ 136 (244)
T ss_pred cc---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceee
Confidence 33 2788999999999999999999988 99999999999999999999999999864
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.3e-19 Score=163.08 Aligned_cols=145 Identities=21% Similarity=0.396 Sum_probs=123.0
Q ss_pred CCcccceeecccCCcceEEEE-EcCCcEEEEEEecccChHhHHHHHHHHHHHhcCC-CCcccceEEEEEeCCEEEEEEEc
Q 047619 278 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYEF 355 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 355 (430)
-+|.+.++||+|+||+++.|+ +-+++.||||.-.+. ...-++..|.+..+.|. .++|...+.+..++.+..||||+
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 479999999999999999998 567999999975432 22345677888888775 58999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCC-----CeeecCCCccccC
Q 047619 356 VPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDM-----NPKISDFGLARAF 430 (430)
Q Consensus 356 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~-----~~kl~DFGlar~~ 430 (430)
+ |.||+++..--. ..++.+++..+|.|++.-++|+|++. +|.|||||+|+||...+ .+.|+|||+||.+
T Consensus 106 L-GPSLEDLFD~Cg--R~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 106 L-GPSLEDLFDLCG--RRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred h-CcCHHHHHHHhc--CcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 9 889999875433 35899999999999999999999998 99999999999997544 4899999999853
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.7e-19 Score=158.49 Aligned_cols=130 Identities=23% Similarity=0.360 Sum_probs=106.9
Q ss_pred eecccCCcceEEEEEcCCcEEEEEEecccC--------hHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEcc
Q 047619 285 KLGEGGFGPVYKGTLVDGQEIAVKRLSKIS--------EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFV 356 (430)
Q Consensus 285 ~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 356 (430)
.||+|+||.||+|.. ++..+++|...... .....++.+|+.++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999985 57889999854311 112356788999999999987766666666777789999999
Q ss_pred CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 357 PNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 357 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+|++|.+++.... . .++.+++.+|.+||+.+ ++|+|++|.|||++ ++.++|+|||+|+.
T Consensus 80 ~g~~l~~~~~~~~-------~---~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN-------D---ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH-------H---HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999998874321 0 78899999999999988 99999999999998 78999999999874
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.8e-19 Score=181.10 Aligned_cols=138 Identities=21% Similarity=0.309 Sum_probs=111.8
Q ss_pred cCCcccceeecccCCcceEEEEEcCCcEEEEEEeccc-------ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEE
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI-------SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 349 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 349 (430)
...|...+.||+|+||.||++.+.....++.+++.+. .....+.+.+|++++..++|++++....+.......
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 3445667899999999999998755443332222221 112245688999999999999999888888887888
Q ss_pred EEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 350 LLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 350 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++||||+++++|.+++. ....++.+++.+|.+||+.+ |+||||||+|||+ .++.++|+|||+|+.
T Consensus 412 ~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999999873 34678999999999999988 9999999999999 677899999999974
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.3e-19 Score=183.86 Aligned_cols=154 Identities=34% Similarity=0.501 Sum_probs=131.8
Q ss_pred HHhhcCCcccceeecccCCcceEEEEEcC--------CcEEEEEEecc-cChHhHHHHHHHHHHHhcC-CCCcccceEEE
Q 047619 273 IANATDNFSINNKLGEGGFGPVYKGTLVD--------GQEIAVKRLSK-ISEQGLKELKNEVILFSKL-QHRNLVKLLGC 342 (430)
Q Consensus 273 ~~~~~~~~~~~~~ig~G~fg~Vy~~~~~~--------~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~ 342 (430)
.+...++..+.+.||+|.||.|++|.... ...||||.++. ......+.+..|+.+|..+ +|+||+.++|+
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 34444556677899999999999997421 35799999875 3345678899999999998 59999999999
Q ss_pred EEeCCEEEEEEEccCCCChhHHhhcCC-----CC--------CCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCC
Q 047619 343 CIQGEEKLLIYEFVPNKSLDSFIFDQE-----RC--------KILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKAS 409 (430)
Q Consensus 343 ~~~~~~~~lv~e~~~~gsL~~~l~~~~-----~~--------~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~ 409 (430)
+......++|+||++.|+|.+++.... .. ..+.....+.++.||+.|++||++.. +|||||-..
T Consensus 371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaR 447 (609)
T KOG0200|consen 371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAAR 447 (609)
T ss_pred eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhh
Confidence 999999999999999999999997654 00 23788899999999999999999987 999999999
Q ss_pred cEEEcCCCCeeecCCCcccc
Q 047619 410 NVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 410 NILl~~~~~~kl~DFGlar~ 429 (430)
||||.++..+||+|||+||.
T Consensus 448 NVLi~~~~~~kIaDFGlar~ 467 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARD 467 (609)
T ss_pred hEEecCCCEEEEccccceec
Confidence 99999999999999999984
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.5e-19 Score=170.55 Aligned_cols=145 Identities=27% Similarity=0.375 Sum_probs=122.2
Q ss_pred CcccceeecccCCcceEEEEEcCC--cEEEEEEecccChHhHHHHHHHHHHHhcCCC----CcccceEEEE-EeCCEEEE
Q 047619 279 NFSINNKLGEGGFGPVYKGTLVDG--QEIAVKRLSKISEQGLKELKNEVILFSKLQH----RNLVKLLGCC-IQGEEKLL 351 (430)
Q Consensus 279 ~~~~~~~ig~G~fg~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~l 351 (430)
+|.+.++||+|+||.||.+..... ..+|+|............+..|+.++..+.. +++..+++.. ......+|
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 899999999999999999996553 4788887765333322377889999988873 5899999998 47778899
Q ss_pred EEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCC-----CCeeecCCCc
Q 047619 352 IYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQD-----MNPKISDFGL 426 (430)
Q Consensus 352 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~-----~~~kl~DFGl 426 (430)
||+.+ |.+|.++..... ...++..+.+.|+.|++.+|++||+.| ++||||||+|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99988 899999875554 456899999999999999999999998 9999999999999755 3589999999
Q ss_pred cc
Q 047619 427 AR 428 (430)
Q Consensus 427 ar 428 (430)
||
T Consensus 174 ar 175 (322)
T KOG1164|consen 174 AR 175 (322)
T ss_pred Cc
Confidence 98
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.6e-19 Score=177.30 Aligned_cols=143 Identities=28% Similarity=0.364 Sum_probs=121.3
Q ss_pred hcCCcccceeecccCCcceEEEEE-cCCcEEEEEEecccChHhHHHHHHHHHHHhcC-CCCcccceEEEEEeCCEEEEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIY 353 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 353 (430)
+.+.|.+...+|.|+|+.|-.+.. .+++..++|++.+. ..+..+|+.++... +||||+++++.+.++.+.|+||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 467889999999999999988875 45889999999764 22334567555555 7999999999999999999999
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEE-cCCCCeeecCCCcccc
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLL-DQDMNPKISDFGLARA 429 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl-~~~~~~kl~DFGlar~ 429 (430)
|++.++-|.+.+.... .....+..|+++|+.|+.|||++| +|||||||+|||+ ++.++++|+|||.|+.
T Consensus 396 e~l~g~ell~ri~~~~----~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~ 465 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKP----EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSE 465 (612)
T ss_pred hhccccHHHHHHHhcc----hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhh
Confidence 9999998888875543 223677789999999999999998 9999999999999 5889999999999975
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2e-19 Score=180.63 Aligned_cols=140 Identities=29% Similarity=0.471 Sum_probs=113.4
Q ss_pred ceeecccCCcc-eEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcC-CCCcccceEEEEEeCCEEEEEEEccCCCC
Q 047619 283 NNKLGEGGFGP-VYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFVPNKS 360 (430)
Q Consensus 283 ~~~ig~G~fg~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~gs 360 (430)
.+.+|.|+.|+ ||+|.. +++.||||++.. ......++||..|+.- .|||||++++.-.+....||..|.| ..+
T Consensus 514 ~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~s 588 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVY-EGREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-ACS 588 (903)
T ss_pred HHHcccCCCCcEEEEEee-CCceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hhh
Confidence 46788999886 799987 688999999853 4556778999999888 5999999999988999999999999 579
Q ss_pred hhHHhhcC-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcC---C--CCeeecCCCccccC
Q 047619 361 LDSFIFDQ-ERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ---D--MNPKISDFGLARAF 430 (430)
Q Consensus 361 L~~~l~~~-~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~---~--~~~kl~DFGlar~~ 430 (430)
|.+++... .......-.....++.|++.||++||+.+ ||||||||+||||+. + ..++|+|||++|.+
T Consensus 589 L~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 589 LQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred HHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 99999663 11111111334567899999999999987 999999999999976 3 46899999999874
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=4.6e-19 Score=163.99 Aligned_cols=148 Identities=22% Similarity=0.297 Sum_probs=125.6
Q ss_pred hcCCcccceeecccCCcceEEEEEcC-CcEEEEEEecccChHhHHHHHHHHHHHhcCCC--Cc----ccceEEEEEeCCE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQH--RN----LVKLLGCCIQGEE 348 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~n----iv~l~~~~~~~~~ 348 (430)
..++|.+...+|+|.||.|-++.+.. +..||||+++. .....+..+-|+++++++.+ |+ +|++.++|...++
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~-V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN-VDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHH-HHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 36789999999999999999998544 68899999865 34556667789999999943 33 8889999999999
Q ss_pred EEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcC-------------
Q 047619 349 KLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ------------- 415 (430)
Q Consensus 349 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~------------- 415 (430)
.+||+|.+ |.|+.++|..+. ..+++...+..|+.|++++++|||+.+ ++|-||||+|||+.+
T Consensus 166 iCivfell-G~S~~dFlk~N~-y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~ 240 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKENN-YIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKV 240 (415)
T ss_pred eEEEEecc-ChhHHHHhccCC-ccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCcc
Confidence 99999988 679999997654 457999999999999999999999988 999999999999932
Q ss_pred -------CCCeeecCCCcccc
Q 047619 416 -------DMNPKISDFGLARA 429 (430)
Q Consensus 416 -------~~~~kl~DFGlar~ 429 (430)
+..+||+|||.|+.
T Consensus 241 ~~~r~~ks~~I~vIDFGsAtf 261 (415)
T KOG0671|consen 241 CFIRPLKSTAIKVIDFGSATF 261 (415)
T ss_pred ceeccCCCcceEEEecCCcce
Confidence 23489999999973
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.8e-19 Score=167.49 Aligned_cols=145 Identities=26% Similarity=0.489 Sum_probs=126.6
Q ss_pred HHhhcCCcccceeecccCCcceEEEEEc----CCcEEEEEEecccChHhHHHHHHHHHHHhcCC-CCcccceEEEEEeCC
Q 047619 273 IANATDNFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGE 347 (430)
Q Consensus 273 ~~~~~~~~~~~~~ig~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 347 (430)
+....+.|.+.++||+|+|++||++.+. ..+.||+|.+...+ ....+.+|+++|..+. +.||+++.+++..++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 4455678899999999999999999853 36789999987543 3456889999999995 789999999999999
Q ss_pred EEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCC-CCeeecCCCc
Q 047619 348 EKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGL 426 (430)
Q Consensus 348 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DFGl 426 (430)
...+|+||++.....+++.. ++...+..+++.++.||.++|.+| ||||||||.|+|.+.. +.-.|+|||+
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred eeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence 99999999999999998833 667888999999999999999999 9999999999999765 5689999999
Q ss_pred cc
Q 047619 427 AR 428 (430)
Q Consensus 427 ar 428 (430)
|.
T Consensus 180 A~ 181 (418)
T KOG1167|consen 180 AQ 181 (418)
T ss_pred HH
Confidence 85
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.75 E-value=2e-18 Score=165.09 Aligned_cols=150 Identities=21% Similarity=0.260 Sum_probs=130.0
Q ss_pred HhhcCCcccceeecccCCcceEEEEEcC-CcEEEEEEecccChHhHHHHHHHHHHHhcCCC------CcccceEEEEEeC
Q 047619 274 ANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQH------RNLVKLLGCCIQG 346 (430)
Q Consensus 274 ~~~~~~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~~~~ 346 (430)
+....+|.+....|+|-|+.|.+|.... ++.||||+|.. ++...+.=+.|++||++|+. -++++|+..|...
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRn-NE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk 506 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRN-NEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK 506 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeec-chHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence 4455789999999999999999998644 88999999975 44445556789999999963 4799999999999
Q ss_pred CEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCC-CCeeecCCC
Q 047619 347 EEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFG 425 (430)
Q Consensus 347 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DFG 425 (430)
++++||+|-+ ..+|.++|........|....+..++.|+..||..|...+ |+|.||||+|||+++. ..+||||||
T Consensus 507 nHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfG 582 (752)
T KOG0670|consen 507 NHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFG 582 (752)
T ss_pred ceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCc
Confidence 9999999988 5789999987777677889999999999999999999887 9999999999999875 468999999
Q ss_pred ccc
Q 047619 426 LAR 428 (430)
Q Consensus 426 lar 428 (430)
.|-
T Consensus 583 SA~ 585 (752)
T KOG0670|consen 583 SAS 585 (752)
T ss_pred ccc
Confidence 985
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1e-17 Score=159.26 Aligned_cols=134 Identities=25% Similarity=0.364 Sum_probs=112.5
Q ss_pred CCcccceeecccCCcceEEEEEc-CCcEEEEEEecccChHhHHHHHHHHHHHhcCC-----CC---cccceEEEEEe---
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-----HR---NLVKLLGCCIQ--- 345 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~---niv~l~~~~~~--- 345 (430)
.+|.+.++||-|.|++||++.+. ..+-||+|+.+. .....+....||++|++++ |+ .||+|++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 68999999999999999999864 467899998864 4455667788999999884 33 59999999985
Q ss_pred -CCEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCC
Q 047619 346 -GEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQD 416 (430)
Q Consensus 346 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~ 416 (430)
+.+++||+|++ |.+|..+|..... +.++...+..|++||+.||.|||.++ +|||-||||+|||+...
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~Y-rGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~ 224 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNY-RGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCST 224 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCC-CCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeecc
Confidence 45789999999 6788888866544 45899999999999999999999976 69999999999999543
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.4e-18 Score=157.43 Aligned_cols=142 Identities=32% Similarity=0.455 Sum_probs=117.5
Q ss_pred CCcccceeecccCCcceEEEEE-cCCcEEEEEEecc--cChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCC------E
Q 047619 278 DNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE------E 348 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~ 348 (430)
.+|.-+..++.|.- .|-.+.+ ..+++||+|++.. ......++..+|..++..++|+||++++.++.-.. .
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 46777778888877 4544442 3488999998864 23445667789999999999999999999987543 4
Q ss_pred EEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCccc
Q 047619 349 KLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428 (430)
Q Consensus 349 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar 428 (430)
.|+|||+| ..+|...+. ..++-..+..|+.|++.|++|||+.+ |+||||||+||++..+..+||.|||+|+
T Consensus 96 ~y~v~e~m-~~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 96 VYLVMELM-DANLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHHHHHhh-hhHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence 58999999 578888885 23677888999999999999999998 9999999999999999999999999997
Q ss_pred c
Q 047619 429 A 429 (430)
Q Consensus 429 ~ 429 (430)
.
T Consensus 167 ~ 167 (369)
T KOG0665|consen 167 T 167 (369)
T ss_pred c
Confidence 4
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.1e-17 Score=148.00 Aligned_cols=135 Identities=21% Similarity=0.231 Sum_probs=96.6
Q ss_pred ceeecccCCcceEEEEEcCCcEEEEEEecccChH--hHHH----------------------HHHHHHHHhcCCCCc--c
Q 047619 283 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQ--GLKE----------------------LKNEVILFSKLQHRN--L 336 (430)
Q Consensus 283 ~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~h~n--i 336 (430)
.+.||+|+||.||+|...+++.||||++...... .... ...|...+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4689999999999999878999999987642111 1111 135566666664433 4
Q ss_pred cceEEEEEeCCEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCcEEeCCCCCCcEEEcC
Q 047619 337 VKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ-DSRLRIIHRDLKASNVLLDQ 415 (430)
Q Consensus 337 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~-~~~~~iiH~Dlkp~NILl~~ 415 (430)
.+.++. ...++||||++++.+......... .. ..+..++.+++.++.++|. .+ |+|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence 445443 346899999998543221111000 11 5567889999999999998 77 99999999999999
Q ss_pred CCCeeecCCCcccc
Q 047619 416 DMNPKISDFGLARA 429 (430)
Q Consensus 416 ~~~~kl~DFGlar~ 429 (430)
++.++|+|||.|+.
T Consensus 150 ~~~~~liDfg~a~~ 163 (187)
T cd05119 150 DGKVYIIDVPQAVE 163 (187)
T ss_pred CCcEEEEECccccc
Confidence 88999999999974
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.8e-17 Score=139.48 Aligned_cols=135 Identities=22% Similarity=0.194 Sum_probs=113.6
Q ss_pred cceeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcCCC--CcccceEEEEEeCCEEEEEEEccCCC
Q 047619 282 INNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH--RNLVKLLGCCIQGEEKLLIYEFVPNK 359 (430)
Q Consensus 282 ~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g 359 (430)
+.+.|++|.++.||++...+ ..+++|....... ...+.+|+.++..++| +.+++++.+....+..+++|||+++.
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 45789999999999999744 7899999865332 5678899999999977 58999999888888899999999887
Q ss_pred ChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 360 SLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 360 sL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
.+..+ +......++.+++.+|.+||.....+++|+||+|+|||+++.+.++++|||+|+.
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77543 4456677889999999999986444599999999999999988999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.1e-16 Score=146.73 Aligned_cols=134 Identities=17% Similarity=0.206 Sum_probs=104.3
Q ss_pred eeec-ccCCcceEEEEEcCCcEEEEEEecccC-------------hHhHHHHHHHHHHHhcCCCCcc--cceEEEEEeCC
Q 047619 284 NKLG-EGGFGPVYKGTLVDGQEIAVKRLSKIS-------------EQGLKELKNEVILFSKLQHRNL--VKLLGCCIQGE 347 (430)
Q Consensus 284 ~~ig-~G~fg~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~~ 347 (430)
..|| .|+.|+||.+... +..++||++.+.. ......+.+|+.++..|.|++| ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4687 8999999999874 7788999875311 1233567889999999998875 67777654432
Q ss_pred E----EEEEEEccCC-CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeec
Q 047619 348 E----KLLIYEFVPN-KSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 422 (430)
Q Consensus 348 ~----~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~ 422 (430)
. .++|||++++ .+|.+++... .++.. .+.+++.+|.+||+.| |+||||||+|||++.++.++|+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence 2 2599999997 6999887432 24443 3578999999999998 9999999999999988899999
Q ss_pred CCCcccc
Q 047619 423 DFGLARA 429 (430)
Q Consensus 423 DFGlar~ 429 (430)
|||.|+.
T Consensus 185 Dfg~~~~ 191 (239)
T PRK01723 185 DFDRGEL 191 (239)
T ss_pred ECCCccc
Confidence 9999874
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.68 E-value=8.7e-16 Score=146.37 Aligned_cols=144 Identities=35% Similarity=0.535 Sum_probs=124.5
Q ss_pred cccceeecccCCcceEEEEEcCCcEEEEEEecccCh---HhHHHHHHHHHHHhcCCCC-cccceEEEEEeCCEEEEEEEc
Q 047619 280 FSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISE---QGLKELKNEVILFSKLQHR-NLVKLLGCCIQGEEKLLIYEF 355 (430)
Q Consensus 280 ~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~ 355 (430)
|.+.+.||.|+|+.||++... ..+++|.+..... .....+.+|+.++..+.|+ +|+++.+.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 677889999999999999876 8889998875322 2477899999999999988 799999999877788999999
Q ss_pred cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCC-CeeecCCCccc
Q 047619 356 VPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLAR 428 (430)
Q Consensus 356 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DFGlar 428 (430)
+.++++.+++........+.......++.|++.++.|+|+.+ ++||||||+||+++..+ .++++|||+|+
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~ 150 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAK 150 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcce
Confidence 999999977744321125888999999999999999999998 99999999999999988 69999999986
|
|
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.7e-16 Score=114.29 Aligned_cols=66 Identities=44% Similarity=0.986 Sum_probs=57.8
Q ss_pred ccCCCceEEEecccCCCCccceeecCCCHHHHHHHhhcCCCeeeEeccccCCCCceeeeeccCCCcc
Q 047619 161 YSTQDGFIKFTELKLPDATSSWVSKSMNLYECQDKCLDNSSCMAYTNSDIRGEGSGCAMWFGDLIDM 227 (430)
Q Consensus 161 C~~~~~f~~~~~~~~p~~~~~~~~~~~~~~~C~~~Cl~~CsC~a~~~~~~~~~~~gC~~~~~~L~~~ 227 (430)
|+.+++|+++++|++|++....+..+.++++|++.||+||+|+||+|.++. ++++|++|.++|+++
T Consensus 1 C~~~d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~-~~~~C~lW~~~L~d~ 66 (66)
T PF08276_consen 1 CGSGDGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLS-GGGGCLLWYGDLVDL 66 (66)
T ss_pred CcCCCEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccC-CCCEEEEEcCEeecC
Confidence 545789999999999999887666779999999999999999999998655 567899999999874
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.63 E-value=4.5e-16 Score=163.20 Aligned_cols=148 Identities=25% Similarity=0.382 Sum_probs=115.6
Q ss_pred hHHhhcCCcccceeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcCC---CCcccceEEEEEeCCE
Q 047619 272 TIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ---HRNLVKLLGCCIQGEE 348 (430)
Q Consensus 272 ~~~~~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~ 348 (430)
+.+.....|.|.+.||+|+||.||+|...+++.||+|+-+....- +|.-=.+++.+|+ -+.|+.+..+....+.
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence 334456789999999999999999999878999999987653221 1111122333333 2456666666777888
Q ss_pred EEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcC-------CCCeee
Q 047619 349 KLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ-------DMNPKI 421 (430)
Q Consensus 349 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~-------~~~~kl 421 (430)
-+||+||.+.|+|.+++. ..+.+++.....++.|++.-++.||..+ |||+||||+|.||.. .-.++|
T Consensus 769 S~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred ceeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEE
Confidence 899999999999999995 4456899999999999999999999988 999999999999942 234899
Q ss_pred cCCCccc
Q 047619 422 SDFGLAR 428 (430)
Q Consensus 422 ~DFGlar 428 (430)
+|||-|-
T Consensus 843 IDfG~si 849 (974)
T KOG1166|consen 843 IDFGRSI 849 (974)
T ss_pred Eecccce
Confidence 9999874
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.9e-15 Score=149.04 Aligned_cols=139 Identities=25% Similarity=0.288 Sum_probs=96.5
Q ss_pred eeecccCCcceEEEEEcCCcEEEEEEecccChHhH----------------------------------------HHHHH
Q 047619 284 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGL----------------------------------------KELKN 323 (430)
Q Consensus 284 ~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~~~ 323 (430)
+.||.|++|+||+|++.+|+.||||+..+...... -.+.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 67999999999999999999999999864211100 01334
Q ss_pred HHHHHhcCC-----CCcccceEEEEEeCCEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHH-HHHHhhhcC
Q 047619 324 EVILFSKLQ-----HRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTAR-GVMYLHQDS 397 (430)
Q Consensus 324 E~~~l~~l~-----h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~-aL~yLH~~~ 397 (430)
|+..+.++. +++|.-..-+.......+|||||++|++|.++...... ..+ ...++..++. .+..+|..|
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~~---~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GLD---RKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CCC---HHHHHHHHHHHHHHHHHhCC
Confidence 555444442 33322111122234557999999999999887643211 122 2345666655 467889887
Q ss_pred CCcEEeCCCCCCcEEEcCCCCeeecCCCccccC
Q 047619 398 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430 (430)
Q Consensus 398 ~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~~ 430 (430)
++|+|+||.||+++.++.++|+|||+++.+
T Consensus 278 ---~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 278 ---FFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred ---ceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 999999999999999999999999998753
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.54 E-value=7.5e-15 Score=136.46 Aligned_cols=157 Identities=25% Similarity=0.411 Sum_probs=131.3
Q ss_pred HHhHHhhcCCcccceeecccCCcceEEEEEcC------CcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEE
Q 047619 270 LATIANATDNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGC 342 (430)
Q Consensus 270 ~~~~~~~~~~~~~~~~ig~G~fg~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 342 (430)
..++.....++++...+-+|.||.||.|.+.+ .+.|-+|.++.. ++-....+..|.-.+..+.|||+..+.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 45566666788888999999999999997644 345667777643 34456778899999999999999999998
Q ss_pred EEeC-CEEEEEEEccCCCChhHHhh-----cCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCC
Q 047619 343 CIQG-EEKLLIYEFVPNKSLDSFIF-----DQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQD 416 (430)
Q Consensus 343 ~~~~-~~~~lv~e~~~~gsL~~~l~-----~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~ 416 (430)
+.+. ...+.++.++.-|+|..++. +......+...+...++.|++.|++|||..+ |||.||...|.+||+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhh
Confidence 7764 56789999999999999997 3344455777888899999999999999988 9999999999999999
Q ss_pred CCeeecCCCcccc
Q 047619 417 MNPKISDFGLARA 429 (430)
Q Consensus 417 ~~~kl~DFGlar~ 429 (430)
-++||+|=.++|-
T Consensus 433 LqVkltDsaLSRD 445 (563)
T KOG1024|consen 433 LQVKLTDSALSRD 445 (563)
T ss_pred eeEEeccchhccc
Confidence 9999999998884
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.50 E-value=9.8e-14 Score=120.59 Aligned_cols=130 Identities=23% Similarity=0.163 Sum_probs=96.6
Q ss_pred eeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcc-cceEEEEEeCCEEEEEEEccCCCChh
Q 047619 284 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL-VKLLGCCIQGEEKLLIYEFVPNKSLD 362 (430)
Q Consensus 284 ~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gsL~ 362 (430)
+.|+.|.++.||++... ++.+++|....... ....+.+|+.++..+.+.++ ++++... ....++||||++|.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence 67899999999999864 77899998764321 22346789999998866554 4555443 33458999999998875
Q ss_pred HHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcC--CCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 363 SFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS--RLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 363 ~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~--~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
... .. ...++.+++++|..||..+ ...++|+|++|.||+++ ++.++|+|||.|..
T Consensus 80 ~~~--------~~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 80 TED--------FS---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc--------cc---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 430 11 1235678999999999876 22369999999999998 66899999999863
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.49 E-value=3.2e-14 Score=143.39 Aligned_cols=143 Identities=20% Similarity=0.215 Sum_probs=90.8
Q ss_pred hcCCcccceeecccCCcceEEEEEcC-CcEEEEEEecccChH----------------------------------hHHH
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQ----------------------------------GLKE 320 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~----------------------------------~~~~ 320 (430)
....|.. +.||.|++|+||+|++.+ |+.||||++.+.... ..+.
T Consensus 118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~ 196 (537)
T PRK04750 118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT 196 (537)
T ss_pred HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence 3445666 789999999999999887 999999998642110 0111
Q ss_pred ------HHHHHHHHhcCC----CCcccceEEEEE-eCCEEEEEEEccCCCChhHHhhcCCCC---CCCCHHHHHHHHHHH
Q 047619 321 ------LKNEVILFSKLQ----HRNLVKLLGCCI-QGEEKLLIYEFVPNKSLDSFIFDQERC---KILDWSKRFHIICGT 386 (430)
Q Consensus 321 ------~~~E~~~l~~l~----h~niv~l~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~---~~~~~~~~~~i~~~i 386 (430)
+.+|+..+.++. +...+.+-.++. .....+|||||++|+.+.++..-...+ ..+....+..++.|
T Consensus 197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q- 275 (537)
T PRK04750 197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ- 275 (537)
T ss_pred HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH-
Confidence 233443333332 333333333332 245678999999999998753211111 11222222233333
Q ss_pred HHHHHHhhhcCCCcEEeCCCCCCcEEEcCCC----CeeecCCCcccc
Q 047619 387 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDM----NPKISDFGLARA 429 (430)
Q Consensus 387 ~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~----~~kl~DFGlar~ 429 (430)
++..| ++|+|+||.||+++.++ .++++|||++..
T Consensus 276 ------if~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~ 313 (537)
T PRK04750 276 ------VFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGS 313 (537)
T ss_pred ------HHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEE
Confidence 33455 99999999999999888 899999999864
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.42 E-value=9.6e-14 Score=149.40 Aligned_cols=93 Identities=20% Similarity=0.311 Sum_probs=73.4
Q ss_pred cCCC-CcccceEEEE-------EeCCEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcE
Q 047619 330 KLQH-RNLVKLLGCC-------IQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRI 401 (430)
Q Consensus 330 ~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~i 401 (430)
.++| +||.++++++ ......++++|++ +++|.++|... ...+++.+++.++.||++||.|||+++ |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 3445 5777777776 2334567888987 66999999543 245899999999999999999999988 9
Q ss_pred EeCCCCCCcEEEcC-------------------CCCeeecCCCccc
Q 047619 402 IHRDLKASNVLLDQ-------------------DMNPKISDFGLAR 428 (430)
Q Consensus 402 iH~Dlkp~NILl~~-------------------~~~~kl~DFGlar 428 (430)
+||||||+||||+. ++.+||+|||+|+
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~ 147 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSR 147 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCccccccccccc
Confidence 99999999999954 4556777777775
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.40 E-value=3.3e-12 Score=112.39 Aligned_cols=134 Identities=16% Similarity=0.152 Sum_probs=97.2
Q ss_pred ceeecccCCcceEEEEEcC-------CcEEEEEEeccc-------------C---------hHhHHHHH----HHHHHHh
Q 047619 283 NNKLGEGGFGPVYKGTLVD-------GQEIAVKRLSKI-------------S---------EQGLKELK----NEVILFS 329 (430)
Q Consensus 283 ~~~ig~G~fg~Vy~~~~~~-------~~~vavK~~~~~-------------~---------~~~~~~~~----~E~~~l~ 329 (430)
...||.|--+.||.|...+ +..+|||+.... . ....+.+. +|++.|.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3579999999999998543 479999976420 0 01122333 8999999
Q ss_pred cCCC--CcccceEEEEEeCCEEEEEEEccCCCChhH-HhhcCCCCCCCCHHHHHHHHHHHHHHHHHh-hhcCCCcEEeCC
Q 047619 330 KLQH--RNLVKLLGCCIQGEEKLLIYEFVPNKSLDS-FIFDQERCKILDWSKRFHIICGTARGVMYL-HQDSRLRIIHRD 405 (430)
Q Consensus 330 ~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~~~~~~i~~~i~~aL~yL-H~~~~~~iiH~D 405 (430)
++.. -++++++++ ...+|||||+.+..+.. .+.+ ..++......+..+++.+|..| |..+ |+|+|
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd----~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGD 150 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD----AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHAD 150 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc----cccCHHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 9864 466777764 56789999997654422 2211 1244556667889999999998 7777 99999
Q ss_pred CCCCcEEEcCCCCeeecCCCccc
Q 047619 406 LKASNVLLDQDMNPKISDFGLAR 428 (430)
Q Consensus 406 lkp~NILl~~~~~~kl~DFGlar 428 (430)
|+|.|||++ ++.+.|+|||-|-
T Consensus 151 Ls~~NIL~~-~~~v~iIDF~qav 172 (197)
T cd05146 151 LSEYNMLWH-DGKVWFIDVSQSV 172 (197)
T ss_pred CCHHHEEEE-CCcEEEEECCCce
Confidence 999999996 4689999999874
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.5e-13 Score=141.21 Aligned_cols=142 Identities=27% Similarity=0.324 Sum_probs=109.8
Q ss_pred ccceeecccCCcceEEEEEcC-CcEEEEEEec----c-cChH-hHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEE
Q 047619 281 SINNKLGEGGFGPVYKGTLVD-GQEIAVKRLS----K-ISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 353 (430)
Q Consensus 281 ~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~----~-~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 353 (430)
.....+|.|++|.|+.+.... .+..+.|... . .... ....+..|+.+-..+.|||++..+....+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 345789999999888776432 3334444322 1 1111 1222667888888999999988777777666666669
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||+++ +|..++... ..+...++-.++.|++.|++|||+.| |.||||||+|+|+..+|.+||+|||.+..
T Consensus 401 E~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~v 469 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASV 469 (601)
T ss_pred hcccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCccee
Confidence 99999 999998554 24777888899999999999999999 99999999999999999999999999864
|
|
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=99.39 E-value=6.6e-13 Score=98.69 Aligned_cols=71 Identities=18% Similarity=0.270 Sum_probs=61.4
Q ss_pred ccCCCceEEEecccCCCCccceeecCCCHHHHHHHhhc---CCCeeeEeccccCCCCceeeeeccCC-CcccccCCCCcc
Q 047619 161 YSTQDGFIKFTELKLPDATSSWVSKSMNLYECQDKCLD---NSSCMAYTNSDIRGEGSGCAMWFGDL-IDMRSFPDGGQD 236 (430)
Q Consensus 161 C~~~~~f~~~~~~~~p~~~~~~~~~~~~~~~C~~~Cl~---~CsC~a~~~~~~~~~~~gC~~~~~~L-~~~~~~~~~~~~ 236 (430)
|...++|+++.+|++|++.. .+.++|++.|++ ||+|.||++.+. +.||++|.++| ++++..+..+.+
T Consensus 5 ~~~~g~fl~~~~~klpd~~~------~s~~eC~~~Cl~~~~nCsC~Aya~~~~---~~gC~~W~~~l~~d~~~~~~~g~~ 75 (80)
T cd00129 5 CKSAGTTLIKIALKIKTTKA------NTADECANRCEKNGLPFSCKAFVFAKA---RKQCLWFPFNSMSGVRKEFSHGFD 75 (80)
T ss_pred eecCCeEEEeecccCCcccc------cCHHHHHHHHhcCCCCCCceeeeccCC---CCCeEEecCcchhhHHhccCCCce
Confidence 44467899999999998755 579999999999 999999999752 35899999999 999888878899
Q ss_pred eEEE
Q 047619 237 FYIR 240 (430)
Q Consensus 237 ~yir 240 (430)
+|+|
T Consensus 76 Ly~r 79 (80)
T cd00129 76 LYEN 79 (80)
T ss_pred eEeE
Confidence 9987
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.38 E-value=4.3e-12 Score=107.98 Aligned_cols=131 Identities=21% Similarity=0.327 Sum_probs=100.5
Q ss_pred eeecccCCcceEEEEEcCCcEEEEEE-eccc---C----hHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEc
Q 047619 284 NKLGEGGFGPVYKGTLVDGQEIAVKR-LSKI---S----EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 355 (430)
Q Consensus 284 ~~ig~G~fg~Vy~~~~~~~~~vavK~-~~~~---~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 355 (430)
..|++|+-+.||.+.+. +..+++|. +++. . .-....-.+|++++.++.--.|....=+..++....|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 45789999999998664 33455553 3331 1 11234567899999999877776666677788899999999
Q ss_pred cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 356 VPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 356 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++|..|.+.+... ...++..+-.-+.-||..+ |+|+||.++||++..+. +.++||||++.
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888433 2456777888888999998 99999999999996654 99999999863
|
|
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=99.35 E-value=2.4e-12 Score=98.06 Aligned_cols=80 Identities=40% Similarity=0.888 Sum_probs=64.5
Q ss_pred CccccCC---CceEEEecccCCCCccceeecCCCHHHHHHHhhcCCCeeeEeccccCCCCceeeeeccCCCcccccCCCC
Q 047619 158 SLNYSTQ---DGFIKFTELKLPDATSSWVSKSMNLYECQDKCLDNSSCMAYTNSDIRGEGSGCAMWFGDLIDMRSFPDGG 234 (430)
Q Consensus 158 ~l~C~~~---~~f~~~~~~~~p~~~~~~~~~~~~~~~C~~~Cl~~CsC~a~~~~~~~~~~~gC~~~~~~L~~~~~~~~~~ 234 (430)
+++|..+ ++|+.++++++|+..... ...++++|++.||+||+|+||++.+ ++.+|++|.+++.+.+.....+
T Consensus 2 ~~~C~~~~~~~~f~~~~~~~~~~~~~~~--~~~s~~~C~~~Cl~nCsC~a~~~~~---~~~~C~~~~~~~~~~~~~~~~~ 76 (84)
T cd01098 2 PLNCGGDGSTDGFLKLPDVKLPDNASAI--TAISLEECREACLSNCSCTAYAYNN---GSGGCLLWNGLLNNLRSLSSGG 76 (84)
T ss_pred CcccCCCCCCCEEEEeCCeeCCCchhhh--ccCCHHHHHHHHhcCCCcceeeecC---CCCeEEEEeceecceEeecCCC
Confidence 4567543 689999999999886653 6789999999999999999999975 2457999999998877654455
Q ss_pred cceEEEec
Q 047619 235 QDFYIRMS 242 (430)
Q Consensus 235 ~~~yirls 242 (430)
...|+|++
T Consensus 77 ~~~yiKv~ 84 (84)
T cd01098 77 GTLYLRLA 84 (84)
T ss_pred cEEEEEeC
Confidence 78888863
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.3e-11 Score=104.49 Aligned_cols=142 Identities=24% Similarity=0.298 Sum_probs=106.8
Q ss_pred cceeecccCCcceEEEEEcCCcEEEEEE-ecc-------cChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEE
Q 047619 282 INNKLGEGGFGPVYKGTLVDGQEIAVKR-LSK-------ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 353 (430)
Q Consensus 282 ~~~~ig~G~fg~Vy~~~~~~~~~vavK~-~~~-------~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 353 (430)
....|-+|+-+.|+++.+ .|+..+||. +.+ ...-...+..+|++++.++.--.|.-..-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 457899999999999987 466666663 332 11223566789999999988666666666777888889999
Q ss_pred EccCC-CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCC---CeeecCCCccc
Q 047619 354 EFVPN-KSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDM---NPKISDFGLAR 428 (430)
Q Consensus 354 e~~~~-gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~---~~kl~DFGlar 428 (430)
||++| .++.+++...-... ........++..|-+.|.-||.++ |||+||..+||+|.+++ .+.|+|||++.
T Consensus 90 E~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchh
Confidence 99987 47788876543322 222333677888999999999998 99999999999997665 35899999974
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.1e-11 Score=112.47 Aligned_cols=142 Identities=20% Similarity=0.236 Sum_probs=108.9
Q ss_pred eeecccCCcceEEEEEcCCcEEEEEEecccCh-HhHHHHHHHHHHHhcCCC--CcccceEEEEEeCC---EEEEEEEccC
Q 047619 284 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISE-QGLKELKNEVILFSKLQH--RNLVKLLGCCIQGE---EKLLIYEFVP 357 (430)
Q Consensus 284 ~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~---~~~lv~e~~~ 357 (430)
+.|+.|..+.||++...++..+++|....... .....+.+|+.+++.+.+ ..+++++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 67899999999999876668999998764221 135678899999999976 44677777766542 5689999999
Q ss_pred CCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcC----------------------------------------
Q 047619 358 NKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS---------------------------------------- 397 (430)
Q Consensus 358 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~---------------------------------------- 397 (430)
|.++...+.. ..++......++.+++++|..||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9988775521 23666777778888888888888521
Q ss_pred -------------CCcEEeCCCCCCcEEEcC--CCCeeecCCCcccc
Q 047619 398 -------------RLRIIHRDLKASNVLLDQ--DMNPKISDFGLARA 429 (430)
Q Consensus 398 -------------~~~iiH~Dlkp~NILl~~--~~~~kl~DFGlar~ 429 (430)
...++|+|++|.|||++. ++.+.|+||+.|..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 235799999999999988 56689999998763
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.31 E-value=2.9e-13 Score=133.60 Aligned_cols=139 Identities=27% Similarity=0.316 Sum_probs=114.0
Q ss_pred eecccCCcceEEEEE----cCCcEEEEEEecccC--hHhHHHHHHHHHHHhcCC-CCcccceEEEEEeCCEEEEEEEccC
Q 047619 285 KLGEGGFGPVYKGTL----VDGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYEFVP 357 (430)
Q Consensus 285 ~ig~G~fg~Vy~~~~----~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 357 (430)
.+|+|.||.|++++. ..++.+|+|.+++.. .........|..++..++ ||.+|+++..++.+...++++++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 378999999998763 337788999886521 111124556778888887 9999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 358 NKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 358 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+|.|...+... ..+.+.....+...++.|++++|+.+ |+|||+|++||+++.+|++|+.|||++|.
T Consensus 81 gg~lft~l~~~---~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske 146 (612)
T KOG0603|consen 81 GGDLFTRLSKE---VMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKE 146 (612)
T ss_pred cchhhhccccC---CchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhH
Confidence 99998877433 33566666667778999999999988 99999999999999999999999999885
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.23 E-value=6.8e-11 Score=109.71 Aligned_cols=146 Identities=25% Similarity=0.371 Sum_probs=96.2
Q ss_pred CcccceeecccCCcceEEEEEcC-CcEEEEEEecc---cChHhHHHHHHHHHHHhcCCC----------CcccceEEEEE
Q 047619 279 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH----------RNLVKLLGCCI 344 (430)
Q Consensus 279 ~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h----------~niv~l~~~~~ 344 (430)
.+...+.||.|+++.||.+++.+ ++++|+|++.. ......+++++|.-.+..+.+ -.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 34556899999999999999865 89999998752 233456778887766666433 12222222222
Q ss_pred ---------eCC--------EEEEEEEccCCCChhHHhhc---CCC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEe
Q 047619 345 ---------QGE--------EKLLIYEFVPNKSLDSFIFD---QER-CKILDWSKRFHIICGTARGVMYLHQDSRLRIIH 403 (430)
Q Consensus 345 ---------~~~--------~~~lv~e~~~~gsL~~~l~~---~~~-~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH 403 (430)
... ..+++|+-+ .++|.+++.. ... ...+....++.+..|+++.+++||+.| |+|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence 111 226788877 5788877532 111 122344555677799999999999999 999
Q ss_pred CCCCCCcEEEcCCCCeeecCCCccc
Q 047619 404 RDLKASNVLLDQDMNPKISDFGLAR 428 (430)
Q Consensus 404 ~Dlkp~NILl~~~~~~kl~DFGlar 428 (430)
+||||+|++++++|.++|+||+...
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~ 193 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLV 193 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEE
T ss_pred cccceeeEEEcCCCCEEEcChHHHe
Confidence 9999999999999999999998764
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.15 E-value=2.6e-10 Score=99.96 Aligned_cols=122 Identities=24% Similarity=0.267 Sum_probs=81.1
Q ss_pred eEEEEEcCCcEEEEEEeccc--------------C------------hHhHHHHHHHHHHHhcCCCC--cccceEEEEEe
Q 047619 294 VYKGTLVDGQEIAVKRLSKI--------------S------------EQGLKELKNEVILFSKLQHR--NLVKLLGCCIQ 345 (430)
Q Consensus 294 Vy~~~~~~~~~vavK~~~~~--------------~------------~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~ 345 (430)
||.|...++..+|||..... . .......++|.+.|.++... ++++++.+-
T Consensus 2 Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-- 79 (188)
T PF01163_consen 2 VYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-- 79 (188)
T ss_dssp EEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE--
T ss_pred EEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe--
Confidence 89999888999999976421 0 01134567899999999865 567776542
Q ss_pred CCEEEEEEEccC--CCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHH-hhhcCCCcEEeCCCCCCcEEEcCCCCeeec
Q 047619 346 GEEKLLIYEFVP--NKSLDSFIFDQERCKILDWSKRFHIICGTARGVMY-LHQDSRLRIIHRDLKASNVLLDQDMNPKIS 422 (430)
Q Consensus 346 ~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~y-LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~ 422 (430)
...|||||++ |..+..+.... ++......++.+++..+.. +|..| |+|+||.+.|||++++ .+.|+
T Consensus 80 --~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 80 --RNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp --TTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE-
T ss_pred --CCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEEE
Confidence 4579999998 66665543211 1133445667777775555 56777 9999999999999877 89999
Q ss_pred CCCccc
Q 047619 423 DFGLAR 428 (430)
Q Consensus 423 DFGlar 428 (430)
|||.|.
T Consensus 149 Df~qav 154 (188)
T PF01163_consen 149 DFGQAV 154 (188)
T ss_dssp -GTTEE
T ss_pred ecCcce
Confidence 999874
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.15 E-value=8.2e-10 Score=102.60 Aligned_cols=140 Identities=19% Similarity=0.112 Sum_probs=99.6
Q ss_pred eeecccCCcceEEEEEcCCcEEEEEEecccChH-hHH----------HHHHHHHHHhcCCCCc--ccceEEEEEe-----
Q 047619 284 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQ-GLK----------ELKNEVILFSKLQHRN--LVKLLGCCIQ----- 345 (430)
Q Consensus 284 ~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-~~~----------~~~~E~~~l~~l~h~n--iv~l~~~~~~----- 345 (430)
+.+-+-....|+++.. +|+.+.||........ ..+ .+.+|...+.+|...+ .++++++.+.
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3444444445667655 6788999977532211 112 3778999988885444 3445556543
Q ss_pred CCEEEEEEEccCCC-ChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcC-------CC
Q 047619 346 GEEKLLIYEFVPNK-SLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ-------DM 417 (430)
Q Consensus 346 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~-------~~ 417 (430)
....+||||++++. +|.+++.... ....+...+..++.+++..+.-||..| |+|+|++|.|||++. +.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~ 182 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDL 182 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCc
Confidence 23568999999986 8998874321 123456677789999999999999999 999999999999975 46
Q ss_pred CeeecCCCccc
Q 047619 418 NPKISDFGLAR 428 (430)
Q Consensus 418 ~~kl~DFGlar 428 (430)
.+.|+||+.++
T Consensus 183 ~~~LIDl~r~~ 193 (268)
T PRK15123 183 KLSVIDLHRAQ 193 (268)
T ss_pred eEEEEECCccc
Confidence 79999999874
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.14 E-value=7.4e-12 Score=130.18 Aligned_cols=141 Identities=18% Similarity=0.253 Sum_probs=113.1
Q ss_pred CcccceeecccCCcceEEEEEcCCcEEEEEEecccC-hHhHHHHH---HHHHHHhcCCCCcccceEEEEEeCCEEEEEEE
Q 047619 279 NFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKIS-EQGLKELK---NEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 354 (430)
Q Consensus 279 ~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~---~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 354 (430)
++...+.||.+.|=+|.+|++.+|. |+||++-+.. .-.++.+. .|++ ...++|||++.+.-.-+.....|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 5777799999999999999987776 8899886533 22233333 3444 556689999998888777778889989
Q ss_pred ccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCccc
Q 047619 355 FVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428 (430)
Q Consensus 355 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar 428 (430)
|.. .+|.+.|..+ ..+...+...|+.|++.||.-.|..+ |+|+|||.+||||+.-.-+.|+||..=|
T Consensus 102 yvk-hnLyDRlSTR---PFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFK 168 (1431)
T KOG1240|consen 102 YVK-HNLYDRLSTR---PFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFK 168 (1431)
T ss_pred HHh-hhhhhhhccc---hHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccC
Confidence 884 5888888433 45777888899999999999999998 9999999999999988889999996533
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.12 E-value=9.2e-11 Score=109.92 Aligned_cols=88 Identities=26% Similarity=0.479 Sum_probs=70.7
Q ss_pred CCCcccceEEEEEe---------------------------CCEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHH
Q 047619 332 QHRNLVKLLGCCIQ---------------------------GEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIIC 384 (430)
Q Consensus 332 ~h~niv~l~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~ 384 (430)
+|||||++.++|.+ +..+|+||.-++ .+|..++-.+. .+.....-|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~----~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH----RSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC----CchHHHHHHHH
Confidence 59999999988754 234589998774 68999886543 45566677899
Q ss_pred HHHHHHHHhhhcCCCcEEeCCCCCCcEEE--cCCC--CeeecCCCcc
Q 047619 385 GTARGVMYLHQDSRLRIIHRDLKASNVLL--DQDM--NPKISDFGLA 427 (430)
Q Consensus 385 ~i~~aL~yLH~~~~~~iiH~Dlkp~NILl--~~~~--~~kl~DFGla 427 (430)
|+++|+.|||.++ |.|||+|.+|||| |+|+ .+.|+|||.+
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCc 392 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCC 392 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEccccee
Confidence 9999999999998 9999999999999 3443 4788999975
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=4.9e-11 Score=106.38 Aligned_cols=141 Identities=24% Similarity=0.460 Sum_probs=114.9
Q ss_pred CcccceeecccCCcceEEEEEcCCcEEEEEEecc--cChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEcc
Q 047619 279 NFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFV 356 (430)
Q Consensus 279 ~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 356 (430)
...+..+|.+...|+.|+|++. |..+++|++.- ......+.|..|.-.|+-+.||||..+++.|..+.++.++..||
T Consensus 191 ~lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m 269 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM 269 (448)
T ss_pred hhhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence 4455678999999999999985 45566676642 23444567888999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeec
Q 047619 357 PNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 422 (430)
Q Consensus 357 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~ 422 (430)
+.|+|...++.... -.++..++.+++.++++|+.|||+..+. |.---|....++||++.+++|+
T Consensus 270 p~gslynvlhe~t~-vvvd~sqav~faldiargmaflhslep~-ipr~~lns~hvmidedltaris 333 (448)
T KOG0195|consen 270 PFGSLYNVLHEQTS-VVVDHSQAVRFALDIARGMAFLHSLEPM-IPRFYLNSKHVMIDEDLTARIS 333 (448)
T ss_pred cchHHHHHHhcCcc-EEEecchHHHHHHHHHhhHHHHhhcchh-hhhhhcccceEEecchhhhhee
Confidence 99999999976543 4578889999999999999999998631 3334688899999999887764
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.00 E-value=1.9e-09 Score=97.29 Aligned_cols=132 Identities=21% Similarity=0.225 Sum_probs=95.1
Q ss_pred cccceeecccCCcceEEEEEcCCcEEEEEEecc----------c----------C--hHhHHHHHHHHHHHhcCCCC--c
Q 047619 280 FSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSK----------I----------S--EQGLKELKNEVILFSKLQHR--N 335 (430)
Q Consensus 280 ~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~----------~----------~--~~~~~~~~~E~~~l~~l~h~--n 335 (430)
..+..+||.|--+.||.|..+++.++|||.=.- . + .......++|.++|.+|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 456689999999999999999999999994211 0 0 11234467899999999765 6
Q ss_pred ccceEEEEEeCCEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcC
Q 047619 336 LVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ 415 (430)
Q Consensus 336 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~ 415 (430)
|++.+++ +...+||||++|-.|...- ++....-.++..|+.-+.-+-..| |||+|+.+-|||+++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTE 237 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEec
Confidence 7777654 5678999999987765432 112222334444444444444556 999999999999999
Q ss_pred CCCeeecCCCc
Q 047619 416 DMNPKISDFGL 426 (430)
Q Consensus 416 ~~~~kl~DFGl 426 (430)
+|.+.++||-=
T Consensus 238 dg~~~vIDwPQ 248 (304)
T COG0478 238 DGDIVVIDWPQ 248 (304)
T ss_pred CCCEEEEeCcc
Confidence 99999999953
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.97 E-value=7.3e-11 Score=121.48 Aligned_cols=149 Identities=28% Similarity=0.360 Sum_probs=120.1
Q ss_pred cCCcccceeecccCCcceEEEEEcC--CcEEEEEEecccC--hHhHHHHHHHHHHHhcCC-CCcccceEEEEEeCCEEEE
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLVD--GQEIAVKRLSKIS--EQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLL 351 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 351 (430)
...|.+.+.||+|+|+.|-...... ...+|+|.+.... .........|..+-..+. |+|++++++...+.+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 4567788899999999998877533 4456677665432 334455666888888887 9999999999999999999
Q ss_pred EEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhh-hcCCCcEEeCCCCCCcEEEcCCC-CeeecCCCcccc
Q 047619 352 IYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLH-QDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLARA 429 (430)
Q Consensus 352 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH-~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DFGlar~ 429 (430)
++||..++++...+.... ....+......++.|+..+|.|+| ..+ +.||||||+|.+++..+ .++++|||+|..
T Consensus 99 ~~~~s~g~~~f~~i~~~~-~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPD-STGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred ccCcccccccccccccCC-ccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcc
Confidence 999999999988874221 223555666778999999999999 777 99999999999999999 999999999975
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.91 E-value=2.2e-09 Score=106.07 Aligned_cols=98 Identities=32% Similarity=0.537 Sum_probs=87.9
Q ss_pred HhcCCCCcccceEEEEEeCCEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCC
Q 047619 328 FSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLK 407 (430)
Q Consensus 328 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlk 407 (430)
|+.+.|.|+.+++|.+.++...++|.+|++.|+|.+.+.... ..+++.-...++++++.||.|||... -..|+.|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~--~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED--IKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc--cCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence 467899999999999999999999999999999999997633 34888889999999999999999864 12999999
Q ss_pred CCcEEEcCCCCeeecCCCcccc
Q 047619 408 ASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 408 p~NILl~~~~~~kl~DFGlar~ 429 (430)
+.|.++|..+.+||+|||+..+
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~ 98 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSL 98 (484)
T ss_pred cccceeeeeEEEEechhhhccc
Confidence 9999999999999999999754
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.87 E-value=8e-09 Score=103.45 Aligned_cols=120 Identities=16% Similarity=0.230 Sum_probs=99.6
Q ss_pred EcCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEccCCCChhHHhhcCCCCCCCCHHH
Q 047619 299 LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSK 378 (430)
Q Consensus 299 ~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~ 378 (430)
..++.+|.|...+...........+-++-|+.++||||+++++.++.....|||+|-+ ..|..++... ....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l------~~~~ 105 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKEL------GKEE 105 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHh------HHHH
Confidence 4568888888887655544566788889999999999999999999999999999988 4677776432 2455
Q ss_pred HHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCccc
Q 047619 379 RFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428 (430)
Q Consensus 379 ~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar 428 (430)
....+.||+.||.|||..+ +++|++|.-+-|+|++.|+.||.+|-++.
T Consensus 106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~ 153 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVS 153 (690)
T ss_pred HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEe
Confidence 5667899999999999765 59999999999999999999999997653
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.86 E-value=1.9e-08 Score=90.24 Aligned_cols=106 Identities=26% Similarity=0.293 Sum_probs=83.1
Q ss_pred HHHHHHHHHHHhcCCC--CcccceEEEEEeCC----EEEEEEEccCCC-ChhHHhhcCCCCCCCCHHHHHHHHHHHHHHH
Q 047619 318 LKELKNEVILFSKLQH--RNLVKLLGCCIQGE----EKLLIYEFVPNK-SLDSFIFDQERCKILDWSKRFHIICGTARGV 390 (430)
Q Consensus 318 ~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~----~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL 390 (430)
.....+|...+..|.. -.+++.+++.+... ..+||+|++++. +|.+++..... .+......++.+++..+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHH
Confidence 3457788888887754 34566677666532 358999999884 89998854222 55667778999999999
Q ss_pred HHhhhcCCCcEEeCCCCCCcEEEcCCC---CeeecCCCcccc
Q 047619 391 MYLHQDSRLRIIHRDLKASNVLLDQDM---NPKISDFGLARA 429 (430)
Q Consensus 391 ~yLH~~~~~~iiH~Dlkp~NILl~~~~---~~kl~DFGlar~ 429 (430)
.-||+.| |+|+|++|.|||++.+. .+.|+||+-++.
T Consensus 132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999999 99999999999998886 799999987763
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.86 E-value=1.5e-08 Score=101.97 Aligned_cols=138 Identities=16% Similarity=0.204 Sum_probs=91.1
Q ss_pred eeecccCCcceEEEEEcCCcEEEEEEecccChHh------------------------------HH----------HHHH
Q 047619 284 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQG------------------------------LK----------ELKN 323 (430)
Q Consensus 284 ~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~------------------------------~~----------~~~~ 323 (430)
+.|+.++-|+||+|++.+|+.||||+..+.-.+. .+ .+.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 6899999999999999999999999875421110 00 1233
Q ss_pred HHHHHhcCC-----CCcccceEEEEEeCCEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHH-HHHhhhcC
Q 047619 324 EVILFSKLQ-----HRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARG-VMYLHQDS 397 (430)
Q Consensus 324 E~~~l~~l~-----h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~a-L~yLH~~~ 397 (430)
|..-+.++. .++|.-..=+++......|+|||++|..+.+....... ..+.+.+. ..++++ +.-+-..|
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~--g~d~k~ia---~~~~~~f~~q~~~dg 285 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA--GIDRKELA---ELLVRAFLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhc--CCCHHHHH---HHHHHHHHHHHHhcC
Confidence 444444432 34433333344456778999999999999988533322 24433332 222222 22222344
Q ss_pred CCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 398 RLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 398 ~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++|.|.+|.||+++.+|.+.+.|||+...
T Consensus 286 ---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~ 314 (517)
T COG0661 286 ---FFHADPHPGNILVRSDGRIVLLDFGIVGR 314 (517)
T ss_pred ---ccccCCCccceEEecCCcEEEEcCcceec
Confidence 99999999999999999999999999764
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.83 E-value=3.1e-09 Score=110.80 Aligned_cols=111 Identities=27% Similarity=0.428 Sum_probs=77.4
Q ss_pred hcCCcccceeecccCCcceEEEEEcC-CcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 354 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 354 (430)
...+|..++.|..|+||.||.++++. .+++|+| +.+.. -.+++ ++.....|.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~----lilRn---ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQN----LILRN---ILTFAGNPFVV----------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhc-ccccc----hhhhc---cccccCCccee-----------------
Confidence 44688899999999999999998754 6788984 43311 01111 22233334333
Q ss_pred ccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 355 FVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 355 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|+-...+.. .+.++.. ++.|++|||+.+ |+|||+||+|.||..-|++|+.|||+++.
T Consensus 136 ----gDc~tllk~---~g~lPvd--------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~ 192 (1205)
T KOG0606|consen 136 ----GDCATLLKN---IGPLPVD--------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKK 192 (1205)
T ss_pred ----chhhhhccc---CCCCcch--------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhh
Confidence 444444422 1223332 277899999988 99999999999999999999999999875
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.76 E-value=4.2e-08 Score=95.58 Aligned_cols=135 Identities=21% Similarity=0.301 Sum_probs=105.7
Q ss_pred CcceEEEE-EcCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEe----CCEEEEEEEccCC-CChhHH
Q 047619 291 FGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ----GEEKLLIYEFVPN-KSLDSF 364 (430)
Q Consensus 291 fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~-gsL~~~ 364 (430)
....|++. ..+|..+++|+++....+.......-+++++++.|+|||++.+++.. +..+.+|++|+|+ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 35678887 46799999999954333333233445788999999999999998873 4567899999986 577776
Q ss_pred hhcCCC------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCccc
Q 047619 365 IFDQER------------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428 (430)
Q Consensus 365 l~~~~~------------~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar 428 (430)
.+.... ....++..++.++.|+..||.++|+.| +.-+-|.|.+||++.+.+++|+.-|+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~D 441 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMD 441 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEeccccee
Confidence 654322 234678899999999999999999998 8889999999999999899998777654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.76 E-value=5.2e-09 Score=103.66 Aligned_cols=148 Identities=24% Similarity=0.255 Sum_probs=117.1
Q ss_pred hhcCCcccceeecccCCcceEEEEE--cCCcEEEEEEecccChHhHH--HHHHHHHHHhcC-CCCcccceEEEEEeCCEE
Q 047619 275 NATDNFSINNKLGEGGFGPVYKGTL--VDGQEIAVKRLSKISEQGLK--ELKNEVILFSKL-QHRNLVKLLGCCIQGEEK 349 (430)
Q Consensus 275 ~~~~~~~~~~~ig~G~fg~Vy~~~~--~~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 349 (430)
....+|..+..||.|.|+.|+.... .++..+++|.+.+....... .-..|+.+...+ .|.+++++...+....+.
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 3456788999999999999999874 34778999987653222211 123455555555 488899988889888999
Q ss_pred EEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCC-CCeeecCCCccc
Q 047619 350 LLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLAR 428 (430)
Q Consensus 350 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DFGlar 428 (430)
|+-.||++++++...+.- ...+++..++++..|++.++.++|+.. ++|+|+||+||++..+ +.-++.|||.+.
T Consensus 342 ~ip~e~~~~~s~~l~~~~---~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSVT---SQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred cCchhhhcCcchhhhhHH---HHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccc
Confidence 999999999998877622 234788888999999999999999887 9999999999999876 778999999875
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.75 E-value=2.1e-07 Score=84.70 Aligned_cols=138 Identities=17% Similarity=0.175 Sum_probs=85.4
Q ss_pred eeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCc--ccceEEEEEeCCEEEEEEEccCCCC-
Q 047619 284 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN--LVKLLGCCIQGEEKLLIYEFVPNKS- 360 (430)
Q Consensus 284 ~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gs- 360 (430)
..|++|..+.||+. .+..+++|...... ....+.+|.+++..+..-. +++.+++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 68999999999984 25567788876422 3345688999998886443 5778888878888889999999864
Q ss_pred hhHHh---------------------hcCCCCCCCCHHHHH-HHHH----------HHHH-HHHHhhh-cCCCcEEeCCC
Q 047619 361 LDSFI---------------------FDQERCKILDWSKRF-HIIC----------GTAR-GVMYLHQ-DSRLRIIHRDL 406 (430)
Q Consensus 361 L~~~l---------------------~~~~~~~~~~~~~~~-~i~~----------~i~~-aL~yLH~-~~~~~iiH~Dl 406 (430)
+...+ +.... ...+..... .+.. .+.. ...+|.. .....++|+|+
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~-~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKC-DTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCC-CCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 21111 11000 001111100 0000 0011 1122221 11234789999
Q ss_pred CCCcEEEcCCCCeeecCCCccc
Q 047619 407 KASNVLLDQDMNPKISDFGLAR 428 (430)
Q Consensus 407 kp~NILl~~~~~~kl~DFGlar 428 (430)
.|.||++++++ +.|+||+.|.
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcC
Confidence 99999999887 9999999874
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.74 E-value=1.6e-07 Score=82.98 Aligned_cols=139 Identities=15% Similarity=0.131 Sum_probs=101.7
Q ss_pred ecccCCcceEEEEEcCCcEEEEEEeccc-----C-hHhHHHHHHHHHHHhcCCCCc--ccceEEEEEeC----CEEEEEE
Q 047619 286 LGEGGFGPVYKGTLVDGQEIAVKRLSKI-----S-EQGLKELKNEVILFSKLQHRN--LVKLLGCCIQG----EEKLLIY 353 (430)
Q Consensus 286 ig~G~fg~Vy~~~~~~~~~vavK~~~~~-----~-~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~----~~~~lv~ 353 (430)
-++||-+.|++.... |+.+-+|+-... . +.....|.+|+..|..|...+ ++++...-... -..+||+
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 456888899987763 457888876521 1 345678999999999986433 44554222111 2357999
Q ss_pred EccCC-CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCC--eeecCCCcccc
Q 047619 354 EFVPN-KSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMN--PKISDFGLARA 429 (430)
Q Consensus 354 e~~~~-gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~--~kl~DFGlar~ 429 (430)
|-+++ .+|.+++.... ..+.+...+..++.+++..|.-||+.+ +.|+|+-+.|||++.++. ++++||.-+|.
T Consensus 105 e~L~g~~~L~~~l~~~~-~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHA-VSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCC-cCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97653 68888875432 234677778899999999999999998 999999999999986666 99999977653
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.66 E-value=1.4e-08 Score=100.56 Aligned_cols=146 Identities=25% Similarity=0.360 Sum_probs=117.6
Q ss_pred CCcccceeecc--cCCcceEEEEE---cCCcEEEEEEecc--cChHhHHHHHHHHHHHhcCC-CCcccceEEEEEeCCEE
Q 047619 278 DNFSINNKLGE--GGFGPVYKGTL---VDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEK 349 (430)
Q Consensus 278 ~~~~~~~~ig~--G~fg~Vy~~~~---~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 349 (430)
..+.+...+|. |.+|.||.+.. .++..+|+|+-+. ..+.....-.+|+...++++ |++.++.+..++..+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 45667788999 99999999985 3477899987432 22233344456777777774 99999999999999999
Q ss_pred EEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHH----HHHHhhhcCCCcEEeCCCCCCcEEEcCC-CCeeecCC
Q 047619 350 LLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTAR----GVMYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDF 424 (430)
Q Consensus 350 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~----aL~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DF 424 (430)
++-+|++. .+|.++.... ...++....+.++.+... ||..+|... |+|-|+||+||++..+ ...+++||
T Consensus 194 fiqtE~~~-~sl~~~~~~~--~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTP--CNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeeecccc-chhHHhhhcc--cccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCc
Confidence 99999984 7887776433 345788888888999989 999999988 9999999999999998 78999999
Q ss_pred Ccccc
Q 047619 425 GLARA 429 (430)
Q Consensus 425 Glar~ 429 (430)
|+.+.
T Consensus 268 ~~v~~ 272 (524)
T KOG0601|consen 268 GLVSK 272 (524)
T ss_pred ceeEE
Confidence 98764
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.61 E-value=5e-07 Score=80.22 Aligned_cols=137 Identities=15% Similarity=0.159 Sum_probs=88.6
Q ss_pred hcCCcccceeecccCCcceEEEEEcCCcEEEEEEecccChHhHHH---------HHHHHHHHhcCCC---CcccceEEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKE---------LKNEVILFSKLQH---RNLVKLLGCC 343 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~h---~niv~l~~~~ 343 (430)
...+|.+.+.+-......|.+... +++.+++|..........+. ..+++..+.+++. ..++.++.+.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 446788888888877777766654 67889999775422211111 2233333333322 2222222222
Q ss_pred -----EeCCEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCC
Q 047619 344 -----IQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMN 418 (430)
Q Consensus 344 -----~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~ 418 (430)
......+|+|||++|..|.++.. +++ .++..+.+++.-||+.| ++|+|++|.|++++.+ .
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~-~ 172 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN-G 172 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-c
Confidence 22344579999999988866531 222 24456778899999998 9999999999999865 4
Q ss_pred eeecCCCccc
Q 047619 419 PKISDFGLAR 428 (430)
Q Consensus 419 ~kl~DFGlar 428 (430)
++++||+..+
T Consensus 173 i~iID~~~k~ 182 (229)
T PF06176_consen 173 IRIIDTQGKR 182 (229)
T ss_pred EEEEECcccc
Confidence 9999998764
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.57 E-value=7.7e-07 Score=81.08 Aligned_cols=143 Identities=20% Similarity=0.192 Sum_probs=84.8
Q ss_pred ceeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCC--cccceEEEEEe---CCEEEEEEEccC
Q 047619 283 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHR--NLVKLLGCCIQ---GEEKLLIYEFVP 357 (430)
Q Consensus 283 ~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~---~~~~~lv~e~~~ 357 (430)
++.|+.|..+.||++...+ ..+++|..... .....+.+|..++..+... .+++++..... ....+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 3689999999999999766 69999997643 4567788899888888533 35677764433 334689999999
Q ss_pred CCChhH----------------Hhh---cC-CCCCCCCHHH---------HHHH------------HHHHHH-HHHHhhh
Q 047619 358 NKSLDS----------------FIF---DQ-ERCKILDWSK---------RFHI------------ICGTAR-GVMYLHQ 395 (430)
Q Consensus 358 ~gsL~~----------------~l~---~~-~~~~~~~~~~---------~~~i------------~~~i~~-aL~yLH~ 395 (430)
+..+.. .+. .. .......... .... ...+.. .+..+++
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 988877 111 11 0101111100 0000 011122 2333332
Q ss_pred ----cCCCcEEeCCCCCCcEEEc-CCCCeeecCCCccc
Q 047619 396 ----DSRLRIIHRDLKASNVLLD-QDMNPKISDFGLAR 428 (430)
Q Consensus 396 ----~~~~~iiH~Dlkp~NILl~-~~~~~kl~DFGlar 428 (430)
.....++|+|+.|.|||++ +++.+-|+||+.|.
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 1234599999999999999 55666799998875
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.55 E-value=9e-07 Score=81.64 Aligned_cols=141 Identities=16% Similarity=0.127 Sum_probs=86.1
Q ss_pred eeecccCC-cceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcCC-CCcccceEEEEEeCCEEEEEEEccCCCCh
Q 047619 284 NKLGEGGF-GPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYEFVPNKSL 361 (430)
Q Consensus 284 ~~ig~G~f-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL 361 (430)
+.|..|.+ ..||+.... +..+.+|+..... ...+.+|++++..+. +.-+++++++....+..++|||+++|.+|
T Consensus 4 ~~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l 79 (244)
T cd05150 4 ERVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA 79 (244)
T ss_pred eecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence 45666666 788998754 4678888875432 345677888888774 34466788877776778999999999887
Q ss_pred hHHh-------------------hcCCC-CCCCCHH--HHHHHHH--------------------HHHHHHHHhhh----
Q 047619 362 DSFI-------------------FDQER-CKILDWS--KRFHIIC--------------------GTARGVMYLHQ---- 395 (430)
Q Consensus 362 ~~~l-------------------~~~~~-~~~~~~~--~~~~i~~--------------------~i~~aL~yLH~---- 395 (430)
.... +.... ..+.... ....... .+...+..|-.
T Consensus 80 ~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 159 (244)
T cd05150 80 AALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPA 159 (244)
T ss_pred hHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCC
Confidence 6432 11100 0011100 0000000 01111112211
Q ss_pred cCCCcEEeCCCCCCcEEEcCCCCeeecCCCccc
Q 047619 396 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428 (430)
Q Consensus 396 ~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar 428 (430)
...+.++|+|+.|.|||++++..+.|+||+.|.
T Consensus 160 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 160 EEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred cCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 112458999999999999987778899999875
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=98.51 E-value=1.8e-07 Score=81.53 Aligned_cols=58 Identities=22% Similarity=0.202 Sum_probs=51.0
Q ss_pred CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 359 KSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 359 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|+|.+++... ...+++..+..++.|++.||.|||+++ ||+|||++.++.+|+ ||+++.
T Consensus 1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~ 58 (176)
T smart00750 1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAF 58 (176)
T ss_pred CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEe
Confidence 6889998643 345999999999999999999999865 999999999999999 999874
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.49 E-value=2.9e-06 Score=75.06 Aligned_cols=133 Identities=16% Similarity=0.281 Sum_probs=93.9
Q ss_pred ceeecccCCcceEEEEEcCCcEEEEEEecccC----------------hHhHHHHHHHHHHHhcCC------CCcccceE
Q 047619 283 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSKIS----------------EQGLKELKNEVILFSKLQ------HRNLVKLL 340 (430)
Q Consensus 283 ~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------h~niv~l~ 340 (430)
...||+|+.-.||. +++....+||++.... ....++..+|+.....+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 35799999999994 6677888899886533 123566677776666555 78899999
Q ss_pred EEEEeCCEEEEEEEccCC------CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEc
Q 047619 341 GCCIQGEEKLLIYEFVPN------KSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLD 414 (430)
Q Consensus 341 ~~~~~~~~~~lv~e~~~~------gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~ 414 (430)
|+.+++...-+|+|.+.+ .+|.+++.+. .++. .....+ -+-..||-+.+ |+.+||+|.||++.
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~----~~~~-~~~~~L---~~f~~~l~~~~---Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEG----GLTE-ELRQAL---DEFKRYLLDHH---IVIRDLNPHNIVVQ 152 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcC----CccH-HHHHHH---HHHHHHHHHcC---CeecCCCcccEEEE
Confidence 999999999999998743 4677887432 2444 333333 33455666666 99999999999995
Q ss_pred CC--C--CeeecC-CCccc
Q 047619 415 QD--M--NPKISD-FGLAR 428 (430)
Q Consensus 415 ~~--~--~~kl~D-FGlar 428 (430)
.. + .+.|+| ||-..
T Consensus 153 ~~~~~~~~lvlIDG~G~~~ 171 (199)
T PF10707_consen 153 RRDSGEFRLVLIDGLGEKE 171 (199)
T ss_pred ecCCCceEEEEEeCCCCcc
Confidence 43 2 477777 56543
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.45 E-value=7.4e-07 Score=78.46 Aligned_cols=102 Identities=23% Similarity=0.251 Sum_probs=80.0
Q ss_pred HHHHHHHhcCCC-CcccceEEEEEeCCEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCc
Q 047619 322 KNEVILFSKLQH-RNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLR 400 (430)
Q Consensus 322 ~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~ 400 (430)
.+|.-+++.+++ +++++++|+| ..++|.||.+.+++.............+|..+.+|+.++++.+++|++.-...
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 358888888987 6999999999 34678999987765422100011123689999999999999999999865445
Q ss_pred EEeCCCCCCcEEEcCCCCeeecCCCcc
Q 047619 401 IIHRDLKASNVLLDQDMNPKISDFGLA 427 (430)
Q Consensus 401 iiH~Dlkp~NILl~~~~~~kl~DFGla 427 (430)
+.-.|++|+|+.+++++++|++|...+
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v 109 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDV 109 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhc
Confidence 888999999999999999999998754
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.44 E-value=1.3e-06 Score=87.72 Aligned_cols=137 Identities=16% Similarity=0.204 Sum_probs=86.3
Q ss_pred eeecccCCcceEEEEEcCCcEEEEEEecccChHh-------------------------------HHH------HHHHHH
Q 047619 284 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQG-------------------------------LKE------LKNEVI 326 (430)
Q Consensus 284 ~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~-------------------------------~~~------~~~E~~ 326 (430)
+.|+.-+.|+||+|++++|+.||||+-++.-... .+. |.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 6899999999999999999999999765411100 011 222333
Q ss_pred HHh----cCCCCc------ccceEEEEEeCCEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhc
Q 047619 327 LFS----KLQHRN------LVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 396 (430)
Q Consensus 327 ~l~----~l~h~n------iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~ 396 (430)
-.. .+.|-+ |++++- .......|+|||++|..+.+.-.-... .++...+..-+.+.. ++-|-..
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~~--gi~~~~i~~~l~~~~--~~qIf~~ 320 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDKR--GISPHDILNKLVEAY--LEQIFKT 320 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHHc--CCCHHHHHHHHHHHH--HHHHHhc
Confidence 222 223444 344432 234567899999999988776432222 244444333332221 2223333
Q ss_pred CCCcEEeCCCCCCcEEEcC----CCCeeecCCCcccc
Q 047619 397 SRLRIIHRDLKASNVLLDQ----DMNPKISDFGLARA 429 (430)
Q Consensus 397 ~~~~iiH~Dlkp~NILl~~----~~~~kl~DFGlar~ 429 (430)
| ++|+|-+|.||++.. ++.+.+-|||+.+.
T Consensus 321 G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~ 354 (538)
T KOG1235|consen 321 G---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAV 354 (538)
T ss_pred C---CccCCCCCCcEEEecCCCCCccEEEEccccccc
Confidence 4 999999999999984 56899999999764
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.42 E-value=2.4e-06 Score=76.73 Aligned_cols=150 Identities=19% Similarity=0.210 Sum_probs=96.3
Q ss_pred ccHHhHHhhcCCcccce---eecccCCcceEEEEEcCCcEEEEEEecccChHh------------------------HHH
Q 047619 268 FELATIANATDNFSINN---KLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQG------------------------LKE 320 (430)
Q Consensus 268 ~~~~~~~~~~~~~~~~~---~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~------------------------~~~ 320 (430)
.++..+....+...+.+ .|+.|--+.||+|...++..+|+|++....... ...
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 34455555555555544 456677788999988789999999885421110 111
Q ss_pred HHHHHHHHhcCC--CCcccceEEEEEeCCEEEEEEEccCCCChh-HHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcC
Q 047619 321 LKNEVILFSKLQ--HRNLVKLLGCCIQGEEKLLIYEFVPNKSLD-SFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 397 (430)
Q Consensus 321 ~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~gsL~-~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~ 397 (430)
...|+.-|.++. +-.+++.+.+. ...|||||+....+. -.|.+ .++.......+..++++.+.-|-...
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD----v~~e~~e~~~~~~~~v~~~~~l~~~a 186 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD----VPLELEEAEGLYEDVVEYMRRLYKEA 186 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCccc----CCcCchhHHHHHHHHHHHHHHHHHhc
Confidence 345666666664 34455555543 457999999654211 11111 11223356677778888888777632
Q ss_pred CCcEEeCCCCCCcEEEcCCCCeeecCCCccc
Q 047619 398 RLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428 (430)
Q Consensus 398 ~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar 428 (430)
++||+||..-|||+. ++.+.|+|||=|-
T Consensus 187 --~LVHgDLSEyNiL~~-~~~p~iID~~QaV 214 (268)
T COG1718 187 --GLVHGDLSEYNILVH-DGEPYIIDVSQAV 214 (268)
T ss_pred --CcccccchhhheEEE-CCeEEEEECcccc
Confidence 399999999999998 7889999998664
|
|
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=98.41 E-value=1.2e-06 Score=65.28 Aligned_cols=72 Identities=38% Similarity=0.767 Sum_probs=54.5
Q ss_pred CceEEEecccCCCCccceeecCCCHHHHHHHhhc-CCCeeeEeccccCCCCceeeeec-cCCCcccccCCCCcceEEE
Q 047619 165 DGFIKFTELKLPDATSSWVSKSMNLYECQDKCLD-NSSCMAYTNSDIRGEGSGCAMWF-GDLIDMRSFPDGGQDFYIR 240 (430)
Q Consensus 165 ~~f~~~~~~~~p~~~~~~~~~~~~~~~C~~~Cl~-~CsC~a~~~~~~~~~~~gC~~~~-~~L~~~~~~~~~~~~~yir 240 (430)
..|..++++.+++..... ....++++|++.|+. +|+|.|+.|.. .+.+|.+|. +.+.+....+..+.++|.+
T Consensus 4 ~~f~~~~~~~l~~~~~~~-~~~~s~~~C~~~C~~~~~~C~s~~y~~---~~~~C~l~~~~~~~~~~~~~~~~~~~y~~ 77 (78)
T smart00473 4 DCFVRLPNTKLPGFSRIV-ISVASLEECASKCLNSNCSCRSFTYNN---GTKGCLLWSESSLGDARLFPSGGVDLYEK 77 (78)
T ss_pred ceeEEecCccCCCCccee-EcCCCHHHHHHHhCCCCCceEEEEEcC---CCCEEEEeeCCccccceecccCCceeEEe
Confidence 568999999999665542 456799999999999 99999999974 345799999 7777766444445555543
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.33 E-value=8.8e-06 Score=88.06 Aligned_cols=79 Identities=15% Similarity=0.326 Sum_probs=57.9
Q ss_pred ceeecccCCcceEEEEEcCC---cEEEEEEecccC-hHhHHHHHHHHHHHhcCC-CCcc--cceEEEEEeC---CEEEEE
Q 047619 283 NNKLGEGGFGPVYKGTLVDG---QEIAVKRLSKIS-EQGLKELKNEVILFSKLQ-HRNL--VKLLGCCIQG---EEKLLI 352 (430)
Q Consensus 283 ~~~ig~G~fg~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~ni--v~l~~~~~~~---~~~~lv 352 (430)
.++|+.|.+..+|+....++ ..+++|+..... ......+.+|+++++.+. |++| ++++.++.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 47899999999999876553 467777764321 123456889999999995 6654 7888887664 457899
Q ss_pred EEccCCCCh
Q 047619 353 YEFVPNKSL 361 (430)
Q Consensus 353 ~e~~~~gsL 361 (430)
|||++|..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999998653
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.32 E-value=1.3e-07 Score=92.29 Aligned_cols=75 Identities=28% Similarity=0.425 Sum_probs=68.0
Q ss_pred EEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcc
Q 047619 348 EKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427 (430)
Q Consensus 348 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla 427 (430)
.+||.|+++...+|.++|.+.......++...+.++.|++.|++| ++ .+|+|+||.||....+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 568999999999999999876666678888999999999999999 66 999999999999999989999999986
Q ss_pred c
Q 047619 428 R 428 (430)
Q Consensus 428 r 428 (430)
.
T Consensus 404 t 404 (516)
T KOG1033|consen 404 T 404 (516)
T ss_pred e
Confidence 4
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.26 E-value=7e-06 Score=75.27 Aligned_cols=73 Identities=16% Similarity=0.289 Sum_probs=46.8
Q ss_pred eeecccCCc-ceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCC---cccceEEEEEeCC---EEEEEEEcc
Q 047619 284 NKLGEGGFG-PVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHR---NLVKLLGCCIQGE---EKLLIYEFV 356 (430)
Q Consensus 284 ~~ig~G~fg-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~~---~~~lv~e~~ 356 (430)
+.|+.|+.. .||+. +..+++|.... ......+.+|.+++..+... -+.++++.....+ ..+++||++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 567777766 58875 24577776543 22345788899999887532 3455555443322 348899999
Q ss_pred CCCChh
Q 047619 357 PNKSLD 362 (430)
Q Consensus 357 ~~gsL~ 362 (430)
+|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 997764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.25 E-value=7.5e-07 Score=82.24 Aligned_cols=96 Identities=23% Similarity=0.274 Sum_probs=79.4
Q ss_pred HHHhcCCCCcccceEEEEEeCC-----EEEEEEEccCCCChhHHhhcCCC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCC
Q 047619 326 ILFSKLQHRNLVKLLGCCIQGE-----EKLLIYEFVPNKSLDSFIFDQER-CKILDWSKRFHIICGTARGVMYLHQDSRL 399 (430)
Q Consensus 326 ~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~~~i~~~i~~aL~yLH~~~~~ 399 (430)
.-|-.+-|.|||+++.++.+.. ...+++|||+-|+|..+|++..+ .+.+......++.-||+.||.|||+.. +
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-P 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-C
Confidence 3445567999999999987654 35789999999999999976433 455777777789999999999999985 7
Q ss_pred cEEeCCCCCCcEEEcCCCCeeec
Q 047619 400 RIIHRDLKASNVLLDQDMNPKIS 422 (430)
Q Consensus 400 ~iiH~Dlkp~NILl~~~~~~kl~ 422 (430)
+|+|+++..+-|++..+|-+|+.
T Consensus 198 piihgnlTc~tifiq~ngLIkig 220 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIG 220 (458)
T ss_pred ccccCCcchhheeecCCceEEec
Confidence 79999999999999988888764
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.19 E-value=2.1e-05 Score=72.02 Aligned_cols=74 Identities=19% Similarity=0.297 Sum_probs=48.7
Q ss_pred eeecccCCcceEEEEEcC--CcEEEEEEecccChHhHHHHHHHHHHHhcCCCCc-ccceEEEEEeCCEEEEEEEccCCCC
Q 047619 284 NKLGEGGFGPVYKGTLVD--GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN-LVKLLGCCIQGEEKLLIYEFVPNKS 360 (430)
Q Consensus 284 ~~ig~G~fg~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~~~~gs 360 (430)
+.|..|-...+|++...+ ++.+++|+..... .......+|+.++..+...+ .+++++... ..++|||++|.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~-~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKT-ELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCc-cceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 578888888999998654 6788899765422 11223346888888885433 444544332 248999999977
Q ss_pred hh
Q 047619 361 LD 362 (430)
Q Consensus 361 L~ 362 (430)
+.
T Consensus 79 l~ 80 (235)
T cd05157 79 LE 80 (235)
T ss_pred CC
Confidence 63
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.16 E-value=3.1e-05 Score=73.53 Aligned_cols=79 Identities=13% Similarity=0.072 Sum_probs=57.4
Q ss_pred cccceeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcCCC---CcccceEEEEEeC---CEEEEEE
Q 047619 280 FSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH---RNLVKLLGCCIQG---EEKLLIY 353 (430)
Q Consensus 280 ~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~---~~~~lv~ 353 (430)
..-.+.||.|..+.||+....++ .+.+|..+. ......+.+|...|+.|.. ..++++++.+..+ +..+|||
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm 92 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDSQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL 92 (297)
T ss_pred hheeeecCCccceeEEEEEcCCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence 33457899999999999876555 466666432 1123578899999988853 4688888877543 5689999
Q ss_pred EccCCCCh
Q 047619 354 EFVPNKSL 361 (430)
Q Consensus 354 e~~~~gsL 361 (430)
|++++.++
T Consensus 93 E~i~G~~~ 100 (297)
T PRK10593 93 ERLRGVSV 100 (297)
T ss_pred eccCCEec
Confidence 99998765
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.11 E-value=2.8e-05 Score=68.35 Aligned_cols=125 Identities=28% Similarity=0.401 Sum_probs=90.1
Q ss_pred CCcccceeecccCC-cceEEEEEcCCcEEEEEEecc------------cCh---------HhHHHHHHHHHHHhcCC---
Q 047619 278 DNFSINNKLGEGGF-GPVYKGTLVDGQEIAVKRLSK------------ISE---------QGLKELKNEVILFSKLQ--- 332 (430)
Q Consensus 278 ~~~~~~~~ig~G~f-g~Vy~~~~~~~~~vavK~~~~------------~~~---------~~~~~~~~E~~~l~~l~--- 332 (430)
.+++.++.||.|.- |.||++.. +|+.+|+|.+.. ... ....-|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 78999999999999 99999987 678999999321 000 12235778988888886
Q ss_pred CCcc--cceEEEEEeCC------------------EEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHH
Q 047619 333 HRNL--VKLLGCCIQGE------------------EKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMY 392 (430)
Q Consensus 333 h~ni--v~l~~~~~~~~------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~y 392 (430)
+.++ |+.+|+..-.. ...||.||++... .+.. .-+.+|.+-|..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~----~~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQI----RDIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccch----hHHHHHHHHHHH
Confidence 3455 89999874331 2357778775432 1222 235667788888
Q ss_pred hhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcc
Q 047619 393 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427 (430)
Q Consensus 393 LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla 427 (430)
+|..+ |+-+|+|+.|.. + -||+|||.+
T Consensus 180 ~~k~g---I~~~Dv~~~ny~---~--G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLG---IVPRDVKPRNYR---G--GKLVDFSSS 206 (207)
T ss_pred HHHCC---eeeccCcccccc---C--CEEEecccC
Confidence 99888 999999999975 3 489999875
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.08 E-value=2.6e-05 Score=72.53 Aligned_cols=138 Identities=17% Similarity=0.133 Sum_probs=78.1
Q ss_pred eecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcc-cceEEEEEeCCEEEEEEEccCCCChhH
Q 047619 285 KLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL-VKLLGCCIQGEEKLLIYEFVPNKSLDS 363 (430)
Q Consensus 285 ~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gsL~~ 363 (430)
.+..|-...+|+.. .+++.+++|..............+|..+++.+....+ ++++... . .++||||++|..+..
T Consensus 3 ~~~~G~tn~~y~~~-~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIE-HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEE-eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCccccc
Confidence 45667788999887 3567888887654222211234678888888864433 4444433 2 368999999876542
Q ss_pred H-----------------hhcCCC-CCCCCHHHH-HHHHHH---------HHHHHHHhhhc-----CCCcEEeCCCCCCc
Q 047619 364 F-----------------IFDQER-CKILDWSKR-FHIICG---------TARGVMYLHQD-----SRLRIIHRDLKASN 410 (430)
Q Consensus 364 ~-----------------l~~~~~-~~~~~~~~~-~~i~~~---------i~~aL~yLH~~-----~~~~iiH~Dlkp~N 410 (430)
. |+.... ..+++.... .....+ +...+..+-.. .+..++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 111111 111221111 111111 11112222111 12348999999999
Q ss_pred EEEcCCCCeeecCCCccc
Q 047619 411 VLLDQDMNPKISDFGLAR 428 (430)
Q Consensus 411 ILl~~~~~~kl~DFGlar 428 (430)
||+++++ +.|+||..|.
T Consensus 158 il~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred EEEeCCC-CEEEeccccC
Confidence 9998876 8999998875
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.02 E-value=3.2e-05 Score=65.96 Aligned_cols=128 Identities=20% Similarity=0.281 Sum_probs=87.0
Q ss_pred ccceeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCccc-ceEEEEEeCCEEEEEEEccCCC
Q 047619 281 SINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV-KLLGCCIQGEEKLLIYEFVPNK 359 (430)
Q Consensus 281 ~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~g 359 (430)
.+.+.|++|.+|.||++.+. +..+|+|+-.. ......+..|+++|..+.-.++. +++.+- ..++.|||+.|.
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~--ds~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~ 97 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRR--DSPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGR 97 (201)
T ss_pred hhhhhhhcccccEEEEeecc-CceEEEEEecC--CcchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCc
Confidence 34578999999999999874 55888887653 33457788999999999876654 444442 234669999998
Q ss_pred ChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCC-CCcEEEcCCCCeeecCCCccc
Q 047619 360 SLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLK-ASNVLLDQDMNPKISDFGLAR 428 (430)
Q Consensus 360 sL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlk-p~NILl~~~~~~kl~DFGlar 428 (430)
.|.+.-.. .+.++.. .++++---|-..| |-|..|. |..++|-.+..+.|+||.-|+
T Consensus 98 ~L~~~~~~------~~rk~l~----~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At 154 (201)
T COG2112 98 PLGKLEIG------GDRKHLL----RVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSAT 154 (201)
T ss_pred chhhhhhc------ccHHHHH----HHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchh
Confidence 88776421 1233333 3344433344344 8888875 555666566699999999886
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.96 E-value=3.6e-05 Score=73.10 Aligned_cols=142 Identities=20% Similarity=0.182 Sum_probs=84.4
Q ss_pred ceeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCc--ccceEEE------EEeCCEEEEEEE
Q 047619 283 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN--LVKLLGC------CIQGEEKLLIYE 354 (430)
Q Consensus 283 ~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~------~~~~~~~~lv~e 354 (430)
.+.|..|....+|+.... +..+++|+... .....+..|+.++..+.+.+ +++++.. ....+..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTD-SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeC-CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 467888888899998753 45788888764 23455667888877775332 4444431 233456689999
Q ss_pred ccCCCChhH----H-------h---hcC----CC----CCCCCHHHHH----------HHHHHHHHHHHHhhh----cCC
Q 047619 355 FVPNKSLDS----F-------I---FDQ----ER----CKILDWSKRF----------HIICGTARGVMYLHQ----DSR 398 (430)
Q Consensus 355 ~~~~gsL~~----~-------l---~~~----~~----~~~~~~~~~~----------~i~~~i~~aL~yLH~----~~~ 398 (430)
+++|..+.. . + +.. .. .....|.... .....+..++.++.. .-+
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999877532 0 0 100 00 0011111110 011122334444443 112
Q ss_pred CcEEeCCCCCCcEEEcCCCCeeecCCCccc
Q 047619 399 LRIIHRDLKASNVLLDQDMNPKISDFGLAR 428 (430)
Q Consensus 399 ~~iiH~Dlkp~NILl~~~~~~kl~DFGlar 428 (430)
..++|+|+.|.|||+++++.+.|+||+.|.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 349999999999999987767899998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.96 E-value=0.00012 Score=71.69 Aligned_cols=75 Identities=15% Similarity=0.216 Sum_probs=55.1
Q ss_pred eeecccCCcceEEEEEcCC-cEEEEEEeccc-----C--hHhHHHHHHHHHHHhcCC---CCcccceEEEEEeCCEEEEE
Q 047619 284 NKLGEGGFGPVYKGTLVDG-QEIAVKRLSKI-----S--EQGLKELKNEVILFSKLQ---HRNLVKLLGCCIQGEEKLLI 352 (430)
Q Consensus 284 ~~ig~G~fg~Vy~~~~~~~-~~vavK~~~~~-----~--~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv 352 (430)
+.||.|.+..||++...++ +.++||.-... . +...++...|.+.|..+. ...+++++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 6899999999999998776 58999985421 1 224567778888887763 3457777776 44667899
Q ss_pred EEccCCCC
Q 047619 353 YEFVPNKS 360 (430)
Q Consensus 353 ~e~~~~gs 360 (430)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998643
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.0001 Score=70.22 Aligned_cols=140 Identities=24% Similarity=0.343 Sum_probs=82.7
Q ss_pred eeecccCCcceEEEEEcC-------CcEEEEEEecccChHhHHHHHHHHHHHhcCCCCc-ccceEEEEEeCCEEEEEEEc
Q 047619 284 NKLGEGGFGPVYKGTLVD-------GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN-LVKLLGCCIQGEEKLLIYEF 355 (430)
Q Consensus 284 ~~ig~G~fg~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~ 355 (430)
+.|..|-...+|++...+ ++.+++|+..... .......+|.+++..+.... .+++++++.. .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 566777777899887654 4788899875432 23345567888888775433 3455555432 368999
Q ss_pred cCCCChhHH-----------------hhcCCCCC------CCC--HHHHHH--------------------------HHH
Q 047619 356 VPNKSLDSF-----------------IFDQERCK------ILD--WSKRFH--------------------------IIC 384 (430)
Q Consensus 356 ~~~gsL~~~-----------------l~~~~~~~------~~~--~~~~~~--------------------------i~~ 384 (430)
++|..+... ++...... ..+ +..... +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 998776431 11111100 011 101100 111
Q ss_pred HHHHHHHHhhh------cCCCcEEeCCCCCCcEEEcCC----CCeeecCCCccc
Q 047619 385 GTARGVMYLHQ------DSRLRIIHRDLKASNVLLDQD----MNPKISDFGLAR 428 (430)
Q Consensus 385 ~i~~aL~yLH~------~~~~~iiH~Dlkp~NILl~~~----~~~kl~DFGlar 428 (430)
.+...+..|.. .....++|+|+.|.|||++++ +.+.|+||..|.
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 22222334432 134568999999999999874 789999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00092 Score=64.20 Aligned_cols=141 Identities=20% Similarity=0.211 Sum_probs=75.4
Q ss_pred eeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCC--cccceEE------EEEeCCEEEEEEEc
Q 047619 284 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHR--NLVKLLG------CCIQGEEKLLIYEF 355 (430)
Q Consensus 284 ~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~------~~~~~~~~~lv~e~ 355 (430)
+.|+.|....+|+....++ .+++|++.... .+.+..|+.++..|... .+++++. +....+..++++||
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~ 103 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFERLT---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF 103 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEeccCC---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence 5577787789999876444 68889875322 23334455555554321 2334332 12235567899999
Q ss_pred cCCCChh-----------HHhh---cCCC--------CCCCCH-HHHHH------------HHHH-HHHHHHHhhhc---
Q 047619 356 VPNKSLD-----------SFIF---DQER--------CKILDW-SKRFH------------IICG-TARGVMYLHQD--- 396 (430)
Q Consensus 356 ~~~gsL~-----------~~l~---~~~~--------~~~~~~-~~~~~------------i~~~-i~~aL~yLH~~--- 396 (430)
++|..+. ..+. .... ...+.+ ..... .+.+ +...++.+...
T Consensus 104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 183 (319)
T PRK05231 104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP 183 (319)
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence 9987542 1111 1000 000111 11111 1111 11112222211
Q ss_pred -CCCcEEeCCCCCCcEEEcCCCCeeecCCCccc
Q 047619 397 -SRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428 (430)
Q Consensus 397 -~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar 428 (430)
-+..++|+|++|.|||++.+...-|+||+.|.
T Consensus 184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 12359999999999999866556899999874
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.67 E-value=4.2e-05 Score=71.26 Aligned_cols=137 Identities=18% Similarity=0.259 Sum_probs=92.8
Q ss_pred hHHhhcCCcccceeecccCCcceEEEEEcCCcEEEEEEec--cc-------Ch-----------H--hHHHHHHHHHHHh
Q 047619 272 TIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLS--KI-------SE-----------Q--GLKELKNEVILFS 329 (430)
Q Consensus 272 ~~~~~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~--~~-------~~-----------~--~~~~~~~E~~~l~ 329 (430)
++..-..-+.+.++||-|.-+-||.+-..+|++.++|.-. +. .. . ..-...+|+..|+
T Consensus 86 tL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmk 165 (465)
T KOG2268|consen 86 TLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMK 165 (465)
T ss_pred HHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHH
Confidence 3333333467789999999999999999889999988421 10 00 0 1122456888888
Q ss_pred cCCCC--cccceEEEEEeCCEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCC
Q 047619 330 KLQHR--NLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLK 407 (430)
Q Consensus 330 ~l~h~--niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlk 407 (430)
.|... -|++.+++ +..++|||++.+-.|...-. ..+...+.. .+..-+.-|-.+| +||+|..
T Consensus 166 aL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~---~lm~~Iv~la~~G---lIHgDFN 229 (465)
T KOG2268|consen 166 ALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRH------VEDPPTLYD---DLMGLIVRLANHG---LIHGDFN 229 (465)
T ss_pred HHHHcCCCCCCcccc----cceeeHHHhhcccceeeeee------cCChHHHHH---HHHHHHHHHHHcC---ceecccc
Confidence 88532 25555543 56689999999988865431 123333332 2333345566666 9999999
Q ss_pred CCcEEEcCCCCeeecCC
Q 047619 408 ASNVLLDQDMNPKISDF 424 (430)
Q Consensus 408 p~NILl~~~~~~kl~DF 424 (430)
-=||+|++++.++++||
T Consensus 230 EFNimv~dd~~i~vIDF 246 (465)
T KOG2268|consen 230 EFNIMVKDDDKIVVIDF 246 (465)
T ss_pred hheeEEecCCCEEEeec
Confidence 99999999999999999
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.0005 Score=66.73 Aligned_cols=140 Identities=19% Similarity=0.284 Sum_probs=80.8
Q ss_pred eeecccCCcceEEEEEcC-----CcEEEEEEecccChHhHHHHHHHHHHHhcCCCCccc-ceEEEEEeCCEEEEEEEccC
Q 047619 284 NKLGEGGFGPVYKGTLVD-----GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV-KLLGCCIQGEEKLLIYEFVP 357 (430)
Q Consensus 284 ~~ig~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~ 357 (430)
..|..|-.-.+|++...+ ++.+++|+.........+ -.+|..++..+...++. ++++.+..+ .|+||++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 566668888999987532 367888887653332222 26788888888654443 555655322 5899998
Q ss_pred CCChhHH-----------------hhcCC-CC-C-CCCHHHHHHHHHH-----------------HHHHHHHh----hh-
Q 047619 358 NKSLDSF-----------------IFDQE-RC-K-ILDWSKRFHIICG-----------------TARGVMYL----HQ- 395 (430)
Q Consensus 358 ~gsL~~~-----------------l~~~~-~~-~-~~~~~~~~~i~~~-----------------i~~aL~yL----H~- 395 (430)
+.+|... ++... .. . ...+.++..++.+ +...+..| ..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 8776421 11111 00 0 1112222222211 11111112 11
Q ss_pred cCCCcEEeCCCCCCcEEEcC-CCCeeecCCCccc
Q 047619 396 DSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLAR 428 (430)
Q Consensus 396 ~~~~~iiH~Dlkp~NILl~~-~~~~kl~DFGlar 428 (430)
.....++|+|+++.|||+++ ++.+.|+||..|.
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 22345899999999999976 4679999998875
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.0018 Score=61.93 Aligned_cols=143 Identities=22% Similarity=0.202 Sum_probs=80.5
Q ss_pred ceeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCc--ccceEEE------EEeCCEEEEEEE
Q 047619 283 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN--LVKLLGC------CIQGEEKLLIYE 354 (430)
Q Consensus 283 ~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~------~~~~~~~~lv~e 354 (430)
.+.++.|....+|++... +..+++|+..... ..+.+..|+.++..|.... +++++.. ....+..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~-~~~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTD-VGRYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeC-CCcEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 456777777899998754 4467788775421 1234556667666664222 3444332 122456789999
Q ss_pred ccCCCChh-----------HH---hhcCCCC------C---CCCHHHHH------------HHHHHHHHHHHHhhh----
Q 047619 355 FVPNKSLD-----------SF---IFDQERC------K---ILDWSKRF------------HIICGTARGVMYLHQ---- 395 (430)
Q Consensus 355 ~~~~gsL~-----------~~---l~~~~~~------~---~~~~~~~~------------~i~~~i~~aL~yLH~---- 395 (430)
|++|..+. .. ++..... . ...|.... .....+...++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 99986542 11 1110000 0 00111100 001123334555532
Q ss_pred cCCCcEEeCCCCCCcEEEcCCCCeeecCCCccc
Q 047619 396 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428 (430)
Q Consensus 396 ~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar 428 (430)
.-...++|+|+++.||++++++.+.|+||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 122459999999999999988767899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00065 Score=63.78 Aligned_cols=30 Identities=27% Similarity=0.544 Sum_probs=25.1
Q ss_pred CcEEeCCCCCCcEEEcCCCC-eeecCCCccc
Q 047619 399 LRIIHRDLKASNVLLDQDMN-PKISDFGLAR 428 (430)
Q Consensus 399 ~~iiH~Dlkp~NILl~~~~~-~kl~DFGlar 428 (430)
..++|+|++|.|||+++++. .-|+||+.|.
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~ 215 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAK 215 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence 34899999999999987555 4699999875
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.0012 Score=62.69 Aligned_cols=148 Identities=16% Similarity=0.196 Sum_probs=82.8
Q ss_pred cccceeecccCCcceEEEEEcCCcEEEEEEecc--cChHhHHHHHHHHHHHhcCCC--CcccceEEEEEeCC--EEEEEE
Q 047619 280 FSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQH--RNLVKLLGCCIQGE--EKLLIY 353 (430)
Q Consensus 280 ~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~--~~~lv~ 353 (430)
..+.+.+..|-.-.+|..... ++++++. ... ..........+|..+|+.+.- .-+.+.++.|.++. ..|.||
T Consensus 27 ~~~v~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~ 104 (321)
T COG3173 27 LLIVEEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVM 104 (321)
T ss_pred CceeeeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEE
Confidence 344455545544455555433 7778877 331 223344556778888888754 23455666666665 569999
Q ss_pred EccCCCChhHH------------------hhcC---------CCCCC--CCHHHHHHHHH--------------HHHHHH
Q 047619 354 EFVPNKSLDSF------------------IFDQ---------ERCKI--LDWSKRFHIIC--------------GTARGV 390 (430)
Q Consensus 354 e~~~~gsL~~~------------------l~~~---------~~~~~--~~~~~~~~i~~--------------~i~~aL 390 (430)
+|++|..+... |..- ....+ ....+...... ....-.
T Consensus 105 ~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~ 184 (321)
T COG3173 105 EWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLI 184 (321)
T ss_pred EEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHH
Confidence 99988332211 1100 00000 00000111111 112223
Q ss_pred HHhhhc-----CCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 391 MYLHQD-----SRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 391 ~yLH~~-----~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
.+|+++ ++..++|+|+++.||+|+...-+-|+||+++.+
T Consensus 185 ~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 185 KWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred HHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 444433 335699999999999999888899999999863
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.45 E-value=1.5e-05 Score=84.06 Aligned_cols=148 Identities=18% Similarity=0.233 Sum_probs=104.1
Q ss_pred hhcCCcccceeecccCCcceEEEEEc-CCcEEEEEEec---ccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEE
Q 047619 275 NATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLS---KISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 350 (430)
Q Consensus 275 ~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~---~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 350 (430)
...+.+.+.+.+-.|+++.++.+.-. .+...+.|... +......+....+-.++-..++|-+++....+......+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 35567888888999999999987632 24344444332 222222333334433433345566666655555667889
Q ss_pred EEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCccc
Q 047619 351 LIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428 (430)
Q Consensus 351 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar 428 (430)
|+++|+.+++|...++... ..+..-....+..+.+++++||... ++|+|++|.|+|+..++..+++|||+.+
T Consensus 881 L~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~ 952 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLS 952 (1205)
T ss_pred hhhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccc
Confidence 9999999999999886543 3444444556677889999999876 8999999999999999999999999654
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.0011 Score=63.04 Aligned_cols=139 Identities=22% Similarity=0.223 Sum_probs=92.1
Q ss_pred ccceeecccCCcceEEEEEcCCcEEEEEEeccc------------------------ChHh--HHHHHHHHHHHhcCCCC
Q 047619 281 SINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI------------------------SEQG--LKELKNEVILFSKLQHR 334 (430)
Q Consensus 281 ~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~------------------------~~~~--~~~~~~E~~~l~~l~h~ 334 (430)
.+...|..|--+-||.|.-.+|..+|||+++.. ++.- .-....|++-|.+|+..
T Consensus 147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 345788999999999999889999999987531 0111 11234577777777655
Q ss_pred cccceEEEEEeCCEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEc
Q 047619 335 NLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLD 414 (430)
Q Consensus 335 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~ 414 (430)
.|+-.--... ....|||+|+.......-. -+...++...+..+-.+++.-+.-|-+.+ ++||.||.--|+|+
T Consensus 227 GIP~PePIlL--k~hVLVM~FlGrdgw~aPk---LKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Ly- 298 (520)
T KOG2270|consen 227 GIPCPEPILL--KNHVLVMEFLGRDGWAAPK---LKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLY- 298 (520)
T ss_pred CCCCCCceee--ecceEeeeeccCCCCcCcc---cccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheE-
Confidence 5432211111 2346999999643322111 11223566677778888888888887766 59999999999999
Q ss_pred CCCCeeecCCCcc
Q 047619 415 QDMNPKISDFGLA 427 (430)
Q Consensus 415 ~~~~~kl~DFGla 427 (430)
.+|.+.|+|-+=+
T Consensus 299 hdG~lyiIDVSQS 311 (520)
T KOG2270|consen 299 HDGKLYIIDVSQS 311 (520)
T ss_pred ECCEEEEEEcccc
Confidence 4667999987643
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.003 Score=59.42 Aligned_cols=75 Identities=20% Similarity=0.252 Sum_probs=49.3
Q ss_pred ccceeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcCC---CCcccceEEEEEeCCEEEEEEEccC
Q 047619 281 SINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ---HRNLVKLLGCCIQGEEKLLIYEFVP 357 (430)
Q Consensus 281 ~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~ 357 (430)
+-.+.|+.|....+|+.. .+++.+.||.-. ......|..|.+-|+.|. --.+++++++....+..+|||||++
T Consensus 20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~ 95 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE 95 (288)
T ss_dssp -EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred eeeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence 345788989999999887 568889999875 334466788888887773 4568899999888888899999998
Q ss_pred CC
Q 047619 358 NK 359 (430)
Q Consensus 358 ~g 359 (430)
.+
T Consensus 96 ~~ 97 (288)
T PF03881_consen 96 MG 97 (288)
T ss_dssp --
T ss_pred CC
Confidence 76
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.0041 Score=59.93 Aligned_cols=72 Identities=14% Similarity=0.153 Sum_probs=48.3
Q ss_pred eecccCCcceEEEEEcCC-cEEEEEEecc-------cChHhHHHHHHHHHHHhcCC--CC-cccceEEEEEeCCEEEEEE
Q 047619 285 KLGEGGFGPVYKGTLVDG-QEIAVKRLSK-------ISEQGLKELKNEVILFSKLQ--HR-NLVKLLGCCIQGEEKLLIY 353 (430)
Q Consensus 285 ~ig~G~fg~Vy~~~~~~~-~~vavK~~~~-------~~~~~~~~~~~E~~~l~~l~--h~-niv~l~~~~~~~~~~~lv~ 353 (430)
.||.|....||++..+++ +.++||.-.. .-+-..++...|...|+... -| .+++++.+ +++...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 579999999999997654 6899997532 11233455666777776653 23 45555543 556667999
Q ss_pred EccCC
Q 047619 354 EFVPN 358 (430)
Q Consensus 354 e~~~~ 358 (430)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99964
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.0051 Score=59.37 Aligned_cols=73 Identities=16% Similarity=0.275 Sum_probs=46.0
Q ss_pred eeecccCCcceEEEEEcC----CcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcc-cceEEEEEeCCEEEEEEEccCC
Q 047619 284 NKLGEGGFGPVYKGTLVD----GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL-VKLLGCCIQGEEKLLIYEFVPN 358 (430)
Q Consensus 284 ~~ig~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~ 358 (430)
+.|..|=.-.+|++...+ +..+++|+....... .-.-.+|..+++.+...++ +++++++. . . +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~-~-G--~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFG-N-G--MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeC-C-c--EeehhhcC
Confidence 556667777889886543 237888877543322 2223578888888865555 35565552 2 2 58999987
Q ss_pred CCh
Q 047619 359 KSL 361 (430)
Q Consensus 359 gsL 361 (430)
..|
T Consensus 95 ~~l 97 (330)
T PLN02421 95 RTL 97 (330)
T ss_pred CCC
Confidence 765
|
|
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.00098 Score=48.84 Aligned_cols=50 Identities=18% Similarity=0.366 Sum_probs=36.8
Q ss_pred EEecccCCCCccceeecCCCHHHHHHHhhcCCCeeeEeccccCCCCceeeeecc
Q 047619 169 KFTELKLPDATSSWVSKSMNLYECQDKCLDNSSCMAYTNSDIRGEGSGCAMWFG 222 (430)
Q Consensus 169 ~~~~~~~p~~~~~~~~~~~~~~~C~~~Cl~~CsC~a~~~~~~~~~~~gC~~~~~ 222 (430)
.++++.++....... ...+.++|++.|+.+++|.||.|.. ....|+++..
T Consensus 8 ~~~~~~~~g~d~~~~-~~~s~~~Cq~~C~~~~~C~afT~~~---~~~~C~lk~~ 57 (73)
T cd01100 8 QGSNVDFRGGDLSTV-FASSAEQCQAACTADPGCLAFTYNT---KSKKCFLKSS 57 (73)
T ss_pred ccCCCccccCCccee-ecCCHHHHHHHcCCCCCceEEEEEC---CCCeEEcccC
Confidence 345677776655533 3568999999999999999999974 2335998665
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.0056 Score=60.07 Aligned_cols=73 Identities=12% Similarity=0.115 Sum_probs=50.4
Q ss_pred ceeecccCCcceEEEEEcCCcEEEEEEecc----cCh---HhHHHHHHHHHHHhcCC---CCcccceEEEEEeCCEEEEE
Q 047619 283 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSK----ISE---QGLKELKNEVILFSKLQ---HRNLVKLLGCCIQGEEKLLI 352 (430)
Q Consensus 283 ~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~----~~~---~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv 352 (430)
.+.||.|....||+.... ++.++||.-.. ... ....+-..|...|+.+. ...+++++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 478999999999998863 56788997652 111 13444455666666553 357888888776 556789
Q ss_pred EEccCC
Q 047619 353 YEFVPN 358 (430)
Q Consensus 353 ~e~~~~ 358 (430)
||++++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999976
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.82 E-value=0.0023 Score=57.47 Aligned_cols=29 Identities=34% Similarity=0.559 Sum_probs=20.6
Q ss_pred cEEeCCCCCCcEEE-cCCCCeeecCCCccc
Q 047619 400 RIIHRDLKASNVLL-DQDMNPKISDFGLAR 428 (430)
Q Consensus 400 ~iiH~Dlkp~NILl-~~~~~~kl~DFGlar 428 (430)
.+.|+||.|.|||+ +.++.++|+||..|.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 47899999999999 888899999998875
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.005 Score=60.11 Aligned_cols=74 Identities=14% Similarity=0.146 Sum_probs=50.8
Q ss_pred ceeecccCCcceEEEEEcC-CcEEEEEEecc---cC---hHhHHHHHHHHHHHhcCC--CC-cccceEEEEEeCCEEEEE
Q 047619 283 NNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK---IS---EQGLKELKNEVILFSKLQ--HR-NLVKLLGCCIQGEEKLLI 352 (430)
Q Consensus 283 ~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~---~~---~~~~~~~~~E~~~l~~l~--h~-niv~l~~~~~~~~~~~lv 352 (430)
.+.||.|.-..||++...+ ++.|+||.-.. .. +-..++..-|.++|+... -| .+++++.+ +++...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 4689999999999998743 56899997532 11 234566677777777653 23 46666554 55666799
Q ss_pred EEccCC
Q 047619 353 YEFVPN 358 (430)
Q Consensus 353 ~e~~~~ 358 (430)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 999864
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.71 E-value=0.05 Score=51.87 Aligned_cols=29 Identities=24% Similarity=0.353 Sum_probs=25.0
Q ss_pred CcEEeCCCCCCcEEEcCCCCeeecCCCccc
Q 047619 399 LRIIHRDLKASNVLLDQDMNPKISDFGLAR 428 (430)
Q Consensus 399 ~~iiH~Dlkp~NILl~~~~~~kl~DFGlar 428 (430)
..++|+|+.+.|||++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 35999999999999987 678999999664
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.61 E-value=0.021 Score=54.79 Aligned_cols=140 Identities=24% Similarity=0.299 Sum_probs=79.5
Q ss_pred eecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCc------ccceEEE----EEeCCEEEEEEE
Q 047619 285 KLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN------LVKLLGC----CIQGEEKLLIYE 354 (430)
Q Consensus 285 ~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~----~~~~~~~~lv~e 354 (430)
.|.+ .-..+|+....+++. ++|+.... ....++.-|+..|..|.-.. |..+-|- ...+...+-+.+
T Consensus 33 ~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~ 108 (331)
T COG2334 33 GLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE 108 (331)
T ss_pred cccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence 3444 556789988766666 88887653 44556666777776663111 2222221 111236788999
Q ss_pred ccCCCChhH-H-----------h---h----cCC--C---CCCCCHHH-------------HHHHHHHHHHHHHHhhhc-
Q 047619 355 FVPNKSLDS-F-----------I---F----DQE--R---CKILDWSK-------------RFHIICGTARGVMYLHQD- 396 (430)
Q Consensus 355 ~~~~gsL~~-~-----------l---~----~~~--~---~~~~~~~~-------------~~~i~~~i~~aL~yLH~~- 396 (430)
|++|..+.. . + + ... + .....|.. ......++...+..+.+.
T Consensus 109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~ 188 (331)
T COG2334 109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL 188 (331)
T ss_pred ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence 999988872 1 0 0 000 0 11122320 011223334444444432
Q ss_pred ---CC---CcEEeCCCCCCcEEEcCCCC-eeecCCCccc
Q 047619 397 ---SR---LRIIHRDLKASNVLLDQDMN-PKISDFGLAR 428 (430)
Q Consensus 397 ---~~---~~iiH~Dlkp~NILl~~~~~-~kl~DFGlar 428 (430)
-+ ..+||+|+.|.||+++.+.. +.++||+-|.
T Consensus 189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 11 12999999999999998875 8999999875
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.59 E-value=0.00035 Score=70.52 Aligned_cols=141 Identities=16% Similarity=0.098 Sum_probs=95.7
Q ss_pred HhhcCCcccceeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCc-ccceEEEEEeCCEEEEE
Q 047619 274 ANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN-LVKLLGCCIQGEEKLLI 352 (430)
Q Consensus 274 ~~~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv 352 (430)
.+.+..+.....+++++++.++|.+-...+....+.+... ....-++++|.+++||| .+..++-+..+...+++
T Consensus 238 kDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~ 312 (829)
T KOG0576|consen 238 KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIP 312 (829)
T ss_pred cCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchh
Confidence 3344555666778899999999887544455555555432 44556889999999999 77777777777888999
Q ss_pred EEccCCC-ChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 353 YEFVPNK-SLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 353 ~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++++..+ +....+. .....+...+...+.+.-+++|++||+.- -+|+| ||+..+ +..|..||+.+..
T Consensus 313 ~~i~s~~rs~~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~ 380 (829)
T KOG0576|consen 313 MRICSTGRSSALEMT--VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQ 380 (829)
T ss_pred hhhhcCCccccccCC--hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcc
Confidence 9999877 2211110 00111233334445566678899999854 48888 888755 6799999998754
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.53 E-value=0.0092 Score=53.05 Aligned_cols=100 Identities=15% Similarity=0.165 Sum_probs=64.5
Q ss_pred EEEEEecccChH-hHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHH
Q 047619 305 IAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHII 383 (430)
Q Consensus 305 vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~ 383 (430)
..+|++....-. ...-+.++.+++++++ .|+++..- .....-++.|++-.... .. ..++
T Consensus 88 L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------------~~----~N~i 147 (308)
T PF07387_consen 88 LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------------NF----SNFI 147 (308)
T ss_pred hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------------ch----hHHH
Confidence 445666543333 4556788888888875 46666521 22234588888742111 11 1122
Q ss_pred HHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCC
Q 047619 384 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 425 (430)
Q Consensus 384 ~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFG 425 (430)
..=+.+|.-.|+.. ...+|+|..|+|||-|+.|.+||.|=+
T Consensus 148 ~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~ 188 (308)
T PF07387_consen 148 TAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPV 188 (308)
T ss_pred HHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChh
Confidence 22257788889653 469999999999999999999999854
|
The function of this family is unknown. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.53 E-value=0.052 Score=52.28 Aligned_cols=72 Identities=14% Similarity=0.080 Sum_probs=44.2
Q ss_pred cCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCC--cccceE---E--EEEeCCEEEEEEEccCCCCh
Q 047619 289 GGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHR--NLVKLL---G--CCIQGEEKLLIYEFVPNKSL 361 (430)
Q Consensus 289 G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~---~--~~~~~~~~~lv~e~~~~gsL 361 (430)
+.-..||+....+++.+++|.... ......++..|+..+..|... .++... | ....++..+.++++++|...
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~-~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~ 114 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRP-ERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRAP 114 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCc-ccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence 344678998877788899998753 222455666777777666321 122211 1 12335567889999987643
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.47 E-value=0.041 Score=49.37 Aligned_cols=75 Identities=16% Similarity=0.241 Sum_probs=52.6
Q ss_pred eeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcC---CCCcccceEEEEEeCCEEEEEEEccCCCC
Q 047619 284 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL---QHRNLVKLLGCCIQGEEKLLIYEFVPNKS 360 (430)
Q Consensus 284 ~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~gs 360 (430)
+.+.-|---..|.... +..++-||.-. ......|..|+.-|..| +--.+.+++.+-.+..+.|+||||++-+.
T Consensus 22 ~~v~gG~inea~~v~d-g~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~ 97 (286)
T COG3001 22 EEVSGGDINEAWRLRD-GTDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGP 97 (286)
T ss_pred cccCCccccceeEeec-CCcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCC
Confidence 4455555555555443 45678888753 34456777887666555 44668888999889999999999999877
Q ss_pred hh
Q 047619 361 LD 362 (430)
Q Consensus 361 L~ 362 (430)
++
T Consensus 98 ~d 99 (286)
T COG3001 98 LD 99 (286)
T ss_pred CC
Confidence 65
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.45 E-value=0.018 Score=55.85 Aligned_cols=134 Identities=16% Similarity=0.189 Sum_probs=85.9
Q ss_pred ccceeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcC-CCCcccc--------eEEEEEeCCEEEE
Q 047619 281 SINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVK--------LLGCCIQGEEKLL 351 (430)
Q Consensus 281 ~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~--------l~~~~~~~~~~~l 351 (430)
.....||+|+-+.+|-.- +-...+.|++.........+...| |.+. .||-+.. |+|- ..+...-+
T Consensus 14 ~~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aqk~a~---la~~p~~p~~~~rvaWPqa~L~G~-~~~~~iGf 87 (637)
T COG4248 14 PPGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQKVAE---LAATPDAPLLNYRVAWPQATLHGG-RRGKVIGF 87 (637)
T ss_pred CCCccccCCccceeeecc--hhhchhheeecCCCchHHHHHHHH---hccCCCCcchhhhhcccHHHhhCC-CccceeEE
Confidence 345789999999999543 222345577765433333333222 2232 4554332 1221 11222557
Q ss_pred EEEccCCCC-hhHHhh---cCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecC
Q 047619 352 IYEFVPNKS-LDSFIF---DQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD 423 (430)
Q Consensus 352 v~e~~~~gs-L~~~l~---~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~D 423 (430)
+|+.+++.. +..++. +.+.....+|.-.++.++.++.+..-||..| .+-+|+.++|+|+.+++.|.|+|
T Consensus 88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVd 160 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVD 160 (637)
T ss_pred ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEc
Confidence 788776642 222221 2233455789999999999999999999998 88899999999999999998886
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.44 E-value=0.066 Score=51.12 Aligned_cols=30 Identities=23% Similarity=0.308 Sum_probs=27.1
Q ss_pred CcEEeCCCCCCcEEEcCCCCeeecCCCccc
Q 047619 399 LRIIHRDLKASNVLLDQDMNPKISDFGLAR 428 (430)
Q Consensus 399 ~~iiH~Dlkp~NILl~~~~~~kl~DFGlar 428 (430)
..++|+|+.+.|||++.++.+.|+||..|.
T Consensus 196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 196 TVLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 459999999999999999899999998775
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.21 E-value=0.019 Score=55.63 Aligned_cols=60 Identities=15% Similarity=0.129 Sum_probs=43.2
Q ss_pred EEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEc
Q 047619 349 KLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLD 414 (430)
Q Consensus 349 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~ 414 (430)
..|+-+|++|.++..++.... .+++....++.-.+.||.-+-.-. +.+|.|++|.||++-
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~~----~pe~l~kkva~lg~~AllkMl~vD--NFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWKS----QPEALVKKVAKLGVNALLKMLIVD--NFVHADLHPGNVLIR 379 (565)
T ss_pred ceeeeeccccccHHhhhhccc----ChHHHHHHHHHHHHHHHHHHHHhh--cceecccCCCcEEEE
Confidence 457778999999999985433 455556666666666765444332 399999999999994
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.20 E-value=0.089 Score=58.49 Aligned_cols=30 Identities=37% Similarity=0.536 Sum_probs=25.0
Q ss_pred CcEEeCCCCCCcEEEcCCC--Cee-ecCCCccc
Q 047619 399 LRIIHRDLKASNVLLDQDM--NPK-ISDFGLAR 428 (430)
Q Consensus 399 ~~iiH~Dlkp~NILl~~~~--~~k-l~DFGlar 428 (430)
..+||+|+.+.|||++.++ .+. |+|||-+-
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 3499999999999998775 555 99999764
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 430 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-33 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-33 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-27 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 8e-27 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-27 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-26 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 6e-26 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 6e-26 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 8e-16 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-15 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-15 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-15 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-15 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 7e-15 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 7e-15 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 7e-15 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 8e-15 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 8e-15 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 8e-15 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 8e-15 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 8e-15 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 8e-15 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 8e-15 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 8e-15 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 8e-15 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 9e-15 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 9e-15 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-14 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-14 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-14 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-14 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-14 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-14 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-14 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-14 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-14 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-14 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-14 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-14 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-14 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-14 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-14 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-14 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-14 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-14 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 6e-14 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-14 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-14 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 6e-14 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 9e-14 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-13 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-13 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-13 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-13 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-13 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-13 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-13 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-13 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-13 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-13 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-13 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-13 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-13 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-13 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-13 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-13 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-13 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-13 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-13 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-13 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-13 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-13 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-13 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-13 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-13 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-13 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-13 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-13 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-13 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-13 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-13 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-13 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-13 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-13 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-13 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-13 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-13 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-13 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-13 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-13 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 5e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-13 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-13 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-13 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-13 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 6e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 6e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 6e-13 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 6e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-13 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-13 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 7e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 8e-13 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-13 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-12 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-12 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-12 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-12 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-12 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-12 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-12 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-12 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-12 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-12 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-12 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-12 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-12 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-12 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-12 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-12 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-12 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-12 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-12 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-12 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-12 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-12 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-12 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-12 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-12 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-12 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-12 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-12 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-12 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-12 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-12 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-12 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-12 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-12 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-12 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-12 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-12 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-12 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-12 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-12 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-12 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-12 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-12 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-12 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-12 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-12 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-12 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-12 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-12 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-12 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-12 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-12 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-12 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-12 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-12 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-12 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-12 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-12 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-12 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 4e-12 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-12 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-12 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-12 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-12 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-12 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 6e-12 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 6e-12 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-12 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 7e-12 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 7e-12 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 8e-12 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-12 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 9e-12 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 9e-12 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-12 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-12 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-12 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 9e-12 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-11 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-11 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-11 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-11 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-11 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-11 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-11 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-11 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-11 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-11 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-11 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-11 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-11 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-11 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-11 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-11 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-11 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-11 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-11 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-11 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-11 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-11 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-11 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-11 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-11 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 5e-11 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-11 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 5e-11 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 5e-11 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-11 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-11 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-11 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-11 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 5e-11 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 6e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 6e-11 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 6e-11 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 6e-11 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 6e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 6e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 6e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 6e-11 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-11 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 6e-11 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 6e-11 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 6e-11 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 6e-11 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 6e-11 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-11 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 7e-11 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-11 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 7e-11 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 7e-11 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-11 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 7e-11 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 7e-11 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 7e-11 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 7e-11 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 7e-11 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 7e-11 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 7e-11 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-11 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 7e-11 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 7e-11 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 7e-11 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 7e-11 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 7e-11 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 8e-11 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-11 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 8e-11 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 8e-11 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 8e-11 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 8e-11 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-11 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 8e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 9e-11 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 9e-11 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 9e-11 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 9e-11 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 9e-11 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 9e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 9e-11 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-10 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-10 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-10 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-10 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-10 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-10 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-10 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-10 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-10 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-10 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-10 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-10 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-10 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-10 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-10 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-10 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-10 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-10 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-10 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-10 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-10 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-10 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-10 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-10 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-10 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-10 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-10 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-10 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-10 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-10 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-10 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-10 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-10 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-10 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-10 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-10 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-10 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-10 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-10 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-10 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-10 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-10 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-10 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-10 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-10 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-10 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-10 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-10 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-10 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-10 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-10 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-10 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-10 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-10 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-10 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 5e-10 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 5e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-10 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 6e-10 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 6e-10 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 6e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 7e-10 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 7e-10 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 7e-10 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 7e-10 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 8e-10 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 8e-10 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 8e-10 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 8e-10 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 8e-10 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 8e-10 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 9e-10 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 9e-10 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 9e-10 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 9e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-09 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-09 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-09 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-09 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-09 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-09 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-09 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-09 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-09 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-09 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-09 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-09 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-09 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-09 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-09 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-09 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-09 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-09 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-09 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-09 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-09 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-09 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-09 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 4e-09 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-09 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-09 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-09 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-09 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-09 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 5e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-09 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-09 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-09 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 5e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 6e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 6e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 6e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 6e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-09 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 6e-09 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 6e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 6e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 7e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 7e-09 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 7e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 7e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 7e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 8e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 8e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 8e-09 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 8e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 8e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 8e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 8e-09 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 8e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 9e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 9e-09 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 9e-09 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 9e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 9e-09 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 9e-09 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-08 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-08 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-08 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-08 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-08 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-08 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-08 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-08 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-08 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-08 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-08 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-08 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-08 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-08 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-08 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-08 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-08 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-08 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-08 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-08 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-08 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-08 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-08 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-08 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-08 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-08 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-08 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-08 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-08 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-08 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-08 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-08 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-08 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-08 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-08 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-08 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-08 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-08 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-08 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-08 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-08 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-08 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 5e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-08 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-08 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-08 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-08 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 6e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-08 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 6e-08 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 6e-08 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-08 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 6e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 7e-08 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 7e-08 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 8e-08 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-07 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-07 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-07 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-07 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-07 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-07 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-07 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-07 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-07 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-07 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-07 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-07 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-07 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-07 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-07 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-07 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-07 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-07 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-07 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 6e-07 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 6e-07 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-07 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 7e-07 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 7e-07 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 7e-07 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-07 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 7e-07 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 7e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-07 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 9e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 9e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 9e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 9e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-06 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-06 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-06 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-06 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-06 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-06 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-06 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-06 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-06 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-06 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-06 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-06 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-06 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-06 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-06 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-06 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-06 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-06 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-06 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-06 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-06 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-06 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-06 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-06 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-06 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 6e-06 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-06 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 7e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 7e-06 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 7e-06 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 7e-06 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-06 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-06 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 8e-06 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 8e-06 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 8e-06 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 8e-06 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 8e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 9e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-05 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-05 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-05 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-05 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-05 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-05 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-05 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-05 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-05 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-05 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-05 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-05 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-05 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-05 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-05 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-05 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-05 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-05 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-05 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 4e-05 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-05 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-05 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-05 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-05 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-05 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-05 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-05 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-05 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-05 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-05 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-05 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-05 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-05 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 5e-05 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-05 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-05 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-05 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-05 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 5e-05 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 5e-05 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-05 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 5e-05 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 5e-05 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-05 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 6e-05 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 6e-05 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 6e-05 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 6e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 6e-05 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 6e-05 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 7e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 7e-05 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 7e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 7e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 7e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 7e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 7e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 7e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 7e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 7e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 7e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 7e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 7e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 8e-05 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 8e-05 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 8e-05 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 8e-05 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 8e-05 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 8e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 8e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 8e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 8e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-05 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 8e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 9e-05 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 9e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 9e-05 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 9e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 9e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 9e-05 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 9e-05 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 9e-05 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-04 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 1e-04 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-04 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-04 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-04 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 1e-04 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 1e-04 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-04 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-04 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-04 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-04 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 1e-04 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-04 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-04 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-04 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-04 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-04 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-04 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-04 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-04 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-04 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-04 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-04 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-04 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-04 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-04 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-04 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-04 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-04 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-04 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-04 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-04 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-04 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 4e-04 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-04 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 4e-04 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-04 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 5e-04 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-04 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 5e-04 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 6e-04 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-04 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 6e-04 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 7e-04 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-04 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 7e-04 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 7e-04 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 7e-04 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 7e-04 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 7e-04 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 8e-04 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 280 bits (720), Expect = 1e-92
Identities = 69/187 (36%), Positives = 104/187 (55%), Gaps = 14/187 (7%)
Query: 254 ETDQVQNMDLELPLFELATIANATDNFS------INNKLGEGGFGPVYKGTLVDGQEIAV 307
E ++ D F + N T+NF NK+GEGGFG VYKG + + +AV
Sbjct: 1 ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAV 59
Query: 308 KRLSKI----SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDS 363
K+L+ + +E+ ++ E+ + +K QH NLV+LLG G++ L+Y ++PN SL
Sbjct: 60 KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119
Query: 364 FIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD 423
+ + L W R I G A G+ +LH++ IHRD+K++N+LLD+ KISD
Sbjct: 120 RLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISD 176
Query: 424 FGLARAF 430
FGLARA
Sbjct: 177 FGLARAS 183
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 268 bits (687), Expect = 2e-87
Identities = 74/163 (45%), Positives = 104/163 (63%), Gaps = 2/163 (1%)
Query: 268 FELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLK-ELKNEVI 326
F L + A+DNFS N LG GGFG VYKG L DG +AVKRL + QG + + + EV
Sbjct: 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79
Query: 327 LFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKI-LDWSKRFHIICG 385
+ S HRNL++L G C+ E+LL+Y ++ N S+ S + ++ + LDW KR I G
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139
Query: 386 TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
+ARG+ YLH +IIHRD+KA+N+LLD++ + DFGLA+
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 182
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 251 bits (644), Expect = 4e-81
Identities = 63/164 (38%), Positives = 100/164 (60%), Gaps = 4/164 (2%)
Query: 268 FELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVIL 327
L + AT+NF +G G FG VYKG L DG ++A+KR + S QG++E + E+
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 328 FSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKI-LDWSKRFHIICGT 386
S +H +LV L+G C + E +LIY+++ N +L ++ + + + W +R I G
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 387 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
ARG+ YLH + IIHRD+K+ N+LLD++ PKI+DFG+++
Sbjct: 149 ARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKG 189
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 191 bits (486), Expect = 1e-57
Identities = 49/191 (25%), Positives = 83/191 (43%), Gaps = 22/191 (11%)
Query: 251 NNRETDQVQNMDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRL 310
+ +DL ++ + G FG V+K + + +AVK
Sbjct: 2 GHHHHHHSSGVDLGTENLYFQSM-----PLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIF 55
Query: 311 SKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE----EKLLIYEFVPNKSLDSFIF 366
+Q + + EV ++H N+++ +G +G + LI F SL F+
Sbjct: 56 PIQDKQS-WQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL- 113
Query: 367 DQERCKILDWSKRFHIICGTARGVMYLHQD-------SRLRIIHRDLKASNVLLDQDMNP 419
+ ++ W++ HI ARG+ YLH+D + I HRD+K+ NVLL ++
Sbjct: 114 ---KANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTA 170
Query: 420 KISDFGLARAF 430
I+DFGLA F
Sbjct: 171 CIADFGLALKF 181
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 2e-51
Identities = 49/166 (29%), Positives = 74/166 (44%), Gaps = 17/166 (10%)
Query: 276 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN 335
DN + +G G +G VYKG+L D + +AVK S + Q K + ++H N
Sbjct: 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEK-NIYRVPLMEHDN 68
Query: 336 LVKLLGCCIQGE-----EKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGV 390
+ + + + E LL+ E+ PN SL ++ DW + RG+
Sbjct: 69 IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGL 124
Query: 391 MYLHQD------SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
YLH + + I HRDL + NVL+ D ISDFGL+
Sbjct: 125 AYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRL 170
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 3e-48
Identities = 54/190 (28%), Positives = 92/190 (48%), Gaps = 14/190 (7%)
Query: 241 MSASELEKTENNRETDQVQNMDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLV 300
MS ++ TEN + D+++P +L +I K+G G FG V++
Sbjct: 10 MSDYDIPTTENLYFQGAMDGDDMDIPWCDL----------NIKEKIGAGSFGTVHRAEW- 58
Query: 301 DGQEIAVKRL--SKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPN 358
G ++AVK L + + E EV + +L+H N+V +G Q ++ E++
Sbjct: 59 HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSR 118
Query: 359 KSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMN 418
SL + + LD +R + A+G+ YLH I+HR+LK+ N+L+D+
Sbjct: 119 GSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYT 177
Query: 419 PKISDFGLAR 428
K+ DFGL+R
Sbjct: 178 VKVCDFGLSR 187
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 7e-45
Identities = 45/152 (29%), Positives = 67/152 (44%), Gaps = 6/152 (3%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 337
+ +G G FG V K +++A+K++ SE K E+ S++ H N+V
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQI--ESESERKAFIVELRQLSRVNHPNIV 64
Query: 338 KLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 397
KL G C+ L+ E+ SL + + E + ++GV YLH
Sbjct: 65 KLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 398 RLRIIHRDLKASNVLLDQDMN-PKISDFGLAR 428
+IHRDLK N+LL KI DFG A
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTAC 154
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 5e-44
Identities = 39/157 (24%), Positives = 67/157 (42%), Gaps = 7/157 (4%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRL--SKISEQGLKELKNEVILFSKLQHRN 335
+ KL E G ++KG G +I VK L S + ++ E H N
Sbjct: 10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68
Query: 336 LVKLLGCCIQGEEKLL--IYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 393
++ +LG C I ++P SL + + + ++D S+ ARG+ +L
Sbjct: 69 VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTN-FVVDQSQAVKFALDMARGMAFL 127
Query: 394 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
H L I L + +V++D+DM +IS + +F
Sbjct: 128 HTLEPL-IPRHALNSRSVMIDEDMTARISMADVKFSF 163
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 1e-43
Identities = 45/152 (29%), Positives = 73/152 (48%), Gaps = 6/152 (3%)
Query: 278 DNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 336
+ LG+G FG K T G+ + +K L + E+ + EV + L+H N+
Sbjct: 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNV 69
Query: 337 VKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 396
+K +G + + I E++ +L I + WS+R A G+ YLH
Sbjct: 70 LKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDS--QYPWSQRVSFAKDIASGMAYLHS- 126
Query: 397 SRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
+ IIHRDL + N L+ ++ N ++DFGLAR
Sbjct: 127 --MNIIHRDLNSHNCLVRENKNVVVADFGLAR 156
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 3e-43
Identities = 54/181 (29%), Positives = 87/181 (48%), Gaps = 20/181 (11%)
Query: 261 MDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQG-- 317
E P L T+A+ + ++G+GGFG V+KG LV D +A+K L +G
Sbjct: 4 GGSEFPKSRLPTLAD--NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGET 61
Query: 318 -----LKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCK 372
+E + EV + S L H N+VKL G ++ EFVP L + D+
Sbjct: 62 EMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAH-- 117
Query: 373 ILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ-----DMNPKISDFGLA 427
+ WS + ++ A G+ Y+ I+HRDL++ N+ L + K++DFGL+
Sbjct: 118 PIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS 176
Query: 428 R 428
+
Sbjct: 177 Q 177
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-42
Identities = 51/159 (32%), Positives = 81/159 (50%), Gaps = 17/159 (10%)
Query: 282 INNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQ----GLKELKNEVILFSKLQHRNLV 337
+ +G GGFG VY+ G E+AVK ++ ++ ++ E LF+ L+H N++
Sbjct: 11 LEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 338 KLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 397
L G C++ L+ EF L+ + K + + ARG+ YLH ++
Sbjct: 70 ALRGVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLHDEA 125
Query: 398 RLRIIHRDLKASNVLLDQDMNP--------KISDFGLAR 428
+ IIHRDLK+SN+L+ Q + KI+DFGLAR
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-39
Identities = 56/190 (29%), Positives = 87/190 (45%), Gaps = 24/190 (12%)
Query: 241 MSASELEKTENNRETDQVQNMDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLV 300
M +R+ D E+P ++ ++ ++G G FG VYKG
Sbjct: 1 MKKGHHHHHHGSRDAAD----DWEIPDGQI----------TVGQRIGSGSFGTVYKGKW- 45
Query: 301 DGQEIAVKRL--SKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPN 358
++AVK L + + Q L+ KNEV + K +H N++ +G + ++ ++
Sbjct: 46 -HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEG 103
Query: 359 KSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMN 418
SL + E + K I TARG+ YLH IIHRDLK++N+ L +D
Sbjct: 104 SSLYHHLHASET--KFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNT 158
Query: 419 PKISDFGLAR 428
KI DFGLA
Sbjct: 159 VKIGDFGLAT 168
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 6e-39
Identities = 46/149 (30%), Positives = 75/149 (50%), Gaps = 10/149 (6%)
Query: 282 INNKLGEGGFGPVYKGTLVDGQEIAVKRL--SKISEQGLKELKNEVILFSKLQHRNLVKL 339
I +G+G FG VY G E+A++ + + +E LK K EV+ + + +H N+V
Sbjct: 37 IGELIGKGRFGQVYHGRW--HGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94
Query: 340 LGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRL 399
+G C+ +I ++L S + D + +LD +K I +G+ YLH
Sbjct: 95 MGACMSPPHLAIITSLCKGRTLYSVVRDAKI--VLDVNKTRQIAQEIVKGMGYLHA---K 149
Query: 400 RIIHRDLKASNVLLDQDMNPKISDFGLAR 428
I+H+DLK+ NV D + I+DFGL
Sbjct: 150 GILHKDLKSKNVFYD-NGKVVITDFGLFS 177
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-37
Identities = 45/175 (25%), Positives = 78/175 (44%), Gaps = 18/175 (10%)
Query: 265 LPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNE 324
LPL TIA + ++G+G +G V+ G G+++AVK E + E
Sbjct: 27 LPLLVQRTIA---KQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEA-SWFRETE 81
Query: 325 VILFSKLQHRNLVKLLGCCIQGEEK----LLIYEFVPNKSLDSFIFDQERCKILDWSKRF 380
+ ++H N++ + I+G LI ++ N SL ++ + LD
Sbjct: 82 IYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSML 137
Query: 381 HIICGTARGVMYLHQDSRLR-----IIHRDLKASNVLLDQDMNPKISDFGLARAF 430
+ + G+ +LH + I HRDLK+ N+L+ ++ I+D GLA F
Sbjct: 138 KLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKF 192
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-37
Identities = 42/170 (24%), Positives = 75/170 (44%), Gaps = 22/170 (12%)
Query: 272 TIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILF--S 329
T+A + ++ +G+G +G V++G+ G+ +AVK S + K E L+
Sbjct: 5 TVA---RDITLLECVGKGRYGEVWRGSW-QGENVAVK---IFSSRDEKSWFRETELYNTV 57
Query: 330 KLQHRNLVKLLGCCIQGEEK----LLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICG 385
L+H N++ + + LI + SL ++ + LD I+
Sbjct: 58 MLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLS 113
Query: 386 TARGVMYLHQDSRLR-----IIHRDLKASNVLLDQDMNPKISDFGLARAF 430
A G+ +LH + I HRDLK+ N+L+ ++ I+D GLA
Sbjct: 114 IASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMH 163
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 4e-35
Identities = 45/176 (25%), Positives = 78/176 (44%), Gaps = 20/176 (11%)
Query: 265 LPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQG-LKELKN 323
LPL TIA + +G+G FG V++G G+E+AVK S E+ +E
Sbjct: 32 LPLLVQRTIA---RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREA-- 85
Query: 324 EVILFSKLQHRNLVKLLGCCIQGEEK----LLIYEFVPNKSLDSFIFDQERCKILDWSKR 379
E+ L+H N++ + + L+ ++ + SL ++ +
Sbjct: 86 EIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGM 141
Query: 380 FHIICGTARGVMYLHQD-----SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
+ TA G+ +LH + + I HRDLK+ N+L+ ++ I+D GLA
Sbjct: 142 IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 197
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-34
Identities = 41/161 (25%), Positives = 67/161 (41%), Gaps = 19/161 (11%)
Query: 279 NFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 337
++ KLGEGGF V L DG A+KR+ +Q +E + E + H N++
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89
Query: 338 KLLGCCIQ----GEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRF------HIICGTA 387
+L+ C++ E L+ F +L + I + ++ G
Sbjct: 90 RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKG-----NFLTEDQILWLLLGIC 144
Query: 388 RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
RG+ +H HRDLK +N+LL + P + D G
Sbjct: 145 RGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMN 182
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-33
Identities = 42/153 (27%), Positives = 69/153 (45%), Gaps = 7/153 (4%)
Query: 278 DNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRL-SKISEQGLKELKNEVILFSKLQHRN 335
++ + ++G G FG V+ G L D +AVK + + E + + H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 336 LVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ 395
+V+L+G C Q + ++ E V +F+ + L ++ A G+ YL
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFL--RTEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 396 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
IHRDL A N L+ + KISDFG++R
Sbjct: 232 ---KCCIHRDLAARNCLVTEKNVLKISDFGMSR 261
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-33
Identities = 45/169 (26%), Positives = 79/169 (46%), Gaps = 21/169 (12%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDGQE------IAVKRLSKISEQGLKELKNEVILFSKL 331
+ + +LGEG FG V+ + +AVK L + SE ++ + E L + L
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML 100
Query: 332 QHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSF------------IFDQERCKILDWSKR 379
QH+++V+ G C +G L+++E++ + L+ F + L +
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 380 FHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
+ A G++YL + L +HRDL N L+ Q + KI DFG++R
Sbjct: 161 LAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 206
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-32
Identities = 45/170 (26%), Positives = 78/170 (45%), Gaps = 22/170 (12%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDG------QEIAVKRLSKISEQGLKELKNEVILFSKL 331
+ + +LGEG FG V+ + +AVK L + K+ + E L + L
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 74
Query: 332 QHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSF-------------IFDQERCKILDWSK 378
QH ++VK G C G+ ++++E++ + L+ F ++ L S+
Sbjct: 75 QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 379 RFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
HI A G++YL + +HRDL N L+ ++ KI DFG++R
Sbjct: 135 MLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 181
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-31
Identities = 44/165 (26%), Positives = 78/165 (47%), Gaps = 17/165 (10%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDGQE------IAVKRLSKI-SEQGLKELKNEVILFSK 330
+ +++ +LG+G FG VY+G + +A+K +++ S + E NE + +
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84
Query: 331 LQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSF-------IFDQERCKILDWSKRFHII 383
++V+LLG QG+ L+I E + L S+ + + SK +
Sbjct: 85 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144
Query: 384 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
A G+ YL + + +HRDL A N ++ +D KI DFG+ R
Sbjct: 145 GEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 186
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-31
Identities = 48/159 (30%), Positives = 77/159 (48%), Gaps = 12/159 (7%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLV-----DGQEIAVKRLSKISEQGLKELKNEVILFSKLQ 332
+ +LG+G FG V G+ +AVK+L +E+ L++ + E+ + LQ
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 100
Query: 333 HRNLVKLLGCCIQGEEK--LLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGV 390
H N+VK G C + LI E++P SL ++ Q+ + +D K +G+
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 158
Query: 391 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429
YL R IHRDL N+L++ + KI DFGL +
Sbjct: 159 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKV 194
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-31
Identities = 48/159 (30%), Positives = 77/159 (48%), Gaps = 12/159 (7%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLV-----DGQEIAVKRLSKISEQGLKELKNEVILFSKLQ 332
+ +LG+G FG V G+ +AVK+L +E+ L++ + E+ + LQ
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 69
Query: 333 HRNLVKLLGCCIQGEEK--LLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGV 390
H N+VK G C + LI E++P SL ++ Q+ + +D K +G+
Sbjct: 70 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 127
Query: 391 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429
YL R IHRDL N+L++ + KI DFGL +
Sbjct: 128 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKV 163
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 7e-31
Identities = 43/152 (28%), Positives = 71/152 (46%), Gaps = 8/152 (5%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 337
+ +G+G FG V G G ++AVK + + + E + ++L+H NLV
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 77
Query: 338 KLLGCCIQGEEKLLI-YEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 396
+LLG ++ + L I E++ SL ++ + R +L + YL
Sbjct: 78 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYL--- 133
Query: 397 SRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
+HRDL A NVL+ +D K+SDFGL +
Sbjct: 134 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 165
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 8e-31
Identities = 43/159 (27%), Positives = 72/159 (45%), Gaps = 12/159 (7%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLV-----DGQEIAVKRLSKISEQGLKELKNEVILFSKLQ 332
+ ++LG+G FG V G +AVK+L ++ + E+ + L
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 82
Query: 333 HRNLVKLLGCCIQGEEK--LLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGV 390
+VK G + L+ E++P+ L F+ Q LD S+ +G+
Sbjct: 83 SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGM 140
Query: 391 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429
YL R +HRDL A N+L++ + + KI+DFGLA+
Sbjct: 141 EYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKL 176
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-30
Identities = 38/151 (25%), Positives = 71/151 (47%), Gaps = 6/151 (3%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 337
+ ++G G FG V+ G ++ ++A+K + + ++ E + KL H LV
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 66
Query: 338 KLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 397
+L G C++ L+ EF+ + L ++ + + + + G+ YL
Sbjct: 67 QLYGVCLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYL---E 121
Query: 398 RLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
+IHRDL A N L+ ++ K+SDFG+ R
Sbjct: 122 EACVIHRDLAARNCLVGENQVIKVSDFGMTR 152
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-30
Identities = 48/154 (31%), Positives = 74/154 (48%), Gaps = 11/154 (7%)
Query: 281 SINNKLGEGGFGPVYKGTLVDG----QEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRN 335
N +G G FG VY GTL+D AVK L++I + + E I+ H N
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 336 LVKLLGCCIQGEEKLL-IYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLH 394
++ LLG C++ E L + ++ + L +FI + A+G+ YL
Sbjct: 88 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKYL- 144
Query: 395 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
+ + +HRDL A N +LD+ K++DFGLAR
Sbjct: 145 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 176
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-30
Identities = 52/160 (32%), Positives = 67/160 (41%), Gaps = 15/160 (9%)
Query: 278 DNFSINNKLGEGGFGPVYKGTL---VDGQEI--AVKRL-SKISEQGLKELKNEVILFSKL 331
LGEG FG V DG AVK L + Q K E+ + L
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90
Query: 332 QHRNLVKLLGCCIQGEEK--LLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARG 389
H +++K GCC L+ E+VP SL ++ + ++ G
Sbjct: 91 YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEG 146
Query: 390 VMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429
+ YLH IHRDL A NVLLD D KI DFGLA+A
Sbjct: 147 MAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKA 183
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-30
Identities = 46/166 (27%), Positives = 74/166 (44%), Gaps = 18/166 (10%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDG----QEIAVKRLSK--ISEQGLKELKNEVILFSKL 331
F++ LG+G FG V + L ++AVK L I+ ++E E +
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 332 QHRNLVKLLGCCIQGEEK------LLIYEFVPNKSLDSFIFD---QERCKILDWSKRFHI 382
H ++ KL+G ++ K ++I F+ + L +F+ E L
Sbjct: 83 DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 383 ICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
+ A G+ YL S IHRDL A N +L +DM ++DFGL+R
Sbjct: 143 MVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR 185
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-30
Identities = 47/160 (29%), Positives = 74/160 (46%), Gaps = 13/160 (8%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLV-----DGQEIAVKRL-SKISEQGLKELKNEVILFSKL 331
LGEG FG V G+++AVK L + + +LK E+ + L
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80
Query: 332 QHRNLVKLLGCCIQGEEK--LLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARG 389
H N+VK G C + LI EF+P+ SL ++ + ++ ++ +G
Sbjct: 81 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKG 138
Query: 390 VMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429
+ YL + +HRDL A NVL++ + KI DFGL +A
Sbjct: 139 MDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA 175
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-30
Identities = 45/151 (29%), Positives = 72/151 (47%), Gaps = 6/151 (3%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 337
+ ++ +LG G FG V G ++AVK + K E E KL H LV
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLV 66
Query: 338 KLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 397
K G C + ++ E++ N L +++ + K L+ S+ + G+ +L
Sbjct: 67 KFYGVCSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFL---E 121
Query: 398 RLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
+ IHRDL A N L+D+D+ K+SDFG+ R
Sbjct: 122 SHQFIHRDLAARNCLVDRDLCVKVSDFGMTR 152
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 42/152 (27%), Positives = 72/152 (47%), Gaps = 8/152 (5%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 337
+ +G+G FG V G G ++AVK + + + E + ++L+H NLV
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 249
Query: 338 KLLGCCIQGEEKL-LIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 396
+LLG ++ + L ++ E++ SL ++ + R +L + YL
Sbjct: 250 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYL--- 305
Query: 397 SRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
+HRDL A NVL+ +D K+SDFGL +
Sbjct: 306 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 337
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-30
Identities = 44/165 (26%), Positives = 75/165 (45%), Gaps = 17/165 (10%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDGQE----IAVKRLSK--ISEQGLKELKNEVILFSKL 331
+ + LGEG FG V +G L +AVK + S++ ++E +E
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93
Query: 332 QHRNLVKLLGCCIQGE-----EKLLIYEFVPNKSLDSFI---FDQERCKILDWSKRFHII 383
H N+++LLG CI+ + ++I F+ L +++ + K + +
Sbjct: 94 SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153
Query: 384 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
A G+ YL S +HRDL A N +L DM ++DFGL++
Sbjct: 154 VDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK 195
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-30
Identities = 47/154 (30%), Positives = 74/154 (48%), Gaps = 11/154 (7%)
Query: 281 SINNKLGEGGFGPVYKGTLVDG----QEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRN 335
N +G G FG VY GTL+D AVK L++I + + E I+ H N
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 336 LVKLLGCCIQGEEKLL-IYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLH 394
++ LLG C++ E L + ++ + L +FI + A+G+ +L
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKFL- 208
Query: 395 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
+ + +HRDL A N +LD+ K++DFGLAR
Sbjct: 209 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 240
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-30
Identities = 48/169 (28%), Positives = 75/169 (44%), Gaps = 21/169 (12%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDGQE---IAVKRL-SKISEQGLKELKNEVILFSKL-Q 332
++ + +GEG FG V K + A+KR+ S+ ++ E+ + KL
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 333 HRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSF-------------IFDQERCKILDWSKR 379
H N++ LLG C L E+ P+ +L F L +
Sbjct: 85 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 380 FHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
H ARG+ YL S+ + IHRDL A N+L+ ++ KI+DFGL+R
Sbjct: 145 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 190
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-30
Identities = 50/171 (29%), Positives = 76/171 (44%), Gaps = 23/171 (13%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDG------QEIAVKRLSKI-SEQGLKELKNEVILFSK 330
+LGE FG VYKG L Q +A+K L +E ++E +L ++
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRAR 68
Query: 331 LQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSF-------------IFDQERCKILDWS 377
LQH N+V LLG + + +I+ + + L F D+ L+
Sbjct: 69 LQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 378 KRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
H++ A G+ YL S ++H+DL NVL+ +N KISD GL R
Sbjct: 129 DFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR 176
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-30
Identities = 47/158 (29%), Positives = 77/158 (48%), Gaps = 12/158 (7%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDGQE-----IAVKRLSK-ISEQGLKELKNEVILFSKL 331
F LG G FG VYKG + E +A+K L + S + KE+ +E + + +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 332 QHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 391
+ ++ +LLG C+ LI + +P L ++ +E + + A+G+
Sbjct: 75 DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMN 131
Query: 392 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429
YL R++HRDL A NVL+ + KI+DFGLA+
Sbjct: 132 YL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-30
Identities = 40/151 (26%), Positives = 66/151 (43%), Gaps = 6/151 (3%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 337
+ + +LG G FG V G ++A+K + K E E + L H LV
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLV 82
Query: 338 KLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 397
+L G C + +I E++ N L +++ +E + + + YL
Sbjct: 83 QLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYL---E 137
Query: 398 RLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
+ +HRDL A N L++ K+SDFGL+R
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSR 168
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-30
Identities = 45/153 (29%), Positives = 74/153 (48%), Gaps = 11/153 (7%)
Query: 282 INNKLGEGGFGPVYKGTLVDGQE----IAVKRLSKI-SEQGLKELKNEVILFSKLQHRNL 336
+ +G+G FG VY G +D + A+K LS+I Q ++ E +L L H N+
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 337 VKLLGCCIQGEE-KLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ 395
+ L+G + E ++ ++ + L FI + + ARG+ YL
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFI--RSPQRNPTVKDLISFGLQVARGMEYL-- 140
Query: 396 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
+ + +HRDL A N +LD+ K++DFGLAR
Sbjct: 141 -AEQKFVHRDLAARNCMLDESFTVKVADFGLAR 172
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 5e-30
Identities = 46/172 (26%), Positives = 77/172 (44%), Gaps = 28/172 (16%)
Query: 277 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN 335
+F LG+G FG V K +D + A+K++ +E+ L + +EV+L + L H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQY 63
Query: 336 LVKLLGC----------CIQGEEKLLIY---EFVPNKSLDSFIFDQ----ERCKILDWSK 378
+V+ ++K ++ E+ N +L I + +R +
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL-- 121
Query: 379 RFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
F I + Y+H IIHRDLK N+ +D+ N KI DFGLA+
Sbjct: 122 -FRQIL---EALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNV 166
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 6e-30
Identities = 47/179 (26%), Positives = 76/179 (42%), Gaps = 31/179 (17%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDG------QEIAVKRLSKI-SEQGLKELKNEVILFSK 330
+N +GEG FG V++ +AVK L + S + + E L ++
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 331 LQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSF---------------------IFDQE 369
+ N+VKLLG C G+ L++E++ L+ F
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 370 RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
L +++ I A G+ YL S + +HRDL N L+ ++M KI+DFGL+R
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR 222
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 6e-30
Identities = 49/165 (29%), Positives = 74/165 (44%), Gaps = 17/165 (10%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDG------QEIAVKRLSKI-SEQGLKELKNEVILFSK 330
N ++ LG G FG VY+G + ++AVK L ++ SEQ + E ++ SK
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89
Query: 331 LQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFI----FDQERCKILDWSKRFHIICGT 386
H+N+V+ +G +Q + ++ E + L SF+ + L H+
Sbjct: 90 FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 387 ARGVMYLHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLAR 428
A G YL IHRD+ A N LL KI DFG+AR
Sbjct: 150 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 6e-30
Identities = 45/156 (28%), Positives = 80/156 (51%), Gaps = 10/156 (6%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLV--DGQEI--AVKRL-SKISEQGLKELKNEVILFSKLQ 332
I +G G G V G L +++ A+K L + +E+ ++ +E + +
Sbjct: 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD 108
Query: 333 HRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMY 392
H N+++L G +G +++ E++ N SLD+F+ + + ++ G G+ Y
Sbjct: 109 HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRY 166
Query: 393 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
L S L +HRDL A NVL+D ++ K+SDFGL+R
Sbjct: 167 L---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSR 199
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 7e-30
Identities = 52/179 (29%), Positives = 78/179 (43%), Gaps = 31/179 (17%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDG------QEIAVKRLSKI-SEQGLKELKNEVILFSK 330
N + LGEG FG V K T +AVK L + S L++L +E + +
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 331 LQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSF-------------IFDQERCKILDWS 377
+ H +++KL G C Q LLI E+ SL F LD
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 378 KRFHIICGT--------ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
+ G ++G+ YL + ++++HRDL A N+L+ + KISDFGL+R
Sbjct: 143 DERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR 198
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 7e-30
Identities = 49/165 (29%), Positives = 74/165 (44%), Gaps = 17/165 (10%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDG------QEIAVKRLSKI-SEQGLKELKNEVILFSK 330
N ++ LG G FG VY+G + ++AVK L ++ SEQ + E ++ SK
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130
Query: 331 LQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFI----FDQERCKILDWSKRFHIICGT 386
H+N+V+ +G +Q + ++ E + L SF+ + L H+
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 387 ARGVMYLHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLAR 428
A G YL IHRD+ A N LL KI DFG+AR
Sbjct: 191 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 9e-30
Identities = 49/174 (28%), Positives = 79/174 (45%), Gaps = 26/174 (14%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVD--------GQEIAVKRLSKI-SEQGLKELKNEVILF 328
D ++ LGEG FG V V +AVK L +E+ L +L +E+ +
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 329 SKL-QHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSF-------------IFDQERCKIL 374
+ +H+N++ LLG C Q +I E+ +L + ++ + +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 375 DWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
+ ARG+ YL + + IHRDL A NVL+ ++ KI+DFGLAR
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 41/161 (25%), Positives = 78/161 (48%), Gaps = 17/161 (10%)
Query: 278 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHR 334
+ + K+GEG FG DG++ +K +S++S + +E + EV + + ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 335 NLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERC-----KILDWSKRFHIICGTARG 389
N+V+ + ++ ++ L I Q+ +ILDW F IC
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDW---FVQIC---LA 137
Query: 390 VMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
+ ++H +I+HRD+K+ N+ L +D ++ DFG+AR
Sbjct: 138 LKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVL 175
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 49/174 (28%), Positives = 79/174 (45%), Gaps = 26/174 (14%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVD--------GQEIAVKRL-SKISEQGLKELKNEVILF 328
D ++ LGEG FG V V +AVK L +E+ L +L +E+ +
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 329 SKL-QHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSF-------------IFDQERCKIL 374
+ +H+N++ LLG C Q +I E+ +L + ++ + +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 375 DWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
+ ARG+ YL + + IHRDL A NVL+ ++ KI+DFGLAR
Sbjct: 201 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 251
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-29
Identities = 40/167 (23%), Positives = 77/167 (46%), Gaps = 21/167 (12%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVD--------GQEIAVKRLSKISEQGLKELKNEVILFS 329
++ N LG+G F ++KG + E+ +K L K + + S
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 330 KLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARG 389
KL H++LV G C+ G+E +L+ EFV SLD+++ ++ ++ + + A
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL--KKNKNCINILWKLEVAKQLAAA 125
Query: 390 VMYLHQDSRLRIIHRDLKASNVLLDQDMNP--------KISDFGLAR 428
+ +L +IH ++ A N+LL ++ + K+SD G++
Sbjct: 126 MHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI 169
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-29
Identities = 44/152 (28%), Positives = 78/152 (51%), Gaps = 6/152 (3%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDG-QEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 336
+ ++ +KLG G +G VY+G +AVK L K ++E E + +++H NL
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 71
Query: 337 VKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 396
V+LLG C + +I EF+ +L ++ + R + + ++ + + YL
Sbjct: 72 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYL--- 127
Query: 397 SRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
+ IHRDL A N L+ ++ K++DFGL+R
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSR 159
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-29
Identities = 48/161 (29%), Positives = 69/161 (42%), Gaps = 10/161 (6%)
Query: 279 NFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNL 336
+ L EGGF VY+ + G+E A+KRL E+ + + EV KL H N+
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNI 88
Query: 337 VKLLGCCIQGEEK-------LLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARG 389
V+ G+E+ L+ + L F+ E L I T R
Sbjct: 89 VQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRA 148
Query: 390 VMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
V ++H+ + IIHRDLK N+LL K+ DFG A
Sbjct: 149 VQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTI 188
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 47/151 (31%), Positives = 71/151 (47%), Gaps = 6/151 (3%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 337
++ + KLG G FG V+ T ++AVK + K ++ E + LQH LV
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLV 246
Query: 338 KLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 397
KL + E +I EF+ SL F+ E K A G+ ++
Sbjct: 247 KLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFI---E 301
Query: 398 RLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
+ IHRDL+A+N+L+ + KI+DFGLAR
Sbjct: 302 QRNYIHRDLRAANILVSASLVCKIADFGLAR 332
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-29
Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 6/151 (3%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 337
+ + +LG G FG V+ G ++AVK L K E L +LQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 338 KLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 397
+L Q E +I E++ N SL F+ K L +K + A G+ ++
Sbjct: 72 RLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFI---E 126
Query: 398 RLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
IHRDL+A+N+L+ ++ KI+DFGLAR
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLAR 157
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 43/152 (28%), Positives = 78/152 (51%), Gaps = 6/152 (3%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 336
+ ++ +KLG G +G VY+G +AVK L K ++E E + +++H NL
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 278
Query: 337 VKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 396
V+LLG C + +I EF+ +L ++ + R + + ++ + + YL
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYL--- 334
Query: 397 SRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
+ IHR+L A N L+ ++ K++DFGL+R
Sbjct: 335 EKKNFIHRNLAARNCLVGENHLVKVADFGLSR 366
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 4e-29
Identities = 48/156 (30%), Positives = 83/156 (53%), Gaps = 10/156 (6%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLV--DGQEI--AVKRLSK-ISEQGLKELKNEVILFSKLQ 332
N SI+ +G G FG V G L +EI A+K L +E+ ++ E + +
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 333 HRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMY 392
H N+++L G + + +++ E++ N SLDSF+ ++ + ++ G A G+ Y
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 393 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
L S + +HRDL A N+L++ ++ K+SDFGL R
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLGR 195
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-29
Identities = 42/157 (26%), Positives = 76/157 (48%), Gaps = 16/157 (10%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQH 333
+ LG+GGF ++ + D + A K + K + + +E + E+ + L H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 334 RNLVKLLGCCIQGEEKL-LIYEFVPNKSLDSFIFDQERCKILDWSKRFHI--ICGTARGV 390
+++V G + + + ++ E +SL + R + + R+++ I G
Sbjct: 101 QHVVGFHGF-FEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEARYYLRQIVL---GC 154
Query: 391 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
YLH+ R+IHRDLK N+ L++D+ KI DFGLA
Sbjct: 155 QYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLA 188
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-29
Identities = 44/167 (26%), Positives = 72/167 (43%), Gaps = 17/167 (10%)
Query: 278 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLS-KISEQGLKELKNEVILFSKLQHRN 335
+F LG GGFG V++ VD A+KR+ E +++ EV +KL+H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 336 LVKLLGCCI---------QGEEKLLIY---EFVPNKSLDSFIFDQERCKILDWSKRFHII 383
+V+ + K+ +Y + ++L ++ + + + S HI
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 384 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
A V +LH ++HRDLK SN+ D K+ DFGL A
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAM 168
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-29
Identities = 41/155 (26%), Positives = 71/155 (45%), Gaps = 12/155 (7%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQH 333
+ LG+GGF ++ + D + A K + K + + +E + E+ + L H
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 334 RNLVKLLGCCIQGEEKL-LIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMY 392
+++V G + + + ++ E +SL ++ + I G Y
Sbjct: 75 QHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL---GCQY 130
Query: 393 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
LH R R+IHRDLK N+ L++D+ KI DFGLA
Sbjct: 131 LH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLA 162
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 6e-29
Identities = 51/174 (29%), Positives = 70/174 (40%), Gaps = 26/174 (14%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDGQE------IAVKRLSKI-SEQGLKELKNEVILFSK 330
+ S LG G FG V + T + +AVK L + L +E+ + S
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 331 L-QHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSF---------------IFDQERCKIL 374
L H N+V LLG C G L+I E+ L +F ++ L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 375 DWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
D A+G+ +L + IHRDL A N+LL KI DFGLAR
Sbjct: 143 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR 193
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 6e-29
Identities = 48/155 (30%), Positives = 88/155 (56%), Gaps = 11/155 (7%)
Query: 278 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQH 333
++F + N LG+G F VY+ + G E+A+K + K + + G+ + ++NEV + +L+H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 334 RNLVKLLGCCIQGEEKL-LIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMY 392
++++L + + L+ E N ++ ++ + R K ++ H + G++Y
Sbjct: 71 PSILELYNY-FEDSNYVYLVLEMCHNGEMNRYL--KNRVKPFSENEARHFMHQIITGMLY 127
Query: 393 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
LH I+HRDL SN+LL ++MN KI+DFGLA
Sbjct: 128 LH---SHGILHRDLTLSNLLLTRNMNIKIADFGLA 159
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 6e-29
Identities = 40/158 (25%), Positives = 70/158 (44%), Gaps = 12/158 (7%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDGQE-----IAVKRL-SKISEQGLKELKNEVILFSKL 331
LG G FG V+KG + E + +K + K Q + + + ++ L
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72
Query: 332 QHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 391
H ++V+LLG C L+ +++P SL + ++ L + A+G+
Sbjct: 73 DHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHV--RQHRGALGPQLLLNWGVQIAKGMY 129
Query: 392 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429
YL ++HR+L A NVLL +++DFG+A
Sbjct: 130 YL---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADL 164
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 6e-29
Identities = 47/158 (29%), Positives = 76/158 (48%), Gaps = 12/158 (7%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDGQE-----IAVKRL-SKISEQGLKELKNEVILFSKL 331
F LG G FG VYKG + E +A+K L S + KE+ +E + + +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 332 QHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 391
+ ++ +LLG C+ LI + +P L ++ +E + + A+G+
Sbjct: 75 DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMN 131
Query: 392 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429
YL R++HRDL A NVL+ + KI+DFGLA+
Sbjct: 132 YL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 7e-29
Identities = 44/157 (28%), Positives = 80/157 (50%), Gaps = 11/157 (7%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDGQE-----IAVKRLSK-ISEQGLKELKNEVILFSKL 331
+ +G G FG VYKG L +A+K L +E+ + E + +
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103
Query: 332 QHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 391
H N+++L G + + ++I E++ N +LD F+ +E+ + ++ G A G+
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMK 161
Query: 392 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
YL + + +HRDL A N+L++ ++ K+SDFGL+R
Sbjct: 162 YL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSR 195
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 7e-29
Identities = 43/165 (26%), Positives = 74/165 (44%), Gaps = 22/165 (13%)
Query: 278 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRL---SKISEQGLKELKNEVILFSKLQH 333
NF I K+G G F VY+ L+DG +A+K++ + + + E+ L +L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 334 RNLVKLLGCCIQGEEKLLIY-EFVPNKSLDSFIFDQERCK-------ILDWSKRFHIICG 385
N++K I+ + +L I E L I ++ K + + F +C
Sbjct: 92 PNVIKYYASFIE-DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKY---FVQLC- 146
Query: 386 TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
+ ++H R++HRD+K +NV + K+ D GL R F
Sbjct: 147 --SALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF 186
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-28
Identities = 46/150 (30%), Positives = 77/150 (51%), Gaps = 15/150 (10%)
Query: 286 LGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCI 344
LG+G +G VY G L + IA+K + + + + L E+ L L+H+N+V+ LG
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF- 88
Query: 345 QGEEKLLIY-EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTAR----GVMYLHQDSRL 399
+ I+ E VP SL + + + + L ++ I + G+ YLH +
Sbjct: 89 SENGFIKIFMEQVPGGSLSALL--RSKWGPLKDNE--QTIGFYTKQILEGLKYLHDN--- 141
Query: 400 RIIHRDLKASNVLLDQDM-NPKISDFGLAR 428
+I+HRD+K NVL++ KISDFG ++
Sbjct: 142 QIVHRDIKGDNVLINTYSGVLKISDFGTSK 171
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-28
Identities = 45/173 (26%), Positives = 72/173 (41%), Gaps = 25/173 (14%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRL-SKISEQGLKELKNEVILFSK 330
D + LG G FG V + + +AVK L + + L +E+ +
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 331 L-QHRNLVKLLGCCIQGEEKL-LIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGT-- 386
+ H N+V LLG C + L +I EF +L +++ + + +
Sbjct: 87 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 387 -----------ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
A+G+ +L + + IHRDL A N+LL + KI DFGLAR
Sbjct: 147 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-28
Identities = 54/170 (31%), Positives = 74/170 (43%), Gaps = 22/170 (12%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDGQE------IAVKRL-SKISEQGLKELKNEVILFSK 330
+N LG G FG V + T + +AVK L S + L +E+ + S
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 331 L-QHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKR---------- 379
L QH N+V LLG C G L+I E+ L +F+ + R D +
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 380 -FHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
H A+G+ +L + IHRD+ A NVLL KI DFGLAR
Sbjct: 166 LLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 212
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-28
Identities = 39/165 (23%), Positives = 70/165 (42%), Gaps = 13/165 (7%)
Query: 275 NATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQ 332
+ + +++ LG+G V++G G A+K + IS + E + KL
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65
Query: 333 HRNLVKLLGCCIQGEEKLLIY---EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARG 389
H+N+VKL + EF P SL + + + L S+ ++ G
Sbjct: 66 HKNIVKLFAI-EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 390 VMYLHQDSRLRIIHRDLKASNVLL----DQDMNPKISDFGLARAF 430
+ +L + I+HR++K N++ D K++DFG AR
Sbjct: 125 MNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-28
Identities = 41/157 (26%), Positives = 72/157 (45%), Gaps = 14/157 (8%)
Query: 279 NFSINNKLGEGGFGPVYKGTLVDGQEIAVKR--LSKISEQGLKELKNEVILFSKLQHRNL 336
+SI ++G GG V++ Q A+K L + Q L +NE+ +KLQ +
Sbjct: 29 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88
Query: 337 --VKLLGCCIQGEEKL-LIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 393
++L ++ + ++ E N L+S++ ++ K +D +R V +
Sbjct: 89 KIIRLYD-YEITDQYIYMVMECG-NIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTI 143
Query: 394 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
HQ I+H DLK +N L+ D K+ DFG+A
Sbjct: 144 HQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQM 176
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-28
Identities = 49/179 (27%), Positives = 74/179 (41%), Gaps = 31/179 (17%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDGQE------IAVKRL-SKISEQGLKELKNEVILFSK 330
+N LG G FG V T + +AVK L K + L +E+ + ++
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 331 L-QHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSF-----------IFDQERCKILDWSK 378
L H N+V LLG C LI+E+ L ++ + E K L+ +
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 379 RFHIICGT---------ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
+++ A+G+ +L +HRDL A NVL+ KI DFGLAR
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLAR 220
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-28
Identities = 52/175 (29%), Positives = 80/175 (45%), Gaps = 28/175 (16%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVD--------GQEIAVKRLSKI-SEQGLKELKNEVILF 328
D + LGEG FG V + ++AVK L +E+ L +L +E+ +
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128
Query: 329 SKL-QHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGT- 386
+ +H+N++ LLG C Q +I E+ +L ++ R L++S
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPGLEYSYNPSHNPEEQ 187
Query: 387 -------------ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
ARG+ YL + + IHRDL A NVL+ +D KI+DFGLAR
Sbjct: 188 LSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 239
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-28
Identities = 42/167 (25%), Positives = 70/167 (41%), Gaps = 20/167 (11%)
Query: 278 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHR 334
+++ + +G G +G K DG+ + K ++E + L +EV L +L+H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 335 NLVKLLGCCIQGEEKLL--IYEFVPNKSLDSFIFDQERCK-------ILDWSKRFHIICG 385
N+V+ I L + E+ L S I + + +L +
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRV---MTQLT- 121
Query: 386 TARGVMYLHQ--DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
+ H+ D ++HRDLK +NV LD N K+ DFGLAR
Sbjct: 122 --LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL 166
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-28
Identities = 49/170 (28%), Positives = 76/170 (44%), Gaps = 25/170 (14%)
Query: 278 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 336
+F +G GGFG V+K +DG+ +KR+ +E + + EV +KL H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE----KAEREVKALAKLDHVNI 66
Query: 337 VKLLGC---------------CIQGEEKLLIY-EFVPNKSLDSFIFDQERCKILDWSKRF 380
V GC + L I EF +L+ +I ++ R + LD
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLAL 125
Query: 381 HIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
+ +GV Y+H ++I+RDLK SN+ L KI DFGL +
Sbjct: 126 ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSL 172
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-28
Identities = 40/157 (25%), Positives = 72/157 (45%), Gaps = 14/157 (8%)
Query: 279 NFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNL 336
+SI ++G GG V++ Q A+K ++ Q L +NE+ +KLQ +
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69
Query: 337 --VKLLGCCIQGEEKL-LIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 393
++L ++ + ++ E N L+S++ ++ K +D +R V +
Sbjct: 70 KIIRLYD-YEITDQYIYMVMECG-NIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTI 124
Query: 394 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
HQ I+H DLK +N L+ D K+ DFG+A
Sbjct: 125 HQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQM 157
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-28
Identities = 44/152 (28%), Positives = 74/152 (48%), Gaps = 10/152 (6%)
Query: 282 INNKLGEGGFGPVYKGTLVDGQE---IAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLV 337
+ +LG G FG V +G ++ +A+K L + + +E+ E + +L + +V
Sbjct: 14 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 73
Query: 338 KLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 397
+L+G C Q E +L+ E L F+ + + + S ++ + G+ YL
Sbjct: 74 RLIGVC-QAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---E 127
Query: 398 RLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429
+HRDL A NVLL KISDFGL++A
Sbjct: 128 EKNFVHRDLAARNVLLVNRHYAKISDFGLSKA 159
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 7e-28
Identities = 41/157 (26%), Positives = 71/157 (45%), Gaps = 14/157 (8%)
Query: 279 NFSINNKLGEGGFGPVYKGTLVDGQEIAVKR--LSKISEQGLKELKNEVILFSKLQHRNL 336
+SI ++G GG V++ Q A+K L + Q L +NE+ +KLQ +
Sbjct: 57 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 337 --VKLLGCCIQGEEKLLIY-EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 393
++L ++ + + E N L+S++ ++ K +D +R V +
Sbjct: 117 KIIRLYD-YEITDQYIYMVMECG-NIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTI 171
Query: 394 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
HQ I+H DLK +N L+ D K+ DFG+A
Sbjct: 172 HQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQM 204
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 39/165 (23%), Positives = 70/165 (42%), Gaps = 13/165 (7%)
Query: 275 NATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQ 332
+ + +++ LG+G V++G G A+K + IS + E + KL
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65
Query: 333 HRNLVKLLGCCIQGEEKLLIY---EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARG 389
H+N+VKL + EF P SL + + + L S+ ++ G
Sbjct: 66 HKNIVKLF-AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 390 VMYLHQDSRLRIIHRDLKASNVLL----DQDMNPKISDFGLARAF 430
+ +L + I+HR++K N++ D K++DFG AR
Sbjct: 125 MNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-27
Identities = 41/156 (26%), Positives = 70/156 (44%), Gaps = 11/156 (7%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLV--DGQEI--AVKRLSK-ISEQGLKELKNEVILFSKLQ 332
+ + +GEG FG V++G + + + A+K S+ ++ E + +
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 333 HRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMY 392
H ++VKL+G + +I E L SF+ Q R LD + + + Y
Sbjct: 75 HPHIVKLIGVITE-NPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAY 131
Query: 393 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
L R +HRD+ A NVL+ + K+ DFGL+R
Sbjct: 132 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 164
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-27
Identities = 39/155 (25%), Positives = 73/155 (47%), Gaps = 12/155 (7%)
Query: 282 INNKLGEGGFGPVYKGT-LVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRNLVK 338
+ ++G G F VYKG E+A + K+++ + K E + LQH N+V+
Sbjct: 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89
Query: 339 LLGCCI---QGEEKLLIY-EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLH 394
+G++ +++ E + + +L +++ +R K++ +G+ +LH
Sbjct: 90 FYDSWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLH 146
Query: 395 QDSRLRIIHRDLKASNVLLD-QDMNPKISDFGLAR 428
+ IIHRDLK N+ + + KI D GLA
Sbjct: 147 TRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 45/151 (29%), Positives = 78/151 (51%), Gaps = 6/151 (3%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 337
++ + KLG+G FG V+ GT +A+K L K + E + KL+H LV
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 325
Query: 338 KLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 397
+L + E ++ E++ SL F+ + K L + + A G+ Y+
Sbjct: 326 QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYV---E 380
Query: 398 RLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
R+ +HRDL+A+N+L+ +++ K++DFGLAR
Sbjct: 381 RMNYVHRDLRAANILVGENLVCKVADFGLAR 411
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-27
Identities = 42/157 (26%), Positives = 71/157 (45%), Gaps = 11/157 (7%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLV--DGQEI--AVKRLSKI-SEQGLKELKNEVILFSKLQ 332
++ +N LGEG FG VY+G G++I AVK K + ++ +E ++ L
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71
Query: 333 HRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMY 392
H ++VKL+G + E +I E P L ++ + L + + Y
Sbjct: 72 HPHIVKLIGII-EEEPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAMAY 128
Query: 393 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429
L + +HRD+ N+L+ K+ DFGL+R
Sbjct: 129 L---ESINCVHRDIAVRNILVASPECVKLGDFGLSRY 162
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 45/151 (29%), Positives = 78/151 (51%), Gaps = 6/151 (3%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 337
++ + KLG+G FG V+ GT +A+K L K + E + KL+H LV
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 242
Query: 338 KLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 397
+L + E ++ E++ SL F+ + K L + + A G+ Y+
Sbjct: 243 QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYV---E 297
Query: 398 RLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
R+ +HRDL+A+N+L+ +++ K++DFGLAR
Sbjct: 298 RMNYVHRDLRAANILVGENLVCKVADFGLAR 328
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-27
Identities = 53/173 (30%), Positives = 72/173 (41%), Gaps = 14/173 (8%)
Query: 264 ELPLFELATIANATDNFSINNKLGEGGFGPVYKGTL--VDGQEI--AVKRL---SKISEQ 316
E PL L + D + KLG+G FG V +G G+ + AVK L +
Sbjct: 5 EGPLQSLTCLIGEKD-LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPE 63
Query: 317 GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDW 376
+ + EV L HRNL++L G + ++ E P SL + ++
Sbjct: 64 AMDDFIREVNAMHSLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRL--RKHQGHFLL 120
Query: 377 SKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429
A G+ YL R IHRDL A N+LL KI DFGL RA
Sbjct: 121 GTLSRYAVQVAEGMGYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRA 170
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 8e-27
Identities = 44/152 (28%), Positives = 74/152 (48%), Gaps = 10/152 (6%)
Query: 282 INNKLGEGGFGPVYKGTL-VDGQEI--AVKRL-SKISEQGLKELKNEVILFSKLQHRNLV 337
+ +LG G FG V +G + ++I A+K L + +E+ E + +L + +V
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 399
Query: 338 KLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 397
+L+G C Q E +L+ E L F+ + + + S ++ + G+ YL
Sbjct: 400 RLIGVC-QAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---E 453
Query: 398 RLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429
+HR+L A NVLL KISDFGL++A
Sbjct: 454 EKNFVHRNLAARNVLLVNRHYAKISDFGLSKA 485
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 45/160 (28%), Positives = 79/160 (49%), Gaps = 6/160 (3%)
Query: 269 ELATIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVIL 327
+ + + + I +LG+G FG VYK G A K + SE+ L++ E+ +
Sbjct: 10 HVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEI 69
Query: 328 FSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTA 387
+ H +VKLLG + ++ EF P ++D+ + E + L + +
Sbjct: 70 LATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIM--LELDRGLTEPQIQVVCRQML 127
Query: 388 RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
+ +LH RIIHRDLKA NVL+ + + +++DFG++
Sbjct: 128 EALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVS 164
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-26
Identities = 43/150 (28%), Positives = 69/150 (46%), Gaps = 12/150 (8%)
Query: 285 KLGEGGFGPVYKGTL-VDGQEI--AVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKL 339
+LG G FG V KG + AVK L EL E + +L + +V++
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 340 LGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRL 399
+G C + E +L+ E L+ ++ ++ + + ++ + G+ YL
Sbjct: 84 IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYL---EES 136
Query: 400 RIIHRDLKASNVLLDQDMNPKISDFGLARA 429
+HRDL A NVLL KISDFGL++A
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLSKA 166
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 7e-26
Identities = 41/157 (26%), Positives = 71/157 (45%), Gaps = 11/157 (7%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLV--DGQEI--AVKRL-SKISEQGLKELKNEVILFSKLQ 332
+ + +GEG FG V++G + + + A+K + S+ ++ E + +
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449
Query: 333 HRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMY 392
H ++VKL+G + +I E L SF+ Q R LD + + + Y
Sbjct: 450 HPHIVKLIGVITE-NPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAY 506
Query: 393 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429
L R +HRD+ A NVL+ + K+ DFGL+R
Sbjct: 507 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 540
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 8e-26
Identities = 45/166 (27%), Positives = 72/166 (43%), Gaps = 16/166 (9%)
Query: 277 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHR 334
+ + +LG GGFG V + G+++A+K+ + +E E+ + KL H
Sbjct: 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHP 72
Query: 335 NLVKLLGCCIQGEEKL-------LIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTA 387
N+V G +KL L E+ L ++ E C L ++ +
Sbjct: 73 NVVSAR-EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS 131
Query: 388 RGVMYLHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLARAF 430
+ YLH+ RIIHRDLK N++L Q + KI D G A+
Sbjct: 132 SALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL 174
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 42/150 (28%), Positives = 66/150 (44%), Gaps = 19/150 (12%)
Query: 284 NKLGEGGFGPVYKGT-LVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRNLVKLL 340
++G G FG V++ G + AVK RL + E++ + L +V L
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRIVPLY 116
Query: 341 GCCIQGEEKLLIY-EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRL 399
G +G + I+ E + SL I ++ L + + + G+ YLH
Sbjct: 117 GAVREG-PWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHTR--- 169
Query: 400 RIIHRDLKASNVLLDQDMNP-KISDFGLAR 428
RI+H D+KA NVLL D + + DFG A
Sbjct: 170 RILHGDVKADNVLLSSDGSRAALCDFGHAL 199
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 54/180 (30%), Positives = 91/180 (50%), Gaps = 12/180 (6%)
Query: 252 NRETDQVQNMDLELPLFELATIANATD---NFSINNKLGEGGFGPVYKGT-LVDGQEIAV 307
+ ET Q++N L +L + F + KLGEG +G VYK GQ +A+
Sbjct: 1 SLETVQLRNPP-RRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAI 59
Query: 308 KRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFD 367
K++ E L+E+ E+ + + ++VK G + + ++ E+ S+ I
Sbjct: 60 KQVP--VESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDII-- 115
Query: 368 QERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
+ R K L + I+ T +G+ YLH R IHRD+KA N+LL+ + + K++DFG+A
Sbjct: 116 RLRNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVA 172
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-25
Identities = 46/155 (29%), Positives = 76/155 (49%), Gaps = 12/155 (7%)
Query: 278 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQH 333
++F I LG+G FG VY +A+K L K + + G++ L+ EV + S L+H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 334 RNLVKLLGCCIQGEEKL-LIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMY 392
N+++L G ++ LI E+ P ++ + ++ D + I A + Y
Sbjct: 69 PNILRLYGY-FHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSY 124
Query: 393 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
H R+IHRD+K N+LL KI+DFG +
Sbjct: 125 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWS 156
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 46/187 (24%), Positives = 82/187 (43%), Gaps = 8/187 (4%)
Query: 242 SASELEKTENNRETDQVQNMDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGT-LV 300
S +L ++ V + + L + + K+GEG G V
Sbjct: 9 SGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKH 68
Query: 301 DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKS 360
G+++AVK + +Q + L NEV++ QH N+V++ + GEE ++ EF+ +
Sbjct: 69 SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGA 128
Query: 361 LDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPK 420
L + L+ + + + + YLH +IHRD+K+ ++LL D K
Sbjct: 129 LTDIV----SQVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVK 181
Query: 421 ISDFGLA 427
+SDFG
Sbjct: 182 LSDFGFC 188
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-25
Identities = 39/165 (23%), Positives = 85/165 (51%), Gaps = 14/165 (8%)
Query: 267 LFELATIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEV 325
L + ++ + ++ K+G+G G VY + GQE+A+++++ + + + NE+
Sbjct: 9 LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68
Query: 326 ILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHI--I 383
++ + ++ N+V L + G+E ++ E++ SL + +D I +
Sbjct: 69 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV----TETCMD---EGQIAAV 121
Query: 384 C-GTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
C + + +LH + ++IHRD+K+ N+LL D + K++DFG
Sbjct: 122 CRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC 163
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 9e-25
Identities = 47/165 (28%), Positives = 80/165 (48%), Gaps = 10/165 (6%)
Query: 267 LFELATIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLS---KISEQGLKELK 322
+ EL + FS ++G G FG VY + + + +A+K++S K S + +++
Sbjct: 43 VAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDII 102
Query: 323 NEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHI 382
EV KL+H N ++ GC ++ L+ E+ + D + K L + +
Sbjct: 103 KEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASD---LLEVHKKPLQEVEIAAV 159
Query: 383 ICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
G +G+ YLH +IHRD+KA N+LL + K+ DFG A
Sbjct: 160 THGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA 201
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 38/156 (24%), Positives = 62/156 (39%), Gaps = 12/156 (7%)
Query: 278 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKL-QH 333
+F ++LG G +G V+K DG+ AVKR + EV K+ QH
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 334 RNLVKLLGCCIQGEEKLLIY-EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMY 392
V+L + L + E SL + L ++ + + T + +
Sbjct: 117 PCCVRLEQA-WEEGGILYLQTELC-GPSLQQHC--EAWGASLPEAQVWGYLRDTLLALAH 172
Query: 393 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
LH ++H D+K +N+ L K+ DFGL
Sbjct: 173 LHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLV 205
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 51/165 (30%), Positives = 85/165 (51%), Gaps = 17/165 (10%)
Query: 275 NATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG-----LKELKNEVILF 328
+++ F KLG G + VYKG G +A+K + SE+G ++E+ L
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREIS----LM 57
Query: 329 SKLQHRNLVKLLGCCIQGEEKL-LIYEFVPN--KSLDSFIFDQERCKILDWSKRFHIICG 385
+L+H N+V+L I E KL L++EF+ N K + L+ + +
Sbjct: 58 KELKHENIVRLY-DVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116
Query: 386 TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
+G+ + H++ +I+HRDLK N+L+++ K+ DFGLARAF
Sbjct: 117 LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF 158
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 38/176 (21%), Positives = 74/176 (42%), Gaps = 33/176 (18%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLV--DGQEIAVKRLSK-----------------ISEQGL 318
+++ I L +G F + L D + A+K+ K +
Sbjct: 31 NDYRIIRTLNQGKFNKII---LCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKY 87
Query: 319 KELKNEVILFSKLQHRNLVKLLGCCIQGEEKL-LIYEFVPNKSLDSFIFDQERCKILDWS 377
+ KNE+ + + +++ + G I +++ +IYE++ N S+ F +++
Sbjct: 88 DDFKNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLD-KNYT 145
Query: 378 KRF------HIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
II Y+H + I HRD+K SN+L+D++ K+SDFG +
Sbjct: 146 CFIPIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGES 199
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 52/161 (32%), Positives = 85/161 (52%), Gaps = 18/161 (11%)
Query: 278 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQ------GLKELKNEVILFSK 330
+NF K+GEG +G VYK + G+ +A+K++ +E ++E+ L +
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREIS----LLKE 58
Query: 331 LQHRNLVKLLGCCIQGEEKL-LIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARG 389
L H N+VKLL I E KL L++EF+ + L F+ D + + +G
Sbjct: 59 LNHPNIVKLL-DVIHTENKLYLVFEFLH-QDLKKFM-DASALTGIPLPLIKSYLFQLLQG 115
Query: 390 VMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
+ + H R++HRDLK N+L++ + K++DFGLARAF
Sbjct: 116 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 153
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 55/165 (33%), Positives = 83/165 (50%), Gaps = 28/165 (16%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQ------GLKELKNEVILFSKL 331
+ + K+GEG +G VYK G+ +A+KR+ +E ++E+ L +L
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREIS----LLKEL 76
Query: 332 QHRNLVKLLGCCIQGEEKL-LIYEFVPN---KSLDSF--IFDQERCKILDWSKRFHIICG 385
H N+V L+ I E L L++EF+ K LD + KI + +
Sbjct: 77 HHPNIVSLI-DVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIY-----LYQLL- 129
Query: 386 TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
RGV + HQ RI+HRDLK N+L++ D K++DFGLARAF
Sbjct: 130 --RGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF 169
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 6e-24
Identities = 46/166 (27%), Positives = 81/166 (48%), Gaps = 29/166 (17%)
Query: 278 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQ------GLKELKNEVILFSK 330
+ K+GEG +G V+K + +A+KR+ + L+E+ L +
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREIC----LLKE 57
Query: 331 LQHRNLVKLLGCCIQGEEKL-LIYEFVPN---KSLDS--FIFDQERCKILDWSKRFHIIC 384
L+H+N+V+L + ++KL L++EF K DS D E K +
Sbjct: 58 LKHKNIVRLH-DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSF-----LFQLL 111
Query: 385 GTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
+G+ + H ++HRDLK N+L++++ K+++FGLARAF
Sbjct: 112 ---KGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAF 151
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 1e-23
Identities = 44/165 (26%), Positives = 74/165 (44%), Gaps = 27/165 (16%)
Query: 278 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKN-----EVILFSKL 331
+ + K+GEG +G V+K GQ +A+K K E + E+ + +L
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIK---KFLESEDDPVIKKIALREIRMLKQL 59
Query: 332 QHRNLVKLLGCCIQGEEKL-LIYEFVPN---KSLDSF--IFDQERCKILDWSKRFHIICG 385
+H NLV LL + + +L L++E+ + LD + + K + W
Sbjct: 60 KHPNLVNLL-EVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQ-------- 110
Query: 386 TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
T + V + H+ IHRD+K N+L+ + K+ DFG AR
Sbjct: 111 TLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLL 152
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 1e-23
Identities = 48/165 (29%), Positives = 82/165 (49%), Gaps = 28/165 (16%)
Query: 278 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG-----LKELKNEVILFSKL 331
+ + +KLGEG + VYKG + +A+K + E+G ++E+ L L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVS----LLKDL 57
Query: 332 QHRNLVKLLGCCIQGEEKL-LIYEFVPN---KSLDS--FIFDQERCKILDWSKRFHIICG 385
+H N+V L I E+ L L++E++ + LD I + K+ +
Sbjct: 58 KHANIVTLH-DIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQ-------- 108
Query: 386 TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
RG+ Y H+ +++HRDLK N+L+++ K++DFGLARA
Sbjct: 109 LLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAK 150
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 2e-23
Identities = 48/165 (29%), Positives = 79/165 (47%), Gaps = 28/165 (16%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQ------GLKELKNEVILFSKL 331
+ + K+GEG +G VYK G+ A+K++ E ++E+ + +L
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREIS----ILKEL 57
Query: 332 QHRNLVKLLGCCIQGEEKL-LIYEFVPN---KSLDS--FIFDQERCKILDWSKRFHIICG 385
+H N+VKL I +++L L++E + K LD + K
Sbjct: 58 KHSNIVKLY-DVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQ-------- 108
Query: 386 TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
G+ Y H R++HRDLK N+L++++ KI+DFGLARAF
Sbjct: 109 LLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF 150
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 2e-23
Identities = 46/165 (27%), Positives = 76/165 (46%), Gaps = 24/165 (14%)
Query: 278 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKN-----EVILFSKL 331
+ + LGEG F VYK Q +A+K++ K+ N E+ L +L
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 332 QHRNLVKLLGCCIQGEEKL-LIYEFVPN---KSLDS--FIFDQERCKILDWSKRFHIICG 385
H N++ LL + + L+++F+ + + K
Sbjct: 70 SHPNIIGLLDA-FGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLM-------- 120
Query: 386 TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
T +G+ YLHQ I+HRDLK +N+LLD++ K++DFGLA++F
Sbjct: 121 TLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF 162
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-23
Identities = 53/157 (33%), Positives = 85/157 (54%), Gaps = 13/157 (8%)
Query: 279 NFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRL--SKISEQGLKELKNEVILFSKLQHRN 335
N+ + +G+G F V ++ G+E+A+K + ++++ L++L EV + L H N
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 336 LVKLLGCCIQGEEKL-LIYEFVPNKSLDSFIFDQERCKILDWSKRFH-IICGTARGVMYL 393
+VKL I+ E+ L LI E+ + ++ R K + +F I+ V Y
Sbjct: 76 IVKLFEV-IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSA----VQYC 130
Query: 394 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
H + RI+HRDLKA N+LLD DMN KI+DFG + F
Sbjct: 131 H---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEF 164
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 2e-23
Identities = 47/168 (27%), Positives = 83/168 (49%), Gaps = 13/168 (7%)
Query: 268 FELATIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVI 326
+L+ + + F + +G G +G VYKG + GQ A+K + ++ +E+K E+
Sbjct: 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGDEEEEIKQEIN 72
Query: 327 LFSKL-QHRNLVKLLGCCIQG-----EEKL-LIYEFVPNKSLDSFIFDQERCKILDWSKR 379
+ K HRN+ G I+ +++L L+ EF S+ + + L
Sbjct: 73 MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGNTLKEEWI 131
Query: 380 FHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
+I RG+ +LHQ ++IHRD+K NVLL ++ K+ DFG++
Sbjct: 132 AYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVS 176
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 3e-23
Identities = 42/156 (26%), Positives = 77/156 (49%), Gaps = 14/156 (8%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQH 333
D+F I LG+G FG VY +A+K L K + ++G++ L+ E+ + S L+H
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 334 RNLVKLLGCCIQGEEKL-LIYEFVPNKSLDSFIFDQ-ERCKILDWSKRFHIICGTARGVM 391
N++++ +++ L+ EF P L + + ++ D + + A +
Sbjct: 74 PNILRMYNY-FHDRKRIYLMLEFAPRGEL----YKELQKHGRFDEQRSATFMEELADALH 128
Query: 392 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
Y H ++IHRD+K N+L+ KI+DFG +
Sbjct: 129 YCH---ERKVIHRDIKPENLLMGYKGELKIADFGWS 161
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 3e-23
Identities = 44/154 (28%), Positives = 70/154 (45%), Gaps = 22/154 (14%)
Query: 286 LGEGGFGPVYKGT-LVDGQEIAVKRLSK----ISEQGLKELKNEVILFSKLQHRNLVKLL 340
LGEG +G V + AVK L K G +K E+ L +L+H+N+++L+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 341 GCCIQGEEKLLIY---EFVPNKSLDSFIFD---QERCKILDWSKRFH-IICGTARGVMYL 393
+ EEK +Y E+ + + D ++R + F +I G + YL
Sbjct: 73 DV-LYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDG----LEYL 125
Query: 394 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
H I+H+D+K N+LL KIS G+A
Sbjct: 126 H---SQGIVHKDIKPGNLLLTTGGTLKISALGVA 156
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 4e-23
Identities = 43/156 (27%), Positives = 83/156 (53%), Gaps = 9/156 (5%)
Query: 274 ANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLS-KISEQGLKELKNEVILFSKL 331
A+ + F+ K+G+G FG V+KG + +A+K + + +E +++++ E+ + S+
Sbjct: 18 ADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC 77
Query: 332 QHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 391
+ K G ++ + +I E++ S D LD ++ I+ +G+
Sbjct: 78 DSPYVTKYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLD 133
Query: 392 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
YLH + + IHRD+KA+NVLL + K++DFG+A
Sbjct: 134 YLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVA 166
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 4e-23
Identities = 37/159 (23%), Positives = 70/159 (44%), Gaps = 17/159 (10%)
Query: 279 NFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLV 337
+F + LG G G + + D +++AVKR+ + EV L + +H N++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP---ECFSFADREVQLLRESDEHPNVI 81
Query: 338 KLLGCCIQGEEKL-LIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 396
+ C + + + E +L ++ +++ + ++ T G+ +LH
Sbjct: 82 RYF-CTEKDRQFQYIAIELCA-ATLQEYV--EQKDFAHLGLEPITLLQQTTSGLAHLHS- 136
Query: 397 SRLRIIHRDLKASNVLL-----DQDMNPKISDFGLARAF 430
L I+HRDLK N+L+ + ISDFGL +
Sbjct: 137 --LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 6e-23
Identities = 44/165 (26%), Positives = 73/165 (44%), Gaps = 27/165 (16%)
Query: 278 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKN-----EVILFSKL 331
+ + +GEG +G V K G+ +A+K K E ++ E+ L +L
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIK---KFLESDDDKMVKKIAMREIKLLKQL 81
Query: 332 QHRNLVKLLGCCIQGEEKL-LIYEFVPN---KSLDSF--IFDQERCKILDWSKRFHIICG 385
+H NLV LL + +++ L++EFV + L+ F D + + +
Sbjct: 82 RHENLVNLL-EVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQ-------- 132
Query: 386 TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
G+ + H IIHRD+K N+L+ Q K+ DFG AR
Sbjct: 133 IINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL 174
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 1e-22
Identities = 51/166 (30%), Positives = 77/166 (46%), Gaps = 25/166 (15%)
Query: 278 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQ------GLKELKNEVILFSK 330
D + KLGEG +G VYK V + +A+KR+ E+ ++E+ L +
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVS----LLKE 89
Query: 331 LQHRNLVKLLGCCIQGEEKL-LIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARG 389
LQHRN+++L I +L LI+E+ L ++ ++ + + G
Sbjct: 90 LQHRNIIELK-SVIHHNHRLHLIFEYA-ENDLKKYM---DKNPDVSMRVIKSFLYQLING 144
Query: 390 VMYLHQDSRLRIIHRDLKASNVLLDQDMNP-----KISDFGLARAF 430
V + H R +HRDLK N+LL KI DFGLARAF
Sbjct: 145 VNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-22
Identities = 41/177 (23%), Positives = 67/177 (37%), Gaps = 29/177 (16%)
Query: 277 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKR--LSKISEQGLKELKNEVILFSKL-Q 332
T F K+G G FG V+K +DG A+KR + EV + L Q
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 333 HRNLVKLLGCCIQGEEKLLIY-EFVPNKSLDSFIFDQER-CKILDWSKRFHIICGTARGV 390
H ++V+ + + +LI E+ SL I + R ++ ++ RG+
Sbjct: 70 HSHVVRYFSAWAEDD-HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128
Query: 391 MYLHQDSRLRIIHRDLKASNVLLDQDMNP-------------------KISDFGLAR 428
Y+H ++H D+K SN+ + + P KI D G
Sbjct: 129 RYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT 182
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 3e-22
Identities = 39/169 (23%), Positives = 73/169 (43%), Gaps = 30/169 (17%)
Query: 277 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 336
++ +G G FG V++ LV+ E+A+K++ + +EL+ + ++H N+
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQ----IMRIVKHPNV 94
Query: 337 VKLLGCCIQGEEKL------LIYEFVP---NKSLDSF-----IFDQERCKILDWSKRFHI 382
V L +K L+ E+VP ++ + K+ + +
Sbjct: 95 VDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLY----MYQL 150
Query: 383 ICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLARAF 430
+ R + Y+H + I HRD+K N+LLD K+ DFG A+
Sbjct: 151 L----RSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 4e-22
Identities = 48/148 (32%), Positives = 73/148 (49%), Gaps = 14/148 (9%)
Query: 286 LGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQHRNLVKLLG 341
LG G FG V G + G ++AVK L++ I + +K E+ +H +++KL
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 342 CCIQGEEKL-LIYEFVPNKSLDSFIFDQERCKILDWSKRFH-IICGTARGVMYLHQDSRL 399
I ++ E+V L +I R + ++ + F I+ V Y H R
Sbjct: 79 V-ISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSA----VDYCH---RH 130
Query: 400 RIIHRDLKASNVLLDQDMNPKISDFGLA 427
++HRDLK NVLLD MN KI+DFGL+
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLS 158
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 4e-22
Identities = 46/180 (25%), Positives = 75/180 (41%), Gaps = 47/180 (26%)
Query: 278 DNFSINNKLGEGGFGPVYKG--TLVDGQEIAVKRLSKISEQG------------LKELKN 323
+ ++GEG +G V+K G+ +A+KR+ + + L+ L+
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 70
Query: 324 EVILFSKLQHRNLVKLL----GCCIQGEEKL-LIYEFVPNKSLDSFIFDQERCKILDWSK 378
+H N+V+L E KL L++E V DQ+ LD
Sbjct: 71 F-------EHPNVVRLFDVCTVSRTDRETKLTLVFEHV----------DQDLTTYLDKVP 113
Query: 379 RFHIICGTA--------RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
+ T RG+ +LH R++HRDLK N+L+ K++DFGLAR +
Sbjct: 114 EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY 170
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 8e-22
Identities = 43/164 (26%), Positives = 72/164 (43%), Gaps = 20/164 (12%)
Query: 279 NFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--------ISEQGLKELKNEVILFS 329
+S + LG G FG V+ +E+ VK + K I + L ++ E+ + S
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 330 KLQHRNLVKLLGCCIQGEEKL-LIYEF-VPNKSLDSFIFDQERCKILDWSKRFH-IICGT 386
+++H N++K+L + + L+ E L +FI R S F ++
Sbjct: 85 RVEHANIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSA- 142
Query: 387 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
V YL IIHRD+K N+++ +D K+ DFG A
Sbjct: 143 ---VGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 1e-21
Identities = 49/146 (33%), Positives = 67/146 (45%), Gaps = 12/146 (8%)
Query: 286 LGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHRNLVKLLGCC 343
LGEG +G V V + +AVK + E +K E+ + L H N+VK G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 73
Query: 344 IQGEEKL-LIYEFVPNKSLDSFIFDQERCKILDWSKRFH-IICGTARGVMYLHQDSRLRI 401
+ L E+ L I D + FH ++ G V+YLH + I
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG----VVYLH---GIGI 126
Query: 402 IHRDLKASNVLLDQDMNPKISDFGLA 427
HRD+K N+LLD+ N KISDFGLA
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLA 152
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 1e-21
Identities = 47/184 (25%), Positives = 76/184 (41%), Gaps = 49/184 (26%)
Query: 276 ATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG---------------LK 319
AT + ++G G +G VYK G +A+K + + G L+
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 320 ELKNEVILFSKLQHRNLVKLL----GCCIQGEEKL-LIYEFVPNKSLDSFIFDQERCKIL 374
L+ +H N+V+L+ E K+ L++E V DQ+ L
Sbjct: 67 RLEAF-------EHPNVVRLMDVCATSRTDREIKVTLVFEHV----------DQDLRTYL 109
Query: 375 DWSKRFHIICGTA--------RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 426
D + + T RG+ +LH + I+HRDLK N+L+ K++DFGL
Sbjct: 110 DKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGL 166
Query: 427 ARAF 430
AR +
Sbjct: 167 ARIY 170
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 94.7 bits (235), Expect = 1e-21
Identities = 28/171 (16%), Positives = 52/171 (30%), Gaps = 22/171 (12%)
Query: 277 TDNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKISEQGLKELKNEVILFSK 330
+ +++ LGEG F VY+ T D Q+ +K + +
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123
Query: 331 LQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFI--FDQERCKILDWSKRFHIICGTAR 388
+K + +L+ E +L + I + K++
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183
Query: 389 GVMYLHQDSRLRIIHRDLKASNVLL-----------DQDMNPKISDFGLAR 428
+ +H IIH D+K N +L D + D G +
Sbjct: 184 MIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 2e-21
Identities = 42/172 (24%), Positives = 66/172 (38%), Gaps = 27/172 (15%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEV-ILFSKLQHRNL 336
+ LG G G V G+ +AVKR+ E+ +L H N+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI---DFCDIALMEIKLLTESDDHPNV 71
Query: 337 VKLLGCCIQGEEKL-LIYEFVPNKSLDSFI----FDQERCKILDWSKRFHIICGTARGVM 391
++ C + L + E N +L + E K+ ++ A GV
Sbjct: 72 IRYY-CSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129
Query: 392 YLHQDSRLRIIHRDLKASNVLLD-------------QDMNPKISDFGLARAF 430
+LH L+IIHRDLK N+L+ +++ ISDFGL +
Sbjct: 130 HLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL 178
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 3e-21
Identities = 39/160 (24%), Positives = 76/160 (47%), Gaps = 10/160 (6%)
Query: 275 NATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLS-KISEQGLKELKNEVILFSKLQ 332
D++ + +G G V +++A+KR++ + + + EL E+ S+
Sbjct: 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH 71
Query: 333 HRNLVKLLGCCIQGEEKLLIYEFVPNKSL-----DSFIFDQERCKILDWSKRFHIICGTA 387
H N+V + +E L+ + + S+ + + +LD S I+
Sbjct: 72 HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131
Query: 388 RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
G+ YLH++ IHRD+KA N+LL +D + +I+DFG++
Sbjct: 132 EGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVS 168
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 3e-21
Identities = 49/146 (33%), Positives = 67/146 (45%), Gaps = 12/146 (8%)
Query: 286 LGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHRNLVKLLGCC 343
LGEG +G V V + +AVK + E +K E+ + L H N+VK G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 73
Query: 344 IQGEEKL-LIYEFVPNKSLDSFIFDQERCKILDWSKRFH-IICGTARGVMYLHQDSRLRI 401
+ L E+ L I D + FH ++ G V+YLH + I
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG----VVYLH---GIGI 126
Query: 402 IHRDLKASNVLLDQDMNPKISDFGLA 427
HRD+K N+LLD+ N KISDFGLA
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLA 152
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 94.5 bits (235), Expect = 3e-21
Identities = 48/148 (32%), Positives = 73/148 (49%), Gaps = 14/148 (9%)
Query: 286 LGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQHRNLVKLLG 341
LG G FG V G + G ++AVK L++ I + ++ E+ +H +++KL
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 342 CCIQGEEKL-LIYEFVPNKSLDSFIFDQERCKILDWSKRFH-IICGTARGVMYLHQDSRL 399
I + ++ E+V L +I R + + F I+ G V Y H R
Sbjct: 84 V-ISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSG----VDYCH---RH 135
Query: 400 RIIHRDLKASNVLLDQDMNPKISDFGLA 427
++HRDLK NVLLD MN KI+DFGL+
Sbjct: 136 MVVHRDLKPENVLLDAHMNAKIADFGLS 163
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 93.6 bits (232), Expect = 3e-21
Identities = 22/223 (9%), Positives = 49/223 (21%), Gaps = 36/223 (16%)
Query: 240 RMSASELEKTENNRETDQVQNMDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTL 299
L++ E + ++ + L G V+
Sbjct: 24 YCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRD 83
Query: 300 VD-GQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCC----------IQ 345
V+ ++ A+K + S L+ L ++L + + +Q
Sbjct: 84 VERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQ 143
Query: 346 GEEK----------------LLIYEFVP---NKSLDSFIFDQERCKILDWSKRFHIICGT 386
+ LL+ + F +
Sbjct: 144 SQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQL 203
Query: 387 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429
R L ++H N+ + D + D
Sbjct: 204 IRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWK 243
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 5e-21
Identities = 32/166 (19%), Positives = 61/166 (36%), Gaps = 15/166 (9%)
Query: 270 LATIANATDNFSINNKLGEG--GFGPVYKGT-LVDGQEIAVKR--LSKISEQGLKELKNE 324
+++ + + +G+G V G+ + V+R L S + + L+ E
Sbjct: 17 MSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGE 76
Query: 325 VILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHI-- 382
+ + H N+V I E ++ F+ S I +D I
Sbjct: 77 LHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLI----CTHFMDGMNELAIAY 132
Query: 383 IC-GTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
I G + + Y+H +HR +KAS++L+ D +S
Sbjct: 133 ILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSN 175
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 1e-20
Identities = 41/166 (24%), Positives = 73/166 (43%), Gaps = 25/166 (15%)
Query: 282 INNKLGEGGFGPVYKG---TLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNL 336
K+G G +G VYK D ++ A+K++ IS +E + L +L+H N+
Sbjct: 25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACRE----IALLRELKHPNV 80
Query: 337 VKLLGCCIQ-GEEKL-LIYEFVPNKSLDSFIFDQERCKILDWSKRF------HIICGTAR 388
+ L + + K+ L++++ L I K + ++
Sbjct: 81 ISLQKVFLSHADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 139
Query: 389 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNP----KISDFGLARAF 430
G+ YLH + ++HRDLK +N+L+ + KI+D G AR F
Sbjct: 140 GIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 182
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 2e-20
Identities = 42/166 (25%), Positives = 78/166 (46%), Gaps = 23/166 (13%)
Query: 277 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN 335
+++ +G G FG VY+ L D G+ +A+K++ + +EL+ + KL H N
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCN 108
Query: 336 LVKLLGCCIQGEEKL------LIYEFVPNKSLDSFI--FDQERCKILDWSKRFHI--ICG 385
+V+L EK L+ ++VP +++ + + + + + ++ +
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVP-ETVYRVARHYSRAKQTLPVIYVKLYMYQLF- 166
Query: 386 TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLARAF 430
R + Y+H I HRD+K N+LLD D K+ DFG A+
Sbjct: 167 --RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-20
Identities = 43/210 (20%), Positives = 73/210 (34%), Gaps = 38/210 (18%)
Query: 242 SASELEKTENNRETDQVQNMDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGT-LV 300
+ + E Q+M E L + A + + +G G V +
Sbjct: 58 AKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRA 117
Query: 301 DGQEIAVKRLSK--------ISEQGLKELKNEV-ILFSKLQHRNLVKLLGCCIQGEEKLL 351
G E AVK + E+ + + E IL H +++ L+ E
Sbjct: 118 TGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY---ESSSF 174
Query: 352 IY---EFVPNKSLDSFIFD--------QERCKILDWSKRFHIICGTARGVMYLHQDSRLR 400
++ + + L FD E+ + + V +LH
Sbjct: 175 MFLVFDLMRKGEL----FDYLTEKVALSEK----ETRSIMRSLLE---AVSFLHA---NN 220
Query: 401 IIHRDLKASNVLLDQDMNPKISDFGLARAF 430
I+HRDLK N+LLD +M ++SDFG +
Sbjct: 221 IVHRDLKPENILLDDNMQIRLSDFGFSCHL 250
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 2e-20
Identities = 44/159 (27%), Positives = 75/159 (47%), Gaps = 17/159 (10%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRL-SKISEQGLKELKNEV-ILFSKLQHR 334
D+ +LG G +G V K V GQ +AVKR+ + ++ Q K L ++ I +
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 335 NLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRF------HIICGTAR 388
V G + + + E + + SLD F +++D + I +
Sbjct: 67 FTVTFYGALFREGDVWICMELM-DTSLDKFY-----KQVIDKGQTIPEDILGKIAVSIVK 120
Query: 389 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
+ +LH S+L +IHRD+K SNVL++ K+ DFG++
Sbjct: 121 ALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGIS 157
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 2e-20
Identities = 46/148 (31%), Positives = 79/148 (53%), Gaps = 15/148 (10%)
Query: 286 LGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQHRNLVKLLG 341
LGEG FG V T Q++A+K +S+ + + + ++ E+ L+H +++KL
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 342 CCIQGEEKL-LIYEFVPNKSLDSFIFDQERCKILDWSKRFH-IICGTARGVMYLHQDSRL 399
I + ++ E+ L +I +++R + + F IIC + Y H R
Sbjct: 77 V-ITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICA----IEYCH---RH 127
Query: 400 RIIHRDLKASNVLLDQDMNPKISDFGLA 427
+I+HRDLK N+LLD ++N KI+DFGL+
Sbjct: 128 KIVHRDLKPENLLLDDNLNVKIADFGLS 155
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 4e-20
Identities = 50/173 (28%), Positives = 86/173 (49%), Gaps = 35/173 (20%)
Query: 278 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQ------GLKELKNEVILFSK 330
+ K+G+G FG V+K GQ++A+K++ +E+ L+E+K IL
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIK---IL-QL 72
Query: 331 LQHRNLVKLLGCCIQGEEKL--------LIYEFVPN---KSLDS--FIFDQERCKILDWS 377
L+H N+V L+ C L+++F + L + F K +
Sbjct: 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRV--- 129
Query: 378 KRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
++ G+ Y+H++ +I+HRD+KA+NVL+ +D K++DFGLARAF
Sbjct: 130 --MQMLL---NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAF 174
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 5e-20
Identities = 52/196 (26%), Positives = 79/196 (40%), Gaps = 24/196 (12%)
Query: 247 EKTENNRETDQVQNMDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEI 305
+ ++ +F + + ++ + KLG G +G V V E
Sbjct: 6 HHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVER 65
Query: 306 AVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDS 363
A+K + K +S +L EV + L H N++KL L+ E L
Sbjct: 66 AIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGEL-- 123
Query: 364 FIFDQERCKILDWSKRF------HIICGTARGVMYLHQDSRLRIIHRDLKASNVLL---D 414
FD +I+ +F II GV YLH+ I+HRDLK N+LL +
Sbjct: 124 --FD----EIIH-RMKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKE 173
Query: 415 QDMNPKISDFGLARAF 430
+D KI DFGL+ F
Sbjct: 174 KDALIKIVDFGLSAVF 189
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 90.5 bits (224), Expect = 6e-20
Identities = 24/178 (13%), Positives = 51/178 (28%), Gaps = 37/178 (20%)
Query: 286 LGEGGFGPVYKGT-LVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQ--------- 332
LG+ + T G+ V +K++K EV+ L+
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 333 -------------HRNLVKLLGCCIQGEEKLLIYEFVP-------NKSLDSFIFDQER-C 371
K++ + + ++ F ++ +
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 372 KILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429
K L R + R + LH ++H L+ +++LDQ ++ F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 91.1 bits (226), Expect = 6e-20
Identities = 42/168 (25%), Positives = 71/168 (42%), Gaps = 30/168 (17%)
Query: 277 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN 335
D++ I+ +LG G FG V++ T G A K + E + ++ E+ S L+H
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215
Query: 336 LVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHI-----------IC 384
LV L E ++IYEF+ L F+ K+ D + + +C
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGEL----FE----KVAD--EHNKMSEDEAVEYMRQVC 265
Query: 385 GTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNP--KISDFGLARAF 430
G+ ++H+ +H DLK N++ + K+ DFGL
Sbjct: 266 K---GLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 307
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 6e-20
Identities = 55/169 (32%), Positives = 78/169 (46%), Gaps = 30/169 (17%)
Query: 277 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQH 333
+ ++I LG+G FG V K + QE AVK ++K + + EV L KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 334 RNLVKLLGCCIQGEEKLLIY---EFVPNKSLDSFIFDQERCKILDWSKRF------HIIC 384
N++KL E+ Y E L FD +I+ KRF II
Sbjct: 81 PNIMKLFEIL---EDSSSFYIVGELYTGGEL----FD----EIIK-RKRFSEHDAARIIK 128
Query: 385 GTARGVMYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAF 430
G+ Y+H+ I+HRDLK N+LL ++D + KI DFGL+ F
Sbjct: 129 QVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 7e-20
Identities = 41/157 (26%), Positives = 71/157 (45%), Gaps = 16/157 (10%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRL-SKISEQGLKELKNEV-ILFSKLQHR 334
++ ++G G +G V K GQ +AVKR+ S + E+ K+L ++ ++
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 335 NLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRF------HIICGTAR 388
+V+ G + + + E + + S D F + I T +
Sbjct: 82 YIVQFYGALFREGDCWICMELM-STSFDKFY----KYVYSVLDDVIPEEILGKITLATVK 136
Query: 389 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 425
+ +L L+IIHRD+K SN+LLD+ N K+ DFG
Sbjct: 137 ALNHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFG 171
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 7e-20
Identities = 39/164 (23%), Positives = 64/164 (39%), Gaps = 16/164 (9%)
Query: 274 ANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ 332
+ +++ N +G G +G V A K++ K + + K E+ + L
Sbjct: 5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLD 64
Query: 333 HRNLVKLLGCCIQGEEKLLIY---EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARG 389
H N+++L E+ IY E L + + + D ++ +
Sbjct: 65 HPNIIRLYETF---EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLS---A 118
Query: 390 VMYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAF 430
V Y H+ L + HRDLK N L D K+ DFGLA F
Sbjct: 119 VAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 7e-20
Identities = 40/166 (24%), Positives = 69/166 (41%), Gaps = 20/166 (12%)
Query: 274 ANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ 332
+ D + I +LG G FG V++ G+ K ++ +KNE+ + ++L
Sbjct: 47 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLH 106
Query: 333 HRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRF------HIICGT 386
H L+ L E +LI EF+ L FD +I + + +
Sbjct: 107 HPKLINLHDAFEDKYEMVLILEFLSGGEL----FD----RIAAEDYKMSEAEVINYMRQA 158
Query: 387 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNP--KISDFGLARAF 430
G+ ++H+ I+H D+K N++ + KI DFGLA
Sbjct: 159 CEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKL 201
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 8e-20
Identities = 55/169 (32%), Positives = 78/169 (46%), Gaps = 30/169 (17%)
Query: 277 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQH 333
+ ++I LG+G FG V K + QE AVK ++K + + EV L KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 334 RNLVKLLGCCIQGEEKLLIY---EFVPNKSLDSFIFDQERCKILDWSKRF------HIIC 384
N++KL E+ Y E L FD +I+ KRF II
Sbjct: 81 PNIMKLFEIL---EDSSSFYIVGELYTGGEL----FD----EIIK-RKRFSEHDAARIIK 128
Query: 385 GTARGVMYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAF 430
G+ Y+H+ I+HRDLK N+LL ++D + KI DFGL+ F
Sbjct: 129 QVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 8e-20
Identities = 43/183 (23%), Positives = 78/183 (42%), Gaps = 20/183 (10%)
Query: 254 ETDQVQNMDLELPLFELATIANAT-DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLS 311
E D+ Q LE L + + D+F ++LG G G V+K + G +A K +
Sbjct: 8 ELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH 67
Query: 312 -KISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQER 370
+I ++ E+ + + +V G E + E + SLD
Sbjct: 68 LEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD-------- 119
Query: 371 CKILDWSKRF------HIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDF 424
++L + R + +G+ YL + +I+HRD+K SN+L++ K+ DF
Sbjct: 120 -QVLKKAGRIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDF 176
Query: 425 GLA 427
G++
Sbjct: 177 GVS 179
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 1e-19
Identities = 47/199 (23%), Positives = 83/199 (41%), Gaps = 51/199 (25%)
Query: 271 ATIANATDNFSINN-----KLGEGGFGPVYKGT-LVDGQEIAVKRLSK------------ 312
+ ++ D +N ++G+G +G V D A+K LSK
Sbjct: 1 GSSGSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRR 60
Query: 313 --------------ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY---EF 355
++++ E+ + KL H N+VKL+ + + +Y E
Sbjct: 61 PPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFEL 119
Query: 356 VPNKSLDSFIFDQERCKIL--DWSKRFH--IICGTARGVMYLHQDSRLRIIHRDLKASNV 411
V + + K L D ++ + +I G + YLH +IIHRD+K SN+
Sbjct: 120 VNQGPV----MEVPTLKPLSEDQARFYFQDLIKG----IEYLH---YQKIIHRDIKPSNL 168
Query: 412 LLDQDMNPKISDFGLARAF 430
L+ +D + KI+DFG++ F
Sbjct: 169 LVGEDGHIKIADFGVSNEF 187
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 1e-19
Identities = 51/208 (24%), Positives = 87/208 (41%), Gaps = 37/208 (17%)
Query: 247 EKTENNRETDQVQNMDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEI 305
+ RE Q + + ++ +++ KLG G +G V E
Sbjct: 5 HHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEK 64
Query: 306 AVKRLSK-------------ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL-L 351
A+K + K E+ +E+ NE+ L L H N++KL + ++ L
Sbjct: 65 AIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF-EDKKYFYL 123
Query: 352 IYEFVPNKSLDSFIFDQERCKILDWSKRF------HIICGTARGVMYLHQDSRLRIIHRD 405
+ EF L F+ +I++ +F +I+ G+ YLH+ I+HRD
Sbjct: 124 VTEFYEGGEL----FE----QIIN-RHKFDECDAANIMKQILSGICYLHK---HNIVHRD 171
Query: 406 LKASNVLL---DQDMNPKISDFGLARAF 430
+K N+LL + +N KI DFGL+ F
Sbjct: 172 IKPENILLENKNSLLNIKIVDFGLSSFF 199
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 1e-19
Identities = 42/177 (23%), Positives = 64/177 (36%), Gaps = 37/177 (20%)
Query: 274 ANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKL 331
D F KLG G FG V+ G E +K ++K Q E ++ E+ + L
Sbjct: 18 GTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL 77
Query: 332 QHRNLVKLLGCCIQGEEKLLIY---EFVPNKSLDSFIFDQERCKILDWSKR--------- 379
H N++K+ E+ +Y E L + +I+ R
Sbjct: 78 DHPNIIKIFEVF---EDYHNMYIVMETCEGGEL----LE----RIVSAQARGKALSEGYV 126
Query: 380 ---FHIICGTARGVMYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAF 430
+ + Y H ++H+DLK N+L KI DFGLA F
Sbjct: 127 AELMKQMMN---ALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 1e-19
Identities = 40/162 (24%), Positives = 69/162 (42%), Gaps = 19/162 (11%)
Query: 278 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK------ISEQGLKELKNEVILFSK 330
+ + LG GGFG VY G + D +A+K + K + EV+L K
Sbjct: 43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 102
Query: 331 LQHR--NLVKLLGCCIQGEEKLLIYEFV-PNKSLDSFIFDQERCKILDWSKRFH-IICGT 386
+ +++LL + + +LI E P + L FI ++ + F ++
Sbjct: 103 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEA- 161
Query: 387 ARGVMYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLA 427
V + H ++HRD+K N+L+D + K+ DFG
Sbjct: 162 ---VRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSG 197
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 1e-19
Identities = 47/245 (19%), Positives = 92/245 (37%), Gaps = 43/245 (17%)
Query: 198 DNSSCMAYTNSDIRGEGSGCAMWFGDLIDMRSFPDGGQDFYIRMSASELEKTENNRETDQ 257
D+S + N+++ G+G + I + ++ + +++ +
Sbjct: 79 DHSGNGTFVNTELVGKGKRRPLNNNSEI---ALSLSRNKVFVFFDLTVDDQSVYPK---- 131
Query: 258 VQNMDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK---- 312
D + ++ LG G G V +++A++ +SK
Sbjct: 132 -----------------ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFA 174
Query: 313 ----ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQ 368
++ E+ + KL H ++K+ E+ ++ E + L +
Sbjct: 175 IGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGN 233
Query: 369 ERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFG 425
+R K F+ + V YLH+ IIHRDLK NVLL ++D KI+DFG
Sbjct: 234 KRLKEATCKLYFYQMLL---AVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFG 287
Query: 426 LARAF 430
++
Sbjct: 288 HSKIL 292
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 1e-19
Identities = 52/163 (31%), Positives = 73/163 (44%), Gaps = 28/163 (17%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQH 333
++F LGEG F V + A+K L K I E + + E + S+L H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 334 RNLVKLLGCCIQGEEKL-LIYEFVPNKSLDSFI-----FDQERCKILDWSKRFH---IIC 384
VKL Q +EKL + N L +I FD+ RF+ I+
Sbjct: 90 PFFVKLYFTF-QDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-------RFYTAEIVS 141
Query: 385 GTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
+ YLH IIHRDLK N+LL++DM+ +I+DFG A
Sbjct: 142 A----LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTA 177
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 2e-19
Identities = 55/168 (32%), Positives = 79/168 (47%), Gaps = 27/168 (16%)
Query: 277 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQ 332
+D + LG+G FG V + GQE AVK +SK + + L EV L +L
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 333 HRNLVKLLGCCIQGEEKL-LIYEFVPNKSLDSFIFDQERCKILDWSKRF------HIICG 385
H N++KL + + L+ E L FD +I+ KRF II
Sbjct: 85 HPNIMKLYEFF-EDKGYFYLVGEVYTGGEL----FD----EIIS-RKRFSEVDAARIIRQ 134
Query: 386 TARGVMYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAF 430
G+ Y+H+ +I+HRDLK N+LL +D N +I DFGL+ F
Sbjct: 135 VLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 88.1 bits (218), Expect = 2e-19
Identities = 23/177 (12%), Positives = 50/177 (28%), Gaps = 37/177 (20%)
Query: 286 LGEGGFGPVYKGT-LVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQ--------- 332
LG+ + T G+ V +K++K EV+ L+
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 333 ----------------HRNLVKLLGCCIQGEEK--LLIYEFVPNKSLDSF--IFD-QERC 371
+ ++++ +Y + + +
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 372 KILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
K L R + R + LH ++H L+ +++LDQ ++ F
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV 254
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 3e-19
Identities = 47/168 (27%), Positives = 80/168 (47%), Gaps = 22/168 (13%)
Query: 274 ANATDNFSINNK--LGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSK 330
++++ LG G FG V+K G ++A K + + +E+KNE+ + ++
Sbjct: 83 GAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQ 142
Query: 331 LQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRF------HIIC 384
L H NL++L + +L+ E+V L FD +I+D S +
Sbjct: 143 LDHANLIQLYDAFESKNDIVLVMEYVDGGEL----FD----RIIDESYNLTELDTILFMK 194
Query: 385 GTARGVMYLHQDSRLRIIHRDLKASNVLL-DQDMNP-KISDFGLARAF 430
G+ ++HQ + I+H DLK N+L ++D KI DFGLAR +
Sbjct: 195 QICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRY 239
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 4e-19
Identities = 45/155 (29%), Positives = 74/155 (47%), Gaps = 16/155 (10%)
Query: 282 INNKLGEGGFGPVYKGT-LVDGQEIAVKRLS---KISEQGLKELKNEVILFSKLQHRNLV 337
I +KLG GG VY + ++A+K + + E+ LK + EV S+L H+N+V
Sbjct: 15 IVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIV 74
Query: 338 KLLGCCIQGEEKLLIY---EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLH 394
++ EE Y E++ +L +I L + G+ + H
Sbjct: 75 SMID---VDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAH 128
Query: 395 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429
+RI+HRD+K N+L+D + KI DFG+A+A
Sbjct: 129 ---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKA 160
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 7e-19
Identities = 43/174 (24%), Positives = 70/174 (40%), Gaps = 35/174 (20%)
Query: 277 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--------ISEQGLKELKNEVIL 327
D + ++ LG G G V +++A+K +SK ++ E+ +
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 328 FSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFD--------QERCKILDWSKR 379
KL H ++K+ E+ ++ E + L FD +E
Sbjct: 69 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEA----TCKLY 119
Query: 380 FHIICGTARGVMYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAF 430
F+ + V YLH IIHRDLK NVLL ++D KI+DFG ++
Sbjct: 120 FYQMLL---AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 7e-19
Identities = 46/171 (26%), Positives = 73/171 (42%), Gaps = 34/171 (19%)
Query: 277 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQH 333
+DN+ + +LG+G F V + G E A K ++ +S + ++L+ E + KLQH
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 334 RNLVKLLGCCIQGEEKLLIY---EFVPNKSLDSFIFDQ--------ERCKILDWSKRFHI 382
N+V+L +E+ Y + V L F+ E D S
Sbjct: 65 PNIVRLHDSI---QEESFHYLVFDLVTGGEL----FEDIVAREFYSEA----DASHCIQQ 113
Query: 383 ICGTARGVMYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAF 430
I + Y H I+HR+LK N+LL + K++DFGLA
Sbjct: 114 ILE---SIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 9e-19
Identities = 33/165 (20%), Positives = 63/165 (38%), Gaps = 21/165 (12%)
Query: 275 NATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH 333
+ + I LG G FG V++ + K + +K E+ + + +H
Sbjct: 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARH 60
Query: 334 RNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRF------HIICGTA 387
RN++ L EE ++I+EF+ + F+ +I + +
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDI----FE----RINTSAFELNEREIVSYVHQVC 112
Query: 388 RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNP--KISDFGLARAF 430
+ +LH I H D++ N++ + KI +FG AR
Sbjct: 113 EALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 1e-18
Identities = 44/169 (26%), Positives = 68/169 (40%), Gaps = 32/169 (18%)
Query: 277 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN 335
F LG G F V+ + G+ A+K + K L+NE+ + K++H N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 336 LVKLLGCCIQGEEKLLIY---EFVPNKSLDSFIFDQ--------ERCKILDWSKRFHIIC 384
+V L E Y + V L FD+ E+ D S +
Sbjct: 68 IVTLEDIY---ESTTHYYLVMQLVSGGEL----FDRILERGVYTEK----DASLVIQQVL 116
Query: 385 GTARGVMYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAF 430
V YLH+ I+HRDLK N+L +++ I+DFGL++
Sbjct: 117 S---AVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 2e-18
Identities = 44/168 (26%), Positives = 73/168 (43%), Gaps = 17/168 (10%)
Query: 274 ANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK------ISEQGLKELKNEVI 326
+ D++ + +LG G F V K G+E A K + K +E++ EV
Sbjct: 1 SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 60
Query: 327 LFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGT 386
+ +++H N++ L + +LI E V L F+ ++E + ++ I
Sbjct: 61 ILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD- 119
Query: 387 ARGVMYLHQDSRLRIIHRDLKASNVLL----DQDMNPKISDFGLARAF 430
GV YLH RI H DLK N++L + K+ DFG+A
Sbjct: 120 --GVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI 162
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 2e-18
Identities = 42/173 (24%), Positives = 64/173 (36%), Gaps = 33/173 (19%)
Query: 277 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKE---------LKNEV- 325
+N+ LG G V + +E AVK + EV
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 326 ILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQ--------ERCKILDWS 377
IL H N+++L L+++ + L FD E+ +
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKVTLSEK----ETR 127
Query: 378 KRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
K + + LH+ L I+HRDLK N+LLD DMN K++DFG +
Sbjct: 128 KIMRALLE---VICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 174
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 4e-18
Identities = 45/165 (27%), Positives = 69/165 (41%), Gaps = 26/165 (15%)
Query: 277 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN 335
TD + + +G G + + E AVK + K +E++ IL QH N
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIE---ILLRYGQHPN 77
Query: 336 LVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRF------HIICGTARG 389
++ L G+ ++ E + L D KIL K F ++ +
Sbjct: 78 IITLKDVYDDGKYVYVVTELMKGGEL----LD----KILR-QKFFSEREASAVLFTITKT 128
Query: 390 VMYLHQDSRLRIIHRDLKASNVLL-DQDMNP---KISDFGLARAF 430
V YLH ++HRDLK SN+L D+ NP +I DFG A+
Sbjct: 129 VEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 4e-18
Identities = 36/165 (21%), Positives = 68/165 (41%), Gaps = 23/165 (13%)
Query: 278 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK------ISEQGLKELKNEV----I 326
+ + LG+GGFG V+ G L D ++A+K + + EV
Sbjct: 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWK 90
Query: 327 LFSKLQHRNLVKLLGCCIQGEEKL-LIYEF-VPNKSLDSFIFDQERCKILDWSKRFH-II 383
+ + H +++LL + +E L+ E +P + L +I ++ F ++
Sbjct: 91 VGAGGGHPGVIRLLDW-FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVV 149
Query: 384 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLA 427
+ + H ++HRD+K N+L+D K+ DFG
Sbjct: 150 AA----IQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSG 187
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 4e-18
Identities = 39/167 (23%), Positives = 65/167 (38%), Gaps = 19/167 (11%)
Query: 277 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVK-----RLSKISEQGLKELKNEVILFSK 330
D + + +G+G F V + GQ+ AVK + + ++LK E +
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 331 LQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKIL----DWSKRFHIICGT 386
L+H ++V+LL +++EF+ L I + + S I
Sbjct: 83 LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE- 141
Query: 387 ARGVMYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAF 430
+ Y H IIHRD+K VLL + K+ FG+A
Sbjct: 142 --ALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL 183
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 5e-18
Identities = 31/153 (20%), Positives = 65/153 (42%), Gaps = 8/153 (5%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRL-SKISEQGLKELKNEV-ILFSKLQHR 334
++ ++G G G V+K G IAVK++ +++ K + ++ ++
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84
Query: 335 NLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLH 394
+V+ G I + + E + + + + + + + YL
Sbjct: 85 YIVQCFGTFITNTDVFIAMELM-GTCAEKLK--KRMQGPIPERILGKMTVAIVKALYYLK 141
Query: 395 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
+ +IHRD+K SN+LLD+ K+ DFG++
Sbjct: 142 --EKHGVIHRDVKPSNILLDERGQIKLCDFGIS 172
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 5e-18
Identities = 45/168 (26%), Positives = 67/168 (39%), Gaps = 17/168 (10%)
Query: 274 ANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKIS------EQGLKELKNEVI 326
D + I +LG G F V K G E A K + K +E++ EV
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67
Query: 327 LFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGT 386
+ ++ H N++ L + +LI E V L F+ +E + + I
Sbjct: 68 ILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD- 126
Query: 387 ARGVMYLHQDSRLRIIHRDLKASNVLL----DQDMNPKISDFGLARAF 430
GV YLH +I H DLK N++L + K+ DFGLA
Sbjct: 127 --GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 6e-18
Identities = 39/174 (22%), Positives = 71/174 (40%), Gaps = 29/174 (16%)
Query: 275 NATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKN----EVILFS 329
D F + G+G FG V G G +A+K K+ + +N + +
Sbjct: 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIK---KVIQD--PRFRNRELQIMQDLA 74
Query: 330 KLQHRNLVKLLGC-CIQGEEKL------LIYEFVP---NKSLDSFIFDQERCKILDWSKR 379
L H N+V+L GE ++ E+VP ++ ++ + + +
Sbjct: 75 VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYY--RRQVAPPPILIK 132
Query: 380 FHI--ICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLARAF 430
+ + R + LH S + + HRD+K NVL+++ K+ DFG A+
Sbjct: 133 VFLFQLI---RSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL 182
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 6e-18
Identities = 46/168 (27%), Positives = 67/168 (39%), Gaps = 17/168 (10%)
Query: 274 ANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK------ISEQGLKELKNEVI 326
D + I +LG G F V K G E A K + K +E++ EV
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 327 LFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGT 386
+ ++ H N++ L + +LI E V L F+ +E + + I
Sbjct: 68 ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD- 126
Query: 387 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNP----KISDFGLARAF 430
GV YLH +I H DLK N++L P K+ DFGLA
Sbjct: 127 --GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 7e-18
Identities = 42/166 (25%), Positives = 66/166 (39%), Gaps = 24/166 (14%)
Query: 277 TDNFSINNK-LGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-H 333
D + + LGEG V L+ QE AVK + K + EV + + Q H
Sbjct: 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGH 70
Query: 334 RNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRF------HIICGTA 387
RN+++L+ + + L++E + S+ I + F ++ A
Sbjct: 71 RNVLELIEFFEEEDRFYLVFEKMRGGSI----LS----HIHK-RRHFNELEASVVVQDVA 121
Query: 388 RGVMYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAF 430
+ +LH I HRDLK N+L +Q KI DF L
Sbjct: 122 SALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 7e-18
Identities = 36/199 (18%), Positives = 65/199 (32%), Gaps = 48/199 (24%)
Query: 277 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVK-----RLSKISEQGLKELKNEVILFSK 330
+ + +G+G +G V A+K ++ +I+ + ++ +K EV L K
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 331 LQHRNLVKLLGC-------------CIQGE------------------EKLLIYEFVPNK 359
L H N+ +L C G + + +
Sbjct: 85 LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144
Query: 360 SLDSFIFDQERCKILDWSKRF------HIICGTARGVMYLHQDSRLRIIHRDLKASNVLL 413
+ I +I+ + YLH I HRD+K N L
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLF 201
Query: 414 --DQDMNPKISDFGLARAF 430
++ K+ DFGL++ F
Sbjct: 202 STNKSFEIKLVDFGLSKEF 220
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 8e-18
Identities = 46/167 (27%), Positives = 70/167 (41%), Gaps = 17/167 (10%)
Query: 275 NATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK------ISEQGLKELKNEVIL 327
N D + +LG G F V K G + A K + K ++++ EV +
Sbjct: 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 328 FSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTA 387
++QH N++ L + +LI E V L F+ ++E + ++ I
Sbjct: 68 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN-- 125
Query: 388 RGVMYLHQDSRLRIIHRDLKASNVLL----DQDMNPKISDFGLARAF 430
GV YLH L+I H DLK N++L KI DFGLA
Sbjct: 126 -GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 8e-18
Identities = 41/151 (27%), Positives = 65/151 (43%), Gaps = 16/151 (10%)
Query: 286 LGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHRNLVKLLGCC 343
+G G FG + + +AVK + + + E ++ E+I L+H N+V+
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIER--GAAIDENVQREIINHRSLRHPNIVRFKEV- 84
Query: 344 IQGEEKL-LIYEFVPNKSLDSFIFDQERCKILDWSKRFH-IICGTARGVMYLHQDSRLRI 401
I L +I E+ L I + R + F ++ G V Y H ++I
Sbjct: 85 ILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSG----VSYCH---SMQI 137
Query: 402 IHRDLKASNVLLDQD--MNPKISDFGLARAF 430
HRDLK N LLD KI DFG +++
Sbjct: 138 CHRDLKLENTLLDGSPAPRLKICDFGYSKSS 168
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 9e-18
Identities = 48/169 (28%), Positives = 75/169 (44%), Gaps = 30/169 (17%)
Query: 277 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQH 333
+DN+ + +LG+G F V + G E A K ++ +S + ++L+ E + KLQH
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 334 RNLVKLLGCCIQGEEKL-LIYEFVPNKSLDSFIFDQ--------ERCKILDWSKRFHIIC 384
N+V+L IQ E L+++ V L F+ E D S I
Sbjct: 88 PNIVRLHD-SIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEA----DASHCIQQIL 138
Query: 385 GTARGVMYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAF 430
+ Y H I+HR+LK N+LL + K++DFGLA
Sbjct: 139 E---SIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 1e-17
Identities = 29/159 (18%), Positives = 63/159 (39%), Gaps = 23/159 (14%)
Query: 282 INNKLGEGGFGPVYKG--TLVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHRNLVK 338
+ + GG G +Y V+G+ + +K L + + E +++ H ++V+
Sbjct: 84 VKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQ 143
Query: 339 LLGCCIQGEE-----KLLIY---EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGV 390
+ E + Y E+V +SL ++ L ++ + +
Sbjct: 144 IFN---FVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQK---LPVAEAIAYLLEILPAL 195
Query: 391 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429
YLH + +++ DLK N++L ++ K+ D G
Sbjct: 196 SYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR 230
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 2e-17
Identities = 50/167 (29%), Positives = 73/167 (43%), Gaps = 32/167 (19%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQH 333
D F LG GGFG V+ + ++ A K+L+K +G + E + +K+
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 334 RNLVKLLGCCIQGEEKL-LIYEFVP---------NKSLDSFIFDQERCKILDWSKRF--- 380
R +V L + + L L+ + N D+ F + R F
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRA-------IFYTA 296
Query: 381 HIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
I+ G + +LHQ II+RDLK NVLLD D N +ISD GLA
Sbjct: 297 QIVSG----LEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLA 336
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 5e-17
Identities = 36/160 (22%), Positives = 68/160 (42%), Gaps = 22/160 (13%)
Query: 282 INNKLGEGGFGPVYKGT-LVDGQEIAVK----RLSKISEQGLKELKNEVILFSKLQHRNL 336
+ LG GG V+ L D +++AVK L++ + E + L H +
Sbjct: 16 LGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLAR-DPSFYLRFRREAQNAAALNHPAI 74
Query: 337 VKLLGCCIQGEEKL-------LIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARG 389
V + GE + ++ E+V +L + + + + +I +
Sbjct: 75 VAVYD---TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQA 128
Query: 390 VMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429
+ + H + IIHRD+K +N+++ K+ DFG+ARA
Sbjct: 129 LNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARA 165
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 6e-17
Identities = 43/175 (24%), Positives = 78/175 (44%), Gaps = 30/175 (17%)
Query: 271 ATIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVIL 327
T T+ + + +LG+G F V + ++ GQE A ++ +S + ++L+ E +
Sbjct: 4 ITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARI 63
Query: 328 FSKLQHRNLVKLLGCCIQGEEKLLIY---EFVPNKSLDSFIFDQERCKILDWSKRF---- 380
L+H N+V+L E+ Y + V L F+ I+ + +
Sbjct: 64 CRLLKHPNIVRLHDSI---SEEGHHYLIFDLVTGGEL----FE----DIVA-REYYSEAD 111
Query: 381 --HIICGTARGVMYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAF 430
H I V++ HQ + ++HR+LK N+LL + K++DFGLA
Sbjct: 112 ASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 8e-17
Identities = 47/193 (24%), Positives = 76/193 (39%), Gaps = 24/193 (12%)
Query: 252 NRETDQVQNMDLELPLFELATIANATDNFSINNK-LGEGGFGPVYKGT-LVDGQEIAVKR 309
+ +DL ++ N + + + +K LG G F V + GQE A K
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKF 61
Query: 310 LSK--ISEQGLKELKNEVILFSKLQHR-NLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIF 366
L K + E+ +E+ + + ++ L E +LI E+ + F
Sbjct: 62 LKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEI----F 117
Query: 367 D---QERCKIL---DWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLL---DQDM 417
E +++ D + I GV YLHQ I+H DLK N+LL
Sbjct: 118 SLCLPELAEMVSENDVIRLIKQILE---GVYYLHQ---NNIVHLDLKPQNILLSSIYPLG 171
Query: 418 NPKISDFGLARAF 430
+ KI DFG++R
Sbjct: 172 DIKIVDFGMSRKI 184
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 1e-16
Identities = 47/165 (28%), Positives = 69/165 (41%), Gaps = 30/165 (18%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQH 333
+ F LG+GGFG V + ++ A K+L K +G NE + K+
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 334 RNLVKLLGCCIQGEEKL-LIYEFVPNKSL-------DSFIFDQERCKILDWSKRF---HI 382
R +V L + ++ L L+ + L F + R F I
Sbjct: 244 RFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARA-------VFYAAEI 295
Query: 383 ICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
CG + LH R RI++RDLK N+LLD + +ISD GLA
Sbjct: 296 CCG----LEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLA 333
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 2e-16
Identities = 35/155 (22%), Positives = 63/155 (40%), Gaps = 16/155 (10%)
Query: 282 INNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQHRNLV 337
+ +G GG G VY+ V + +A+K +S+ S+ + ++ E +LQ ++V
Sbjct: 38 LRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVV 97
Query: 338 KLLGCCIQGEEKLLIY---EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLH 394
+ GE +Y + L + + Q L + I+ + H
Sbjct: 98 PIHD---FGEIDGQLYVDMRLINGVDLAAMLRRQGP---LAPPRAVAIVRQIGSALDAAH 151
Query: 395 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429
HRD+K N+L+ D + DFG+A A
Sbjct: 152 AA---GATHRDVKPENILVSADDFAYLVDFGIASA 183
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 2e-16
Identities = 45/205 (21%), Positives = 93/205 (45%), Gaps = 37/205 (18%)
Query: 242 SASELEKTENNRETDQVQNMDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGT-LV 300
S E ++ + + + +M +++ D + I + +G G +G V + +
Sbjct: 23 SQQEGQQRKQHHSSKPTASMPRPHSDWQI------PDRYEIRHLIGTGSYGHVCEAYDKL 76
Query: 301 DGQEIAVKRLSKISEQG------LKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL---- 350
+ + +A+K++ ++ E L+E+ + ++L H ++VK+L I + +
Sbjct: 77 EKRVVAIKKILRVFEDLIDCKRILREIA----ILNRLNHDHVVKVLDIVIPKDVEKFDEL 132
Query: 351 -LIYEFVP---NKSLDSFIF-DQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRD 405
++ E K + ++ + K ++ GV Y+H S I+HRD
Sbjct: 133 YVVLEIADSDFKKLFRTPVYLTELHIK--------TLLYNLLVGVKYVH--SA-GILHRD 181
Query: 406 LKASNVLLDQDMNPKISDFGLARAF 430
LK +N L++QD + K+ DFGLAR
Sbjct: 182 LKPANCLVNQDCSVKVCDFGLARTV 206
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 78.4 bits (193), Expect = 3e-16
Identities = 42/208 (20%), Positives = 68/208 (32%), Gaps = 56/208 (26%)
Query: 278 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLS-KISEQGLKELKNEVILFSKLQHRN 335
+F +G GGFG V++ VD A+KR+ E +++ EV +KL+H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 336 LVKLLGCCIQGE----EKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 391
+V+ ++ ++ + ++ ++S D + R T V
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 392 YLHQDSR----------------------------------LRI---------------- 401
L S L I
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185
Query: 402 IHRDLKASNVLLDQDMNPKISDFGLARA 429
+HRDLK SN+ D K+ DFGL A
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTA 213
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 3e-16
Identities = 47/165 (28%), Positives = 72/165 (43%), Gaps = 26/165 (15%)
Query: 277 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN 335
+D F + ++LG G VY+ + A+K L K ++ K ++ E+ + +L H N
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPN 109
Query: 336 LVKLLGCCIQGEEKLLIY---EFVPNKSLDSFIFDQ----ERCKILDWSKRFHIICGTAR 388
++KL E I E V L I ++ ER D + I
Sbjct: 110 IIKLKEIF---ETPTEISLVLELVTGGELFDRIVEKGYYSER----DAADAVKQILE--- 159
Query: 389 GVMYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAF 430
V YLH+ I+HRDLK N+L D KI+DFGL++
Sbjct: 160 AVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 4e-16
Identities = 40/171 (23%), Positives = 70/171 (40%), Gaps = 33/171 (19%)
Query: 277 TDNFSINNK-LGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEV-ILFSKLQH 333
TD++ ++ + LG G G V + GQ+ A+K L + + EV +
Sbjct: 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGG 81
Query: 334 RNLVKLLGCC---IQGEEKL-LIYEFVPNKSLDSFIFDQERCKILD-WSKRF------HI 382
++V +L G+ L +I E + L F +I + + F I
Sbjct: 82 PHIVCILDVYENMHHGKRCLLIIMECMEGGEL----FS----RIQERGDQAFTEREAAEI 133
Query: 383 ICGTARGVMYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAF 430
+ + +LH I HRD+K N+L ++D K++DFG A+
Sbjct: 134 MRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET 181
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 5e-16
Identities = 37/178 (20%), Positives = 67/178 (37%), Gaps = 32/178 (17%)
Query: 266 PLFELATIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNE 324
++ A D + LG G G V + ++ A+K L + + E
Sbjct: 6 SGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARRE 60
Query: 325 V-ILFSKLQHRNLVKLLGCC---IQGEEKL-LIYEFVPNKSLDSFIFDQERCKILDWSKR 379
V + + Q ++V+++ G + L ++ E + L F +I D +
Sbjct: 61 VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGEL----FS----RIQDRGDQ 112
Query: 380 F-------HIICGTARGVMYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLA 427
I+ + YLH + I HRD+K N+L + K++DFG A
Sbjct: 113 AFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 5e-16
Identities = 42/157 (26%), Positives = 63/157 (40%), Gaps = 26/157 (16%)
Query: 285 KLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGC 342
LGEG F K Q AVK +SK + + E+ + H N+VKL
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEV 74
Query: 343 CIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRF------HIICGTARGVMYLHQD 396
L+ E + L F+ +I K F +I+ V ++H
Sbjct: 75 FHDQLHTFLVMELLNGGEL----FE----RIKK-KKHFSETEASYIMRKLVSAVSHMHD- 124
Query: 397 SRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAF 430
+ ++HRDLK N+L + ++ KI DFG AR
Sbjct: 125 --VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK 159
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 6e-16
Identities = 36/166 (21%), Positives = 70/166 (42%), Gaps = 31/166 (18%)
Query: 275 NATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ- 332
D++ + KLG G + V++ + + +++ VK L + + K++K E+ + L+
Sbjct: 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRG 89
Query: 333 HRNLVKLLGCCIQGEEK--LLIYEFVPNKSLDSFI--FDQERCK-----ILDWSKRFHII 383
N++ L + L++E V N + IL
Sbjct: 90 GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEIL--------- 140
Query: 384 CGTARGVMYLHQDSRLRIIHRDLKASNVLLD-QDMNPKISDFGLAR 428
+ + Y H S I+HRD+K NV++D + ++ D+GLA
Sbjct: 141 ----KALDYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 179
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 7e-16
Identities = 37/171 (21%), Positives = 70/171 (40%), Gaps = 33/171 (19%)
Query: 277 TDNFSINNK-LGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEV-ILFSKLQH 333
D++ + ++ LG G G V + ++ A+K L + + EV + + Q
Sbjct: 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQC 114
Query: 334 RNLVKLLGCC---IQGEEKL-LIYEFVPNKSLDSFIFDQERCKILD-WSKRF------HI 382
++V+++ G + L ++ E + L F +I D + F I
Sbjct: 115 PHIVRIVDVYENLYAGRKCLLIVMECLDGGEL----FS----RIQDRGDQAFTEREASEI 166
Query: 383 ICGTARGVMYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAF 430
+ + YLH + I HRD+K N+L + K++DFG A+
Sbjct: 167 MKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 214
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 76.1 bits (187), Expect = 6e-15
Identities = 46/166 (27%), Positives = 76/166 (45%), Gaps = 31/166 (18%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKL-- 331
++FS++ +G GGFG VY D ++ A+K L K +QG NE I+ S +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 332 -QHRNLVKLLGCCIQGEEKL-LIYEFVPNKSLDSFI-----FDQERCKILDWSKRFH--- 381
+V + +KL I + + L + F + RF+
Sbjct: 249 GDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADM-------RFYAAE 300
Query: 382 IICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
II G + ++H +++RDLK +N+LLD+ + +ISD GLA
Sbjct: 301 IILG----LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLA 339
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 73.3 bits (181), Expect = 1e-14
Identities = 43/163 (26%), Positives = 74/163 (45%), Gaps = 28/163 (17%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSKISEQGLKEL---KNEVILFSKLQH 333
+F I LG G FG V+ A+K L K LK++ +E ++ S + H
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 334 RNLVKLLGCCIQGEEKL-LIYEFVPNKSLDSFI-----FDQERCKILDWSKRFH---IIC 384
++++ G Q +++ +I +++ L S + F +F+ +
Sbjct: 66 PFIIRMWGTF-QDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVA-------KFYAAEVCL 117
Query: 385 GTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
+ YLH II+RDLK N+LLD++ + KI+DFG A
Sbjct: 118 A----LEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFA 153
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 2e-14
Identities = 48/165 (29%), Positives = 79/165 (47%), Gaps = 30/165 (18%)
Query: 278 DNFSINNKLGEGGFGPVY---KGTLVDGQEI-AVKRLSK--ISEQGLKELKNEVILFSKL 331
F + LG+G FG V+ K + D +++ A+K L K + + K E + ++
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 332 QHRNLVKLLGCCIQGEEKL-LIYEFVPNKSL-----DSFIFDQERCKILDWSKRFH---I 382
H +VKL Q E KL LI +F+ L +F +E +F+ +
Sbjct: 84 NHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDV-------KFYLAEL 135
Query: 383 ICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
+ +LH L II+RDLK N+LLD++ + K++DFGL+
Sbjct: 136 ALA----LDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLS 173
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 4e-14
Identities = 38/199 (19%), Positives = 69/199 (34%), Gaps = 53/199 (26%)
Query: 275 NATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQH 333
++ +S+ LG G FG V + ++ G+ A+K++ + +EL + L H
Sbjct: 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELD----IMKVLDH 59
Query: 334 RNLVKLLGC--------------------CIQGEEKLLIYEFVPNKSLDSFIF------- 366
N++KL+ + + + +
Sbjct: 60 VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119
Query: 367 -DQERCKILDWSKR-------FHI------ICGTARGVMYLHQDSRLRIIHRDLKASNVL 412
K+L R I + R V ++H L I HRD+K N+L
Sbjct: 120 VPDTLHKVLKSFIRSGRSIPMNLISIYIYQLF---RAVGFIHS---LGICHRDIKPQNLL 173
Query: 413 LDQDMNP-KISDFGLARAF 430
++ N K+ DFG A+
Sbjct: 174 VNSKDNTLKLCDFGSAKKL 192
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 5e-14
Identities = 45/163 (27%), Positives = 66/163 (40%), Gaps = 28/163 (17%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSKISEQGLKEL---KNEVILFSKLQH 333
D F LG G FG V + A+K L K LK++ NE + +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 334 RNLVKLLGCCIQGEEKL-LIYEFVPNKSLDSFI-----FDQERCKILDWSKRF---HIIC 384
LVKL + L ++ E+V + S + F + RF I+
Sbjct: 101 PFLVKLEFSF-KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA-------RFYAAQIVL 152
Query: 385 GTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
YLH L +I+RDLK N+L+DQ +++DFG A
Sbjct: 153 T----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 5e-14
Identities = 46/205 (22%), Positives = 77/205 (37%), Gaps = 27/205 (13%)
Query: 239 IRMSASELEKTENNRETDQVQNMDLELPLFELATIANAT------DNFSINNKLGEGGFG 292
I+ A L+K + + E+ + F LG+G FG
Sbjct: 103 IQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFG 162
Query: 293 PVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 348
V A+K L K +++ + E + +H L L Q +
Sbjct: 163 KVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQTHD 221
Query: 349 KL-LIYEFVPNKSL-----DSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRII 402
+L + E+ L +F ++R RF+ + YLH S ++
Sbjct: 222 RLCFVMEYANGGELFFHLSRERVFSEDRA-------RFYGAE-IVSALDYLH--SEKNVV 271
Query: 403 HRDLKASNVLLDQDMNPKISDFGLA 427
+RDLK N++LD+D + KI+DFGL
Sbjct: 272 YRDLKLENLMLDKDGHIKITDFGLC 296
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 8e-14
Identities = 44/161 (27%), Positives = 75/161 (46%), Gaps = 22/161 (13%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQH 333
D+F I +G+G FG V D +++ A+K ++K + ++ + E+ + L+H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 334 RNLVKLLGCCIQGEEKL-LIYEFVPNKSL-----DSFIFDQERCKILDWSKRFHIICGTA 387
LV L Q EE + ++ + + L + F +E K+ IC
Sbjct: 75 PFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLF--------ICELV 125
Query: 388 RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
+ YL RIIHRD+K N+LLD+ + I+DF +A
Sbjct: 126 MALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAA 163
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 1e-13
Identities = 44/172 (25%), Positives = 71/172 (41%), Gaps = 40/172 (23%)
Query: 277 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG------LKELKNEVILFS 329
+ +G G G V V + +A+K+LS+ + +EL L
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV----LMK 116
Query: 330 KLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSF--------IFDQERCKIL-----DW 376
+ H+N++ LL F P K+L+ F + D C+++
Sbjct: 117 CVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE 164
Query: 377 SKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
+ ++ G+ +LH IIHRDLK SN+++ D KI DFGLAR
Sbjct: 165 RMSY-LLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 212
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 3e-13
Identities = 41/160 (25%), Positives = 67/160 (41%), Gaps = 22/160 (13%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQH 333
++F LG+G FG V A+K L K I++ + E + +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 334 RNLVKLLGCCIQGEEKL-LIYEFVPNKSL-----DSFIFDQERCKILDWSKRFHIICGTA 387
L L Q ++L + E+ L +F +ER RF+
Sbjct: 65 PFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERA-------RFYGAE-IV 115
Query: 388 RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
+ YLH +++RD+K N++LD+D + KI+DFGL
Sbjct: 116 SALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLC 152
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 3e-13
Identities = 44/164 (26%), Positives = 69/164 (42%), Gaps = 29/164 (17%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNE-VILFSKLQ 332
+F +G+G FG V + AVK L K + ++ K + +E +L ++
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97
Query: 333 HRNLVKLLGCCIQGEEKL-LIYEFVPNKSL-----DSFIFDQERCKILDWSKRF---HII 383
H LV L Q +KL + +++ L F + R RF I
Sbjct: 98 HPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRA-------RFYAAEIA 149
Query: 384 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
+ YLH L I++RDLK N+LLD + ++DFGL
Sbjct: 150 SA----LGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLC 186
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 3e-13
Identities = 44/174 (25%), Positives = 71/174 (40%), Gaps = 40/174 (22%)
Query: 277 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG------LKELKNEVILFS 329
+ +G G G V + + +A+K+LS+ + +EL L
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELV----LMK 79
Query: 330 KLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSF--------IFDQERCKIL-----DW 376
+ H+N++ LL F P KSL+ F + D C+++
Sbjct: 80 CVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHE 127
Query: 377 SKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
+ ++ G+ +LH IIHRDLK SN+++ D KI DFGLAR
Sbjct: 128 RMSY-LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 177
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 3e-13
Identities = 41/174 (23%), Positives = 70/174 (40%), Gaps = 40/174 (22%)
Query: 277 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG------LKELKNEVILFS 329
+ +G G +G V G+++A+K+LS+ + +EL L
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELL----LLK 78
Query: 330 KLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSF---IFDQE----------RCKILDW 376
+QH N++ LL F P SL +F K +
Sbjct: 79 HMQHENVIGLLDV------------FTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEE 126
Query: 377 SKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
++ ++ +G+ Y+H ++HRDLK N+ +++D KI DFGLAR
Sbjct: 127 KIQY-LVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHA 176
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 4e-13
Identities = 46/167 (27%), Positives = 74/167 (44%), Gaps = 32/167 (19%)
Query: 278 DNFSINNKLGEGGFGPVY---KGTLVDGQEI-AVKRLSK---ISEQGLKE-LKNEVILFS 329
+ F + LG+GG+G V+ K T + +I A+K L K + K E +
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 330 KLQHRNLVKLLGCCIQGEEKL-LIYEFVPNKSL-----DSFIFDQERCKILDWSKRF--- 380
+++H +V L+ Q KL LI E++ L IF ++ F
Sbjct: 77 EVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTA-------CFYLA 128
Query: 381 HIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
I + +LHQ II+RDLK N++L+ + K++DFGL
Sbjct: 129 EISMA----LGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLC 168
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 6e-13
Identities = 39/166 (23%), Positives = 75/166 (45%), Gaps = 29/166 (17%)
Query: 277 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG-----LKELKNEVILFSK 330
++ + +GEG +G V ++ +A+K++S Q L+E+K + +
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIK----ILLR 81
Query: 331 LQHRNLVKLLGCCI-QGEEKL----LIYEFVP---NKSLDSFIFDQERCKILDWSKRFHI 382
+H N++ + E++ ++ + + K L + + +
Sbjct: 82 FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHIC--------YF 133
Query: 383 ICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
+ RG+ Y+H S ++HRDLK SN+LL+ + KI DFGLAR
Sbjct: 134 LYQILRGLKYIH--SA-NVLHRDLKPSNLLLNTTCDLKICDFGLAR 176
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 68.8 bits (167), Expect = 6e-13
Identities = 34/198 (17%), Positives = 62/198 (31%), Gaps = 46/198 (23%)
Query: 276 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRL--------SKISEQGLKELKNEVIL 327
T+ K+GEG FG V++ D +A+K + + ++ +E+ E+I+
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 328 FSKLQ---------HRNLVKLLGCCI-------------------QGEEKLLIYEFVPNK 359
+L + L +G F ++
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 360 SLDSFIF-------DQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVL 412
F +Q R K+ + I+ + LR HRDL NVL
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVL 194
Query: 413 LDQDMNPKISDFGLARAF 430
L + K+ ++
Sbjct: 195 LKKTSLKKLHYTLNGKSS 212
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 8e-13
Identities = 41/174 (23%), Positives = 71/174 (40%), Gaps = 39/174 (22%)
Query: 277 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG------LKELKNEVILFS 329
+ +G G +G V G ++A+K+L + + +EL+ L
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELR----LLK 79
Query: 330 KLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSF---IFDQE----------RCKILDW 376
++H N++ LL F P+++LD F + + L
Sbjct: 80 HMRHENVIGLLDV------------FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGE 127
Query: 377 SKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
+ ++ +G+ Y+H IIHRDLK N+ +++D KI DFGLAR
Sbjct: 128 DRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQA 178
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 9e-13
Identities = 44/170 (25%), Positives = 76/170 (44%), Gaps = 31/170 (18%)
Query: 277 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG------LKELKNEVILFS 329
DN+ I + +G G +G VY + +A+K+++++ E L+E+ + +
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREIT----ILN 80
Query: 330 KLQHRNLVKLLGCCI-QGEEKL----LIYEFVP---NKSLDSFI-FDQERCKILDWSKRF 380
+L+ +++L I K ++ E K + I +E K
Sbjct: 81 RLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIK-------- 132
Query: 381 HIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
I+ G ++H IIHRDLK +N LL+QD + K+ DFGLAR
Sbjct: 133 TILYNLLLGENFIH--ES-GIIHRDLKPANCLLNQDCSVKVCDFGLARTI 179
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 1e-12
Identities = 44/164 (26%), Positives = 68/164 (41%), Gaps = 29/164 (17%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNE-VILFSKLQ 332
+F+ LG+G FG V E+ AVK L K I + ++ E +L +
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 79
Query: 333 HRNLVKLLGCCIQGEEKL-LIYEFVPNKSL-----DSFIFDQERCKILDWSKRFH---II 383
L +L C Q ++L + E+V L F + F+ I
Sbjct: 80 PPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA-------VFYAAEIA 131
Query: 384 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
G + +L II+RDLK NV+LD + + KI+DFG+
Sbjct: 132 IG----LFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMC 168
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 1e-12
Identities = 53/167 (31%), Positives = 75/167 (44%), Gaps = 35/167 (20%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSK--ISEQGLKELKNEV--------I 326
DNF LG+G FG V + + ++ AVK L K I + ++V I
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQ------DDDVECTMTEKRI 76
Query: 327 LFSKLQHRNLVKLLGCCIQGEEKL-LIYEFVPNKSL-----DSFIFDQERCKILDWSKRF 380
L H L +L CC Q ++L + EFV L S FD+ R RF
Sbjct: 77 LSLARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARA-------RF 128
Query: 381 HIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
+ +M+LH II+RDLK NVLLD + + K++DFG+
Sbjct: 129 YAAE-IISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMC 171
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 39/161 (24%), Positives = 69/161 (42%), Gaps = 23/161 (14%)
Query: 278 DNFSINNKLGEGGFGPVY----KGTLVDGQEIAVKRLSK---ISEQGLKELKNEVILFSK 330
D+F I +G G F V K T GQ A+K ++K + + + E +
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQT---GQVYAMKIMNKWDMLKRGEVSCFREERDVLVN 117
Query: 331 LQHRNLVKLLGCCIQGEEKL-LIYEFVPNKSLDSFIFDQERCKILDWSKRFH---IICGT 386
R + +L Q E L L+ E+ L + + + + RF+ I+
Sbjct: 118 GDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMA-RFYLAEIVMA- 174
Query: 387 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
+ +H+ L +HRD+K N+LLD+ + +++DFG
Sbjct: 175 ---IDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSC 209
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 35/158 (22%), Positives = 69/158 (43%), Gaps = 17/158 (10%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSKISEQGLKEL---KNEVILFSKLQH 333
++F I +G G FG V L + ++ A+K L+K E + E +
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 334 RNLVKLLGCCIQGEEKL-LIYEFVPNKSLDSFIFDQERCKILDWSKRFH---IICGTARG 389
+ + L Q + L L+ ++ L + + E + + RF+ ++
Sbjct: 134 KWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMA-RFYLAEMVIA---- 187
Query: 390 VMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
+ +HQ L +HRD+K N+L+D + + +++DFG
Sbjct: 188 IDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSC 222
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 2e-12
Identities = 43/161 (26%), Positives = 72/161 (44%), Gaps = 23/161 (14%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNE-VILFSKLQ 332
++F ++ LG+G FG V+ + A+K L K + + ++ E +L +
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76
Query: 333 HRNLVKLLGCCIQGEEKL-LIYEFVPNKSL-----DSFIFDQERCKILDWSKRFHIICGT 386
H L + C Q +E L + E++ L FD R F+
Sbjct: 77 HPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRA-------TFYAAE-I 127
Query: 387 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
G+ +LH I++RDLK N+LLD+D + KI+DFG+
Sbjct: 128 ILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMC 165
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 2e-12
Identities = 42/164 (25%), Positives = 68/164 (41%), Gaps = 29/164 (17%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNE-VILFSKLQ 332
+F + +G G + V L I A+K + K ++ + ++ E +
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 333 HRNLVKLLGCCIQGEEKL-LIYEFVPNKSL-----DSFIFDQERCKILDWSKRFH---II 383
H LV L C Q E +L + E+V L +E RF+ I
Sbjct: 69 HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA-------RFYSAEIS 120
Query: 384 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
+ YLH+ II+RDLK NVLLD + + K++D+G+
Sbjct: 121 LA----LNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMC 157
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 44/161 (27%), Positives = 68/161 (42%), Gaps = 23/161 (14%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNE-VILFSKLQ 332
+F+ LG+G FG V E+ AVK L K I + ++ E +L +
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400
Query: 333 HRNLVKLLGCCIQGEEKL-LIYEFVPNKSL-----DSFIFDQERCKILDWSKRFHIICGT 386
L +L C Q ++L + E+V L F + F+
Sbjct: 401 PPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA-------VFYAAE-I 451
Query: 387 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
A G+ +L II+RDLK NV+LD + + KI+DFG+
Sbjct: 452 AIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMC 489
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 3e-12
Identities = 41/164 (25%), Positives = 68/164 (41%), Gaps = 29/164 (17%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNE-VILFSKLQ 332
+F + +G G + V L I A++ + K ++ + ++ E +
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111
Query: 333 HRNLVKLLGCCIQGEEKL-LIYEFVPNKSL-----DSFIFDQERCKILDWSKRFH---II 383
H LV L C Q E +L + E+V L +E RF+ I
Sbjct: 112 HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA-------RFYSAEIS 163
Query: 384 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
+ YLH+ II+RDLK NVLLD + + K++D+G+
Sbjct: 164 LA----LNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMC 200
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 66.5 bits (162), Expect = 4e-12
Identities = 35/160 (21%), Positives = 60/160 (37%), Gaps = 19/160 (11%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRL-SKISEQGLKELKNEVILFSK 330
D + LG G FG V + + +AVK L + + L +E+ +
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 331 L-QHRNLVKLLGCCIQ-GEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTAR 388
+ H N+V LLG C + G ++I EF +L +++ SKR + +
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTK 131
Query: 389 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
G + + I DLK + + S F +
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 20/42 (47%), Positives = 27/42 (64%), Gaps = 3/42 (7%)
Query: 387 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
A+G+ +L + + IHRDL A N+LL + KI DFGLAR
Sbjct: 203 AKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 241
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 4e-12
Identities = 45/168 (26%), Positives = 75/168 (44%), Gaps = 33/168 (19%)
Query: 278 DNFSINNKLGEGGFGPVY---KGTLVDGQEI-AVKRLSK---ISEQGLKE-LKNE-VILF 328
+NF + LG G +G V+ K + D ++ A+K L K + + E + E +L
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 329 SKLQHRNLVKLLGCCIQGEEKL-LIYEFVPNKSL-----DSFIFDQERCKILDWSKRFH- 381
Q LV L Q E KL LI +++ L F + + +
Sbjct: 114 HIRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEHEV-------QIYV 165
Query: 382 --IICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
I+ + +LH+ L II+RD+K N+LLD + + ++DFGL+
Sbjct: 166 GEIVLA----LEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLS 206
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 4e-12
Identities = 47/172 (27%), Positives = 73/172 (42%), Gaps = 39/172 (22%)
Query: 277 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG------LKELKNEVILFS 329
+ + + +G G +G V G +AVK+LS+ + +EL+ L
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR----LLK 83
Query: 330 KLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSF---IFDQE----------RCKILDW 376
++H N++ LL F P +SL+ F +C+ L
Sbjct: 84 HMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD 131
Query: 377 SKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
+I RG+ Y+H IIHRDLK SN+ +++D KI DFGLAR
Sbjct: 132 DHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 180
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 5e-12
Identities = 38/180 (21%), Positives = 67/180 (37%), Gaps = 42/180 (23%)
Query: 277 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQG---------------LKEL 321
+++ + G +G V G +G +A+KR+ G L+E+
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 322 KNEVILFSKLQHRNLVKLLGCCI-QGEEKL----LIYEFVPN------KSLDSFIFDQER 370
+ L + H N++ L + E + L+ E + I Q
Sbjct: 81 R----LLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHI 136
Query: 371 CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
+ +HI+ G+ LH+ ++HRDL N+LL + + I DF LAR
Sbjct: 137 QYFM-----YHIL----LGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLARED 184
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 6e-12
Identities = 40/166 (24%), Positives = 80/166 (48%), Gaps = 26/166 (15%)
Query: 277 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG------LKELKNEVILFS 329
+ + KLG+G +G V+K G+ +AVK++ + +E+ IL
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIM---ILTE 64
Query: 330 KLQHRNLVKLLGCCI--QGEEKLLIYEFVP---NKSLDSFIFDQERCKILDWSKRFHIIC 384
H N+V LL + L+++++ + + + I + + +++
Sbjct: 65 LSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQ--------YVVY 116
Query: 385 GTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
+ + YLH S ++HRD+K SN+LL+ + + K++DFGL+R+F
Sbjct: 117 QLIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSF 159
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 6e-12
Identities = 42/169 (24%), Positives = 70/169 (41%), Gaps = 22/169 (13%)
Query: 277 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKN---EVILFSKLQ 332
+ LG GG G V+ + +A+K KI + +K+ E+ + +L
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIK---KIVLTDPQSVKHALREIKIIRRLD 66
Query: 333 HRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQE----------RCKILDWSKRFHI 382
H N+VK+ + L + L+S QE L
Sbjct: 67 HDNIVKVFEI-LGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLF 125
Query: 383 ICGTARGVMYLHQDSRLRIIHRDLKASNVLLD-QDMNPKISDFGLARAF 430
+ RG+ Y+H + ++HRDLK +N+ ++ +D+ KI DFGLAR
Sbjct: 126 MYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIM 171
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 8e-12
Identities = 41/168 (24%), Positives = 77/168 (45%), Gaps = 29/168 (17%)
Query: 277 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG-----LKELKNEVILFSK 330
+ +F + + LGEG +G V T G+ +A+K++ + L+E+K +
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIK----ILKH 65
Query: 331 LQHRNLVKLLGCCI-QGEEKL----LIYEFVP---NKSLDSFIFDQERCKILDWSKRFHI 382
+H N++ + E +I E + ++ + + + + + +
Sbjct: 66 FKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQ--------YF 117
Query: 383 ICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
I T R V LH + +IHRDLK SN+L++ + + K+ DFGLAR
Sbjct: 118 IYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARII 162
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 8e-12
Identities = 34/162 (20%), Positives = 69/162 (42%), Gaps = 27/162 (16%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQH 333
+++ + +G G FG V +++ A+K LSK I E + +
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128
Query: 334 RNLVKLLGCCIQGEEKL-LIYEFVPN----KSLDSFIFDQERCKILDWSKRFH---IICG 385
+V+L Q + L ++ E++P + ++ ++ RF+ ++
Sbjct: 129 PWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWA-------RFYTAEVVLA 180
Query: 386 TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427
+ +H + IHRD+K N+LLD+ + K++DFG
Sbjct: 181 ----LDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTC 215
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 3e-10
Identities = 16/149 (10%), Positives = 43/149 (28%), Gaps = 12/149 (8%)
Query: 285 KLGEGGFGPVYKGT-LVDGQEIAVKRL---SKISEQGLKELKNEVILFSKLQHRNLVKLL 340
G ++ +++A+ + + + L+E + + S++ + ++L
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 341 GCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLR 400
L++ E++ SL + A H R
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQEVA--DTS---PSPVGAIRAMQSLAAAADAAH---RAG 149
Query: 401 IIHRDLKASNVLLDQDMNPKISDFGLARA 429
+ S V + D + ++
Sbjct: 150 VALSIDHPSRVRVSIDGDVVLAYPATMPD 178
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 1e-09
Identities = 39/164 (23%), Positives = 73/164 (44%), Gaps = 25/164 (15%)
Query: 278 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH-RN 335
+ + + K+G G FG +Y GT + G+E+A+K ++ L E ++ +Q
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ--LHIESKIYKMMQGGVG 66
Query: 336 LVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHI--ICGTA----RG 389
+ + C +G+ +++ E + SL+ C S++F + + A
Sbjct: 67 IPTIRWCGAEGDYNVMVMELL-GPSLEDLF---NFC-----SRKFSLKTVLLLADQMISR 117
Query: 390 VMYLHQDSRLRIIHRDLKASNVLLDQDMNPK---ISDFGLARAF 430
+ Y+H + IHRD+K N L+ I DFGLA+ +
Sbjct: 118 IEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 38/165 (23%), Positives = 70/165 (42%), Gaps = 27/165 (16%)
Query: 278 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 336
+ F + K+G G FG +Y GT + +E+A+K + ++ L E ++ LQ
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ--LLYESKIYRILQGGTG 64
Query: 337 V-KLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQER-------CKILDWSKRFHIICGTAR 388
+ + ++G+ +L+ + + SL+ R + D +I
Sbjct: 65 IPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQ-----MIN---- 114
Query: 389 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPK---ISDFGLARAF 430
V ++H S +HRD+K N L+ I DFGLA+ +
Sbjct: 115 RVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 34/208 (16%), Positives = 75/208 (36%), Gaps = 23/208 (11%)
Query: 241 MSASELEKTENNRETDQVQNMDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGT-L 299
M + + T+ + + P ++ + + + K+G GGFG +Y
Sbjct: 1 MHHHHHHSSGVDLGTENLYFQSMPFPEGKVLDDMEG-NQWVLGKKIGSGGFGLIYLAFPT 59
Query: 300 VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV----KLLGCCIQGEEKLLIYEF 355
++ A + K+ Q L +E+ + ++ ++ + + G
Sbjct: 60 NKPEKDARH-VVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGL 118
Query: 356 VPNKSLDSFIFDQERC-----KILDWSKRFHI--ICGTA----RGVMYLHQDSRLRIIHR 404
K ER KI + F + + Y+H++ +H
Sbjct: 119 TEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE---YVHG 175
Query: 405 DLKASNVLLDQDMNPKI--SDFGLARAF 430
D+KA+N+LL ++ +D+GL+ +
Sbjct: 176 DIKAANLLLGYKNPDQVYLADYGLSYRY 203
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 33/166 (19%), Positives = 78/166 (46%), Gaps = 27/166 (16%)
Query: 278 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH-RN 335
++ + ++GEG FG +++GT L++ Q++A+K + S+ L++E + L
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ--LRDEYRTYKLLAGCTG 67
Query: 336 LVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHI--ICGTA----RG 389
+ + +G +L+ + + SL+ + + C ++F + + A
Sbjct: 68 IPNVYYFGQEGLHNVLVIDLLG-PSLEDLL---DLC-----GRKFSVKTVAMAAKQMLAR 118
Query: 390 VMYLHQDSRLRIIHRDLKASNVLLDQDMNPK-----ISDFGLARAF 430
V +H+ S +++RD+K N L+ + + + DFG+ + +
Sbjct: 119 VQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 38/165 (23%), Positives = 69/165 (41%), Gaps = 27/165 (16%)
Query: 279 NFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH-RNL 336
NF + K+G G FG + G L + +A+K S +L E + +L +
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGI 67
Query: 337 VKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHI--ICGTA----RGV 390
++ G+ ++ E + SL+ +FD C + F + + A +
Sbjct: 68 PQVYYFGPCGKYNAMVLELL-GPSLED-LFDL--C-----DRTFSLKTVLMIAIQLISRM 118
Query: 391 MYLHQDSRLRIIHRDLKASNVLLDQDMNPK-----ISDFGLARAF 430
Y+H + +I+RD+K N L+ + N I DF LA+ +
Sbjct: 119 EYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 6e-07
Identities = 32/183 (17%), Positives = 62/183 (33%), Gaps = 45/183 (24%)
Query: 279 NFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLS--KISEQGLKELKNEVILFSKLQHRNL 336
+ + +G+GGFG +Y + + + K+ L E+ + +
Sbjct: 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQ 95
Query: 337 VKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHII------------- 383
++ + L Y VP + S RF I+
Sbjct: 96 IQKW-----IRTRKLKYLGVPK------YWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEA 144
Query: 384 CG---TARGVM-----------YLHQDSRLRIIHRDLKASNVLLDQDMNPKI--SDFGLA 427
+ + V+ Y+H+ +H D+KASN+LL+ ++ D+GLA
Sbjct: 145 NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLA 201
Query: 428 RAF 430
+
Sbjct: 202 YRY 204
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 42/213 (19%), Positives = 78/213 (36%), Gaps = 45/213 (21%)
Query: 237 FYIRMSASELEKTENNRETDQVQNMDLELPLFELATIANATDNFSINNKLGEGGFGPVYK 296
++ MS+ + E+ N D + + + + + + I++ +G+G FG V K
Sbjct: 19 YFQSMSSHKKERKVYNDGYD---DDNYDYIVKNGEKWMD---RYEIDSLIGKGSFGQVVK 72
Query: 297 GT-LVDGQEIAVK---RLSKISEQGLKELKNEVILFSKLQHR------NLVKLLGC---- 342
V+ + +A+K Q E++ +L + +V L
Sbjct: 73 AYDRVEQEWVAIKIIKNKKAFLNQAQIEVR---LL-ELMNKHDTEMKYYIVHLKRHFMFR 128
Query: 343 ---CIQGEEKLL---IYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 396
C+ E +L +Y+ + N + + R +++L
Sbjct: 129 NHLCLVFE--MLSYNLYDLLRNTNFRGVSLNLTR----------KFAQQMCTALLFLA-T 175
Query: 397 SRLRIIHRDLKASNVLLDQDMNP--KISDFGLA 427
L IIH DLK N+LL KI DFG +
Sbjct: 176 PELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 24/174 (13%), Positives = 56/174 (32%), Gaps = 27/174 (15%)
Query: 279 NFSINNKLGEGGFGPVYKGT---------LVDGQEIAVKRLSKISEQGLKELKNEVILFS 329
+ + + G +Y+ Q+ ++K L + E
Sbjct: 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAK 101
Query: 330 KLQHRNLVKLLGCCIQGEEKLL---IYEFVPN--------KSLDSFIFDQERCKILDWSK 378
LQ KL + + +++ +SL S D +L
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQS-ALDVSPKHVLSERS 160
Query: 379 RFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKI--SDFGLARAF 430
+ C + +LH++ +H ++ A N+ +D + ++ + +G A +
Sbjct: 161 VLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRY 211
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 3e-06
Identities = 41/170 (24%), Positives = 66/170 (38%), Gaps = 41/170 (24%)
Query: 280 FSINNKLGEGGFGPVYKGT-LVDGQEIAVKRL---SKISEQGLKELKNEVILFSKLQHR- 334
+ + +G+G FG V K Q +A+K + + Q +E++ IL L+ +
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIR---IL-EHLRKQD 154
Query: 335 -----NLVKLLGC-------CIQGEEKLL---IYEFVPNKSLDSFIFDQERCKILDWSKR 379
N++ +L C+ E LL +YE + F R
Sbjct: 155 KDNTMNVIHMLENFTFRNHICMTFE--LLSMNLYELIKKNKFQGFSLPLVR--------- 203
Query: 380 FHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNP--KISDFGLA 427
+ + LH + RIIH DLK N+LL Q K+ DFG +
Sbjct: 204 -KFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 9e-06
Identities = 37/186 (19%), Positives = 64/186 (34%), Gaps = 63/186 (33%)
Query: 282 INNKLGEGGFGPVYKGT-LVDGQEIAVKRL---SKISEQGLKELK-------NEVILFSK 330
+ KLG G F V+ +V+ +A+K + +E E+K +
Sbjct: 23 LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDS 82
Query: 331 LQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCK------------ILDWSK 378
+ +++KLL D F +L K
Sbjct: 83 MGANHILKLL---------------------DHFNHKGPNGVHVVMVFEVLGENLLALIK 121
Query: 379 RFH-------IICGTAR----GVMYLHQDSRLRIIHRDLKASNVLLDQDMNP------KI 421
++ + ++ G+ Y+H R IIH D+K NVL++ +P KI
Sbjct: 122 KYEHRGIPLIYVKQISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKI 179
Query: 422 SDFGLA 427
+D G A
Sbjct: 180 ADLGNA 185
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 35/153 (22%), Positives = 59/153 (38%), Gaps = 38/153 (24%)
Query: 280 FSINNKLGEGGFGPVYKGT-LVDGQEIAVK---RLSKISEQGLKELKNEVILFSKLQHR- 334
F + K+G+G FG V + + + AVK + K + E IL K+Q+
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEAD---IL-KKIQNDD 92
Query: 335 ----NLVKLLGC-------CIQGEEKLL---IYEFVPNKSLDSFIFDQERCKILDWSKRF 380
N+VK G C+ E L +YE + + + F + +
Sbjct: 93 INNNNIVKYHGKFMYYDHMCLIFE--PLGPSLYEIITRNNYNGFHIEDIK---------- 140
Query: 381 HIICGTARGVMYLHQDSRLRIIHRDLKASNVLL 413
+ + YL ++ + H DLK N+LL
Sbjct: 141 LYCIEILKALNYLR---KMSLTHTDLKPENILL 170
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 4e-04
Identities = 39/170 (22%), Positives = 62/170 (36%), Gaps = 40/170 (23%)
Query: 280 FSINNKLGEGGFGPVYKG--TLVDGQEIAVK---RLSKISEQGLKELKNEVILFSKLQHR 334
+ I + LGEG FG V + G+ +AVK + + E E++ +L L
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQ---VL-EHLNTT 71
Query: 335 ------NLVKLLGC-------CIQGEEKLL---IYEFVPNKSLDSFIFDQERCKILDWSK 378
V++L CI E LL Y+F+ F D R
Sbjct: 72 DPNSTFRCVQMLEWFEHHGHICIVFE--LLGLSTYDFIKENGFLPFRLDHIR-------- 121
Query: 379 RFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
+ + V +LH ++ H DLK N+L Q + + + R
Sbjct: 122 --KMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKR 166
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 6e-04
Identities = 33/173 (19%), Positives = 59/173 (34%), Gaps = 40/173 (23%)
Query: 277 TDNFSINNKLGEGGFGPVYKG--TLVDGQEIAVK---RLSKISEQGLKELKNEVILFSKL 331
+ + I LGEG FG V + ++A+K + K E E+ +L K+
Sbjct: 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEIN---VL-KKI 73
Query: 332 QHR------NLVKLLGC-------CIQGEEKLL---IYEFVPNKSLDSFIFDQERCKILD 375
+ + V + CI E LL +EF+ + + R
Sbjct: 74 KEKDKENKFLCVLMSDWFNFHGHMCIAFE--LLGKNTFEFLKENNFQPYPLPHVR----- 126
Query: 376 WSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
H+ + +LH ++ H DLK N+L + + +
Sbjct: 127 -----HMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSC 171
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 430 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 99.98 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 99.98 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 99.97 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 99.97 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.96 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.96 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.96 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.96 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.96 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.96 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.96 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.96 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.96 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.96 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.96 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.96 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.96 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.96 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.96 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.96 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.96 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.96 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.95 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.95 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.95 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.95 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.95 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.95 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.95 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.95 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.95 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.95 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.95 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.95 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.95 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.95 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.95 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.95 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.95 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.95 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.95 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.95 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.95 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.95 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.95 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.95 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.95 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.95 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.95 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.95 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.95 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.95 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.95 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.95 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.95 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.95 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.95 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.95 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.95 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.95 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.95 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.95 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.95 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.95 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.95 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.95 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.95 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.95 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.95 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.95 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.95 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.95 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.95 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.95 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.95 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.95 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.95 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.95 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.95 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.94 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.94 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.94 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.94 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.94 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.94 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.94 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.94 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.94 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.94 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.94 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.94 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.94 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.94 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.94 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.94 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.94 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.94 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.94 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.94 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.94 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.94 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.94 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.94 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.94 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.94 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.94 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.94 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.94 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.94 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.94 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.94 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.94 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.94 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.94 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.94 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.94 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.94 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.94 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.94 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.94 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.94 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.94 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.94 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.94 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.94 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.94 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.94 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.94 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.94 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.94 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.94 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.94 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.94 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.94 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.94 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.94 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.94 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.94 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.94 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.94 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.94 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.94 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.94 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.94 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.94 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.94 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.94 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.94 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.94 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.94 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.94 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.94 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.94 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.94 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.94 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.94 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.94 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.94 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.94 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.94 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.94 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.94 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.94 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.94 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.94 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.94 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.94 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.94 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.94 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.94 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.94 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.94 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.94 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.94 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.93 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.93 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.93 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.93 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.93 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.93 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.93 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.93 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.93 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.93 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.93 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.93 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.93 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.93 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.93 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.93 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.93 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.93 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.93 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.93 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.93 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.93 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.93 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.93 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.93 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.93 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.93 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.93 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.93 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.93 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.93 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.93 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.93 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.93 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.93 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.93 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.92 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.92 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.92 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.92 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.92 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.92 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.92 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.92 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.92 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.92 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.92 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.92 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.92 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.92 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.92 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.92 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.91 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.91 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.91 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.91 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.91 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.91 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.91 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.91 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.91 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.89 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.87 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.86 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.75 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.53 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.37 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.25 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 99.13 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.95 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.86 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.81 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.76 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.73 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.64 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 98.6 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.57 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.36 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.34 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.15 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.11 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.07 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.89 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.82 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.79 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.75 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.74 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.71 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.7 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.53 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 97.48 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.33 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.18 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 96.66 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 96.61 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 96.55 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.37 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 96.36 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 96.27 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 96.05 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 95.87 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 95.53 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.26 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 95.02 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 93.22 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 93.07 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 92.98 | |
| 1b9w_A | 95 | Protein (merozoite surface protein 1); MSP-1, cand | 91.77 | |
| 2ll3_A | 82 | Micronemal protein 4; cell adhesion; NMR {Toxoplas | 89.94 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 89.87 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 89.1 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 88.96 | |
| 1n1i_A | 105 | Merozoite surface protein-1; MSP1, malaria, surfac | 87.86 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 83.34 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 82.79 | |
| 1edm_B | 39 | Factor IX; epidermal growth factor, EGF, calcium- | 80.33 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=290.07 Aligned_cols=149 Identities=22% Similarity=0.412 Sum_probs=130.3
Q ss_pred CCcccceeecccCCcceEEEEEc-CCcEEEEEEecc--cChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 354 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 354 (430)
++|+++++||+|+||.||+|+.. +++.||||++.+ ......+.+.+|+.+|++|+|||||++++++.+++..|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 68999999999999999999964 589999999964 345567889999999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCccccC
Q 047619 355 FVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430 (430)
Q Consensus 355 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~~ 430 (430)
|++||+|.++|.... ...+++.++..++.||+.||+|||+++ ||||||||+||||++++.+||+|||+|+.+
T Consensus 104 y~~gg~L~~~i~~~~-~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 175 (350)
T 4b9d_A 104 YCEGGDLFKRINAQK-GVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVL 175 (350)
T ss_dssp CCTTCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCC
T ss_pred CCCCCcHHHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceee
Confidence 999999999996543 345789999999999999999999998 999999999999999999999999999863
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=285.31 Aligned_cols=149 Identities=32% Similarity=0.612 Sum_probs=134.2
Q ss_pred CCcccceeecccCCcceEEEEEc------CCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 351 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 351 (430)
++|.+.++||+|+||.||+|++. ++..||||+++.......++|.+|+++|++++|||||++++++.+++..+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 57888999999999999999863 367899999987777778899999999999999999999999999999999
Q ss_pred EEEccCCCChhHHhhcCC----------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeee
Q 047619 352 IYEFVPNKSLDSFIFDQE----------RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKI 421 (430)
Q Consensus 352 v~e~~~~gsL~~~l~~~~----------~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl 421 (430)
||||+++|+|.++|.... ....+++.+++.|+.||+.||+|||+++ ||||||||+||||++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 999999999999996532 2346899999999999999999999988 999999999999999999999
Q ss_pred cCCCcccc
Q 047619 422 SDFGLARA 429 (430)
Q Consensus 422 ~DFGlar~ 429 (430)
+|||+||.
T Consensus 170 ~DFGla~~ 177 (299)
T 4asz_A 170 GDFGMSRD 177 (299)
T ss_dssp CCCSCHHH
T ss_pred CCccccee
Confidence 99999974
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=284.27 Aligned_cols=146 Identities=31% Similarity=0.431 Sum_probs=134.0
Q ss_pred CCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc---ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 353 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 353 (430)
++|++.+.||+|+||+||+|+.. +++.||||++.+. .....+.+.+|+++|++++|||||++++++.+++..||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57999999999999999999964 5899999999752 2344678999999999999999999999999999999999
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||++||+|.++|... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.
T Consensus 112 Ey~~gG~L~~~i~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~ 181 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKV 181 (311)
T ss_dssp CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCcee
Confidence 999999999999643 35899999999999999999999998 99999999999999999999999999985
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-36 Score=286.46 Aligned_cols=149 Identities=30% Similarity=0.561 Sum_probs=132.8
Q ss_pred CCcccceeecccCCcceEEEEEc------CCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 351 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 351 (430)
++|.+.++||+|+||.||+|++. +++.||||+++.......++|.+|+++|++++|||||++++++.+++..+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 56788899999999999999864 378899999988777788899999999999999999999999999999999
Q ss_pred EEEccCCCChhHHhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCe
Q 047619 352 IYEFVPNKSLDSFIFDQER------------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNP 419 (430)
Q Consensus 352 v~e~~~~gsL~~~l~~~~~------------~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~ 419 (430)
||||+++|+|.++|..... ..++++.+++.|+.||+.||+|||+++ ||||||||+||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 9999999999999975421 246899999999999999999999988 9999999999999999999
Q ss_pred eecCCCcccc
Q 047619 420 KISDFGLARA 429 (430)
Q Consensus 420 kl~DFGlar~ 429 (430)
||+|||+||.
T Consensus 198 Ki~DFGla~~ 207 (329)
T 4aoj_A 198 KIGDFGMSRD 207 (329)
T ss_dssp EECCCC----
T ss_pred EEccccccee
Confidence 9999999985
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=287.87 Aligned_cols=146 Identities=27% Similarity=0.446 Sum_probs=134.3
Q ss_pred cCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEc
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 355 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 355 (430)
.+.|++.++||+|+||.||+|... +++.||||++........+.+.+|+.+|++++|||||++++++.+++.+||||||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 357999999999999999999975 5899999999765555566788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 356 VPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 356 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+++|+|.+++.. ..+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.
T Consensus 153 ~~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~ 219 (346)
T 4fih_A 153 LEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQ 219 (346)
T ss_dssp CTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCcee
Confidence 999999999854 24899999999999999999999998 99999999999999999999999999985
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=289.79 Aligned_cols=146 Identities=27% Similarity=0.446 Sum_probs=134.7
Q ss_pred cCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEc
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 355 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 355 (430)
.+.|++.++||+|+||.||+|... +++.||||++........+.+.+|+.+|++++|||||++++++.+.+.+||||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 467999999999999999999975 5899999999765555567789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 356 VPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 356 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++||+|.+++.. ..+++.++..++.||+.||+|||+++ ||||||||+||||+.+|.+||+|||+|+.
T Consensus 230 ~~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~ 296 (423)
T 4fie_A 230 LEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQ 296 (423)
T ss_dssp CTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEE
T ss_pred CCCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceE
Confidence 999999999854 24899999999999999999999998 99999999999999999999999999985
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=279.80 Aligned_cols=149 Identities=32% Similarity=0.537 Sum_probs=131.6
Q ss_pred CCcccceeecccCCcceEEEEEc------CCcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 350 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 350 (430)
+++++.++||+|+||.||+|.+. +++.||||+++.. .....++|.+|+.++++++|||||+++|++.+++..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 45777899999999999999863 3678999999753 3445678999999999999999999999999999999
Q ss_pred EEEEccCCCChhHHhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCC
Q 047619 351 LIYEFVPNKSLDSFIFDQER-------------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDM 417 (430)
Q Consensus 351 lv~e~~~~gsL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~ 417 (430)
|||||+++|+|.++|..... ...+++..++.|+.||+.||+|||+++ ||||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence 99999999999999965321 245899999999999999999999988 99999999999999999
Q ss_pred CeeecCCCcccc
Q 047619 418 NPKISDFGLARA 429 (430)
Q Consensus 418 ~~kl~DFGlar~ 429 (430)
.+||+|||+||.
T Consensus 183 ~~Ki~DFGlar~ 194 (308)
T 4gt4_A 183 NVKISDLGLFRE 194 (308)
T ss_dssp CEEECCSCCBCG
T ss_pred CEEECCccccee
Confidence 999999999985
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-35 Score=275.57 Aligned_cols=149 Identities=28% Similarity=0.448 Sum_probs=128.7
Q ss_pred CCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCC--------
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-------- 347 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------- 347 (430)
++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.+|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46899999999999999999964 5899999998643 3445678999999999999999999999997654
Q ss_pred ----EEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecC
Q 047619 348 ----EKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD 423 (430)
Q Consensus 348 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~D 423 (430)
..||||||+++|+|.+++.........++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 36899999999999999976655455677778899999999999999998 99999999999999999999999
Q ss_pred CCcccc
Q 047619 424 FGLARA 429 (430)
Q Consensus 424 FGlar~ 429 (430)
||+|+.
T Consensus 162 FGla~~ 167 (299)
T 4g31_A 162 FGLVTA 167 (299)
T ss_dssp CCCC--
T ss_pred Ccccee
Confidence 999985
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-35 Score=270.83 Aligned_cols=145 Identities=30% Similarity=0.507 Sum_probs=126.1
Q ss_pred CCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc---ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 353 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 353 (430)
++|++.+.||+|+||.||+|... +++.||||++.+. .....+.+.+|+.++++++|||||++++++.+++..||||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999964 5899999999753 2344677999999999999999999999999999999999
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||+ +|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+.
T Consensus 93 Ey~-~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~ 161 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR---DKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNI 161 (275)
T ss_dssp ECC-CEEHHHHHHHS---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC--
T ss_pred eCC-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCee
Confidence 999 68999998654 35999999999999999999999998 99999999999999999999999999985
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-35 Score=275.73 Aligned_cols=146 Identities=31% Similarity=0.550 Sum_probs=130.3
Q ss_pred hcCCcccceeecccCCcceEEEEEcCCcEEEEEEecc--cChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 353 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 353 (430)
..+++++.++||+|+||.||+|++. ..||||+++. ...+..+.|.+|+.+|++++|||||++++++. .+..+|||
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~~~iVm 110 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KDNLAIVT 110 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CCeEEEEE
Confidence 3467888999999999999999864 4699999864 34566788999999999999999999999875 45689999
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||+++|+|.++|.... ..+++.++..|+.||+.||+|||+++ ||||||||+||||++++.+||+|||+|+.
T Consensus 111 Ey~~gGsL~~~l~~~~--~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 181 (307)
T 3omv_A 111 QWCEGSSLYKHLHVQE--TKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATV 181 (307)
T ss_dssp ECCSSCBHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC
T ss_pred EcCCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCcee
Confidence 9999999999996543 45999999999999999999999988 99999999999999999999999999985
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=270.07 Aligned_cols=145 Identities=26% Similarity=0.422 Sum_probs=127.7
Q ss_pred ccceeecccCCcceEEEEEc-CCcEEEEEEecc--cChHhHHHHHHHHHHHhcCCCCcccceEEEEEe----CCEEEEEE
Q 047619 281 SINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ----GEEKLLIY 353 (430)
Q Consensus 281 ~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 353 (430)
++.++||+|+||.||+|... ++..||+|++.. ......+.+.+|+.+|++|+|||||++++++.+ .+.++|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 66788999999999999975 488999999864 345567789999999999999999999999876 34579999
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcC-CCCeeecCCCcccc
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLARA 429 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DFGlar~ 429 (430)
||+++|+|.++|... ..+++..+..++.||+.||+|||+++ ++||||||||+||||+. ++.+||+|||+|+.
T Consensus 109 Ey~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~ 181 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp ECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred eCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence 999999999999653 45899999999999999999999875 45999999999999974 78999999999984
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=276.54 Aligned_cols=142 Identities=27% Similarity=0.364 Sum_probs=128.3
Q ss_pred cCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEc
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 355 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 355 (430)
.+.|++.++||+|+||.||+|+.. +++.||||++.... ...+|+.++++++|||||++++++.+++..||||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 356888999999999999999974 48999999997522 124699999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCC-CeeecCCCcccc
Q 047619 356 VPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLARA 429 (430)
Q Consensus 356 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DFGlar~ 429 (430)
++||+|.++|... ..+++..+..++.||+.||+|||+++ ||||||||+||||+.++ .+||+|||+|+.
T Consensus 132 ~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~ 200 (336)
T 4g3f_A 132 LEGGSLGQLIKQM---GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALC 200 (336)
T ss_dssp CTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEE
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeE
Confidence 9999999999653 35999999999999999999999998 99999999999999987 699999999985
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=277.78 Aligned_cols=146 Identities=27% Similarity=0.348 Sum_probs=126.5
Q ss_pred CCcccceeecccCCcceEEEEEc----CCcEEEEEEeccc--ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 351 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 351 (430)
++|++.+.||+|+||+||+|+.. .++.||||++.+. .......+.+|+.+|++++|||||++++++.+++..||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999853 3679999999752 22334568899999999999999999999999999999
Q ss_pred EEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 352 IYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 352 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||||++||+|.++|... ..+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.
T Consensus 104 vmEy~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~ 175 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKE 175 (304)
T ss_dssp EECCCTTCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC
T ss_pred EEEcCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEeccccccee
Confidence 99999999999999653 35899999999999999999999998 99999999999999999999999999985
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-34 Score=269.06 Aligned_cols=146 Identities=25% Similarity=0.405 Sum_probs=124.6
Q ss_pred CCcccceeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCC----EEEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE----EKLLIY 353 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~ 353 (430)
++|.+.++||+|+||.||+|++ +++.||||++.... .......+|+..+.+++|||||++++++.+++ .++|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 4578889999999999999987 68999999997532 22223345666777899999999999998764 579999
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhc-----CCCcEEeCCCCCCcEEEcCCCCeeecCCCccc
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD-----SRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~-----~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar 428 (430)
||+++|+|.++|... .+++..+..++.|++.||+|||++ +.++||||||||+||||+.++.+||+|||+|+
T Consensus 81 Ey~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 999999999999643 489999999999999999999986 12349999999999999999999999999997
Q ss_pred c
Q 047619 429 A 429 (430)
Q Consensus 429 ~ 429 (430)
.
T Consensus 157 ~ 157 (303)
T 3hmm_A 157 R 157 (303)
T ss_dssp E
T ss_pred c
Confidence 4
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=271.39 Aligned_cols=159 Identities=28% Similarity=0.463 Sum_probs=136.4
Q ss_pred cHHhHHhhcCCcccceeecccCCcceEEEEEcC------CcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCC-CcccceE
Q 047619 269 ELATIANATDNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQH-RNLVKLL 340 (430)
Q Consensus 269 ~~~~~~~~~~~~~~~~~ig~G~fg~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h-~niv~l~ 340 (430)
+....+...++|++.++||+|+||.||+|.+.. ++.||||++... .....+.+.+|+.+|.++.| ||||+++
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 344455667899999999999999999998643 368999999753 34556789999999999965 8999999
Q ss_pred EEEEeC-CEEEEEEEccCCCChhHHhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCC
Q 047619 341 GCCIQG-EEKLLIYEFVPNKSLDSFIFDQER-------------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDL 406 (430)
Q Consensus 341 ~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dl 406 (430)
++|.++ +.++|||||+++|+|.++|..... ...+++.++..++.||+.||+|||+++ ||||||
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDL 211 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 211 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCcc
Confidence 999765 568999999999999999965321 245899999999999999999999998 999999
Q ss_pred CCCcEEEcCCCCeeecCCCccccC
Q 047619 407 KASNVLLDQDMNPKISDFGLARAF 430 (430)
Q Consensus 407 kp~NILl~~~~~~kl~DFGlar~~ 430 (430)
||+||||++++.+||+|||+||.+
T Consensus 212 K~~NILl~~~~~vKi~DFGlar~~ 235 (353)
T 4ase_A 212 AARNILLSEKNVVKICDFGLARDI 235 (353)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCT
T ss_pred CccceeeCCCCCEEECcchhhhhc
Confidence 999999999999999999999853
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.9e-32 Score=267.37 Aligned_cols=147 Identities=25% Similarity=0.488 Sum_probs=130.4
Q ss_pred cCCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc--ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeC------C
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG------E 347 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 347 (430)
.++|++.+.||+|+||.||+|... +++.||||++.+. .....+.+.+|+.+|+.++|||||++++++... +
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 468999999999999999999964 5899999999752 344567788999999999999999999997643 5
Q ss_pred EEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcc
Q 047619 348 EKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427 (430)
Q Consensus 348 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla 427 (430)
.+||||||++ |+|.+++... ..+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~---~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSS---QPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSS---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEeCCC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeeccee
Confidence 7899999996 6799998543 45999999999999999999999998 999999999999999999999999999
Q ss_pred ccC
Q 047619 428 RAF 430 (430)
Q Consensus 428 r~~ 430 (430)
+.+
T Consensus 206 ~~~ 208 (398)
T 4b99_A 206 RGL 208 (398)
T ss_dssp BCC
T ss_pred eec
Confidence 853
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.8e-32 Score=263.63 Aligned_cols=147 Identities=24% Similarity=0.399 Sum_probs=130.7
Q ss_pred hHHhhcCCcccceeecccCCcceEEEEEc----CCcEEEEEEecccChHhHHHHHHHHHHHhcC-CCCcccceEEEEEeC
Q 047619 272 TIANATDNFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG 346 (430)
Q Consensus 272 ~~~~~~~~~~~~~~ig~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 346 (430)
.++...++|++.++||+|+||.||+|+.+ .++.||+|++.+.. ...++.+|+++|+.+ +|||||++++++.+.
T Consensus 15 ~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~ 92 (361)
T 4f9c_A 15 AVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKN 92 (361)
T ss_dssp HSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred hcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence 34456688999999999999999999853 36789999986532 345678999999998 699999999999999
Q ss_pred CEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCC-CCeeecCCC
Q 047619 347 EEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFG 425 (430)
Q Consensus 347 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DFG 425 (430)
+..+|||||+++++|.+++. .+++.++..++.||+.||+|||+++ |+||||||+||||+.+ +.+||+|||
T Consensus 93 ~~~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFG 163 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFG 163 (361)
T ss_dssp TEEEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred CEEEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCC
Confidence 99999999999999999982 3889999999999999999999998 9999999999999877 799999999
Q ss_pred cccc
Q 047619 426 LARA 429 (430)
Q Consensus 426 lar~ 429 (430)
+|+.
T Consensus 164 la~~ 167 (361)
T 4f9c_A 164 LAQG 167 (361)
T ss_dssp TCEE
T ss_pred CCcc
Confidence 9974
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=274.78 Aligned_cols=149 Identities=25% Similarity=0.337 Sum_probs=129.9
Q ss_pred hcCCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc------ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI------SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 348 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 348 (430)
..++|++.+.||+|+||.||+|+.. +++.||||++.+. ........+.++.+++.++|||||++++++.+.+.
T Consensus 187 slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ 266 (689)
T 3v5w_A 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 266 (689)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred chHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCE
Confidence 3468999999999999999999975 4899999999642 11122233445677888999999999999999999
Q ss_pred EEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCccc
Q 047619 349 KLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428 (430)
Q Consensus 349 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar 428 (430)
+||||||++||+|.++|... ..+++..+..++.||+.||+|||+++ ||||||||+||||+.+|.+||+|||+|+
T Consensus 267 lylVmEy~~GGdL~~~l~~~---~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 267 LSFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp EEEEECCCCSCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceee
Confidence 99999999999999999653 45899999999999999999999998 9999999999999999999999999998
Q ss_pred cC
Q 047619 429 AF 430 (430)
Q Consensus 429 ~~ 430 (430)
.+
T Consensus 341 ~~ 342 (689)
T 3v5w_A 341 DF 342 (689)
T ss_dssp EC
T ss_pred ec
Confidence 53
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-31 Score=271.74 Aligned_cols=149 Identities=26% Similarity=0.441 Sum_probs=135.8
Q ss_pred cCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEc
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 355 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 355 (430)
.++|++.+.||+|+||.||+|... +++.||+|++........+.+.+|+.+|+.++|||||++++++.+.+.++|||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 368999999999999999999975 5899999999876666778899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCC--CCeeecCCCccccC
Q 047619 356 VPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQD--MNPKISDFGLARAF 430 (430)
Q Consensus 356 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~--~~~kl~DFGlar~~ 430 (430)
++||+|.++|... ...+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+.+
T Consensus 236 ~~gg~L~~~i~~~--~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~ 307 (573)
T 3uto_A 236 MSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 307 (573)
T ss_dssp CCCCBHHHHHTCT--TSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEEC
T ss_pred cCCCcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEc
Confidence 9999999998543 245899999999999999999999998 9999999999999854 89999999999853
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-28 Score=234.94 Aligned_cols=148 Identities=30% Similarity=0.516 Sum_probs=137.1
Q ss_pred cCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEc
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 355 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 355 (430)
.++|.+.+.||+|+||.||+|... +++.||+|++........+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 367999999999999999999975 4889999999877777888999999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 356 VPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 356 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+++++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 89 ~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 157 (310)
T 3s95_A 89 IKGGTLRGIIKSMD--SQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARL 157 (310)
T ss_dssp CTTCBHHHHHHHCC--TTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEE
T ss_pred cCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeeccccee
Confidence 99999999996532 45899999999999999999999998 99999999999999999999999999974
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.96 E-value=4.4e-29 Score=239.71 Aligned_cols=148 Identities=31% Similarity=0.489 Sum_probs=135.3
Q ss_pred hcCCcccceeecccCCcceEEEEE-cCCcEEEEEEeccc--ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 352 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 352 (430)
..++|++.+.||+|+||.||+|.. .+++.||||++.+. .....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 457899999999999999999997 56899999998653 455677889999999999999999999999999999999
Q ss_pred EEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 353 YEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 353 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 93 ~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 163 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAH---GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNE 163 (328)
T ss_dssp ECCCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGG
T ss_pred EECCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCcee
Confidence 9999999999998654 34899999999999999999999998 99999999999999999999999999974
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.5e-29 Score=237.75 Aligned_cols=151 Identities=26% Similarity=0.423 Sum_probs=133.0
Q ss_pred hcCCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCC------
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE------ 347 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 347 (430)
..++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.++++++||||+++++++.+..
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 3467999999999999999999975 6899999998643 3345678999999999999999999999987654
Q ss_pred ---------------------------------------------------EEEEEEEccCCCChhHHhhcCCCCCCCCH
Q 047619 348 ---------------------------------------------------EKLLIYEFVPNKSLDSFIFDQERCKILDW 376 (430)
Q Consensus 348 ---------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~ 376 (430)
..++||||+++++|.+++.........++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 37999999999999999987666566777
Q ss_pred HHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 377 SKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 377 ~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 213 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTA 213 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccc
Confidence 788999999999999999998 99999999999999999999999999874
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-28 Score=233.18 Aligned_cols=147 Identities=24% Similarity=0.486 Sum_probs=134.5
Q ss_pred hcCCcccceeecccCCcceEEEEE-cCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 354 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 354 (430)
..++|++.+.||+|+||.||+|.. .+++.||+|++........+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 456899999999999999999985 4589999999876555556788999999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 355 FVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 355 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|+++++|.+++... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 98 ~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (297)
T 3fxz_A 98 YLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQ 165 (297)
T ss_dssp CCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CCCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCcee
Confidence 99999999999543 4889999999999999999999998 99999999999999999999999999864
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.1e-29 Score=239.09 Aligned_cols=156 Identities=40% Similarity=0.750 Sum_probs=141.2
Q ss_pred HhHHhhcCCcccceeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEE
Q 047619 271 ATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 350 (430)
Q Consensus 271 ~~~~~~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 350 (430)
.++....++|++.+.||+|+||.||+|...+++.||||++........+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 32 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 111 (321)
T 2qkw_B 32 VDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMI 111 (321)
T ss_dssp SCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCE
T ss_pred HHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence 34455778999999999999999999998889999999988766667788999999999999999999999999999999
Q ss_pred EEEEccCCCChhHHhhcCCC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 351 LIYEFVPNKSLDSFIFDQER-CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 351 lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+||||+++++|.+++..... ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+.
T Consensus 112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 188 (321)
T 2qkw_B 112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKK 188 (321)
T ss_dssp EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEE
T ss_pred EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecccccc
Confidence 99999999999999865432 235899999999999999999999998 99999999999999999999999999864
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.4e-29 Score=248.37 Aligned_cols=155 Identities=19% Similarity=0.253 Sum_probs=136.6
Q ss_pred HHhHHhhcCCcccceeecccCCcceEEEEEcC-CcEEEEEEecccC---hHhHHHHHHHHHHHhcCCCCcccceEEEEEe
Q 047619 270 LATIANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQ 345 (430)
Q Consensus 270 ~~~~~~~~~~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 345 (430)
+.++....++|++.++||+|+||.||+|+... ++.||+|++.+.. ......+.+|+.++..++||||+++++++.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 44555667899999999999999999999765 7899999997521 1223348899999999999999999999999
Q ss_pred CCEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCC
Q 047619 346 GEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 425 (430)
Q Consensus 346 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFG 425 (430)
.+..+|||||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchh
Confidence 99999999999999999999653 245899999999999999999999998 9999999999999999999999999
Q ss_pred cccc
Q 047619 426 LARA 429 (430)
Q Consensus 426 lar~ 429 (430)
+|+.
T Consensus 221 la~~ 224 (437)
T 4aw2_A 221 SCLK 224 (437)
T ss_dssp TCEE
T ss_pred hhhh
Confidence 9974
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-28 Score=236.94 Aligned_cols=147 Identities=23% Similarity=0.331 Sum_probs=133.1
Q ss_pred cCCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc---ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEE
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 352 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 352 (430)
.++|++.+.||+|+||.||+|... +++.||+|++.+. .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 367999999999999999999975 5899999999752 233466788999999999999999999999999999999
Q ss_pred EEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 353 YEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 353 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|||+++++|..++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.
T Consensus 84 ~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 154 (337)
T 1o6l_A 84 MEYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKE 154 (337)
T ss_dssp EECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhh
Confidence 9999999999998643 35899999999999999999999998 99999999999999999999999999974
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.7e-29 Score=246.26 Aligned_cols=153 Identities=20% Similarity=0.259 Sum_probs=135.2
Q ss_pred HHhHHhhcCCcccceeecccCCcceEEEEEcC-CcEEEEEEecccC---hHhHHHHHHHHHHHhcCCCCcccceEEEEEe
Q 047619 270 LATIANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQ 345 (430)
Q Consensus 270 ~~~~~~~~~~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 345 (430)
+..+....++|++.+.||+|+||.||+|+... ++.||+|++.+.. ....+.+.+|+.++..++||||+++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 44555567899999999999999999999754 8899999986521 1223457889999999999999999999999
Q ss_pred CCEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCC
Q 047619 346 GEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 425 (430)
Q Consensus 346 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFG 425 (430)
.+..+|||||+++|+|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG 213 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG 213 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccc
Confidence 99999999999999999998542 4889999999999999999999998 9999999999999999999999999
Q ss_pred cccc
Q 047619 426 LARA 429 (430)
Q Consensus 426 lar~ 429 (430)
+|+.
T Consensus 214 ~a~~ 217 (410)
T 3v8s_A 214 TCMK 217 (410)
T ss_dssp TCEE
T ss_pred eeEe
Confidence 9974
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.1e-29 Score=237.04 Aligned_cols=165 Identities=45% Similarity=0.763 Sum_probs=143.9
Q ss_pred CCcccHHhHHhhcCCcccceeecccCCcceEEEEEcCCcEEEEEEecccC-hHhHHHHHHHHHHHhcCCCCcccceEEEE
Q 047619 265 LPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCC 343 (430)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 343 (430)
+..+++.++....++|++.+.||+|+||.||+|...+++.||||++.... ......+.+|+.+++.++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 34567788899999999999999999999999998789999999997532 22334688999999999999999999999
Q ss_pred EeCCEEEEEEEccCCCChhHHhhcCCC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeec
Q 047619 344 IQGEEKLLIYEFVPNKSLDSFIFDQER-CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 422 (430)
Q Consensus 344 ~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~ 422 (430)
...+..++||||+++++|.+++..... ...+++..+..++.|++.||.|||+....+|+||||||+|||++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 999999999999999999999976532 3458999999999999999999999821229999999999999999999999
Q ss_pred CCCcccc
Q 047619 423 DFGLARA 429 (430)
Q Consensus 423 DFGlar~ 429 (430)
|||+|+.
T Consensus 177 Dfg~~~~ 183 (326)
T 3uim_A 177 DFGLAKL 183 (326)
T ss_dssp CCSSCEE
T ss_pred cCccccc
Confidence 9999974
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.3e-29 Score=245.04 Aligned_cols=156 Identities=20% Similarity=0.260 Sum_probs=137.5
Q ss_pred cHHhHHhhcCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccC---hHhHHHHHHHHHHHhcCCCCcccceEEEEE
Q 047619 269 ELATIANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCI 344 (430)
Q Consensus 269 ~~~~~~~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 344 (430)
.+.+.....++|++.+.||+|+||.||+|+.. +++.||||++.+.. ....+.+.+|..++..++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 34455566789999999999999999999975 58999999997521 223445889999999999999999999999
Q ss_pred eCCEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCC
Q 047619 345 QGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDF 424 (430)
Q Consensus 345 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DF 424 (430)
+.+..+|||||+++|+|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+||
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DF 206 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADF 206 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeec
Confidence 9999999999999999999996532 35899999999999999999999998 999999999999999999999999
Q ss_pred Ccccc
Q 047619 425 GLARA 429 (430)
Q Consensus 425 Glar~ 429 (430)
|+|+.
T Consensus 207 Gla~~ 211 (412)
T 2vd5_A 207 GSCLK 211 (412)
T ss_dssp TTCEE
T ss_pred hhhee
Confidence 99974
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-28 Score=237.97 Aligned_cols=148 Identities=30% Similarity=0.451 Sum_probs=132.4
Q ss_pred hcCCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc---ChHhHHHHHHHHHHHhcC-CCCcccceEEEEEeCCEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKL 350 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 350 (430)
..++|++.+.||+|+||.||+|+.. +++.||||++.+. .....+.+.+|..++..+ +||||+++++++.+.+..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 4478999999999999999999975 4889999999752 234456788999999988 7999999999999999999
Q ss_pred EEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 351 LIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 351 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+||||+++++|..++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.
T Consensus 101 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~ 173 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKS---RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKE 173 (353)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceee
Confidence 999999999999999653 34899999999999999999999998 99999999999999999999999999974
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.5e-28 Score=232.75 Aligned_cols=143 Identities=29% Similarity=0.452 Sum_probs=131.7
Q ss_pred cccceeecccCCcceEEEEEc-CCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEccCC
Q 047619 280 FSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPN 358 (430)
Q Consensus 280 ~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 358 (430)
|...+.||+|+||.||+|... +++.||||++........+.+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 126 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG 126 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCC
Confidence 677789999999999999976 6899999999765556677899999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 359 KSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 359 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 127 ~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 190 (321)
T 2c30_A 127 GALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQ 190 (321)
T ss_dssp CBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeee
Confidence 999999843 34899999999999999999999998 99999999999999999999999999874
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=5.6e-28 Score=231.37 Aligned_cols=148 Identities=22% Similarity=0.334 Sum_probs=133.3
Q ss_pred hcCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 354 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 354 (430)
..++|++.+.||+|+||.||+|... +++.+|+|.+.. .......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC-CTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEec-CcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 3578999999999999999999975 478999999875 34456678999999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcC--CCCeeecCCCcccc
Q 047619 355 FVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ--DMNPKISDFGLARA 429 (430)
Q Consensus 355 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~--~~~~kl~DFGlar~ 429 (430)
|+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||+|+.
T Consensus 82 ~~~g~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~ 153 (321)
T 1tki_A 82 FISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQ 153 (321)
T ss_dssp CCCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred eCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeE
Confidence 99999999999543 235899999999999999999999998 999999999999987 78999999999975
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.2e-28 Score=229.27 Aligned_cols=148 Identities=28% Similarity=0.456 Sum_probs=134.5
Q ss_pred hcCCcccceeecccCCcceEEEEEc-CCcEEEEEEecc---cChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 351 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 351 (430)
..++|++.+.||+|+||.||+|... +++.||+|++.. ......+.+.+|+.++.+++||||+++++++.+.+..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 3578999999999999999999864 588999999853 244556789999999999999999999999999999999
Q ss_pred EEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 352 IYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 352 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 89 v~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 160 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIESH---GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKA 160 (294)
T ss_dssp EEECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTT
T ss_pred EEeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccc
Confidence 99999999999999643 35899999999999999999999998 99999999999999999999999999975
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.3e-28 Score=233.33 Aligned_cols=148 Identities=29% Similarity=0.524 Sum_probs=133.5
Q ss_pred cCCcccceeecccCCcceEEEEEc----CCcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEE
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 351 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 351 (430)
.++|++.+.||+|+||.||+|... .+..||||++... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 467999999999999999999974 3456999999753 45566789999999999999999999999999999999
Q ss_pred EEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 352 IYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 352 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+||||+.++.+||+|||+|+.
T Consensus 128 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHD--GQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRV 200 (325)
T ss_dssp EEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred EeeCCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccc
Confidence 999999999999996442 35899999999999999999999998 99999999999999999999999999975
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3e-28 Score=237.81 Aligned_cols=151 Identities=32% Similarity=0.552 Sum_probs=133.7
Q ss_pred hcCCcccceeecccCCcceEEEEEc--------CCcEEEEEEeccc-ChHhHHHHHHHHHHHhcC-CCCcccceEEEEEe
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV--------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQ 345 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 345 (430)
..++|++.+.||+|+||.||+|... ++..||||++... .....+.+.+|+.+++++ +||||+++++++.+
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 3468999999999999999999853 2457999999753 445567899999999999 89999999999999
Q ss_pred CCEEEEEEEccCCCChhHHhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEE
Q 047619 346 GEEKLLIYEFVPNKSLDSFIFDQER-------------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVL 412 (430)
Q Consensus 346 ~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NIL 412 (430)
.+..++||||+++++|.+++..... ...+++..+..++.||+.||+|||+++ |+||||||+|||
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIl 235 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 235 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEE
Confidence 9999999999999999999975431 234789999999999999999999998 999999999999
Q ss_pred EcCCCCeeecCCCcccc
Q 047619 413 LDQDMNPKISDFGLARA 429 (430)
Q Consensus 413 l~~~~~~kl~DFGlar~ 429 (430)
|+.++.+||+|||+|+.
T Consensus 236 l~~~~~~kl~DFG~a~~ 252 (370)
T 2psq_A 236 VTENNVMKIADFGLARD 252 (370)
T ss_dssp ECTTCCEEECCCSSCEE
T ss_pred ECCCCCEEEccccCCcc
Confidence 99999999999999974
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=2.8e-28 Score=233.05 Aligned_cols=147 Identities=27% Similarity=0.413 Sum_probs=132.8
Q ss_pred cCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccC---hHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEE
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 352 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 352 (430)
.++|++.+.||+|+||.||+|... +++.||+|++.+.. ....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 367999999999999999999975 58999999997521 23456788999999999999999999999999999999
Q ss_pred EEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 353 YEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 353 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|||+++++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.
T Consensus 85 ~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~ 155 (318)
T 1fot_A 85 MDYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKY 155 (318)
T ss_dssp ECCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EeCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCccee
Confidence 9999999999999653 34899999999999999999999988 99999999999999999999999999974
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-28 Score=227.85 Aligned_cols=147 Identities=27% Similarity=0.512 Sum_probs=134.0
Q ss_pred cCCcccceeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEcc
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFV 356 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 356 (430)
.++|++.+.||+|+||.||+|...+++.||+|++... ....+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccc-ccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 4679999999999999999999888899999999753 234567899999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 357 PNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 357 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 88 ~~~~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 155 (269)
T 4hcu_A 88 EHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRF 155 (269)
T ss_dssp TTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGG
T ss_pred CCCcHHHHHHhcC--cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccc
Confidence 9999999996533 45899999999999999999999998 99999999999999999999999999974
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6.1e-28 Score=234.64 Aligned_cols=148 Identities=30% Similarity=0.416 Sum_probs=132.9
Q ss_pred hcCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccCh------HhHHHHHHHHHHHhcCCCCcccceEEEEEeCCE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISE------QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 348 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 348 (430)
..+.|++.+.||+|+||.||+|... +++.||+|++.+... ...+.+.+|+.++++++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 4568999999999999999999975 489999999975322 135789999999999999999999999999999
Q ss_pred EEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCC----CeeecCC
Q 047619 349 KLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDM----NPKISDF 424 (430)
Q Consensus 349 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~----~~kl~DF 424 (430)
.++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTC---SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 99999999999999999543 45899999999999999999999998 99999999999998776 7999999
Q ss_pred Ccccc
Q 047619 425 GLARA 429 (430)
Q Consensus 425 Glar~ 429 (430)
|+|+.
T Consensus 164 G~a~~ 168 (361)
T 2yab_A 164 GLAHE 168 (361)
T ss_dssp SSCEE
T ss_pred CCceE
Confidence 99974
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.9e-28 Score=238.53 Aligned_cols=147 Identities=26% Similarity=0.401 Sum_probs=133.2
Q ss_pred cCCcccceeecccCCcceEEEEEcC-CcEEEEEEeccc---ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEE
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 352 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 352 (430)
.++|++.+.||+|+||.||+|.... ++.||+|++.+. .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 4689999999999999999999654 889999998652 233457788999999999999999999999999999999
Q ss_pred EEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 353 YEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 353 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|||+++++|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+|+.
T Consensus 94 ~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 164 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQN---VHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAM 164 (384)
T ss_dssp ECCCTTEEHHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeee
Confidence 9999999999999643 35899999999999999999999998 99999999999999999999999999974
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.6e-28 Score=233.90 Aligned_cols=153 Identities=30% Similarity=0.537 Sum_probs=133.2
Q ss_pred hhcCCcccceeecccCCcceEEEEEcCCcEEEEEEeccc--ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEE
Q 047619 275 NATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 352 (430)
Q Consensus 275 ~~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 352 (430)
...++|++.+.||+|+||.||+|.. .++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV 112 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEE
T ss_pred CChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEE
Confidence 3456899999999999999999986 6889999998753 345567899999999999999999999999999999999
Q ss_pred EEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 353 YEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 353 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|||+++++|.+++........+++..++.++.|++.||+|||+.+ .+|+||||||+|||++.++.+||+|||+|+.
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 113 TEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188 (309)
T ss_dssp EECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred EecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence 999999999999976543345899999999999999999999875 3499999999999999999999999999864
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6.5e-28 Score=229.03 Aligned_cols=162 Identities=41% Similarity=0.716 Sum_probs=143.9
Q ss_pred CCCcccHHhHHhhcCCcccc------eeecccCCcceEEEEEcCCcEEEEEEeccc----ChHhHHHHHHHHHHHhcCCC
Q 047619 264 ELPLFELATIANATDNFSIN------NKLGEGGFGPVYKGTLVDGQEIAVKRLSKI----SEQGLKELKNEVILFSKLQH 333 (430)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~------~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h 333 (430)
..+.+.+.++...+++|... +.||+|+||.||+|.. +++.||+|++... .....+.+.+|+.++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 44567788888888888766 8999999999999986 6889999998642 23456789999999999999
Q ss_pred CcccceEEEEEeCCEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEE
Q 047619 334 RNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLL 413 (430)
Q Consensus 334 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl 413 (430)
|||+++++++.+.+..++||||+++++|.+++........+++..+..++.|++.||.|||+.+ |+||||||+|||+
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence 9999999999999999999999999999999976544556899999999999999999999998 9999999999999
Q ss_pred cCCCCeeecCCCcccc
Q 047619 414 DQDMNPKISDFGLARA 429 (430)
Q Consensus 414 ~~~~~~kl~DFGlar~ 429 (430)
+.++.+||+|||+|+.
T Consensus 167 ~~~~~~kl~Dfg~~~~ 182 (307)
T 2nru_A 167 DEAFTAKISDFGLARA 182 (307)
T ss_dssp CTTCCEEECCCTTCEE
T ss_pred cCCCcEEEeecccccc
Confidence 9999999999999864
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.4e-28 Score=233.05 Aligned_cols=148 Identities=30% Similarity=0.424 Sum_probs=130.8
Q ss_pred hcCCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 353 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 353 (430)
..++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 3478999999999999999999975 5889999998643 2233467889999999999999999999999999999999
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 85 e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 154 (323)
T 3tki_A 85 EYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATV 154 (323)
T ss_dssp ECCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EcCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccce
Confidence 999999999998433 45899999999999999999999998 99999999999999999999999999974
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.6e-28 Score=234.78 Aligned_cols=150 Identities=27% Similarity=0.407 Sum_probs=132.4
Q ss_pred HhhcCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccC---hHhHHHHHHHHHHHhcC-CCCcccceEEEEEeCCE
Q 047619 274 ANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEE 348 (430)
Q Consensus 274 ~~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 348 (430)
....++|.+.+.||+|+||.||+|+.. +++.||||++.+.. ....+.+.+|..++..+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 345678999999999999999999975 48899999997521 23456788899999876 89999999999999999
Q ss_pred EEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCccc
Q 047619 349 KLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428 (430)
Q Consensus 349 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar 428 (430)
.++||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~ 166 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK 166 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhh
Confidence 99999999999999999643 34899999999999999999999998 9999999999999999999999999997
Q ss_pred c
Q 047619 429 A 429 (430)
Q Consensus 429 ~ 429 (430)
.
T Consensus 167 ~ 167 (345)
T 1xjd_A 167 E 167 (345)
T ss_dssp C
T ss_pred h
Confidence 4
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.5e-28 Score=234.32 Aligned_cols=147 Identities=25% Similarity=0.385 Sum_probs=132.8
Q ss_pred cCCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc---ChHhHHHHHHHHHHHhcC-CCCcccceEEEEEeCCEEEE
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLL 351 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 351 (430)
.++|++.+.||+|+||.||+|+.. +++.||+|++.+. .....+.+.+|+.++.++ +||||+++++++.+.+..++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 357999999999999999999975 4889999999753 344567788999999988 89999999999999999999
Q ss_pred EEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 352 IYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 352 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||||+++++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.
T Consensus 88 v~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~ 159 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE 159 (345)
T ss_dssp EECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBC
T ss_pred EEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecccccc
Confidence 99999999999998643 34899999999999999999999998 99999999999999999999999999974
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=4.3e-28 Score=234.85 Aligned_cols=147 Identities=26% Similarity=0.316 Sum_probs=133.2
Q ss_pred cCCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc---ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEE
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 352 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 352 (430)
.++|++.+.||+|+||.||+|... +++.||+|++.+. .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 368999999999999999999975 5899999998652 223456788999999999999999999999999999999
Q ss_pred EEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 353 YEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 353 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|||+++++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.
T Consensus 120 ~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~ 190 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR 190 (350)
T ss_dssp EECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEccccccee
Confidence 9999999999999653 34899999999999999999999998 99999999999999999999999999974
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.5e-28 Score=239.83 Aligned_cols=148 Identities=24% Similarity=0.383 Sum_probs=130.7
Q ss_pred hcCCcccceeecccCCcceEEEEEcC-CcEEEEEEeccc---ChHhHHHHHHHHHHHhcC-CCCcccceEEEEEeCCEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKL 350 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 350 (430)
..++|++.+.||+|+||.||+|+... ++.||+|++.+. .....+.+.+|..++.++ +||||+++++++.+.+..+
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 34679999999999999999999754 789999999753 233345678899999887 8999999999999999999
Q ss_pred EEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 351 LIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 351 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|||||+++++|..++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.
T Consensus 130 lV~E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~ 202 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE 202 (396)
T ss_dssp EEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEcCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeee
Confidence 999999999999998653 35899999999999999999999998 99999999999999999999999999974
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.5e-28 Score=230.36 Aligned_cols=150 Identities=32% Similarity=0.463 Sum_probs=132.0
Q ss_pred HhhcCCcccceeecccCCcceEEEEEcCCcEEEEEEeccc--ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEE
Q 047619 274 ANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 351 (430)
Q Consensus 274 ~~~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 351 (430)
+...++|++.++||+|+||.||+|...+++.||+|++... .......+.+|+.++++++||||+++++++.+.+..++
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 96 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTL 96 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEE
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEE
Confidence 3456789999999999999999999888999999998643 22335678899999999999999999999999999999
Q ss_pred EEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 352 IYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 352 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||||+++ +|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 97 v~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 168 (311)
T 3niz_A 97 VFEFMEK-DLKKVLDENK--TGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARA 168 (311)
T ss_dssp EEECCSE-EHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEcCCCC-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCcee
Confidence 9999985 7888775433 45899999999999999999999998 99999999999999999999999999974
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=3e-28 Score=238.04 Aligned_cols=148 Identities=30% Similarity=0.540 Sum_probs=128.9
Q ss_pred cCCcccceeecccCCcceEEEEEc----CCcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEE
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 351 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 351 (430)
.++|++.+.||+|+||.||+|... .+..||||++... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 357999999999999999999864 4678999999753 45566789999999999999999999999999999999
Q ss_pred EEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 352 IYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 352 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||||+++++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 124 v~e~~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRV 196 (373)
T ss_dssp EEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccc
Confidence 99999999999999653 245899999999999999999999998 99999999999999999999999999975
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-27 Score=234.04 Aligned_cols=149 Identities=26% Similarity=0.381 Sum_probs=134.4
Q ss_pred hcCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 354 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 354 (430)
..++|++.+.||+|+||.||+|... +++.+|+|++..........+.+|+.+++.++||||+++++++.+....++|||
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E 128 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence 3468999999999999999999875 588999999987666667789999999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcC--CCCeeecCCCcccc
Q 047619 355 FVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ--DMNPKISDFGLARA 429 (430)
Q Consensus 355 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~--~~~~kl~DFGlar~ 429 (430)
|+++++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+|+.
T Consensus 129 ~~~gg~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~ 200 (387)
T 1kob_A 129 FLSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATK 200 (387)
T ss_dssp CCCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred cCCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEeccccee
Confidence 99999999998543 235899999999999999999999998 999999999999974 46799999999975
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.2e-28 Score=225.74 Aligned_cols=148 Identities=30% Similarity=0.487 Sum_probs=134.4
Q ss_pred hcCCcccceeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEc
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 355 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 355 (430)
..++|++.+.||+|+||.||+|...++..||+|++... ....+++.+|+.++.+++||||+++++++.+....++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEG-SMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBT-TBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccC-CCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 34689999999999999999999888889999999753 23456789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 356 VPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 356 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 85 ~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~ 153 (268)
T 3sxs_A 85 ISNGCLLNYLRSHG--KGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRY 153 (268)
T ss_dssp CTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEE
T ss_pred cCCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCcccee
Confidence 99999999996532 35899999999999999999999998 99999999999999999999999999874
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-27 Score=225.29 Aligned_cols=146 Identities=27% Similarity=0.453 Sum_probs=128.7
Q ss_pred CCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc--ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 354 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 354 (430)
++|++.+.||+|+||.||+|... +++.||+|++... .......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57999999999999999999975 4889999998642 33445778899999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 355 FVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 355 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|+++ +|.+.+... ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+.
T Consensus 82 ~~~~-~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~ 150 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARA 150 (292)
T ss_dssp CCSE-EHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred cCCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccccee
Confidence 9986 555555332 245899999999999999999999998 99999999999999999999999999974
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=2.7e-28 Score=230.40 Aligned_cols=149 Identities=31% Similarity=0.572 Sum_probs=133.6
Q ss_pred hcCCcccceeecccCCcceEEEEE-----cCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeC--CE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTL-----VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EE 348 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~ 348 (430)
..++|++.+.||+|+||.||+|.+ .+++.||||++........+.+.+|+.++++++||||+++++++... ..
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 87 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence 346899999999999999999984 35889999999877777788899999999999999999999998654 55
Q ss_pred EEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCccc
Q 047619 349 KLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428 (430)
Q Consensus 349 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar 428 (430)
.++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 88 LKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp CEEEEECCTTCBHHHHHHHCG--GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred eEEEEEeCCCCCHHHHHHhcc--cccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 899999999999999996543 34899999999999999999999998 9999999999999999999999999997
Q ss_pred c
Q 047619 429 A 429 (430)
Q Consensus 429 ~ 429 (430)
.
T Consensus 163 ~ 163 (295)
T 3ugc_A 163 V 163 (295)
T ss_dssp -
T ss_pred c
Confidence 5
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=8e-28 Score=227.59 Aligned_cols=146 Identities=28% Similarity=0.450 Sum_probs=125.7
Q ss_pred cCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccCh--------------------------HhHHHHHHHHHHHh
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISE--------------------------QGLKELKNEVILFS 329 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~ 329 (430)
.++|++.+.||+|+||.||+|... +++.||||++..... ...+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 468999999999999999999864 588999999864321 12356889999999
Q ss_pred cCCCCcccceEEEEEe--CCEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCC
Q 047619 330 KLQHRNLVKLLGCCIQ--GEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLK 407 (430)
Q Consensus 330 ~l~h~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlk 407 (430)
+++||||+++++++.+ ....++||||+++++|.+++. ...+++..+..++.|++.||+|||+++ |+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT----LKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC----SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence 9999999999999987 568899999999999987652 245899999999999999999999998 9999999
Q ss_pred CCcEEEcCCCCeeecCCCcccc
Q 047619 408 ASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 408 p~NILl~~~~~~kl~DFGlar~ 429 (430)
|+|||++.++.+||+|||+|+.
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~ 186 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNE 186 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEE
T ss_pred HHHEEECCCCCEEEecCCCccc
Confidence 9999999999999999999974
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.6e-28 Score=231.97 Aligned_cols=147 Identities=27% Similarity=0.404 Sum_probs=125.5
Q ss_pred cCCcccceeecccCCcceEEEEE----cCCcEEEEEEecccC----hHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCE
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTL----VDGQEIAVKRLSKIS----EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 348 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 348 (430)
.++|++.+.||+|+||.||+|.. .+++.||+|++.+.. ......+.+|+.+++.++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46899999999999999999986 368999999997532 2345668899999999999999999999999999
Q ss_pred EEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCccc
Q 047619 349 KLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428 (430)
Q Consensus 349 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar 428 (430)
.++||||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLERE---GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 99999999999999998643 34889999999999999999999998 9999999999999999999999999987
Q ss_pred c
Q 047619 429 A 429 (430)
Q Consensus 429 ~ 429 (430)
.
T Consensus 170 ~ 170 (327)
T 3a62_A 170 E 170 (327)
T ss_dssp -
T ss_pred c
Confidence 4
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=8.8e-28 Score=229.59 Aligned_cols=151 Identities=28% Similarity=0.432 Sum_probs=133.9
Q ss_pred hcCCcccceeecccCCcceEEEEEcC-CcEEEEEEecccC-hHhHHHHHHHHHHHhcCCCCcccceEEEEEeCC--EEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE--EKLL 351 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~l 351 (430)
..++|.+.+.||+|+||.||+|.... ++.||||++.... ....+.+.+|+.++++++||||+++++++.... ..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence 34679999999999999999999754 8999999997532 344677889999999999999999999998765 7799
Q ss_pred EEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEE----cCCCCeeecCCCcc
Q 047619 352 IYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLL----DQDMNPKISDFGLA 427 (430)
Q Consensus 352 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl----~~~~~~kl~DFGla 427 (430)
||||+++++|.+++........+++..+..++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||+|
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 9999999999999976554455899999999999999999999998 9999999999999 77788999999999
Q ss_pred cc
Q 047619 428 RA 429 (430)
Q Consensus 428 r~ 429 (430)
+.
T Consensus 164 ~~ 165 (319)
T 4euu_A 164 RE 165 (319)
T ss_dssp EE
T ss_pred ee
Confidence 75
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.8e-28 Score=233.20 Aligned_cols=148 Identities=26% Similarity=0.341 Sum_probs=132.6
Q ss_pred hcCCcccceeecccCCcceEEEEEcC-CcEEEEEEeccc---ChHhHHHHHHHHHHHhcC-CCCcccceEEEEEeCCEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKL 350 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 350 (430)
..++|++.+.||+|+||.||+|.... ++.||||++.+. .....+.+.+|..++..+ +||+|+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 44789999999999999999999765 789999999753 223456788999999988 7999999999999999999
Q ss_pred EEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 351 LIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 351 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+||||+++++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.
T Consensus 98 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 170 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE 170 (353)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence 999999999999999643 34899999999999999999999998 99999999999999999999999999974
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.95 E-value=6.2e-28 Score=226.45 Aligned_cols=149 Identities=26% Similarity=0.444 Sum_probs=132.0
Q ss_pred hhcCCcccceeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEE
Q 047619 275 NATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 354 (430)
Q Consensus 275 ~~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 354 (430)
...++|++.+.||+|+||.||++...++..||+|++.... ...+++.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 99 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 99 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence 3456899999999999999999998888899999997532 334678999999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 355 FVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 355 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|+++++|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+.
T Consensus 100 ~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 169 (283)
T 3gen_A 100 YMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRY 169 (283)
T ss_dssp CCTTCBHHHHHHCGG--GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGG
T ss_pred ccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccc
Confidence 999999999996532 35899999999999999999999998 99999999999999999999999999974
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-27 Score=229.25 Aligned_cols=148 Identities=29% Similarity=0.414 Sum_probs=132.4
Q ss_pred hcCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccCh------HhHHHHHHHHHHHhcCCCCcccceEEEEEeCCE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISE------QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 348 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 348 (430)
..+.|.+.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+.++++++||||+++++++.+...
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 3457999999999999999999975 488999999865321 246789999999999999999999999999999
Q ss_pred EEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCC----CeeecCC
Q 047619 349 KLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDM----NPKISDF 424 (430)
Q Consensus 349 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~----~~kl~DF 424 (430)
.++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp EEEEEECCCSCBHHHHHTTS---SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEEcCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 99999999999999999543 45899999999999999999999998 99999999999998877 7999999
Q ss_pred Ccccc
Q 047619 425 GLARA 429 (430)
Q Consensus 425 Glar~ 429 (430)
|+|+.
T Consensus 163 g~a~~ 167 (326)
T 2y0a_A 163 GLAHK 167 (326)
T ss_dssp TTCEE
T ss_pred CCCeE
Confidence 99974
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.1e-28 Score=237.53 Aligned_cols=150 Identities=28% Similarity=0.500 Sum_probs=134.6
Q ss_pred hhcCCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEE
Q 047619 275 NATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 352 (430)
Q Consensus 275 ~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 352 (430)
...++|.+.+.||+|+||.||+|... +++.||||.+... .....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 190 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 190 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence 34568999999999999999999975 6899999998753 344456788999999999999999999999999999999
Q ss_pred EEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 353 YEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 353 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|||+++++|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+.
T Consensus 191 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~ 262 (377)
T 3cbl_A 191 MELVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSRE 262 (377)
T ss_dssp EECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCcee
Confidence 9999999999999643 235899999999999999999999998 99999999999999999999999999874
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.95 E-value=7.1e-28 Score=233.53 Aligned_cols=150 Identities=26% Similarity=0.372 Sum_probs=130.9
Q ss_pred cCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccC-----hHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEE
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-----EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 350 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 350 (430)
.++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 357999999999999999999864 58999999986421 124678999999999999999999999999999999
Q ss_pred EEEEccCCCChhHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCC---eeecCCCc
Q 047619 351 LIYEFVPNKSLDSFIFDQE-RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMN---PKISDFGL 426 (430)
Q Consensus 351 lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~---~kl~DFGl 426 (430)
+||||+++++|.+.+.... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999988875432 2345899999999999999999999998 999999999999987654 99999999
Q ss_pred ccc
Q 047619 427 ARA 429 (430)
Q Consensus 427 ar~ 429 (430)
|+.
T Consensus 180 a~~ 182 (351)
T 3c0i_A 180 AIQ 182 (351)
T ss_dssp CEE
T ss_pred eeE
Confidence 974
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.7e-28 Score=229.06 Aligned_cols=153 Identities=33% Similarity=0.527 Sum_probs=135.1
Q ss_pred HhhcCCcccceeecccCCcceEEEEEc------CCcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeC
Q 047619 274 ANATDNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG 346 (430)
Q Consensus 274 ~~~~~~~~~~~~ig~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 346 (430)
....++|.+.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 98 (314)
T 2ivs_A 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD 98 (314)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Confidence 334578999999999999999999852 3478999999753 455667899999999999999999999999999
Q ss_pred CEEEEEEEccCCCChhHHhhcCCC---------------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCC
Q 047619 347 EEKLLIYEFVPNKSLDSFIFDQER---------------------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRD 405 (430)
Q Consensus 347 ~~~~lv~e~~~~gsL~~~l~~~~~---------------------~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~D 405 (430)
+..++||||+++++|.+++..... ...+++..+..++.||+.||.|||+++ |+|||
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~d 175 (314)
T 2ivs_A 99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRD 175 (314)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccc
Confidence 999999999999999999975432 134889999999999999999999998 99999
Q ss_pred CCCCcEEEcCCCCeeecCCCcccc
Q 047619 406 LKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 406 lkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|||+|||++.++.+||+|||+|+.
T Consensus 176 ikp~NIli~~~~~~kl~Dfg~~~~ 199 (314)
T 2ivs_A 176 LAARNILVAEGRKMKISDFGLSRD 199 (314)
T ss_dssp CSGGGEEEETTTEEEECCCTTCEE
T ss_pred cchheEEEcCCCCEEEcccccccc
Confidence 999999999999999999999874
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=9e-28 Score=229.96 Aligned_cols=145 Identities=32% Similarity=0.539 Sum_probs=128.3
Q ss_pred hcCCcccceeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCC----EEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE----EKLL 351 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~l 351 (430)
..++|++.+.||+|+||.||+|... ++.||||++... ........+|+.++.+++||||+++++++.... ..++
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ-DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG-GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecC-chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 3468999999999999999999875 789999999653 334455677999999999999999999998754 4699
Q ss_pred EEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhc----------CCCcEEeCCCCCCcEEEcCCCCeee
Q 047619 352 IYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD----------SRLRIIHRDLKASNVLLDQDMNPKI 421 (430)
Q Consensus 352 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~----------~~~~iiH~Dlkp~NILl~~~~~~kl 421 (430)
||||+++++|.+++... .+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||
T Consensus 100 v~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL 172 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACI 172 (322)
T ss_dssp EEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEE
T ss_pred EEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEE
Confidence 99999999999999543 389999999999999999999987 6 999999999999999999999
Q ss_pred cCCCcccc
Q 047619 422 SDFGLARA 429 (430)
Q Consensus 422 ~DFGlar~ 429 (430)
+|||+|+.
T Consensus 173 ~DFg~a~~ 180 (322)
T 3soc_A 173 ADFGLALK 180 (322)
T ss_dssp CCCTTCEE
T ss_pred ccCCcccc
Confidence 99999964
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-27 Score=232.10 Aligned_cols=148 Identities=29% Similarity=0.477 Sum_probs=132.4
Q ss_pred hcCCcccceeecccCCcceEEEEEc-CCcEEEEEEecc--cChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 352 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 352 (430)
..++|++.+.||+|+||.||+|... +++.||+|++.. ......+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4467999999999999999999875 488999999964 2445567899999999999999999999999999999999
Q ss_pred EEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCC---CCeeecCCCcccc
Q 047619 353 YEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQD---MNPKISDFGLARA 429 (430)
Q Consensus 353 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~---~~~kl~DFGlar~ 429 (430)
|||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.+ +.+||+|||+|+.
T Consensus 107 ~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp ECCCCSCBHHHHHTTC---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 9999999999998543 45899999999999999999999998 9999999999999765 4599999999975
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.1e-28 Score=234.88 Aligned_cols=159 Identities=28% Similarity=0.475 Sum_probs=137.4
Q ss_pred ccHHhHHhhcCCcccceeecccCCcceEEEEE------cCCcEEEEEEeccc-ChHhHHHHHHHHHHHhcC-CCCcccce
Q 047619 268 FELATIANATDNFSINNKLGEGGFGPVYKGTL------VDGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKL 339 (430)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~ig~G~fg~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l 339 (430)
+.........++|++.+.||+|+||.||+|.+ .+++.||||++... .....+.+.+|+.++.++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 44556666778999999999999999999974 23578999999753 445567899999999999 78999999
Q ss_pred EEEEEeCCE-EEEEEEccCCCChhHHhhcCCC------------------------------------------------
Q 047619 340 LGCCIQGEE-KLLIYEFVPNKSLDSFIFDQER------------------------------------------------ 370 (430)
Q Consensus 340 ~~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------ 370 (430)
++++.+.+. .++||||+++++|.+++.....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 999988654 8999999999999999976432
Q ss_pred ---------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 371 ---------------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 371 ---------------~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
...+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+.
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 242 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARD 242 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSC
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceee
Confidence 122889999999999999999999998 99999999999999999999999999974
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-27 Score=225.17 Aligned_cols=146 Identities=29% Similarity=0.468 Sum_probs=130.9
Q ss_pred CCcccceeecccCCcceEEEEEcCCcEEEEEEecccC--hHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEc
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 355 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 355 (430)
++|++.+.||+|+||.||+|...+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 5799999999999999999998779999999986432 22346788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 356 VPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 356 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+++ +|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+.
T Consensus 82 ~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 149 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARA 149 (288)
T ss_dssp CSE-EHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHH
T ss_pred cCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccc
Confidence 975 8988886432 45889999999999999999999998 99999999999999999999999999863
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.6e-27 Score=232.00 Aligned_cols=146 Identities=25% Similarity=0.345 Sum_probs=130.9
Q ss_pred hcCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 354 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 354 (430)
..++|++.+.||+|+||.||++... +++.||||++.+. ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERG-AAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESS-TTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecC-ccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 4578999999999999999999975 5889999999753 2334678899999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCC--eeecCCCccc
Q 047619 355 FVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMN--PKISDFGLAR 428 (430)
Q Consensus 355 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~--~kl~DFGlar 428 (430)
|+++++|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+||||+.++. +||+|||+|+
T Consensus 97 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~ 166 (361)
T 3uc3_A 97 YASGGELYERICNA---GRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSK 166 (361)
T ss_dssp CCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC-
T ss_pred eCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccc
Confidence 99999999998543 34899999999999999999999998 999999999999987765 9999999987
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=9.1e-28 Score=231.57 Aligned_cols=157 Identities=30% Similarity=0.524 Sum_probs=137.8
Q ss_pred HHhHHhhcCCcccceeecccCCcceEEEEEcC------CcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEE
Q 047619 270 LATIANATDNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGC 342 (430)
Q Consensus 270 ~~~~~~~~~~~~~~~~ig~G~fg~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 342 (430)
+..+....++|++.+.||+|+||.||+|.... ++.||+|++... .....+.+.+|+.++++++||||++++++
T Consensus 39 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 118 (343)
T 1luf_A 39 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 118 (343)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 33445566889999999999999999999743 478999999753 44556789999999999999999999999
Q ss_pred EEeCCEEEEEEEccCCCChhHHhhcCCC---------------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcE
Q 047619 343 CIQGEEKLLIYEFVPNKSLDSFIFDQER---------------------CKILDWSKRFHIICGTARGVMYLHQDSRLRI 401 (430)
Q Consensus 343 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------------~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~i 401 (430)
+.+.+..++||||+++++|.+++..... ...+++..++.++.||+.||.|||+++ |
T Consensus 119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---i 195 (343)
T 1luf_A 119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---F 195 (343)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred EccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 9999999999999999999999975321 146899999999999999999999998 9
Q ss_pred EeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 402 IHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 402 iH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+||||||+|||++.++.+||+|||+|+.
T Consensus 196 vH~Dlkp~NIl~~~~~~~kl~Dfg~~~~ 223 (343)
T 1luf_A 196 VHRDLATRNCLVGENMVVKIADFGLSRN 223 (343)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHH
T ss_pred ecCCCCcceEEECCCCeEEEeecCCCcc
Confidence 9999999999999999999999999863
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.6e-27 Score=232.72 Aligned_cols=149 Identities=19% Similarity=0.269 Sum_probs=135.0
Q ss_pred hcCCcccceeeccc--CCcceEEEEEc-CCcEEEEEEeccc--ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEE
Q 047619 276 ATDNFSINNKLGEG--GFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 350 (430)
Q Consensus 276 ~~~~~~~~~~ig~G--~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 350 (430)
..++|++.+.||+| +||.||+|... +++.||||++... .....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 44689999999999 99999999975 5899999999742 3455678899999999999999999999999999999
Q ss_pred EEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCccc
Q 047619 351 LIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428 (430)
Q Consensus 351 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar 428 (430)
+||||+++++|.+++..... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|.
T Consensus 103 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~ 176 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHFM-DGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNL 176 (389)
T ss_dssp EEEECCTTCBHHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCE
T ss_pred EEEEccCCCCHHHHHhhhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccce
Confidence 99999999999999976432 45899999999999999999999998 9999999999999999999999999875
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.95 E-value=9.5e-28 Score=243.13 Aligned_cols=150 Identities=28% Similarity=0.497 Sum_probs=135.5
Q ss_pred hhcCCcccceeecccCCcceEEEEEcC-CcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEE
Q 047619 275 NATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 353 (430)
Q Consensus 275 ~~~~~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 353 (430)
...++|++.+.||+|+||.||+|.+.. +..||||++... ....+.+.+|+.+|++++||||+++++++...+..+|||
T Consensus 217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 295 (495)
T 1opk_A 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 295 (495)
T ss_dssp CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCc-ccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEE
Confidence 345679999999999999999999765 889999999753 335678999999999999999999999999999999999
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||+++++|.+++..... ..+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.
T Consensus 296 E~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 367 (495)
T 1opk_A 296 EFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRL 367 (495)
T ss_dssp ECCTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEEC
T ss_pred EccCCCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeeccccee
Confidence 99999999999975432 45899999999999999999999998 99999999999999999999999999985
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-27 Score=234.82 Aligned_cols=152 Identities=33% Similarity=0.525 Sum_probs=134.7
Q ss_pred hhcCCcccceeecccCCcceEEEEEc--------CCcEEEEEEeccc-ChHhHHHHHHHHHHHhcC-CCCcccceEEEEE
Q 047619 275 NATDNFSINNKLGEGGFGPVYKGTLV--------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCI 344 (430)
Q Consensus 275 ~~~~~~~~~~~ig~G~fg~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 344 (430)
...++|.+.+.||+|+||.||+|... .+..||||++... .....+.+.+|+++++++ +||||+++++++.
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 34578999999999999999999853 2357999999753 455667899999999999 9999999999999
Q ss_pred eCCEEEEEEEccCCCChhHHhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcE
Q 047619 345 QGEEKLLIYEFVPNKSLDSFIFDQER-------------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNV 411 (430)
Q Consensus 345 ~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NI 411 (430)
..+..++||||+++++|.+++..... ...+++..+..++.||+.||.|||+.+ |+||||||+||
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NI 222 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV 222 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGE
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceE
Confidence 99999999999999999999975431 235899999999999999999999998 99999999999
Q ss_pred EEcCCCCeeecCCCcccc
Q 047619 412 LLDQDMNPKISDFGLARA 429 (430)
Q Consensus 412 Ll~~~~~~kl~DFGlar~ 429 (430)
||+.++.+||+|||+|+.
T Consensus 223 ll~~~~~~kL~DFG~a~~ 240 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARD 240 (382)
T ss_dssp EECTTCCEEECSCSCCCC
T ss_pred EEcCCCcEEEcccCcccc
Confidence 999999999999999974
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.95 E-value=4.6e-28 Score=242.99 Aligned_cols=152 Identities=31% Similarity=0.468 Sum_probs=135.1
Q ss_pred hHHhhcCCcccceeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEE
Q 047619 272 TIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 351 (430)
Q Consensus 272 ~~~~~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 351 (430)
......++|++.+.||+|+||.||+|...++..||||++... ....+.+.+|+.+|++++||||+++++++. .+..++
T Consensus 182 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~l 259 (454)
T 1qcf_A 182 AWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYI 259 (454)
T ss_dssp CSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred ceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCC-CccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEE
Confidence 334556789999999999999999999988899999999753 345778999999999999999999999986 667899
Q ss_pred EEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 352 IYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 352 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||||+++|+|.+++.... ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.
T Consensus 260 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 333 (454)
T 1qcf_A 260 ITEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARV 333 (454)
T ss_dssp EECCCTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGG
T ss_pred EEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceE
Confidence 999999999999996432 234788999999999999999999998 99999999999999999999999999985
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.1e-27 Score=238.66 Aligned_cols=148 Identities=30% Similarity=0.500 Sum_probs=133.7
Q ss_pred hcCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccC---hHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 351 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 351 (430)
..++|.+.+.||+|+||.||+|... +++.||||++.+.. ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 93 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFM 93 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 3468999999999999999999975 68999999996532 2235678999999999999999999999999999999
Q ss_pred EEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 352 IYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 352 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 94 v~E~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~ 165 (476)
T 2y94_A 94 VMEYVSGGELFDYICKN---GRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNM 165 (476)
T ss_dssp EEECCSSEEHHHHTTSS---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred EEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhh
Confidence 99999999999999543 45899999999999999999999988 99999999999999999999999999974
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-27 Score=222.57 Aligned_cols=148 Identities=24% Similarity=0.407 Sum_probs=134.4
Q ss_pred hcCCcccceeecccCCcceEEEEEcC-CcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 354 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 354 (430)
..++|++.+.||+|+||.||+|.... +..+|+|++........+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 45679999999999999999999754 77999999976555667889999999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEE---cCCCCeeecCCCcccc
Q 047619 355 FVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARA 429 (430)
Q Consensus 355 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl---~~~~~~kl~DFGlar~ 429 (430)
|+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||+|+.
T Consensus 87 ~~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~ 158 (277)
T 3f3z_A 87 LCTGGELFERVVHK---RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR 158 (277)
T ss_dssp CCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred ccCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEeccccee
Confidence 99999999988653 34899999999999999999999998 9999999999999 7888999999999864
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-27 Score=243.79 Aligned_cols=150 Identities=27% Similarity=0.373 Sum_probs=134.5
Q ss_pred hcCCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc---ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 351 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 351 (430)
..++|.+.+.||+|+||.||+|... +++.||||++.+. .......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 4567999999999999999999975 5899999999652 22345678899999999999999999999999999999
Q ss_pred EEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 352 IYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 352 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||||+++|+|.+++.... ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.
T Consensus 262 VmEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~ 335 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVH 335 (576)
T ss_dssp EECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEeccccee
Confidence 999999999999986543 234899999999999999999999998 99999999999999999999999999974
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=7.5e-28 Score=230.35 Aligned_cols=153 Identities=28% Similarity=0.492 Sum_probs=123.8
Q ss_pred HhhcCCcccceeecccCCcceEEEEEcCC----cEEEEEEeccc--ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCC
Q 047619 274 ANATDNFSINNKLGEGGFGPVYKGTLVDG----QEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE 347 (430)
Q Consensus 274 ~~~~~~~~~~~~ig~G~fg~Vy~~~~~~~----~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 347 (430)
....++|++.+.||+|+||.||+|..... ..||||++... .....+.+.+|+.++++++||||+++++++....
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence 34557899999999999999999986543 27999998753 3455778999999999999999999999998877
Q ss_pred EE------EEEEEccCCCChhHHhhcCCC---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCC
Q 047619 348 EK------LLIYEFVPNKSLDSFIFDQER---CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMN 418 (430)
Q Consensus 348 ~~------~lv~e~~~~gsL~~~l~~~~~---~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~ 418 (430)
.. ++||||+++++|.+++..... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~ 175 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMT 175 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSC
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCC
Confidence 65 999999999999999864321 225899999999999999999999998 999999999999999999
Q ss_pred eeecCCCcccc
Q 047619 419 PKISDFGLARA 429 (430)
Q Consensus 419 ~kl~DFGlar~ 429 (430)
+||+|||+|+.
T Consensus 176 ~kl~Dfg~a~~ 186 (323)
T 3qup_A 176 VCVADFGLSRK 186 (323)
T ss_dssp EEECCCCC---
T ss_pred EEEeecccccc
Confidence 99999999974
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-27 Score=237.32 Aligned_cols=149 Identities=28% Similarity=0.413 Sum_probs=131.5
Q ss_pred hhcCCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc--ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEE
Q 047619 275 NATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 351 (430)
Q Consensus 275 ~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 351 (430)
...++|++.+.||+|+||.||+|... +++.+|+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 35578999999999999999999864 5889999998653 34456778999999999999999999999999999999
Q ss_pred EEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEc---CCCCeeecCCCccc
Q 047619 352 IYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLAR 428 (430)
Q Consensus 352 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~---~~~~~kl~DFGlar 428 (430)
||||+++++|.+.+... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+|+
T Consensus 88 v~E~~~gg~L~~~i~~~---~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 88 IFDLVTGGELFEDIVAR---EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp EECCCBCCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEEeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 99999999999998654 34899999999999999999999998 99999999999998 45789999999997
Q ss_pred c
Q 047619 429 A 429 (430)
Q Consensus 429 ~ 429 (430)
.
T Consensus 162 ~ 162 (444)
T 3soa_A 162 E 162 (444)
T ss_dssp C
T ss_pred E
Confidence 5
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-27 Score=230.07 Aligned_cols=147 Identities=28% Similarity=0.461 Sum_probs=131.0
Q ss_pred hcCCcccceeecccCCcceEEEEE-cCCcEEEEEEecccC---hHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 351 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 351 (430)
..++|.+.+.||+|+||.||+|.. .+++.||+|++.+.. ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 347899999999999999999996 458899999986421 2234578899999999999999999999999999999
Q ss_pred EEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 352 IYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 352 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||||+ +|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 87 v~E~~-~g~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~ 157 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVEK---KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNI 157 (336)
T ss_dssp EECCC-CEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBT
T ss_pred EEECC-CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEecccee
Confidence 99999 68888888543 34899999999999999999999998 99999999999999999999999999974
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.9e-28 Score=229.16 Aligned_cols=148 Identities=24% Similarity=0.392 Sum_probs=130.6
Q ss_pred hcCCcccceeecccCCcceEEEEE-cCCcEEEEEEeccc---ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCE---
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE--- 348 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--- 348 (430)
..++|++.+.||+|+||.||+|.. .+++.||||++... .......+.+|+.++.+++||||+++++++.....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 457899999999999999999996 55889999999753 34456788999999999999999999999876543
Q ss_pred -EEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcc
Q 047619 349 -KLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427 (430)
Q Consensus 349 -~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla 427 (430)
.++||||+++++|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred ccEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 49999999999999999643 35899999999999999999999998 999999999999999999999999999
Q ss_pred cc
Q 047619 428 RA 429 (430)
Q Consensus 428 r~ 429 (430)
+.
T Consensus 164 ~~ 165 (311)
T 3ork_A 164 RA 165 (311)
T ss_dssp --
T ss_pred cc
Confidence 74
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-27 Score=233.22 Aligned_cols=150 Identities=19% Similarity=0.231 Sum_probs=129.8
Q ss_pred HhhcCCcccceeecccCCcceEEEE------EcCCcEEEEEEecccChHhHHHHHHHHHHHhcCC---CCcccceEEEEE
Q 047619 274 ANATDNFSINNKLGEGGFGPVYKGT------LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ---HRNLVKLLGCCI 344 (430)
Q Consensus 274 ~~~~~~~~~~~~ig~G~fg~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~ 344 (430)
....++|.+.+.||+|+||.||+|. ...++.||||++.... ..++.+|+.++..++ |+||+++++++.
T Consensus 61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~ 137 (365)
T 3e7e_A 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHL 137 (365)
T ss_dssp ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence 3456789999999999999999994 4458899999997543 446677777777776 999999999999
Q ss_pred eCCEEEEEEEccCCCChhHHhhcCC--CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcC-------
Q 047619 345 QGEEKLLIYEFVPNKSLDSFIFDQE--RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ------- 415 (430)
Q Consensus 345 ~~~~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~------- 415 (430)
..+..+|||||+++++|.+++.... ....+++..+..++.||+.||+|||+.+ |+||||||+||||+.
T Consensus 138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC--
T ss_pred cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccc
Confidence 9999999999999999999996421 2346999999999999999999999988 999999999999998
Q ss_pred ----CCCeeecCCCcccc
Q 047619 416 ----DMNPKISDFGLARA 429 (430)
Q Consensus 416 ----~~~~kl~DFGlar~ 429 (430)
++.+||+|||+|+.
T Consensus 215 ~~~~~~~~kl~DFG~a~~ 232 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSID 232 (365)
T ss_dssp ----CTTEEECCCTTCEE
T ss_pred cccccCCEEEeeCchhhh
Confidence 89999999999963
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-27 Score=224.03 Aligned_cols=148 Identities=28% Similarity=0.510 Sum_probs=133.6
Q ss_pred cCCcccceeecccCCcceEEEEEcC-C-------cEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCE
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLVD-G-------QEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 348 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 348 (430)
.++|.+.+.||+|+||.||+|.... + ..||+|++........+.+.+|+.++++++||||+++++++.+++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 4679999999999999999998643 3 4799999987666777889999999999999999999999999999
Q ss_pred EEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCC--------ee
Q 047619 349 KLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMN--------PK 420 (430)
Q Consensus 349 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~--------~k 420 (430)
.++||||+++++|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++. +|
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNK--NCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CEEEEECCCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence 999999999999999996543 34899999999999999999999998 999999999999998887 99
Q ss_pred ecCCCcccc
Q 047619 421 ISDFGLARA 429 (430)
Q Consensus 421 l~DFGlar~ 429 (430)
|+|||+|+.
T Consensus 162 l~Dfg~~~~ 170 (289)
T 4fvq_A 162 LSDPGISIT 170 (289)
T ss_dssp ECCCCSCTT
T ss_pred eccCccccc
Confidence 999999864
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-27 Score=232.89 Aligned_cols=148 Identities=24% Similarity=0.329 Sum_probs=122.9
Q ss_pred hcCCcccceeecccCCcceEEEEEcC-CcEEEEEEecccC---hHhHHHHHHHHHH-HhcCCCCcccceEEEEEeCCEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVIL-FSKLQHRNLVKLLGCCIQGEEKL 350 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~ 350 (430)
..++|++.+.||+|+||.||+|+... ++.||||++.+.. ......+.+|..+ ++.++||||+++++++.+.+..+
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~ 115 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence 34689999999999999999999754 7899999997532 2344556777776 57789999999999999999999
Q ss_pred EEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 351 LIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 351 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+||||+++++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.
T Consensus 116 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~ 188 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKE 188 (373)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGG
T ss_pred EEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccc
Confidence 999999999999998653 34889999999999999999999998 99999999999999999999999999974
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-27 Score=238.99 Aligned_cols=147 Identities=27% Similarity=0.483 Sum_probs=121.7
Q ss_pred hcCCcccceeecccCCcceEEEEEc-CCcEEEEEEecc--cChHhHHHHHHHHHHHhcCCCCcccceEEEEEeC-----C
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-----E 347 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~ 347 (430)
..++|++.+.||+|+||.||+|... +++.||||++.+ ......+.+.+|+.+|+.++||||+++++++... .
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 3478999999999999999999864 588999999965 2445567899999999999999999999998543 5
Q ss_pred EEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcc
Q 047619 348 EKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427 (430)
Q Consensus 348 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla 427 (430)
..|+||||+ +++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 131 ELYVVLEIA-DSDFKKLFRTP---VYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp CEEEEECCC-SEEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-ccchhhhcccC---CCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccc
Confidence 689999998 57899988543 45899999999999999999999998 999999999999999999999999999
Q ss_pred cc
Q 047619 428 RA 429 (430)
Q Consensus 428 r~ 429 (430)
+.
T Consensus 204 ~~ 205 (458)
T 3rp9_A 204 RT 205 (458)
T ss_dssp BC
T ss_pred hh
Confidence 85
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.95 E-value=6.1e-29 Score=239.49 Aligned_cols=145 Identities=22% Similarity=0.316 Sum_probs=123.0
Q ss_pred cCCcccceeecccCCcceEEEEEcCCcEEEEEEecccC--------hHhHHHHHHHHHHHhcCC---------CCcccce
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKIS--------EQGLKELKNEVILFSKLQ---------HRNLVKL 339 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------h~niv~l 339 (430)
.++|++.+.||+|+||.||+|+. +++.||||++.... ....+.+.+|+.+++.++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46799999999999999999997 68999999997532 233477889999988886 7777777
Q ss_pred EEEEE------------------------------eCCEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHH
Q 047619 340 LGCCI------------------------------QGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARG 389 (430)
Q Consensus 340 ~~~~~------------------------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~a 389 (430)
.+.+. ..+..+|||||+++|++.+.+.. ..+++..+..++.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence 76643 26789999999999976666632 348999999999999999
Q ss_pred HHHhh-hcCCCcEEeCCCCCCcEEEcCCC--------------------CeeecCCCcccc
Q 047619 390 VMYLH-QDSRLRIIHRDLKASNVLLDQDM--------------------NPKISDFGLARA 429 (430)
Q Consensus 390 L~yLH-~~~~~~iiH~Dlkp~NILl~~~~--------------------~~kl~DFGlar~ 429 (430)
|+||| +.+ |+||||||+||||+.++ .+||+|||+|+.
T Consensus 174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~ 231 (336)
T 2vuw_A 174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRL 231 (336)
T ss_dssp HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBE
T ss_pred HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEe
Confidence 99999 888 99999999999999887 899999999985
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.2e-27 Score=229.89 Aligned_cols=142 Identities=31% Similarity=0.431 Sum_probs=123.9
Q ss_pred ceeecccCCcceEEEEEc-CCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEccCCCCh
Q 047619 283 NNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSL 361 (430)
Q Consensus 283 ~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 361 (430)
.+.||+|+||.||+|... +++.||+|++........+.+.+|+.++++++||||+++++++.+.+..+|||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 578999999999999864 5899999999876666778899999999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEE--cCCCCeeecCCCcccc
Q 047619 362 DSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLL--DQDMNPKISDFGLARA 429 (430)
Q Consensus 362 ~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl--~~~~~~kl~DFGlar~ 429 (430)
.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+|+.
T Consensus 174 ~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~ 238 (373)
T 2x4f_A 174 FDRIIDES--YNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARR 238 (373)
T ss_dssp HHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEE
T ss_pred HHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCcee
Confidence 99886432 35899999999999999999999998 9999999999999 5677899999999975
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-27 Score=239.89 Aligned_cols=148 Identities=24% Similarity=0.327 Sum_probs=123.9
Q ss_pred hcCCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc---ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 351 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 351 (430)
..++|++.+.||+|+||.||+|... +++.||||++.+. .......+.+|+.+++.++||||+++++++.+.+..+|
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 3467999999999999999999964 5889999999752 33445677899999999999999999999999999999
Q ss_pred EEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 352 IYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ-DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 352 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~-~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||||+++++|.+++... ..+++..+..++.||+.||+|||+ .+ |+||||||+||||+.++.+||+|||+|+.
T Consensus 226 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~ 298 (446)
T 4ejn_A 226 VMEYANGGELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKE 298 (446)
T ss_dssp EECCCSSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCT
T ss_pred EEeeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCcee
Confidence 99999999999998543 358999999999999999999998 77 99999999999999999999999999974
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-27 Score=224.57 Aligned_cols=151 Identities=28% Similarity=0.508 Sum_probs=136.2
Q ss_pred HhhcCCcccceeecccCCcceEEEEEcC-CcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEE
Q 047619 274 ANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 352 (430)
Q Consensus 274 ~~~~~~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 352 (430)
....++|++.+.||+|+||.||+|.... +..||+|++.. .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v 87 (288)
T 3kfa_A 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 87 (288)
T ss_dssp BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECS-CSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEE
Confidence 3455789999999999999999999765 88999999975 334567889999999999999999999999999999999
Q ss_pred EEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 353 YEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 353 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|||+++++|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 88 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~ 160 (288)
T 3kfa_A 88 TEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRL 160 (288)
T ss_dssp EECCTTEEHHHHHHHCCT-TTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGT
T ss_pred EEcCCCCcHHHHHHhccc-CCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCcccee
Confidence 999999999999976433 45899999999999999999999998 99999999999999999999999999974
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=7.1e-27 Score=222.29 Aligned_cols=147 Identities=29% Similarity=0.412 Sum_probs=131.9
Q ss_pred cCCcccceeecccCCcceEEEEEcC-CcEEEEEEeccc--ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEE
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 353 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 353 (430)
.++|++.+.||+|+||.||+|.... ++.||+|++... .....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 3689999999999999999999754 899999998643 3344677889999999999999999999999999999999
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||+++++|..++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 82 e~~~~~~l~~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 151 (311)
T 4agu_A 82 EYCDHTVLHELDRYQ---RGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARL 151 (311)
T ss_dssp ECCSEEHHHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EeCCCchHHHHHhhh---cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchh
Confidence 999999999988543 34899999999999999999999998 99999999999999999999999999974
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.95 E-value=4.2e-27 Score=235.71 Aligned_cols=148 Identities=27% Similarity=0.481 Sum_probs=132.3
Q ss_pred hhcCCcccceeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCC-EEEEEE
Q 047619 275 NATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-EKLLIY 353 (430)
Q Consensus 275 ~~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~ 353 (430)
...++|++.+.||+|+||.||+|... ++.||||+++... ..+.+.+|+.+|++++||||+++++++...+ ..+|||
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~ 266 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence 34568999999999999999999874 7899999997532 4578999999999999999999999988766 789999
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||+++++|.+++.... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.
T Consensus 267 e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 338 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKE 338 (450)
T ss_dssp ECCTTCBHHHHHHHHC-TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccc
Confidence 9999999999997543 234789999999999999999999998 99999999999999999999999999974
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.95 E-value=3.5e-27 Score=226.95 Aligned_cols=152 Identities=32% Similarity=0.547 Sum_probs=133.4
Q ss_pred hhcCCcccceeecccCCcceEEEEEc--------CCcEEEEEEeccc-ChHhHHHHHHHHHHHhcC-CCCcccceEEEEE
Q 047619 275 NATDNFSINNKLGEGGFGPVYKGTLV--------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCI 344 (430)
Q Consensus 275 ~~~~~~~~~~~ig~G~fg~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 344 (430)
...++|++.+.||+|+||.||+|... ++..||+|++... .....+.+.+|+.+++++ +||||+++++++.
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 34578999999999999999999863 3678999999753 445567899999999999 8999999999999
Q ss_pred eCCEEEEEEEccCCCChhHHhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcE
Q 047619 345 QGEEKLLIYEFVPNKSLDSFIFDQER-------------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNV 411 (430)
Q Consensus 345 ~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NI 411 (430)
..+..++||||+++++|.+++..... ...+++..+..++.||+.||.|||+.+ |+||||||+||
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NI 188 (334)
T 2pvf_A 112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNV 188 (334)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGE
T ss_pred cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceE
Confidence 99999999999999999999975432 124889999999999999999999998 99999999999
Q ss_pred EEcCCCCeeecCCCcccc
Q 047619 412 LLDQDMNPKISDFGLARA 429 (430)
Q Consensus 412 Ll~~~~~~kl~DFGlar~ 429 (430)
|++.++.+||+|||+|+.
T Consensus 189 ll~~~~~~kL~Dfg~~~~ 206 (334)
T 2pvf_A 189 LVTENNVMKIADFGLARD 206 (334)
T ss_dssp EECTTCCEEECCCTTCEE
T ss_pred EEcCCCCEEEcccccccc
Confidence 999999999999999874
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.95 E-value=4.3e-27 Score=239.27 Aligned_cols=151 Identities=30% Similarity=0.408 Sum_probs=134.8
Q ss_pred hcCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccC---hHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 351 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 351 (430)
..++|.+.+.||+|+||.||+|+.. +++.||+|++.+.. ......+.+|+.++++++||||+++++++.+....++
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 262 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCL 262 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEE
Confidence 3468999999999999999999975 58999999996522 2345678899999999999999999999999999999
Q ss_pred EEEccCCCChhHHhhcCCC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 352 IYEFVPNKSLDSFIFDQER-CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 352 v~e~~~~gsL~~~l~~~~~-~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||||+++++|..++..... ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.
T Consensus 263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~ 338 (543)
T 3c4z_A 263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVE 338 (543)
T ss_dssp EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeee
Confidence 9999999999999865432 346899999999999999999999998 99999999999999999999999999974
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-27 Score=232.11 Aligned_cols=149 Identities=33% Similarity=0.566 Sum_probs=131.1
Q ss_pred cCCcccceeecccCCcceEEEEEc------CCcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEE
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 349 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 349 (430)
.++|++.+.||+|+||.||+|... +++.||||++... .......+.+|+.++++++||||+++++++......
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 467999999999999999999843 3668999999653 455667889999999999999999999999999999
Q ss_pred EEEEEccCCCChhHHhhcCC----CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCC---Ceeec
Q 047619 350 LLIYEFVPNKSLDSFIFDQE----RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDM---NPKIS 422 (430)
Q Consensus 350 ~lv~e~~~~gsL~~~l~~~~----~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~---~~kl~ 422 (430)
++||||+++++|.+++.... ....+++..++.++.||+.||+|||+++ |+||||||+||||+.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999996532 1245889999999999999999999998 99999999999998555 59999
Q ss_pred CCCccc
Q 047619 423 DFGLAR 428 (430)
Q Consensus 423 DFGlar 428 (430)
|||+|+
T Consensus 227 DFG~a~ 232 (367)
T 3l9p_A 227 DFGMAR 232 (367)
T ss_dssp CCHHHH
T ss_pred CCcccc
Confidence 999986
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.1e-27 Score=225.68 Aligned_cols=149 Identities=30% Similarity=0.476 Sum_probs=117.5
Q ss_pred cCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccC-hHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEE
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 354 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 354 (430)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 468999999999999999999864 58999999986532 2344678899999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCC---CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 355 FVPNKSLDSFIFDQE---RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 355 ~~~~gsL~~~l~~~~---~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|++ ++|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~ 157 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARA 157 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEE
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCcccee
Confidence 998 59998886432 1235889999999999999999999998 99999999999999999999999999974
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.1e-27 Score=219.60 Aligned_cols=147 Identities=27% Similarity=0.499 Sum_probs=133.9
Q ss_pred cCCcccceeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEcc
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFV 356 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 356 (430)
.++|++.+.||+|+||.||+|...+++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 46799999999999999999998888999999997532 34467899999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 357 PNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 357 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+|+.
T Consensus 86 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 153 (267)
T 3t9t_A 86 EHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRF 153 (267)
T ss_dssp TTCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGG
T ss_pred CCCcHHHHHhhCc--ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccc
Confidence 9999999996542 35889999999999999999999998 99999999999999999999999999874
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.94 E-value=6.2e-27 Score=227.47 Aligned_cols=158 Identities=26% Similarity=0.313 Sum_probs=137.8
Q ss_pred CcccHHhHHhhcCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccChHhHHHHHHHHHHHhcCC-----CCcccce
Q 047619 266 PLFELATIANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-----HRNLVKL 339 (430)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l 339 (430)
..+.+.......++|.+.++||+|+||.||+|... +++.||||++.. .......+..|+.+++.++ ||||+++
T Consensus 23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~ 101 (360)
T 3llt_A 23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNIVKY 101 (360)
T ss_dssp GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence 34445555667789999999999999999999974 588999999975 3455667788999999987 9999999
Q ss_pred EEEEEeCCEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcC----
Q 047619 340 LGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ---- 415 (430)
Q Consensus 340 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~---- 415 (430)
++++...+..++||||+ +++|.+++..... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.
T Consensus 102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~ 176 (360)
T 3llt_A 102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNNY-NGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFE 176 (360)
T ss_dssp EEEEEETTEEEEEECCC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCC
T ss_pred cceeeECCeeEEEEcCC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcccccc
Confidence 99999999999999999 9999999976433 35899999999999999999999998 999999999999975
Q ss_pred ---------------------CCCeeecCCCcccc
Q 047619 416 ---------------------DMNPKISDFGLARA 429 (430)
Q Consensus 416 ---------------------~~~~kl~DFGlar~ 429 (430)
++.+||+|||+|+.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~ 211 (360)
T 3llt_A 177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATF 211 (360)
T ss_dssp EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEE
T ss_pred ccccchhcccccccccccccCCCCEEEEeccCcee
Confidence 78899999999974
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.1e-27 Score=233.85 Aligned_cols=147 Identities=28% Similarity=0.499 Sum_probs=131.4
Q ss_pred hcCCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc--ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeC-----C
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-----E 347 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~ 347 (430)
..++|++.+.||+|+||.||+|... +++.||||++.+. .....+.+.+|+.+++.++||||+++++++... .
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 4578999999999999999999965 4789999999752 345567899999999999999999999999876 5
Q ss_pred EEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcc
Q 047619 348 EKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427 (430)
Q Consensus 348 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla 427 (430)
..++||||++ ++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKTP---IFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecCC-cCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 7899999996 5999998543 45899999999999999999999998 999999999999999999999999999
Q ss_pred cc
Q 047619 428 RA 429 (430)
Q Consensus 428 r~ 429 (430)
+.
T Consensus 177 ~~ 178 (432)
T 3n9x_A 177 RT 178 (432)
T ss_dssp EE
T ss_pred cc
Confidence 75
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.9e-27 Score=223.03 Aligned_cols=147 Identities=32% Similarity=0.544 Sum_probs=128.8
Q ss_pred CCcccceeecccCCcceEEEEE-----cCCcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeC--CEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTL-----VDGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEK 349 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 349 (430)
+.|++.+.||+|+||.||+|.+ .+++.||+|++... .....+.+.+|+.++++++||||+++++++... ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 5689999999999999999983 35889999999743 334567899999999999999999999999877 668
Q ss_pred EEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 350 LLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 350 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence 99999999999999995433 34899999999999999999999998 99999999999999999999999999874
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-27 Score=227.54 Aligned_cols=155 Identities=29% Similarity=0.507 Sum_probs=135.5
Q ss_pred hHHhhcCCcccceeecccCCcceEEEEEc------CCcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEE
Q 047619 272 TIANATDNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCI 344 (430)
Q Consensus 272 ~~~~~~~~~~~~~~ig~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 344 (430)
+.....++|++.+.||+|+||.||+|... .++.||+|++... .......+.+|+.++++++||||+++++++.
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 98 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 98 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence 33445678999999999999999999854 3678999999753 3445667899999999999999999999999
Q ss_pred eCCEEEEEEEccCCCChhHHhhcCC-------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCC
Q 047619 345 QGEEKLLIYEFVPNKSLDSFIFDQE-------RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDM 417 (430)
Q Consensus 345 ~~~~~~lv~e~~~~gsL~~~l~~~~-------~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~ 417 (430)
+.+..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++
T Consensus 99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDF 175 (322)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTC
T ss_pred cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCC
Confidence 9999999999999999999986421 1245789999999999999999999998 99999999999999999
Q ss_pred CeeecCCCcccc
Q 047619 418 NPKISDFGLARA 429 (430)
Q Consensus 418 ~~kl~DFGlar~ 429 (430)
.+||+|||+|+.
T Consensus 176 ~~kl~Dfg~~~~ 187 (322)
T 1p4o_A 176 TVKIGDFGMTRD 187 (322)
T ss_dssp CEEECCTTCCCG
T ss_pred eEEECcCccccc
Confidence 999999999874
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.94 E-value=6.6e-27 Score=222.99 Aligned_cols=148 Identities=26% Similarity=0.373 Sum_probs=131.4
Q ss_pred hcCCcccc-eeecccCCcceEEEEE-cCCcEEEEEEecccChHhHHHHHHHHHHHhcC-CCCcccceEEEEEeCCEEEEE
Q 047619 276 ATDNFSIN-NKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLI 352 (430)
Q Consensus 276 ~~~~~~~~-~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 352 (430)
..+.|++. +.||+|+||.||+|.. .+++.||||++........+.+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 89 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV 89 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 34678885 7899999999999985 45899999999765555677899999999885 799999999999999999999
Q ss_pred EEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCC---eeecCCCcccc
Q 047619 353 YEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMN---PKISDFGLARA 429 (430)
Q Consensus 353 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~---~kl~DFGlar~ 429 (430)
|||+++++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|||+|+.
T Consensus 90 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 90 FEKMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp EECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred EEcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 9999999999999653 35899999999999999999999998 999999999999988766 99999999864
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=2.6e-27 Score=228.60 Aligned_cols=151 Identities=31% Similarity=0.515 Sum_probs=130.7
Q ss_pred hcCCcccceeecccCCcceEEEEEc------CCcEEEEEEeccc-ChHhHHHHHHHHHHHhcC-CCCcccceEEEEEeCC
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGE 347 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 347 (430)
..++|.+.+.||+|+||.||+|... .+..||+|++... .....+.+.+|+.++.++ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 4578999999999999999999862 3568999999753 334457889999999999 8999999999999999
Q ss_pred EEEEEEEccCCCChhHHhhcCCCC--------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCC
Q 047619 348 EKLLIYEFVPNKSLDSFIFDQERC--------------------KILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLK 407 (430)
Q Consensus 348 ~~~lv~e~~~~gsL~~~l~~~~~~--------------------~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlk 407 (430)
..++||||+++++|.+++...... ..+++..+..++.||+.||+|||+.+ |+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence 999999999999999999754321 34789999999999999999999998 9999999
Q ss_pred CCcEEEcCCCCeeecCCCcccc
Q 047619 408 ASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 408 p~NILl~~~~~~kl~DFGlar~ 429 (430)
|+||||+.++.+||+|||+|+.
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~ 221 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARD 221 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSC
T ss_pred hhhEEEcCCCcEEeCCCccCcc
Confidence 9999999999999999999974
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=6e-27 Score=219.12 Aligned_cols=149 Identities=31% Similarity=0.557 Sum_probs=133.6
Q ss_pred hcCCcccceeecccCCcceEEEEE-cCCcEEEEEEecccC---hHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 351 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 351 (430)
..++|++.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.++.+++||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 446799999999999999999996 468999999986422 2235778999999999999999999999999999999
Q ss_pred EEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 352 IYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 352 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 89 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 161 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQ 161 (278)
T ss_dssp EEECCTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEecCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceee
Confidence 99999999999999653 245899999999999999999999998 99999999999999999999999999874
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=5e-27 Score=227.37 Aligned_cols=146 Identities=29% Similarity=0.420 Sum_probs=122.2
Q ss_pred hcCCcccceeecccCCcceEEEEEcC-CcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 354 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 354 (430)
..++|++.+.||+|+||.||+|.... ++.||||++... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc--hhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 45689999999999999999999764 789999999753 244678899999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcC---CCCeeecCCCcccc
Q 047619 355 FVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKISDFGLARA 429 (430)
Q Consensus 355 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~DFGlar~ 429 (430)
|+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||+|+.
T Consensus 129 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~ 200 (349)
T 2w4o_A 129 LVTGGELFDRIVEK---GYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKI 200 (349)
T ss_dssp CCCSCBHHHHHTTC---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred eCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence 99999999998543 45899999999999999999999998 999999999999975 78999999999874
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.3e-27 Score=224.96 Aligned_cols=147 Identities=28% Similarity=0.475 Sum_probs=133.2
Q ss_pred CCcccceeecccCCcceEEEEE-----cCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEE--eCCEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTL-----VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCI--QGEEKL 350 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~ 350 (430)
++|++.+.||+|+||.||+|.+ .+++.||||++........+.+.+|+.++++++||||+++++++. .....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5799999999999999999984 357899999998777777788999999999999999999999987 456689
Q ss_pred EEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 351 LIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 351 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 103 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEeecCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccccee
Confidence 9999999999999996532 35899999999999999999999998 99999999999999999999999999974
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.2e-27 Score=229.12 Aligned_cols=154 Identities=23% Similarity=0.318 Sum_probs=131.3
Q ss_pred HHhhcCCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc-----ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeC
Q 047619 273 IANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-----SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG 346 (430)
Q Consensus 273 ~~~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 346 (430)
+....++|++.+.||+|+||.||+|... +++.||+|++.+. .....+.+.+|+.++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 3456678999999999999999999864 4789999998642 334567899999999999999999999999999
Q ss_pred CEEEEEEEccCCCChhHHhhcCC-------------------------------------CCCCCCHHHHHHHHHHHHHH
Q 047619 347 EEKLLIYEFVPNKSLDSFIFDQE-------------------------------------RCKILDWSKRFHIICGTARG 389 (430)
Q Consensus 347 ~~~~lv~e~~~~gsL~~~l~~~~-------------------------------------~~~~~~~~~~~~i~~~i~~a 389 (430)
+..++||||+++++|.+++.... ....+++..+..++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 99999999999999999984210 01123567788999999999
Q ss_pred HHHhhhcCCCcEEeCCCCCCcEEEcCCC--CeeecCCCcccc
Q 047619 390 VMYLHQDSRLRIIHRDLKASNVLLDQDM--NPKISDFGLARA 429 (430)
Q Consensus 390 L~yLH~~~~~~iiH~Dlkp~NILl~~~~--~~kl~DFGlar~ 429 (430)
|+|||+.+ |+||||||+|||++.++ .+||+|||+|+.
T Consensus 181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~ 219 (345)
T 3hko_A 181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKE 219 (345)
T ss_dssp HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEE
T ss_pred HHHHHHCC---ccccCCChhhEEEecCCCceEEEeecccccc
Confidence 99999998 99999999999998776 899999999974
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.8e-27 Score=219.82 Aligned_cols=151 Identities=27% Similarity=0.404 Sum_probs=131.7
Q ss_pred hcCCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc--ChHhHHHHHHHHHHHhcC-CCCcccceEEEEEeCCEEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLL 351 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 351 (430)
..++|++.+.||+|+||.||+|... +++.||+|++... .......+.+|+.++..+ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 4467999999999999999999975 6899999998752 344567788999999999 99999999999999999999
Q ss_pred EEEccCCCChhHHhhcCCC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCC--------------
Q 047619 352 IYEFVPNKSLDSFIFDQER-CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQD-------------- 416 (430)
Q Consensus 352 v~e~~~~gsL~~~l~~~~~-~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~-------------- 416 (430)
||||+++++|.+++..... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence 9999999999999965321 245899999999999999999999998 9999999999999844
Q ss_pred -----CCeeecCCCcccc
Q 047619 417 -----MNPKISDFGLARA 429 (430)
Q Consensus 417 -----~~~kl~DFGlar~ 429 (430)
..+||+|||+|+.
T Consensus 166 ~~~~~~~~kl~Dfg~~~~ 183 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTR 183 (289)
T ss_dssp ----CCCEEECCCTTCEE
T ss_pred ccCCceEEEEcccccccc
Confidence 4799999999874
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.6e-27 Score=232.38 Aligned_cols=150 Identities=28% Similarity=0.433 Sum_probs=133.0
Q ss_pred cCCcccceeecccCCcceEEEEEcC-CcEEEEEEecccC-hHhHHHHHHHHHHHhcCCCCcccceEEEEEeCC--EEEEE
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE--EKLLI 352 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv 352 (430)
.++|.+.+.||+|+||.||+|.... ++.||||++.... ....+.+.+|+.++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 4679999999999999999999754 8999999997532 334677889999999999999999999998765 77999
Q ss_pred EEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEE----cCCCCeeecCCCccc
Q 047619 353 YEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLL----DQDMNPKISDFGLAR 428 (430)
Q Consensus 353 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl----~~~~~~kl~DFGlar 428 (430)
|||+++++|.+++........+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+|+
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999976544445899999999999999999999998 9999999999999 777789999999997
Q ss_pred c
Q 047619 429 A 429 (430)
Q Consensus 429 ~ 429 (430)
.
T Consensus 165 ~ 165 (396)
T 4eut_A 165 E 165 (396)
T ss_dssp E
T ss_pred E
Confidence 4
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.94 E-value=4.5e-27 Score=221.06 Aligned_cols=151 Identities=26% Similarity=0.396 Sum_probs=132.8
Q ss_pred hcCCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 353 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 353 (430)
..++|.+.+.||+|+||.||++... ++..+|+|++... .....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 3467999999999999999999964 4889999998753 2335678999999999999999999999999999999999
Q ss_pred EccCCCChhHHhhcC-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEE---cCCCCeeecCCCcccc
Q 047619 354 EFVPNKSLDSFIFDQ-ERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARA 429 (430)
Q Consensus 354 e~~~~gsL~~~l~~~-~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl---~~~~~~kl~DFGlar~ 429 (430)
||+++++|.+++... .....+++..+..++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||+|+.
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~ 176 (285)
T 3is5_A 100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176 (285)
T ss_dssp CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence 999999999988543 12346899999999999999999999998 9999999999999 4567899999999975
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=3.2e-27 Score=221.09 Aligned_cols=148 Identities=31% Similarity=0.505 Sum_probs=131.4
Q ss_pred hcCCcccceeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEc
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 355 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 355 (430)
..++|++.+.||+|+||.||+|...++..||+|++... ....+.+.+|+.++++++||||+++++++. .+..++||||
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 88 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEY 88 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCC-cccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEec
Confidence 44689999999999999999999888889999999753 234678899999999999999999999876 5568999999
Q ss_pred cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 356 VPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 356 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+++++|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+|+.
T Consensus 89 ~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 158 (279)
T 1qpc_A 89 MENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARL 158 (279)
T ss_dssp CTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CCCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCccccc
Confidence 99999999985432 125899999999999999999999998 99999999999999999999999999874
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=7.1e-27 Score=222.62 Aligned_cols=147 Identities=27% Similarity=0.306 Sum_probs=127.0
Q ss_pred cCCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc--ChHhHHHHHHHHHHHhcC-CCCcccceEEEEEeCCEEEEE
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLI 352 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 352 (430)
.++|++.++||+|+||.||+|... +++.||||++... ..........|+..+.++ +||||+++++++.+.+..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 357999999999999999999976 6899999998642 334444555666666555 899999999999999999999
Q ss_pred EEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 353 YEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 353 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|||+ +++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||||+.++.+||+|||+|+.
T Consensus 136 ~e~~-~~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~ 206 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWG--ASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVE 206 (311)
T ss_dssp EECC-CCBHHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEE
T ss_pred Eecc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeee
Confidence 9999 678988886543 45899999999999999999999998 99999999999999999999999999864
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-27 Score=238.18 Aligned_cols=150 Identities=29% Similarity=0.494 Sum_probs=132.7
Q ss_pred HhhcCCcccceeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEE
Q 047619 274 ANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 353 (430)
Q Consensus 274 ~~~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 353 (430)
....++|++.++||+|+||.||+|.+..+..||||++.... ...+.+.+|+.+|++++||||+++++++.+ +..+|||
T Consensus 180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~ 257 (452)
T 1fmk_A 180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 257 (452)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred ccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEe
Confidence 34557899999999999999999998888889999997532 345789999999999999999999999865 6789999
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||+++++|.+++.... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.
T Consensus 258 e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 329 (452)
T 1fmk_A 258 EYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARL 329 (452)
T ss_dssp CCCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred hhhcCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCcccee
Confidence 9999999999995422 245899999999999999999999998 99999999999999999999999999975
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.6e-27 Score=221.18 Aligned_cols=148 Identities=26% Similarity=0.439 Sum_probs=125.5
Q ss_pred hcCCcccceeecccCCcceEEEEEcC----CcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 350 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 350 (430)
..++|++.+.||+|+||.||+|.... +..||+|++... .....+.+.+|+.++++++||||+++++++ ..+..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccE
Confidence 44689999999999999999998643 457999998753 445567899999999999999999999997 456789
Q ss_pred EEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 351 LIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 351 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 92 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp EEEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccc
Confidence 9999999999999996542 35899999999999999999999998 99999999999999999999999999874
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-26 Score=228.40 Aligned_cols=147 Identities=27% Similarity=0.551 Sum_probs=123.2
Q ss_pred hhcCCcccceeecccCCcceEEEEEc-CCcEEEEEEecc--cChHhHHHHHHHHHHHhcCC-CCcccceEEEEEeCC--E
Q 047619 275 NATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGE--E 348 (430)
Q Consensus 275 ~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~ 348 (430)
...++|++.+.||+|+||.||+|... +++.||||++.+ ........+.+|+.++..+. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 35578999999999999999999864 589999999864 24556677889999999997 999999999998655 6
Q ss_pred EEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCccc
Q 047619 349 KLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428 (430)
Q Consensus 349 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar 428 (430)
.++||||++ ++|..++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|+
T Consensus 86 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 899999997 689998854 24889999999999999999999998 9999999999999999999999999997
Q ss_pred c
Q 047619 429 A 429 (430)
Q Consensus 429 ~ 429 (430)
.
T Consensus 158 ~ 158 (388)
T 3oz6_A 158 S 158 (388)
T ss_dssp E
T ss_pred c
Confidence 4
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=8.8e-27 Score=220.37 Aligned_cols=143 Identities=28% Similarity=0.461 Sum_probs=123.4
Q ss_pred hcCCcccceeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhc--CCCCcccceEEEEEeC----CEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSK--LQHRNLVKLLGCCIQG----EEK 349 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~----~~~ 349 (430)
..++|++.+.||+|+||.||+|.. +++.||||++... ....+.+|.+++.. ++||||+++++++... ...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 456899999999999999999987 6899999998642 33455566666655 8999999999987653 457
Q ss_pred EEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhh--------hcCCCcEEeCCCCCCcEEEcCCCCeee
Q 047619 350 LLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLH--------QDSRLRIIHRDLKASNVLLDQDMNPKI 421 (430)
Q Consensus 350 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH--------~~~~~~iiH~Dlkp~NILl~~~~~~kl 421 (430)
++||||+++++|.+++.. ..+++..+..++.|++.||+||| +.+ |+||||||+|||++.++.+||
T Consensus 82 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQL----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp EEEECCCTTCBHHHHHTT----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEE
T ss_pred EEehhhccCCCHHHHHhh----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEE
Confidence 999999999999999943 35899999999999999999999 766 999999999999999999999
Q ss_pred cCCCcccc
Q 047619 422 SDFGLARA 429 (430)
Q Consensus 422 ~DFGlar~ 429 (430)
+|||+|+.
T Consensus 155 ~Dfg~a~~ 162 (301)
T 3q4u_A 155 ADLGLAVM 162 (301)
T ss_dssp CCCTTCEE
T ss_pred eeCCCeee
Confidence 99999863
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=6.8e-27 Score=218.96 Aligned_cols=148 Identities=30% Similarity=0.434 Sum_probs=132.0
Q ss_pred hcCCcccceeecccCCcceEEEEEcC-CcEEEEEEecccC---hHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 351 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 351 (430)
..++|++.+.||+|+||.||+|.... +..||+|++.+.. ......+.+|+.++++++||||+++++++.+....++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 44689999999999999999998654 7799999986421 2235678999999999999999999999999999999
Q ss_pred EEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 352 IYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 352 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 87 v~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~ 158 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVH 158 (279)
T ss_dssp EECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESC
T ss_pred EEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEecccccc
Confidence 99999999999998543 34899999999999999999999988 99999999999999999999999998853
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-26 Score=218.32 Aligned_cols=148 Identities=26% Similarity=0.413 Sum_probs=133.6
Q ss_pred hcCCcccceeecccCCcceEEEEEcC-CcEEEEEEeccc---ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 351 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 351 (430)
..++|.+.+.||+|+||.||++.... ++.+|+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 44689999999999999999999754 789999998642 34556788999999999999999999999999999999
Q ss_pred EEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 352 IYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 352 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 93 v~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 164 (294)
T 2rku_A 93 VLELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATK 164 (294)
T ss_dssp EEECCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCcee
Confidence 99999999999988543 35899999999999999999999998 99999999999999999999999999864
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-26 Score=223.36 Aligned_cols=148 Identities=26% Similarity=0.413 Sum_probs=133.8
Q ss_pred hcCCcccceeecccCCcceEEEEEcC-CcEEEEEEeccc---ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 351 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 351 (430)
..++|.+.+.||+|+||.||++.... ++.+|+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 44689999999999999999999754 789999998642 34556788999999999999999999999999999999
Q ss_pred EEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 352 IYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 352 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||||+++++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.
T Consensus 119 v~e~~~~~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 190 (335)
T 2owb_A 119 VLELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATK 190 (335)
T ss_dssp EECCCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEecCCCCCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCcee
Confidence 99999999999988543 35899999999999999999999998 99999999999999999999999999874
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.8e-27 Score=225.61 Aligned_cols=145 Identities=23% Similarity=0.323 Sum_probs=129.3
Q ss_pred cCCcccceeecccCCcceEEEEE-cCCcEEEEEEecccChHhHHHHHHHHHHHhcC-CCCcccceEEEEEeCCEEEEEEE
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYE 354 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 354 (430)
.++|++.+.||+|+||.||+|.. .+++.||||++.... ..+.+.+|+.+++++ +||||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 46899999999999999999996 468999999986432 234678999999999 99999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCC-----eeecCCCcccc
Q 047619 355 FVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMN-----PKISDFGLARA 429 (430)
Q Consensus 355 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~-----~kl~DFGlar~ 429 (430)
|+ +++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||+|+.
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 99999999654 245899999999999999999999998 999999999999998876 99999999974
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-26 Score=216.56 Aligned_cols=148 Identities=29% Similarity=0.479 Sum_probs=132.5
Q ss_pred hcCCcccceeecccCCcceEEEEEc-CCcEEEEEEecc--cChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 352 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 352 (430)
..++|++.+.||+|+||.||+|... +++.||+|++.. ......+.+.+|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 4578999999999999999999865 488999999864 2445567889999999999999999999999999999999
Q ss_pred EEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCC---eeecCCCcccc
Q 047619 353 YEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMN---PKISDFGLARA 429 (430)
Q Consensus 353 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~---~kl~DFGlar~ 429 (430)
|||+++++|.+.+... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++. +||+|||+|+.
T Consensus 84 ~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 9999999999888543 35899999999999999999999998 999999999999986655 99999999864
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.6e-27 Score=223.56 Aligned_cols=152 Identities=34% Similarity=0.485 Sum_probs=134.3
Q ss_pred hhcCCcccceeecccCCcceEEEEE------cCCcEEEEEEeccc-ChHhHHHHHHHHHHHhcC-CCCcccceEEEEEeC
Q 047619 275 NATDNFSINNKLGEGGFGPVYKGTL------VDGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG 346 (430)
Q Consensus 275 ~~~~~~~~~~~ig~G~fg~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 346 (430)
...++|++.+.||+|+||.||+|.. .+++.||+|++... .....+.+.+|+.++.++ +||||+++++++...
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 99 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence 3456899999999999999999984 23678999999753 334567899999999999 999999999999999
Q ss_pred CEEEEEEEccCCCChhHHhhcCCC---------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcE
Q 047619 347 EEKLLIYEFVPNKSLDSFIFDQER---------------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNV 411 (430)
Q Consensus 347 ~~~~lv~e~~~~gsL~~~l~~~~~---------------~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NI 411 (430)
+..++||||+++++|.+++..... ...+++..+..++.|++.||.|||+.+ |+||||||+||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Ni 176 (313)
T 1t46_A 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNI 176 (313)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceE
Confidence 999999999999999999975432 124899999999999999999999998 99999999999
Q ss_pred EEcCCCCeeecCCCcccc
Q 047619 412 LLDQDMNPKISDFGLARA 429 (430)
Q Consensus 412 Ll~~~~~~kl~DFGlar~ 429 (430)
|++.++.+||+|||+|+.
T Consensus 177 l~~~~~~~kl~Dfg~~~~ 194 (313)
T 1t46_A 177 LLTHGRITKICDFGLARD 194 (313)
T ss_dssp EEETTTEEEECCCGGGSC
T ss_pred EEcCCCCEEEcccccccc
Confidence 999999999999999975
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-26 Score=217.26 Aligned_cols=149 Identities=29% Similarity=0.408 Sum_probs=130.9
Q ss_pred CCcccceeecccCCcceEEEEEc-CCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEcc
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFV 356 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 356 (430)
++|.....||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 34555569999999999999964 58899999997665566788999999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcC-CCCeeecCCCcccc
Q 047619 357 PNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLARA 429 (430)
Q Consensus 357 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DFGlar~ 429 (430)
++++|.+++........+++..+..++.|++.||.|||+.+ |+|+||||+|||++. ++.+||+|||+|+.
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~ 172 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKR 172 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEE
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccc
Confidence 99999999976544445778899999999999999999998 999999999999987 88999999999864
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=8.2e-27 Score=222.45 Aligned_cols=151 Identities=27% Similarity=0.426 Sum_probs=132.4
Q ss_pred hcCCcccceeecccCCcceEEEEE-cCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEe----CCEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ----GEEKL 350 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~ 350 (430)
..++|++.+.||+|+||.||++.. .+++.||||++........+.+.+|+.+++.++||||+++++++.. ....+
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 346899999999999999999996 5689999999876666778889999999999999999999999873 34779
Q ss_pred EEEEccCCCChhHHhhcC-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 351 LIYEFVPNKSLDSFIFDQ-ERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 351 lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+||||+++++|.+++... .....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 999999999999998652 12356899999999999999999999998 99999999999999999999999998764
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-26 Score=216.22 Aligned_cols=148 Identities=30% Similarity=0.424 Sum_probs=133.1
Q ss_pred hcCCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 353 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 353 (430)
..++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 3467999999999999999999975 5889999998642 3345678899999999999999999999999999999999
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+|+.
T Consensus 85 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 154 (276)
T 2yex_A 85 EYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATV 154 (276)
T ss_dssp ECCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EecCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccc
Confidence 999999999998432 45899999999999999999999998 99999999999999999999999999864
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.94 E-value=9.5e-27 Score=222.66 Aligned_cols=148 Identities=30% Similarity=0.422 Sum_probs=132.5
Q ss_pred hcCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccCh------HhHHHHHHHHHHHhcCCCCcccceEEEEEeCCE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISE------QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 348 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 348 (430)
..++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+.++++++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 3467999999999999999999975 488999999865321 136789999999999999999999999999999
Q ss_pred EEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCC----CeeecCC
Q 047619 349 KLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDM----NPKISDF 424 (430)
Q Consensus 349 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~----~~kl~DF 424 (430)
.++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTC---SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccC
Confidence 99999999999999999643 35899999999999999999999998 99999999999999887 7999999
Q ss_pred Ccccc
Q 047619 425 GLARA 429 (430)
Q Consensus 425 Glar~ 429 (430)
|+|+.
T Consensus 164 g~~~~ 168 (321)
T 2a2a_A 164 GLAHE 168 (321)
T ss_dssp TTCEE
T ss_pred cccee
Confidence 99874
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.9e-27 Score=226.86 Aligned_cols=149 Identities=28% Similarity=0.384 Sum_probs=131.7
Q ss_pred hhcCCcccceeecccCCcceEEEEE-cCCcEEEEEEecccC--------hHhHHHHHHHHHHHhcCCCCcccceEEEEEe
Q 047619 275 NATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKIS--------EQGLKELKNEVILFSKLQHRNLVKLLGCCIQ 345 (430)
Q Consensus 275 ~~~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 345 (430)
...++|++.+.||+|+||.||+|.. .+++.||||++.... ......+.+|+.++++++||||+++++++.+
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 3457899999999999999999986 458899999987532 1134467789999999999999999999999
Q ss_pred CCEEEEEEEccCCC-ChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCC
Q 047619 346 GEEKLLIYEFVPNK-SLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDF 424 (430)
Q Consensus 346 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DF 424 (430)
.+..++||||+.++ +|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDRH---PRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHTC---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEEeCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeec
Confidence 99999999999776 999998543 34899999999999999999999998 999999999999999999999999
Q ss_pred Ccccc
Q 047619 425 GLARA 429 (430)
Q Consensus 425 Glar~ 429 (430)
|+|+.
T Consensus 175 g~a~~ 179 (335)
T 3dls_A 175 GSAAY 179 (335)
T ss_dssp TTCEE
T ss_pred ccceE
Confidence 99974
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=9.2e-27 Score=221.77 Aligned_cols=156 Identities=28% Similarity=0.517 Sum_probs=129.0
Q ss_pred HhHHhhcCCcccceeecccCCcceEEEEEcC----CcEEEEEEeccc--ChHhHHHHHHHHHHHhcCCCCcccceEEEEE
Q 047619 271 ATIANATDNFSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCI 344 (430)
Q Consensus 271 ~~~~~~~~~~~~~~~ig~G~fg~Vy~~~~~~----~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 344 (430)
..+....++|.+.+.||+|+||.||+|.... +..||+|++... .....+.+.+|+.++++++||||+++++++.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 3444566789999999999999999998542 458999998642 4455678999999999999999999999998
Q ss_pred eCCE-----EEEEEEccCCCChhHHhhcC---CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCC
Q 047619 345 QGEE-----KLLIYEFVPNKSLDSFIFDQ---ERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQD 416 (430)
Q Consensus 345 ~~~~-----~~lv~e~~~~gsL~~~l~~~---~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~ 416 (430)
+... .++||||+++++|.+++... .....+++..++.++.|++.||.|||+.+ |+||||||+|||++.+
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~ 183 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDD 183 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTT
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCC
Confidence 7654 49999999999999998532 22356899999999999999999999988 9999999999999999
Q ss_pred CCeeecCCCcccc
Q 047619 417 MNPKISDFGLARA 429 (430)
Q Consensus 417 ~~~kl~DFGlar~ 429 (430)
+.+||+|||+|+.
T Consensus 184 ~~~kl~Dfg~~~~ 196 (313)
T 3brb_A 184 MTVCVADFGLSKK 196 (313)
T ss_dssp SCEEECSCSCC--
T ss_pred CcEEEeecCccee
Confidence 9999999999974
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.94 E-value=7.9e-27 Score=217.40 Aligned_cols=148 Identities=35% Similarity=0.592 Sum_probs=125.3
Q ss_pred cCCcccceeecccCCcceEEEEEcCCcEEEEEEecccC----hHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEE
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKIS----EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 352 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 352 (430)
.++|++.+.||+|+||.||+|... ++.+|||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 468999999999999999999974 8899999986532 23457789999999999999999999999999999999
Q ss_pred EEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcC--------CCCeeecCC
Q 047619 353 YEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ--------DMNPKISDF 424 (430)
Q Consensus 353 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~--------~~~~kl~DF 424 (430)
|||+++++|.+++.. ..+++..+..++.|++.||.|||+++..+|+||||||+|||++. ++.+||+||
T Consensus 85 ~e~~~~~~L~~~~~~----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 85 MEFARGGPLNRVLSG----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EECCTTEEHHHHHTS----SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEcCCCCCHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 999999999999842 35899999999999999999999987556899999999999986 678999999
Q ss_pred Ccccc
Q 047619 425 GLARA 429 (430)
Q Consensus 425 Glar~ 429 (430)
|+|+.
T Consensus 161 g~~~~ 165 (271)
T 3dtc_A 161 GLARE 165 (271)
T ss_dssp CC---
T ss_pred Ccccc
Confidence 99974
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.6e-26 Score=219.34 Aligned_cols=146 Identities=35% Similarity=0.532 Sum_probs=130.0
Q ss_pred cCCc-ccceeecccCCcceEEEEEc-----CCcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeC--C
Q 047619 277 TDNF-SINNKLGEGGFGPVYKGTLV-----DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--E 347 (430)
Q Consensus 277 ~~~~-~~~~~ig~G~fg~Vy~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~ 347 (430)
.++| ++.++||+|+||.||++... +++.||||++... .....+.+.+|+.++++++||||+++++++.+. .
T Consensus 29 ~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (318)
T 3lxp_A 29 HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAA 108 (318)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTT
T ss_pred cHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCc
Confidence 3455 99999999999999988642 5789999999753 345577899999999999999999999999984 6
Q ss_pred EEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcc
Q 047619 348 EKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427 (430)
Q Consensus 348 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla 427 (430)
..++||||+++++|.+++... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a 181 (318)
T 3lxp_A 109 SLQLVMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLA 181 (318)
T ss_dssp EEEEEECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGC
T ss_pred eEEEEEecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccc
Confidence 789999999999999999543 3899999999999999999999998 999999999999999999999999999
Q ss_pred cc
Q 047619 428 RA 429 (430)
Q Consensus 428 r~ 429 (430)
+.
T Consensus 182 ~~ 183 (318)
T 3lxp_A 182 KA 183 (318)
T ss_dssp EE
T ss_pred cc
Confidence 74
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-26 Score=222.80 Aligned_cols=148 Identities=31% Similarity=0.573 Sum_probs=132.2
Q ss_pred cCCcccceeecccCCcceEEEEE-----cCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCC--EE
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTL-----VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE--EK 349 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~ 349 (430)
.++|++.+.||+|+||.||++.. .+++.||+|++........+.+.+|+.++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 35799999999999999999984 358899999998766677788999999999999999999999987654 67
Q ss_pred EEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 350 LLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 350 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEEECCCTTCBHHHHHHHST--TSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 99999999999999996543 35899999999999999999999998 99999999999999999999999999874
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=6.2e-27 Score=226.12 Aligned_cols=146 Identities=28% Similarity=0.385 Sum_probs=131.0
Q ss_pred hcCCcccceeecccCCcceEEEEEcCCcEEEEEEecc--cChHhHHHHHHHHHHHhcCCC--CcccceEEEEEeCCEEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQH--RNLVKLLGCCIQGEEKLL 351 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~l 351 (430)
..++|++.+.||+|+||.||++...+++.||||++.. ......+.+.+|+.++.+++| |||+++++++......++
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 4567999999999999999999988899999999864 345566889999999999987 999999999999999999
Q ss_pred EEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 352 IYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 352 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||| +.+++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||||+ ++.+||+|||+|+.
T Consensus 87 v~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~ 156 (343)
T 3dbq_A 87 VME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQ 156 (343)
T ss_dssp EEC-CCSEEHHHHHHHS---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred EEe-CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccc
Confidence 999 5688999999653 35899999999999999999999998 99999999999996 67899999999975
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=3e-27 Score=241.72 Aligned_cols=151 Identities=28% Similarity=0.487 Sum_probs=133.8
Q ss_pred HHhhcCCcccceeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEE
Q 047619 273 IANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 352 (430)
Q Consensus 273 ~~~~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 352 (430)
.....++|++.++||+|+||.||+|.+..+..||||++.... ...+.+.+|+.+|++++||||+++++++.+ +..+||
T Consensus 262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv 339 (535)
T 2h8h_A 262 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 339 (535)
T ss_dssp SBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred eecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEe
Confidence 344557899999999999999999999888899999997533 345789999999999999999999999865 678999
Q ss_pred EEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 353 YEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 353 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|||+++++|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.
T Consensus 340 ~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 412 (535)
T 2h8h_A 340 TEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARL 412 (535)
T ss_dssp ECCCTTEEHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTT
T ss_pred eehhcCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEccccccee
Confidence 99999999999995422 235889999999999999999999998 99999999999999999999999999985
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-26 Score=230.44 Aligned_cols=148 Identities=26% Similarity=0.381 Sum_probs=126.4
Q ss_pred hhcCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccC--------hHhHHHHHHHHHHHhcCCCCcccceEEEEEe
Q 047619 275 NATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--------EQGLKELKNEVILFSKLQHRNLVKLLGCCIQ 345 (430)
Q Consensus 275 ~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 345 (430)
...++|.+.+.||+|+||.||+|... +++.||||++.+.. ......+.+|+.++++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 35678999999999999999999864 47899999986421 122335789999999999999999999975
Q ss_pred CCEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCC---Ceeec
Q 047619 346 GEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDM---NPKIS 422 (430)
Q Consensus 346 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~---~~kl~ 422 (430)
.+..++||||+++++|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++ .+||+
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSSS---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred cCceEEEEEcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence 56689999999999999988543 45899999999999999999999998 99999999999997544 59999
Q ss_pred CCCcccc
Q 047619 423 DFGLARA 429 (430)
Q Consensus 423 DFGlar~ 429 (430)
|||+|+.
T Consensus 285 DFG~a~~ 291 (419)
T 3i6u_A 285 DFGHSKI 291 (419)
T ss_dssp CSSTTTS
T ss_pred eccccee
Confidence 9999985
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.9e-26 Score=224.75 Aligned_cols=154 Identities=23% Similarity=0.399 Sum_probs=135.8
Q ss_pred HHhHHhhcCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccC--------hHhHHHHHHHHHHHhcC-CCCcccce
Q 047619 270 LATIANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--------EQGLKELKNEVILFSKL-QHRNLVKL 339 (430)
Q Consensus 270 ~~~~~~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l-~h~niv~l 339 (430)
........++|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++.++ +||||+++
T Consensus 86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 165 (365)
T 2y7j_A 86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL 165 (365)
T ss_dssp HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 3444556678999999999999999999975 68999999986422 12245688999999999 79999999
Q ss_pred EEEEEeCCEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCe
Q 047619 340 LGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNP 419 (430)
Q Consensus 340 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~ 419 (430)
++++......++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~i 239 (365)
T 2y7j_A 166 IDSYESSSFMFLVFDLMRKGELFDYLTEK---VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQI 239 (365)
T ss_dssp EEEEEBSSEEEEEECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCE
T ss_pred EEEEeeCCEEEEEEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCE
Confidence 99999999999999999999999999643 35899999999999999999999998 9999999999999999999
Q ss_pred eecCCCcccc
Q 047619 420 KISDFGLARA 429 (430)
Q Consensus 420 kl~DFGlar~ 429 (430)
||+|||+++.
T Consensus 240 kl~DfG~~~~ 249 (365)
T 2y7j_A 240 RLSDFGFSCH 249 (365)
T ss_dssp EECCCTTCEE
T ss_pred EEEecCcccc
Confidence 9999999864
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=9.6e-27 Score=220.31 Aligned_cols=148 Identities=29% Similarity=0.509 Sum_probs=131.5
Q ss_pred hcCCcccceeecccCCcceEEEEEcC-CcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 354 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 354 (430)
..++|++.+.||+|+||.||+|.... ++.+|+|++........+.+.+|+.++..++||||+++++++...+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 45789999999999999999999754 88999999976556667889999999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCccc
Q 047619 355 FVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428 (430)
Q Consensus 355 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar 428 (430)
|+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+
T Consensus 97 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 165 (302)
T 2j7t_A 97 FCPGGAVDAIMLELD--RGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSA 165 (302)
T ss_dssp CCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHH
T ss_pred eCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCc
Confidence 999999999886432 34899999999999999999999998 9999999999999999999999999874
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=2.8e-27 Score=229.71 Aligned_cols=147 Identities=24% Similarity=0.331 Sum_probs=131.0
Q ss_pred cCCcccceeecccCCcceEEEEE----cCCcEEEEEEecccC----hHhHHHHHHHHHHHhcC-CCCcccceEEEEEeCC
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTL----VDGQEIAVKRLSKIS----EQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGE 347 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 347 (430)
.++|++.+.||+|+||.||+|.. .+++.||||++.+.. ....+.+.+|+.++..+ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36799999999999999999987 368999999986421 23345677899999999 6999999999999999
Q ss_pred EEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcc
Q 047619 348 EKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427 (430)
Q Consensus 348 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla 427 (430)
..++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+|
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eEEEEeecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 999999999999999999653 34899999999999999999999998 999999999999999999999999998
Q ss_pred cc
Q 047619 428 RA 429 (430)
Q Consensus 428 r~ 429 (430)
+.
T Consensus 207 ~~ 208 (355)
T 1vzo_A 207 KE 208 (355)
T ss_dssp EE
T ss_pred ee
Confidence 74
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-26 Score=218.46 Aligned_cols=147 Identities=29% Similarity=0.519 Sum_probs=131.1
Q ss_pred cCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEe----------
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ---------- 345 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---------- 345 (430)
.++|++.+.||+|+||.||+|... +++.||||++.. .....+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 457999999999999999999964 689999999965 44566789999999999999999999999875
Q ss_pred ---CCEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeec
Q 047619 346 ---GEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 422 (430)
Q Consensus 346 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~ 422 (430)
....++||||+++++|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSC--GGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred cccCCceEEEEecCCCCCHHHhhhccc--cccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence 356799999999999999996532 35788899999999999999999998 9999999999999999999999
Q ss_pred CCCcccc
Q 047619 423 DFGLARA 429 (430)
Q Consensus 423 DFGlar~ 429 (430)
|||+|+.
T Consensus 159 dfg~~~~ 165 (303)
T 1zy4_A 159 DFGLAKN 165 (303)
T ss_dssp CCCCCSC
T ss_pred eCcchhh
Confidence 9999874
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-26 Score=223.80 Aligned_cols=146 Identities=30% Similarity=0.496 Sum_probs=129.8
Q ss_pred CCcccceeecccCCcceEEEEE-cCCcEEEEEEeccc---ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 353 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 353 (430)
+.|++.+.||+|+||.||+|.. .+++.||||++... .....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4589999999999999999996 46889999998642 2344567899999999999999999999999999999999
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||++ |+|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 134 e~~~-g~l~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 203 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASI 203 (348)
T ss_dssp ECCS-EEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBS
T ss_pred ecCC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCcee
Confidence 9997 67877775332 45899999999999999999999998 99999999999999999999999999975
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-26 Score=221.93 Aligned_cols=149 Identities=29% Similarity=0.509 Sum_probs=130.3
Q ss_pred hcCCcccceeecccCCcceEEEEEcC-----CcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLVD-----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 349 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 349 (430)
..++|++.+.||+|+||.||+|.... +..||+|++... .......+.+|+.++++++||||+++++++...+..
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 121 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 121 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCc
Confidence 34678899999999999999998643 236999999753 344566789999999999999999999999999999
Q ss_pred EEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 350 LLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 350 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 122 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 122 MIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp EEEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchh
Confidence 99999999999999996532 45899999999999999999999998 99999999999999999999999999974
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-26 Score=222.54 Aligned_cols=137 Identities=29% Similarity=0.365 Sum_probs=122.9
Q ss_pred eeecccCCcceEEEEEc-CCcEEEEEEecccChHhHHHHHHHHHHHhcCC-CCcccceEEEEEeCCEEEEEEEccCCCCh
Q 047619 284 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYEFVPNKSL 361 (430)
Q Consensus 284 ~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL 361 (430)
+.||+|+||.||+|... +++.||||++.+ .....+.+|+.+++.+. ||||+++++++.+....++||||+++++|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 78999999999999975 489999999964 34567788999999997 99999999999999999999999999999
Q ss_pred hHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCC---CeeecCCCcccc
Q 047619 362 DSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDM---NPKISDFGLARA 429 (430)
Q Consensus 362 ~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~---~~kl~DFGlar~ 429 (430)
.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++ .+||+|||+|+.
T Consensus 94 ~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~ 158 (325)
T 3kn6_A 94 FERIKKK---KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARL 158 (325)
T ss_dssp HHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEecccccee
Confidence 9999654 45899999999999999999999998 99999999999997765 799999999974
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.1e-26 Score=221.23 Aligned_cols=147 Identities=31% Similarity=0.502 Sum_probs=130.8
Q ss_pred cCCcccceeecccCCcceEEEEEcC-CcEEEEEEeccc--ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEE
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 353 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 353 (430)
.++|++.+.||+|+||.||+|.... ++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 3579999999999999999999754 889999998542 3344567889999999999999999999999999999999
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||+++++|..++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 104 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 173 (331)
T 4aaa_A 104 EFVDHTILDDLELFP---NGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFART 173 (331)
T ss_dssp ECCSEEHHHHHHHST---TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred ecCCcchHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCcee
Confidence 999999999887443 34899999999999999999999998 99999999999999999999999999964
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.6e-26 Score=218.44 Aligned_cols=148 Identities=20% Similarity=0.280 Sum_probs=131.2
Q ss_pred hcCCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc---ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 351 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 351 (430)
..++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.++.+++||||+++++++...+..++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 4578999999999999999999975 5889999998753 23345789999999999999999999999999999999
Q ss_pred EEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 352 IYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 352 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 112 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~ 183 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASA 183 (309)
T ss_dssp EEECCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC---
T ss_pred EEEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcc
Confidence 99999999999999653 35899999999999999999999998 99999999999999999999999999864
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.9e-26 Score=215.40 Aligned_cols=148 Identities=28% Similarity=0.473 Sum_probs=133.5
Q ss_pred hcCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccC---hHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 351 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 351 (430)
..++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++...+..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 3478999999999999999999975 68999999986422 2345678999999999999999999999999999999
Q ss_pred EEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 352 IYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 352 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||+|+.
T Consensus 89 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~ 160 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKH---GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNM 160 (276)
T ss_dssp EEECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGC
T ss_pred EEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccc
Confidence 99999999999999653 34889999999999999999999998 99999999999999999999999999875
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-26 Score=224.32 Aligned_cols=146 Identities=23% Similarity=0.333 Sum_probs=133.1
Q ss_pred cCCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEE
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 354 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 354 (430)
.++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 467999999999999999999975 5889999998753 45556789999999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCcEEeCCCCCCcEEEcCCCCeeecCCCccc
Q 047619 355 FVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD-SRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428 (430)
Q Consensus 355 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar 428 (430)
|+++++|.+++... ..+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||+|+
T Consensus 112 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 180 (360)
T 3eqc_A 112 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSG 180 (360)
T ss_dssp CCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCH
T ss_pred CCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCc
Confidence 99999999999653 3488999999999999999999985 7 9999999999999999999999999986
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-26 Score=242.79 Aligned_cols=148 Identities=26% Similarity=0.341 Sum_probs=132.1
Q ss_pred hcCCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc---ChHhHHHHHHHHHHHhcC-CCCcccceEEEEEeCCEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKL 350 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 350 (430)
..++|++.+.||+|+||.||+|... +++.||||++.+. .....+.+..|..++..+ +||+|+++++++.+.+..|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 4578999999999999999999965 4789999999752 233456788899999988 7999999999999999999
Q ss_pred EEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 351 LIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 351 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|||||+++++|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|+.
T Consensus 419 lV~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE 491 (674)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred EEEeCcCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeec
Confidence 999999999999999653 34899999999999999999999998 99999999999999999999999999974
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.6e-26 Score=215.94 Aligned_cols=150 Identities=25% Similarity=0.357 Sum_probs=132.9
Q ss_pred HhhcCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccC---------hHhHHHHHHHHHHHhcCC-CCcccceEEE
Q 047619 274 ANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---------EQGLKELKNEVILFSKLQ-HRNLVKLLGC 342 (430)
Q Consensus 274 ~~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~~~ 342 (430)
....++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.+++++. ||||++++++
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (298)
T 1phk_A 13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT 92 (298)
T ss_dssp --CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred cchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeee
Confidence 445689999999999999999999975 58899999986432 233567889999999996 9999999999
Q ss_pred EEeCCEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeec
Q 047619 343 CIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 422 (430)
Q Consensus 343 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~ 422 (430)
+......++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 93 ~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~ 166 (298)
T 1phk_A 93 YETNTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLT 166 (298)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred eccCCeEEEEEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEe
Confidence 99999999999999999999999653 35899999999999999999999998 9999999999999999999999
Q ss_pred CCCcccc
Q 047619 423 DFGLARA 429 (430)
Q Consensus 423 DFGlar~ 429 (430)
|||+|+.
T Consensus 167 dfg~~~~ 173 (298)
T 1phk_A 167 DFGFSCQ 173 (298)
T ss_dssp CCTTCEE
T ss_pred cccchhh
Confidence 9999864
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.94 E-value=2.5e-26 Score=215.37 Aligned_cols=146 Identities=29% Similarity=0.443 Sum_probs=131.3
Q ss_pred CCcccceeecccCCcceEEEEEc-CCcEEEEEEecccC------hHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS------EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 350 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 350 (430)
++|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+....+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 57999999999999999999975 58999999986422 123678999999999999999999999999999999
Q ss_pred EEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCC----CeeecCCCc
Q 047619 351 LIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDM----NPKISDFGL 426 (430)
Q Consensus 351 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~----~~kl~DFGl 426 (430)
+||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++ .+||+|||+
T Consensus 85 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK---ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 999999999999999543 35899999999999999999999998 99999999999998877 799999999
Q ss_pred ccc
Q 047619 427 ARA 429 (430)
Q Consensus 427 ar~ 429 (430)
|+.
T Consensus 159 ~~~ 161 (283)
T 3bhy_A 159 AHK 161 (283)
T ss_dssp CEE
T ss_pred cee
Confidence 874
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=2.9e-26 Score=215.64 Aligned_cols=147 Identities=32% Similarity=0.548 Sum_probs=129.9
Q ss_pred cCCcccce-eecccCCcceEEEEEc---CCcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEE
Q 047619 277 TDNFSINN-KLGEGGFGPVYKGTLV---DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 351 (430)
Q Consensus 277 ~~~~~~~~-~ig~G~fg~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 351 (430)
.++|.+.+ .||+|+||.||+|... ++..||+|++... .....+.+.+|+.++++++||||+++++++ ..+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 35677776 9999999999999853 4778999999763 445677899999999999999999999999 5667899
Q ss_pred EEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 352 IYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 352 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 87 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 159 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKA 159 (287)
T ss_dssp EEECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEeCCCCCHHHHHHhC--CccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceee
Confidence 99999999999999543 345899999999999999999999998 99999999999999999999999999874
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-26 Score=218.86 Aligned_cols=149 Identities=32% Similarity=0.547 Sum_probs=129.4
Q ss_pred hcCCcccceeecccCCcceEEEEEcC----CcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEe-CCEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ-GEEK 349 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 349 (430)
...+|++.+.||+|+||.||+|...+ ...+|+|.+... .....+.+.+|+.++++++||||+++++++.. .+..
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 34578999999999999999998643 236899998753 44556789999999999999999999998654 5578
Q ss_pred EEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 350 LLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 350 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 103 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp EEEEECCTTCBHHHHHHCTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred EEEEeCCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccc
Confidence 99999999999999996533 45789999999999999999999998 99999999999999999999999999974
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=9.5e-27 Score=233.77 Aligned_cols=145 Identities=29% Similarity=0.433 Sum_probs=125.7
Q ss_pred hcCCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc--ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeC------
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG------ 346 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 346 (430)
..++|++.+.||+|+||.||+|... +++.||||++.+. .....+.+.+|+.+++.++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 3478999999999999999999864 4889999999753 445567889999999999999999999999755
Q ss_pred CEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCc
Q 047619 347 EEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 426 (430)
Q Consensus 347 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGl 426 (430)
...+|||||++++ |.+.+.. .+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 140 ~~~~lv~E~~~~~-l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 140 QDVYLVMELMDAN-LCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp CEEEEEEECCSEE-HHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred CeEEEEEeCCCCC-HHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEe
Confidence 4579999999764 6666622 3889999999999999999999998 99999999999999999999999999
Q ss_pred ccc
Q 047619 427 ARA 429 (430)
Q Consensus 427 ar~ 429 (430)
|+.
T Consensus 211 a~~ 213 (464)
T 3ttj_A 211 ART 213 (464)
T ss_dssp C--
T ss_pred eee
Confidence 975
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.2e-26 Score=232.66 Aligned_cols=148 Identities=30% Similarity=0.442 Sum_probs=129.7
Q ss_pred hcCCcccceeecccCCcceEEEEEcC-CcEEEEEEecccCh-------------HhHHHHHHHHHHHhcCCCCcccceEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISE-------------QGLKELKNEVILFSKLQHRNLVKLLG 341 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l~~ 341 (430)
..++|.+.++||+|+||.||+|.... ++.||+|++.+... ...+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 55789999999999999999999754 78999999875321 33577899999999999999999999
Q ss_pred EEEeCCEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCC---C
Q 047619 342 CCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDM---N 418 (430)
Q Consensus 342 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~---~ 418 (430)
++.+....++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINR---HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence 999999999999999999999988553 34899999999999999999999998 99999999999998776 6
Q ss_pred eeecCCCcccc
Q 047619 419 PKISDFGLARA 429 (430)
Q Consensus 419 ~kl~DFGlar~ 429 (430)
+||+|||+|+.
T Consensus 188 ~kl~Dfg~a~~ 198 (504)
T 3q5i_A 188 IKIVDFGLSSF 198 (504)
T ss_dssp EEECCCTTCEE
T ss_pred EEEEECCCCEE
Confidence 99999999974
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-26 Score=221.22 Aligned_cols=158 Identities=28% Similarity=0.468 Sum_probs=135.3
Q ss_pred cHHhHHhhcCCcccceeecccCCcceEEEEE------cCCcEEEEEEeccc-ChHhHHHHHHHHHHHhcC-CCCcccceE
Q 047619 269 ELATIANATDNFSINNKLGEGGFGPVYKGTL------VDGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLL 340 (430)
Q Consensus 269 ~~~~~~~~~~~~~~~~~ig~G~fg~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~ 340 (430)
.........++|++.+.||+|+||.||+|.. .+++.||||++... .....+.+.+|+.++.++ +||||++++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 3444455668999999999999999999984 23678999999753 344567889999999999 789999999
Q ss_pred EEEEeCC-EEEEEEEccCCCChhHHhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCC
Q 047619 341 GCCIQGE-EKLLIYEFVPNKSLDSFIFDQER-------------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDL 406 (430)
Q Consensus 341 ~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dl 406 (430)
+++...+ ..++||||+++++|.+++..... ...+++..+..++.|++.||.|||+.+ |+||||
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~di 174 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 174 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccC
Confidence 9988765 48999999999999999975432 123789999999999999999999998 999999
Q ss_pred CCCcEEEcCCCCeeecCCCcccc
Q 047619 407 KASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 407 kp~NILl~~~~~~kl~DFGlar~ 429 (430)
||+|||++.++.+||+|||+|+.
T Consensus 175 kp~Nil~~~~~~~kl~Dfg~~~~ 197 (316)
T 2xir_A 175 AARNILLSEKNVVKICDFGLARD 197 (316)
T ss_dssp SGGGEEECGGGCEEECCCGGGSC
T ss_pred ccceEEECCCCCEEECCCccccc
Confidence 99999999999999999999974
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-26 Score=225.48 Aligned_cols=146 Identities=29% Similarity=0.471 Sum_probs=123.9
Q ss_pred hcCCcccceeecccCCcceEEEEEc-CCcEEEEEEecc--cChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCC-----
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE----- 347 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 347 (430)
..++|++.+.||+|+||.||+|... +++.||||++.. ......+.+.+|+.+++.++||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 3468999999999999999999974 589999999964 23445678899999999999999999999998763
Q ss_pred -EEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCc
Q 047619 348 -EKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 426 (430)
Q Consensus 348 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGl 426 (430)
..++||||+ +++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeec
Confidence 459999999 8899999864 24889999999999999999999998 99999999999999999999999999
Q ss_pred ccc
Q 047619 427 ARA 429 (430)
Q Consensus 427 ar~ 429 (430)
|+.
T Consensus 175 a~~ 177 (367)
T 1cm8_A 175 ARQ 177 (367)
T ss_dssp CEE
T ss_pred ccc
Confidence 974
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.9e-27 Score=224.62 Aligned_cols=154 Identities=34% Similarity=0.511 Sum_probs=134.6
Q ss_pred HHhhcCCcccceeecccCCcceEEEEEcC------CcEEEEEEeccc-ChHhHHHHHHHHHHHhcC-CCCcccceEEEEE
Q 047619 273 IANATDNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCI 344 (430)
Q Consensus 273 ~~~~~~~~~~~~~ig~G~fg~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 344 (430)
.....++|++.+.||+|+||.||+|.... ...||+|.+... .....+.+.+|+.++.++ +||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 34456789999999999999999998643 247999999753 345567899999999999 8999999999999
Q ss_pred eCCEEEEEEEccCCCChhHHhhcCCC-----------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEE
Q 047619 345 QGEEKLLIYEFVPNKSLDSFIFDQER-----------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLL 413 (430)
Q Consensus 345 ~~~~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl 413 (430)
+.+..++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ |+||||||+|||+
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLL 197 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEE
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEE
Confidence 99999999999999999999864321 235789999999999999999999998 9999999999999
Q ss_pred cCCCCeeecCCCcccc
Q 047619 414 DQDMNPKISDFGLARA 429 (430)
Q Consensus 414 ~~~~~~kl~DFGlar~ 429 (430)
+.++.+||+|||+|+.
T Consensus 198 ~~~~~~kl~Dfg~~~~ 213 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARD 213 (333)
T ss_dssp EGGGEEEBCCCGGGCC
T ss_pred CCCCeEEECccccccc
Confidence 9999999999999974
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-26 Score=222.84 Aligned_cols=146 Identities=31% Similarity=0.561 Sum_probs=124.7
Q ss_pred CCcccceeecccCCcceEEEEEcC-Cc----EEEEEEecc-cChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLVD-GQ----EIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 351 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~~-~~----~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 351 (430)
++|++.+.||+|+||.||+|.+.. ++ .||+|.+.. ......+.+.+|+.++++++||||+++++++.++. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 579999999999999999998643 43 468888754 23455678999999999999999999999998765 789
Q ss_pred EEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 352 IYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 352 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|+||+++++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 94 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEECCTTCBHHHHHHHST--TSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred EEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeE
Confidence 999999999999996543 45899999999999999999999998 99999999999999999999999999864
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.9e-27 Score=224.52 Aligned_cols=147 Identities=27% Similarity=0.491 Sum_probs=126.7
Q ss_pred cCCcccceeecccCCcceEEEEEcC-Cc----EEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEE
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLVD-GQ----EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 350 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~~-~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 350 (430)
.++|++.+.||+|+||.||+|.... ++ .||+|.+... .......+.+|+.++.+++||||+++++++. .+..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 3679999999999999999998643 44 3788887542 2333456778999999999999999999886 56689
Q ss_pred EEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 351 LIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 351 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+||||+++++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 91 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp EEEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred EEEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccc
Confidence 999999999999999654 245889999999999999999999998 99999999999999999999999999975
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.9e-26 Score=219.82 Aligned_cols=149 Identities=34% Similarity=0.619 Sum_probs=129.4
Q ss_pred CCcccceeecccCCcceEEEEEc-CCcE--EEEEEeccc-ChHhHHHHHHHHHHHhcC-CCCcccceEEEEEeCCEEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV-DGQE--IAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLI 352 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 352 (430)
++|++.+.||+|+||.||+|... ++.. +|+|.+... .....+.+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 57999999999999999999864 4554 499988652 344566789999999999 899999999999999999999
Q ss_pred EEccCCCChhHHhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCe
Q 047619 353 YEFVPNKSLDSFIFDQE-------------RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNP 419 (430)
Q Consensus 353 ~e~~~~gsL~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~ 419 (430)
|||+++++|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999996542 2346899999999999999999999998 9999999999999999999
Q ss_pred eecCCCcccc
Q 047619 420 KISDFGLARA 429 (430)
Q Consensus 420 kl~DFGlar~ 429 (430)
||+|||+|+.
T Consensus 182 kL~Dfg~~~~ 191 (327)
T 1fvr_A 182 KIADFGLSRG 191 (327)
T ss_dssp EECCTTCEES
T ss_pred EEcccCcCcc
Confidence 9999999863
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.6e-26 Score=215.31 Aligned_cols=147 Identities=28% Similarity=0.472 Sum_probs=132.9
Q ss_pred hcCCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 353 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 353 (430)
..+.|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.+++.++||||+++++++......++||
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 3457999999999999999999864 5889999998643 2345678999999999999999999999999999999999
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 100 e~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~ 168 (303)
T 3a7i_A 100 EYLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQ 168 (303)
T ss_dssp ECCTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EeCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeeccccee
Confidence 99999999999843 35899999999999999999999998 99999999999999999999999999864
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-26 Score=216.62 Aligned_cols=148 Identities=28% Similarity=0.431 Sum_probs=132.1
Q ss_pred hcCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccC---hHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 351 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 351 (430)
..++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 91 (284)
T 2vgo_A 12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYL 91 (284)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEE
Confidence 3468999999999999999999975 47889999986421 2235678999999999999999999999999999999
Q ss_pred EEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 352 IYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 352 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 92 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~ 163 (284)
T 2vgo_A 92 MLEFAPRGELYKELQKH---GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVH 163 (284)
T ss_dssp EECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEeccccccc
Confidence 99999999999998653 34899999999999999999999988 99999999999999999999999999853
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=2.8e-26 Score=220.51 Aligned_cols=145 Identities=26% Similarity=0.465 Sum_probs=125.4
Q ss_pred HhhcCCcccceeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcC--CCCcccceEEEEEeC----C
Q 047619 274 ANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL--QHRNLVKLLGCCIQG----E 347 (430)
Q Consensus 274 ~~~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~----~ 347 (430)
....++|++.+.||+|+||.||+|... ++.||||++... ....+.+|.+++..+ +||||+++++++... .
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 344578999999999999999999875 899999998642 233444555555554 899999999999988 7
Q ss_pred EEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhc--------CCCcEEeCCCCCCcEEEcCCCCe
Q 047619 348 EKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD--------SRLRIIHRDLKASNVLLDQDMNP 419 (430)
Q Consensus 348 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~--------~~~~iiH~Dlkp~NILl~~~~~~ 419 (430)
..++||||+++++|.+++... .+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~ 181 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNGTC 181 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTSCE
T ss_pred ceEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCCCE
Confidence 899999999999999999543 489999999999999999999988 6 9999999999999999999
Q ss_pred eecCCCcccc
Q 047619 420 KISDFGLARA 429 (430)
Q Consensus 420 kl~DFGlar~ 429 (430)
||+|||+|+.
T Consensus 182 kl~Dfg~a~~ 191 (337)
T 3mdy_A 182 CIADLGLAVK 191 (337)
T ss_dssp EECCCTTCEE
T ss_pred EEEeCCCcee
Confidence 9999999964
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-26 Score=221.97 Aligned_cols=149 Identities=32% Similarity=0.474 Sum_probs=125.7
Q ss_pred HhhcCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccC--hHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEE
Q 047619 274 ANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 350 (430)
Q Consensus 274 ~~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 350 (430)
....++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 335578999999999999999999864 58899999997532 233566789999999999999999999999999999
Q ss_pred EEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEc-----CCCCeeecCCC
Q 047619 351 LIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLD-----QDMNPKISDFG 425 (430)
Q Consensus 351 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~-----~~~~~kl~DFG 425 (430)
+||||++ ++|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++ ..+.+||+|||
T Consensus 110 lv~e~~~-~~L~~~~~~~~---~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg 182 (329)
T 3gbz_A 110 LIFEYAE-NDLKKYMDKNP---DVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFG 182 (329)
T ss_dssp EEEECCS-EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred EEEecCC-CCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCC
Confidence 9999998 59999986543 4899999999999999999999998 99999999999994 44559999999
Q ss_pred cccc
Q 047619 426 LARA 429 (430)
Q Consensus 426 lar~ 429 (430)
+|+.
T Consensus 183 ~a~~ 186 (329)
T 3gbz_A 183 LARA 186 (329)
T ss_dssp HHHH
T ss_pred Cccc
Confidence 9863
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-26 Score=217.54 Aligned_cols=147 Identities=29% Similarity=0.495 Sum_probs=128.5
Q ss_pred hcCCcccce-eecccCCcceEEEEEc---CCcEEEEEEecccC--hHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEE
Q 047619 276 ATDNFSINN-KLGEGGFGPVYKGTLV---DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 349 (430)
Q Consensus 276 ~~~~~~~~~-~ig~G~fg~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 349 (430)
..++|.+.+ .||+|+||.||+|... .++.||||++.... ....+.+.+|+.+++.++||||+++++++ ..+..
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 92 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW 92 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence 446788888 9999999999999642 36789999997532 33467899999999999999999999998 66778
Q ss_pred EEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 350 LLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 350 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 93 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp EEEEECCTTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCCHHHHHHhC---cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 9999999999999999653 34899999999999999999999998 99999999999999999999999999874
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-26 Score=222.71 Aligned_cols=146 Identities=31% Similarity=0.514 Sum_probs=127.1
Q ss_pred CCcccceeecccCCcceEEEEEc-CCcEEEEEEecccChH-hHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEc
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 355 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 355 (430)
++|.+.+.||+|+||.||+|... +++.||+|++...... ....+.+|+.++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57999999999999999999975 5889999998643221 122455799999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 356 VPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 356 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++ ++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 82 ~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 149 (324)
T 3mtl_A 82 LD-KDLKQYLDDCG--NIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARA 149 (324)
T ss_dssp CS-EEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEEC
T ss_pred cc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCccccc
Confidence 97 58888886543 45899999999999999999999998 99999999999999999999999999874
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-26 Score=224.77 Aligned_cols=155 Identities=24% Similarity=0.397 Sum_probs=133.0
Q ss_pred cHHhHHhhcCCcccceeecccCCcceEEEEEcCCcEEEEEEeccc-----------ChHhHHHHHHHHHHHhcCCCCccc
Q 047619 269 ELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI-----------SEQGLKELKNEVILFSKLQHRNLV 337 (430)
Q Consensus 269 ~~~~~~~~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~-----------~~~~~~~~~~E~~~l~~l~h~niv 337 (430)
...++....++|++.+.||+|+||.||+|...+++.||||++... .....+.+.+|+.++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 355677788999999999999999999999888999999998542 122347899999999999999999
Q ss_pred ceEEEEEeC-----CEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEE
Q 047619 338 KLLGCCIQG-----EEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVL 412 (430)
Q Consensus 338 ~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NIL 412 (430)
++++++... ...++||||++ ++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 166 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ--RIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNIL 166 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEE
Confidence 999998653 36799999998 6888887643 345899999999999999999999998 999999999999
Q ss_pred EcCCCCeeecCCCcccc
Q 047619 413 LDQDMNPKISDFGLARA 429 (430)
Q Consensus 413 l~~~~~~kl~DFGlar~ 429 (430)
++.++.+||+|||+|+.
T Consensus 167 ~~~~~~~kl~Dfg~~~~ 183 (362)
T 3pg1_A 167 LADNNDITICDFNLARE 183 (362)
T ss_dssp ECTTCCEEECCTTC---
T ss_pred EcCCCCEEEEecCcccc
Confidence 99999999999999963
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.9e-26 Score=216.98 Aligned_cols=149 Identities=30% Similarity=0.478 Sum_probs=124.6
Q ss_pred hcCCcccceeecccCCcceEEEEE-cCCcEEEEEEecccC-----hHhHHHHHHHHHHHhcC---CCCcccceEEEEEeC
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKIS-----EQGLKELKNEVILFSKL---QHRNLVKLLGCCIQG 346 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~ 346 (430)
..++|++.+.||+|+||.||+|.. .+++.||||++.... ......+.+|+.+++.+ +||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 457899999999999999999996 458899999986321 11234566777777666 499999999999886
Q ss_pred C-----EEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeee
Q 047619 347 E-----EKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKI 421 (430)
Q Consensus 347 ~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl 421 (430)
. ..++||||++ ++|.+++..... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP-PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence 5 5799999997 599999865433 34899999999999999999999998 999999999999999999999
Q ss_pred cCCCcccc
Q 047619 422 SDFGLARA 429 (430)
Q Consensus 422 ~DFGlar~ 429 (430)
+|||+|+.
T Consensus 162 ~Dfg~a~~ 169 (308)
T 3g33_A 162 ADFGLARI 169 (308)
T ss_dssp CSCSCTTT
T ss_pred eeCccccc
Confidence 99999974
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-26 Score=221.62 Aligned_cols=156 Identities=31% Similarity=0.509 Sum_probs=135.6
Q ss_pred cHHhHHhhcCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccChHhHHHHHHHHHHHhcC-CCCcccceEEEEEe-
Q 047619 269 ELATIANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQ- 345 (430)
Q Consensus 269 ~~~~~~~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~- 345 (430)
++.++....++|++.+.||+|+||.||+|... +++.||||++... ....+.+.+|+.++.++ +||||+++++++..
T Consensus 15 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 15 DLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp -CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred cchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecC-cccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence 34445556789999999999999999999974 5889999998653 23456788999999999 79999999999987
Q ss_pred -----CCEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCee
Q 047619 346 -----GEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPK 420 (430)
Q Consensus 346 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~k 420 (430)
.+..++||||+++++|.+++.... ...+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+|
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~k 169 (326)
T 2x7f_A 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVK 169 (326)
T ss_dssp C--CCCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEE
T ss_pred cCccccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEE
Confidence 467899999999999999997543 345899999999999999999999998 99999999999999999999
Q ss_pred ecCCCcccc
Q 047619 421 ISDFGLARA 429 (430)
Q Consensus 421 l~DFGlar~ 429 (430)
|+|||+|+.
T Consensus 170 l~Dfg~~~~ 178 (326)
T 2x7f_A 170 LVDFGVSAQ 178 (326)
T ss_dssp ECCCTTTC-
T ss_pred EeeCcCcee
Confidence 999999874
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-26 Score=220.09 Aligned_cols=148 Identities=30% Similarity=0.468 Sum_probs=126.4
Q ss_pred cCCcccceeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEcc
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFV 356 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 356 (430)
.++|++.+.||+|+||.||+|... ++.||+|++.. ....+.+.+|+.++++++||||+++++++. +..++||||+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~ 81 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYA 81 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSS--TTHHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECC
T ss_pred HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecC--hhHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcC
Confidence 357899999999999999999874 78899999964 344578899999999999999999999876 4579999999
Q ss_pred CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCC-eeecCCCcccc
Q 047619 357 PNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMN-PKISDFGLARA 429 (430)
Q Consensus 357 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~-~kl~DFGlar~ 429 (430)
++++|.+++........+++..++.++.|+++||+|||+.+..+|+||||||+|||++.++. +||+|||+|+.
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~ 155 (307)
T 2eva_A 82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD 155 (307)
T ss_dssp TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence 99999999976654455789999999999999999999932223999999999999998887 79999999864
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.94 E-value=5.7e-26 Score=213.75 Aligned_cols=144 Identities=11% Similarity=0.071 Sum_probs=128.3
Q ss_pred hcCCcccceeecccCCcceEEEEEcC-CcEEEEEEeccc---ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 351 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 351 (430)
..++|++.+.||+|+||.||+|.... ++.||||++... .....+.+.+|+.++.+++||||+++++++.+.+..++
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 108 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV 108 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence 34689999999999999999999754 899999999753 24456789999999999999999999999999999999
Q ss_pred EEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcc
Q 047619 352 IYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427 (430)
Q Consensus 352 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla 427 (430)
||||+++++|.+++... ....++..++.|++.||+|||+++ |+||||||+||||+.++.+||+++|.+
T Consensus 109 v~e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~~~ 176 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPATM 176 (286)
T ss_dssp EEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCCCC
T ss_pred EEEecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecccc
Confidence 99999999999998431 355578889999999999999998 999999999999999999999988764
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4e-26 Score=217.06 Aligned_cols=151 Identities=24% Similarity=0.447 Sum_probs=129.0
Q ss_pred hcCCcccceeecccCCcceEEEEE-cCCcEEEEEEecc---cChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 351 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 351 (430)
..++|++.+.||+|+||.||+|.. .+++.||+|++.. ......+.+.+|+.++++++||||+++++++...+..++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 346799999999999999999986 4689999999874 235567789999999999999999999999999999999
Q ss_pred EEEccCCCChhHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 352 IYEFVPNKSLDSFIFDQE-RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 352 v~e~~~~gsL~~~l~~~~-~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~ 185 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRF 185 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-----
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceee
Confidence 999999999999986421 2345899999999999999999999998 99999999999999999999999999864
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.2e-26 Score=233.19 Aligned_cols=148 Identities=30% Similarity=0.393 Sum_probs=127.2
Q ss_pred hcCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccC--hHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 352 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 352 (430)
..++|++.+.||+|+||.||+|... ++..+|+|++.+.. ......+.+|+.+++.++||||+++++++.+....++|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3457999999999999999999975 58899999987532 33457789999999999999999999999999999999
Q ss_pred EEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCC---CCeeecCCCcccc
Q 047619 353 YEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQD---MNPKISDFGLARA 429 (430)
Q Consensus 353 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~---~~~kl~DFGlar~ 429 (430)
|||+++++|.+.+... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.. +.+||+|||+|+.
T Consensus 115 ~e~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 115 MECYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp EECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 9999999999988543 34899999999999999999999998 9999999999999764 4599999999874
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.94 E-value=2.4e-26 Score=218.09 Aligned_cols=148 Identities=27% Similarity=0.423 Sum_probs=130.3
Q ss_pred hcCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 354 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 354 (430)
..++|.+.+.||+|+||.||++... +++.||+|++........+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 3467999999999999999999975 589999999976544455678999999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEE---cCCCCeeecCCCcccc
Q 047619 355 FVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARA 429 (430)
Q Consensus 355 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl---~~~~~~kl~DFGlar~ 429 (430)
|+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||+|+.
T Consensus 87 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~ 158 (304)
T 2jam_A 87 LVSGGELFDRILER---GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKM 158 (304)
T ss_dssp CCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCC
T ss_pred cCCCccHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCccee
Confidence 99999999998543 34899999999999999999999998 9999999999999 7788999999999874
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-26 Score=224.23 Aligned_cols=149 Identities=32% Similarity=0.464 Sum_probs=124.5
Q ss_pred hhcCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccCh-----HhHHHHHHHHHHHhcCCCCcccceEEEEEeCCE
Q 047619 275 NATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISE-----QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 348 (430)
Q Consensus 275 ~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 348 (430)
...++|++.+.||+|+||.||+|... +++.||||++..... ...+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34578999999999999999999965 489999999864221 112467899999999999999999999999999
Q ss_pred EEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCccc
Q 047619 349 KLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428 (430)
Q Consensus 349 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar 428 (430)
.++||||+++ +|..++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred eEEEEEcCCC-CHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccce
Confidence 9999999986 888888543 245888999999999999999999998 9999999999999999999999999997
Q ss_pred c
Q 047619 429 A 429 (430)
Q Consensus 429 ~ 429 (430)
.
T Consensus 161 ~ 161 (346)
T 1ua2_A 161 S 161 (346)
T ss_dssp T
T ss_pred e
Confidence 5
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-26 Score=226.15 Aligned_cols=147 Identities=32% Similarity=0.560 Sum_probs=123.8
Q ss_pred CCcccceeecccCCcceEEEEEcC--C--cEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEe-CCEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLVD--G--QEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ-GEEKLL 351 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~~--~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~l 351 (430)
..|++.+.||+|+||.||+|...+ + ..||+|.+... .....+.+.+|+.++++++||||+++++++.. .+..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 357788999999999999998642 2 36899998653 34567889999999999999999999998765 457899
Q ss_pred EEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 352 IYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 352 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||||+++++|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+.
T Consensus 169 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 241 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARD 241 (373)
T ss_dssp EEECCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEECCCCCCHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccc
Confidence 999999999999996533 35788999999999999999999998 99999999999999999999999999974
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.9e-26 Score=216.18 Aligned_cols=146 Identities=31% Similarity=0.502 Sum_probs=128.9
Q ss_pred hcCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEe---------
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ--------- 345 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------- 345 (430)
..++|++.+.||+|+||.||+|... +++.||+|++.... +.+.+|+.++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 4467999999999999999999975 68999999997533 346789999999999999999998865
Q ss_pred -------CCEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCC
Q 047619 346 -------GEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMN 418 (430)
Q Consensus 346 -------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~ 418 (430)
....++||||+++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence 345799999999999999996542 245899999999999999999999998 999999999999999999
Q ss_pred eeecCCCcccc
Q 047619 419 PKISDFGLARA 429 (430)
Q Consensus 419 ~kl~DFGlar~ 429 (430)
+||+|||+|+.
T Consensus 161 ~kl~Dfg~~~~ 171 (284)
T 2a19_B 161 VKIGDFGLVTS 171 (284)
T ss_dssp EEECCCTTCEE
T ss_pred EEECcchhhee
Confidence 99999999874
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.8e-26 Score=237.91 Aligned_cols=146 Identities=31% Similarity=0.535 Sum_probs=128.1
Q ss_pred CCcccce-eecccCCcceEEEEEc---CCcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEE
Q 047619 278 DNFSINN-KLGEGGFGPVYKGTLV---DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 352 (430)
Q Consensus 278 ~~~~~~~-~ig~G~fg~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 352 (430)
+++.+.+ .||+|+||.||+|.+. ++..||||+++.. .....+.+.+|+.+|++++||||+++++++.. +..+||
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 3455555 8999999999999864 3567999999753 33457889999999999999999999999876 568999
Q ss_pred EEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 353 YEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 353 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|||+++++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.
T Consensus 414 ~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~ 485 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKA 485 (613)
T ss_dssp EECCTTCBHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTT
T ss_pred EEeCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCccc
Confidence 9999999999999543 345899999999999999999999998 99999999999999999999999999985
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3e-26 Score=225.18 Aligned_cols=145 Identities=28% Similarity=0.385 Sum_probs=129.6
Q ss_pred cCCcccceeecccCCcceEEEEEcCCcEEEEEEecc--cChHhHHHHHHHHHHHhcCC--CCcccceEEEEEeCCEEEEE
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQ--HRNLVKLLGCCIQGEEKLLI 352 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv 352 (430)
.++|++.+.||+|+||.||+|...+++.||||++.. ......+.+.+|+.++.+++ ||||+++++++...+..+||
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 346999999999999999999987799999999864 34556788999999999996 59999999999999999999
Q ss_pred EEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 353 YEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 353 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|| +.+++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||||+ ++.+||+|||+|+.
T Consensus 135 ~E-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~ 203 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQ 203 (390)
T ss_dssp EE-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCC
T ss_pred Ee-cCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCcccc
Confidence 99 5688999999654 35888899999999999999999988 99999999999995 57899999999975
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-26 Score=222.70 Aligned_cols=149 Identities=25% Similarity=0.385 Sum_probs=132.8
Q ss_pred hcCCcccceeecccCCcceEEEEEcCCcEEEEEEecccChH-----------------hHHHHHHHHHHHhcCCCCcccc
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQ-----------------GLKELKNEVILFSKLQHRNLVK 338 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~E~~~l~~l~h~niv~ 338 (430)
..++|++.+.||+|+||.||+|.. +++.||+|++...... ..+.+.+|+.++.+++||||++
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred ccCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 347899999999999999999998 8999999998642111 1278999999999999999999
Q ss_pred eEEEEEeCCEEEEEEEccCCCChhHH------hhcCCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCcEEeCCCCCCcE
Q 047619 339 LLGCCIQGEEKLLIYEFVPNKSLDSF------IFDQERCKILDWSKRFHIICGTARGVMYLHQ-DSRLRIIHRDLKASNV 411 (430)
Q Consensus 339 l~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~-~~~~~iiH~Dlkp~NI 411 (430)
+++++.+.+..++||||+++++|.++ +... ....+++..+..++.|++.||.|||+ .+ |+||||||+||
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Ni 183 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN-YTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNI 183 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS-SCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGE
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc-cccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhE
Confidence 99999999999999999999999998 5332 13568999999999999999999998 87 99999999999
Q ss_pred EEcCCCCeeecCCCcccc
Q 047619 412 LLDQDMNPKISDFGLARA 429 (430)
Q Consensus 412 Ll~~~~~~kl~DFGlar~ 429 (430)
|++.++.+||+|||+|+.
T Consensus 184 l~~~~~~~kl~dfg~~~~ 201 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEY 201 (348)
T ss_dssp EECTTSCEEECCCTTCEE
T ss_pred EEcCCCcEEEeccccccc
Confidence 999999999999999874
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=2.6e-26 Score=216.87 Aligned_cols=146 Identities=31% Similarity=0.494 Sum_probs=128.3
Q ss_pred CcccceeecccCCcceEEEEEcC-C---cEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEE-EEE
Q 047619 279 NFSINNKLGEGGFGPVYKGTLVD-G---QEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK-LLI 352 (430)
Q Consensus 279 ~~~~~~~ig~G~fg~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~lv 352 (430)
.|.+.+.||+|+||.||+|...+ + ..+|+|++... .....+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 46667999999999999998543 2 37999998753 345667899999999999999999999999877665 999
Q ss_pred EEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 353 YEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 353 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|||+.+++|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+.
T Consensus 102 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 173 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSP--QRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARD 173 (298)
T ss_dssp ECCCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCT
T ss_pred EecccCCCHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCccc
Confidence 9999999999999653 345889999999999999999999998 99999999999999999999999999974
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.9e-26 Score=233.26 Aligned_cols=148 Identities=32% Similarity=0.469 Sum_probs=131.9
Q ss_pred hcCCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc--ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 352 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 352 (430)
..++|++.+.||+|+||.||+|... +++.||||++.+. .......+.+|+.++++++||||+++++++.+....++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 4468999999999999999999975 5899999998642 233467889999999999999999999999999999999
Q ss_pred EEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEc---CCCCeeecCCCcccc
Q 047619 353 YEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLARA 429 (430)
Q Consensus 353 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~---~~~~~kl~DFGlar~ 429 (430)
|||+++++|.+.+... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+|+.
T Consensus 100 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 100 GELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 9999999999988553 34899999999999999999999998 99999999999995 456799999999974
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.94 E-value=2.9e-26 Score=223.30 Aligned_cols=148 Identities=22% Similarity=0.316 Sum_probs=124.4
Q ss_pred hcCCcccceeecccCCcceEEEEEcC------CcEEEEEEecccChHhH-----------HHHHHHHHHHhcCCCCcccc
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKISEQGL-----------KELKNEVILFSKLQHRNLVK 338 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~ 338 (430)
..++|++.+.||+|+||.||+|.+.. ++.||||++........ ..+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 44689999999999999999998754 47899999875432211 12345667788899999999
Q ss_pred eEEEEEeC----CEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEc
Q 047619 339 LLGCCIQG----EEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLD 414 (430)
Q Consensus 339 l~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~ 414 (430)
+++++... ...+|||||+ +++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+||||+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN--AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence 99998875 4579999999 99999999653 245899999999999999999999998 99999999999998
Q ss_pred --CCCCeeecCCCcccc
Q 047619 415 --QDMNPKISDFGLARA 429 (430)
Q Consensus 415 --~~~~~kl~DFGlar~ 429 (430)
.++.+||+|||+|+.
T Consensus 187 ~~~~~~~kl~DFG~a~~ 203 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYR 203 (364)
T ss_dssp SSCTTCEEECCCTTCEE
T ss_pred cCCCCeEEEEECCccee
Confidence 889999999999964
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=2.1e-26 Score=216.93 Aligned_cols=147 Identities=35% Similarity=0.564 Sum_probs=125.2
Q ss_pred hhcCCcccceeecccCCcceEEEEEcCCcEEEEEEecc--cChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEE
Q 047619 275 NATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 352 (430)
Q Consensus 275 ~~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 352 (430)
...++|++.++||+|+||.||+|.. ...+|+|++.. ......+.+.+|+.++++++||||++++++. .....++|
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv 97 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV 97 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEES--SSEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred cCccceeeeeEecCCCCeEEEEEEE--cCceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEE
Confidence 3457899999999999999999985 34699999864 2455677899999999999999999999964 56678999
Q ss_pred EEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 353 YEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 353 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|||+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 98 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 169 (289)
T 3og7_A 98 TQWCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATE 169 (289)
T ss_dssp EECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC----
T ss_pred EEecCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccc
Confidence 9999999999998543 345899999999999999999999998 99999999999999999999999999864
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.9e-26 Score=233.15 Aligned_cols=148 Identities=34% Similarity=0.448 Sum_probs=132.7
Q ss_pred hcCCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc---ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 351 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 351 (430)
..++|++.+.||+|+||.||+|... +++.||||++.+. .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 4467999999999999999999975 5899999998642 23456789999999999999999999999999999999
Q ss_pred EEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEE---cCCCCeeecCCCccc
Q 047619 352 IYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLAR 428 (430)
Q Consensus 352 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl---~~~~~~kl~DFGlar 428 (430)
||||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+|+
T Consensus 104 v~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISR---KRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp EECCCCSCBHHHHHHTC---SCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 99999999999998654 34899999999999999999999998 9999999999999 467899999999986
Q ss_pred c
Q 047619 429 A 429 (430)
Q Consensus 429 ~ 429 (430)
.
T Consensus 178 ~ 178 (484)
T 3nyv_A 178 H 178 (484)
T ss_dssp H
T ss_pred E
Confidence 4
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.94 E-value=2.2e-26 Score=222.12 Aligned_cols=144 Identities=26% Similarity=0.431 Sum_probs=125.6
Q ss_pred hcCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccChHhHHHHHHHHHHHhcC-CCCcccceEEEEEeCCEEEEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIY 353 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 353 (430)
..++|++.+.||+|+||.||++... +++.||||++.+... ...+|++++.++ +||||+++++++.+.+..++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 4567999999999999999999975 488999999975332 234688888887 7999999999999999999999
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCC----CCeeecCCCcccc
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQD----MNPKISDFGLARA 429 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~----~~~kl~DFGlar~ 429 (430)
||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+..+ +.+||+|||+|+.
T Consensus 96 E~~~gg~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 96 ELMKGGELLDKILRQ---KFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp CCCCSCBHHHHHHTC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred eCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 999999999998653 35899999999999999999999998 9999999999998543 3499999999974
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=5.2e-26 Score=216.76 Aligned_cols=146 Identities=27% Similarity=0.439 Sum_probs=125.2
Q ss_pred hcCCcccceeecccCCcceEEEEEcC-CcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEE----------
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCI---------- 344 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~---------- 344 (430)
..++|++.+.||+|+||.||+|.... ++.||+|++........+.+.+|+.++++++||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence 34789999999999999999999765 8999999998766777888999999999999999999999873
Q ss_pred ----eCCEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEc-CCCCe
Q 047619 345 ----QGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLD-QDMNP 419 (430)
Q Consensus 345 ----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~-~~~~~ 419 (430)
+....++||||++ ++|.+++.. ..+++..+..++.|++.||+|||+++ |+||||||+|||++ +++.+
T Consensus 89 ~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp --CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEE
T ss_pred ccccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeE
Confidence 4467899999997 699999843 34889999999999999999999998 99999999999997 56789
Q ss_pred eecCCCcccc
Q 047619 420 KISDFGLARA 429 (430)
Q Consensus 420 kl~DFGlar~ 429 (430)
||+|||+|+.
T Consensus 161 kl~Dfg~~~~ 170 (320)
T 2i6l_A 161 KIGDFGLARI 170 (320)
T ss_dssp EECCCTTCBC
T ss_pred EEccCccccc
Confidence 9999999975
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-26 Score=219.32 Aligned_cols=153 Identities=26% Similarity=0.432 Sum_probs=119.1
Q ss_pred HhhcCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccC-hHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEE
Q 047619 274 ANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 351 (430)
Q Consensus 274 ~~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 351 (430)
....++|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++.+++||||+++++++...+..++
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 90 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL 90 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence 345678999999999999999999854 58899999986432 3446678899999999999999999999999999999
Q ss_pred EEEccCCCChhHHhhcC-----CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCc
Q 047619 352 IYEFVPNKSLDSFIFDQ-----ERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 426 (430)
Q Consensus 352 v~e~~~~gsL~~~l~~~-----~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGl 426 (430)
||||+++++|.+++... .....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccc
Confidence 99999999999998631 12345899999999999999999999998 99999999999999999999999998
Q ss_pred ccc
Q 047619 427 ARA 429 (430)
Q Consensus 427 ar~ 429 (430)
|+.
T Consensus 168 ~~~ 170 (303)
T 2vwi_A 168 SAF 170 (303)
T ss_dssp HHH
T ss_pred hhe
Confidence 853
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.6e-26 Score=218.71 Aligned_cols=147 Identities=27% Similarity=0.383 Sum_probs=125.3
Q ss_pred hcCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccC--------hHhHHHHHHHHHHHhcCCCCcccceEEEEEeC
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--------EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG 346 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 346 (430)
..++|.+.+.||+|+||.||+|... +++.||||++.... ......+.+|+.++++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3467999999999999999999875 47899999986421 12234588999999999999999999998765
Q ss_pred CEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCC---eeecC
Q 047619 347 EEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMN---PKISD 423 (430)
Q Consensus 347 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~---~kl~D 423 (430)
. .++||||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++. +||+|
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECC
T ss_pred c-eEEEEecCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEcc
Confidence 5 89999999999999998543 45899999999999999999999998 999999999999987654 99999
Q ss_pred CCcccc
Q 047619 424 FGLARA 429 (430)
Q Consensus 424 FGlar~ 429 (430)
||+|+.
T Consensus 161 fg~~~~ 166 (322)
T 2ycf_A 161 FGHSKI 166 (322)
T ss_dssp CTTCEE
T ss_pred Ccccee
Confidence 999974
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.5e-26 Score=220.64 Aligned_cols=147 Identities=30% Similarity=0.506 Sum_probs=127.6
Q ss_pred cCCcccceeecccCCcceEEEEE-cCCcEEEEEEeccc--ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeC-------
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG------- 346 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------- 346 (430)
.++|++.+.||+|+||.||+|.. .+++.||||++... .......+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 46899999999999999999997 45899999998642 223345678999999999999999999999874
Q ss_pred -CEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCC
Q 047619 347 -EEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 425 (430)
Q Consensus 347 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFG 425 (430)
+..++||||+++ +|...+.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVL--VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCC-CHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence 468999999975 7777765432 34899999999999999999999998 9999999999999999999999999
Q ss_pred cccc
Q 047619 426 LARA 429 (430)
Q Consensus 426 lar~ 429 (430)
+|+.
T Consensus 170 ~a~~ 173 (351)
T 3mi9_A 170 LARA 173 (351)
T ss_dssp TCEE
T ss_pred hccc
Confidence 9874
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.8e-26 Score=213.42 Aligned_cols=149 Identities=33% Similarity=0.611 Sum_probs=127.8
Q ss_pred hcCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccChH-------hHHHHHHHHHHHhcCCCCcccceEEEEEeCC
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQ-------GLKELKNEVILFSKLQHRNLVKLLGCCIQGE 347 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 347 (430)
..++|++.+.||+|+||.||+|... +++.||+|++...... ..+.+.+|+.++++++||||+++++++.+..
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP 96 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence 3478999999999999999999974 5889999998642211 1267899999999999999999999986555
Q ss_pred EEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCC-----eeec
Q 047619 348 EKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMN-----PKIS 422 (430)
Q Consensus 348 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~-----~kl~ 422 (430)
++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ .+|+||||||+|||++.++. +||+
T Consensus 97 --~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 97 --RMVMEFVPCGDLYHRLLDKA--HPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp --EEEEECCTTCBHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred --eEEEEecCCCCHHHHHhccc--CCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 79999999999999886543 45899999999999999999999875 34999999999999988776 9999
Q ss_pred CCCcccc
Q 047619 423 DFGLARA 429 (430)
Q Consensus 423 DFGlar~ 429 (430)
|||+|+.
T Consensus 172 Dfg~~~~ 178 (287)
T 4f0f_A 172 DFGLSQQ 178 (287)
T ss_dssp CCTTCBC
T ss_pred CCCcccc
Confidence 9999874
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.94 E-value=5.4e-27 Score=229.56 Aligned_cols=150 Identities=17% Similarity=0.209 Sum_probs=124.6
Q ss_pred hcCCcccceeecccCCcceEEEEE-cCCcEEEEEEecc---cChHhHHHHHHHH---HHHhcCCCCcccceE-------E
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSK---ISEQGLKELKNEV---ILFSKLQHRNLVKLL-------G 341 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~E~---~~l~~l~h~niv~l~-------~ 341 (430)
..++|++.+.||+|+||.||+|.. .+++.||||++.. ......+.+.+|+ .++++++||||++++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 346899999999999999999996 4589999999863 2344567899999 556666899999998 7
Q ss_pred EEEeCCE-----------------EEEEEEccCCCChhHHhhcCCC----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCc
Q 047619 342 CCIQGEE-----------------KLLIYEFVPNKSLDSFIFDQER----CKILDWSKRFHIICGTARGVMYLHQDSRLR 400 (430)
Q Consensus 342 ~~~~~~~-----------------~~lv~e~~~~gsL~~~l~~~~~----~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~ 400 (430)
++...+. .+|||||+ +|+|.+++..... ...+++..++.++.||+.||+|||+++
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 226 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--- 226 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 7665542 78999999 6899999965321 112345888899999999999999998
Q ss_pred EEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 401 IIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 401 iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|+||||||+||||+.++.+||+|||+|+.
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~ 255 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEE
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhhee
Confidence 99999999999999999999999999974
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.93 E-value=5.6e-26 Score=224.00 Aligned_cols=145 Identities=25% Similarity=0.334 Sum_probs=123.3
Q ss_pred hcCCcccc-eeecccCCcceEEEEEc-CCcEEEEEEecccChHhHHHHHHHHHHH-hcCCCCcccceEEEEEe----CCE
Q 047619 276 ATDNFSIN-NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILF-SKLQHRNLVKLLGCCIQ----GEE 348 (430)
Q Consensus 276 ~~~~~~~~-~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~ 348 (430)
..++|.+. +.||+|+||.||++... +++.||||++... ..+.+|+.++ +..+||||+++++++.. ...
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~ 133 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence 34567776 68999999999999975 4889999999642 3566788877 44589999999999876 567
Q ss_pred EEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcC---CCCeeecCCC
Q 047619 349 KLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKISDFG 425 (430)
Q Consensus 349 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~DFG 425 (430)
.+|||||+++++|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+||||+. ++.+||+|||
T Consensus 134 ~~lv~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp EEEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEEeCCCCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecc
Confidence 899999999999999996543 245899999999999999999999988 999999999999987 7889999999
Q ss_pred cccc
Q 047619 426 LARA 429 (430)
Q Consensus 426 lar~ 429 (430)
+|+.
T Consensus 210 ~a~~ 213 (400)
T 1nxk_A 210 FAKE 213 (400)
T ss_dssp TCEE
T ss_pred cccc
Confidence 9974
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.1e-26 Score=218.89 Aligned_cols=157 Identities=27% Similarity=0.403 Sum_probs=136.0
Q ss_pred cHHhHHhhcCCcccc-eeecccCCcceEEEEEc-CCcEEEEEEeccc--ChHhHHHHHHHHHHHhcCC-CCcccceEEEE
Q 047619 269 ELATIANATDNFSIN-NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQ-HRNLVKLLGCC 343 (430)
Q Consensus 269 ~~~~~~~~~~~~~~~-~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~ 343 (430)
.+.......+.|.+. +.||+|+||.||+|... +++.||+|++... .......+.+|+.++..+. ||||+++++++
T Consensus 19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~ 98 (327)
T 3lm5_A 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY 98 (327)
T ss_dssp CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 344556666788887 88999999999999875 4899999998753 2334678899999999995 69999999999
Q ss_pred EeCCEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcC---CCCee
Q 047619 344 IQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ---DMNPK 420 (430)
Q Consensus 344 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~k 420 (430)
...+..++||||+++++|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++. ++.+|
T Consensus 99 ~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~k 174 (327)
T 3lm5_A 99 ENTSEIILILEYAAGGEIFSLCLPEL-AEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIK 174 (327)
T ss_dssp ECSSEEEEEEECCTTEEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEE
T ss_pred EeCCeEEEEEEecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEE
Confidence 99999999999999999999985432 346899999999999999999999998 999999999999987 78999
Q ss_pred ecCCCcccc
Q 047619 421 ISDFGLARA 429 (430)
Q Consensus 421 l~DFGlar~ 429 (430)
|+|||+|+.
T Consensus 175 L~Dfg~a~~ 183 (327)
T 3lm5_A 175 IVDFGMSRK 183 (327)
T ss_dssp ECCGGGCEE
T ss_pred EeeCccccc
Confidence 999999975
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=6.8e-26 Score=215.75 Aligned_cols=148 Identities=30% Similarity=0.516 Sum_probs=127.2
Q ss_pred hhcCCcccceeecccCCcceEEEEEcC-CcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEE
Q 047619 275 NATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 353 (430)
Q Consensus 275 ~~~~~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 353 (430)
...++|++.+.||+|+||.||+|.... ++.||+|++... ...+.+.+|+.++..++||||+++++++...+..++||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 345789999999999999999999754 899999998753 24567889999999999999999999999999999999
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||+|+.
T Consensus 104 e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 174 (314)
T 3com_A 104 EYCGAGSVSDIIRLR--NKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQ 174 (314)
T ss_dssp ECCTTEEHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred ecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchh
Confidence 999999999998532 245899999999999999999999998 99999999999999999999999999864
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=6.1e-26 Score=217.62 Aligned_cols=141 Identities=24% Similarity=0.447 Sum_probs=127.0
Q ss_pred cCCcccceeecccCCcceEEEEE-cCCcEEEEEEecccChHhHHHHHHHHHHHhcCC-CCcccceEEEEEe--CCEEEEE
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQ--GEEKLLI 352 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lv 352 (430)
.++|++.+.||+|+||.||+|.. .+++.||||++... ..+.+.+|+.++++++ ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 36799999999999999999986 45889999999753 3467889999999997 9999999999998 6678999
Q ss_pred EEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCC-CeeecCCCcccc
Q 047619 353 YEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLARA 429 (430)
Q Consensus 353 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DFGlar~ 429 (430)
|||+++++|.+++. .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||+|+.
T Consensus 112 ~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~ 180 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 180 (330)
T ss_dssp EECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceE
Confidence 99999999999883 3788999999999999999999998 99999999999999776 899999999974
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.1e-26 Score=213.47 Aligned_cols=154 Identities=28% Similarity=0.426 Sum_probs=131.6
Q ss_pred hcCCcccceeecccCCcceEEEEEc-CCcEEEEEEecc--cChHhHHHHHHHHHHHhcCCCCcccceEEEEEe--CCEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ--GEEKL 350 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~ 350 (430)
..++|++.+.||+|+||.||++... +++.||+|++.. ......+.+.+|+.++++++||||+++++++.. ....+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 3468999999999999999999975 589999999864 244566789999999999999999999998864 56889
Q ss_pred EEEEccCCCChhHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHhhhcC--CCcEEeCCCCCCcEEEcCCCCeeecCCCcc
Q 047619 351 LIYEFVPNKSLDSFIFDQE-RCKILDWSKRFHIICGTARGVMYLHQDS--RLRIIHRDLKASNVLLDQDMNPKISDFGLA 427 (430)
Q Consensus 351 lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~~i~~~i~~aL~yLH~~~--~~~iiH~Dlkp~NILl~~~~~~kl~DFGla 427 (430)
+||||+++++|.+++.... ....+++..+..++.|++.||+|||+.+ ..+|+||||||+|||++.++.+||+|||+|
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~ 163 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence 9999999999999986532 2345899999999999999999999875 134999999999999999999999999998
Q ss_pred cc
Q 047619 428 RA 429 (430)
Q Consensus 428 r~ 429 (430)
+.
T Consensus 164 ~~ 165 (279)
T 2w5a_A 164 RI 165 (279)
T ss_dssp HH
T ss_pred ee
Confidence 64
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.3e-26 Score=219.77 Aligned_cols=152 Identities=33% Similarity=0.452 Sum_probs=131.9
Q ss_pred hcCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccChHhHHHHHHHHHHHhcCC-CCcccceEEEEEe--------
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQ-------- 345 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~-------- 345 (430)
...+|++.+.||+|+||.||+|... +++.||||++........+.+.+|+.++.++. ||||+++++++..
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 3457999999999999999999964 58999999987666677788999999999996 9999999999953
Q ss_pred CCEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCC
Q 047619 346 GEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 425 (430)
Q Consensus 346 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFG 425 (430)
....++||||++ |+|.+++........+++..+..++.||+.||.|||+.+ .+|+||||||+||||+.++.+||+|||
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCc
Confidence 345799999996 789888865333456999999999999999999999864 349999999999999999999999999
Q ss_pred cccc
Q 047619 426 LARA 429 (430)
Q Consensus 426 lar~ 429 (430)
+|+.
T Consensus 184 ~~~~ 187 (337)
T 3ll6_A 184 SATT 187 (337)
T ss_dssp TCBC
T ss_pred ccee
Confidence 9974
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=4.5e-26 Score=218.63 Aligned_cols=147 Identities=31% Similarity=0.557 Sum_probs=126.4
Q ss_pred cCCcccceeecccCCcceEEEEEcC-Cc----EEEEEEecc-cChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEE
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLVD-GQ----EIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 350 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~~-~~----~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 350 (430)
.++|++.+.||+|+||.||+|.... ++ .||+|.+.. ......+.+.+|+.++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 3689999999999999999998643 44 457777753 23456788999999999999999999999998765 78
Q ss_pred EEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 351 LIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 351 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+|+||+++++|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+.
T Consensus 93 ~v~~~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEECCCSSCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred EEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 9999999999999996543 35899999999999999999999998 99999999999999999999999999974
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-25 Score=211.39 Aligned_cols=149 Identities=26% Similarity=0.407 Sum_probs=129.8
Q ss_pred cCCcccceeecccCCcceEEEEEc-CCcEEEEEEecc--cChHhHHHHHHHHHHHhcCCCCcccceEEEEEe----CCEE
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ----GEEK 349 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~ 349 (430)
...|.+.+.||+|+||.||+|... ++..||+|++.. ......+.+.+|+.++++++||||+++++++.. ....
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 345888899999999999999874 478999999864 345567789999999999999999999999876 3568
Q ss_pred EEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEc-CCCCeeecCCCccc
Q 047619 350 LLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLD-QDMNPKISDFGLAR 428 (430)
Q Consensus 350 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~-~~~~~kl~DFGlar 428 (430)
++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ .+|+||||||+|||++ .++.+||+|||+|+
T Consensus 105 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEEecCCCCHHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 9999999999999999643 35889999999999999999999874 3499999999999997 78899999999986
Q ss_pred c
Q 047619 429 A 429 (430)
Q Consensus 429 ~ 429 (430)
.
T Consensus 181 ~ 181 (290)
T 1t4h_A 181 L 181 (290)
T ss_dssp G
T ss_pred c
Confidence 4
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=8.4e-26 Score=214.15 Aligned_cols=149 Identities=26% Similarity=0.425 Sum_probs=126.8
Q ss_pred hcCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccC----hHhHHHHHHHHHHHhcCCCCcccceEEEEE--eCCE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS----EQGLKELKNEVILFSKLQHRNLVKLLGCCI--QGEE 348 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~ 348 (430)
..++|.+.+.||+|+||.||++... +++.+|+|++.... ....+.+.+|+.++++++||||+++++++. +...
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 3478999999999999999999964 58899999997532 234678999999999999999999999985 4457
Q ss_pred EEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCccc
Q 047619 349 KLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428 (430)
Q Consensus 349 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar 428 (430)
.++||||++++ |.+++.... ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHST-TCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEehhccCC-HHHHHHhCc-ccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccccc
Confidence 89999999876 777765433 345899999999999999999999998 9999999999999999999999999986
Q ss_pred c
Q 047619 429 A 429 (430)
Q Consensus 429 ~ 429 (430)
.
T Consensus 158 ~ 158 (305)
T 2wtk_C 158 A 158 (305)
T ss_dssp E
T ss_pred c
Confidence 4
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=7.6e-26 Score=213.81 Aligned_cols=147 Identities=30% Similarity=0.495 Sum_probs=128.5
Q ss_pred cCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccC--hHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEE
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 353 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 353 (430)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (299)
T 2r3i_A 2 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 81 (299)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceEEEE
Confidence 368999999999999999999975 58999999986432 233467889999999999999999999999999999999
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCccc
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar 428 (430)
||++ ++|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+
T Consensus 82 e~~~-~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~ 151 (299)
T 2r3i_A 82 EFLH-QDLKKFMDASAL-TGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 151 (299)
T ss_dssp ECCS-EEHHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECSTTHHH
T ss_pred Eccc-CCHHHHHHhhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHeEEcCCCCEEECcchhhh
Confidence 9997 699999865432 34889999999999999999999998 9999999999999999999999999885
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.4e-26 Score=213.07 Aligned_cols=148 Identities=28% Similarity=0.459 Sum_probs=129.9
Q ss_pred hcCCcccceeecccCCcceEEEEEcC----CcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 350 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 350 (430)
..++|.+.+.||+|+||.||+|.... +..||+|.+... .....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 45689999999999999999998643 336999998753 44567789999999999999999999999764 5578
Q ss_pred EEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 351 LIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 351 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 89 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNK--NSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp EEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred EEEecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcc
Confidence 9999999999999996532 35899999999999999999999998 99999999999999999999999999874
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1e-25 Score=216.69 Aligned_cols=143 Identities=34% Similarity=0.560 Sum_probs=120.1
Q ss_pred hcCCcccceeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHH--HHhcCCCCcccceEEEEEe-----CCE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVI--LFSKLQHRNLVKLLGCCIQ-----GEE 348 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~--~l~~l~h~niv~l~~~~~~-----~~~ 348 (430)
..++|++.+.||+|+||.||+|.. +++.||||++.... ...+..|.+ .+..++||||+++++.+.. ...
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 457899999999999999999976 68999999996432 233344444 4556899999999986543 235
Q ss_pred EEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhc---------CCCcEEeCCCCCCcEEEcCCCCe
Q 047619 349 KLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD---------SRLRIIHRDLKASNVLLDQDMNP 419 (430)
Q Consensus 349 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~---------~~~~iiH~Dlkp~NILl~~~~~~ 419 (430)
.++||||+++++|.+++... ..++..+..++.||+.||.|||+. + |+||||||+||||+.++.+
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~ 159 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLH----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTC 159 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCE
T ss_pred EEEEEecCCCCcHHHHHhhc----ccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcE
Confidence 68999999999999999543 258889999999999999999998 7 9999999999999999999
Q ss_pred eecCCCcccc
Q 047619 420 KISDFGLARA 429 (430)
Q Consensus 420 kl~DFGlar~ 429 (430)
||+|||+|+.
T Consensus 160 kL~DFG~a~~ 169 (336)
T 3g2f_A 160 VISDFGLSMR 169 (336)
T ss_dssp EECCCTTCEE
T ss_pred EEeeccceee
Confidence 9999999964
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.3e-26 Score=211.46 Aligned_cols=149 Identities=26% Similarity=0.390 Sum_probs=131.6
Q ss_pred cCCcccceeecccCCcceEEEEEcCCcEEEEEEeccc--ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeC--CEEEEE
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKLLI 352 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 352 (430)
.++|++.+.||+|+||.||+|... ++.+|||++... .....+.+.+|+.++++++||||+++++++.+. ...++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 467999999999999999999974 889999998753 345567899999999999999999999999887 778999
Q ss_pred EEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCccc
Q 047619 353 YEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428 (430)
Q Consensus 353 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar 428 (430)
|||+++++|.+++.... ...+++..+..++.|++.||.|||+.+ .+|+||||||+|||++.++.++|+|||++.
T Consensus 88 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~ 161 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKF 161 (271)
T ss_dssp EECCTTCBHHHHHHSCS-SCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred ecccCCCcHHHHHhhcc-cCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEecccee
Confidence 99999999999997543 235899999999999999999999864 349999999999999999999999888764
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=9.8e-26 Score=212.85 Aligned_cols=146 Identities=20% Similarity=0.354 Sum_probs=129.6
Q ss_pred hcCCcccceeecccCCcceEEEEE-cCCcEEEEEEecccChHhHHHHHHHHHHHhcC-CCCcccceEEEEEeCCEEEEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIY 353 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 353 (430)
..++|++.+.||+|+||.||+|.. .+++.||||++.... ..+.+.+|+.++..+ +|+|++++++++......++||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 85 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence 446899999999999999999996 568999999986432 334678899999999 7999999999999999999999
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCC-----eeecCCCccc
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMN-----PKISDFGLAR 428 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~-----~kl~DFGlar 428 (430)
||+ +++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||+|+
T Consensus 86 e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 86 DLL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp ECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred Eec-CCCHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 999 999999996542 35899999999999999999999988 999999999999987766 9999999997
Q ss_pred c
Q 047619 429 A 429 (430)
Q Consensus 429 ~ 429 (430)
.
T Consensus 160 ~ 160 (298)
T 1csn_A 160 F 160 (298)
T ss_dssp E
T ss_pred c
Confidence 4
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-25 Score=219.60 Aligned_cols=144 Identities=28% Similarity=0.433 Sum_probs=125.8
Q ss_pred cCCcccceeecccCCcceEEEEEc-CCcEEEEEEecc--cChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCC------
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE------ 347 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 347 (430)
.++|++.+.||+|+||.||+|... +++.||||++.. ......+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 478999999999999999999864 588999999865 23455677889999999999999999999998765
Q ss_pred EEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcc
Q 047619 348 EKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427 (430)
Q Consensus 348 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla 427 (430)
..++||||+++ +|.+.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 104 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence 78999999974 7888774 23889999999999999999999998 999999999999999999999999999
Q ss_pred cc
Q 047619 428 RA 429 (430)
Q Consensus 428 r~ 429 (430)
+.
T Consensus 175 ~~ 176 (371)
T 2xrw_A 175 RT 176 (371)
T ss_dssp --
T ss_pred cc
Confidence 74
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.93 E-value=3.9e-26 Score=214.73 Aligned_cols=150 Identities=26% Similarity=0.350 Sum_probs=122.4
Q ss_pred hcCCcccceeecccCCcceEEEEE-cCCcEEEEEEeccc-Ch-HhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI-SE-QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 352 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 352 (430)
..++|++.+.||+|+||.||+|.. .+++.||+|++... .. ...+.+..+...++.++||||+++++++.+.+..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 457899999999999999999997 45889999999753 22 2334455555668889999999999999999999999
Q ss_pred EEccCCCChhHHhhcC-CCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 353 YEFVPNKSLDSFIFDQ-ERCKILDWSKRFHIICGTARGVMYLHQD-SRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 353 ~e~~~~gsL~~~l~~~-~~~~~~~~~~~~~i~~~i~~aL~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|||++ ++|.+++... .....+++..+..++.|++.||.|||++ + |+||||||+|||++.++.+||+|||+|+.
T Consensus 85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T 3fme_A 85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGY 159 (290)
T ss_dssp EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-----
T ss_pred Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccc
Confidence 99997 5887776431 2234689999999999999999999998 8 99999999999999999999999999874
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-25 Score=216.60 Aligned_cols=145 Identities=26% Similarity=0.451 Sum_probs=128.8
Q ss_pred HhhcCCcccceeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhc--CCCCcccceEEEEEeCC----
Q 047619 274 ANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSK--LQHRNLVKLLGCCIQGE---- 347 (430)
Q Consensus 274 ~~~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~---- 347 (430)
....++|++.+.||+|+||.||+|.. +++.||||++.. .....+.+|++++.. ++||||+++++++....
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECG---GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCc---hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 44557899999999999999999987 589999999964 234567788888877 78999999999999876
Q ss_pred EEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhh--------hcCCCcEEeCCCCCCcEEEcCCCCe
Q 047619 348 EKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLH--------QDSRLRIIHRDLKASNVLLDQDMNP 419 (430)
Q Consensus 348 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH--------~~~~~~iiH~Dlkp~NILl~~~~~~ 419 (430)
..++||||+++++|.+++... .+++..+..++.|++.||.||| +.+ |+||||||+||||+.++.+
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~ 186 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTC 186 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCE
T ss_pred eeEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCE
Confidence 789999999999999999542 4899999999999999999999 666 9999999999999999999
Q ss_pred eecCCCcccc
Q 047619 420 KISDFGLARA 429 (430)
Q Consensus 420 kl~DFGlar~ 429 (430)
||+|||+|+.
T Consensus 187 kL~Dfg~~~~ 196 (342)
T 1b6c_B 187 CIADLGLAVR 196 (342)
T ss_dssp EECCCTTCEE
T ss_pred EEEECCCcee
Confidence 9999999864
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.7e-26 Score=234.53 Aligned_cols=137 Identities=18% Similarity=0.236 Sum_probs=110.1
Q ss_pred eecccCCcceEEEE-EcCCcEEEEEEeccc----------ChHhHHHHHHHHHHHhcC-CCCcccceEEEEEeCCEEEEE
Q 047619 285 KLGEGGFGPVYKGT-LVDGQEIAVKRLSKI----------SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLI 352 (430)
Q Consensus 285 ~ig~G~fg~Vy~~~-~~~~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 352 (430)
..+.|+.|.+..++ .--|+.+|+|.+.+. .....++|.+|+++|+++ .|+||++++++++++...|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 45666666666554 234888999998642 234467799999999999 699999999999999999999
Q ss_pred EEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCccccC
Q 047619 353 YEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430 (430)
Q Consensus 353 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~~ 430 (430)
|||++|++|.++|... .++++. .|+.||+.||+|+|++| ||||||||+||||++++.+||+|||+||.+
T Consensus 321 MEyv~G~~L~d~i~~~---~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~ 389 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAG---EEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTT 389 (569)
T ss_dssp EECCCSEEHHHHHHTT---CCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESC
T ss_pred EecCCCCcHHHHHHhC---CCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeC
Confidence 9999999999999654 346654 47899999999999999 999999999999999999999999999853
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=7.1e-26 Score=217.09 Aligned_cols=150 Identities=33% Similarity=0.561 Sum_probs=128.7
Q ss_pred hcCCcccceeecccCCcceEEEEE------cCCcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTL------VDGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 348 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 348 (430)
..++|++.+.||+|+||.||+|.. .++..||||++... .......+.+|+.++++++||||+++++++.....
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 346899999999999999999983 24678999999643 45566789999999999999999999999999999
Q ss_pred EEEEEEccCCCChhHHhhcCCC----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcC---CCCeee
Q 047619 349 KLLIYEFVPNKSLDSFIFDQER----CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKI 421 (430)
Q Consensus 349 ~~lv~e~~~~gsL~~~l~~~~~----~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kl 421 (430)
.++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEE
Confidence 9999999999999999975432 134889999999999999999999998 999999999999984 446999
Q ss_pred cCCCccc
Q 047619 422 SDFGLAR 428 (430)
Q Consensus 422 ~DFGlar 428 (430)
+|||+|+
T Consensus 185 ~Dfg~~~ 191 (327)
T 2yfx_A 185 GDFGMAR 191 (327)
T ss_dssp CCCHHHH
T ss_pred Ccccccc
Confidence 9999986
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.93 E-value=6.1e-26 Score=222.52 Aligned_cols=148 Identities=26% Similarity=0.403 Sum_probs=122.3
Q ss_pred HhhcCCcccceeecccCCcceEEEEE-cCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeC------
Q 047619 274 ANATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG------ 346 (430)
Q Consensus 274 ~~~~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 346 (430)
....++|++.+.||+|+||.||+|.. .+++.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 34567899999999999999999986 458999999986432 2234799999999999999999998543
Q ss_pred --------------------------------CEEEEEEEccCCCChhHHhhcC-CCCCCCCHHHHHHHHHHHHHHHHHh
Q 047619 347 --------------------------------EEKLLIYEFVPNKSLDSFIFDQ-ERCKILDWSKRFHIICGTARGVMYL 393 (430)
Q Consensus 347 --------------------------------~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~~~i~~~i~~aL~yL 393 (430)
...++||||++ ++|.+.+... .....+++..+..++.||+.||.||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 34789999998 5877776531 2234689999999999999999999
Q ss_pred hhcCCCcEEeCCCCCCcEEEc-CCCCeeecCCCcccc
Q 047619 394 HQDSRLRIIHRDLKASNVLLD-QDMNPKISDFGLARA 429 (430)
Q Consensus 394 H~~~~~~iiH~Dlkp~NILl~-~~~~~kl~DFGlar~ 429 (430)
|+.+ |+||||||+|||++ .++.+||+|||+|+.
T Consensus 158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~ 191 (383)
T 3eb0_A 158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKK 191 (383)
T ss_dssp HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEE
T ss_pred HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcc
Confidence 9988 99999999999997 678999999999974
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=5.3e-26 Score=221.59 Aligned_cols=146 Identities=30% Similarity=0.470 Sum_probs=117.0
Q ss_pred hcCCcccceeecccCCcceEEEEE-cCCcEEEEEEeccc--ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeC------
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG------ 346 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 346 (430)
..++|++.+.||+|+||.||+|.. .+++.||||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 347899999999999999999986 45889999999652 345567888999999999999999999998764
Q ss_pred CEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCc
Q 047619 347 EEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 426 (430)
Q Consensus 347 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGl 426 (430)
...++|||++ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC---
T ss_pred CeEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccc
Confidence 5679999999 7899988843 34899999999999999999999998 99999999999999999999999999
Q ss_pred ccc
Q 047619 427 ARA 429 (430)
Q Consensus 427 ar~ 429 (430)
|+.
T Consensus 179 a~~ 181 (367)
T 2fst_X 179 ARH 181 (367)
T ss_dssp ---
T ss_pred ccc
Confidence 974
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.4e-26 Score=214.08 Aligned_cols=147 Identities=27% Similarity=0.487 Sum_probs=126.1
Q ss_pred hcCCcccceeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeC-CEEEEEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-EEKLLIYE 354 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e 354 (430)
..++|++.+.||+|+||.||++.. .++.||||++... ...+.+.+|+.++++++||||+++++++.+. +..++|||
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred ChhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 346899999999999999999987 4889999999753 2457789999999999999999999997655 46899999
Q ss_pred ccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 355 FVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 355 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|+++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 96 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~ 166 (278)
T 1byg_A 96 YMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKE 166 (278)
T ss_dssp CCTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---
T ss_pred cCCCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccc
Confidence 999999999996432 223788999999999999999999998 99999999999999999999999999864
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-25 Score=212.10 Aligned_cols=145 Identities=25% Similarity=0.333 Sum_probs=126.1
Q ss_pred hcCCcccc-eeecccCCcceEEEEE-cCCcEEEEEEecccChHhHHHHHHHHHHH-hcCCCCcccceEEEEEe----CCE
Q 047619 276 ATDNFSIN-NKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILF-SKLQHRNLVKLLGCCIQ----GEE 348 (430)
Q Consensus 276 ~~~~~~~~-~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~ 348 (430)
..++|.+. +.||+|+||.||+|.. .+++.||+|++... ..+.+|+.++ +.++||||+++++++.. ...
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 89 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 89 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence 44678877 7799999999999987 45889999999642 3566788887 66699999999999987 677
Q ss_pred EEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcC---CCCeeecCCC
Q 047619 349 KLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKISDFG 425 (430)
Q Consensus 349 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~DFG 425 (430)
.++||||+++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 899999999999999997643 245899999999999999999999998 999999999999998 7889999999
Q ss_pred cccc
Q 047619 426 LARA 429 (430)
Q Consensus 426 lar~ 429 (430)
+|+.
T Consensus 166 ~a~~ 169 (299)
T 3m2w_A 166 FAKE 169 (299)
T ss_dssp TCEE
T ss_pred cccc
Confidence 9974
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=1.4e-25 Score=218.47 Aligned_cols=146 Identities=24% Similarity=0.423 Sum_probs=129.2
Q ss_pred hcCCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeC-----CE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-----EE 348 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 348 (430)
..++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.++.+++||||+++++++... ..
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 3468999999999999999999864 5889999999753 344557889999999999999999999999765 36
Q ss_pred EEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCccc
Q 047619 349 KLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428 (430)
Q Consensus 349 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar 428 (430)
.++||||++ ++|.+++... .+++..+..++.|++.||.|||+.+ |+||||||+||||+.++.+||+|||+|+
T Consensus 105 ~~iv~e~~~-~~L~~~l~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp EEEEEECCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEcccC-cCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceE
Confidence 899999997 5899988542 4899999999999999999999998 9999999999999999999999999997
Q ss_pred c
Q 047619 429 A 429 (430)
Q Consensus 429 ~ 429 (430)
.
T Consensus 177 ~ 177 (364)
T 3qyz_A 177 V 177 (364)
T ss_dssp E
T ss_pred e
Confidence 4
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.93 E-value=4.5e-26 Score=224.31 Aligned_cols=146 Identities=25% Similarity=0.374 Sum_probs=122.1
Q ss_pred cCCcccceeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCE------EE
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE------KL 350 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------~~ 350 (430)
..+|++.+.||+|+||.||+|....+..+|+|++..... ...+|+.+++.++||||+++++++..... .+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 357999999999999999999987777899998864221 22369999999999999999999976443 78
Q ss_pred EEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEc-CCCCeeecCCCcccc
Q 047619 351 LIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLD-QDMNPKISDFGLARA 429 (430)
Q Consensus 351 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~-~~~~~kl~DFGlar~ 429 (430)
+||||++++.+............+++..+..++.||+.||+|||+.+ |+||||||+||||+ .++.+||+|||+|+.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 99999987655444322222346899999999999999999999998 99999999999998 789999999999975
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.7e-25 Score=216.65 Aligned_cols=146 Identities=29% Similarity=0.477 Sum_probs=129.8
Q ss_pred hcCCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeC-----CE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-----EE 348 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 348 (430)
..++|++.+.||+|+||.||+|... +++.||||++... .......+.+|+.++++++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 4578999999999999999999975 5889999999753 344566788999999999999999999988764 67
Q ss_pred EEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCccc
Q 047619 349 KLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428 (430)
Q Consensus 349 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar 428 (430)
.++||||++ ++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+
T Consensus 89 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 899999997 689998854 34899999999999999999999998 9999999999999999999999999997
Q ss_pred c
Q 047619 429 A 429 (430)
Q Consensus 429 ~ 429 (430)
.
T Consensus 161 ~ 161 (353)
T 2b9h_A 161 I 161 (353)
T ss_dssp E
T ss_pred c
Confidence 4
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=8.4e-26 Score=218.35 Aligned_cols=146 Identities=19% Similarity=0.297 Sum_probs=121.1
Q ss_pred cCCcccceeecccCCcceEEEEEc----CCcEEEEEEecccChH-----------hHHHHHHHHHHHhcCCCCcccceEE
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSKISEQ-----------GLKELKNEVILFSKLQHRNLVKLLG 341 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~~ 341 (430)
.++|.+.+.||+|+||.||+|... .+..+|+|++...... ....+.+|+.++..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 468999999999999999999975 4678999998753211 1223667889999999999999999
Q ss_pred EEEe----CCEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCC
Q 047619 342 CCIQ----GEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDM 417 (430)
Q Consensus 342 ~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~ 417 (430)
++.. ....++||||+ +++|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence 9998 77899999999 999999985432 6899999999999999999999998 99999999999998887
Q ss_pred --CeeecCCCcccc
Q 047619 418 --NPKISDFGLARA 429 (430)
Q Consensus 418 --~~kl~DFGlar~ 429 (430)
.+||+|||+|+.
T Consensus 189 ~~~~kL~Dfg~a~~ 202 (345)
T 2v62_A 189 PDQVYLADYGLSYR 202 (345)
T ss_dssp TTSEEECCCTTCEE
T ss_pred CCcEEEEeCCCcee
Confidence 999999999964
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=6.8e-26 Score=235.75 Aligned_cols=139 Identities=31% Similarity=0.498 Sum_probs=123.5
Q ss_pred eeecccCCcceEEEEEc---CCcEEEEEEeccc--ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEccCC
Q 047619 284 NKLGEGGFGPVYKGTLV---DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPN 358 (430)
Q Consensus 284 ~~ig~G~fg~Vy~~~~~---~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 358 (430)
++||+|+||.||+|.+. .++.||||+++.. .....+++.+|+.++++++|||||++++++. .+..+|||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 47999999999999653 3678999999753 3345688999999999999999999999986 4568899999999
Q ss_pred CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 359 KSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 359 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.
T Consensus 454 g~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~ 518 (635)
T 4fl3_A 454 GPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKA 518 (635)
T ss_dssp EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHH
T ss_pred CCHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccc
Confidence 9999999643 35899999999999999999999998 99999999999999999999999999874
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.93 E-value=9.4e-26 Score=212.25 Aligned_cols=147 Identities=32% Similarity=0.468 Sum_probs=122.3
Q ss_pred cCCcccceeecccCCcceEEEEEcC--Cc--EEEEEEeccc---ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEE
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLVD--GQ--EIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 349 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~~--~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 349 (430)
.++|++.+.||+|+||.||+|.+.. ++ .||+|++... .....+.+.+|+.++++++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 4679999999999999999998532 33 6899988643 2345678999999999999999999999988765 8
Q ss_pred EEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 350 LLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 350 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeEecccCCCHHHHHHhcc--CCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence 89999999999999996532 35889999999999999999999998 99999999999999999999999999874
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.9e-25 Score=210.07 Aligned_cols=150 Identities=31% Similarity=0.453 Sum_probs=132.6
Q ss_pred HhhcCCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc--ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEE
Q 047619 274 ANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 350 (430)
Q Consensus 274 ~~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 350 (430)
....++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.++++++||||+++++++...+..+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 344578999999999999999999975 5889999998642 2345678899999999999999999999999999999
Q ss_pred EEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCC---CCeeecCCCcc
Q 047619 351 LIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQD---MNPKISDFGLA 427 (430)
Q Consensus 351 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~---~~~kl~DFGla 427 (430)
+||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.+ +.+||+|||+|
T Consensus 98 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EEECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEEEccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 999999999999988543 34899999999999999999999998 9999999999999754 46999999998
Q ss_pred cc
Q 047619 428 RA 429 (430)
Q Consensus 428 r~ 429 (430)
+.
T Consensus 172 ~~ 173 (287)
T 2wei_A 172 TC 173 (287)
T ss_dssp GT
T ss_pred ee
Confidence 74
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.1e-25 Score=219.86 Aligned_cols=148 Identities=22% Similarity=0.307 Sum_probs=129.2
Q ss_pred hcCCcccceeecccCCcceEEEEEcC-CcEEEEEEecccChHhHHHHHHHHHHHhcC------CCCcccceEEEEEeCCE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKL------QHRNLVKLLGCCIQGEE 348 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~ 348 (430)
...+|++.+.||+|+||.||+|.... ++.||||++.. .......+.+|+.+++.+ +|+||+++++++.....
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~-~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN-EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECC-ccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 44689999999999999999998654 88999999975 344556778888888777 57799999999999999
Q ss_pred EEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCC--eeecCCCc
Q 047619 349 KLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMN--PKISDFGL 426 (430)
Q Consensus 349 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~--~kl~DFGl 426 (430)
.++||||++ ++|.+++..... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++. +||+|||+
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKNKF-QGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEEeccC-CCHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeeccc
Confidence 999999996 689998865432 34899999999999999999999998 999999999999999887 99999999
Q ss_pred ccc
Q 047619 427 ARA 429 (430)
Q Consensus 427 ar~ 429 (430)
|+.
T Consensus 249 a~~ 251 (429)
T 3kvw_A 249 SCY 251 (429)
T ss_dssp CEE
T ss_pred cee
Confidence 863
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.7e-25 Score=235.21 Aligned_cols=145 Identities=18% Similarity=0.337 Sum_probs=126.8
Q ss_pred hcCCcccceeecccCCcceEEEEEc--CCcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCE----
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV--DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE---- 348 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 348 (430)
..++|++.+.||+|+||.||+|.+. +++.||||++... .......+.+|+.++.+++||||+++++++...+.
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 3478999999999999999999975 5889999998643 34556788999999999999999999999988665
Q ss_pred -EEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcc
Q 047619 349 -KLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427 (430)
Q Consensus 349 -~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla 427 (430)
.+|||||+++++|.+++.. .+++..+..++.||+.||.|||+++ |+||||||+||||+.+ .+||+|||+|
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a 228 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAV 228 (681)
T ss_dssp EEEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred eeEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccc
Confidence 7999999999999987732 5899999999999999999999998 9999999999999875 8999999999
Q ss_pred cc
Q 047619 428 RA 429 (430)
Q Consensus 428 r~ 429 (430)
+.
T Consensus 229 ~~ 230 (681)
T 2pzi_A 229 SR 230 (681)
T ss_dssp EE
T ss_pred hh
Confidence 74
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.93 E-value=2.6e-25 Score=217.09 Aligned_cols=145 Identities=28% Similarity=0.483 Sum_probs=127.7
Q ss_pred hcCCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc--ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEE---
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK--- 349 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~--- 349 (430)
..++|.+.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.+++.++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 3468999999999999999999864 5889999999752 344567889999999999999999999999887765
Q ss_pred ---EEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCc
Q 047619 350 ---LLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 426 (430)
Q Consensus 350 ---~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGl 426 (430)
++||||++ ++|.+++. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eeEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999997 68888772 23899999999999999999999998 99999999999999999999999999
Q ss_pred ccc
Q 047619 427 ARA 429 (430)
Q Consensus 427 ar~ 429 (430)
|+.
T Consensus 191 a~~ 193 (371)
T 4exu_A 191 ARH 193 (371)
T ss_dssp C--
T ss_pred ccc
Confidence 974
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.3e-25 Score=231.47 Aligned_cols=151 Identities=25% Similarity=0.420 Sum_probs=132.1
Q ss_pred HHhhcCCcccceeecccCCcceEEEEEcC----CcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCC
Q 047619 273 IANATDNFSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE 347 (430)
Q Consensus 273 ~~~~~~~~~~~~~ig~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 347 (430)
.....++|++.+.||+|+||.||+|.... +..||+|++... .....+.+.+|+.++++++||||+++++++. .+
T Consensus 385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~ 463 (656)
T 2j0j_A 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 463 (656)
T ss_dssp TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cC
Confidence 34445789999999999999999998643 457999998753 4455678999999999999999999999984 56
Q ss_pred EEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcc
Q 047619 348 EKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427 (430)
Q Consensus 348 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla 427 (430)
..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a 538 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQVRK--FSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLS 538 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHHTT--TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred ceEEEEEcCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCC
Confidence 7899999999999999996532 35899999999999999999999998 999999999999999999999999999
Q ss_pred cc
Q 047619 428 RA 429 (430)
Q Consensus 428 r~ 429 (430)
+.
T Consensus 539 ~~ 540 (656)
T 2j0j_A 539 RY 540 (656)
T ss_dssp CS
T ss_pred ee
Confidence 75
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.5e-25 Score=217.57 Aligned_cols=153 Identities=25% Similarity=0.319 Sum_probs=116.1
Q ss_pred hHHhhcCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCE--
Q 047619 272 TIANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE-- 348 (430)
Q Consensus 272 ~~~~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-- 348 (430)
......++|++.+.||+|+||.||+|... +++.||||++... ........+|+..+..++||||+++++++.....
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 34556789999999999999999999974 5889999998652 2333456678888899999999999999976443
Q ss_pred -----EEEEEEccCCCChhHHhhc-CCCCCCCCHHHHHHHHHHHHHHHHHhh--hcCCCcEEeCCCCCCcEEEcC-CCCe
Q 047619 349 -----KLLIYEFVPNKSLDSFIFD-QERCKILDWSKRFHIICGTARGVMYLH--QDSRLRIIHRDLKASNVLLDQ-DMNP 419 (430)
Q Consensus 349 -----~~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~~~~i~~~i~~aL~yLH--~~~~~~iiH~Dlkp~NILl~~-~~~~ 419 (430)
.++||||++++ |...+.. ......+++..+..++.|++.||.||| +.+ |+||||||+||||+. ++.+
T Consensus 96 ~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp TTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEE
T ss_pred ccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcE
Confidence 78999999864 4443322 223456889999999999999999999 877 999999999999996 8999
Q ss_pred eecCCCcccc
Q 047619 420 KISDFGLARA 429 (430)
Q Consensus 420 kl~DFGlar~ 429 (430)
||+|||+|+.
T Consensus 172 kl~Dfg~a~~ 181 (360)
T 3e3p_A 172 KLCDFGSAKK 181 (360)
T ss_dssp EECCCTTCBC
T ss_pred EEeeCCCcee
Confidence 9999999975
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=7.2e-26 Score=219.40 Aligned_cols=143 Identities=17% Similarity=0.306 Sum_probs=125.7
Q ss_pred cCCcccceeecccCCcceEEEEEcC---------CcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccc---------
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLVD---------GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK--------- 338 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------- 338 (430)
.++|++.+.||+|+||.||+|.... ++.||+|.+... +.+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 4689999999999999999999753 789999998753 46788999999999999987
Q ss_pred ------eEEEEEe-CCEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcE
Q 047619 339 ------LLGCCIQ-GEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNV 411 (430)
Q Consensus 339 ------l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NI 411 (430)
+++++.. ....++||||+ +++|.+++.... ...+++..+..++.||+.||.|||+++ |+||||||+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI 190 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI 190 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence 6777776 77889999999 999999997542 245899999999999999999999998 99999999999
Q ss_pred EEcCCC--CeeecCCCcccc
Q 047619 412 LLDQDM--NPKISDFGLARA 429 (430)
Q Consensus 412 Ll~~~~--~~kl~DFGlar~ 429 (430)
|++.++ .+||+|||+|+.
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~ 210 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFR 210 (352)
T ss_dssp EEETTEEEEEEECCGGGCBC
T ss_pred EEcCCCCceEEEecCcceee
Confidence 999998 899999999974
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.92 E-value=1.8e-25 Score=213.91 Aligned_cols=149 Identities=28% Similarity=0.489 Sum_probs=125.8
Q ss_pred hcCCcccceeecccCCcceEEEEE--cCCcEEEEEEecccC--hHhHHHHHHHHHHHhcC---CCCcccceEEEEE----
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTL--VDGQEIAVKRLSKIS--EQGLKELKNEVILFSKL---QHRNLVKLLGCCI---- 344 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~--~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~---- 344 (430)
..++|++.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999997 357899999986422 12223456677776665 8999999999987
Q ss_pred -eCCEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecC
Q 047619 345 -QGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD 423 (430)
Q Consensus 345 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~D 423 (430)
.....++||||++ ++|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCceEEEEEecCC-CCHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence 4567899999998 699999865432 34899999999999999999999998 99999999999999999999999
Q ss_pred CCcccc
Q 047619 424 FGLARA 429 (430)
Q Consensus 424 FGlar~ 429 (430)
||+|+.
T Consensus 164 fg~~~~ 169 (326)
T 1blx_A 164 FGLARI 169 (326)
T ss_dssp CCSCCC
T ss_pred Cccccc
Confidence 999975
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.6e-25 Score=218.49 Aligned_cols=146 Identities=12% Similarity=0.118 Sum_probs=111.3
Q ss_pred cCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccC---hHhHHHHHHHHH---HHhcCCCCcccceE-------EE
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVI---LFSKLQHRNLVKLL-------GC 342 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~---~l~~l~h~niv~l~-------~~ 342 (430)
..+|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+. +|+. +||||++++ ++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehh
Confidence 346999999999999999999965 58999999997632 344567778854 5555 699988755 55
Q ss_pred EEeC-----------------CEEEEEEEccCCCChhHHhhcCCCCCCCCHHHH------HHHHHHHHHHHHHhhhcCCC
Q 047619 343 CIQG-----------------EEKLLIYEFVPNKSLDSFIFDQERCKILDWSKR------FHIICGTARGVMYLHQDSRL 399 (430)
Q Consensus 343 ~~~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~------~~i~~~i~~aL~yLH~~~~~ 399 (430)
+... ...+|||||++ ++|.+++.... ..+++..+ +.++.||+.||+|||+++
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~-- 214 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD--FVYVFRGDEGILALHILTAQLIRLAANLQSKG-- 214 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH--HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc--cccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--
Confidence 5443 33799999998 89999996542 23455555 778899999999999998
Q ss_pred cEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 400 RIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 400 ~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|+||||||+||||+.++.+||+|||+|+.
T Consensus 215 -ivHrDikp~NIll~~~~~~kL~DFG~a~~ 243 (371)
T 3q60_A 215 -LVHGHFTPDNLFIMPDGRLMLGDVSALWK 243 (371)
T ss_dssp -EEETTCSGGGEEECTTSCEEECCGGGEEE
T ss_pred -CccCcCCHHHEEECCCCCEEEEecceeee
Confidence 99999999999999999999999999974
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=7.1e-25 Score=210.48 Aligned_cols=148 Identities=24% Similarity=0.385 Sum_probs=129.9
Q ss_pred hcCCcccceeecccCCcceEEEEE--cCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCc------ccceEEEEEeCC
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTL--VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN------LVKLLGCCIQGE 347 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~ 347 (430)
..++|++.+.||+|+||.||+|.. .+++.||||++.. .....+.+.+|+.+++.++|++ ++++++++...+
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~ 90 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN-VDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG 90 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS-SHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEec-CCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence 447899999999999999999986 3588999999975 3455677889999999887654 999999999999
Q ss_pred EEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcC------------
Q 047619 348 EKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ------------ 415 (430)
Q Consensus 348 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~------------ 415 (430)
..++||||+ +++|.+++..... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.
T Consensus 91 ~~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 91 HICIVFELL-GLSTYDFIKENGF-LPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----
T ss_pred cEEEEEcCC-CCCHHHHHHhcCC-CCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccc
Confidence 999999999 8999999865432 35889999999999999999999998 999999999999987
Q ss_pred -------CCCeeecCCCcccc
Q 047619 416 -------DMNPKISDFGLARA 429 (430)
Q Consensus 416 -------~~~~kl~DFGlar~ 429 (430)
++.+||+|||+|+.
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~ 186 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATY 186 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEE
T ss_pred cccccccCCCceEeeCccccc
Confidence 66899999999874
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=1.5e-25 Score=222.36 Aligned_cols=144 Identities=27% Similarity=0.419 Sum_probs=119.1
Q ss_pred CCcccceeecccCCcceEEEEEc-CCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeC----C--EEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG----E--EKL 350 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----~--~~~ 350 (430)
.+|++.+.||+|+||.||+|... +++.||||++.... ....+|+.+++.++||||+++++++... + ..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46899999999999999999975 48999999986532 2234799999999999999999998642 2 357
Q ss_pred EEEEccCCCChhHHhhcC-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCC-CCeeecCCCccc
Q 047619 351 LIYEFVPNKSLDSFIFDQ-ERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLAR 428 (430)
Q Consensus 351 lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DFGlar 428 (430)
+||||+++ +|.+.+... .....+++..+..++.||+.||+|||+.+ |+||||||+||||+.+ +.+||+|||+|+
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999985 565555321 22345899999999999999999999988 9999999999999965 568999999997
Q ss_pred c
Q 047619 429 A 429 (430)
Q Consensus 429 ~ 429 (430)
.
T Consensus 206 ~ 206 (420)
T 1j1b_A 206 Q 206 (420)
T ss_dssp E
T ss_pred h
Confidence 4
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.5e-25 Score=217.61 Aligned_cols=136 Identities=24% Similarity=0.363 Sum_probs=115.1
Q ss_pred hcCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccChHhHHHHHHHHHHHhcCC--------CCcccceEEEEE--
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQ--------HRNLVKLLGCCI-- 344 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~-- 344 (430)
..++|++.++||+|+||.||+|... +++.||||++.. .....+.+.+|+.+++.++ |+||+++++++.
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~ 113 (397)
T 1wak_A 35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS-AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS 113 (397)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec-CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence 3478999999999999999999864 588999999975 3455678889999999985 788999999988
Q ss_pred --eCCEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCcEEeCCCCCCcEEEcCCC
Q 047619 345 --QGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD-SRLRIIHRDLKASNVLLDQDM 417 (430)
Q Consensus 345 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~-~~~~iiH~Dlkp~NILl~~~~ 417 (430)
.....++||||+ +++|.+.+.... ...+++..+..++.||+.||+|||++ + |+||||||+||||+.++
T Consensus 114 ~~~~~~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~ 184 (397)
T 1wak_A 114 GVNGTHICMVFEVL-GHHLLKWIIKSN-YQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNE 184 (397)
T ss_dssp ETTEEEEEEEECCC-CCBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCH
T ss_pred CCCCceEEEEEecc-CccHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccc
Confidence 456789999999 556666554432 24589999999999999999999998 7 99999999999998775
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2e-25 Score=212.63 Aligned_cols=152 Identities=27% Similarity=0.377 Sum_probs=133.8
Q ss_pred HHhHHhhcCCcccceeecccCCcceEEEEEcCCcEEEEEEecc--cChHhHHHHHHHHHHHhcCC--CCcccceEEEEEe
Q 047619 270 LATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQ--HRNLVKLLGCCIQ 345 (430)
Q Consensus 270 ~~~~~~~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~ 345 (430)
+..+....++|++.+.||+|+||.||++...+++.||||++.. ......+.+.+|+.++.+++ ||||+++++++..
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~ 99 (313)
T 3cek_A 20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 99 (313)
T ss_dssp CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC
T ss_pred eeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec
Confidence 3344555678999999999999999999988899999999864 34556788999999999997 5999999999999
Q ss_pred CCEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCC
Q 047619 346 GEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 425 (430)
Q Consensus 346 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFG 425 (430)
.+..++||| +.+++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++ ++.+||+|||
T Consensus 100 ~~~~~lv~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~-~~~~kL~Dfg 171 (313)
T 3cek_A 100 DQYIYMVME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFG 171 (313)
T ss_dssp SSEEEEEEC-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCS
T ss_pred CCEEEEEEe-cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEE-CCeEEEeecc
Confidence 999999999 5688999999654 35889999999999999999999998 99999999999996 4789999999
Q ss_pred cccc
Q 047619 426 LARA 429 (430)
Q Consensus 426 lar~ 429 (430)
+|+.
T Consensus 172 ~~~~ 175 (313)
T 3cek_A 172 IANQ 175 (313)
T ss_dssp SSCC
T ss_pred cccc
Confidence 9974
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=4.2e-25 Score=214.03 Aligned_cols=144 Identities=28% Similarity=0.487 Sum_probs=127.5
Q ss_pred cCCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc--ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCE-----
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE----- 348 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 348 (430)
.++|.+.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 468999999999999999999974 5899999999652 34456788999999999999999999999987754
Q ss_pred -EEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcc
Q 047619 349 -KLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427 (430)
Q Consensus 349 -~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla 427 (430)
.++||||++ ++|.+++. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999997 68887762 23899999999999999999999998 999999999999999999999999999
Q ss_pred cc
Q 047619 428 RA 429 (430)
Q Consensus 428 r~ 429 (430)
+.
T Consensus 174 ~~ 175 (353)
T 3coi_A 174 RH 175 (353)
T ss_dssp TC
T ss_pred cC
Confidence 74
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-25 Score=214.15 Aligned_cols=152 Identities=24% Similarity=0.383 Sum_probs=121.6
Q ss_pred hHHhhcCCcccceeecccCCcceEEEEE-cCCcEEEEEEecccCh------HhHHHHHHHHHHHhcC----CCCcccceE
Q 047619 272 TIANATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISE------QGLKELKNEVILFSKL----QHRNLVKLL 340 (430)
Q Consensus 272 ~~~~~~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l----~h~niv~l~ 340 (430)
......++|++.+.||+|+||.||+|.. .+++.||||++..... .....+.+|+.++.++ +||||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 3455668899999999999999999986 4588999999965321 1233456789988888 899999999
Q ss_pred EEEEeCCEEEEEEEc-cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEc-CCCC
Q 047619 341 GCCIQGEEKLLIYEF-VPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLD-QDMN 418 (430)
Q Consensus 341 ~~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~-~~~~ 418 (430)
+++...+..++|||+ +++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++ .++.
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~ 178 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITEK---GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGC 178 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTE
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCe
Confidence 999999999999999 7899999999653 34899999999999999999999998 99999999999999 7889
Q ss_pred eeecCCCcccc
Q 047619 419 PKISDFGLARA 429 (430)
Q Consensus 419 ~kl~DFGlar~ 429 (430)
+||+|||+|+.
T Consensus 179 ~kl~dfg~~~~ 189 (312)
T 2iwi_A 179 AKLIDFGSGAL 189 (312)
T ss_dssp EEECCCSSCEE
T ss_pred EEEEEcchhhh
Confidence 99999999874
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.92 E-value=6.7e-25 Score=206.79 Aligned_cols=146 Identities=24% Similarity=0.431 Sum_probs=121.9
Q ss_pred hcCCcccceeecccCCcceEEEEE-cCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEE-EeCCEEEEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC-IQGEEKLLIY 353 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~ 353 (430)
..++|++.+.||+|+||.||+|.. .+++.||||++... .....+.+|+.++..++|++++..+..+ ...+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccc--ccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 457899999999999999999996 55889999987542 2234578899999999988766665554 6778889999
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEE---cCCCCeeecCCCcccc
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARA 429 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl---~~~~~~kl~DFGlar~ 429 (430)
||+ +++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||+|+.
T Consensus 85 e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~ 157 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp ECC-CCBHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred Ecc-CCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence 999 999999986432 35899999999999999999999998 9999999999999 7889999999999974
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=9.4e-25 Score=209.21 Aligned_cols=150 Identities=26% Similarity=0.386 Sum_probs=127.2
Q ss_pred hcCCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc-ChHhHHHHHHHHH-HHhcCCCCcccceEEEEEeCCEEEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVI-LFSKLQHRNLVKLLGCCIQGEEKLLI 352 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv 352 (430)
..++|++.+.||+|+||.||+|... +++.||||++... ......++..|+. +++.++||||+++++++...+..++|
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv 99 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC 99 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence 3478999999999999999999974 5889999999753 3344555666666 77888999999999999999999999
Q ss_pred EEccCCCChhHHhhcC--CCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 353 YEFVPNKSLDSFIFDQ--ERCKILDWSKRFHIICGTARGVMYLHQD-SRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 353 ~e~~~~gsL~~~l~~~--~~~~~~~~~~~~~i~~~i~~aL~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|||+++ +|.+++... .....+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||+|+.
T Consensus 100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 175 (327)
T 3aln_A 100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQ 175 (327)
T ss_dssp ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence 999985 887776421 1134589999999999999999999998 8 99999999999999999999999999975
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.3e-25 Score=220.03 Aligned_cols=146 Identities=27% Similarity=0.441 Sum_probs=116.0
Q ss_pred CCccc-ceeecccCCcceEEEEEc---CCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEe--CCEEEE
Q 047619 278 DNFSI-NNKLGEGGFGPVYKGTLV---DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ--GEEKLL 351 (430)
Q Consensus 278 ~~~~~-~~~ig~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 351 (430)
+.|.+ .++||+|+||.||+|... +++.||||++.... ....+.+|+.++++++||||+++++++.. ....++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 45665 458999999999999965 47899999997532 23467899999999999999999999965 678999
Q ss_pred EEEccCCCChhHHhhcC------CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEE----cCCCCeee
Q 047619 352 IYEFVPNKSLDSFIFDQ------ERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLL----DQDMNPKI 421 (430)
Q Consensus 352 v~e~~~~gsL~~~l~~~------~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl----~~~~~~kl 421 (430)
||||++ ++|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||| +.++.+||
T Consensus 98 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEE
Confidence 999997 5777776421 11234899999999999999999999998 9999999999999 67789999
Q ss_pred cCCCcccc
Q 047619 422 SDFGLARA 429 (430)
Q Consensus 422 ~DFGlar~ 429 (430)
+|||+|+.
T Consensus 174 ~Dfg~a~~ 181 (405)
T 3rgf_A 174 ADMGFARL 181 (405)
T ss_dssp CCTTCCC-
T ss_pred EECCCcee
Confidence 99999975
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=7.5e-26 Score=215.88 Aligned_cols=150 Identities=31% Similarity=0.530 Sum_probs=128.6
Q ss_pred hHHhhcCCcccceeecccCCcceEEEEEcCCcEEEEEEeccc--ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEE
Q 047619 272 TIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 349 (430)
Q Consensus 272 ~~~~~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 349 (430)
......++|++.+.||+|+||.||+|.... .+|+|++... .....+.+.+|+.++++++||||+++++++.+.+..
T Consensus 27 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (319)
T 2y4i_B 27 EWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHL 104 (319)
T ss_dssp GSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCE
T ss_pred cccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCce
Confidence 334456889999999999999999998743 5999998642 233345678899999999999999999999999999
Q ss_pred EEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 350 LLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 350 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++||||+++++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++ ++.+||+|||+|+.
T Consensus 105 ~iv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~ 178 (319)
T 2y4i_B 105 AIITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSI 178 (319)
T ss_dssp EEECBCCCSEEHHHHTTSS--CCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC-
T ss_pred EEEeecccCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccc
Confidence 9999999999999999543 245889999999999999999999998 99999999999998 67999999999764
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.2e-24 Score=205.10 Aligned_cols=146 Identities=23% Similarity=0.403 Sum_probs=125.3
Q ss_pred hcCCcccceeecccCCcceEEEEE-cCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEE-EEeCCEEEEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGC-CIQGEEKLLIY 353 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~-~~~~~~~~lv~ 353 (430)
..++|++.+.||+|+||.||+|.. .+++.||||++.... ....+.+|+.++..++|++++..+.. .......++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 457899999999999999999996 568999999986432 23468899999999998876655554 46677889999
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEE---cCCCCeeecCCCcccc
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARA 429 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl---~~~~~~kl~DFGlar~ 429 (430)
||+ +++|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+|||+ +.++.+||+|||+|+.
T Consensus 85 e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 157 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp ECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred Eec-CCCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence 999 999999996432 35899999999999999999999998 9999999999999 4888999999999874
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=3.7e-25 Score=211.55 Aligned_cols=150 Identities=26% Similarity=0.390 Sum_probs=129.9
Q ss_pred HhhcCCcccceeecccCCcceEEEEE-cCCcEEEEEEecccCh------HhHHHHHHHHHHHhcCC--CCcccceEEEEE
Q 047619 274 ANATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISE------QGLKELKNEVILFSKLQ--HRNLVKLLGCCI 344 (430)
Q Consensus 274 ~~~~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~~~~~ 344 (430)
....++|++.+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|+.++++++ ||||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 44567899999999999999999986 4588999999865221 12345678999999996 599999999999
Q ss_pred eCCEEEEEEEccCC-CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEc-CCCCeeec
Q 047619 345 QGEEKLLIYEFVPN-KSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLD-QDMNPKIS 422 (430)
Q Consensus 345 ~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~-~~~~~kl~ 422 (430)
..+..++|||++.+ ++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++ +++.+||+
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~ 192 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLI 192 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEEC
T ss_pred cCCcEEEEEEcCCCCccHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEe
Confidence 99999999999976 8999998653 35899999999999999999999998 99999999999998 77899999
Q ss_pred CCCcccc
Q 047619 423 DFGLARA 429 (430)
Q Consensus 423 DFGlar~ 429 (430)
|||+|+.
T Consensus 193 Dfg~~~~ 199 (320)
T 3a99_A 193 DFGSGAL 199 (320)
T ss_dssp CCTTCEE
T ss_pred eCccccc
Confidence 9999874
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.6e-24 Score=218.15 Aligned_cols=146 Identities=25% Similarity=0.416 Sum_probs=126.3
Q ss_pred hcCCcccceeecccCCcceEEEEE-cCCcEEEEEEecccChHhHHHHHHHHHHHhcCCC-CcccceEEEEEeCCEEEEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH-RNLVKLLGCCIQGEEKLLIY 353 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~ 353 (430)
..++|++.++||+|+||.||+|.. .+++.||||++.... ...++.+|+.++..++| ++|+.+..++...+..+|||
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm 82 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC--SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc--ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence 347899999999999999999996 458999999876422 22457889999999987 56667777778888999999
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEE---cCCCCeeecCCCcccc
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARA 429 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl---~~~~~~kl~DFGlar~ 429 (430)
||+ +++|.+++.... ..+++..++.|+.||+.||+|||+++ |+||||||+|||| +.++.+||+|||+|+.
T Consensus 83 e~~-g~sL~~ll~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (483)
T 3sv0_A 83 DLL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (483)
T ss_dssp ECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred ECC-CCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence 999 999999996432 35899999999999999999999998 9999999999999 6889999999999975
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3e-24 Score=206.68 Aligned_cols=146 Identities=25% Similarity=0.330 Sum_probs=120.7
Q ss_pred hcCCcccce-eecccCCcceEEEEEc-CCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEe----CCEE
Q 047619 276 ATDNFSINN-KLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ----GEEK 349 (430)
Q Consensus 276 ~~~~~~~~~-~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~ 349 (430)
..++|.+.+ .||+|+||.||+|... +++.||||++... .....+ ....+..+.||||+++++++.. ....
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~e---~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-PKARQE---VDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-HHHHHH---HHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-HHHHHH---HHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 446899865 5999999999999975 5899999999652 222222 2334567799999999999886 4458
Q ss_pred EEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcC---CCCeeecCCCc
Q 047619 350 LLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKISDFGL 426 (430)
Q Consensus 350 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~DFGl 426 (430)
++||||+++++|.+++..... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGD-QAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-C-CCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEeccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccc
Confidence 999999999999999975432 46899999999999999999999998 999999999999976 45599999999
Q ss_pred ccc
Q 047619 427 ARA 429 (430)
Q Consensus 427 ar~ 429 (430)
|+.
T Consensus 178 ~~~ 180 (336)
T 3fhr_A 178 AKE 180 (336)
T ss_dssp CEE
T ss_pred cee
Confidence 974
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.2e-24 Score=216.74 Aligned_cols=145 Identities=25% Similarity=0.322 Sum_probs=118.5
Q ss_pred CCcccceeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcC-CCCcccceEEEEEeCCEEEEEEEcc
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFV 356 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 356 (430)
+.|.+.+.||+|+||+||.+...+++.||||++.. ...+.+.+|+.++.++ +||||+++++++.+.+..+|||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~---~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI---DFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEG---GGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcH---HHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 44566788999999999877667799999999864 2345678899999876 8999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCC----CCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCC-------------CCe
Q 047619 357 PNKSLDSFIFDQERCK----ILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQD-------------MNP 419 (430)
Q Consensus 357 ~~gsL~~~l~~~~~~~----~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~-------------~~~ 419 (430)
+ ++|.+++....... ...+..+..++.||+.||+|||+++ |+||||||+||||+.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence 6 69999996543211 1133345789999999999999998 9999999999999754 479
Q ss_pred eecCCCcccc
Q 047619 420 KISDFGLARA 429 (430)
Q Consensus 420 kl~DFGlar~ 429 (430)
||+|||+|+.
T Consensus 168 kL~DFG~a~~ 177 (434)
T 2rio_A 168 LISDFGLCKK 177 (434)
T ss_dssp EECCCTTCEE
T ss_pred EEccccccee
Confidence 9999999974
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.9e-24 Score=209.55 Aligned_cols=152 Identities=24% Similarity=0.345 Sum_probs=128.1
Q ss_pred HhhcCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccChHhHHHHHHHHHHHhcCC-CC-----cccceEEEEEeC
Q 047619 274 ANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HR-----NLVKLLGCCIQG 346 (430)
Q Consensus 274 ~~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~ 346 (430)
....++|++.+.||+|+||.||+|... +++.||||++.. ......++.+|+.+++.++ |+ +|+++++++...
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN-KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS-SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec-cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 345689999999999999999999865 578999999975 3445677888999888875 44 499999999999
Q ss_pred CEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEc--CCCCeeecCC
Q 047619 347 EEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLD--QDMNPKISDF 424 (430)
Q Consensus 347 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~--~~~~~kl~DF 424 (430)
+..+|||||++ ++|.+++..... ..+++..+..++.|++.||.|||++ ..+|+||||||+||||+ .++.+||+||
T Consensus 129 ~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DF 205 (382)
T 2vx3_A 129 NHLCLVFEMLS-YNLYDLLRNTNF-RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDF 205 (382)
T ss_dssp TEEEEEEECCC-CBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred CceEEEEecCC-CCHHHHHhhcCc-CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence 99999999996 599999865432 3489999999999999999999952 12399999999999994 4778999999
Q ss_pred Ccccc
Q 047619 425 GLARA 429 (430)
Q Consensus 425 Glar~ 429 (430)
|+|+.
T Consensus 206 G~a~~ 210 (382)
T 2vx3_A 206 GSSCQ 210 (382)
T ss_dssp TTCEE
T ss_pred cCcee
Confidence 99974
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=4.1e-24 Score=206.64 Aligned_cols=148 Identities=20% Similarity=0.354 Sum_probs=127.1
Q ss_pred hcCCcccceeecccCCcceEEEEEcC-C-cEEEEEEecccChHhHHHHHHHHHHHhcCCCCc------ccceEEEEEeCC
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLVD-G-QEIAVKRLSKISEQGLKELKNEVILFSKLQHRN------LVKLLGCCIQGE 347 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~~-~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~ 347 (430)
..++|++.+.||+|+||.||+|.... + +.||+|++.. .....+.+.+|+.+++.++|++ ++.+++++...+
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~-~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 95 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN-VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG 95 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc-cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence 34789999999999999999998643 4 6899999975 3455677889999999997765 999999999999
Q ss_pred EEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEE--------------
Q 047619 348 EKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLL-------------- 413 (430)
Q Consensus 348 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl-------------- 413 (430)
..++||||+ +++|.+++.... ...+++..+..++.||+.||+|||+++ |+||||||+||||
T Consensus 96 ~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 96 HMCIAFELL-GKNTFEFLKENN-FQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp EEEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred eEEEEEecc-CCChHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccccc
Confidence 999999999 566666665433 245899999999999999999999988 9999999999999
Q ss_pred -----cCCCCeeecCCCcccc
Q 047619 414 -----DQDMNPKISDFGLARA 429 (430)
Q Consensus 414 -----~~~~~~kl~DFGlar~ 429 (430)
+.++.+||+|||+|+.
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~ 191 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATF 191 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEE
T ss_pred ccccccCCCcEEEeecCcccc
Confidence 5678999999999874
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.9e-24 Score=204.65 Aligned_cols=147 Identities=21% Similarity=0.365 Sum_probs=116.8
Q ss_pred cCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccC-h-HhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEE
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-E-QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 353 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 353 (430)
.++|++.+.||+|+||.||+|... +++.||||++.... . ...+.+..+..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 467999999999999999999975 58999999997532 2 22344555556788899999999999999999999999
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD-SRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||+ ++.+..+.... ...+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||+|+.
T Consensus 104 e~~-~~~~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 174 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRM--QGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGR 174 (318)
T ss_dssp CCC-SEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred ecc-CCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchh
Confidence 999 55665555332 24589999999999999999999985 7 99999999999999999999999999864
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=4.4e-25 Score=227.69 Aligned_cols=151 Identities=27% Similarity=0.446 Sum_probs=130.4
Q ss_pred hcCCcccceeecccCCcceEEEEEc-CCcEEEEEEecc-cChHhHHHHHHHHHHHhcCCCCcccceEEEEEe------CC
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ------GE 347 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~ 347 (430)
..++|++.+.||+|+||.||+|... +++.||||++.. ......+.+.+|+.++++++||||+++++++.. .+
T Consensus 12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 3478999999999999999999864 588999999875 345567789999999999999999999998765 66
Q ss_pred EEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCC---eeecCC
Q 047619 348 EKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMN---PKISDF 424 (430)
Q Consensus 348 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~---~kl~DF 424 (430)
..++||||+++++|.+++........+++..+..++.|++.||+|||+.+ |+||||||+|||++.++. +||+||
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccc
Confidence 77999999999999999977555556899999999999999999999998 999999999999987765 899999
Q ss_pred Ccccc
Q 047619 425 GLARA 429 (430)
Q Consensus 425 Glar~ 429 (430)
|+|+.
T Consensus 169 G~a~~ 173 (676)
T 3qa8_A 169 GYAKE 173 (676)
T ss_dssp CCCCB
T ss_pred ccccc
Confidence 99975
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.91 E-value=2e-24 Score=210.51 Aligned_cols=147 Identities=24% Similarity=0.359 Sum_probs=127.1
Q ss_pred cCCcccceeecccCCcceEEEEE-cCCcEEEEEEecccChHhHHHHHHHHHHHhcCC-----------CCcccceEEEEE
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-----------HRNLVKLLGCCI 344 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~ 344 (430)
.++|++.+.||+|+||.||+|.. .+++.||||++.. .....+.+.+|+.++++++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC-CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 46899999999999999999996 4588999999975 3445677889999999886 899999999998
Q ss_pred eCC----EEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCcEEeCCCCCCcEEEc-----
Q 047619 345 QGE----EKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD-SRLRIIHRDLKASNVLLD----- 414 (430)
Q Consensus 345 ~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~-~~~~iiH~Dlkp~NILl~----- 414 (430)
..+ ..++||||+ +++|.+++..... ..+++..+..++.||+.||+|||++ + |+||||||+||||+
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEH-RGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhc-cCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence 754 789999999 8999999875433 3489999999999999999999998 7 99999999999994
Q ss_pred -CCCCeeecCCCcccc
Q 047619 415 -QDMNPKISDFGLARA 429 (430)
Q Consensus 415 -~~~~~kl~DFGlar~ 429 (430)
..+.+||+|||+|+.
T Consensus 172 ~~~~~~kl~Dfg~a~~ 187 (373)
T 1q8y_A 172 ENLIQIKIADLGNACW 187 (373)
T ss_dssp TTEEEEEECCCTTCEE
T ss_pred cCcceEEEcccccccc
Confidence 344799999999974
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.6e-24 Score=214.03 Aligned_cols=144 Identities=24% Similarity=0.382 Sum_probs=120.2
Q ss_pred cCCcccceeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcC-CCCcccceEEEEEeCCEEEEEEEc
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEF 355 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~ 355 (430)
..+|.+.+.||+|+||.|+.....+++.||||++..... ..+.+|+.+++.+ +||||+++++++.+....+|||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 346889999999999997655566799999999965322 2356799999999 799999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcC-----CCCeeecCCCcccc
Q 047619 356 VPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ-----DMNPKISDFGLARA 429 (430)
Q Consensus 356 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~-----~~~~kl~DFGlar~ 429 (430)
++ ++|.+++..... ...+..+..++.||+.||.|||+.+ |+||||||+||||+. ...+||+|||+|+.
T Consensus 100 ~~-g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 100 CA-ATLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp CS-EEHHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred CC-CCHHHHHHhcCC--CccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 96 699999865432 3445566789999999999999998 999999999999953 23578999999975
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=5e-24 Score=199.88 Aligned_cols=141 Identities=20% Similarity=0.175 Sum_probs=113.7
Q ss_pred HhHHhhcCCcccceeecccCCcceEEEEEcCCcEEEEEEecccCh------------------HhHHHHHHHHHHHhcCC
Q 047619 271 ATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISE------------------QGLKELKNEVILFSKLQ 332 (430)
Q Consensus 271 ~~~~~~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~ 332 (430)
..+......|.+.+.||+|+||.||+|...+++.||+|.+..... .....+.+|+.++++++
T Consensus 83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~ 162 (282)
T 1zar_A 83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 162 (282)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence 344445566778899999999999999997799999999864211 23567899999999999
Q ss_pred CCcccceEEEEEeCCEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEE
Q 047619 333 HRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVL 412 (430)
Q Consensus 333 h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NIL 412 (430)
| +++.+++.. +..++||||+++++|.+ +.. .....++.|++.||.|||+.+ |+||||||+|||
T Consensus 163 ~---~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NIL 225 (282)
T 1zar_A 163 G---LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVL 225 (282)
T ss_dssp T---SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEE
T ss_pred C---CCcCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEE
Confidence 4 555554433 55699999999999988 411 123469999999999999998 999999999999
Q ss_pred EcCCCCeeecCCCcccc
Q 047619 413 LDQDMNPKISDFGLARA 429 (430)
Q Consensus 413 l~~~~~~kl~DFGlar~ 429 (430)
++ ++.+||+|||+|+.
T Consensus 226 l~-~~~vkl~DFG~a~~ 241 (282)
T 1zar_A 226 VS-EEGIWIIDFPQSVE 241 (282)
T ss_dssp EE-TTEEEECCCTTCEE
T ss_pred EE-CCcEEEEECCCCeE
Confidence 99 99999999999974
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.4e-23 Score=214.22 Aligned_cols=131 Identities=19% Similarity=0.275 Sum_probs=105.5
Q ss_pred cceeecccCCcceEEEEEcCCcEEEEEEecccC--------hHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEE
Q 047619 282 INNKLGEGGFGPVYKGTLVDGQEIAVKRLSKIS--------EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 353 (430)
Q Consensus 282 ~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 353 (430)
..+.||+|+||.||++.. .++.+++|+..... ....+.+.+|++++++++||||+++..++...+..+|||
T Consensus 340 ~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp --------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 357899999999999954 57888988764311 112456899999999999999997666667888889999
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||+++++|.+++.. +..++.|++.||+|||+++ |+||||||+|||++. .+||+|||+|+.
T Consensus 419 E~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~ 478 (540)
T 3en9_A 419 SYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKI 478 (540)
T ss_dssp ECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEE
T ss_pred ECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEE
Confidence 99999999999843 4579999999999999998 999999999999998 999999999985
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.87 E-value=1.9e-22 Score=199.55 Aligned_cols=150 Identities=17% Similarity=0.222 Sum_probs=113.4
Q ss_pred hcCCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc---ChHhHHHHHHHHHHHhcCCC-Ccc---------cc---
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQH-RNL---------VK--- 338 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h-~ni---------v~--- 338 (430)
....|...+.||+|+||.||+|.+. +++.||||++... .....+.+.+|+.++..++| +|. +.
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 3345788899999999999999954 5899999998732 22346789999999999987 221 11
Q ss_pred ---------eEEEEEe-----CCEEEEEEEccCCCChhHHhhc----CCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCc
Q 047619 339 ---------LLGCCIQ-----GEEKLLIYEFVPNKSLDSFIFD----QERCKILDWSKRFHIICGTARGVMYLHQDSRLR 400 (430)
Q Consensus 339 ---------l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~----~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~ 400 (430)
+..+... ....+++|+++ +++|.+++.. ......+++..++.++.||+.||+|||+++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 231 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--- 231 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 1111111 12356777765 6899988841 122345788899999999999999999998
Q ss_pred EEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 401 IIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 401 iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|+||||||+||||+.++.+||+|||+|+.
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~ 260 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEE
T ss_pred cccCCcccceEEEecCCeEEEEeccceee
Confidence 99999999999999999999999999874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=6.9e-22 Score=182.96 Aligned_cols=137 Identities=17% Similarity=0.174 Sum_probs=107.1
Q ss_pred CCcccceeecccCCcceEEEEE-cCCcE--EEEEEecccCh------------------------HhHHHHHHHHHHHhc
Q 047619 278 DNFSINNKLGEGGFGPVYKGTL-VDGQE--IAVKRLSKISE------------------------QGLKELKNEVILFSK 330 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~-~~~~~--vavK~~~~~~~------------------------~~~~~~~~E~~~l~~ 330 (430)
.-|.+.+.||+|+||.||+|.. .+++. ||||++..... .....+.+|+.++.+
T Consensus 47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 126 (258)
T 1zth_A 47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER 126 (258)
T ss_dssp SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence 3467889999999999999997 67888 99998753211 112367899999999
Q ss_pred CCCCcc--cceEEEEEeCCEEEEEEEccCC-C----ChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhh-hcCCCcEE
Q 047619 331 LQHRNL--VKLLGCCIQGEEKLLIYEFVPN-K----SLDSFIFDQERCKILDWSKRFHIICGTARGVMYLH-QDSRLRII 402 (430)
Q Consensus 331 l~h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH-~~~~~~ii 402 (430)
+.|+++ +.++.. ...+|||||+.+ | +|.+++.. .++..+..++.|++.||.||| +.+ |+
T Consensus 127 l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---iv 193 (258)
T 1zth_A 127 AKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LV 193 (258)
T ss_dssp HHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EE
T ss_pred HHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EE
Confidence 988764 444442 356899999942 3 67666522 234566789999999999999 887 99
Q ss_pred eCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 403 HRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 403 H~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||||||+|||++. .++|+|||+|+.
T Consensus 194 HrDlkp~NILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 194 HADLSEYNIMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp CSSCSTTSEEESS--SEEECCCTTCEE
T ss_pred eCCCCHHHEEEcC--cEEEEECccccc
Confidence 9999999999988 899999999974
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.75 E-value=3.7e-18 Score=164.71 Aligned_cols=143 Identities=14% Similarity=0.158 Sum_probs=102.5
Q ss_pred HhHHhhcCCcccceeecccCCcceEEEEEcCCcEEEEEEecccC-----------------h-Hh----HHHHHHHHHHH
Q 047619 271 ATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKIS-----------------E-QG----LKELKNEVILF 328 (430)
Q Consensus 271 ~~~~~~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~-----------------~-~~----~~~~~~E~~~l 328 (430)
..+..-.--|.+.++||+|+||.||+|...+|+.||||++.... . .. .....+|...|
T Consensus 88 ~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL 167 (397)
T 4gyi_A 88 HTHAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFM 167 (397)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHH
Confidence 34444444599999999999999999998889999999874210 0 00 11124567777
Q ss_pred hcCCCCcccceEEEEEeCCEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCC
Q 047619 329 SKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKA 408 (430)
Q Consensus 329 ~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp 408 (430)
.++.+.++....-+... ..+|||||++|.+|..+.. . .....++.|++.+|.+||+.| ||||||||
T Consensus 168 ~rL~~~gv~vp~p~~~~--~~~LVME~i~G~~L~~l~~-------~--~~~~~l~~qll~~l~~lH~~g---IVHrDLKp 233 (397)
T 4gyi_A 168 KALYEEGFPVPEPIAQS--RHTIVMSLVDALPMRQVSS-------V--PDPASLYADLIALILRLAKHG---LIHGDFNE 233 (397)
T ss_dssp HHHHHTTCSCCCEEEEE--TTEEEEECCSCEEGGGCCC-------C--SCHHHHHHHHHHHHHHHHHTT---EECSCCST
T ss_pred HHHHhcCCCCCeeeecc--CceEEEEecCCccHhhhcc-------c--HHHHHHHHHHHHHHHHHHHCC---CcCCCCCH
Confidence 77765544322111111 2379999999988866531 1 123467899999999999988 99999999
Q ss_pred CcEEEcCCCC----------eeecCCCcc
Q 047619 409 SNVLLDQDMN----------PKISDFGLA 427 (430)
Q Consensus 409 ~NILl~~~~~----------~kl~DFGla 427 (430)
.|||+++++. +.|+||+=|
T Consensus 234 ~NILl~~dgd~~d~~~~~~~~~iID~~Q~ 262 (397)
T 4gyi_A 234 FNILIREEKDAEDPSSITLTPIIIXFPQM 262 (397)
T ss_dssp TSEEEEEEECSSCTTSEEEEEEECCCTTC
T ss_pred HHEEEeCCCCcccccccccceEEEEeCCc
Confidence 9999987763 899999854
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.53 E-value=3.9e-14 Score=130.86 Aligned_cols=145 Identities=15% Similarity=0.067 Sum_probs=113.2
Q ss_pred hhcCCcccceeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcCC-CCcccceEEEEEeCCEEEEEE
Q 047619 275 NATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIY 353 (430)
Q Consensus 275 ~~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 353 (430)
...+.|.+...++.|+.+.||++.. .++.+++|............+.+|+.+++.+. +..+++++++....+..|+||
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 89 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred HHhccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence 3446788888899999999999975 36899999986422123346888999999885 677889999999999999999
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhc-------------------------------------
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD------------------------------------- 396 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~------------------------------------- 396 (430)
||++|.+|.+.+. +......++.+++++|..||+.
T Consensus 90 e~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 90 SEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp ECCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred EecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 9999999987641 1122346788899999999981
Q ss_pred -------------------CCCcEEeCCCCCCcEEEcCCCCeeecCCCccc
Q 047619 397 -------------------SRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428 (430)
Q Consensus 397 -------------------~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar 428 (430)
....++|+|++|.|||++++..+.|+||+.|.
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 11349999999999999876556799999874
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.37 E-value=9.9e-13 Score=120.88 Aligned_cols=139 Identities=17% Similarity=0.119 Sum_probs=101.6
Q ss_pred hcCCcccceeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCc--ccceEEEEEeCCEEEEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN--LVKLLGCCIQGEEKLLIY 353 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~ 353 (430)
....+.+....+.|..+.||++...+++.+++|..... ....+.+|+.+++.+.+.+ +++++++...++..++||
T Consensus 18 ~~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~ 94 (264)
T 1nd4_A 18 RLFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL 94 (264)
T ss_dssp TTTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred hcCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEE
Confidence 34456553333456669999998766788999997643 2345778999988886544 567899888888899999
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcC------------------------------------
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS------------------------------------ 397 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~------------------------------------ 397 (430)
||++|.+|. ... .+. ..++.++++.|..||+..
T Consensus 95 e~i~G~~l~--~~~------~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (264)
T 1nd4_A 95 GEVPGQDLL--SSH------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ 163 (264)
T ss_dssp ECCSSEETT--TSC------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred EecCCcccC--cCc------CCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence 999998884 211 111 246677788888888643
Q ss_pred -------------------CCcEEeCCCCCCcEEEcCCCCeeecCCCccc
Q 047619 398 -------------------RLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428 (430)
Q Consensus 398 -------------------~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar 428 (430)
+..++|+|++|.|||++++..+.|+||+.|.
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1239999999999999877666799999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.25 E-value=2e-11 Score=118.03 Aligned_cols=141 Identities=18% Similarity=0.229 Sum_probs=105.9
Q ss_pred cceeecccCCcceEEEEEcCCcEEEEEEec--ccC-hHhHHHHHHHHHHHhcCC--CCcccceEEEEEeC---CEEEEEE
Q 047619 282 INNKLGEGGFGPVYKGTLVDGQEIAVKRLS--KIS-EQGLKELKNEVILFSKLQ--HRNLVKLLGCCIQG---EEKLLIY 353 (430)
Q Consensus 282 ~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~ 353 (430)
..+.|+.|.++.||++... +..+++|+.. ... ......+.+|+.+++.|. +..+++++.++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 4578999999999998864 4678888775 321 123456788999999887 45688899888776 3479999
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcC------------------------------------
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS------------------------------------ 397 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~------------------------------------ 397 (430)
||++|..+.+.. ...++...+..++.+++.+|..||+..
T Consensus 121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 999998874321 123677888889999999999999731
Q ss_pred -------------------CCcEEeCCCCCCcEEEcCCCC--eeecCCCccc
Q 047619 398 -------------------RLRIIHRDLKASNVLLDQDMN--PKISDFGLAR 428 (430)
Q Consensus 398 -------------------~~~iiH~Dlkp~NILl~~~~~--~kl~DFGlar 428 (430)
...++|+|++|.|||++.++. +.|+||+.|.
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~ 247 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELST 247 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccc
Confidence 246999999999999987753 6899999886
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=99.13 E-value=2.2e-11 Score=112.55 Aligned_cols=99 Identities=13% Similarity=0.095 Sum_probs=69.6
Q ss_pred CccccccCCCCeeEEEEcCCCCCCCCceEEEEEEcCCCCEEEEEcC-CeeEEecCCCCCc----ccc-CCee--------
Q 047619 1 MKLGWDLKTGLERRITSWKSPDDPSPGNFTWAVERQDNPELIMWKG-SRKFHRGGPWNGL----VFN-EDEL-------- 66 (430)
Q Consensus 1 mklg~~~~tg~~~~L~S~~s~~dps~G~~~~~~~~~g~~~~~~~~~-~~~y~~sg~~~~~----~~~-~~~~-------- 66 (430)
||||+|+.+|.. | +|.+||++|.|+++|+++|+ +++|++ +.+||++|+|++. +.+ ++..
T Consensus 143 ~~~~~~l~~g~~--L---~S~~dps~G~fsl~l~~dGn--lvLy~~~~~~yW~Sgt~~~~~~~l~l~~dGnLvl~d~~~~ 215 (276)
T 3m7h_A 143 AIDSLLLAPGSE--L---VQGVVYGAGASKLVFQGDGN--LVAYGPNGAATWNAGTQGKGAVRAVFQGDGNLVVYGAGNA 215 (276)
T ss_dssp CTTCEEECSSEE--E---CTTCEEEETTEEEEECTTSC--EEEECTTSSEEEECCCTTTTCCEEEECTTSCEEEECTTSC
T ss_pred cccccccccCcc--c---ccCCCCCCceEEEeecCCce--EEEEeCCCeEEEECCCCCCccEEEEEcCCCeEEEEeCCCc
Confidence 789999999876 6 67899999999999999995 445654 6899999999754 111 1111
Q ss_pred EEEEEecCCCcEEEEEEeeccceEEEEEEeCCCCcEEEEEEecC
Q 047619 67 YYTFDMTDKDVFSRIVMNQTLYVRHQFTWDKATQSWELYANVPR 110 (430)
Q Consensus 67 ~~~~~~~~~~~~~~~~l~~dG~~~~~~~~~~~~~~W~~~~~~p~ 110 (430)
.+-+.........|++|+.|| ++++|.| +..|..+|..|.
T Consensus 216 ~vWsS~t~~~~~~rl~Ld~dG-nLvly~~---~~~Wqsf~~~P~ 255 (276)
T 3m7h_A 216 VLWHSHTGGHASAVLRLQANG-SIAILDE---KPVWARFGFQPT 255 (276)
T ss_dssp EEEECSCTTCTTCEEEECTTS-CEEEEEE---EEEEESSSCCTT
T ss_pred EEEEecCCCCCCEEEEEcCCc-cEEEEcC---CCeEEccCccCC
Confidence 111111222334899999999 9999998 235666555554
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.86 E-value=5.3e-09 Score=98.43 Aligned_cols=135 Identities=20% Similarity=0.218 Sum_probs=98.3
Q ss_pred ceeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcCC-CCc--ccceEEEEEeCC---EEEEEEEcc
Q 047619 283 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRN--LVKLLGCCIQGE---EKLLIYEFV 356 (430)
Q Consensus 283 ~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~e~~ 356 (430)
.+.++.|....||++. ..+++|+... ......+.+|+.+++.+. +.. +++++......+ ..|+|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 3568999999999763 5688888643 345677899999998873 333 455555443333 348999999
Q ss_pred CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhc----------------------------------------
Q 047619 357 PNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD---------------------------------------- 396 (430)
Q Consensus 357 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~---------------------------------------- 396 (430)
+|.+|..... ..++..++..++.+++..|..||+.
T Consensus 99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9998875432 2256677778888888888888861
Q ss_pred ---------------CCCcEEeCCCCCCcEEEcC--CCCeeecCCCccc
Q 047619 397 ---------------SRLRIIHRDLKASNVLLDQ--DMNPKISDFGLAR 428 (430)
Q Consensus 397 ---------------~~~~iiH~Dlkp~NILl~~--~~~~kl~DFGlar 428 (430)
....++|+|++|.|||+++ ...+.|+||+.|.
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~ 222 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAA 222 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCE
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCc
Confidence 1235899999999999988 4567899999875
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.81 E-value=6.4e-08 Score=91.17 Aligned_cols=135 Identities=22% Similarity=0.163 Sum_probs=94.5
Q ss_pred ceeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCC---cccceEEEEE-eCCEEEEEEEccCC
Q 047619 283 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHR---NLVKLLGCCI-QGEEKLLIYEFVPN 358 (430)
Q Consensus 283 ~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~~ 358 (430)
.+.++.|....||+. +..+++|+.. .......+.+|+.+|..|.+. .+.+++.+.. ..+..++|||+++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 467888888899987 5678888853 334567889999999998752 3667777764 34557899999999
Q ss_pred CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhc------------------------------------------
Q 047619 359 KSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD------------------------------------------ 396 (430)
Q Consensus 359 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~------------------------------------------ 396 (430)
.+|...... .++......++.++.+.|..||+.
T Consensus 98 ~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 98 QILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp EECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred eECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 888763211 133444444555555555555532
Q ss_pred ---------------CCCcEEeCCCCCCcEEEcC---CCCe-eecCCCccc
Q 047619 397 ---------------SRLRIIHRDLKASNVLLDQ---DMNP-KISDFGLAR 428 (430)
Q Consensus 397 ---------------~~~~iiH~Dlkp~NILl~~---~~~~-kl~DFGlar 428 (430)
....++|+|++|.|||++. ++.+ .|+||+.|.
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~ 223 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA 223 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence 2235799999999999987 4554 899999875
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.73 E-value=1.1e-07 Score=87.71 Aligned_cols=135 Identities=16% Similarity=0.140 Sum_probs=96.7
Q ss_pred eeecccCCc-ceEEEEEc-CCcEEEEEEecccChHhHHHHHHHHHHHhcCC-CCcccceEEEEEeCCEEEEEEEccCCCC
Q 047619 284 NKLGEGGFG-PVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYEFVPNKS 360 (430)
Q Consensus 284 ~~ig~G~fg-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gs 360 (430)
+.+..|..+ .||+.... ++..+++|+-.. .....+.+|..+|+.+. +--+.+++.++.+++..++|||+++|.+
T Consensus 30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EEEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred EEccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 456667666 58987754 466788888643 23456788999888774 3347889999999999999999999988
Q ss_pred hhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcC-------------------------------------------
Q 047619 361 LDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS------------------------------------------- 397 (430)
Q Consensus 361 L~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~------------------------------------------- 397 (430)
+.+..... ......+..+++..|.-||...
T Consensus 107 ~~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 107 AFQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp HHHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred ccccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 87765221 1122345556666666666421
Q ss_pred ------------CCcEEeCCCCCCcEEEcCCCCeeecCCCccc
Q 047619 398 ------------RLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428 (430)
Q Consensus 398 ------------~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar 428 (430)
...++|+|+.|.|||++.++.+-|+||+.|.
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1237999999999999887767799999874
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=98.60 E-value=6.1e-08 Score=87.66 Aligned_cols=84 Identities=6% Similarity=0.078 Sum_probs=60.0
Q ss_pred cccc-CCCC-----eeEEEEcCCCCCCCCceEEEEEEcCCCCEEEEEcCCeeEEecCCCCCc-----cccCC--------
Q 047619 4 GWDL-KTGL-----ERRITSWKSPDDPSPGNFTWAVERQDNPELIMWKGSRKFHRGGPWNGL-----VFNED-------- 64 (430)
Q Consensus 4 g~~~-~tg~-----~~~L~S~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~y~~sg~~~~~-----~~~~~-------- 64 (430)
|.|. .+|+ +++|+| .+||++|.|+|+|+++| +++++++..+||++++|++. ...++
T Consensus 124 g~d~L~~gq~~~~~~~~L~s---~~d~s~G~~~l~l~~dG--~LvL~~~~~~~W~s~~~~~~~~~~~~L~~~Gnl~ly~~ 198 (236)
T 1dlp_A 124 GNSILYSTQGNDNHPQTLHA---TQSLQLSPYRLSMETDC--NLVLFDRDDRVWSTNTAGKGTGCRAVLQPNGRMDVLTN 198 (236)
T ss_dssp CCEECCCC--CCCCCCEECS---SCCCBCSSCEEEEETTT--EEEEEBTTBCCSCCCCCSSCSSCEEEEETTTEEEEEET
T ss_pred cceEEecCCcCCCccceEEc---CcEeecCcEEEEECCCC--cEEEEcCCEeEEeCCCcCCCCceEEEECCCCcEEEEeC
Confidence 5566 7777 678884 78999999999999999 68888888899999999643 11111
Q ss_pred ---eeEEEEEecCCCcEEEEEEeeccceEEEEE
Q 047619 65 ---ELYYTFDMTDKDVFSRIVMNQTLYVRHQFT 94 (430)
Q Consensus 65 ---~~~~~~~~~~~~~~~~~~l~~dG~~~~~~~ 94 (430)
+++.+|... .....|++|++|| ++++|.
T Consensus 199 ~~~~vw~s~~~~-~~~~~rl~Ld~dG-~l~ly~ 229 (236)
T 1dlp_A 199 QNIAVWTSGNSR-SAGRYVFVLQPDR-NLAIYG 229 (236)
T ss_dssp TTEEEEECCCCC-SSSCCEEEECSSS-CEEEEC
T ss_pred CCcEEEEeCCCC-CCCCEEEEEcCCC-cEEEeC
Confidence 122222222 2246899999999 999984
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.57 E-value=7.4e-08 Score=92.64 Aligned_cols=80 Identities=8% Similarity=0.008 Sum_probs=55.5
Q ss_pred ceee-cccCCcceEEEEEc-------CCcEEEEEEecccC---hHhHHHHHHHHHHHhcCCC---CcccceEEEEEeC--
Q 047619 283 NNKL-GEGGFGPVYKGTLV-------DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQH---RNLVKLLGCCIQG-- 346 (430)
Q Consensus 283 ~~~i-g~G~fg~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~-- 346 (430)
.+.| +.|....+|+.... ++..+++|+..... ......+.+|+.+++.|.. ..+.+++.+..+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4677 88889999998754 25678888765321 0012456788888887742 3577888877655
Q ss_pred -CEEEEEEEccCCCChh
Q 047619 347 -EEKLLIYEFVPNKSLD 362 (430)
Q Consensus 347 -~~~~lv~e~~~~gsL~ 362 (430)
...++||||++|..+.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 3468999999987764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.36 E-value=1.3e-06 Score=85.31 Aligned_cols=75 Identities=9% Similarity=0.135 Sum_probs=50.2
Q ss_pred ceeecccCCcceEEEEEc-CCcEEEEEEecccCh-------HhHHHHHHHHHHHhcCCC--C-cccceEEEEEeCCEEEE
Q 047619 283 NNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISE-------QGLKELKNEVILFSKLQH--R-NLVKLLGCCIQGEEKLL 351 (430)
Q Consensus 283 ~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~-niv~l~~~~~~~~~~~l 351 (430)
.+.||.|.++.||++... +++.+++|....... .....+..|.+++..+.. | .+++++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 468999999999999754 467899998653211 123456778888887642 3 34566644 4556789
Q ss_pred EEEccCCC
Q 047619 352 IYEFVPNK 359 (430)
Q Consensus 352 v~e~~~~g 359 (430)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999864
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.34 E-value=2.3e-06 Score=81.33 Aligned_cols=140 Identities=16% Similarity=0.209 Sum_probs=78.2
Q ss_pred eeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcCC-----CCcccceE-E--EEEeCCEEEEEEEc
Q 047619 284 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-----HRNLVKLL-G--CCIQGEEKLLIYEF 355 (430)
Q Consensus 284 ~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~-~--~~~~~~~~~lv~e~ 355 (430)
+.|+.|..+.||++...+ ..+++|+... .. ..+..|+.++..|. .|.++... + +....+..+++|||
T Consensus 38 ~~l~gG~~n~~~~v~~~~-~~~vlk~~~~-~~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDS-GAVCLKRIHR-PE---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETT-EEEEEEEECS-CH---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCC-CCEEEEecCC-CH---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 456667788999988654 4589998865 22 23334555554442 24443310 0 12346778999999
Q ss_pred cCCCChh-----------H---Hhhc--CCC--C-------CCCCHHHH-------------------------------
Q 047619 356 VPNKSLD-----------S---FIFD--QER--C-------KILDWSKR------------------------------- 379 (430)
Q Consensus 356 ~~~gsL~-----------~---~l~~--~~~--~-------~~~~~~~~------------------------------- 379 (430)
++|..+. . .++. ... . ....|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 0 1111 000 0 00122111
Q ss_pred HHHHHHHHHHHHHhhh----------cCCCcEEeCCCCCCcEEEcCCCCeeecCCCccc
Q 047619 380 FHIICGTARGVMYLHQ----------DSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428 (430)
Q Consensus 380 ~~i~~~i~~aL~yLH~----------~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar 428 (430)
..+..++..++.+|+. ..+..++|+|++|.|||++.++.+.|+||+.|.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 0111223345666653 123459999999999999878889999999874
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.15 E-value=9.7e-06 Score=75.30 Aligned_cols=80 Identities=18% Similarity=0.210 Sum_probs=58.9
Q ss_pred CCcccceeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcCCC---CcccceEEEEEeCCEEEEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH---RNLVKLLGCCIQGEEKLLIYE 354 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~~~~~lv~e 354 (430)
....-.+.+|.|..+.||+....+|+.+++|+...........+..|+..|+.|.. --+++++.. . ..++|||
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~lv~e 90 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRTLAME 90 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTEEEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c--CceEEEE
Confidence 45566788999999999999999999999998764333334567889998888742 235555554 2 2478999
Q ss_pred ccCCCCh
Q 047619 355 FVPNKSL 361 (430)
Q Consensus 355 ~~~~gsL 361 (430)
|++++..
T Consensus 91 ~l~~~~~ 97 (288)
T 3f7w_A 91 WVDERPP 97 (288)
T ss_dssp CCCCCCC
T ss_pred eecccCC
Confidence 9987654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.11 E-value=4.4e-05 Score=71.69 Aligned_cols=139 Identities=16% Similarity=0.121 Sum_probs=92.8
Q ss_pred cceeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcCC---CCcccceEEEEEeCCEEEEEEEccCC
Q 047619 282 INNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ---HRNLVKLLGCCIQGEEKLLIYEFVPN 358 (430)
Q Consensus 282 ~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~ 358 (430)
-.+.|+.|....+|+... ++..+++|+... .....+..|...|+.|. ...+++++.+....+..++||||+++
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~---~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINER---SYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEG---GGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCc---ccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 347899999999999875 567888988753 23567888998888874 35688999988888899999999998
Q ss_pred CChh--------H---HhhcCCC---C-C---------------CCCHHHHH---HHH----------------HHHHHH
Q 047619 359 KSLD--------S---FIFDQER---C-K---------------ILDWSKRF---HII----------------CGTARG 389 (430)
Q Consensus 359 gsL~--------~---~l~~~~~---~-~---------------~~~~~~~~---~i~----------------~~i~~a 389 (430)
..+. . .|+.... . - .-+|...+ ++. ..++..
T Consensus 116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~ 195 (312)
T 3jr1_A 116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI 195 (312)
T ss_dssp CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence 7652 1 1121111 0 0 01343322 111 111111
Q ss_pred -HHHhhh-cCCCcEEeCCCCCCcEEEcCCCCeeecCCC
Q 047619 390 -VMYLHQ-DSRLRIIHRDLKASNVLLDQDMNPKISDFG 425 (430)
Q Consensus 390 -L~yLH~-~~~~~iiH~Dlkp~NILl~~~~~~kl~DFG 425 (430)
...|.. ...+.++|+|+.+.|||++.++ +.|+||.
T Consensus 196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 223321 2245799999999999999887 9999984
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.07 E-value=1.7e-05 Score=77.95 Aligned_cols=73 Identities=11% Similarity=0.156 Sum_probs=45.7
Q ss_pred ceeecccCCcceEEEEEcCCcEEEEEEeccc----ChH-----hHHHHHHHHHHHh-cCCCCcccceEEEEEeCCEEEEE
Q 047619 283 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI----SEQ-----GLKELKNEVILFS-KLQHRNLVKLLGCCIQGEEKLLI 352 (430)
Q Consensus 283 ~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~----~~~-----~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv 352 (430)
.+.||.|....||++.. +++.++||..... ... ....+..|+..+. ......+++++.+. .+..++|
T Consensus 39 i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv 115 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG 115 (420)
T ss_dssp EEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred EEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence 47899999999999964 4678999943210 111 2233334443322 12234567777665 5677999
Q ss_pred EEcc-CC
Q 047619 353 YEFV-PN 358 (430)
Q Consensus 353 ~e~~-~~ 358 (430)
|||+ ++
T Consensus 116 ~e~l~~g 122 (420)
T 2pyw_A 116 MRYLEPP 122 (420)
T ss_dssp ECCCCTT
T ss_pred EeecCCc
Confidence 9999 76
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.89 E-value=2.8e-05 Score=73.25 Aligned_cols=143 Identities=16% Similarity=0.107 Sum_probs=77.7
Q ss_pred ceeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCc--ccceEE------EEEeCCEEEEEEE
Q 047619 283 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN--LVKLLG------CCIQGEEKLLIYE 354 (430)
Q Consensus 283 ~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~------~~~~~~~~~lv~e 354 (430)
.+.|+.|....+|++...++ .+++|..... .....+..|+.++..|...+ +++++. +....+..+++|+
T Consensus 27 ~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~ 103 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS 103 (322)
T ss_dssp EEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred eeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEE
Confidence 35677788889999886555 6888988652 12234556777666653211 233331 1223466789999
Q ss_pred ccCCCChhH--------------HhhcC--C--CC--CCC---CHHHHHH------------HHHHHHHHHHHhhhc---
Q 047619 355 FVPNKSLDS--------------FIFDQ--E--RC--KIL---DWSKRFH------------IICGTARGVMYLHQD--- 396 (430)
Q Consensus 355 ~~~~gsL~~--------------~l~~~--~--~~--~~~---~~~~~~~------------i~~~i~~aL~yLH~~--- 396 (430)
|++|..+.. .++.. . .. ... .|...+. +...+...++.++..
T Consensus 104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~ 183 (322)
T 2ppq_A 104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK 183 (322)
T ss_dssp CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence 999865421 01110 0 00 001 1211100 001133445555432
Q ss_pred -CCCcEEeCCCCCCcEEEcCCCCeeecCCCccc
Q 047619 397 -SRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428 (430)
Q Consensus 397 -~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar 428 (430)
.+..++|+|++|.|||++.+..+.|+||+.|.
T Consensus 184 ~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 184 DLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp SSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 12359999999999999877556899998874
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.82 E-value=0.00018 Score=67.73 Aligned_cols=141 Identities=16% Similarity=0.137 Sum_probs=79.7
Q ss_pred eeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCC--cccceEEE-----EEeCCEEEEEEEcc
Q 047619 284 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHR--NLVKLLGC-----CIQGEEKLLIYEFV 356 (430)
Q Consensus 284 ~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~-----~~~~~~~~lv~e~~ 356 (430)
..++ |....||++...+++.+++|..... ......+..|+.++..+... .+++++.. ....+..+++||++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~-~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCC-CCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4566 7888999887666778999998632 11234566777777766421 23444432 22355678999999
Q ss_pred CCCChh-----H------H---hhc----CC--CCCCCCHHHH----------------------HHHHHHHHHHHHHhh
Q 047619 357 PNKSLD-----S------F---IFD----QE--RCKILDWSKR----------------------FHIICGTARGVMYLH 394 (430)
Q Consensus 357 ~~gsL~-----~------~---l~~----~~--~~~~~~~~~~----------------------~~i~~~i~~aL~yLH 394 (430)
+|..+. . . ++. .. .....++... ...+..++..++-+.
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 885432 0 0 110 00 0011121110 011111222222111
Q ss_pred h-cCCCcEEeCCCCCCcEEEcCCCCeeecCCCccc
Q 047619 395 Q-DSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428 (430)
Q Consensus 395 ~-~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar 428 (430)
. ..+..++|+|++|.|||++ + .+.|+||+.|.
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 1 1234589999999999998 4 89999998775
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.79 E-value=4.5e-05 Score=75.10 Aligned_cols=73 Identities=19% Similarity=0.305 Sum_probs=49.7
Q ss_pred ceeecccCCcceEEEEEcC--------CcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcc-cceEEEEEeCCEEEEEE
Q 047619 283 NNKLGEGGFGPVYKGTLVD--------GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL-VKLLGCCIQGEEKLLIY 353 (430)
Q Consensus 283 ~~~ig~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~ 353 (430)
.+.|+.|-...||++...+ ++.+++|+.... .....+.+|..++..|...++ +++++.+. + .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEE
Confidence 4678889899999998653 478899987431 112445578888888753333 56776543 2 3899
Q ss_pred EccCCCCh
Q 047619 354 EFVPNKSL 361 (430)
Q Consensus 354 e~~~~gsL 361 (430)
||++|.+|
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99987444
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.75 E-value=8.5e-05 Score=71.67 Aligned_cols=140 Identities=19% Similarity=0.275 Sum_probs=80.8
Q ss_pred eeecccCCcceEEEEEcC--------CcEEEEEEecccChHhHHHHHHHHHHHhcCCCCc-ccceEEEEEeCCEEEEEEE
Q 047619 284 NKLGEGGFGPVYKGTLVD--------GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN-LVKLLGCCIQGEEKLLIYE 354 (430)
Q Consensus 284 ~~ig~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e 354 (430)
+.|..|-...+|++...+ ++.+++|+.... ........+|..+++.|...+ ..++++.+. +. +|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~g--~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFP--EG--RLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--TE--EEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcC--Cc--cEEE
Confidence 678888889999988642 478889886432 223455668999888774322 356666553 32 9999
Q ss_pred ccCCCChhHH-----------------hhcC--CCCCCCC--HHHHHHHHHHHH-------------------HHHHHhh
Q 047619 355 FVPNKSLDSF-----------------IFDQ--ERCKILD--WSKRFHIICGTA-------------------RGVMYLH 394 (430)
Q Consensus 355 ~~~~gsL~~~-----------------l~~~--~~~~~~~--~~~~~~i~~~i~-------------------~aL~yLH 394 (430)
|++|.+|..- |+.. ...+... +.++.++..++. ..+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998665311 1111 1111112 334444433321 1122222
Q ss_pred ----hc-CCCcEEeCCCCCCcEEEcCC----CCeeecCCCccc
Q 047619 395 ----QD-SRLRIIHRDLKASNVLLDQD----MNPKISDFGLAR 428 (430)
Q Consensus 395 ----~~-~~~~iiH~Dlkp~NILl~~~----~~~kl~DFGlar 428 (430)
.. ....++|+|+.+.|||++.+ +.+.|+||..|.
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 11 23458999999999999876 689999999875
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.74 E-value=8.3e-05 Score=69.40 Aligned_cols=71 Identities=10% Similarity=0.170 Sum_probs=44.7
Q ss_pred ceeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcc-cceEEEEEeCCEEEEEEEcc-CCCC
Q 047619 283 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL-VKLLGCCIQGEEKLLIYEFV-PNKS 360 (430)
Q Consensus 283 ~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~gs 360 (430)
.+.|+.|....+|++ +.+++|+....... .....+|+.+++.+...++ .+++.. ..+.-++++||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 688999999999998 56888877542211 1122457777766643222 455544 344457899999 6655
Q ss_pred h
Q 047619 361 L 361 (430)
Q Consensus 361 L 361 (430)
|
T Consensus 95 l 95 (301)
T 3dxq_A 95 M 95 (301)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.71 E-value=0.00018 Score=71.20 Aligned_cols=74 Identities=14% Similarity=0.099 Sum_probs=47.8
Q ss_pred ceeecccCCcceEEEEEcC-CcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcc-cceEEEEEeCCEEEEEEEccCCCC
Q 047619 283 NNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL-VKLLGCCIQGEEKLLIYEFVPNKS 360 (430)
Q Consensus 283 ~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gs 360 (430)
.+.|+.|-...+|++...+ +..+++|+......... .-.+|..++..|...++ +++++.+ .+. +||||++|.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~--~~G--~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFF--TNG--RIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEE--TTE--EEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEe--CCe--EEEEeeCCcc
Confidence 3678889899999998765 47888888743221111 11578888888865444 5677765 232 5999998755
Q ss_pred h
Q 047619 361 L 361 (430)
Q Consensus 361 L 361 (430)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.70 E-value=0.00021 Score=67.66 Aligned_cols=140 Identities=15% Similarity=0.079 Sum_probs=71.4
Q ss_pred eeecccCCcc-eEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcCCC--CcccceEEEEEeCCEEEEEEEccCCCC
Q 047619 284 NKLGEGGFGP-VYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH--RNLVKLLGCCIQGEEKLLIYEFVPNKS 360 (430)
Q Consensus 284 ~~ig~G~fg~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gs 360 (430)
+.|+.|.... +|+....++..+++|....... ..+..|+.++..+.. -.+++++.+.... -+++||++++..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCcc
Confidence 4565555444 6777654467777776543211 234456666665532 3356677653322 378999998766
Q ss_pred hhHHhhcCC-----------------------CCCCCCHHHHH-------H-H------------HHHHHHHHHHhh---
Q 047619 361 LDSFIFDQE-----------------------RCKILDWSKRF-------H-I------------ICGTARGVMYLH--- 394 (430)
Q Consensus 361 L~~~l~~~~-----------------------~~~~~~~~~~~-------~-i------------~~~i~~aL~yLH--- 394 (430)
+.+.+.... ....++..... . + ...+...++.+.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 654432110 00111111100 0 0 001111222221
Q ss_pred hcCCCcEEeCCCCCCcEEEcCC----CCeeecCCCccc
Q 047619 395 QDSRLRIIHRDLKASNVLLDQD----MNPKISDFGLAR 428 (430)
Q Consensus 395 ~~~~~~iiH~Dlkp~NILl~~~----~~~kl~DFGlar 428 (430)
......++|+|+.|.|||++.+ +.+.|+||+.|.
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~ 216 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAK 216 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcC
Confidence 1123459999999999999874 678999999875
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.53 E-value=0.00012 Score=70.36 Aligned_cols=74 Identities=14% Similarity=0.144 Sum_probs=44.2
Q ss_pred ceeecccCCcceEEEEEcC---------CcEEEEEEecccChHhHHHHHHHHHHHhcCCCCc-ccceEEEEEeCCEEEEE
Q 047619 283 NNKLGEGGFGPVYKGTLVD---------GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN-LVKLLGCCIQGEEKLLI 352 (430)
Q Consensus 283 ~~~ig~G~fg~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv 352 (430)
.+.|+.|....+|++...+ ++.+++|+..... ........|..+++.+...+ ++++++.. . -++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence 3578888888999988643 2678888765422 11112356777777775333 45666543 2 3689
Q ss_pred EEccCCCCh
Q 047619 353 YEFVPNKSL 361 (430)
Q Consensus 353 ~e~~~~gsL 361 (430)
|||++|..+
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999998644
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=97.48 E-value=0.00011 Score=57.87 Aligned_cols=42 Identities=17% Similarity=0.378 Sum_probs=35.9
Q ss_pred EEcCCCCCCCCceEEEEEEcCCCCEEEEEc-CCeeEEecCCCCCc
Q 047619 16 TSWKSPDDPSPGNFTWAVERQDNPELIMWK-GSRKFHRGGPWNGL 59 (430)
Q Consensus 16 ~S~~s~~dps~G~~~~~~~~~g~~~~~~~~-~~~~y~~sg~~~~~ 59 (430)
+-|.|.++|++|.|++.|+++|+ +++++ +..+||+|++|+|.
T Consensus 70 ~~W~S~~~~~~g~~~l~l~~dGn--lvl~~~~~~~~W~S~~~~g~ 112 (112)
T 1xd5_A 70 AIWASNTNRQNGNYYLILQRDRN--VVIYDNSNNAIWATHTNVGN 112 (112)
T ss_dssp EEEECCCCCSCCCCEEEECTTSC--EEEECTTSCEEEECCCCCCC
T ss_pred EEEECCccCCCCCEEEEEeCCCc--EEEECCCCceEEECCCccCC
Confidence 45899999999999999999998 55665 46799999999873
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.33 E-value=0.0011 Score=62.84 Aligned_cols=30 Identities=27% Similarity=0.374 Sum_probs=26.8
Q ss_pred CcEEeCCCCCCcEEEcCCCCeeecCCCccc
Q 047619 399 LRIIHRDLKASNVLLDQDMNPKISDFGLAR 428 (430)
Q Consensus 399 ~~iiH~Dlkp~NILl~~~~~~kl~DFGlar 428 (430)
..++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~ 235 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPM 235 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCe
Confidence 469999999999999888889999998764
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=96.66 E-value=0.0016 Score=50.87 Aligned_cols=38 Identities=8% Similarity=0.326 Sum_probs=30.2
Q ss_pred EEcCCCCCCCCceEEEEEEcCCCCEEEEEcCCeeEEecCCCC
Q 047619 16 TSWKSPDDPSPGNFTWAVERQDNPELIMWKGSRKFHRGGPWN 57 (430)
Q Consensus 16 ~S~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~y~~sg~~~ 57 (430)
+-|.|.++|++|.|+++|+++|+ ++++++ .||+|+++.
T Consensus 72 ~~W~S~t~~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~~ 109 (110)
T 3a0c_A 72 VIWQTKTNGKEDHYVLVLQQDRN--VVIYGP--VVWATGSGP 109 (110)
T ss_dssp EEEECCCCCSSSCCEEEECTTSC--EEEECS--EEEECSCCC
T ss_pred EEEecCCCCCCCCEEEEEeCCcc--EEEECC--CEecCCCcC
Confidence 35888899999999999999987 555665 799988763
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=96.61 E-value=0.0018 Score=51.34 Aligned_cols=36 Identities=17% Similarity=0.466 Sum_probs=28.0
Q ss_pred EEcCCCCCCCCceEEEEEEcCCCCEEEEEcCCeeEEecCC
Q 047619 16 TSWKSPDDPSPGNFTWAVERQDNPELIMWKGSRKFHRGGP 55 (430)
Q Consensus 16 ~S~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~y~~sg~ 55 (430)
+-|.|.+||++|.|+++|+++|+ +++++ .+||++|+
T Consensus 82 ~lW~S~~~~~~g~~~l~l~~~Gn--lvl~~--~~~W~Sg~ 117 (119)
T 1b2p_A 82 TVWQSPVAGKAGHYVLVLQPDRN--VVIYG--DALWATQT 117 (119)
T ss_dssp EEEECSCCCCSSCEEEEECTTSC--EEEEE--SEEEECCC
T ss_pred EEEcCCCCCCCCCEEEEEECCCc--EEEEC--ccEeCCCC
Confidence 35888888888889999988887 45555 37888886
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=96.55 E-value=0.0019 Score=50.77 Aligned_cols=39 Identities=13% Similarity=0.319 Sum_probs=32.6
Q ss_pred EEcCCCCCCCCceEEEEEEcCCCCEEEEEcCCeeEEecCCCCC
Q 047619 16 TSWKSPDDPSPGNFTWAVERQDNPELIMWKGSRKFHRGGPWNG 58 (430)
Q Consensus 16 ~S~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~y~~sg~~~~ 58 (430)
+-|.|.+.|++|.|++.|+++|+ |++++. .||+|++|..
T Consensus 72 ~vW~S~~~~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~~~ 110 (115)
T 2dpf_A 72 DVWGSACWGDNGKYALVLQKDGR--FVIYGP--VLWSLGPNGC 110 (115)
T ss_dssp EEEECCCCCSSSCCEEEECTTSC--EEEECS--EEECSSTTCB
T ss_pred EEEEcCCCCCCCCEEEEEeCCCe--EEEECC--CEEECCCCCC
Confidence 45888999999999999999997 556654 8999999964
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.37 E-value=0.013 Score=57.27 Aligned_cols=74 Identities=18% Similarity=0.194 Sum_probs=47.7
Q ss_pred ceeecccCCcceEEEEEcC--------CcEEEEEEecccChHhHHHHHHHHHHHhcCCCCc-ccceEEEEEeCCEEEEEE
Q 047619 283 NNKLGEGGFGPVYKGTLVD--------GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN-LVKLLGCCIQGEEKLLIY 353 (430)
Q Consensus 283 ~~~ig~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~ 353 (430)
.+.|..|-...+|+....+ ++.+++++....... .-.-.+|..+++.+...+ .+++++.+ . -++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEE
Confidence 3678888888999998653 578888886542211 112356777777774222 45566533 2 27899
Q ss_pred EccCCCCh
Q 047619 354 EFVPNKSL 361 (430)
Q Consensus 354 e~~~~gsL 361 (430)
||++|..|
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99998664
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=96.36 E-value=0.012 Score=45.63 Aligned_cols=66 Identities=6% Similarity=0.046 Sum_probs=41.9
Q ss_pred CceEEEEEEcCCCCEEEEEcCCeeEEecCCCCCc-----cc-cCCe---------eEEEEEecCCCcEEEEEEeeccceE
Q 047619 26 PGNFTWAVERQDNPELIMWKGSRKFHRGGPWNGL-----VF-NEDE---------LYYTFDMTDKDVFSRIVMNQTLYVR 90 (430)
Q Consensus 26 ~G~~~~~~~~~g~~~~~~~~~~~~y~~sg~~~~~-----~~-~~~~---------~~~~~~~~~~~~~~~~~l~~dG~~~ 90 (430)
.|.|.|.|+.+|++.+ ++...++|.++..... .+ +++. ..+.-.........+++|+.|| ++
T Consensus 18 ~g~~~L~~q~dGnLvl--y~~~~~vW~snt~~~~~~~~l~l~~dGNLvl~~~~~~~~W~S~t~~~~~~~~~~L~ddG-Nl 94 (109)
T 3dzw_A 18 NGRYVFIMQEDCNLVL--YDVDKPIWATNTGGLDRRCHLSMQSDGNLVVYSPRNNPIWASNTGGENGNYVCVLQKDR-NV 94 (109)
T ss_dssp ETTEEEEECTTSCEEE--EETTEEEEECCCTTSSSSCEEEECTTSCEEEECTTSCEEEECCCCCSSSCEEEEECTTS-CE
T ss_pred CCCEEEEEcCCCcEEE--EeCCEEEEECCcccCCCCEEEEEeCCCCEEEECCCCCEEEECCCCCCCCCEEEEEeCCC-EE
Confidence 6999999999997544 5667899998865321 11 1221 1111111112235689999999 99
Q ss_pred EEEE
Q 047619 91 HQFT 94 (430)
Q Consensus 91 ~~~~ 94 (430)
.+|.
T Consensus 95 vly~ 98 (109)
T 3dzw_A 95 VIYG 98 (109)
T ss_dssp EEEE
T ss_pred EEEC
Confidence 9985
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=96.27 E-value=0.0059 Score=47.78 Aligned_cols=66 Identities=12% Similarity=0.092 Sum_probs=40.6
Q ss_pred CceEEEEEEcCCCCEEEEEcC--CeeEEecCCCCCc-----cc-cCCeeEE-------EEEe--cCCCcEEEEEEeeccc
Q 047619 26 PGNFTWAVERQDNPELIMWKG--SRKFHRGGPWNGL-----VF-NEDELYY-------TFDM--TDKDVFSRIVMNQTLY 88 (430)
Q Consensus 26 ~G~~~~~~~~~g~~~~~~~~~--~~~y~~sg~~~~~-----~~-~~~~~~~-------~~~~--~~~~~~~~~~l~~dG~ 88 (430)
.|.|.|.|+.+|++.+ ++. ..+||.+++.... .+ +++.+.+ .... .......+++|+.||
T Consensus 23 ~g~~~L~~q~dGNLvL--~~~~~~~~vWssnt~~~~~~~~l~l~~dGNLVl~d~~~~~iW~S~t~~~~~~~~~~L~~dG- 99 (113)
T 3mez_B 23 TRDYSLVMRDDCNLVL--TKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDDRLNTVFVSNTVGQEGDYVLILQING- 99 (113)
T ss_dssp ETTEEEEECTTSCEEE--EETTTTEEEEECCCTTSCSSCEEEECTTSCEEEECTTSCEEEECSCCCSSSCCEEEECTTS-
T ss_pred cCCEEEEEcCCCEEEE--EECCCCEEEEECCcccCCcCEEEEEeCCCcEEEECCCCCEEEECCCcCCCCCEEEEEcCCc-
Confidence 4899999999998555 443 5799998865311 11 1221111 1111 111223689999999
Q ss_pred eEEEEE
Q 047619 89 VRHQFT 94 (430)
Q Consensus 89 ~~~~~~ 94 (430)
++.+|.
T Consensus 100 nlvly~ 105 (113)
T 3mez_B 100 QAVVYG 105 (113)
T ss_dssp CEEEEC
T ss_pred eEEEec
Confidence 999984
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=96.05 E-value=0.013 Score=45.52 Aligned_cols=64 Identities=16% Similarity=0.114 Sum_probs=39.5
Q ss_pred CCceEEEEEEcCCCCEEEEEcCCeeEEecCCCCCc-----ccc-CCee---------EEEEEecCCCcEEEEEEeeccce
Q 047619 25 SPGNFTWAVERQDNPELIMWKGSRKFHRGGPWNGL-----VFN-EDEL---------YYTFDMTDKDVFSRIVMNQTLYV 89 (430)
Q Consensus 25 s~G~~~~~~~~~g~~~~~~~~~~~~y~~sg~~~~~-----~~~-~~~~---------~~~~~~~~~~~~~~~~l~~dG~~ 89 (430)
+.|.|.|.|+.+|++.+ +++ ||.+++.... .+. ++.+ .+...........+++|+.|| +
T Consensus 19 ~~g~~~L~~q~dGNLvl--~~~---~Wssnt~~~~~~~~l~l~~dGnLvl~d~~~~~vWss~t~~~~~~~~~~L~~dG-N 92 (109)
T 3r0e_A 19 KNGDFDLVMQDDCNLVL--YNG---NWQSNTANNGRDCKLTLTDYGELVIKNGDGSTVWKSGAQSVKGNYAAVVHPDG-R 92 (109)
T ss_dssp EETTEEEEECTTSCEEE--ETT---TEECCCTTSCSSCEEEECTTSCEEEECTTSCEEEECCCCCSSSCCEEEEETTT-E
T ss_pred ECCCEEEEEecCCeEEE--EeC---eEEcCCCCCCCcEEEEEcCCCeEEEEeCCCCEEEcCCCcCCCcCEEEEEcCCC-e
Confidence 56999999999997655 443 8988766421 111 2211 111111112245689999999 9
Q ss_pred EEEEE
Q 047619 90 RHQFT 94 (430)
Q Consensus 90 ~~~~~ 94 (430)
+++|.
T Consensus 93 lvly~ 97 (109)
T 3r0e_A 93 LVVFG 97 (109)
T ss_dssp EEEEC
T ss_pred EEEEe
Confidence 99995
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=95.87 E-value=0.025 Score=43.51 Aligned_cols=64 Identities=8% Similarity=0.050 Sum_probs=40.3
Q ss_pred ceEEEEEEcCCCCEEEEEcCCeeEEecCCCCCc------cc-cCCe---------eEEEEEecCCCcEEEEEEeeccceE
Q 047619 27 GNFTWAVERQDNPELIMWKGSRKFHRGGPWNGL------VF-NEDE---------LYYTFDMTDKDVFSRIVMNQTLYVR 90 (430)
Q Consensus 27 G~~~~~~~~~g~~~~~~~~~~~~y~~sg~~~~~------~~-~~~~---------~~~~~~~~~~~~~~~~~l~~dG~~~ 90 (430)
|.|+|.|+.+|++. +|++..+.|.++..+.. .+ .++. ..+.........-.+++|..|| ++
T Consensus 19 g~y~l~~q~DgNLv--ly~~~~~vW~ant~~~~~~~~~L~l~~dGnLvL~d~~~~~vWss~t~~~~~~~~l~L~ddG-Nl 95 (105)
T 4h3o_A 19 EPYHFIMQDDCNLV--LYDHSTSTWASNTEIGGKSGCSAVLQSDGNFVVYDSSGRSLWASHSTRGSGNYILILQDDG-NV 95 (105)
T ss_dssp TTEEEEECTTSCEE--EEETTEEEEECCCCCTTCCSCEEEECTTSCEEEECTTCCEEEECCCCCCSSCEEEEECTTS-CE
T ss_pred CCEEEEECCCCeEE--EEECCEEEEEecCCCCCCccEEEEEeCCccEEEECCCcEEEEEecCCCCCCCEEEEEeCCC-eE
Confidence 88999999999754 45778899988765422 11 1111 1222212222334678899999 88
Q ss_pred EEE
Q 047619 91 HQF 93 (430)
Q Consensus 91 ~~~ 93 (430)
.+|
T Consensus 96 Vly 98 (105)
T 4h3o_A 96 IIY 98 (105)
T ss_dssp EEE
T ss_pred EEE
Confidence 887
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=95.53 E-value=0.023 Score=44.15 Aligned_cols=64 Identities=11% Similarity=0.098 Sum_probs=38.8
Q ss_pred ceEEEEEEcCCCCEEEEEcCCeeEEecCCCCCc-----cc-cCCeeE---------EEEEecCCCcEEEEEEeeccceEE
Q 047619 27 GNFTWAVERQDNPELIMWKGSRKFHRGGPWNGL-----VF-NEDELY---------YTFDMTDKDVFSRIVMNQTLYVRH 91 (430)
Q Consensus 27 G~~~~~~~~~g~~~~~~~~~~~~y~~sg~~~~~-----~~-~~~~~~---------~~~~~~~~~~~~~~~l~~dG~~~~ 91 (430)
|.|.|.|+.+|++.+ +++ .+||.++..... .+ +++.+. +.-.......-.+++|+.|| ++.
T Consensus 24 g~~~L~~q~dGnLvl--~~~-~~vW~snt~~~~~~~~l~l~~dGNLvl~d~~~~~iW~S~t~~~~~~~~~~L~~dG-Nlv 99 (110)
T 3r0e_B 24 KNHQLVMQGDCNLVL--YGG-KYGWQSNTHGNGEHCFLRLNHKGELIIKDDDFKTIWSSRSSSKQGEYVLILQDDG-FGV 99 (110)
T ss_dssp SSCEEEECTTSCEEE--ECS-SSCEECCCTTSSSSCEEEECTTSCEEEECTTCCEEEECCCCCSSSCCEEEECTTS-CEE
T ss_pred CCEEEEEcCCCeEEE--ECC-eEEEECCCcCCCcCEEEEEeCCCcEEEEeCCCCEEEEcCCcCCCCCEEEEEcCCc-cEE
Confidence 679999999997544 555 589998765321 11 122111 11111111223689999999 999
Q ss_pred EEE
Q 047619 92 QFT 94 (430)
Q Consensus 92 ~~~ 94 (430)
+|.
T Consensus 100 ly~ 102 (110)
T 3r0e_B 100 IYG 102 (110)
T ss_dssp EEC
T ss_pred Eec
Confidence 985
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.26 E-value=0.055 Score=52.34 Aligned_cols=28 Identities=25% Similarity=0.451 Sum_probs=24.1
Q ss_pred EEeCCCCCCcEEE------cCCCCeeecCCCccc
Q 047619 401 IIHRDLKASNVLL------DQDMNPKISDFGLAR 428 (430)
Q Consensus 401 iiH~Dlkp~NILl------~~~~~~kl~DFGlar 428 (430)
++|+|+.+.|||+ +++..++|+||.+|.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 6799999999999 345679999998875
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=95.02 E-value=0.036 Score=43.03 Aligned_cols=66 Identities=8% Similarity=0.014 Sum_probs=40.5
Q ss_pred CCceEEEEEEcCCCCEEEEEcCCeeEEecCCCCCc------cccCCee----------EEEEEe-c-CCCcEEEEEEeec
Q 047619 25 SPGNFTWAVERQDNPELIMWKGSRKFHRGGPWNGL------VFNEDEL----------YYTFDM-T-DKDVFSRIVMNQT 86 (430)
Q Consensus 25 s~G~~~~~~~~~g~~~~~~~~~~~~y~~sg~~~~~------~~~~~~~----------~~~~~~-~-~~~~~~~~~l~~d 86 (430)
+.|.|.|.|+.+|++.+ ++... ||.+++.... +.+++.+ .+.... . ......+++|+.|
T Consensus 18 ~~g~~~L~~q~dGnLvl--~~~~~-vW~snt~~~~~~~~l~l~~dGNLVl~~~~~~~~vW~S~t~~~~~~~~~~l~Lq~d 94 (111)
T 3mez_A 18 SYESAAFVMQGDCNLVL--YNEAG-GFQSNTHGRGVDCTLRLNNRGQLEIHSANSNTPVWVYPRSVNTVRGNYAATLGPD 94 (111)
T ss_dssp EETTEEEEECTTSCEEE--ECSSC-CEECCCTTSCSSCEEEECTTSCEEEECSSCSSCSEEESSSCCCCSSCCEEEECTT
T ss_pred ecCCEEEEEccCCeEEE--ECCCC-EEECCcccCCcCEEEEEcCCCcEEEEeCCCCEEEEEeccccCCCCcCEEEEECCC
Confidence 46999999999997655 55555 9998765321 1112211 111111 0 1123568999999
Q ss_pred cceEEEEE
Q 047619 87 LYVRHQFT 94 (430)
Q Consensus 87 G~~~~~~~ 94 (430)
| ++.+|.
T Consensus 95 G-Nlvly~ 101 (111)
T 3mez_A 95 Q-HVTIYG 101 (111)
T ss_dssp S-CEEEEC
T ss_pred C-eEEEec
Confidence 9 999995
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=93.22 E-value=0.24 Score=38.28 Aligned_cols=65 Identities=12% Similarity=0.227 Sum_probs=38.3
Q ss_pred CceEEEEEEcCCCCEEEEEcCCeeEEecCCCCCc------cccCCeeEE------EEEe-cC-CCcEEEEEEeeccceEE
Q 047619 26 PGNFTWAVERQDNPELIMWKGSRKFHRGGPWNGL------VFNEDELYY------TFDM-TD-KDVFSRIVMNQTLYVRH 91 (430)
Q Consensus 26 ~G~~~~~~~~~g~~~~~~~~~~~~y~~sg~~~~~------~~~~~~~~~------~~~~-~~-~~~~~~~~l~~dG~~~~ 91 (430)
.|.|.|.|+.+|++.+ ++...++|.++..... +.+++.+.. .... .+ .....+++|+.|| ++.
T Consensus 18 ~~~~~L~~~~dgnlvl--~~~~~~vW~sn~~~~~~~~~l~l~~~GNLvl~d~~~~~W~S~~~~~~g~~~l~l~~dG-nlv 94 (112)
T 1xd5_A 18 EGGYLFIIQNDCNLVL--YDNNRAVWASGTNGKASGCVLKMQNDGNLVIYSGSRAIWASNTNRQNGNYYLILQRDR-NVV 94 (112)
T ss_dssp ETTEEEEECTTSCEEE--EETTEEEEECCCTTSCSSEEEEECTTSCEEEEETTEEEEECCCCCSCCCCEEEECTTS-CEE
T ss_pred CCCEEEEEcCCCcEEE--EECCEEEEeCCCcCCCCCEEEEEeCCCCEEEEcCCEEEEECCccCCCCCEEEEEeCCC-cEE
Confidence 5889999999997554 5557789998865311 111221111 1111 11 1223578899999 877
Q ss_pred EE
Q 047619 92 QF 93 (430)
Q Consensus 92 ~~ 93 (430)
+|
T Consensus 95 l~ 96 (112)
T 1xd5_A 95 IY 96 (112)
T ss_dssp EE
T ss_pred EE
Confidence 76
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=93.07 E-value=0.26 Score=38.34 Aligned_cols=65 Identities=9% Similarity=0.128 Sum_probs=39.6
Q ss_pred CceEEEEEEcCCCCEEEEEcCCeeEEecCCCCCc------cccCCeeEE-------EEEecC--CCcEEEEEEeeccceE
Q 047619 26 PGNFTWAVERQDNPELIMWKGSRKFHRGGPWNGL------VFNEDELYY-------TFDMTD--KDVFSRIVMNQTLYVR 90 (430)
Q Consensus 26 ~G~~~~~~~~~g~~~~~~~~~~~~y~~sg~~~~~------~~~~~~~~~-------~~~~~~--~~~~~~~~l~~dG~~~ 90 (430)
.|.|.|.|+.+|++.+ ++...++|.++..... +.+++.+.. .....+ .....+++|+.|| ++
T Consensus 19 ~g~~~L~~~~dgnlvl--y~~~~~vW~sn~~~~~~~~~l~l~~~GnLvl~d~~~~~vW~S~~~~~~g~~~l~l~~dG-nl 95 (115)
T 2dpf_A 19 AGAYTLTIQNKCNLVK--YQNGRQIWASNTDRRGSGCRLTLLSDGNLVIYDHNNNDVWGSACWGDNGKYALVLQKDG-RF 95 (115)
T ss_dssp ETTEEEEECTTSCEEE--EETTEEEEECSCTTSCSSCEEEECTTSCEEEECTTCCEEEECCCCCSSSCCEEEECTTS-CE
T ss_pred CCCEEEEEcCCCcEEE--EeCCEEEEeCCCCCCCCceEEEECCCCcEEEECCCceEEEEcCCCCCCCCEEEEEeCCC-eE
Confidence 5899999999997554 4567799998865321 111111111 111111 1234579999999 88
Q ss_pred EEE
Q 047619 91 HQF 93 (430)
Q Consensus 91 ~~~ 93 (430)
.+|
T Consensus 96 vl~ 98 (115)
T 2dpf_A 96 VIY 98 (115)
T ss_dssp EEE
T ss_pred EEE
Confidence 876
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=92.98 E-value=0.71 Score=36.06 Aligned_cols=30 Identities=3% Similarity=0.151 Sum_probs=23.6
Q ss_pred CCceEEEEEEcCCCCEEEEEcCCeeEEecCCC
Q 047619 25 SPGNFTWAVERQDNPELIMWKGSRKFHRGGPW 56 (430)
Q Consensus 25 s~G~~~~~~~~~g~~~~~~~~~~~~y~~sg~~ 56 (430)
..|.|.|.|+.+|++ ++++...+.|.++..
T Consensus 28 ~~g~~~L~~~~dgnl--vly~~~~~vW~sn~~ 57 (119)
T 1b2p_A 28 GTHVYRFIMQTDCNL--VLYDNNNPIWATNTG 57 (119)
T ss_dssp TTEEEEEEECTTSCE--EEEETTEEEEECCCT
T ss_pred CCCCEEEEEecCCCE--EEEECCEEEEeCCCc
Confidence 468999999999974 456667889988764
|
| >1b9w_A Protein (merozoite surface protein 1); MSP-1, candidate malaria vaccine, surface antigen; 1.80A {Plasmodium cynomolgi} SCOP: g.3.11.4 g.3.11.4 PDB: 2npr_A | Back alignment and structure |
|---|
Probab=91.77 E-value=0.058 Score=39.46 Aligned_cols=47 Identities=19% Similarity=0.336 Sum_probs=36.4
Q ss_pred cCCCcccCCcccCceeeec--CCCCccccCCCcccCCCCCCCCCCCcccCCCccccC
Q 047619 109 PRDLCDTYALCGDYGICII--SDTPFCQCLKGFKPKSRGYVDWSQGCVRDKSLNYST 163 (430)
Q Consensus 109 p~~~C~~~~~CG~~~~C~~--~~~~~C~C~~gf~~~~~~~~~~~~GC~r~~~l~C~~ 163 (430)
+...| ++..|+.|+.|-. +..+.|.|+.||... ...|+++...+|..
T Consensus 3 ~~h~C-~~tkcp~NA~Cyr~~dg~EecRCllnykk~-------~~kCV~~~~~~C~~ 51 (95)
T 1b9w_A 3 SEHRC-IDTNVPENAACYRYLDGTEEWRCLLYFKED-------AGKCVPAPNMTCKD 51 (95)
T ss_dssp GGGSC-SSCCCCTTEEEEECTTSCEEEEECTTEEEE-------TTEEEECTTCCTTT
T ss_pred cCccc-ccCCCCCCcCeEEEcCCCEEEEEECCeEec-------CCEEEcCCCCCccc
Confidence 45678 6779999999943 567899999999863 35688888777754
|
| >2ll3_A Micronemal protein 4; cell adhesion; NMR {Toxoplasma gondii} PDB: 2ll4_M* | Back alignment and structure |
|---|
Probab=89.94 E-value=0.36 Score=34.87 Aligned_cols=35 Identities=26% Similarity=0.532 Sum_probs=28.5
Q ss_pred cCCCHHHHHHHhhcCCCeeeEeccccCCCCceeeeecc
Q 047619 185 KSMNLYECQDKCLDNSSCMAYTNSDIRGEGSGCAMWFG 222 (430)
Q Consensus 185 ~~~~~~~C~~~Cl~~CsC~a~~~~~~~~~~~gC~~~~~ 222 (430)
..+++++|+..|+.+-.|.+|.|.. ....|+++.+
T Consensus 28 ~~~sl~~Cq~aC~a~~~C~aFTyN~---~s~~CflKs~ 62 (82)
T 2ll3_A 28 RASSLSECRARCQAEKECSHYTYNV---KSGLCYPKRG 62 (82)
T ss_dssp ECSSHHHHHHHHHHCTTEEEEEEET---TTTEEEEEES
T ss_pred cCCCHHHHHHHhhccCCCCeEEecc---CCCceEcccC
Confidence 4578999999999999999999964 2345998765
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=89.87 E-value=0.9 Score=39.56 Aligned_cols=81 Identities=9% Similarity=0.092 Sum_probs=59.4
Q ss_pred CCCcccceEEEEEeCCEEEEEEEccCC-CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHH-HhhhcCCCcEEeCCCCCC
Q 047619 332 QHRNLVKLLGCCIQGEEKLLIYEFVPN-KSLDSFIFDQERCKILDWSKRFHIICGTARGVM-YLHQDSRLRIIHRDLKAS 409 (430)
Q Consensus 332 ~h~niv~l~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~-yLH~~~~~~iiH~Dlkp~ 409 (430)
.||++ -..+-.+.+.+.+.++.-++ .++.. + ..++...+++++..|+.... +++. -+|--|.|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~-i------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAA-I------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPE 113 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHH-H------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHH-H------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCc
Confidence 57887 44455777888887776533 34443 3 23677888888888877666 5553 578889999
Q ss_pred cEEEcCCCCeeecCCCc
Q 047619 410 NVLLDQDMNPKISDFGL 426 (430)
Q Consensus 410 NILl~~~~~~kl~DFGl 426 (430)
||+++.++.++|.=.|+
T Consensus 114 NL~f~~~~~p~i~hRGi 130 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGV 130 (219)
T ss_dssp GEEECTTCCEEESCCEE
T ss_pred eEEEeCCCcEEEEEcCC
Confidence 99999999999998876
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=89.10 E-value=1.3 Score=34.02 Aligned_cols=29 Identities=3% Similarity=0.061 Sum_probs=21.9
Q ss_pred CceEEEEEEcCCCCEEEEEcCCeeEEecCCC
Q 047619 26 PGNFTWAVERQDNPELIMWKGSRKFHRGGPW 56 (430)
Q Consensus 26 ~G~~~~~~~~~g~~~~~~~~~~~~y~~sg~~ 56 (430)
.|.|.|.|+.+|++. +++...+.|.++..
T Consensus 19 ~~~~~l~~~~dGnlv--l~~~~~~vW~sn~~ 47 (110)
T 3a0c_A 19 GPSYRLIMQGDCNFV--LYDSGKPVWASNTG 47 (110)
T ss_dssp TTTEEEEECTTSCEE--EEETTEEEEECCCT
T ss_pred CCCEEEEEcCCCcEE--EEECCEEEEECCCC
Confidence 578999999998754 45567788987764
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=88.96 E-value=0.72 Score=40.05 Aligned_cols=83 Identities=11% Similarity=0.095 Sum_probs=60.8
Q ss_pred CCCCcccceEEEEEeCCEEEEEEEccC-CCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCC
Q 047619 331 LQHRNLVKLLGCCIQGEEKLLIYEFVP-NKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKAS 409 (430)
Q Consensus 331 l~h~niv~l~~~~~~~~~~~lv~e~~~-~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~ 409 (430)
..||+++.. .+-.+.+.+.+.++.-+ ..++.. + ..++...+++++..|+....+++. -+|--|.|+
T Consensus 42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i------k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~ 108 (215)
T 4ann_A 42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I------KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPD 108 (215)
T ss_dssp SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G------GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGG
T ss_pred ccCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H------HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecc
Confidence 368888866 56666777767666544 223333 2 336788899999999887766654 478889999
Q ss_pred cEEEcCCCCeeecCCCc
Q 047619 410 NVLLDQDMNPKISDFGL 426 (430)
Q Consensus 410 NILl~~~~~~kl~DFGl 426 (430)
||+++.++.|++.=-|+
T Consensus 109 NL~f~~~~~p~i~~RGi 125 (215)
T 4ann_A 109 ELFFTRDGLPIAKTRGL 125 (215)
T ss_dssp GEEECTTSCEEESCCEE
T ss_pred eEEEcCCCCEEEEEccC
Confidence 99999999999987775
|
| >1n1i_A Merozoite surface protein-1; MSP1, malaria, surface antigen, glycoprotein, EGF domain, cell adhesion; HET: HIS; 2.40A {Plasmodium knowlesi strain H} SCOP: g.3.11.4 g.3.11.4 | Back alignment and structure |
|---|
Probab=87.86 E-value=0.3 Score=36.71 Aligned_cols=34 Identities=24% Similarity=0.367 Sum_probs=26.7
Q ss_pred EecCCCcccCCcccCceeeec--CCCCccccCCCccc
Q 047619 107 NVPRDLCDTYALCGDYGICII--SDTPFCQCLKGFKP 141 (430)
Q Consensus 107 ~~p~~~C~~~~~CG~~~~C~~--~~~~~C~C~~gf~~ 141 (430)
..+.+.| +...|.+|+.|.. ++...|.|++||..
T Consensus 7 ~~~~h~C-~~t~Cp~NA~C~r~~~G~e~CrCl~gY~~ 42 (105)
T 1n1i_A 7 MSSAHKC-IDTNVPENAACYRYLDGTEEWRCLLGFKE 42 (105)
T ss_dssp -CCTTSC-CSSCCCTTEEEEECTTSCEEEEECTTEEE
T ss_pred CCcCcEe-cCCCCCCCCCeEECCCCCEeEEEECCeec
Confidence 3467889 6779999999954 34568999999985
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=83.34 E-value=0.14 Score=50.38 Aligned_cols=62 Identities=15% Similarity=0.188 Sum_probs=18.8
Q ss_pred ccceeecccCCcceEEEEEcC-CcEEEE------EEecc--cChHhHHHHHHHHHHHhcCCCCcccceEEEEEe
Q 047619 281 SINNKLGEGGFGPVYKGTLVD-GQEIAV------KRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ 345 (430)
Q Consensus 281 ~~~~~ig~G~fg~Vy~~~~~~-~~~vav------K~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 345 (430)
.+.++|| ||.||++.+.. ..+||+ |.... ...+....+.+|..++..++|||+++.+++-..
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 3446676 99999998754 357888 66543 123334567889999999999999999887654
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=82.79 E-value=0.81 Score=35.07 Aligned_cols=37 Identities=11% Similarity=0.233 Sum_probs=21.3
Q ss_pred cCCCCCCCCceEEEEEEcCCCCEEEEEcC-CeeEEecCCC
Q 047619 18 WKSPDDPSPGNFTWAVERQDNPELIMWKG-SRKFHRGGPW 56 (430)
Q Consensus 18 ~~s~~dps~G~~~~~~~~~g~~~~~~~~~-~~~y~~sg~~ 56 (430)
|.+.+........+.++.+|+..+ ++. ....|+++.-
T Consensus 40 Wssnt~~~~~~~~l~l~~dGnLvl--~d~~~~~vWss~t~ 77 (109)
T 3r0e_A 40 WQSNTANNGRDCKLTLTDYGELVI--KNGDGSTVWKSGAQ 77 (109)
T ss_dssp EECCCTTSCSSCEEEECTTSCEEE--ECTTSCEEEECCCC
T ss_pred EEcCCCCCCCcEEEEEcCCCeEEE--EeCCCCEEEcCCCc
Confidence 666554322246778888876443 443 3567777653
|
| >1edm_B Factor IX; epidermal growth factor, EGF, calcium- binding, EGF-like domain, structure and function, coagulation factor; 1.50A {Homo sapiens} SCOP: g.3.11.1 PDB: 1ixa_A | Back alignment and structure |
|---|
Probab=80.33 E-value=0.71 Score=27.84 Aligned_cols=30 Identities=30% Similarity=0.596 Sum_probs=22.3
Q ss_pred CCcccCCcccCceeeecC-CCCccccCCCccc
Q 047619 111 DLCDTYALCGDYGICIIS-DTPFCQCLKGFKP 141 (430)
Q Consensus 111 ~~C~~~~~CG~~~~C~~~-~~~~C~C~~gf~~ 141 (430)
++|. ...|...|.|... ..-.|.|++||+-
T Consensus 4 d~C~-~~pC~ngg~C~~~~~~~~C~C~~G~~G 34 (39)
T 1edm_B 4 DQCE-SNPCLNGGSCKDDINSYECWCPFGFEG 34 (39)
T ss_dssp CTTT-TCCCCTTCEEEEETTEEEEECCTTCCS
T ss_pred ccCC-CCCCCCCCEeEcCCCceEeECCCCCcC
Confidence 5676 4678888999643 3457999999974
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 430 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-45 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 6e-45 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-44 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-43 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 9e-43 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 8e-42 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-41 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-41 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-40 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-40 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-40 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-40 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-40 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-39 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-39 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-39 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-39 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-38 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-38 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 9e-38 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 9e-38 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-37 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-37 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-36 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-36 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-36 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-36 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 8e-36 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-35 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-35 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-34 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-34 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-34 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-33 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-33 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-33 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-32 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-32 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 9e-32 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-31 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 8e-31 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 8e-31 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-30 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-30 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-29 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 8e-29 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-28 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-27 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-27 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-27 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-26 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 9e-26 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-25 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-25 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-25 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-25 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-24 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 7e-24 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-23 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-23 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 6e-23 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-22 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-17 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 3e-45
Identities = 47/153 (30%), Positives = 76/153 (49%), Gaps = 6/153 (3%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 337
++ ++G G FG VYKG + + ++ + Q L+ KNEV + K +H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 338 KLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 397
+G + ++ ++ SL + E + K I TA+G+ YLH S
Sbjct: 68 LFMGYSTAP-QLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS 124
Query: 398 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
IIHRDLK++N+ L +D+ KI DFGLA
Sbjct: 125 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVK 154
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 6e-45
Identities = 49/157 (31%), Positives = 78/157 (49%), Gaps = 6/157 (3%)
Query: 275 NATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQH 333
N D + I +LG+G FG VYK + A K + SE+ L++ E+ + + H
Sbjct: 9 NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDH 68
Query: 334 RNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 393
N+VKLL ++ EF ++D+ + + ER L S+ + T + YL
Sbjct: 69 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYL 126
Query: 394 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
H +IIHRDLKA N+L D + K++DFG++
Sbjct: 127 HD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKN 160
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 6e-44
Identities = 36/157 (22%), Positives = 66/157 (42%), Gaps = 7/157 (4%)
Query: 276 ATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK-ISEQGLKELKNEVILFSKLQH 333
D+F ++LG G G V+K + G +A K + I ++ E+ + +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 334 RNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 393
+V G E + E + SLD + R + + +G+ YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYL 120
Query: 394 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
+ +I+HRD+K SN+L++ K+ DFG++
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 155
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 3e-43
Identities = 48/153 (31%), Positives = 76/153 (49%), Gaps = 6/153 (3%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 337
+ + +LG G FG V+ G ++AVK L + E L +LQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLV 71
Query: 338 KLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 397
+L Q E +I E++ N SL F+ K L +K + A G+ ++ + +
Sbjct: 72 RLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN 129
Query: 398 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
IHRDL+A+N+L+ ++ KI+DFGLAR
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLI 159
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 150 bits (380), Expect = 9e-43
Identities = 46/166 (27%), Positives = 78/166 (46%), Gaps = 10/166 (6%)
Query: 269 ELATIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK---ISEQGLKELKNE 324
EL + FS ++G G FG VY + + + +A+K++S S + +++ E
Sbjct: 6 ELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKE 65
Query: 325 VILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIIC 384
V KL+H N ++ GC ++ L+ E+ + D + K L + +
Sbjct: 66 VRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK---KPLQEVEIAAVTH 122
Query: 385 GTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
G +G+ YLH +IHRD+KA N+LL + K+ DFG A
Sbjct: 123 GALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM 165
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 8e-42
Identities = 36/153 (23%), Positives = 69/153 (45%), Gaps = 6/153 (3%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 337
+ ++G G FG V+ G ++ ++A+K + + ++ E + KL H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 338 KLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 397
+L G C++ L++EF+ + L + + + + + G +
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEG---MAYLE 118
Query: 398 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
+IHRDL A N L+ ++ K+SDFG+ R
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFV 151
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (368), Expect = 2e-41
Identities = 44/161 (27%), Positives = 72/161 (44%), Gaps = 8/161 (4%)
Query: 278 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHR 334
+++ + +G G +G K DG+ + K L ++E + L +EV L +L+H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 335 NLVKLLGCCIQGEEKLL--IYEFVPNKSLDSFIFDQERCK-ILDWSKRFHIICGTARGVM 391
N+V+ I L + E+ L S I + + LD ++ +
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 392 YLHQ--DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
H+ D ++HRDLK +NV LD N K+ DFGLAR
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL 164
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 3e-41
Identities = 38/153 (24%), Positives = 65/153 (42%), Gaps = 6/153 (3%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 337
+ + +LG G FG V G ++A+K + + E E + L H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLV 62
Query: 338 KLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 397
+L G C + +I E++ N L +++ + + + + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK- 119
Query: 398 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
+ +HRDL A N L++ K+SDFGL+R
Sbjct: 120 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYV 150
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 1e-40
Identities = 42/152 (27%), Positives = 72/152 (47%), Gaps = 8/152 (5%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 337
+ +G+G FG V G G ++AVK + + + E + ++L+H NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLV 63
Query: 338 KLLGCCIQGEEKL-LIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 396
+LLG ++ + L ++ E++ SL ++ + R +L + YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLE-- 120
Query: 397 SRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
+HRDL A NVL+ +D K+SDFGL +
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 151
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 1e-40
Identities = 48/160 (30%), Positives = 78/160 (48%), Gaps = 11/160 (6%)
Query: 276 ATDNFSI-NNKLGEGGFGPVYKGTLV---DGQEIAVKRLSKISEQG-LKELKNEVILFSK 330
DN I + +LG G FG V +G ++A+K L + +E+ +E+ E + +
Sbjct: 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65
Query: 331 LQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGV 390
L + +V+L+G C Q E +L+ E L F+ + + S ++ + G+
Sbjct: 66 LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGM 122
Query: 391 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
YL + +HRDL A NVLL KISDFGL++A
Sbjct: 123 KYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 159
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 1e-40
Identities = 44/153 (28%), Positives = 77/153 (50%), Gaps = 6/153 (3%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 337
++ + KLG+G FG V+ GT +A+K L + E + KL+H LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLV 75
Query: 338 KLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 397
+L + E ++ E++ SL F+ E K L + + A G+ Y+ +
Sbjct: 76 QLYAVVSE-EPIYIVTEYMSKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAYVER-- 131
Query: 398 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
+ +HRDL+A+N+L+ +++ K++DFGLAR
Sbjct: 132 -MNYVHRDLRAANILVGENLVCKVADFGLARLI 163
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 143 bits (362), Expect = 2e-40
Identities = 46/171 (26%), Positives = 84/171 (49%), Gaps = 8/171 (4%)
Query: 261 MDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLK 319
MD P ++ + + ++ +KLG G +G VY+G +AVK L + ++
Sbjct: 2 MDPSSPNYDKWEMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVE 58
Query: 320 ELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKR 379
E E + +++H NLV+LLG C + +I EF+ +L ++ + R + +
Sbjct: 59 EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVL 117
Query: 380 FHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
++ + + YL + IHRDL A N L+ ++ K++DFGL+R
Sbjct: 118 LYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM 165
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 142 bits (360), Expect = 5e-40
Identities = 47/177 (26%), Positives = 79/177 (44%), Gaps = 19/177 (10%)
Query: 268 FELATIANATDNFS---------INNKLGEGGFGPVYKGTLV----DGQEIAVKRLSK-I 313
F A F+ I +G G FG V G L +A+K L
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 314 SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKI 373
+E+ ++ +E + + H N++ L G + ++I EF+ N SLD F ++
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLD--SFLRQNDGQ 124
Query: 374 LDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
+ ++ G A G+ YL + +HRDL A N+L++ ++ K+SDFGL+R
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 2e-39
Identities = 45/155 (29%), Positives = 70/155 (45%), Gaps = 10/155 (6%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH 333
++F I LG+G FG VY +A+K L K +L+ EV + S L+H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 334 RNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 393
N+++L G LI E+ P ++ + ++ D + I A + Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYC 122
Query: 394 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
H R+IHRD+K N+LL KI+DFG +
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSV 154
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 140 bits (354), Expect = 3e-39
Identities = 47/190 (24%), Positives = 82/190 (43%), Gaps = 31/190 (16%)
Query: 269 ELATIANATDNFSINNKLGEGGFGPVYKGTL------VDGQEIAVKRLSK-ISEQGLKEL 321
+L ++ +N +GEG FG V++ +AVK L + S +
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 322 KNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKI-------- 373
+ E L ++ + N+VKLLG C G+ L++E++ L+ F+ +
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 374 -------------LDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPK 420
L +++ I A G+ YL + + +HRDL N L+ ++M K
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVK 180
Query: 421 ISDFGLARAF 430
I+DFGL+R
Sbjct: 181 IADFGLSRNI 190
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 3e-39
Identities = 47/155 (30%), Positives = 70/155 (45%), Gaps = 8/155 (5%)
Query: 278 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRN 335
+++ + LGEG +G V V + +AVK + + + +K E+ + L H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 336 LVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ 395
+VK G +G + L E+ L I + GV+YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLHG 121
Query: 396 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
+ I HRD+K N+LLD+ N KISDFGLA F
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVF 153
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 7e-39
Identities = 36/163 (22%), Positives = 82/163 (50%), Gaps = 8/163 (4%)
Query: 269 ELATIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVIL 327
+ ++ + ++ K+G+G G VY + GQE+A+++++ + + + NE+++
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 328 FSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTA 387
+ ++ N+V L + G+E ++ E++ SL + + D + +
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----DEGQIAAVCRECL 126
Query: 388 RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
+ + +LH ++IHRD+K+ N+LL D + K++DFG
Sbjct: 127 QALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 1e-38
Identities = 48/171 (28%), Positives = 77/171 (45%), Gaps = 21/171 (12%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDG---QEIAVKRLSKI-SEQGLKELKNEVILFSKL-Q 332
++ + +GEG FG V K + + A+KR+ + S+ ++ E+ + KL
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 333 HRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFI-------------FDQERCKILDWSKR 379
H N++ LLG C L E+ P+ +L F+ L +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 380 FHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
H ARG+ YL Q + IHRDL A N+L+ ++ KI+DFGL+R
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQ 177
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 5e-38
Identities = 38/162 (23%), Positives = 71/162 (43%), Gaps = 15/162 (9%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 337
+ +G+G FG V++G G+E+AVK S E+ + E+ L+H N++
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENIL 60
Query: 338 KLLGCCIQGEEKL----LIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 393
+ + L+ ++ + SL ++ + + TA G+ +L
Sbjct: 61 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHL 116
Query: 394 HQD-----SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
H + + I HRDLK+ N+L+ ++ I+D GLA
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 9e-38
Identities = 52/176 (29%), Positives = 70/176 (39%), Gaps = 26/176 (14%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKISEQG-LKELKNEVILFSK 330
+ S LG G FG V + T +AVK L + + L +E+ + S
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 331 L-QHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKI---------------L 374
L H N+V LLG C G L+I E+ L +F+ + I L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 375 DWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
D A+G+ +L IHRDL A N+LL KI DFGLAR
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDI 195
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 9e-38
Identities = 47/181 (25%), Positives = 73/181 (40%), Gaps = 31/181 (17%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKISEQG-LKELKNEVILFSK 330
+N LG G FG V T ++AVK L + ++ + L +E+ + ++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 331 L-QHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQ--------------------E 369
L H N+V LLG C LI+E+ L +++ + E
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 370 RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429
+L + A+G+ +L +HRDL A NVL+ KI DFGLAR
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 430 F 430
Sbjct: 214 I 214
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 4e-37
Identities = 39/157 (24%), Positives = 69/157 (43%), Gaps = 12/157 (7%)
Query: 280 FSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNL 336
+ ++G G F VYKG + E+A L +++ + K E + LQH N+
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 337 VKLLGCCIQGEEK----LLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMY 392
V+ + +L+ E + + +L +++ R K++ +G+ +
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQF 127
Query: 393 LHQDSRLRIIHRDLKASNVLL-DQDMNPKISDFGLAR 428
LH + IIHRDLK N+ + + KI D GLA
Sbjct: 128 LHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLAT 163
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 136 bits (343), Expect = 5e-37
Identities = 39/156 (25%), Positives = 68/156 (43%), Gaps = 8/156 (5%)
Query: 278 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 336
D++ I+ +LG G FG V++ T G A K + E + ++ E+ S L+H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 337 VKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 396
V L E ++IYEF+ L + D+ + + + +G+ ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMH-- 141
Query: 397 SRLRIIHRDLKASNVLLDQDMNP--KISDFGLARAF 430
+H DLK N++ + K+ DFGL
Sbjct: 142 -ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 176
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 1e-36
Identities = 46/154 (29%), Positives = 77/154 (50%), Gaps = 11/154 (7%)
Query: 283 NNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKISEQG-LKELKNEVILFSKLQHRNLV 337
N +G G FG VY GTL+D AVK L++I++ G + + E I+ H N++
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 338 KLLGCCIQGEEK-LLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 396
LLG C++ E L++ ++ + L +FI ++ + F + +
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG-----MKFL 146
Query: 397 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
+ + +HRDL A N +LD+ K++DFGLAR
Sbjct: 147 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 180
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 3e-36
Identities = 50/160 (31%), Positives = 70/160 (43%), Gaps = 13/160 (8%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSK---ISEQGLKELKNEVILFSK 330
+ + KLG+G FG V +G +AVK L + + + EV
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 331 LQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGV 390
L HRNL++L G + K+ + E P SL + + +L R+ + A G+
Sbjct: 68 LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV--AEGM 124
Query: 391 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
YL R IHRDL A N+LL KI DFGL RA
Sbjct: 125 GYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 161
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 3e-36
Identities = 47/157 (29%), Positives = 68/157 (43%), Gaps = 10/157 (6%)
Query: 278 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH 333
++F LGEG F V L +E A+K L K I E + + E + S+L H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 334 RNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 393
VKL E+ + N L +I + D + + YL
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYL 124
Query: 394 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
H IIHRDLK N+LL++DM+ +I+DFG A+
Sbjct: 125 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVL 158
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 4e-36
Identities = 43/153 (28%), Positives = 69/153 (45%), Gaps = 12/153 (7%)
Query: 283 NNKLGEGGFGPVYKGTLVD---GQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLV 337
+ +LG G FG V KG + +AVK L EL E + +L + +V
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 338 KLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 397
+++G C + E +L+ E L+ ++ + ++ + G+ YL +
Sbjct: 72 RMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEES- 126
Query: 398 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
+HRDL A NVLL KISDFGL++A
Sbjct: 127 --NFVHRDLAARNVLLVTQHYAKISDFGLSKAL 157
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 132 bits (334), Expect = 8e-36
Identities = 38/156 (24%), Positives = 66/156 (42%), Gaps = 8/156 (5%)
Query: 278 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 336
D + I +LG G FG V++ G+ K ++ +KNE+ + ++L H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 337 VKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 396
+ L E +LI EF+ L I + ++ + + G+ ++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRI--AAEDYKMSEAEVINYMRQACEGLKHMH-- 144
Query: 397 SRLRIIHRDLKASNVLLDQDMNP--KISDFGLARAF 430
I+H D+K N++ + KI DFGLA
Sbjct: 145 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL 179
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 1e-35
Identities = 35/161 (21%), Positives = 74/161 (45%), Gaps = 5/161 (3%)
Query: 272 TIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG-LKELKNEVILFS 329
+ + ++ + +GEG +G V V+ +A+K++S Q + E+ +
Sbjct: 2 QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 61
Query: 330 KLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARG 389
+ +H N++ + + + ++ + + ++ + + L + + RG
Sbjct: 62 RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRG 121
Query: 390 VMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
+ Y+H ++HRDLK SN+LL+ + KI DFGLAR
Sbjct: 122 LKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 159
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 131 bits (331), Expect = 3e-35
Identities = 42/160 (26%), Positives = 69/160 (43%), Gaps = 13/160 (8%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK---ISEQGLKELKNEVI---LFSK 330
++FS++ +G GGFG VY D G+ A+K L K +QG NE I L S
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 331 LQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGV 390
+V + ++ I + + L + + G+
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF---SEADMRFYAAEIILGL 120
Query: 391 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
++H +++RDLK +N+LLD+ + +ISD GLA F
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDF 157
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 2e-34
Identities = 40/158 (25%), Positives = 68/158 (43%), Gaps = 11/158 (6%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKISEQGLKE-LKNEVILFSKLQ 332
+ + +GEG FG V++G + +A+K + ++E E + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 333 HRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMY 392
H ++VKL+G + +I E L SF+ R LD + + + Y
Sbjct: 67 HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQ--VRKYSLDLASLILYAYQLSTALAY 123
Query: 393 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
L R +HRD+ A NVL+ + K+ DFGL+R
Sbjct: 124 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 4e-34
Identities = 44/159 (27%), Positives = 78/159 (49%), Gaps = 11/159 (6%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDGQE-----IAVKRLSK-ISEQGLKELKNEVILFSKL 331
+ +G G FG VYKG L +A+K L +E+ + E + +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 332 QHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 391
H N+++L G + + ++I E++ N +LD F +E+ + ++ G A G+
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKF--LREKDGEFSVLQLVGMLRGIAAGMK 124
Query: 392 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
YL + +HRDL A N+L++ ++ K+SDFGL+R
Sbjct: 125 YLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 160
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 4e-34
Identities = 44/167 (26%), Positives = 78/167 (46%), Gaps = 17/167 (10%)
Query: 278 DNFSINNKLGEGGFGPVYKGTL------VDGQEIAVKRLSKI-SEQGLKELKNEVILFSK 330
+ +++ +LG+G FG VY+G +A+K +++ S + E NE + +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 331 LQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIF-------DQERCKILDWSKRFHII 383
++V+LLG QG+ L+I E + L S++ + SK +
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 384 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
A G+ YL+ + + +HRDL A N ++ +D KI DFG+ R
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDI 183
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 1e-33
Identities = 34/156 (21%), Positives = 64/156 (41%), Gaps = 9/156 (5%)
Query: 278 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 336
+ + I LG G FG V++ + K + K+ +K E+ + + +HRN+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNI 63
Query: 337 VKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 396
+ L EE ++I+EF+ + I L+ + + + +LH
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLHS- 120
Query: 397 SRLRIIHRDLKASNVLLDQDMNP--KISDFGLARAF 430
I H D++ N++ + KI +FG AR
Sbjct: 121 --HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 1e-33
Identities = 48/164 (29%), Positives = 79/164 (48%), Gaps = 13/164 (7%)
Query: 273 IANATDNFSINNKLGEGGFGPVYKGTLVDGQE-----IAVKRLSKI-SEQGLKELKNEVI 326
I T+ F LG G FG VYKG + E +A+K L + S + KE+ +E
Sbjct: 5 ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 63
Query: 327 LFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGT 386
+ + + + ++ +LLG C+ LI + +P L ++ + + +
Sbjct: 64 VMASVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNI--GSQYLLNWCVQI 120
Query: 387 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
A+G+ YL R++HRDL A NVL+ + KI+DFGLA+
Sbjct: 121 AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 125 bits (316), Expect = 2e-33
Identities = 39/157 (24%), Positives = 73/157 (46%), Gaps = 10/157 (6%)
Query: 278 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH 333
+F I LG G FG V+ +G+ A+K L K + + ++ +E ++ S + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 334 RNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 393
++++ G ++ +I +++ L S + +R +C + L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVC------LAL 117
Query: 394 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
II+RDLK N+LLD++ + KI+DFG A+
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV 154
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 2e-32
Identities = 45/173 (26%), Positives = 67/173 (38%), Gaps = 25/173 (14%)
Query: 278 DNFSINNKLGEGGFGPVYKGT------LVDGQEIAVKRLSKISEQGLKE--LKNEVILFS 329
D + LG G FG V + + +AVK L + + + IL
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 330 KLQHRNLVKLLGCCIQGEEKLLI-YEFVPNKSLDSFIFDQERC-------------KILD 375
H N+V LLG C + L++ EF +L +++ + L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 376 WSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
A+G+ +L + IHRDL A N+LL + KI DFGLAR
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLAR 182
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 120 bits (302), Expect = 6e-32
Identities = 39/164 (23%), Positives = 67/164 (40%), Gaps = 17/164 (10%)
Query: 278 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK---------ISEQGLKELKNEVIL 327
+N+ LG G V + +E AVK + ++ + EV +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 328 FSKLQ-HRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGT 386
K+ H N+++L L+++ + L ++ L + I+
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRAL 119
Query: 387 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
+ LH +L I+HRDLK N+LLD DMN K++DFG +
Sbjct: 120 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 160
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 120 bits (301), Expect = 9e-32
Identities = 46/155 (29%), Positives = 74/155 (47%), Gaps = 8/155 (5%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRN 335
+ + K+GEG +G VYK G+ A+K RL K E E+ + +L+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 336 LVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ 395
+VKL + +L++E + + L+ + G+ Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHD 118
Query: 396 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
R++HRDLK N+L++++ KI+DFGLARAF
Sbjct: 119 ---RRVLHRDLKPQNLLINREGELKIADFGLARAF 150
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 3e-31
Identities = 42/161 (26%), Positives = 68/161 (42%), Gaps = 15/161 (9%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 336
+++ +G G FG VY+ L D G+ +A+K++ + E+ + KL H N+
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNI 75
Query: 337 VKLLGCCIQGEEK------LLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGV 390
V+L EK L+ ++VP + L + R +
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 391 MYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLARAF 430
Y+H I HRD+K N+LLD D K+ DFG A+
Sbjct: 136 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (295), Expect = 8e-31
Identities = 50/176 (28%), Positives = 77/176 (43%), Gaps = 26/176 (14%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLV--------DGQEIAVKRLSK-ISEQGLKELKNEVILF 328
D + LGEG FG V + ++AVK L +E+ L +L +E+ +
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 329 SKL-QHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKI-------------L 374
+ +H+N++ LLG C Q +I E+ +L ++ + + L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 375 DWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
ARG+ YL + IHRDL A NVL+ +D KI+DFGLAR
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDI 185
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (295), Expect = 8e-31
Identities = 48/156 (30%), Positives = 76/156 (48%), Gaps = 8/156 (5%)
Query: 278 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHR 334
+NF K+GEG +G VYK + G+ +A+K RL +E E+ L +L H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 335 NLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLH 394
N+VKLL + L++EF+ D + + +G+ + H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 395 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
R++HRDLK N+L++ + K++DFGLARAF
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 152
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 4e-30
Identities = 41/158 (25%), Positives = 70/158 (44%), Gaps = 11/158 (6%)
Query: 278 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK---ISEQGLKELKNEV-ILFSKLQ 332
++F ++ LG+G FG V+ Q A+K L K + + ++ E +L +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 333 HRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMY 392
H L + E + E++ L I + C D S+ G+ +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI---QSCHKFDLSRATFYAAEIILGLQF 118
Query: 393 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
LH I++RDLK N+LLD+D + KI+DFG+ +
Sbjct: 119 LH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN 153
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 116 bits (291), Expect = 5e-30
Identities = 37/156 (23%), Positives = 61/156 (39%), Gaps = 5/156 (3%)
Query: 275 NATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG-LKELKNEVILFSKLQ 332
+ D + + LG G F V + +A+K ++K + +G ++NE+ + K++
Sbjct: 6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIK 65
Query: 333 HRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMY 392
H N+V L G LI + V L I +I V Y
Sbjct: 66 HPNIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVLDAVKY 122
Query: 393 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
LH + + LD+D ISDFGL++
Sbjct: 123 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK 158
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 112 bits (281), Expect = 5e-29
Identities = 35/162 (21%), Positives = 65/162 (40%), Gaps = 14/162 (8%)
Query: 277 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQ 332
+D + + LG GG V+ L +++AVK L + E + L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 333 HRNLVKLLGCCI----QGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTAR 388
H +V + G ++ E+V +L + + + +I +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQ 122
Query: 389 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
+ + H + IIHRD+K +N+++ K+ DFG+ARA
Sbjct: 123 ALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAI 161
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (282), Expect = 8e-29
Identities = 42/164 (25%), Positives = 75/164 (45%), Gaps = 17/164 (10%)
Query: 278 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHR 334
+ K+G+G FG V+K GQ++A+K++ E E+ + L+H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 335 NLVKLLGCCIQGEEK--------LLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGT 386
N+V L+ C L+++F + + + + + ++
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL-- 127
Query: 387 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
L+ R +I+HRD+KA+NVL+ +D K++DFGLARAF
Sbjct: 128 ----NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 167
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 4e-28
Identities = 46/153 (30%), Positives = 75/153 (49%), Gaps = 12/153 (7%)
Query: 284 NKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKE-----LKNEVILFSKLQHRNLV 337
+ LGEG F VYK Q +A+K++ K+ E+ L +L H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 338 KLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 397
LL L+++F+ ++ +L S + T +G+ YLHQ
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEV---IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119
Query: 398 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
I+HRDLK +N+LLD++ K++DFGLA++F
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSF 150
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (269), Expect = 4e-27
Identities = 41/165 (24%), Positives = 71/165 (43%), Gaps = 13/165 (7%)
Query: 276 ATDNFSINNKLGEGGFGPVYKGTLV--DGQEIAVKRLSK--ISEQGLKELKNEVILFSKL 331
A + ++GEG +G V+K + G+ +A+KR+ E EV + L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 332 ---QHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDS---FIFDQERCKILDWSKRFHIICG 385
+H N+V+L C + + +D D+ + ++
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 386 TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
RG+ +LH R++HRDLK N+L+ K++DFGLAR +
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIY 166
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 108 bits (271), Expect = 4e-27
Identities = 40/155 (25%), Positives = 60/155 (38%), Gaps = 10/155 (6%)
Query: 278 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH 333
D F LG G FG V G A+K L K + + ++ NE + +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 334 RNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 393
LVKL ++ E+V + S + R YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYL 157
Query: 394 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
H L +I+RDLK N+L+DQ +++DFG A+
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 5e-27
Identities = 36/157 (22%), Positives = 64/157 (40%), Gaps = 10/157 (6%)
Query: 278 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH 333
++F LG+G FG V G+ A+K L K I++ + E + +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 334 RNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 393
L L + + E+ L + R ++ + + YL
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYL 121
Query: 394 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
H +++RD+K N++LD+D + KI+DFGL +
Sbjct: 122 H---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG 155
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (261), Expect = 3e-26
Identities = 40/156 (25%), Positives = 72/156 (46%), Gaps = 9/156 (5%)
Query: 278 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHR 334
+ K+GEG +G V+K + +A+KR+ E E+ L +L+H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 335 NLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLH 394
N+V+L ++ L++EF F D + +G+ + H
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL---DPEIVKSFLFQLLKGLGFCH 118
Query: 395 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
++HRDLK N+L++++ K+++FGLARAF
Sbjct: 119 S---RNVLHRDLKPQNLLINRNGELKLANFGLARAF 151
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (261), Expect = 9e-26
Identities = 40/155 (25%), Positives = 70/155 (45%), Gaps = 7/155 (4%)
Query: 278 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHR 334
+ +G G +G V G ++A+K+L + SE K E+ L ++H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 335 NLVKLLGCCIQGEEKLLIYEF-VPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 393
N++ LL E +F + + + + + + L + ++ +G+ Y+
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137
Query: 394 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
H IIHRDLK N+ +++D KI DFGLAR
Sbjct: 138 H---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR 169
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (260), Expect = 1e-25
Identities = 35/163 (21%), Positives = 67/163 (41%), Gaps = 19/163 (11%)
Query: 278 DNFSINNK-LGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEV-ILFSKLQHR 334
D++ + ++ LG G G V + ++ A+K L + + EV + + Q
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCP 65
Query: 335 NLVKLLGCCIQGEEK----LLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGV 390
++V+++ L++ E + L S I D+ + + I+ +
Sbjct: 66 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAI 124
Query: 391 MYLHQDSRLRIIHRDLKASNVLLDQDMNP---KISDFGLARAF 430
YLH + I HRD+K N+L K++DFG A+
Sbjct: 125 QYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 164
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 1e-25
Identities = 47/167 (28%), Positives = 70/167 (41%), Gaps = 17/167 (10%)
Query: 275 NATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKIS------EQGLKELKNEVIL 327
N D + +LG G F V K G + A K + K ++++ EV +
Sbjct: 7 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 66
Query: 328 FSKLQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTA 387
++QH N++ L + +LI E V L F+ ++E L + +
Sbjct: 67 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQIL 123
Query: 388 RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNP----KISDFGLARAF 430
GV YLH L+I H DLK N++L P KI DFGLA
Sbjct: 124 NGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (256), Expect = 2e-25
Identities = 39/163 (23%), Positives = 62/163 (38%), Gaps = 15/163 (9%)
Query: 278 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKN------EVILFSK 330
+ + LG GGFG VY G + D +A+K + K EL N EV+L K
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 331 LQ--HRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTAR 388
+ +++LL + + +LI E + L
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLE 121
Query: 389 GVMYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLARAF 430
V + H ++HRD+K N+L+D + K+ DFG
Sbjct: 122 AVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL 161
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 102 bits (255), Expect = 2e-25
Identities = 28/159 (17%), Positives = 68/159 (42%), Gaps = 13/159 (8%)
Query: 278 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 336
++ + ++GEG FG +++GT L++ Q++A+K + S+ +L++E + L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62
Query: 337 VKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 396
+ + Q ++ + SL+ + + V +H+
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLL--DLCGRKFSVKTVAMAAKQMLARVQSIHE- 119
Query: 397 SRLRIIHRDLKASNVLLDQDMNP-----KISDFGLARAF 430
+++RD+K N L+ + + + DFG+ + +
Sbjct: 120 --KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99 bits (248), Expect = 4e-24
Identities = 38/162 (23%), Positives = 71/162 (43%), Gaps = 15/162 (9%)
Query: 278 DNFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSKIS----EQGLKELKNEVILFS 329
+NF + LG G +G V+ + G+ A+K L K + + + + E +
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 330 KLQHR-NLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTAR 388
++ LV L + LI +++ L + + +ER + I
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIV---- 139
Query: 389 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
+ L +L II+RD+K N+LLD + + ++DFGL++ F
Sbjct: 140 --LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 98.8 bits (245), Expect = 7e-24
Identities = 34/157 (21%), Positives = 63/157 (40%), Gaps = 11/157 (7%)
Query: 278 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 336
+ + + K+G G FG +Y GT + G+E+A+K ++ +L E ++ +Q
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 64
Query: 337 VKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 396
+ + C + ++ + SL+ R + + Y+H
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIH-- 120
Query: 397 SRLRIIHRDLKASNVL---LDQDMNPKISDFGLARAF 430
IHRD+K N L + I DFGLA+ +
Sbjct: 121 -SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 98.0 bits (243), Expect = 2e-23
Identities = 34/158 (21%), Positives = 71/158 (44%), Gaps = 17/158 (10%)
Query: 278 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRN 335
D++ + KLG G + V++ + + +++ VK L + + K++K E+ + L+ N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPN 91
Query: 336 LVKLLGCCIQGEEKL--LIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 393
++ L + L++E V N + L + + + Y
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYC 145
Query: 394 HQDSRLRIIHRDLKASNVLLD-QDMNPKISDFGLARAF 430
H + I+HRD+K NV++D + ++ D+GLA +
Sbjct: 146 HS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 180
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 94.5 bits (234), Expect = 2e-23
Identities = 30/158 (18%), Positives = 54/158 (34%), Gaps = 20/158 (12%)
Query: 281 SINNKLGEGGFGPVYKGTLVDGQEIAVK--RLSKIS--------EQGLKELKNEVILFSK 330
+I +GEG V+ E VK ++ S + G I ++
Sbjct: 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSAR 62
Query: 331 LQHRNLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGV 390
+ R L KL G + +Y + N ++ + D + + ++ V
Sbjct: 63 NEFRALQKLQGLAVPK-----VYAWEGN-AVLMELIDAKELYRVRVENPDEVLDMILEEV 116
Query: 391 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428
+ I+H DL NVL+ + I DF +
Sbjct: 117 AKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.9 bits (240), Expect = 6e-23
Identities = 45/163 (27%), Positives = 74/163 (45%), Gaps = 7/163 (4%)
Query: 272 TIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILF 328
TI + + + +G G +G V G +AVK+LS+ S K E+ L
Sbjct: 12 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 329 SKLQHRNLVKLLGCCIQGEE-KLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTA 387
++H N++ LL + ++ + + + + +C+ L +I
Sbjct: 72 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 131
Query: 388 RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
RG+ Y+H IIHRDLK SN+ +++D KI DFGLAR
Sbjct: 132 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT 171
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.2 bits (233), Expect = 5e-22
Identities = 41/156 (26%), Positives = 67/156 (42%), Gaps = 6/156 (3%)
Query: 278 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHR 334
+ +G G G V V + +A+K+LS+ ++ K E++L + H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 335 NLVKLLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLH 394
N++ LL + + L Q LD + +++ G+ +LH
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 136
Query: 395 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430
IIHRDLK SN+++ D KI DFGLAR
Sbjct: 137 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 80.1 bits (196), Expect = 4e-17
Identities = 35/171 (20%), Positives = 65/171 (38%), Gaps = 23/171 (13%)
Query: 280 FSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK 338
+ + KLG G F V+ +V+ +A+K + + + ++E+ L ++ + K
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTK 73
Query: 339 LLGCCIQGEEKLLIYEFVPNKSLDSFIFDQERC-------------KILDWSKRFHIICG 385
KLL + + + E + + I
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133
Query: 386 TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNP------KISDFGLARAF 430
G+ Y+H+ R IIH D+K NVL++ +P KI+D G A +
Sbjct: 134 LLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY 182
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 430 | |||
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 99.98 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 99.98 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 99.98 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 99.98 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 99.97 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 99.97 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 99.97 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 99.97 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 99.97 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 99.97 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.97 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.97 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 99.97 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 99.97 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 99.97 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 99.97 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 99.97 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 99.97 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.97 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 99.97 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.97 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.97 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 99.97 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 99.96 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.96 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 99.96 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.96 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.96 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.96 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.96 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.96 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.96 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 99.95 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.95 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.95 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.94 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.89 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.87 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.34 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.01 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 97.86 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.68 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 97.58 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.38 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 97.2 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 97.06 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.9 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 96.7 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 96.29 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 94.85 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 94.56 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 91.72 | |
| d1xkba1 | 39 | Factor X, N-terminal module {Human (Homo sapiens) | 89.54 | |
| d1uzka1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 87.59 | |
| d1lmja1 | 44 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 87.05 | |
| d1emoa1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 87.0 | |
| d2vj3a2 | 39 | Neurogenic locus notch homolog protein 1, Notch1 { | 86.36 | |
| d1i0ua2 | 41 | Low density lipoprotein (LDL) receptor, different | 85.96 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 85.43 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 85.23 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 85.04 | |
| d1edmb_ | 39 | Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606 | 84.54 | |
| d1dx5i2 | 35 | Thrombomodulin, different EGF-like domains {Human | 83.65 | |
| d1lmja2 | 42 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 82.64 | |
| d3egfa_ | 53 | Epidermal growth factor, EGF {Mouse (Mus musculus) | 81.72 | |
| d1gl4a2 | 40 | EGF-like domain of nidogen-1 {Mouse (Mus musculus) | 81.36 | |
| d2vj3a3 | 35 | Neurogenic locus notch homolog protein 1, Notch1 { | 80.86 | |
| d1g1ta2 | 39 | E-selectin, EGF-domain {Human (Homo sapiens) [TaxI | 80.74 |
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-35 Score=277.24 Aligned_cols=152 Identities=28% Similarity=0.477 Sum_probs=137.0
Q ss_pred HHhhcCCcccceeecccCCcceEEEEEcC-CcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEE
Q 047619 273 IANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 351 (430)
Q Consensus 273 ~~~~~~~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 351 (430)
.+...++|++.++||+|+||.||+|.+.. ++.||||+++.. ....+++.+|+.+|++++|||||++++++.+++..+|
T Consensus 12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (287)
T d1opja_ 12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 90 (287)
T ss_dssp TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEE
Confidence 34455789999999999999999999754 889999999753 3456789999999999999999999999999999999
Q ss_pred EEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 352 IYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 352 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||||+++|+|.+++.... ...+++..+..++.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+.
T Consensus 91 v~E~~~~g~l~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~ 164 (287)
T d1opja_ 91 ITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRL 164 (287)
T ss_dssp EEECCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred EeecccCcchHHHhhhcc-ccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceee
Confidence 999999999999986543 346899999999999999999999998 99999999999999999999999999985
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-35 Score=272.00 Aligned_cols=147 Identities=31% Similarity=0.432 Sum_probs=131.1
Q ss_pred cCCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEE
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 354 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 354 (430)
.++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.++++++|||||++++++.+++..+||||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 468999999999999999999974 5899999998653 23345678999999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 355 FVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 355 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+.
T Consensus 84 y~~gg~L~~~l~~~---~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~ 152 (271)
T d1nvra_ 84 YCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATV 152 (271)
T ss_dssp CCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred ccCCCcHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhhee
Confidence 99999999998533 45899999999999999999999998 99999999999999999999999999985
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-35 Score=271.63 Aligned_cols=146 Identities=25% Similarity=0.489 Sum_probs=134.4
Q ss_pred cCCcccceeecccCCcceEEEEE-cCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEc
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 355 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 355 (430)
.++|++.++||+|+||.||+|.. .+++.||||++........+.+.+|+.++++++|||||++++++.+++..+|||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 45799999999999999999986 45899999999765555667899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 356 VPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 356 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+++|+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.
T Consensus 99 ~~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~ 165 (293)
T d1yhwa1 99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQ 165 (293)
T ss_dssp CTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred cCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhhee
Confidence 999999998854 24899999999999999999999998 99999999999999999999999999975
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-35 Score=272.16 Aligned_cols=147 Identities=32% Similarity=0.491 Sum_probs=135.5
Q ss_pred CCcccceeecccCCcceEEEEEc-CCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEcc
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFV 356 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 356 (430)
+.|++.++||+|+||.||+|+.. +++.||||++.+......+.+.+|+++|++++|||||++++++.+++..+|||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 57999999999999999999975 58899999998766667788999999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 357 PNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 357 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++|+|.+++.+.. ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.
T Consensus 92 ~~g~L~~~~~~~~--~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~ 159 (288)
T d2jfla1 92 AGGAVDAVMLELE--RPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAK 159 (288)
T ss_dssp TTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhc
Confidence 9999999875432 45899999999999999999999998 99999999999999999999999999974
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-34 Score=267.11 Aligned_cols=147 Identities=27% Similarity=0.523 Sum_probs=131.8
Q ss_pred cCCcccceeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEcc
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFV 356 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 356 (430)
.++|++.++||+|+||.||+|.+.+++.||||++.. .....+++.+|+.++++++|||||++++++.+++..++||||+
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCS-SSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECC-CcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 367999999999999999999998889999999976 3345578999999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 357 PNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 357 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++|+|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+||||++++.+||+|||+|+.
T Consensus 83 ~~g~L~~~l~~~~--~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~ 150 (263)
T d1sm2a_ 83 EHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRF 150 (263)
T ss_dssp TTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC----
T ss_pred CCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchhee
Confidence 9999999986543 45889999999999999999999998 99999999999999999999999999985
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-34 Score=264.98 Aligned_cols=146 Identities=30% Similarity=0.436 Sum_probs=133.0
Q ss_pred CCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc---ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 353 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 353 (430)
++|++.+.||+|+||.||+|+.. +++.||+|++.+. .....+.+.+|+.++++++|||||++++++.+++..+|||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999975 5889999998642 2334677899999999999999999999999999999999
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+.
T Consensus 86 Ey~~~g~L~~~l~~~---~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~ 155 (263)
T d2j4za1 86 EYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVH 155 (263)
T ss_dssp ECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSC
T ss_pred eecCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeee
Confidence 999999999999643 35899999999999999999999998 99999999999999999999999999975
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-34 Score=268.50 Aligned_cols=148 Identities=31% Similarity=0.505 Sum_probs=132.1
Q ss_pred hcCCcccceeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEc
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 355 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 355 (430)
..++|++.++||+|+||.||+|.+.+++.||||++... ....+.+.+|+.++++++|||||++++++. .+..+|||||
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey 88 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEY 88 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEEEEe
Confidence 34679999999999999999999988899999999753 345678999999999999999999999875 4567999999
Q ss_pred cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 356 VPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 356 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+++|+|.+++.... ...+++..++.|+.||++||.|||+++ |+||||||+||||++++.+||+|||+|+.
T Consensus 89 ~~~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~ 158 (272)
T d1qpca_ 89 MENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARL 158 (272)
T ss_dssp CTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CCCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEE
Confidence 99999999875432 234899999999999999999999988 99999999999999999999999999985
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-34 Score=274.66 Aligned_cols=148 Identities=23% Similarity=0.327 Sum_probs=134.2
Q ss_pred hcCCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 353 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 353 (430)
..++|++.++||+|+||.||+|... +++.||+|++... .....+.+.+|+.+|++++|||||++++++.+.+..+|||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3578999999999999999999964 5899999998753 3445678999999999999999999999999999999999
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD-SRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||+++|+|.+++.+. ..+++..+..++.|++.||.|||+. + |+||||||+||||+.++.+||+|||+|+.
T Consensus 84 Ey~~gg~L~~~l~~~---~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~ 154 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQ 154 (322)
T ss_dssp ECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred EcCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccc
Confidence 999999999999653 3489999999999999999999974 7 99999999999999999999999999974
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.8e-33 Score=269.69 Aligned_cols=148 Identities=26% Similarity=0.387 Sum_probs=135.0
Q ss_pred cCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEc
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 355 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 355 (430)
.++|++.+.||+|+||.||+|... +++.||||++.+......+.+.+|+.+|++++|||||++++++.+++..||||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 467999999999999999999964 5899999999876666677889999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEc--CCCCeeecCCCcccc
Q 047619 356 VPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLD--QDMNPKISDFGLARA 429 (430)
Q Consensus 356 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~--~~~~~kl~DFGlar~ 429 (430)
+++|+|.+++... ...+++.++..++.||+.||+|||+++ |+||||||+||||+ .++.+||+|||+|+.
T Consensus 108 ~~gg~L~~~~~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~ 178 (352)
T d1koba_ 108 LSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATK 178 (352)
T ss_dssp CCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred CCCChHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeeccccee
Confidence 9999999887443 345899999999999999999999998 99999999999997 568999999999975
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.1e-33 Score=269.06 Aligned_cols=148 Identities=26% Similarity=0.440 Sum_probs=135.3
Q ss_pred cCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEc
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 355 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 355 (430)
.++|++.+.||+|+||.||+|... +++.||||++.+......+.+.+|+.+|++++|||||++++++.+.+..+|||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 468999999999999999999964 5899999999876667778899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcC--CCCeeecCCCcccc
Q 047619 356 VPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ--DMNPKISDFGLARA 429 (430)
Q Consensus 356 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~--~~~~kl~DFGlar~ 429 (430)
+++|+|.+++... ...+++..+..++.||+.||+|||+++ ||||||||+||||+. ++.+||+|||+|+.
T Consensus 105 ~~gg~L~~~l~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~ 175 (350)
T d1koaa2 105 MSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAH 175 (350)
T ss_dssp CCSCBHHHHHTCT--TSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEE
T ss_pred CCCCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchhee
Confidence 9999999998543 245999999999999999999999998 999999999999954 57899999999975
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.5e-34 Score=266.39 Aligned_cols=148 Identities=31% Similarity=0.530 Sum_probs=127.9
Q ss_pred cCCcccceeecccCCcceEEEEEcC-C---cEEEEEEecc-cChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEE
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLVD-G---QEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 351 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~~-~---~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 351 (430)
.++|++.+.||+|+||.||+|.+.. + ..||||++.. ......+.|.+|+.+|++++|||||++++++.+++..++
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 3568888999999999999998643 2 3589998865 345567789999999999999999999999999999999
Q ss_pred EEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 352 IYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 352 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||||+++|+|.+++.... ..+++.+++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.
T Consensus 105 v~Ey~~~g~L~~~~~~~~--~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 177 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRF 177 (299)
T ss_dssp EEECCTTEEHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEEecCCCcceeeecccc--CCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceE
Confidence 999999999999886533 45899999999999999999999988 99999999999999999999999999985
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-34 Score=264.70 Aligned_cols=146 Identities=31% Similarity=0.431 Sum_probs=133.2
Q ss_pred CCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc---ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 353 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 353 (430)
++|++.+.||+|+||.||+|... +++.||||++.+. .....+.+.+|+.++++++||||+++++++.+.+..||||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999974 5899999998742 2334577999999999999999999999999999999999
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||+++|+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+||||++++.+||+|||+|+.
T Consensus 88 Ey~~gg~L~~~~~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~ 157 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKV 157 (288)
T ss_dssp CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EccCCCCHHHhhhcc---CCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEeccccccee
Confidence 999999999988543 35899999999999999999999998 99999999999999999999999999985
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-34 Score=263.79 Aligned_cols=152 Identities=28% Similarity=0.418 Sum_probs=126.0
Q ss_pred CCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc--ChHhHHHHHHHHHHHhcCCCCcccceEEEEEe--CCEEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ--GEEKLLI 352 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv 352 (430)
++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|++++++++|||||++++++.+ .+..|||
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 57999999999999999999864 5899999998753 45556789999999999999999999999865 4568999
Q ss_pred EEccCCCChhHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCC--CcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 353 YEFVPNKSLDSFIFDQE-RCKILDWSKRFHIICGTARGVMYLHQDSR--LRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 353 ~e~~~~gsL~~~l~~~~-~~~~~~~~~~~~i~~~i~~aL~yLH~~~~--~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|||+++|+|.+++.... ....+++..+..++.||+.||+|||+++. .+|+||||||+||||+.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 99999999999986432 23469999999999999999999998642 3499999999999999999999999999975
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-34 Score=262.90 Aligned_cols=146 Identities=35% Similarity=0.573 Sum_probs=129.9
Q ss_pred hcCCcccceeecccCCcceEEEEEcCCcEEEEEEecc--cChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 353 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 353 (430)
..++|++.+.||+|+||.||+|+.. ..||||++.. ......+.|.+|+.++++++|||||++++++. .+..+|||
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~ 82 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVT 82 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred ccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEE
Confidence 3478999999999999999999853 4699999864 34556788999999999999999999999875 45689999
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||+++|+|.+++.... ..+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.
T Consensus 83 Ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~ 153 (276)
T d1uwha_ 83 QWCEGSSLYHHLHIIE--TKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATV 153 (276)
T ss_dssp ECCCEEEHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC
T ss_pred ecCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceee
Confidence 9999999999996543 35899999999999999999999988 99999999999999999999999999975
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-33 Score=258.10 Aligned_cols=147 Identities=26% Similarity=0.453 Sum_probs=134.7
Q ss_pred cCCcccceeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEcc
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFV 356 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 356 (430)
.++|++.++||+|+||.||+|+.++++.||||++++. ....+++.+|+.++++++||||+++++++.+++..++||||+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcC-cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 3689999999999999999999988889999999763 345578999999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 357 PNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 357 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++|+|..++.... ..+++..+.+++.|+++||+|||+.+ |+||||||+||||++++.+||+|||+|+.
T Consensus 82 ~~g~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~ 149 (258)
T d1k2pa_ 82 ANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRY 149 (258)
T ss_dssp TTEEHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCB
T ss_pred CCCcHHHhhhccc--cCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhhee
Confidence 9999999975543 45889999999999999999999988 99999999999999999999999999975
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.6e-33 Score=263.94 Aligned_cols=146 Identities=31% Similarity=0.513 Sum_probs=131.6
Q ss_pred CCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc---ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 353 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 353 (430)
+.|++.++||+|+||.||+|+.. +++.||||++... .....+.+.+|+.+|++++|||||++++++.+++..+|||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 35999999999999999999864 5889999998753 2344567899999999999999999999999999999999
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||+++|+|..++... ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+.
T Consensus 95 E~~~~g~l~~~~~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~ 164 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASI 164 (309)
T ss_dssp ECCSEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBS
T ss_pred EecCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccc
Confidence 999999998776443 45899999999999999999999998 99999999999999999999999999985
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=6.7e-33 Score=257.14 Aligned_cols=147 Identities=26% Similarity=0.370 Sum_probs=132.9
Q ss_pred cCCcccceeecccCCcceEEEEE-cCCcEEEEEEecccC---------hHhHHHHHHHHHHHhcCC-CCcccceEEEEEe
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKIS---------EQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQ 345 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~ 345 (430)
.++|++.+.||+|+||+||+|+. .+++.||||++.+.. ....+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 47899999999999999999996 458999999986521 123456889999999997 9999999999999
Q ss_pred CCEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCC
Q 047619 346 GEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 425 (430)
Q Consensus 346 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFG 425 (430)
++..||||||+++|+|.++|... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred CcceEEEEEcCCCchHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccch
Confidence 99999999999999999999653 35899999999999999999999998 9999999999999999999999999
Q ss_pred cccc
Q 047619 426 LARA 429 (430)
Q Consensus 426 lar~ 429 (430)
+|+.
T Consensus 156 ~a~~ 159 (277)
T d1phka_ 156 FSCQ 159 (277)
T ss_dssp TCEE
T ss_pred heeE
Confidence 9975
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-33 Score=265.82 Aligned_cols=147 Identities=23% Similarity=0.335 Sum_probs=134.0
Q ss_pred cCCcccceeecccCCcceEEEEE-cCCcEEEEEEeccc---ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEE
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 352 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 352 (430)
.++|++.+.||+|+||.||+|+. .+++.||||++.+. .....+.+.+|+.+|++++||||+++++++.+.+..|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 36799999999999999999996 45899999999752 233467789999999999999999999999999999999
Q ss_pred EEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 353 YEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 353 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+++|.+||+|||+|+.
T Consensus 84 ~ey~~gg~L~~~~~~~---~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~ 154 (337)
T d1o6la_ 84 MEYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKE 154 (337)
T ss_dssp EECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred eeccCCCchhhhhhcc---cCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccc
Confidence 9999999999998653 35899999999999999999999998 99999999999999999999999999985
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.6e-33 Score=263.83 Aligned_cols=148 Identities=29% Similarity=0.414 Sum_probs=124.1
Q ss_pred hcCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccC-hHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 353 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 353 (430)
..+.|++.+.||+|+||.||+|... +++.||||++.+.. ....+.+.+|+.+|++++|||||++++++.+++..||||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4567999999999999999999975 58899999997532 233466889999999999999999999999999999999
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEc---CCCCeeecCCCcccc
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLARA 429 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~---~~~~~kl~DFGlar~ 429 (430)
||+++|+|.++|... ..+++..+..++.||+.||+|||+++ |+||||||+|||+. +++.+||+|||+|+.
T Consensus 87 E~~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~ 159 (307)
T d1a06a_ 87 QLVSGGELFDRIVEK---GFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 159 (307)
T ss_dssp CCCCSCBHHHHHHTC---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred eccCCCcHHHhhhcc---cCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEE
Confidence 999999999999643 45999999999999999999999998 99999999999994 578999999999975
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-32 Score=254.73 Aligned_cols=146 Identities=26% Similarity=0.425 Sum_probs=127.5
Q ss_pred cccceeecccCCcceEEEEEc-CCcEEEEEEecc--cChHhHHHHHHHHHHHhcCCCCcccceEEEEEe----CCEEEEE
Q 047619 280 FSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ----GEEKLLI 352 (430)
Q Consensus 280 ~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv 352 (430)
|++.++||+|+||+||+|... +++.||+|++.. ......+.+.+|+++|++++|||||++++++.+ ....+||
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 366788999999999999975 478999999864 245566789999999999999999999999876 3457999
Q ss_pred EEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEc-CCCCeeecCCCcccc
Q 047619 353 YEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLD-QDMNPKISDFGLARA 429 (430)
Q Consensus 353 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~-~~~~~kl~DFGlar~ 429 (430)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+++ .+|+||||||+||||+ +++.+||+|||+|+.
T Consensus 91 mE~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~ 164 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 164 (270)
T ss_dssp EECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EeCCCCCcHHHHHhcc---ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence 9999999999999653 35899999999999999999999875 4599999999999996 578999999999974
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.3e-33 Score=262.23 Aligned_cols=146 Identities=27% Similarity=0.422 Sum_probs=132.5
Q ss_pred CCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc---ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 353 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 353 (430)
++|++.+.||+|+||.||+|+.. +++.||||++.+. .....+.+.+|+.+++.++|||||++++++.+++..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 57999999999999999999974 5899999999742 2334678899999999999999999999999999999999
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||+++++|..++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.
T Consensus 84 E~~~gg~l~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~ 153 (316)
T d1fota_ 84 DYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKY 153 (316)
T ss_dssp CCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred eecCCcccccccccc---ccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceE
Confidence 999999999998654 34788899999999999999999998 99999999999999999999999999985
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-33 Score=261.82 Aligned_cols=147 Identities=29% Similarity=0.501 Sum_probs=131.9
Q ss_pred cCCcccceeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEcc
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFV 356 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 356 (430)
.++|++.+.||+|+||.||+|.+.+++.||||++... ....+.|.+|+.++++++|||||++++++. .+..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEec
Confidence 4679999999999999999999988889999999753 345678999999999999999999999985 56689999999
Q ss_pred CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 357 PNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 357 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++|+|..++.... ...+++.+++.++.||+.||+|||+++ |+||||||+||||++++++||+|||+|+.
T Consensus 94 ~~g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~ 162 (285)
T d1fmka3 94 SKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARL 162 (285)
T ss_dssp TTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred CCCchhhhhhhcc-cccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhh
Confidence 9999999886532 245899999999999999999999998 99999999999999999999999999985
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-33 Score=257.41 Aligned_cols=146 Identities=32% Similarity=0.540 Sum_probs=128.2
Q ss_pred CCcccce-eecccCCcceEEEEEc---CCcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEE
Q 047619 278 DNFSINN-KLGEGGFGPVYKGTLV---DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 352 (430)
Q Consensus 278 ~~~~~~~-~ig~G~fg~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 352 (430)
++|.+.+ +||+|+||.||+|.+. ++..||||+++.. .....++|.+|+++|++++|||||++++++.+ +..+||
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 4677777 4999999999999753 3557999999753 45567889999999999999999999999864 568999
Q ss_pred EEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 353 YEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 353 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|||+++|+|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.
T Consensus 87 mE~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~ 158 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKA 158 (285)
T ss_dssp EECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEeCCCCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhc
Confidence 9999999999998543 245899999999999999999999998 99999999999999999999999999985
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-32 Score=259.85 Aligned_cols=148 Identities=22% Similarity=0.327 Sum_probs=132.6
Q ss_pred hcCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 354 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 354 (430)
..++|++.+.||+|+||+||+|... +++.||||++... ......+.+|+.+|+.++|||||++++++.+.+..|||||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC-cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 4578999999999999999999975 5889999999764 3345678899999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCC--CCeeecCCCcccc
Q 047619 355 FVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQD--MNPKISDFGLARA 429 (430)
Q Consensus 355 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~--~~~kl~DFGlar~ 429 (430)
|+++++|.++|... ...+++.++..++.||+.||+|||+.+ |+||||||+|||++.+ ..+||+|||+|+.
T Consensus 82 ~~~gg~L~~~i~~~--~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~ 153 (321)
T d1tkia_ 82 FISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQ 153 (321)
T ss_dssp CCCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred cCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhc
Confidence 99999999999543 235899999999999999999999998 9999999999999854 4799999999975
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-32 Score=257.94 Aligned_cols=148 Identities=29% Similarity=0.412 Sum_probs=132.8
Q ss_pred hcCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccC------hHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS------EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 348 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 348 (430)
..++|++.+.||+|+||+||+|... +++.||||++.+.. ....+.+.+|+.+|++++|||||++++++.+.+.
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 3468999999999999999999974 58999999986421 2246789999999999999999999999999999
Q ss_pred EEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCC----CeeecCC
Q 047619 349 KLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDM----NPKISDF 424 (430)
Q Consensus 349 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~----~~kl~DF 424 (430)
.+|||||+++|+|.++|... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~---~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEEcCCCccccchhccc---cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecch
Confidence 99999999999999999653 35899999999999999999999998 99999999999998776 4999999
Q ss_pred Ccccc
Q 047619 425 GLARA 429 (430)
Q Consensus 425 Glar~ 429 (430)
|+|+.
T Consensus 162 G~a~~ 166 (293)
T d1jksa_ 162 GLAHK 166 (293)
T ss_dssp TTCEE
T ss_pred hhhhh
Confidence 99975
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=1.7e-32 Score=255.68 Aligned_cols=148 Identities=29% Similarity=0.525 Sum_probs=129.7
Q ss_pred cCCcccceeecccCCcceEEEEEcCC-----cEEEEEEecc-cChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEE
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLVDG-----QEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 350 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~~~-----~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 350 (430)
.+.|++.+.||+|+||.||+|.+... ..||||++.. .......+|.+|+.++++++|||||++++++.+.+..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 35688899999999999999986542 3799999965 34455667999999999999999999999999999999
Q ss_pred EEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 351 LIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 351 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+||||+.++++.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|+.
T Consensus 86 ~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 86 IITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp EEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEecccCcchhhhhccc--ccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhc
Confidence 9999999999999886543 45899999999999999999999988 99999999999999999999999999985
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=1.8e-32 Score=254.52 Aligned_cols=139 Identities=31% Similarity=0.496 Sum_probs=122.3
Q ss_pred eeecccCCcceEEEEEcC---CcEEEEEEeccc--ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEccCC
Q 047619 284 NKLGEGGFGPVYKGTLVD---GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFVPN 358 (430)
Q Consensus 284 ~~ig~G~fg~Vy~~~~~~---~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 358 (430)
++||+|+||.||+|.+.+ ++.||||+++.. .....+++.+|+.+|++++|||||++++++.. +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 479999999999998643 468999999642 33446789999999999999999999999864 567899999999
Q ss_pred CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 359 KSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 359 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.
T Consensus 92 g~L~~~l~~~---~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~ 156 (277)
T d1xbba_ 92 GPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKA 156 (277)
T ss_dssp EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred CcHHHHHhhc---cCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhh
Confidence 9999998653 35899999999999999999999988 99999999999999999999999999985
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.98 E-value=2.2e-32 Score=261.98 Aligned_cols=147 Identities=26% Similarity=0.320 Sum_probs=133.7
Q ss_pred CCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc---ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 353 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 353 (430)
++|++++.||+|+||.||+|+.. +++.||||++.+. .....+.+.+|+.+|+.++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999974 5899999998642 2334577899999999999999999999999999999999
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCccccC
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 430 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~~ 430 (430)
||+.+|+|..++... ..+++..+..++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+.+
T Consensus 121 e~~~~g~l~~~l~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~ 191 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191 (350)
T ss_dssp ECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred ccccccchhhhHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeec
Confidence 999999999998654 35899999999999999999999998 999999999999999999999999999853
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=1.4e-32 Score=261.17 Aligned_cols=150 Identities=31% Similarity=0.527 Sum_probs=128.9
Q ss_pred cCCcccceeecccCCcceEEEEEcC-C-----cEEEEEEeccc-ChHhHHHHHHHHHHHhcC-CCCcccceEEEEEeCCE
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLVD-G-----QEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEE 348 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~~-~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 348 (430)
.++|++.++||+|+||+||+|+... + ..||+|++... .......+.+|+.+|.++ +|||||++++++.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 4679999999999999999998643 2 36999998643 344556789999999998 89999999999999999
Q ss_pred EEEEEEccCCCChhHHhhcCCC--------------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCC
Q 047619 349 KLLIYEFVPNKSLDSFIFDQER--------------------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKA 408 (430)
Q Consensus 349 ~~lv~e~~~~gsL~~~l~~~~~--------------------~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp 408 (430)
.+|||||+++|+|.++|..... ...+++..++.++.||+.||+|||+++ ||||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence 9999999999999999965432 235889999999999999999999998 99999999
Q ss_pred CcEEEcCCCCeeecCCCcccc
Q 047619 409 SNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 409 ~NILl~~~~~~kl~DFGlar~ 429 (430)
+|||++.++.+||+|||+|+.
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~ 213 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARD 213 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSC
T ss_pred hccccccCCeEEEeecccccc
Confidence 999999999999999999985
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.97 E-value=8e-32 Score=259.48 Aligned_cols=147 Identities=25% Similarity=0.345 Sum_probs=128.5
Q ss_pred cCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccC---hHhHHHH---HHHHHHHhcCCCCcccceEEEEEeCCEE
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKEL---KNEVILFSKLQHRNLVKLLGCCIQGEEK 349 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~---~~E~~~l~~l~h~niv~l~~~~~~~~~~ 349 (430)
.++|++.+.||+|+||.||+|+.. +++.||||++.+.. ......+ .+|+.+++.++|||||++++++.+.+..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 468999999999999999999975 58999999986421 1222233 3457788888999999999999999999
Q ss_pred EEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 350 LLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 350 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||||||+++|+|.++|... ..+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.
T Consensus 83 ~ivmE~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEEECCCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEEecCCCcHHHHHHhc---ccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeee
Confidence 9999999999999999653 35889999999999999999999998 99999999999999999999999999985
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.97 E-value=3.4e-32 Score=255.88 Aligned_cols=156 Identities=29% Similarity=0.517 Sum_probs=136.4
Q ss_pred HhHHhhcCCcccceeecccCCcceEEEEEc------CCcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEE
Q 047619 271 ATIANATDNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCC 343 (430)
Q Consensus 271 ~~~~~~~~~~~~~~~ig~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 343 (430)
.+++...++|++.+.||+|+||.||+|+.. +++.||||++... ..+..+++.+|+.++++++||||+++++++
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 344556678999999999999999999864 2578999999753 344567899999999999999999999999
Q ss_pred EeCCEEEEEEEccCCCChhHHhhcCC---------------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEE
Q 047619 344 IQGEEKLLIYEFVPNKSLDSFIFDQE---------------------RCKILDWSKRFHIICGTARGVMYLHQDSRLRII 402 (430)
Q Consensus 344 ~~~~~~~lv~e~~~~gsL~~~l~~~~---------------------~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~ii 402 (430)
...+..+++|||+++|+|.+++.... ....+++..++.|+.|++.||+|||+++ ||
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iv 162 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FV 162 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eE
Confidence 99999999999999999999986422 1234789999999999999999999988 99
Q ss_pred eCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 403 HRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 403 H~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||||||+||||+.++.+||+|||+|+.
T Consensus 163 HrDlKp~NILld~~~~~Kl~DFGls~~ 189 (301)
T d1lufa_ 163 HRDLATRNCLVGENMVVKIADFGLSRN 189 (301)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHH
T ss_pred eeEEcccceEECCCCcEEEccchhhee
Confidence 999999999999999999999999973
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=7.2e-32 Score=253.38 Aligned_cols=147 Identities=30% Similarity=0.491 Sum_probs=127.1
Q ss_pred CCcccceeecccCCcceEEEEE-cCCcEEEEEEecccC--hHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 354 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 354 (430)
++|++.++||+|+||.||+|.. .+++.||||++.... ....+++.+|+.+|++++|||||++++++.+++..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 6899999999999999999996 458999999996432 2346788999999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 355 FVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 355 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|+.++.+. ++.... ...+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+.
T Consensus 82 ~~~~~~~~-~~~~~~-~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~ 151 (298)
T d1gz8a_ 82 FLHQDLKK-FMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARA 151 (298)
T ss_dssp CCSEEHHH-HHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHH
T ss_pred ecCCchhh-hhhhhc-ccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCccee
Confidence 99765444 443322 345899999999999999999999998 99999999999999999999999999863
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.6e-31 Score=253.01 Aligned_cols=146 Identities=27% Similarity=0.433 Sum_probs=130.1
Q ss_pred CCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc---ChHhHHHHHHHHHHHh-cCCCCcccceEEEEEeCCEEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFS-KLQHRNLVKLLGCCIQGEEKLLI 352 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv 352 (430)
++|.+.+.||+|+||+||+|... +++.||||++.+. .....+.+.+|+.++. .++|||||++++++.+++..|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 67999999999999999999975 5899999999752 2334556677777765 68999999999999999999999
Q ss_pred EEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 353 YEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 353 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
|||+++|+|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.
T Consensus 82 mEy~~~g~L~~~i~~~---~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~ 152 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE 152 (320)
T ss_dssp EECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EeecCCCcHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhh
Confidence 9999999999999653 34889999999999999999999998 99999999999999999999999999985
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=99.97 E-value=1.2e-31 Score=250.39 Aligned_cols=146 Identities=28% Similarity=0.430 Sum_probs=132.0
Q ss_pred CCcccceeecccCCcceEEEEEcCCcEEEEEEeccc--ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEc
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 355 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 355 (430)
++|++.++||+|+||+||+|++++++.||||++... .....+.+.+|+.+|++++|||||++++++..++..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 689999999999999999999988999999999653 233467899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 356 VPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 356 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+.++.+..+... ...+++..+..++.||+.||+|||+.+ ||||||||+||||+.++.+||+|||+|..
T Consensus 82 ~~~~~~~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~ 149 (286)
T d1ob3a_ 82 LDQDLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARA 149 (286)
T ss_dssp CSEEHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHH
T ss_pred ehhhhHHHHHhh---cCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEeccccccee
Confidence 988777776633 245999999999999999999999988 99999999999999999999999999863
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.2e-31 Score=248.56 Aligned_cols=147 Identities=26% Similarity=0.441 Sum_probs=124.9
Q ss_pred cCCcccceeecccCCcceEEEEEcC----CcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEE
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 351 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 351 (430)
.++|++.+.||+|+||.||+|.+.. +..||||++... .....+.+.+|+.++++++|||||++++++. .+..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 4689999999999999999998643 356899998653 4455678999999999999999999999985 567899
Q ss_pred EEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 352 IYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 352 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
||||+++|+|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.
T Consensus 85 v~E~~~~g~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY 157 (273)
T ss_dssp EEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEeccCCcHHhhhhccC--CCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhhee
Confidence 999999999999875443 45899999999999999999999998 99999999999999999999999999985
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.6e-31 Score=249.70 Aligned_cols=149 Identities=33% Similarity=0.615 Sum_probs=129.9
Q ss_pred CCcccceeecccCCcceEEEEEcC-Cc--EEEEEEeccc-ChHhHHHHHHHHHHHhcC-CCCcccceEEEEEeCCEEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLVD-GQ--EIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLI 352 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 352 (430)
++|++.++||+|+||.||+|.+.+ +. .||||++... .....+.+.+|+++|.++ +|||||++++++.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 678999999999999999998654 43 5788887643 344567899999999999 799999999999999999999
Q ss_pred EEccCCCChhHHhhcC-------------CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCe
Q 047619 353 YEFVPNKSLDSFIFDQ-------------ERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNP 419 (430)
Q Consensus 353 ~e~~~~gsL~~~l~~~-------------~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~ 419 (430)
|||+++|+|.++|... .....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999999653 22356899999999999999999999998 9999999999999999999
Q ss_pred eecCCCcccc
Q 047619 420 KISDFGLARA 429 (430)
Q Consensus 420 kl~DFGlar~ 429 (430)
||+|||+|+.
T Consensus 167 kl~DfG~a~~ 176 (309)
T d1fvra_ 167 KIADFGLSRG 176 (309)
T ss_dssp EECCTTCEES
T ss_pred EEcccccccc
Confidence 9999999975
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.8e-31 Score=250.36 Aligned_cols=152 Identities=30% Similarity=0.519 Sum_probs=134.0
Q ss_pred hhcCCcccceeecccCCcceEEEEEc------CCcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCC
Q 047619 275 NATDNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE 347 (430)
Q Consensus 275 ~~~~~~~~~~~ig~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 347 (430)
...++|++.++||+|+||.||+|.+. ++..||||++.+. .......+.+|+.++++++||||+++++++...+
T Consensus 17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~ 96 (308)
T d1p4oa_ 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 96 (308)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC
Confidence 34578999999999999999999863 2578999999753 4455667899999999999999999999999999
Q ss_pred EEEEEEEccCCCChhHHhhcC-------CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCee
Q 047619 348 EKLLIYEFVPNKSLDSFIFDQ-------ERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPK 420 (430)
Q Consensus 348 ~~~lv~e~~~~gsL~~~l~~~-------~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~k 420 (430)
..++||||+++|+|.+++... .....+++..+..++.|+++||.|||+++ |+||||||+||||++++++|
T Consensus 97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~K 173 (308)
T d1p4oa_ 97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK 173 (308)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEE
T ss_pred ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEE
Confidence 999999999999999988542 22234788999999999999999999988 99999999999999999999
Q ss_pred ecCCCcccc
Q 047619 421 ISDFGLARA 429 (430)
Q Consensus 421 l~DFGlar~ 429 (430)
|+|||+|+.
T Consensus 174 l~DFGla~~ 182 (308)
T d1p4oa_ 174 IGDFGMTRD 182 (308)
T ss_dssp ECCTTCCCG
T ss_pred Eeeccccee
Confidence 999999985
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.5e-31 Score=249.81 Aligned_cols=157 Identities=29% Similarity=0.474 Sum_probs=124.7
Q ss_pred HHhHHhhcCCcccceeecccCCcceEEEEEcC------CcEEEEEEecc-cChHhHHHHHHHHHHHhcC-CCCcccceEE
Q 047619 270 LATIANATDNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSK-ISEQGLKELKNEVILFSKL-QHRNLVKLLG 341 (430)
Q Consensus 270 ~~~~~~~~~~~~~~~~ig~G~fg~Vy~~~~~~------~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~ 341 (430)
....+...++|++.++||+|+||.||+|.... ++.||||++.. ......+.+.+|+.++.++ +|+||+++++
T Consensus 5 ~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~ 84 (299)
T d1ywna1 5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 84 (299)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeee
Confidence 33444455789999999999999999998532 46899999975 3345566788888888777 6899999999
Q ss_pred EEEeCC-EEEEEEEccCCCChhHHhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCC
Q 047619 342 CCIQGE-EKLLIYEFVPNKSLDSFIFDQER-------------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLK 407 (430)
Q Consensus 342 ~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlk 407 (430)
++...+ ..++||||+++|+|.++|..... ...+++..+..++.||+.||+|||+++ |+|||||
T Consensus 85 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlK 161 (299)
T d1ywna1 85 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLA 161 (299)
T ss_dssp EECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCC
T ss_pred eeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCC
Confidence 987654 68999999999999999965321 235889999999999999999999998 9999999
Q ss_pred CCcEEEcCCCCeeecCCCcccc
Q 047619 408 ASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 408 p~NILl~~~~~~kl~DFGlar~ 429 (430)
|+||||++++.+||+|||+|+.
T Consensus 162 p~NILl~~~~~~Kl~DFGla~~ 183 (299)
T d1ywna1 162 ARNILLSEKNVVKICDFGLARD 183 (299)
T ss_dssp GGGEEECGGGCEEECC------
T ss_pred ccceeECCCCcEEEccCcchhh
Confidence 9999999999999999999974
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.97 E-value=6.8e-31 Score=244.07 Aligned_cols=147 Identities=23% Similarity=0.372 Sum_probs=131.5
Q ss_pred cCCcccceeecccCCcceEEEEE-cCCcEEEEEEeccc---ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCC----E
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE----E 348 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~ 348 (430)
.++|++.+.||+|+||.||+|.. .+++.||||++.+. .....+.+.+|+.+++.++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 47899999999999999999996 45899999999753 3445678999999999999999999999998754 3
Q ss_pred EEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCccc
Q 047619 349 KLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428 (430)
Q Consensus 349 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar 428 (430)
.||||||+++++|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+||||+.++.++|+|||+++
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhccc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence 78999999999999988543 35899999999999999999999998 9999999999999999999999999886
Q ss_pred c
Q 047619 429 A 429 (430)
Q Consensus 429 ~ 429 (430)
.
T Consensus 160 ~ 160 (277)
T d1o6ya_ 160 A 160 (277)
T ss_dssp E
T ss_pred h
Confidence 3
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2e-31 Score=246.80 Aligned_cols=146 Identities=32% Similarity=0.467 Sum_probs=121.9
Q ss_pred CCcccceeecccCCcceEEEEEcC--C--cEEEEEEeccc---ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLVD--G--QEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 350 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~~--~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 350 (430)
++|++.+.||+|+||.||+|+... + ..||||++.+. ..+..++|.+|+.+|++++|||||++++++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 579999999999999999998532 2 37899998652 34456789999999999999999999999965 5678
Q ss_pred EEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 351 LIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 351 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+||||+++++|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+||||+.++.+||+|||+|+.
T Consensus 87 lv~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeeeecCcchhhhhhccc--CCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhh
Confidence 9999999999998876432 45899999999999999999999988 99999999999999999999999999985
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.4e-31 Score=249.89 Aligned_cols=142 Identities=31% Similarity=0.406 Sum_probs=122.4
Q ss_pred cceeecccCCcceEEEEEc-CCcEEEEEEecccCh-----HhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEEc
Q 047619 282 INNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISE-----QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 355 (430)
Q Consensus 282 ~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 355 (430)
.++.||+|+||+||+|... +++.||||++..... ...+.+.+|+.++++++|||||++++++.+++..+|||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 3579999999999999964 589999999864321 1234688999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 356 VPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 356 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++++++..++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.
T Consensus 82 ~~~~~~~~~~~---~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~ 149 (299)
T d1ua2a_ 82 METDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKS 149 (299)
T ss_dssp CSEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred hcchHHhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccc
Confidence 99887776653 2345889999999999999999999998 99999999999999999999999999975
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.8e-31 Score=245.46 Aligned_cols=146 Identities=27% Similarity=0.491 Sum_probs=126.7
Q ss_pred cCCcccceeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeC-CEEEEEEEc
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-EEKLLIYEF 355 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~ 355 (430)
.++|++.+.||+|+||.||+|.+ .++.||||++++. ...+.+.+|++++++++||||+++++++.++ +..++||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 45788999999999999999998 4789999999753 3457899999999999999999999998654 568999999
Q ss_pred cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 356 VPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 356 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+++|+|.++|.... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 83 ~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~ 152 (262)
T d1byga_ 83 MAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKE 152 (262)
T ss_dssp CTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---
T ss_pred cCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeeccccccee
Confidence 99999999996532 235899999999999999999999988 99999999999999999999999999985
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=5.9e-31 Score=249.17 Aligned_cols=146 Identities=31% Similarity=0.552 Sum_probs=126.5
Q ss_pred CCcccceeecccCCcceEEEEEcC-Cc----EEEEEEecc-cChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLVD-GQ----EIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 351 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~~-~~----~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 351 (430)
++|++.+.||+|+||.||+|.+.. ++ .||+|++.. ...+..+++.+|+.++++++|||||++++++.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 469999999999999999998643 43 689998864 3445678899999999999999999999999865 5678
Q ss_pred EEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 352 IYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 352 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+|||+.+++|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.
T Consensus 88 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~ 160 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 160 (317)
T ss_dssp EEECCTTCBHHHHHHHT--SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHH
T ss_pred EEEeccCCccccccccc--ccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeecccccee
Confidence 88999999999988654 345899999999999999999999988 99999999999999999999999999974
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.2e-30 Score=244.26 Aligned_cols=142 Identities=32% Similarity=0.571 Sum_probs=125.8
Q ss_pred ceeecccCCcceEEEEEcCC----cEEEEEEecc-cChHhHHHHHHHHHHHhcCCCCcccceEEEEEeC-CEEEEEEEcc
Q 047619 283 NNKLGEGGFGPVYKGTLVDG----QEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-EEKLLIYEFV 356 (430)
Q Consensus 283 ~~~ig~G~fg~Vy~~~~~~~----~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~~ 356 (430)
.++||+|+||+||+|.+.++ ..||||++++ ......++|.+|+++|++++||||+++++++.+. ...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 57899999999999997542 3689999975 3556678899999999999999999999998764 5889999999
Q ss_pred CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 357 PNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 357 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++++|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+||||++++.+||+|||+|+.
T Consensus 112 ~~g~l~~~~~~~~--~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~ 179 (311)
T d1r0pa_ 112 KHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARD 179 (311)
T ss_dssp TTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCC
T ss_pred ecCchhhhhcccc--ccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhh
Confidence 9999999986543 45778889999999999999999988 99999999999999999999999999985
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.5e-30 Score=247.87 Aligned_cols=144 Identities=25% Similarity=0.337 Sum_probs=124.3
Q ss_pred cCCcccce-eecccCCcceEEEEE-cCCcEEEEEEecccChHhHHHHHHHHHHHhc-CCCCcccceEEEEEe----CCEE
Q 047619 277 TDNFSINN-KLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSK-LQHRNLVKLLGCCIQ----GEEK 349 (430)
Q Consensus 277 ~~~~~~~~-~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~----~~~~ 349 (430)
.++|.+.+ .||+|+||.||+|.. .+++.||||++.+. ..+.+|+.++.+ ++|||||++++++.+ ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 46898875 599999999999996 45899999999642 456789988765 489999999999876 3568
Q ss_pred EEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcC---CCCeeecCCCc
Q 047619 350 LLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKISDFGL 426 (430)
Q Consensus 350 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~DFGl 426 (430)
||||||++||+|.++|.... ...+++.++..++.||+.||+|||+++ |+||||||+|||++. .+.+||+|||+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCS-CCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEECCCCCcHHHHHHhcC-CCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence 99999999999999996542 245899999999999999999999998 999999999999975 46799999999
Q ss_pred ccc
Q 047619 427 ARA 429 (430)
Q Consensus 427 ar~ 429 (430)
|+.
T Consensus 161 a~~ 163 (335)
T d2ozaa1 161 AKE 163 (335)
T ss_dssp CEE
T ss_pred eee
Confidence 975
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.6e-30 Score=242.97 Aligned_cols=146 Identities=25% Similarity=0.405 Sum_probs=122.8
Q ss_pred CCcccceeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCC----EEEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE----EKLLIY 353 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~ 353 (430)
.+|.+.+.||+|+||.||+|++ +++.||||++.... ........|+..+.+++|||||++++++.+.+ ..++||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~-~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc-hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 4678889999999999999986 68899999996432 22222334556667889999999999998764 579999
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhc-----CCCcEEeCCCCCCcEEEcCCCCeeecCCCccc
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD-----SRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~-----~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar 428 (430)
||+++|+|.++|.+. .+++..++.++.|++.||.|||+. ...+|+||||||+||||+.++.+||+|||+|+
T Consensus 81 Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 999999999999653 489999999999999999999974 12359999999999999999999999999997
Q ss_pred c
Q 047619 429 A 429 (430)
Q Consensus 429 ~ 429 (430)
.
T Consensus 157 ~ 157 (303)
T d1vjya_ 157 R 157 (303)
T ss_dssp E
T ss_pred c
Confidence 4
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=4.8e-30 Score=240.09 Aligned_cols=146 Identities=27% Similarity=0.430 Sum_probs=132.6
Q ss_pred CCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc--ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCCEEEEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 354 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 354 (430)
++|+++++||+|+||+||+|++. +++.||||+++.. ......++.+|+.+++.++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 58999999999999999999964 5889999998642 34457889999999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 355 FVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 355 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
++.+++|..++... ..+++..+..++.|++.||+|||+++ |+||||||+||||+.++.+||+|||+|+.
T Consensus 82 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~ 150 (292)
T d1unla_ 82 FCDQDLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARA 150 (292)
T ss_dssp CCSEEHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred eccccccccccccc---cccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhc
Confidence 99999998887543 45889999999999999999999998 99999999999999999999999999975
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.6e-30 Score=245.43 Aligned_cols=151 Identities=34% Similarity=0.499 Sum_probs=133.3
Q ss_pred hcCCcccceeecccCCcceEEEEEc------CCcEEEEEEeccc-ChHhHHHHHHHHHHHhcC-CCCcccceEEEEEeCC
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGE 347 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 347 (430)
..++|++.++||+|+||.||+|++. .++.||||+++.. ......++.+|+.+++++ +|||||++++++.+.+
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence 3468999999999999999999852 3568999999753 344566799999999999 6999999999999999
Q ss_pred EEEEEEEccCCCChhHHhhcCC---------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEE
Q 047619 348 EKLLIYEFVPNKSLDSFIFDQE---------------RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVL 412 (430)
Q Consensus 348 ~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NIL 412 (430)
..+|||||+++|+|.+++.... ....+++..+..++.||+.||+|||+++ |+||||||+|||
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl 177 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL 177 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccccccc
Confidence 9999999999999999986532 1235889999999999999999999998 999999999999
Q ss_pred EcCCCCeeecCCCcccc
Q 047619 413 LDQDMNPKISDFGLARA 429 (430)
Q Consensus 413 l~~~~~~kl~DFGlar~ 429 (430)
++.++.+||+|||+|+.
T Consensus 178 ~~~~~~~ki~DfG~~~~ 194 (311)
T d1t46a_ 178 LTHGRITKICDFGLARD 194 (311)
T ss_dssp EETTTEEEECCCGGGSC
T ss_pred ccccCcccccccchhee
Confidence 99999999999999985
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.1e-30 Score=243.28 Aligned_cols=151 Identities=33% Similarity=0.536 Sum_probs=128.5
Q ss_pred hcCCcccceeecccCCcceEEEEEcC--------CcEEEEEEeccc-ChHhHHHHHHHHHHHhcC-CCCcccceEEEEEe
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLVD--------GQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQ 345 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~~--------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 345 (430)
..++|.+.+.||+|+||.||+|+... +..||||++++. ......++.+|+..+.++ +|||||++++++.+
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 45789999999999999999998533 247999999753 445567889999999888 79999999999999
Q ss_pred CCEEEEEEEccCCCChhHHhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEE
Q 047619 346 GEEKLLIYEFVPNKSLDSFIFDQER-------------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVL 412 (430)
Q Consensus 346 ~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NIL 412 (430)
++..++||||+++|+|.++|..... ...+++..++.++.||+.||+|||+.+ ||||||||+|||
T Consensus 91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiL 167 (299)
T d1fgka_ 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 167 (299)
T ss_dssp SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeeccccee
Confidence 9999999999999999999965432 245899999999999999999999998 999999999999
Q ss_pred EcCCCCeeecCCCcccc
Q 047619 413 LDQDMNPKISDFGLARA 429 (430)
Q Consensus 413 l~~~~~~kl~DFGlar~ 429 (430)
++.++.+||+|||+|+.
T Consensus 168 l~~~~~~kl~dfg~~~~ 184 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARD 184 (299)
T ss_dssp ECTTCCEEECSTTCCCC
T ss_pred ecCCCCeEeccchhhcc
Confidence 99999999999999984
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=5.8e-30 Score=245.21 Aligned_cols=147 Identities=24% Similarity=0.414 Sum_probs=125.1
Q ss_pred hcCCcccceeecccCCcceEEEEE-cCCcEEEEEEeccc-ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCC----EE
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE----EK 349 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~ 349 (430)
..++|+++++||+|+||+||+|.. .+++.||||++.+. .....+.+.+|+.+|++++||||+++++++.... ..
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 346799999999999999999986 46999999999753 3445678899999999999999999999987653 23
Q ss_pred EEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcccc
Q 047619 350 LLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 429 (430)
Q Consensus 350 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar~ 429 (430)
+++++|+.+++|.+++... .+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.
T Consensus 86 ~~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceee
Confidence 4555667799999999543 4899999999999999999999998 99999999999999999999999999974
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.3e-30 Score=241.50 Aligned_cols=147 Identities=27% Similarity=0.413 Sum_probs=126.9
Q ss_pred cCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccC------hHhHHHHHHHHHHHhcCC--CCcccceEEEEEeCC
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS------EQGLKELKNEVILFSKLQ--HRNLVKLLGCCIQGE 347 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~ 347 (430)
.++|++.+.||+|+||.||+|+.. +++.||||++.+.. .....++.+|+.++++++ |||||++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 468999999999999999999964 58999999986421 112244678999999987 899999999999999
Q ss_pred EEEEEEEccCC-CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCC-CCeeecCCC
Q 047619 348 EKLLIYEFVPN-KSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFG 425 (430)
Q Consensus 348 ~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DFG 425 (430)
..++||||+.+ +++.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~---~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEEEEEeccCcchHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccc
Confidence 99999999976 5777777543 35899999999999999999999998 9999999999999854 789999999
Q ss_pred cccc
Q 047619 426 LARA 429 (430)
Q Consensus 426 lar~ 429 (430)
+|+.
T Consensus 157 ~a~~ 160 (273)
T d1xwsa_ 157 SGAL 160 (273)
T ss_dssp TCEE
T ss_pred ccee
Confidence 9974
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.96 E-value=8e-30 Score=242.65 Aligned_cols=140 Identities=24% Similarity=0.455 Sum_probs=124.3
Q ss_pred CCcccceeecccCCcceEEEEE-cCCcEEEEEEecccChHhHHHHHHHHHHHhcCC-CCcccceEEEEEeC--CEEEEEE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQG--EEKLLIY 353 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~ 353 (430)
++|+++++||+|+||+||+|+. .+++.||||++++. ..+++.+|+.+|++++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5799999999999999999997 45899999999753 3467889999999995 99999999999854 5689999
Q ss_pred EccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCC-CeeecCCCcccc
Q 047619 354 EFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLARA 429 (430)
Q Consensus 354 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DFGlar~ 429 (430)
||+++++|..+. ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++ .+||+|||+|+.
T Consensus 112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~ 179 (328)
T d3bqca1 112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 179 (328)
T ss_dssp ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEE
T ss_pred eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeeccccccee
Confidence 999999997764 34899999999999999999999998 99999999999998765 589999999974
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=5.2e-30 Score=246.03 Aligned_cols=144 Identities=27% Similarity=0.399 Sum_probs=121.0
Q ss_pred CcccceeecccCCcceEEEEEc-CCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcccceEEEEEeC------CEEEE
Q 047619 279 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG------EEKLL 351 (430)
Q Consensus 279 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~l 351 (430)
+|+..++||+|+||+||+|++. +++.||||++.+... ...+|+.+|++++||||+++++++... ...+|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 6888999999999999999975 589999999975322 234799999999999999999998653 34789
Q ss_pred EEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCC-CeeecCCCcccc
Q 047619 352 IYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLARA 429 (430)
Q Consensus 352 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DFGlar~ 429 (430)
||||++++.+..+.........+++..+..++.||+.||+|||+++ |+||||||+||||+.++ .+||+|||+|+.
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhh
Confidence 9999987654444332233456999999999999999999999988 99999999999999775 899999999975
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.1e-29 Score=243.39 Aligned_cols=146 Identities=29% Similarity=0.471 Sum_probs=123.6
Q ss_pred hcCCcccceeecccCCcceEEEEEc-CCcEEEEEEecc--cChHhHHHHHHHHHHHhcCCCCcccceEEEEEeCC-----
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE----- 347 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 347 (430)
..++|+++++||+|+||+||+|... +++.||||++.+ ......+.+.+|+.+|+.++|||||++++++...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 3578999999999999999999964 589999999975 34455678899999999999999999999998765
Q ss_pred -EEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCc
Q 047619 348 -EKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 426 (430)
Q Consensus 348 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGl 426 (430)
..+|||||+ +.+|..++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEecc-cccHHHHHHh----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccc
Confidence 469999999 6678777643 34899999999999999999999998 99999999999999999999999999
Q ss_pred ccc
Q 047619 427 ARA 429 (430)
Q Consensus 427 ar~ 429 (430)
|+.
T Consensus 168 a~~ 170 (346)
T d1cm8a_ 168 ARQ 170 (346)
T ss_dssp CEE
T ss_pred eec
Confidence 975
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=3.7e-29 Score=236.93 Aligned_cols=147 Identities=29% Similarity=0.471 Sum_probs=125.3
Q ss_pred cCCcccceeecccCCcceEEEEE-cCCcEEEEEEeccc--ChHhHHHHHHHHHHHhcCCCCcccceEEEEEe--------
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ-------- 345 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------- 345 (430)
.++|+++++||+|+||+||+|.. .+++.||||++... .....+++.+|+.+|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 47899999999999999999997 46899999998642 33445778899999999999999999999865
Q ss_pred CCEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCC
Q 047619 346 GEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 425 (430)
Q Consensus 346 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFG 425 (430)
....++||||++++.+..... ....+++..+..++.|++.||+|||+++ |+||||||+||||+.++.+||+|||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~---~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTC---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCCCccchhhh---cccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecc
Confidence 345799999998877765542 2345889999999999999999999998 9999999999999999999999999
Q ss_pred cccc
Q 047619 426 LARA 429 (430)
Q Consensus 426 lar~ 429 (430)
+|+.
T Consensus 163 ~~~~ 166 (318)
T d3blha1 163 LARA 166 (318)
T ss_dssp TCEE
T ss_pred eeee
Confidence 9974
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=7.8e-30 Score=241.59 Aligned_cols=146 Identities=24% Similarity=0.351 Sum_probs=130.1
Q ss_pred CCcccceeecccCCcceEEEEEc----CCcEEEEEEeccc----ChHhHHHHHHHHHHHhcCCC-CcccceEEEEEeCCE
Q 047619 278 DNFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSKI----SEQGLKELKNEVILFSKLQH-RNLVKLLGCCIQGEE 348 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~~----~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~ 348 (430)
++|++.+.||+|+||+||+|... +++.||||++.+. .....+.+.+|+.++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 67999999999999999999852 3789999998642 22345678899999999976 899999999999999
Q ss_pred EEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCccc
Q 047619 349 KLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428 (430)
Q Consensus 349 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar 428 (430)
.+++|||+.+++|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHhcc---cccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence 999999999999999986543 4778899999999999999999998 9999999999999999999999999997
Q ss_pred c
Q 047619 429 A 429 (430)
Q Consensus 429 ~ 429 (430)
.
T Consensus 178 ~ 178 (322)
T d1vzoa_ 178 E 178 (322)
T ss_dssp E
T ss_pred h
Confidence 5
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=6e-29 Score=238.47 Aligned_cols=147 Identities=29% Similarity=0.442 Sum_probs=125.3
Q ss_pred hcCCcccceeecccCCcceEEEEE-cCCcEEEEEEeccc--ChHhHHHHHHHHHHHhcCCCCcccceEEEEEeC-----C
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-----E 347 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~ 347 (430)
..++|+++++||+|+||+||+|+. .+++.||||++.+. .....+++.+|+.+|++++|||||++++++... .
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 357899999999999999999996 46999999999753 344566789999999999999999999998643 3
Q ss_pred EEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcc
Q 047619 348 EKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427 (430)
Q Consensus 348 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla 427 (430)
..+++|+|+.+++|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||+|
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC---
T ss_pred ceEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchh
Confidence 34667778889999999843 24899999999999999999999998 999999999999999999999999998
Q ss_pred cc
Q 047619 428 RA 429 (430)
Q Consensus 428 r~ 429 (430)
..
T Consensus 169 ~~ 170 (348)
T d2gfsa1 169 RH 170 (348)
T ss_dssp -C
T ss_pred cc
Confidence 64
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1.1e-28 Score=232.33 Aligned_cols=149 Identities=28% Similarity=0.437 Sum_probs=122.1
Q ss_pred hcCCcccceeecccCCcceEEEEEc-C-CcEEEEEEeccc--ChHhHHHHHHHHHHHhcC---CCCcccceEEEEEe---
Q 047619 276 ATDNFSINNKLGEGGFGPVYKGTLV-D-GQEIAVKRLSKI--SEQGLKELKNEVILFSKL---QHRNLVKLLGCCIQ--- 345 (430)
Q Consensus 276 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~--- 345 (430)
..++|+++++||+|+||+||+|+.. + ++.||||++... .......+.+|+.+++.| +||||+++++++..
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 3478999999999999999999973 4 567999998642 222233455677776655 89999999999864
Q ss_pred --CCEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecC
Q 047619 346 --GEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD 423 (430)
Q Consensus 346 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~D 423 (430)
....+++|||++++.+....... ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred ccCceEEEEEEeccCCchhhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecc
Confidence 24679999999988776554332 345899999999999999999999998 99999999999999999999999
Q ss_pred CCcccc
Q 047619 424 FGLARA 429 (430)
Q Consensus 424 FGlar~ 429 (430)
||+++.
T Consensus 160 fg~~~~ 165 (305)
T d1blxa_ 160 FGLARI 165 (305)
T ss_dssp CCSCCC
T ss_pred hhhhhh
Confidence 999875
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.95 E-value=3.7e-28 Score=227.14 Aligned_cols=145 Identities=20% Similarity=0.351 Sum_probs=126.7
Q ss_pred cCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccChHhHHHHHHHHHHHhcCCC-CcccceEEEEEeCCEEEEEEE
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQH-RNLVKLLGCCIQGEEKLLIYE 354 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e 354 (430)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+|+++++.++| +|++.+++++.++...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 468999999999999999999965 58899999886432 23456788999999976 899999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcC-----CCCeeecCCCcccc
Q 047619 355 FVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ-----DMNPKISDFGLARA 429 (430)
Q Consensus 355 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~-----~~~~kl~DFGlar~ 429 (430)
|+ +++|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+||||+. ++.+||+|||+|+.
T Consensus 82 ~~-~~~l~~~~~~~~--~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHhhc--cchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 99 689999886543 35899999999999999999999998 999999999999974 56799999999985
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=6.2e-28 Score=231.86 Aligned_cols=144 Identities=28% Similarity=0.422 Sum_probs=122.2
Q ss_pred cCCcccceeecccCCcceEEEEEc-CCcEEEEEEeccc--ChHhHHHHHHHHHHHhcCCCCcccceEEEEEe------CC
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ------GE 347 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~ 347 (430)
.++|+++++||+|+||+||+|.+. +++.||||++.+. .......+.+|+.++++++||||+++++++.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 368999999999999999999975 5899999999742 34556778999999999999999999999964 36
Q ss_pred EEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeeecCCCcc
Q 047619 348 EKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 427 (430)
Q Consensus 348 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla 427 (430)
..|+||||+.++.+. .+. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 96 ~~~iv~Ey~~~~l~~-~~~-----~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 96 DVYLVMELMDANLCQ-VIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEEECCSEEHHH-HHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eeEEEEeccchHHHH-hhh-----cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhh
Confidence 889999999766554 442 24889999999999999999999998 999999999999999999999999998
Q ss_pred cc
Q 047619 428 RA 429 (430)
Q Consensus 428 r~ 429 (430)
+.
T Consensus 167 ~~ 168 (355)
T d2b1pa1 167 RT 168 (355)
T ss_dssp --
T ss_pred hc
Confidence 74
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.94 E-value=1.9e-27 Score=223.03 Aligned_cols=145 Identities=24% Similarity=0.431 Sum_probs=120.1
Q ss_pred cCCcccceeecccCCcceEEEEEc-CCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCc-ccceEEEEEeCCEEEEEEE
Q 047619 277 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN-LVKLLGCCIQGEEKLLIYE 354 (430)
Q Consensus 277 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e 354 (430)
.++|++.++||+|+||.||+|++. +++.||||++.... ...++.+|+++++.++|++ |+.+..+..+.+..++|||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 367999999999999999999964 58899999886532 2345788999999998776 5555666778889999999
Q ss_pred ccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcC---CCCeeecCCCcccc
Q 047619 355 FVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKISDFGLARA 429 (430)
Q Consensus 355 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~DFGlar~ 429 (430)
|+ +++|...+.... ..+++..+..++.|++.||+|||+++ |+||||||+|||++. +..+||+|||+|+.
T Consensus 84 ~~-~~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~ 155 (299)
T d1ckia_ 84 LL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 155 (299)
T ss_dssp CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEE
T ss_pred Ec-CCchhhhhhhcc--CCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCccee
Confidence 99 456666554332 45899999999999999999999998 999999999999853 45799999999985
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=1.5e-24 Score=189.51 Aligned_cols=132 Identities=21% Similarity=0.184 Sum_probs=105.5
Q ss_pred cccceeecccCCcceEEEEEcCCcEEEEEEecccC------------------hHhHHHHHHHHHHHhcCCCCcccceEE
Q 047619 280 FSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKIS------------------EQGLKELKNEVILFSKLQHRNLVKLLG 341 (430)
Q Consensus 280 ~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~------------------~~~~~~~~~E~~~l~~l~h~niv~l~~ 341 (430)
+.+.++||+|+||.||+|...+++.||||++.... ........+|...+.++.|++++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 34678999999999999998889999999864210 111234567889999999999999876
Q ss_pred EEEeCCEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEeCCCCCCcEEEcCCCCeee
Q 047619 342 CCIQGEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKI 421 (430)
Q Consensus 342 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl 421 (430)
+. ..+++|||+++..+.. ++......++.|++.||.|||+.+ |+||||||+|||+++++ ++|
T Consensus 82 ~~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~~-~~l 143 (191)
T d1zara2 82 WE----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEG-IWI 143 (191)
T ss_dssp EE----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETTE-EEE
T ss_pred ec----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCCC-EEE
Confidence 53 2379999998765533 333445678999999999999998 99999999999998664 999
Q ss_pred cCCCcccc
Q 047619 422 SDFGLARA 429 (430)
Q Consensus 422 ~DFGlar~ 429 (430)
+|||+|+.
T Consensus 144 iDFG~a~~ 151 (191)
T d1zara2 144 IDFPQSVE 151 (191)
T ss_dssp CCCTTCEE
T ss_pred EECCCccc
Confidence 99999864
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.89 E-value=1.4e-23 Score=201.84 Aligned_cols=148 Identities=22% Similarity=0.244 Sum_probs=118.9
Q ss_pred CCcccceeecccCCcceEEEEE-cCCcEEEEEEecccChHhHHHHHHHHHHHhcCC-----------CCcccceEEEEEe
Q 047619 278 DNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-----------HRNLVKLLGCCIQ 345 (430)
Q Consensus 278 ~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~ 345 (430)
++|+++++||+|+||+||+|+. .+++.||||++.+. ....+.+.+|+.+++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 4699999999999999999997 46899999999763 334567788999888875 5789999988764
Q ss_pred --CCEEEEEEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCcEEeCCCCCCcEEEcCCCC----
Q 047619 346 --GEEKLLIYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ-DSRLRIIHRDLKASNVLLDQDMN---- 418 (430)
Q Consensus 346 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~-~~~~~iiH~Dlkp~NILl~~~~~---- 418 (430)
....+++|++..................+++..+..++.||+.||+|||+ .+ |+||||||+||||+.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence 45667777776655443333333344568999999999999999999998 66 999999999999986654
Q ss_pred --eeecCCCcccc
Q 047619 419 --PKISDFGLARA 429 (430)
Q Consensus 419 --~kl~DFGlar~ 429 (430)
+||+|||.|+.
T Consensus 169 ~~~kl~dfg~s~~ 181 (362)
T d1q8ya_ 169 IQIKIADLGNACW 181 (362)
T ss_dssp EEEEECCCTTCEE
T ss_pred ceeeEeecccccc
Confidence 99999999874
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.87 E-value=7.1e-09 Score=92.99 Aligned_cols=147 Identities=15% Similarity=0.082 Sum_probs=99.1
Q ss_pred HHhhcCCcccceeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcCC-CCcccceEEEEEeCCEEEE
Q 047619 273 IANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLL 351 (430)
Q Consensus 273 ~~~~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 351 (430)
+......|+..+..+-++.+.||+... +++.+++|+...........+.+|+.++..+. +--+.+++.+...++..++
T Consensus 9 l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~l 87 (263)
T d1j7la_ 9 LKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEE
Confidence 344445777666544445578998864 56778889886544334445677888877664 4446788888888999999
Q ss_pred EEEccCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcC----------------------------------
Q 047619 352 IYEFVPNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS---------------------------------- 397 (430)
Q Consensus 352 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~yLH~~~---------------------------------- 397 (430)
||++++|.++.+..... . ....++.++++.|..||+..
T Consensus 88 v~~~l~G~~~~~~~~~~-----~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T d1j7la_ 88 LMSEADGVLCSEEYEDE-----Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEECCSSEEHHHHTTTC-----S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred EEEeccccccccccccc-----c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence 99999998886654211 1 11223444555555555321
Q ss_pred ----------------------CCcEEeCCCCCCcEEEcCCCCeeecCCCccc
Q 047619 398 ----------------------RLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428 (430)
Q Consensus 398 ----------------------~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar 428 (430)
...++|+|+.|.|||+++++.+-|+||+.|.
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1237999999999999877666799998875
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.34 E-value=1.1e-06 Score=77.90 Aligned_cols=76 Identities=20% Similarity=0.165 Sum_probs=54.7
Q ss_pred eeecccCC-cceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcCCC--CcccceEEEEEeCCEEEEEEEccCCCC
Q 047619 284 NKLGEGGF-GPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH--RNLVKLLGCCIQGEEKLLIYEFVPNKS 360 (430)
Q Consensus 284 ~~ig~G~f-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gs 360 (430)
+.+..|.. +.||+....++..+++|...... ...+..|+..++.+.. ..+.+++.+..+++..++|||+++|.+
T Consensus 16 ~~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~ 92 (255)
T d1nd4a_ 16 AQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD 92 (255)
T ss_dssp EECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred EEcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence 45566654 57899987778888889765432 2345667777766643 346788888888888999999999876
Q ss_pred hh
Q 047619 361 LD 362 (430)
Q Consensus 361 L~ 362 (430)
+.
T Consensus 93 ~~ 94 (255)
T d1nd4a_ 93 LL 94 (255)
T ss_dssp TT
T ss_pred cc
Confidence 53
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.01 E-value=1.3e-05 Score=75.75 Aligned_cols=76 Identities=11% Similarity=0.158 Sum_probs=49.0
Q ss_pred ceeecccCCcceEEEEEcC-CcEEEEEEeccc---C----hHhHHHHHHHHHHHhcCC-C--CcccceEEEEEeCCEEEE
Q 047619 283 NNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---S----EQGLKELKNEVILFSKLQ-H--RNLVKLLGCCIQGEEKLL 351 (430)
Q Consensus 283 ~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~---~----~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~l 351 (430)
.+.||.|....||++...+ ++.++||.-... . +....+...|.+.|..+. + ..+++++.+ +++..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 3679999999999998654 678999975321 1 112344556777776552 2 346666654 5566789
Q ss_pred EEEccCCCC
Q 047619 352 IYEFVPNKS 360 (430)
Q Consensus 352 v~e~~~~gs 360 (430)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999998754
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=97.86 E-value=3.2e-05 Score=59.53 Aligned_cols=79 Identities=9% Similarity=0.052 Sum_probs=51.3
Q ss_pred eEEEEcCCCCCC--------------CCceEEEEEEcCCCCEEEEEcCCeeEEecCCCCCc-----ccc-CCe-------
Q 047619 13 RRITSWKSPDDP--------------SPGNFTWAVERQDNPELIMWKGSRKFHRGGPWNGL-----VFN-EDE------- 65 (430)
Q Consensus 13 ~~L~S~~s~~dp--------------s~G~~~~~~~~~g~~~~~~~~~~~~y~~sg~~~~~-----~~~-~~~------- 65 (430)
..|.||.+.+++ +.|.|+|.|+.||++. ++++..++|.++..... .+. ++.
T Consensus 2 ~~~~s~~~~~~~~~~l~~~q~l~~~~~~~~y~l~mQ~DGNLV--Ly~~~~~vWssnt~~~~~~~~l~l~~dGnLvL~d~~ 79 (119)
T d1b2pa_ 2 NIIFSKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCNLV--LYDNNNPIWATNTGGLGNGCRAVLQPDGVLVVITNE 79 (119)
T ss_dssp CEEECSCSSSCCCCEEETTCEEEEEETTEEEEEEECTTSCEE--EEETTEEEEECCCTTSCSSCEEEECTTSCEEEECTT
T ss_pred CEEEeeecCCCCCCEEeCCCeEEEecCCceEEEEECCCCcEE--EEECCeEEEEecCCCCCcceEEEEEeCCCEEEECCC
Confidence 346666666666 6899999999999855 46788899998875422 111 111
Q ss_pred --eEEEEEecCCCcEEEEEEeeccceEEEEE
Q 047619 66 --LYYTFDMTDKDVFSRIVMNQTLYVRHQFT 94 (430)
Q Consensus 66 --~~~~~~~~~~~~~~~~~l~~dG~~~~~~~ 94 (430)
..+...........+++|+.|| ++.+|.
T Consensus 80 g~~vWsS~t~~~~~~~~l~Lq~DG-NlvlYg 109 (119)
T d1b2pa_ 80 NVTVWQSPVAGKAGHYVLVLQPDR-NVVIYG 109 (119)
T ss_dssp CCEEEECSCCCCSSCEEEEECTTS-CEEEEE
T ss_pred CcEEEECCCcCCCCceEEEEcCCC-CEEEEC
Confidence 2222111222344689999999 999983
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.68 E-value=0.00011 Score=67.08 Aligned_cols=70 Identities=13% Similarity=0.067 Sum_probs=46.2
Q ss_pred CcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCcc-----cce--EEEEEeCCEEEEEEEccCCCCh
Q 047619 291 FGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL-----VKL--LGCCIQGEEKLLIYEFVPNKSL 361 (430)
Q Consensus 291 fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----v~l--~~~~~~~~~~~lv~e~~~~gsL 361 (430)
--.||++...+|+.+++|+... .....+++..|...+..|....| +.. -......+..+.++++++|..+
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp-~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~ 111 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRP-ERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF 111 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECT-TTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred cceeEEEEcCCCCEEEEEEeCC-CCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCC
Confidence 3579999988999999998764 22345667788887777642221 111 1123456778899999987443
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=97.58 E-value=0.00012 Score=55.63 Aligned_cols=80 Identities=8% Similarity=0.134 Sum_probs=51.7
Q ss_pred CceEEEEEEcCCCCEEEEEcCCeeEEecCCCCCc-----cccCC---------eeEEEEEecCCCcEEEEEEeeccceEE
Q 047619 26 PGNFTWAVERQDNPELIMWKGSRKFHRGGPWNGL-----VFNED---------ELYYTFDMTDKDVFSRIVMNQTLYVRH 91 (430)
Q Consensus 26 ~G~~~~~~~~~g~~~~~~~~~~~~y~~sg~~~~~-----~~~~~---------~~~~~~~~~~~~~~~~~~l~~dG~~~~ 91 (430)
.|.|.|.|+.+|++. +|.+..++|.++..... ++..+ ...+...........+++|..|| ++.
T Consensus 18 ~g~~~l~~q~DGNLv--ly~~~~~vW~s~~~~~~~~~~l~l~~dGnLvl~~~~~~~w~s~t~~~~~~~~l~L~ddG-Nlv 94 (112)
T d1xd5a_ 18 EGGYLFIIQNDCNLV--LYDNNRAVWASGTNGKASGCVLKMQNDGNLVIYSGSRAIWASNTNRQNGNYYLILQRDR-NVV 94 (112)
T ss_dssp ETTEEEEECTTSCEE--EEETTEEEEECCCTTSCSSEEEEECTTSCEEEEETTEEEEECCCCCSCCCCEEEECTTS-CEE
T ss_pred ECCEEEEEcCCCCEE--EEcCCcEEEEccCccCCCCcEEEEeccccEEEEecCCeEEEEeeccCCCceEEEEcCCC-CEE
Confidence 499999999999854 46778899988765422 22221 12222122223345789999999 998
Q ss_pred EEEEeCCCCcEEEEEEecCCCc
Q 047619 92 QFTWDKATQSWELYANVPRDLC 113 (430)
Q Consensus 92 ~~~~~~~~~~W~~~~~~p~~~C 113 (430)
+|. . ...+.|+...+.|
T Consensus 95 ly~--~---~~~~~W~S~t~~~ 111 (112)
T d1xd5a_ 95 IYD--N---SNNAIWATHTNVG 111 (112)
T ss_dssp EEC--T---TSCEEEECCCCCC
T ss_pred EEC--C---CCcEEecCCCccC
Confidence 883 1 2346788777766
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.38 E-value=0.00024 Score=66.70 Aligned_cols=72 Identities=18% Similarity=0.296 Sum_probs=48.6
Q ss_pred eeecccCCcceEEEEEcC--------CcEEEEEEecccChHhHHHHHHHHHHHhcCCCCc-ccceEEEEEeCCEEEEEEE
Q 047619 284 NKLGEGGFGPVYKGTLVD--------GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN-LVKLLGCCIQGEEKLLIYE 354 (430)
Q Consensus 284 ~~ig~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e 354 (430)
+.|+.|-.-.+|++...+ .+.|.+++... . .......+|..+++.+.-.+ .+++++++.. .+|||
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-P-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-C-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-c-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 688888889999998654 34566666543 2 22334567888888875334 4577776632 68999
Q ss_pred ccCCCCh
Q 047619 355 FVPNKSL 361 (430)
Q Consensus 355 ~~~~gsL 361 (430)
|++|..|
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987554
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=97.20 E-value=0.00028 Score=54.16 Aligned_cols=66 Identities=8% Similarity=0.043 Sum_probs=42.1
Q ss_pred CCceEEEEEEcCCCCEEEEEcCCeeEEecCCCCCc-----cc-cCCe---------eEEEEEecCCCcEEEEEEeeccce
Q 047619 25 SPGNFTWAVERQDNPELIMWKGSRKFHRGGPWNGL-----VF-NEDE---------LYYTFDMTDKDVFSRIVMNQTLYV 89 (430)
Q Consensus 25 s~G~~~~~~~~~g~~~~~~~~~~~~y~~sg~~~~~-----~~-~~~~---------~~~~~~~~~~~~~~~~~l~~dG~~ 89 (430)
+.|.|+|.|+.+|++ +++++..++|.++.-... .+ +++. ..+...........+++|++|| +
T Consensus 33 ~~g~y~L~~q~DGNL--vL~~~~~~vW~s~t~~~~~~~~~~l~~~GnLvl~d~~~~~lW~S~t~~~~~~~~l~Lq~DG-n 109 (120)
T d1dlpa2 33 QLSPYRLSMETDCNL--VLFDRDDRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQNIAVWTSGNSRSAGRYVFVLQPDR-N 109 (120)
T ss_dssp BCSSCEEEEETTTEE--EEEBTTBCCSCCCCCSSCSSCEEEEETTTEEEEEETTTEEEEECCCCCSSSCCEEEECSSS-C
T ss_pred EcCCEEEEEcCCCcE--EEecCCcEEEEEccccCCCcEEEEEeCCeeEEEEcCCCCEEEEeCCCCCCCcEEEEECCCC-c
Confidence 789999999999975 456777888987754321 11 1121 1122111222234589999999 9
Q ss_pred EEEE
Q 047619 90 RHQF 93 (430)
Q Consensus 90 ~~~~ 93 (430)
+++|
T Consensus 110 lvlY 113 (120)
T d1dlpa2 110 LAIY 113 (120)
T ss_dssp EEEE
T ss_pred EEEe
Confidence 9998
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=97.06 E-value=0.0009 Score=50.16 Aligned_cols=66 Identities=5% Similarity=0.077 Sum_probs=43.0
Q ss_pred CceEEEEEEcCCCCEEEEEcCCeeEEecCCCCCc-----ccc-CC---------eeEEEEEecCCCcEEEEEEeeccceE
Q 047619 26 PGNFTWAVERQDNPELIMWKGSRKFHRGGPWNGL-----VFN-ED---------ELYYTFDMTDKDVFSRIVMNQTLYVR 90 (430)
Q Consensus 26 ~G~~~~~~~~~g~~~~~~~~~~~~y~~sg~~~~~-----~~~-~~---------~~~~~~~~~~~~~~~~~~l~~dG~~~ 90 (430)
.|.|+|.|+.+|++ ++|++..++|.++..... ++. ++ ...+...........+++|..|| ++
T Consensus 18 ng~~~l~~q~DGNL--vly~~~~~vW~s~~~~~~~~~~l~l~~~Gnlvl~~~~g~~vWsS~t~~~~~~~~l~L~ddG-Nl 94 (108)
T d1jpca_ 18 YGSFVFIMQEDCNL--VLYDVDKPIWATNTGGLSRSCFLSMQTDGNLVVYNPSNKPIWASNTGGQNGNYVCILQKDR-NV 94 (108)
T ss_dssp ETTEEEEECTTSCE--EEEETTEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECCCCCSCSCEEEEECTTS-CE
T ss_pred cCCEEEEECCCCeE--EEEeCCceeeEeCCCCCCCccEEEEeccceEEEECCCccceEEccccCCCCcEEEEEcCCC-CE
Confidence 58999999999985 457888899988865422 111 11 12222222222344678999999 99
Q ss_pred EEEE
Q 047619 91 HQFT 94 (430)
Q Consensus 91 ~~~~ 94 (430)
.+|.
T Consensus 95 Vly~ 98 (108)
T d1jpca_ 95 VIYG 98 (108)
T ss_dssp EEEE
T ss_pred EEeC
Confidence 9983
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.90 E-value=0.0052 Score=55.09 Aligned_cols=156 Identities=15% Similarity=0.052 Sum_probs=78.3
Q ss_pred HHhHHhhcCCcccc-----eeecccCCcceEEEEEcCCcEEEEEEecccChHhHHHHHHHHHHHhcCCCCc-----ccce
Q 047619 270 LATIANATDNFSIN-----NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN-----LVKL 339 (430)
Q Consensus 270 ~~~~~~~~~~~~~~-----~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-----iv~l 339 (430)
.++++....+|.+. +.|..|---+.|+....++ .+++|+.... ...+++..|+.++..|...+ .+..
T Consensus 5 ~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~--~~~~~l~~~~~~l~~L~~~g~pvp~pi~~ 81 (316)
T d2ppqa1 5 EDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPR 81 (316)
T ss_dssp HHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCB
T ss_pred HHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCC--CCHHHHHHHHHHHHhhhhcccccccccee
Confidence 34555556667664 3345666677899886554 5899988642 12234455666666653221 1111
Q ss_pred E---EEEEeCCEEEEEEEccCCCChhHH--------------hh---c---CCCCCCC------------------CHHH
Q 047619 340 L---GCCIQGEEKLLIYEFVPNKSLDSF--------------IF---D---QERCKIL------------------DWSK 378 (430)
Q Consensus 340 ~---~~~~~~~~~~lv~e~~~~gsL~~~--------------l~---~---~~~~~~~------------------~~~~ 378 (430)
. .+.........++.++.+...... ++ . ....... ....
T Consensus 82 ~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (316)
T d2ppqa1 82 KDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKG 161 (316)
T ss_dssp TTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTT
T ss_pred cCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchh
Confidence 0 012234556677777766433110 00 0 0000000 0011
Q ss_pred HHHHHHHHHHHHHHhhh-cCCCcEEeCCCCCCcEEEcCCCCeeecCCCccc
Q 047619 379 RFHIICGTARGVMYLHQ-DSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 428 (430)
Q Consensus 379 ~~~i~~~i~~aL~yLH~-~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGlar 428 (430)
....+..+...+.-.+. .-+.++||+|+.++||+++.+...-|+||+.|-
T Consensus 162 ~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 162 LREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp HHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 11122222222222222 122359999999999999988767899999874
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=96.70 E-value=0.0011 Score=50.30 Aligned_cols=66 Identities=5% Similarity=0.066 Sum_probs=41.3
Q ss_pred CCceEEEEEEcCCCCEEEEEcCCeeEEecCCCCCc-----cccCCe---------eEEEEEecCCCcEEEEEEeeccceE
Q 047619 25 SPGNFTWAVERQDNPELIMWKGSRKFHRGGPWNGL-----VFNEDE---------LYYTFDMTDKDVFSRIVMNQTLYVR 90 (430)
Q Consensus 25 s~G~~~~~~~~~g~~~~~~~~~~~~y~~sg~~~~~-----~~~~~~---------~~~~~~~~~~~~~~~~~l~~dG~~~ 90 (430)
..|.|+|.|+.+|++. ++++...||.+++-... +.+++. ..+...........+++|+.|| ++
T Consensus 24 ~~g~~~l~~q~DGNLv--L~~~~~~vW~s~t~~~~~~~l~l~~dGNLvl~d~~~~~vWsS~t~~~~g~y~l~Lq~DG-Nl 100 (115)
T d1dlpa1 24 ELSSFRFTMQSDCNLV--LFDSDVRVWASNTAGATGCRAVLQSDGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDR-TV 100 (115)
T ss_dssp CSTTEEEEECTTSCEE--EEESSSEEECCCCCSCSCCBCCBCSSSCBCCBCTTTCCSCCCCCCCCSSCCEEEECSSS-CE
T ss_pred EcCCEEEEECCCCeEE--EEcCCeeEEEcccCCCCceEEEEeccCCEEEEccCCCEEEEcCCCCCCCCEEEEECCCC-cE
Confidence 4689999999999854 46778899998754221 111221 1111111122234579999999 99
Q ss_pred EEE
Q 047619 91 HQF 93 (430)
Q Consensus 91 ~~~ 93 (430)
.+|
T Consensus 101 vlY 103 (115)
T d1dlpa1 101 TIY 103 (115)
T ss_dssp EEE
T ss_pred EEe
Confidence 988
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=96.29 E-value=0.0066 Score=45.26 Aligned_cols=65 Identities=6% Similarity=0.004 Sum_probs=40.8
Q ss_pred CceEEEEEEcCCCCEEEEEcCCeeEEecCCCCCc------ccc-CCe---------eEEEEEecCCCcEEEEEEeeccce
Q 047619 26 PGNFTWAVERQDNPELIMWKGSRKFHRGGPWNGL------VFN-EDE---------LYYTFDMTDKDVFSRIVMNQTLYV 89 (430)
Q Consensus 26 ~G~~~~~~~~~g~~~~~~~~~~~~y~~sg~~~~~------~~~-~~~---------~~~~~~~~~~~~~~~~~l~~dG~~ 89 (430)
.|.|+|.|+.+|++. ++.+..++|.++.-... .+. ++. ..+.-....+..-.+++|..|| +
T Consensus 18 ~g~~~l~~q~dgnLv--l~~~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~s~t~~~~~~~~l~L~ddG-N 94 (109)
T d1kj1a_ 18 VEPYHFIMQEDCNLV--LYDHSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDG-N 94 (109)
T ss_dssp ETTEEEEECTTSCEE--EEETTEEEEECCCCCTTCCCCEEEECTTSCEEEECSSSCEEEECCCCCCSSCCEEEECTTS-C
T ss_pred eCCEEEEecCCCeEE--EEeCCEEEEEeCCCCCCceeEEEEEcCCceEEEEeCCCcEEEEEeeECCCCCEEEEEeCCC-c
Confidence 589999999999854 45678889987653211 111 222 2221112222334589999999 9
Q ss_pred EEEE
Q 047619 90 RHQF 93 (430)
Q Consensus 90 ~~~~ 93 (430)
+.+|
T Consensus 95 lvly 98 (109)
T d1kj1a_ 95 VVIY 98 (109)
T ss_dssp EEEE
T ss_pred EEEE
Confidence 9988
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=94.85 E-value=0.011 Score=44.41 Aligned_cols=37 Identities=16% Similarity=0.355 Sum_probs=30.0
Q ss_pred EEcCCCCCCCCceEEEEEEcCCCCEEEEEcCCeeEEecCCC
Q 047619 16 TSWKSPDDPSPGNFTWAVERQDNPELIMWKGSRKFHRGGPW 56 (430)
Q Consensus 16 ~S~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~y~~sg~~ 56 (430)
+-|.|.++.++|.|.|.|+++|+..+ | +..+|.+|+-
T Consensus 77 ~vWsS~t~~~~g~y~l~Lq~DGNlvl--Y--~~~~Wssgt~ 113 (115)
T d1dlpa1 77 IRWSSGTKGSIGNYVLVLQPDRTVTI--Y--GPGLWDSGTS 113 (115)
T ss_dssp CSCCCCCCCCSSCCEEEECSSSCEEE--E--CSEEEECSCC
T ss_pred EEEEcCCCCCCCCEEEEECCCCcEEE--e--CCCeecCCCC
Confidence 34899999999999999999998544 4 3479998863
|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.56 E-value=0.0078 Score=33.77 Aligned_cols=32 Identities=34% Similarity=0.760 Sum_probs=25.5
Q ss_pred CCCcccCCcccCceeeecC-CCCccccCCCcccC
Q 047619 110 RDLCDTYALCGDYGICIIS-DTPFCQCLKGFKPK 142 (430)
Q Consensus 110 ~~~C~~~~~CG~~~~C~~~-~~~~C~C~~gf~~~ 142 (430)
.|+|.+-..||. |-|+.- +.-.|.|-.||+|.
T Consensus 1 tdECsignpCGn-GTCtNviGgFec~C~~GFepg 33 (39)
T d1emoa2 1 TDECSVGNPCGN-GTCKNVIGGFECTCEEGFEPG 33 (39)
T ss_dssp CCGGGTTCSSSS-SCEEECSSSEEECCSSSSCCC
T ss_pred CCccccCCccCC-ceeeecccceEEeecCCcCCC
Confidence 478999999995 789653 34579999999984
|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.72 E-value=0.039 Score=32.99 Aligned_cols=31 Identities=35% Similarity=0.760 Sum_probs=24.3
Q ss_pred CCccc-CCcccCceeeecC-CCCccccCCCccc
Q 047619 111 DLCDT-YALCGDYGICIIS-DTPFCQCLKGFKP 141 (430)
Q Consensus 111 ~~C~~-~~~CG~~~~C~~~-~~~~C~C~~gf~~ 141 (430)
|+|.. ...|..+|.|... +.-.|.|++||+-
T Consensus 4 deC~~~~~pC~n~g~C~n~~g~y~C~C~~G~~G 36 (42)
T d2vj3a1 4 DECSLGANPCEHAGKCINTLGSFECQCLQGYTG 36 (42)
T ss_dssp CTTTSSSCSSSTTCEEEECSSSEEEECCTTEES
T ss_pred ccccCCCCCCCCCcEeECCCCCEEeECCCCCcC
Confidence 56775 4789999999764 3458999999974
|
| >d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor X, N-terminal module species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.54 E-value=0.1 Score=30.40 Aligned_cols=31 Identities=35% Similarity=0.806 Sum_probs=23.2
Q ss_pred CCcccCCcccCceeeecC-CCCccccCCCcccC
Q 047619 111 DLCDTYALCGDYGICIIS-DTPFCQCLKGFKPK 142 (430)
Q Consensus 111 ~~C~~~~~CG~~~~C~~~-~~~~C~C~~gf~~~ 142 (430)
|+|. ...|...|.|... ..-.|.|++||+-.
T Consensus 1 D~C~-~~PC~ngg~C~~~~~~y~C~C~~G~~G~ 32 (39)
T d1xkba1 1 DQCE-TSPCQNQGKCKDGLGEYTCTCLEGFEGK 32 (39)
T ss_dssp CTTT-TCCCCSSCEECCCSSSCCEECCTTEETT
T ss_pred CcCC-CCCCCCCcEEECCCCCEEEECCCCCCcC
Confidence 4565 4678889999764 45689999999753
|
| >d1uzka1 g.3.11.1 (A:1486-1528) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=87.59 E-value=0.085 Score=31.58 Aligned_cols=31 Identities=23% Similarity=0.574 Sum_probs=23.6
Q ss_pred CCcccCCcccCceeeecC-CCCccccCCCcccC
Q 047619 111 DLCDTYALCGDYGICIIS-DTPFCQCLKGFKPK 142 (430)
Q Consensus 111 ~~C~~~~~CG~~~~C~~~-~~~~C~C~~gf~~~ 142 (430)
|+|.....| -.+.|... ++-.|.|++||+..
T Consensus 4 dEC~~~~~~-c~~~C~Nt~G~y~C~C~~Gy~l~ 35 (43)
T d1uzka1 4 NECLDPTTC-ISGNCVNTPGSYICDCPPDFELN 35 (43)
T ss_dssp CGGGSTTSS-BTSEEEEETTEEEEECCTTCEEC
T ss_pred cccCCCCcC-cCCEeECCCCCEEEecCCCCEEC
Confidence 678877666 57899653 45689999999874
|
| >d1lmja1 g.3.11.1 (A:3-46) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=87.05 E-value=0.15 Score=30.63 Aligned_cols=31 Identities=29% Similarity=0.735 Sum_probs=22.5
Q ss_pred CCcccC-CcccCceeeecC-CCCccccCCCcccC
Q 047619 111 DLCDTY-ALCGDYGICIIS-DTPFCQCLKGFKPK 142 (430)
Q Consensus 111 ~~C~~~-~~CG~~~~C~~~-~~~~C~C~~gf~~~ 142 (430)
|+|... ..| .++.|... ++-.|.|++||+..
T Consensus 4 dEC~~~~~~C-~~~~C~Nt~Gsy~C~C~~Gy~~~ 36 (44)
T d1lmja1 4 DECRISPDLC-GRGQCVNTPGDFECKCDEGYESG 36 (44)
T ss_dssp CTTTTCSSTT-TTSCEEEETTEEEECCCSSEEEC
T ss_pred cccCCCCCCC-CCCEeEcCCCCeEEeCCCCCccC
Confidence 678764 456 47899653 45689999999864
|
| >d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=87.00 E-value=0.19 Score=29.99 Aligned_cols=31 Identities=26% Similarity=0.491 Sum_probs=23.2
Q ss_pred CCCcccCCcccCceeeecC-CCCccccCCCccc
Q 047619 110 RDLCDTYALCGDYGICIIS-DTPFCQCLKGFKP 141 (430)
Q Consensus 110 ~~~C~~~~~CG~~~~C~~~-~~~~C~C~~gf~~ 141 (430)
-|+|.... |+.++.|... ++-.|.|++||+.
T Consensus 5 idEC~~~~-~~~~~~C~Nt~Gsy~C~C~~Gy~~ 36 (43)
T d1emoa1 5 MDECKEPD-VCKHGQCINTDGSYRCECPFGYIL 36 (43)
T ss_dssp CCSSSSTT-SCSSSCCCCCSSCCCCCCCTTEEE
T ss_pred eeccCCcC-CCCCCEeECCCCCeEeECCCCccc
Confidence 47887654 5578899654 4568999999985
|
| >d2vj3a2 g.3.11.1 (A:453-491) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.36 E-value=0.2 Score=29.17 Aligned_cols=31 Identities=19% Similarity=0.544 Sum_probs=22.7
Q ss_pred CCcccCCcccCceeeecC-CCCccccCCCcccC
Q 047619 111 DLCDTYALCGDYGICIIS-DTPFCQCLKGFKPK 142 (430)
Q Consensus 111 ~~C~~~~~CG~~~~C~~~-~~~~C~C~~gf~~~ 142 (430)
|+|. ...|...|.|... +.-.|.|++||+-.
T Consensus 2 d~C~-~~PC~n~g~C~~~~~~y~C~C~~G~~G~ 33 (39)
T d2vj3a2 2 NECV-SNPCQNDATCLDQIGEFQCICMPGYEGV 33 (39)
T ss_dssp CTTT-TCCCCSSCEEEECSSCEEEECCTTEESS
T ss_pred cCCc-CCCCCCCCEEECCCCCEEEeCCCCCccC
Confidence 4554 3568899999764 34589999999753
|
| >d1i0ua2 g.3.11.1 (A:42-82) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Low density lipoprotein (LDL) receptor, different EGF domains species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.96 E-value=0.22 Score=29.30 Aligned_cols=30 Identities=30% Similarity=0.675 Sum_probs=22.4
Q ss_pred CCcccCCcccCceeeecC-CCCccccCCCcccC
Q 047619 111 DLCDTYALCGDYGICIIS-DTPFCQCLKGFKPK 142 (430)
Q Consensus 111 ~~C~~~~~CG~~~~C~~~-~~~~C~C~~gf~~~ 142 (430)
|+|...+.| ..+|... ++-.|.|++||...
T Consensus 2 dEC~~~~~C--~~~C~n~~Gsy~C~C~~Gy~L~ 32 (41)
T d1i0ua2 2 DECQDPDTC--SQLCVNLEGGYKCQCEEGFQLD 32 (41)
T ss_dssp CTTTTTTSC--SSCEECSSSCCEECCCTTEEEC
T ss_pred ccCCCCCCC--CCEeECCCCCEEeECCCCCeEC
Confidence 678777777 3589654 45689999999864
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=85.43 E-value=0.18 Score=37.74 Aligned_cols=37 Identities=5% Similarity=0.109 Sum_probs=19.9
Q ss_pred cCCCCCCCCceEEEEEEcCCCCEEEEEcC-CeeEEecCCC
Q 047619 18 WKSPDDPSPGNFTWAVERQDNPELIMWKG-SRKFHRGGPW 56 (430)
Q Consensus 18 ~~s~~dps~G~~~~~~~~~g~~~~~~~~~-~~~y~~sg~~ 56 (430)
|.+.+.-......+.|+.+|+..+ ++. ....|.|+..
T Consensus 57 W~s~t~~~~~~~~~~l~~~GnLvl--~d~~~~~lW~S~t~ 94 (120)
T d1dlpa2 57 WSTNTAGKGTGCRAVLQPNGRMDV--LTNQNIAVWTSGNS 94 (120)
T ss_dssp SCCCCCSSCSSCEEEEETTTEEEE--EETTTEEEEECCCC
T ss_pred EEEccccCCCcEEEEEeCCeeEEE--EcCCCCEEEEeCCC
Confidence 555443222235677777775433 343 4567777754
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=85.23 E-value=0.34 Score=36.05 Aligned_cols=37 Identities=3% Similarity=0.013 Sum_probs=21.8
Q ss_pred cCCCCCCCCceEEEEEEcCCCCEEEEEcC-CeeEEecCCC
Q 047619 18 WKSPDDPSPGNFTWAVERQDNPELIMWKG-SRKFHRGGPW 56 (430)
Q Consensus 18 ~~s~~dps~G~~~~~~~~~g~~~~~~~~~-~~~y~~sg~~ 56 (430)
|.+.+......-.+.++.+|++ +++++ ....|+++..
T Consensus 52 Wssnt~~~~~~~~l~l~~dGnL--vL~d~~g~~vWsS~t~ 89 (119)
T d1b2pa_ 52 WATNTGGLGNGCRAVLQPDGVL--VVITNENVTVWQSPVA 89 (119)
T ss_dssp EECCCTTSCSSCEEEECTTSCE--EEECTTCCEEEECSCC
T ss_pred EEecCCCCCcceEEEEEeCCCE--EEECCCCcEEEECCCc
Confidence 6655543322356888888864 34455 4577877653
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=85.04 E-value=0.38 Score=35.11 Aligned_cols=37 Identities=11% Similarity=0.188 Sum_probs=25.0
Q ss_pred cCCCC-CCCCceEEEEEEcCCCCEEEEEcC-CeeEEecCCC
Q 047619 18 WKSPD-DPSPGNFTWAVERQDNPELIMWKG-SRKFHRGGPW 56 (430)
Q Consensus 18 ~~s~~-dps~G~~~~~~~~~g~~~~~~~~~-~~~y~~sg~~ 56 (430)
|.+.+ +|.....++.|+.+|++ ++++. ..+.|++++-
T Consensus 41 W~ant~~~~~~~~~l~l~~dGnL--vl~~~~g~~vW~s~t~ 79 (109)
T d1kj1a_ 41 WASNTGILGKKGCKAVLQSDGNF--VVYDAEGRSLWASHSV 79 (109)
T ss_dssp EECCCCCTTCCCCEEEECTTSCE--EEECSSSCEEEECCCC
T ss_pred EEeCCCCCCceeEEEEEcCCceE--EEEeCCCcEEEEEeeE
Confidence 65544 45555678999999964 44554 5678988764
|
| >d1edmb_ g.3.11.1 (B:) Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor IX (IXa) species: Human (Homo sapiens) [TaxId: 9606]
Probab=84.54 E-value=0.19 Score=29.25 Aligned_cols=32 Identities=31% Similarity=0.582 Sum_probs=24.3
Q ss_pred CCCcccCCcccCceeeecC-CCCccccCCCcccC
Q 047619 110 RDLCDTYALCGDYGICIIS-DTPFCQCLKGFKPK 142 (430)
Q Consensus 110 ~~~C~~~~~CG~~~~C~~~-~~~~C~C~~gf~~~ 142 (430)
.|+|. ...|-..|.|... +.-.|.|++||+-.
T Consensus 3 ~d~C~-~~PC~ngg~C~~~~~~y~C~C~~g~~G~ 35 (39)
T d1edmb_ 3 GDQCE-SNPCLNGGSCKDDINSYECWCPFGFEGK 35 (39)
T ss_dssp CCTTT-TCCCCTTCEEEEETTEEEEECCTTCCST
T ss_pred cccCC-CCCCCCCcEEEcCCCCEEEECCCCCCCC
Confidence 46776 4779999999654 45689999999743
|
| >d1dx5i2 g.3.11.1 (I:388-422) Thrombomodulin, different EGF-like domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Thrombomodulin, different EGF-like domains species: Human (Homo sapiens) [TaxId: 9606]
Probab=83.65 E-value=0.21 Score=27.23 Aligned_cols=18 Identities=22% Similarity=0.567 Sum_probs=13.6
Q ss_pred eeecCCCCccccCCCccc
Q 047619 124 ICIISDTPFCQCLKGFKP 141 (430)
Q Consensus 124 ~C~~~~~~~C~C~~gf~~ 141 (430)
.|+.+....|+||.||-.
T Consensus 11 dCdP~~p~~C~CPeGyIl 28 (35)
T d1dx5i2 11 DCDPNTQASCECPEGYIL 28 (35)
T ss_dssp EECTTSTTCEECCTTEEE
T ss_pred ccCCCCCCcccCCCceEe
Confidence 355555678999999965
|
| >d1lmja2 g.3.11.1 (A:47-88) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=82.64 E-value=0.19 Score=29.76 Aligned_cols=31 Identities=29% Similarity=0.655 Sum_probs=21.9
Q ss_pred CCccc-CCcccCceeeecC-CCCccccCCCcccC
Q 047619 111 DLCDT-YALCGDYGICIIS-DTPFCQCLKGFKPK 142 (430)
Q Consensus 111 ~~C~~-~~~CG~~~~C~~~-~~~~C~C~~gf~~~ 142 (430)
|+|.. .+.|. +++|... ++-.|.|++||.+.
T Consensus 3 dEC~~~~~~C~-~~~C~Nt~Gsy~C~C~~Gy~l~ 35 (42)
T d1lmja2 3 DECQRDPLLCR-GGVCHNTEGSYRCECPPGHQLS 35 (42)
T ss_dssp CHHHHCSSTTT-TSEEEEETTEEEEESCTTSCCC
T ss_pred cccCCCCCCCC-CCEeECCCCCeEEeCCCCCeEC
Confidence 45544 56674 7899654 45589999999864
|
| >d3egfa_ g.3.11.1 (A:) Epidermal growth factor, EGF {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Epidermal growth factor, EGF species: Mouse (Mus musculus) [TaxId: 10090]
Probab=81.72 E-value=0.49 Score=29.48 Aligned_cols=28 Identities=25% Similarity=0.661 Sum_probs=22.0
Q ss_pred cCCcccCceeeec---CCCCccccCCCcccC
Q 047619 115 TYALCGDYGICII---SDTPFCQCLKGFKPK 142 (430)
Q Consensus 115 ~~~~CG~~~~C~~---~~~~~C~C~~gf~~~ 142 (430)
..+.|...|.|.. .....|.|++||.-.
T Consensus 10 ~~~~C~NgG~C~~~~~~~~~~C~C~~gy~G~ 40 (53)
T d3egfa_ 10 YDGYCLNGGVCMHIESLDSYTCNCVIGYSGD 40 (53)
T ss_dssp SSCCSCSSCEEEEESSSSCEEEECCTTCCSS
T ss_pred CCCCCCCCcEeeccCCCCCeEeECCCCCcCC
Confidence 4678999999964 235789999999754
|
| >d1gl4a2 g.3.11.5 (A:359-398) EGF-like domain of nidogen-1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-like domain of nidogen-1 domain: EGF-like domain of nidogen-1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=81.36 E-value=0.23 Score=29.02 Aligned_cols=25 Identities=16% Similarity=0.398 Sum_probs=19.4
Q ss_pred CcccCceeeecC-CCCccccCCCccc
Q 047619 117 ALCGDYGICIIS-DTPFCQCLKGFKP 141 (430)
Q Consensus 117 ~~CG~~~~C~~~-~~~~C~C~~gf~~ 141 (430)
..|.+++.|... ++-.|.|.+||.-
T Consensus 7 ~~C~~~A~C~Nt~Gsy~C~C~~Gy~G 32 (40)
T d1gl4a2 7 HQCSVHAECRDYATGFCCRCVANYTG 32 (40)
T ss_dssp GGSCTTEEEEECSSCEEEEECTTEEE
T ss_pred CCCCCCCEeecCCCCeEeECCCCCcC
Confidence 468899999754 3457999999974
|
| >d2vj3a3 g.3.11.1 (A:492-526) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=80.86 E-value=0.35 Score=27.28 Aligned_cols=29 Identities=28% Similarity=0.650 Sum_probs=21.3
Q ss_pred CcccCCcccCceeeecC-CCCccccCCCccc
Q 047619 112 LCDTYALCGDYGICIIS-DTPFCQCLKGFKP 141 (430)
Q Consensus 112 ~C~~~~~CG~~~~C~~~-~~~~C~C~~gf~~ 141 (430)
+|. ...|...|.|... ..-.|.|++||+-
T Consensus 2 ~C~-~~PC~ngg~C~~~~~~y~C~C~~g~~G 31 (35)
T d2vj3a3 2 ECA-SSPCLHNGRCLDKINEFQCECPTGFTG 31 (35)
T ss_dssp TTT-TCCSTTTCEEEECSSCEEEECCTTEES
T ss_pred CCC-CCCCCCCcEEECCCCCeEEECCCCCCC
Confidence 453 4668888999654 3568999999974
|
| >d1g1ta2 g.3.11.1 (A:119-157) E-selectin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: E-selectin, EGF-domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=80.74 E-value=0.2 Score=29.14 Aligned_cols=31 Identities=26% Similarity=0.661 Sum_probs=22.7
Q ss_pred CCcccCCcccCceeeecC-CCCccccCCCcccC
Q 047619 111 DLCDTYALCGDYGICIIS-DTPFCQCLKGFKPK 142 (430)
Q Consensus 111 ~~C~~~~~CG~~~~C~~~-~~~~C~C~~gf~~~ 142 (430)
+.|. ...|...|.|... +...|.|++||.-.
T Consensus 2 ~~C~-~~pC~ngg~C~~~~~~~~C~C~~g~~G~ 33 (39)
T d1g1ta2 2 AACT-NTSCSGHGECVETINNYTCKCDPGFSGL 33 (39)
T ss_dssp CCCC-TTGGGGSEEEEEETTEEEEEECTTEEST
T ss_pred Cccc-CCcCCCCcEEECCCCCEEEeCCCCCcCc
Confidence 3454 4678899999654 45679999999753
|